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A B S TRA C T
Glycoconjugates are widespread in nature and have been implicated
in a variety of biological functions including energy source,
protection, lubrication, structural support, cell adhesion, molecular
and cellular recognition and receptors for hormones and viruses. In
this thesis studies on the following glycoconjugates are presented;
ovine submaxillary mucin, human respiratory mucins (normal and
bronchial asthmatic), keratan sulfates (bovine cornea, human skeletal
cartilage and chick allantoic fluid), human follicle-stimulating
hormone and the glycoproteins and glycosaminoglycans of a variety
of normal and cancer cells. The information obtained on the structures
of these complex carbohydrate molecules is of value in understanding
the biosynthesis, degradation, structure-function relationships and
the changes in theLse macromolecules in disease. Studies on animal
neuraminidases, an endoglycosidase and a lectin, all of which are
important tools in the investigation of glycoconjugates, are also
described.
The carbohydrate prosthetic group of ovine submaxillary mucin,
consisting of N-acetylneuraminyl a2->6 N-acetylgalactosamine, was
shown to be linked to serine and threonine and not to aspartic acid
or glutamic acid as previously believed. The human respiratory
mucins were shown to consist of a complex series of oligosaccharides
composed of galactose, fucose, glucosamine, galactosamine and sialic
acid. The high apparent molecular weight of the glycopeptides derived
from the respiratory mucins could be due to clustering of the
oligosaccharides on the peptide core. Our finding of the non-covalent
association of lipids with the supposedly hydrophilic tracheobronchial
mucins, suggests a role for the mucins in the clearing of lipids from
the trachea. A new endoglycosidase capable of hydrolysing the
O-glycosidic linkage between ct-N-acetylgalactosamine and serine
and threonine in mucins was isolated from Diplococcus pneumoniae
culture filtrate and characterized. Among other uses, this
enzyme became invaluable in the structural investigation of the
mucin -type glycoproteins of cancer cells and in the elucidation
of the antigenic determinant of epiglycanin.
The extensive studies on keratan sulfates led to the elucidation
of several interesting and new structural features such as the
sulfation of galactose, the presence of small amounts of mannose
and the insolubility of the desulfated polysaccharide. Subsequently,
this information was utilized by other researchers to understand the
abnormal metabolism of keratan sulfate in diseases such as Marfan's
syndrome and macular corneal dystrophy. Our discovery of the
presence of glycosaminoglycans in animal cell nuclei was a surprise
since these molecules have previously been considered secretory
products found in the extracellular matrix. Several investigators
have since confirmed the association of glycosaminoglycans with
the nuclei. We have investigated the possibility that these
molecules may also serve intracellular (for example, regulatory
or modulatory) functions in addition to their accepted extracellular
functions. Experiments designed to test the influence of anionic
polysaccharides on endogenous DNA synthesis have yielded several
provoking results. For example, concentrations of heparin,
chondroitin sulfate H and heparan sulfate which stimulated DNA
synthesis in normal cell nuclei inhibited DNA synthesis in cancer
cell nuclei. It was found that this differential effect was
dependent on the molecular size, charge (degree of sulfation)
and other structural features of the polysaccharides.
A new sensitive radioisotopic assay for neuraminidases was
developed as part of our investigations on mammalian neuraminidases.
A neuraminidase capable of acting on sialoglycoproteins but not
gangliosides was detected in Golgi apparatus. The presence of this
degradative enzyme in an organelle involved in biosynthesis suggests
that it may be involved in processing of the newly synthesized
glycoconjugates.
The wheat germ agglutinin, which was previously believed to be
specific for N- acetylglucosaminyl residues was shown to be able
to interact specifically with N-acetylneuraminyl and multiple
N-acetylgalactosaminyl residues as well. On this basis we proposed
that in the interaction between cell surface and wheat germ agglutinin,
the non-reducing terminal sialic acid residues of glycoproteins and
glycolipids play a more important role rather than the usually
internal glucosamine residues. The new information has been very
helpful in understanding the differential interaction of this lectin
with normal and malignant cells and in the use of this lectin to
select for non-tumorigenic and non-metastatic cell clones.
Over a period of ten years, extensive studies have been carried out
to biochemically and immunologically characterize the glycosaminoglycans
and glycoproteins derived from mouse melanoma, human melanoma, Morris
hepatoma and appropriate control (non-malignant) cells. Chondroitin
sulfate with properties distinct from those of the connective tissue
counterpart was isolated from mouse melanoma cells. It was also
observed that the heparan sulfates produced by cancer cells had a
lower degree of sulfation compared to those produced by normal cells.
A murine melanoma-associated antigen was purified and its glycoprotein
structure established. A most important finding was the production
of markedly increased quantities of mucin-type glycoproteins by
a variety of tumorigenic cells compared to non-tumorigenic cells.
The mucin-type glycoprotein from human melanoma cells was purified
to homogeneity and partially characterized. A review by us on cell
surface glycoprotein markers in neoplasia has been published. The
research which is presently being carried out indicates that a new
human cancer marker recently described (The Lancet, 3 July 1982, p.l.)
is also a mucin-type glycoprotein.
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In recent years a considerable amount of information on
the molecular structure of glycoproteins has been pub¬
lished. Little is known, however, on the biosynthesis of
these compounds and no information is available on the
enzymic breakdown of glycoproteins to their individual
constituents. In the present paper the purification and
properties of a B-N-acetylhexosaminidase and its action
on glycopeptides containing O-seryl and O-tkreonyl linked
N-acetylgalactosamine are described.
EXPERIMENTAL AND RESULTS
Purification and Properties of B-N-Acetylhexosaminidase
The purification of the enzyme present in bovine
spleen homogenates was carried out by fractional precipi¬
tation with ammonium sulfate (crude enzyme) followed by
chromatography on TEAE and CM Cellulose columns (highly
purified enzyme). The anomeric specificity of the enzyme
was shown to be of th.e B-type. Several natural and syn¬
thetic glycosides were found to be substrates for the
enzyme (see also Weissmann et al., 1964). The K values x
3 m10 for B-phenyl-N-acetyl-D-glucosaminide, B-phenyl-N-
acetyl-D-galactosaminide and B-p-nitrophenyl-N-acetyl-D-
glucosaminide were 2.0, 1.1 and 1.4 respectively. The
enzyme requires for its activity a terminal non-reducing
On leave from the Oklahoma Medical Research Institute,
Oklahoma City, Oklahoma, U. S. A.
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N-acetylhexosamine residue. The increase in specific ac¬
tivity, referred to the homogenate as unity, was 42 fold
for the crude enzyme and 20 000 fold for the highly puri¬
fied enzyme.
Preparation and Properties of Glycopeptides from OSM
Ovine submaxillary gland glycoprotein (OSM) was pre¬
pared as previously described (Graham and Gottschalk,
1960) with the modification that the precipitation of
glycoproteins and proteins to be discarded was carried
out at pH 4.5 instead of pH 4.0. Yield 5$ of the dry
weight of the glands. The compound displayed a single and
almost symmetrical peak in the analytical centrifuge. It
contained about 40$ carbohydrate (as residues) consisting
of equimolar amounts of N-acetylneuraminic acid and N-
acetylgalactosamine. 250 mg OSM was exhaustively treated
with Pronase and the digest fractionated on a Sephadex
G25 column. The pooled fractions of the sialoglycopeptide
peak reacting with both ninhydrin and resorcinol were
submitted to neuraminidase action and the enzyme was re¬
moved by a second passage through a Sephadex G25 column.
The sialic acid-free glycopeptides were separated from
sialic acid on a Towex I-X2 (formate form) column and the
effluent was concentrated to dryness. Yield about 50 mg
containing 50$ of the galactosamine of OSM. On the Dowex
I column about 35$ of the applied glycopeptides, ex¬
pressed in terms of galactosamine, were retained. The
quantitative analysis of the glycopeptide fraction is
shown in Table I. The near lack of dicarboxylic acids in
the glycopeptide fraction (OSM contains 0.84 moles di¬
carboxylic acids/mole galactosamine) would indicate that
a considerable amount of the glycopeptides, applied to
the Dowex I column, contained aspartyl and glutamyl re¬
sidues with unsubstituted B- and y-carboxyl groups re¬
spectively and were therefore retained on the column. In
fact, when the column was eluted with 2 N acetic acid,
analysis of the eluate showed the presence of 20$ of the
total dicarboxylic acids. Another 58$ of dicarboxylic
acids was found in the pool of free amino acids and
small peptides emerging from the first Sephadex column
354
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Table I. Amino acid composition of glycopeptide fraction
(expressed in moles per 1 mole of galactosamine)
Aspartic acid 0.03 Proline 0.36
Glutamic acid 0.08 Glycine 0.56
Serine 0.62 Alanine 0.30
Threonine 0.67 Valine 0.17
lysine 0.01 Leucine 0.07
Arginine 0.09
after the sialoglycopeptide peak. The average molecular
weight of the glycopeptides was about 660 (potentio-
metric titration) and the molar ratio amino acids/hex-
osamine (after hydrolysis of the glycopeptides) was
found to be 3-3. These data would indicate that on an
average the glycopeptides were tetrapeptides with 1.3
residues of ^-acetylgalactosamine attached.
Type of Linkage between ^-Acetylgalactosamine and Peptide
It is evident from Table I that in the glycopeptides
only serine and threonine are conceivable as sugar accep¬
tors. On treatment of the glycopeptide fraction with 0.5
N NaOH at 0° for 20 hr (see Anderson et_ al. , 1963) fol¬
lowed by acid hydrolysis, only 504yUmoles of serine and
576 ^moles of threonine were recovered from 900 and 960
^moles of serine and threonine respectively present in
1 gram of untreated glycopeptide, whereas the other amino
acids were recovered quantitatively. When the experiment
was extended to 68 hr, 456 and 475^umoles of serine and
threonine respectively were recovered. The combined loss
of 929yumoles of serine and threonine coincided with the
appearance of 900yiimoles of free N-acetylhexosamine in
the assay prior to acid hydrolysis. When Dl-seryl-glycyl-
glycinamide and L-seryl-leuqyl-leucine were treated
similarly, the losses of serine did not exceed 10$.
These data can only be interpreted as resulting from
B-elimination of N-acetylhexosamine residues linked
0-glycosidically to the h.ydroxyl groups of peptide-bonded
serine and threonine residues.
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Enzymic Degradation of Glycopeptide3
When the glycopeptides were treated with crude enzyme
added in portions (0.025 M citrate buffer, pH 4.3, 37°),
40.0, 75.9 and 94.7$ of the total hexosamine were re¬
leased after 48, 96 and 144 hr respectively*, paper
chromatography of the digest revealed in addition to
free ^-acetylgalactosamine all the amino acids listed
in Table I. The presence of peptides in the digest freed
from proteins was seen from a 40$ increase of the nin-
hydrin value (corrected for hexosamine) after acid
hydrolysis of the digest. The highly purified enzyme
released under same conditions 6.7, 9-8 and 13.2$ re¬
spectively of the total hexosamine. Prom sialoglycopep-
tides only 4.5 and 6.5$ of hexosamine were split off
after 54 and 97 hr incubation respectively with the
crude enzyme.
DISCUSSION
These results indicate that in OSM, as prepared above,
at least 50$ of the total hexosamine is linked B-0-
glycosidically to the OH-groups of seryl and threonyl
residues of the peptide and that this linkage is suscep¬
tible to N-acetylhexosaminidase. The enzymic cleavage
takes place only after removal of sialic acid and after
shortening of the glycotetrapeptide by at least one or
two amino acid residues. The shortening is effected by
peptidases the presence of which in the crude enzyme was
also evidenced by its action at pH 4.3 on L-seryl-L-
leucyl-L-leucine. This type of peptidases is quite
distinct from the known exopeptidases. The occurrence
of these peptidases and B-N-acetylhexosaminidase in the
same tissue and their activity at the same pH favours
the view that the sequence of reactions shown in the
diagram may be the physiological degradation mechanism.
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GalNAc-Peptides + N-acetylneuraminic acid
(Glycopeptides)
j PEPTIDASES
O-Seryl-N-Acetylgalactosaminide + amino acids
j B-N-ACETYLGALACTOSAMINIDASE
Serine + N-acetylgalactosamine
A similar scheme would hold for O-threonyl-N-acetyl-
galactosaminide.
The relative proportion of glycosidic-ester linkages
(Graham et al., 1963) and O-seryl (threonyl)-glycosidic
linkages in various OSM preparations is at present under
investigation.
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SUMMARY
Ovine submaxillary glycoprotein (OSM) was digested exhaustively with pronase
and the sialoglycopeptides separated by gel filtration. By subsequent neuraminidase
(EC 3.2.1. iS) treatment and further purification, glycopeptides of average molecular
weight (160 and containing 50% of the total galactosamine of OSM were obtained.
Serine and threonine were the only amino acids with a functional group in the side
chain present in a concentration high enough to accommodate all nexosamine
residues. Treatment of the glycopeptides with 0.5 X XaOH at o' or 22° resulted in
the release of A'-acetylgalactosamine coincident with the loss of an equimolecular
amount of hydroxyamino acids. Most likely the carbohydrate was released by the
mechanism of /Lcarbonyl elimination. Some evidence for the formation of an un¬
saturated compound, presumable a-aminoacrylic acid, was afforded spectrophoto-
metrically.
It is concluded that in OSM at least 50% of the prosthetic groups are joined
glycosidically to the hydroxyl groups of serine and threonine.
When native OSM was treated at pH 8.0 and 420 for 120 h, about one-third
of the prosthetic groups was released. After this treatment the isolated, non-dialyzable
residual glycoprotein reacted strongly positive in the Warren test. The mechanism
of the reaction is discussed.
INTRODUCTION
Some evidence suggesting the presence in glycoproteins of animal origin of
0-glvcosidic linkages involving the hvdroxvl groups of serine and threonine residues
was presented in 1962 from the laboratories of Blix, Gottschalk and Pigman. In the
former laboratories OSM was used for the investigation. This glycoprotein contains
Abbreviations: OSM, ovine submaxillary gland glycoprotein: NANA. .Y-acetvlneuraminic
acid.
* On leave from the Oklahoma Medical Research Institute, Oklahoma City, Okla. (U.S.A.).
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several hundred prosthetic groups of the structure iV-acetylneuraminyl (2 -> 6) N-
acetylgalactosanune1. Murphy2 submitted OSM, pretreated with 0.01 N NaOH at 8oc
for 4 h, to hydrazinolysis. The resulting mixture of glvcopeptide hydrazides was frac¬
tionated bv high-voltage paper-electrophoresis and further by ion-exchange column
chromatography. By this procedure a glycopeptide, containing 2% (w/w) of the ga-
lactosamine of native OSM, was isolated; it yielded on acid hydrolysis glycine, serine,
alanine, valine and galactosamine in the molar ratios 1:1:3:1:1. This result strongly-
suggested that in the isolated glycopeptide galactosamine was attached to serine,
most likely through an O-glycosidic linkage. Blix3 obtained by papain (EC 3.4.4.10)
digestion of OSM and fractionation of the resulting dialysable glycopeptides a fraction
(0.25% w/w of native OSM) which on analysis showed the following molar com¬
position:— proline (8), threonine (5), alanine (5), glutamic acid (3), glycine (3),
serine (1), IV-acetylgalactosamine (6). Similar results were reported for glycopeptides
prepared from bovine submaxillary glycoprotein by Hashimoto et al.25.
Shortly afterwards, conclusive proof for the presence in ovine and bovine
submaxillar}- gland glycoproteins of O-glycosidic linkages involving the hydroxyl
groups of servl and threonyl residues was presented in short communications in¬
dependently by three laboratories. The workers concerned made use of the ease
with which on mild alkali treatment an alkoxide (sugar residue) is released from the
O-substituted, peptide-bonded a-amino-/?-hydroxycarboxylic acid residues by the
mechanism of /3-carbonyl elimination, first demonstrated on chondromucoprotein
from bovine nasal septa by Anderson et al.i. Bhavanandan et al.5 treated OSM
exhaustively with pronase and fractionated the digest by gel filtration. The sialo-
glycopeptide fraction was submitted to neuraminidase (EC 3.2.1.18) action and the
resulting glycopeptides were separated from the enzyme and free sialic acid by gel
filtration and anion-exchange resins respectively. On mild alkali treatment at o°
of the short glycopeptides which contained only minute amounts of dicarboxylic
acids, IV-acetylhexosamine was liberated concomitantly with the disappearance of
an equimolar amount of a-amino-/?-hydroxycarboxylic acids. Tanaka et al.6 treated
bovine submaxillary glycoprotein at 50 with mild alkali in the presence of sodium
borohydride. The result was a progressive release of carbohydrate, a decrease in
serine and threonine, an increase in alanine (corresponding to the decrease in serine)
and the appearance of a small amount of a-aminobutyric acid. The decrease of bound
hexosamine proceeded initially at a higher rate than the decrease of the a-amino-/?-
hydroxycarboxylic acids. Similar results for bovine submaxillary mucin were re¬
ported by Anderson et al.1. Finally Harbon et al.9 observed as a result of OSM
treatment at pH 12.8 and 70° a decrease of bound hexosamine by 83% of the total
and a loss of serine and threonine. Since under these conditions the serine and
threonine content of lysozyme (EC 3.2.1.17) which is free of sugar also diminished
by about 15%, the quantitative relationship between sugar released and a-amino-/?-
hydroxycarboxylic acids disappeared could not be elucidated. The formation of an
unsaturated serine derivative (a-aminoacrylic acid) in the process was shown by the
addition of sulphite to the alkali-treated OSM. 54% of the missing serine was trans¬
formed by this addition to cysteic acid.
In the present paper a detailed account will be given of the preparation, com¬
position and average molecular weight of glycopeptides from OSM and of the effect
of mild alkali treatment on these glycopeptides.
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Materials
OSM was prepared as previously described9 lor bovine submaxillary glyco¬
protein with the modification that the precipitation of glycoproteins and proteins
to be discarded was carried out at pH 4.5 instead of pH 4.0. The successive aqueous
extracts of the glands were processed separately. Total yield 5of the dry weight
of the glands. On sedimenting the OSM preparation, dissolved in 0.1 M phosphate
buffer (pH 7.6), in a Spinco Model E analytical ultracentrifuge. using a double
sector cell, a single peak with no appreciable asymmetry was observed.
The pronase preparation used was a product of Sigma. St. Louis (protease
from Streptomyces griseits, repurified, Type VI).
Neuraminidase, purified. Type V from Clostridium pcrfringens was also a
product of Sigma, St. Louis.
Sephadex G-25 was the preparation from Pharmacia, Uppsala, Sweden.
Resins used were Dowex 50-X4 (50-100 mesh), Dowex 1-X2 (50-100 mesh)
and Amberlite IR-4B (50-100 mesh).
Crystalline methoxyneuraminic acid was a gift from Professor H. Faillakd,
Cologne.
Methods
Measurements of pH were made with a Radiometer type TTTib equipped
with a glass electrode type G 222C.
Bound and total (bound plus free) XAXA were determined by the resorcinol
method of Svennerholm10 using crystalline NANA as standard. Free XAXA was
estimated by the thiobarbituric acid method11.
A'-Acetylhexosamine was determined according to Morgan and Eison as
modified by Reissig et al.12.
Hexosamine was determined as described previously13. Prior to assay the
material was hydrolysed with 3 X HC1 at 100 ~ for 8 h in a sealed tube. The hydro-
lysate was dried in vacuo. On the basis of model experiments a correction for the
destruction of 10% galactosamine was applied.
The non-amino sugar- were determined according to Gottschalk and Ada14.
The ninhvdrin value of the untreated glycopeptides was determined according
to Moore and Stein13 with l-leucine as standard and the result was expressed as
jumoles of leucine. The total amino acid content of the glycopeptides, after hydro¬
lysis with 6 X HC1 for 24 h at no° in an atmosphere of nitrogen in sealed tubes, was
determined with the ninhvdrin reagent of Moore and Stein; l-leucine was the
standard. The experimental figure was corrected for the proline content (see Table II)
and for the contribution made to the ninhydrin value by the degradation products
of ^'-acetylgalactosamine. It was found that galactosamine- HC1, when treated with
6 N HC1 at no0 for 16 h, gave in the ninhydrin test a molar absorhancy equivalent
to that of the leucine standard. The quantitative analvsis of the individual amino
acids in the glycopeptide hvdrolysate was carried out with an amino acid analyser
Spinco Model 120.
Gel filtration: Sephadex G-25 was allowed to swell in 0.05 M XaCl and the
fines were removed by repeated^decantation. The suspension was slurried into the
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column (83 cm x 2.x cm). The column was washed first with 0.1 M acetic acid
until free of chloride and then with degassed distilled water until neutral. Between
runs the column was washed with 0.1 M acetic acid followed by water. Monoamino-
dicarboxylic acids were determined as described previously16.
Paper chromatography: Whatman No. 1 paper was used with the solvents (a)
w-butanol-pyridine-water (6:4:3, v/v), (b) w-propanol-pyridine-water (6:4:3, v/v),
(c) w-butanol-acetic acid-water (12:3:5, v/v), (d) phenol-water-ammonia, prepared
by adding 40 ml of 0.1% ammonia to 160 g of phenol. The spray reagents were
the same as previously described13. To locate peptides, the spray of Pan and Dut-
cher17 was used.
For potentiometric titration the micrometer syringe "Agla" (total volume
500^1), Burroughs Wellcome & Co., London, and the above mentioned Radio¬
meter were used.
High-voltage paper electrophoresis was performed in pyridine-acetic acid-
water buffer (1:10:289, v/v) at pH 3.6 and 40 for about 90 min, 80 V/cm, with the
apparatus designed by Zillig et ai.ls and manufactured by A. Holzel, Munich 2,
Blutenburgstr. 96.
Preparation of glycopeptides
First step: Pronase digestion of OSM. 250 mg of OSM was dissolved in 50 ml
of 0.01 M CaCl2, saturated with toluene, and the pH was adjusted to 8.0 with 1 N
NaOH. The mixture was digested at 420 with 14 mg pronase, added in three portions
at 24 h intervals. The incubation lasted for a total of 120 h; the pH was maintained
at 8.0. The progress of the digestion was followed by the quantitative ninhydrin
reaction. The digest, after neutralization, was freed from insoluble material by
filtration. NANA was retained on the molecule because it facilitated fractionation
of the digest by increasing the molecular size of the glycopeptides and by affording
a sensitive and easily detectable marker of the sialoglycopeptide fraction.
Second step: Fractionation of digest. 25 ml of the above digest was concentrated
in a rotary evaporator at 270 to about 2 ml volume. The concentrate was applied
to the Sephadex G-25 column which was developed with air-free distilled water.
The flow-rate was adjusted to about 15 ml/h and 2.5 ml fractions were collected
automatically. The elution pattern is shown in Fig. 1. When Fractions 1-37 (pool A)
were screened for protein with the Folin reagent, they gave a negative test; even
after concentration to a small volume the test was only faintly positive (see results).
The Fractions 38-64 reacting with both resorcinol and ninhydrin were pooled and
concentrated to about 10 ml volume (pool B). The fractions from 65 onwards,
reacting only with ninhydrin, were pooled separately (poolC). The remaining half
of the digest was fractionated similarly and the resulting pools were combined with
the corresponding pools from the first half of the digest.
Third step: Treatment with neuraminidase. To the 20 ml of sialoglycopeptides
(pool B) were added 0.25 ml of 1 M CaCl2 and water to a final volume of 25 ml and the
pH was adjusted to 5.7. Two additions of 2.5 mg neuraminidase each were made
at times o and 24 h and the mixture was kept in the presence of toluene at 370 for
48 h. At the end of this period there was no appreciable difference between free
and total IV-acetylneuraminic acid indicating quantitative release of the latter.
Fourth step: Separation ofglycopeptides. The^glycopeptides resulting from step 3
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Fig. 1. Elution pattern from a Sephadex G-25 column (83 X 2.1 cm) of the pronase digest of
OSM (corresponding to 94 mg OSM). Elution carried out with air-free distilled water. Fractions
of 2.5 ml were collected. 0—0, absorbancy at 570 m/t in the Moore and Stein15 test (o. 1 ml
aliquot in final volume of 3.5 ml); ^ absorbancy at 380 m« in the resorcinol test
(0.1 ml aliquot in final volume of 2.5 ml). The bar denotes fractions containing chloride.
were separated from neuraminidase and salt by another passage through Sephadex
G-25 as above. The fractions containing glycopeptides (ninhydrin positive) emerged
from the column together with free sialic acid. To remove sialic acid the mixture,
concentrated to 15 ml volume, was applied to a Dowex 1 (formate) column (12 cm X
1.1 cm) and the effluent was recycled once. The column was washed with 85 ml water
and the pooled effluent and washings were concentrated to a small volume and
finally dried in a desiccator at o°. Yield about 50 mg. The recovery from the individual
steos is shown in Table I.
TABLE I
recovery of hexosamine bound to peptide from the individual steps of the preparation
of glycopeptides from 250 mg OSM
The figures of this table refer to preparation No. 15.























* This figure is not corrected for the moisture content of OSM.
** At this stage the recovery of NANA was nearly quantitative.
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results
Carbohydrate analysis of OSM
The composition of the carbohydrate of OSM, prepared as above, was similar
to the Australian OSM. It contained 24.2% sialic acid (expressed as NANA) and
14.6% hexosamine (expressed as free galactosamine base); both values are corrected
for moisture content of OSM. Practically all sialic acid was NANA and practically
all hexosamine was galactosamine, as seen on paper chromatograms. There were
also present 0.2% galactose, 0.2% mannose, 0.25% fucose and traces of glucosamine.
Characterization of glycopeptides
Quantitative analysis
The quantitative analyses of two representative glycopeptide preparations
are given in Table II.
TABLE II
COMPOSITION OF GLYCOPEPTIDE FRACTION FROM ENZYMATIC DIGEST OF OSM
Figures expressed in moles per 1 mole of hexosamine.
Amino acid Preparation Amino acid Preparation
15 17 15 17
Aspartic acid 0.03 0.05 Proline 0.36 0.40
Glutamic acid 0.08 0.13 Glycine 0.56 0.70
Serine 0.62 0.66 Alanine 0.30 0.40
Threonine 0.67 0.62 Valine 0.17 0.21
Lysine O.OI trace Leucine 0.07 O.IO
Arginine 0.09 trace
Molecular weight
About 10 mg of the glycopeptide preparation was dissolved in 5 ml of 0.1 M
KC1. This solution was titrated potentiometrically with 0.1 N NaOH at 20°. The
mixture was stirred magnetically and a continuous stream of N2 was passed over
the surface. In the critical region between pH 5.0 and 10.o the alkali was added in
20 n1 portions between the individual pH measurements. Appropriate corrections
were made for the alkali consumption of the 0.1 M KC1 blank. From the plot of
alkali consumption against pH it was seen that between pH 5.0 and 9.75 the mixture
of glycopeptides contained essentially one type of titratable group (—NHJ). The
plot for the back titration using 0.1 N HC1 almost coincided with the curve obtained
with 0.1 N NaOH. From the alkali consumed within this range the molecular weights
were calculated (see Table III). Each figure represents the average molecular weight
of the respective glycopeptide preparation.
Ninhydrin values before and after hydrolysis
To characterize further the glycopeptides the ninhydrin value before and
after hydrolysis (see methods) and the hexosamine content after hydrolysis were
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determined. From the figures in Table III it would appear that the average glyco-
peptide, as prepared in our laboratory, is a tetrapeptide with 1.3 residues N-acetyl¬
galactosamine attached to it.
'\
TABLE III
molar ratios ninhydrin value'/hexosamine in preparations of glycopeptides from
OSM and molecular weights
Molar ratios
Preparation Before After Mol. wt.
hydrolysis hydrolysis
No. 7 0.48 3-29
No. 11 0.63 3x>3
No. 14 0.65 3-19 644
No. 15" 0.52 3-41 677
No. 17 0.51 3-39 658
No. 18 0.57 3-49
* Value expressed as leucine.
" Pool of three preparations.
When glycopeptide preparation No. 14 was treated with pronase at pH 8.0
and 420 for 88 h, the ratios before and after hydrolysis changed to 0.75 and 2.55,
respectively, indicating a further shortening of the glycopeptides. It may be men¬
tioned that this shortening of the peptide was possible only because the glycopeptide
was free from sialic acid (see third step of glycopeptide preparation). This was shown
by the following experiment. Sialoglycopeptides, obtained from fractionation (on
Sephadex column) of the pronase digest of OSM, were submitted to two further
pronase treatments and fractionations. After removal of the bound sialic acid, the
ratios of the final glycopeptide (Table III, preparation No. 18) did not reveal any
difference from those prepared by the standard procedure.
High-voltage paper electrophoresis
When electrophoretograms of the glycopeptides were sprayed with the peptide
reagent and the periodate-benzidine reagent, a series of spots was seen which had
migrated towards the cathode and which reacted with both reagents.
Paper chromatography
Paper chromatograms of the glycopeptides in solvents a, c and d (see methods)
did not reveal free amino acids or free Ar-acetylgalactosamine. Paper chromatograms
of the acid hydrolysate of the glycopeptides (6 N HC1, no°, 24 h) in solvents a and
c showed the amino acids listed in Table II. The relative intensities of the spots
roughly agreed with the molar ratios in Table II.
Balance of monoaminodicarboxylic acids
250 mg of O.SM contained 156.2 ymoles of monoaminodicarboxylic acids:
this figure is uncorrected for the 11% moisture of the lyophilized OSM. When pool C
(see methods) was hydrolysed with 6 N HC1 at uo° for 24 h and analysed for
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dicarboxylic amino acids, 91.0 /tmoles were recovered. When the Dowex-i column,
used in the fourth step of glycopeptide preparation, was eluted with 2 N acetic acid,
29.9 /xmoles of dicarboxylic amino acids were found in the acid hydrolysate of the
eluate. In the glycopeptide fraction (Table II) 10.1 ^moles of aspartic and glutamic
acids were present. The total recovery of monoaminodicarboxylic acids, referred to
250 mg OSM, was therefore 83.9%. The above figures refer to preparation 15.
PoolC
The major components of pool C are free amino acids. A minor contribution
is made by small peptides, as indicated by an increase of the ninhydrin value of the
pool after acid hydrolysis by not more than 26%. Tests for hexosamine after acid
hydrolysis of the pool were always negative.
Self-digestion of pronase
The observation that pool A of the fractionated OSM-pronase digest (second
step of glycopeptide preparation) did not reveal appreciable amounts of protein
prompted an investigation into the self-digestion of pronase.
6.83 mg of pronase, dissolved in 25 ml of 0.01 M CaCl2 and the pH adjusted
to 8.0, was incubated for 3 days at 420 in the presence of toluene. After neutralization
and removal of some insoluble material by filtration, the concentrated digest was
fractionated on a Sephadex G-25 column under the conditions described in the
second step of glycopeptide preparation (see methods). The elution pattern is shown
in Fig. 2. In order to assess the size of polypeptides and/or peptides emerging from
Fig. 2. Elution pattern from a Sephadex G-25 column (83 x 2.1 cm) of the products of self-
digestion of 6.83 mg of pronase incubated at 420 for 3 days in 25 ml of 0.01 M CaCl, at pH 8.
Elution carried out with air-free distilled water. Fractions of 2.5 ml were collected. 0—• ab-
sorbancy at 570 m/i in the Moore and Stein15 test (0.5 ml aliquot in final volume of 3.5 ml).
The bar denotes fractions containing chloride.
the column and to obtain information on their distribution over the fractions cor¬
responding to pools A, B and C (see Second step of preparation of glycopeptides under
methods), the pools a, b, and c (see Table IV) were analysed for ninhydrin value
before and after hydrolysis with 6N HC1 at 110° for 24 h. It would appear from
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Table IV that no appreciable amounts of protein or larger polypeptides are present
in pool a. The pools a, b and c consist of short peptides decreasing in size from pool
a to pool c. Pool c is essentially a mixture of free amino acids and small peptides and
is in that respect similar to pool C from the OSM-pronase digest. In pool c the
TABLE IV
ANALYSIS OF THE POOLS OBTAINED FROM FRACTIONATION OF THE PRONASE SELF-DIGEST
Pool Fractions Total ninhydrin value Ninhydrin value
(expressed in /unoles leucine) • (after hydrolysis)
expressed in % of total
Before hydrolysis After hydrolysis ninhydrin value of
a + b + c
a i- 37 0.40 1.62 5.2
b 38- 64 0.34 1.25 4.0
c 65-145 16.30 28.10 90.8
increase in ninhydrin value after acid hydrolysis amounted to about 72%. It can
be calculated from Table IV that contamination of the sialoglycopeptides, resulting
from pronase digestion of OSM and collected in pool B, by products of pronase
self-digestion (pool b) is negligible. The contribution of pool b (after hydrolysis)
from the pronase autodigest to the total ninhydrin value of pool B (after hydrolysis)
was less than 1%.
Alkali treatment of glycopeptide fraction
The analysis of the glycopeptide fraction (see Table II) suggested the hydroxyl
groups of serine and threonine as acceptors for the IV-acetylgalactosamine residues.
It is well known19 that glycosidic linkages with a carbonyl group in /S-position are
alkali-sensitive.
On treatment of glycopeptide preparation 17 with 0.5 N NaOH at o° 52.0,
65.7 and 69.2% iV-acetylhexosamine were released after 48,96 and 120 h, respectively.
When carrying out the experiment at room temperature (about 220), 66.6 and
79.6% /V-acetylhexosamine were liberated after 24 and 48 h, respectively. These
figures are corrected for loss of /V-acetylhexosamine by destruction, as estimated
from a control. The control contained an amount of free /^-acetylgalactosamine
equivalent to the hexosamine content of the glycopeptide and was treated under
the same conditions but only for 2/3 of the time. The detailed analysis of the ex¬
periment is given in Table V. As may be seen from the table, after 48 h the release
of 1518 //moles of Ar-acetylgalactosamine coincided with the loss of 1527 //moles of
serine plus threonine; the concentration of the other amino acids did not change
significantly. No correction was applied for the contribution to the loss of serine
and threonine made by the destruction of serine and threonine residues with a
free hydroxyl group because of the small amount of such residues in the glyco-
peptides. The losses of serine in L-Ser-L-Leu-L-Leu and in Gly-L-Ser, treated with
0.5 N NaOH for 72 h at o°, were 4.7 and 5.7%, respectively. The time curve of the
release of V-acetylhaxosamine from glycopeptide preparation 17 is shown in Fig. 3.
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TABLE V
EFFECT OF ALKALI TREATMENT ON COMPOSITION OF GLYCOPEPTIDE PREPARATION No. 17
Results expressed in/imoles/gram glycopeptide. Conditions: 0.5 N NaOH; 220.




o o 1241 1164 1323 754 749 400 179 236 92 trace trace
48 1518 562 316 1257 702 710 392 150 251 72 — —
Change +1518 —679 —848 —66 —52 —39 —8 —29 +15 —20 — —
-1527
On treatment of glycopeptides with 0.5 N NaOH at room temperature an
increase in the absorbancy at 241 m/u was observed. Fig. 4 shows this increase with
time when preparation 18 was treated as above. The experiment was recorded
0 12 24 36 48
Time (h)
Fig. 3. Logarithmic plot of decrease of bound hexosamine as function of time on alkali treatment
of glycopeptide (0.5 N NaOH; 220).
automatically in a Zeiss recording spectrophotometer Model RPQ 20 A V and the
absorbancies at 241 m/u, at 5-min intervals, were plotted. .iV-acetylgalactosamine,
exposed to the same conditions, did not disclose any change in absorbancy.
Alkali treatment of OSM and analysis of the reaction products
As is evident from Table I, the recovery of total hexosamine after treatment
of OSM with pronase at pH 8.0 was only 81.3%, whereas the sialic acid was recovered
•nearly quantitatively. Experiments were carried out to investigate the effect of
alkaline treatment alone, i.e. in the absence of pronase, on OSM.
58.7 mg of OSM was dissolved in 10.o ml of 0.01 M CaCl2; 9.0 ml of this solu¬
tion (containing 52.8 mg OSM) was adjusted to pH 8.0 and incubated for 5 days
at 420 in the presence of toluene, the remainder being used for analysis of the un¬
treated OSM. The pH was kept constant by re-adjustment from time to time. At
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Fig. 4. Change in absorbancy at 241 mfi with time when glycopeptide preparation No. 18 and
iV-acetylgalactosamine respectively were treated with alkali at room temperature. Assay (#—•):
116 //g glycopeptide per ml 0.5 N NaOH. Control (J^. A) 5° j"g ^-acetylgalactosamine per
ml 0.5 N NaOH. The compounds, dissolved in a small volume of water, were added to the alkali
in the cuvettes at time o. The absorbancy at 241 m/a was recorded with a Carl Zeiss recording
spectrophotometer Model RPQ 20a V using cuvettes of 0.5-cm light path.
the end of this treatment the volume was made up to 10.0 ml and aliquots were
analysed for material reacting in the Morgan-Elson test, for total hexosamine (after
standard acid treatment) and for free and total IV-acetylneuraminic acid. The residual
volume (9.0 ml) was dialysed against distilled water (300 ml) with stirring at 4° for
96 h in the presence of toluene. The bag content and the concentrated dialysate
were analysed for the same substances as described above for the unfractionated
assay. The results are presented in Table VI. This table shows that in the. un¬
fractionated assay IV-acetylneuraminic acid was recovered quantitatively. Even on
prolonged dialysis the substance(s) reacting in the Warren test did not pass through
the wall of the dialysing bag, whereas from an OSM-neuraminidase digest 92.1% of
TABLE VI
carbohydrate analysis of alkali-treated OSM before and after dialysis
Conditions: pH 8.0, 420, 120 h. The experimental figures are expressed as //moles/52.8 mg OSM;
the figures are not corrected for the moisture content of lyophilized OSM.





Warren11 value" 0.63 8.42 8-75 0.69
Total NANA 35-49 35-89 27.00 8.91
Percent recovery of NANA — ioi.i 76.1 25-1
Morgan-Elson value* o.39 6.80 0.12 6.00
Hexosamine 36.06 29.66 22.93 5-7°
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the hberated iV-acetylneuranumc acid passed into the dialysate within 48 h. When
an aliquot of the retentate was treated with 0.1 N H2S04 at 8o° for 60 min, the
Warren test11 gave a value of 27.3 //moles (expressed as NANA), as compared with
27.0 //moles for the non-hydrolysed retentate by the resorcinol method (see Table VI).
A similar figure for the iV-acetylneuraminic acid content of the non-hydrolysed
retentate was obtained by the direct Ehrlich reaction.
Hexosamine was recovered only to the extent of 82.3%, thus establishing that
the loss of 18.7% of hexosamine recorded in Table I can be accounted for solely by
the effect of alkali on OSM. 63.6% of the total hexosamine was recovered as bound
hexosamine in the retentate. That, in fact, all hexosamine present in the retentate
was bound in a glycosidic linkage, was suggested by the minute amount of material
reacting in the Morgan-Elson test. It was also shown that enzymatic removal of sialic
acid from the alkali-treated OSM prior to dialysis did not change the distribution
of hexosamine. In this case 63% of the total hexosamine was found in the retentate.
It would appear, therefore, that in the experiment of Table VI 36.4% of the total
hexosamine was released by the mild alkali treatment.
In the dialysate 5.70 //moles of hexosamine, after acid treatment, were re¬
covered, i.e. 15.8% of the total hexosamine and 43.4% of the hexosamine released on
alkali treatment of OSM. When, however, the dialysate was submitted to the Morgan-
Elson reaction, 6.00 pinoles of material reacting as iV-acetylhexosamine and ex¬
pressed as such were found, i.e. 88.2% of the same material present in the unfrac-
tionated assay. This material represents 16.6% of the total IV-acetylhexosamine
and 45.7% of the A-acetvlhexosamine released from OSM upon mild alkali treat¬
ment. Chemically it is most likely a mixture of iV-acetylhexosamine (substituted at
C-6 by NANA) and chromogens I and III (substituted at C-6 by NANA). This is
suggested by the observation that the dialysate reacted not only in the Morgan-
Elson reaction but also produced a purplish colour on addition of Ehrlich's reagent
in the cold. This colour was unstable to heating and to mineral acid. The 6-substituted
chromogens I and III are known to be formed from the free prosthetic groups
(IV-acetylneuraminyl (2 —> 6) ^-acetylgalactosamine) by loss of 1 and 2 molecules
of H20, respectively, on mild alkali treatment and they are characterized by the
above properties1-20.
51% of the total hexosamine released from OSM on alkali treatment was de¬
graded to such a degree that it reacted neither in the Morgan-Elson nor in the
Elson-Morgan tests. In a model experiment in which 18.73 //moles of IV-acetyl-
galactosamine were treated at pH 8.0 and 420 for 120 h, 12.89 //moles of material
reacting in the Morgan-Elson procedure and expressed as AZ-acetylhexosamine were
recovered, i.e. 68.8% of the total. The alkali-treated ^-acetylgalactosamine gave a
purple colour with Ehrlich's reagent in the cold. When the alkali-treated A1-acetyl¬
galactosamine was heated with 2 N HC1 at ioo° for 4 h, 10.56 //moles of hexosamine,
i.e. 56.4% of the theoretical were recovered.
Methoxyneuraminic acid in the thiobarbituric acid and resorcinol tests
109.2 //g (= 0.389 //moles) of crystalline methoxyneuraminic acid in 0.2 ml
water and 11.05//g (= 0.036 //moles) of crystalline A^-acetylneuraminic acid were
submitted separately to the Warren test11. The absorbancies, measured at 549 m/z
in cuvettes of i-cm light path in a Zeiss Spectrophotometer PMQ II, were 0.428 and
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0.468, respectively. The molecular extinction coefficient of methoxyneuraminic acid
is therefore only 8.5% of that of iV-acetylneuraminic acid.
36.0//g (= 0.128 //moles) of crystalline methoxyneuraminic acid in 2.0 ml
water and 33.2 pig ( = 0.107 ^moles) of crystalline iV-acetylneuraminic acid in 2.0 ml
water were submitted separately to the resorcinol procedure of Svennerholm10.
The absorbancies, determined at 580 mpi as above, were 0.251 and 0.169, respectively,
1.e. mole per mole methoxyneuraminic acid gives 24.3% more colour than iV-acetyl-
neuraminic acid.
discussion
From the data presented it would appear that digestion of OSM with pronase
over a period of 120 h, followed by neuraminidase treatment, resulted in the for¬
mation of glycopeptides with an average content of four amino acid residues to
which about 1.3 residues of iV-acetylgalactosamine were attached. Quantitative
amino acid analysis of the glycopeptides (Table II) revealed hydroxvamino acids
as the only amino acids with a functional group in the side chain present in a total
concentration high enough to accommodate all iv-acetylgalactosamine residues. It
is also evident from Table II when taken together with the average molecular
weight of the preparations 15 and 17 (see Table III) that each preparation is a fraction
consisting of glycopeptides of varying composition with serine and threonine as the
predominant amino acids. The heterogeneity of the glycopeptide preparation is also
seen in the electrophoretograms; this heterogeneity is to be expected from the
random action of pronase on a polypeptide chain along which several hundred
prosthetic groups are distributed. Proline and glycine prevailed among the amino
acids without a functional group in the side chain. This finding may be due to" the
fact that certain peptide bonds, especially those involving glycine and proline (l-Pro-
l-Leu, Gly-l-Pro, Gly-Gly), are resistant to pronase21'22. The low aspartic and
glutamic acid content of the glycopeptides is accounted for by the presence in
pool C (see results) of 58.3% of the total 156.2 ^moles of dicarboxylic amino acids
present in 250 mg OSM and by retention on the Dowex-i column of glycopeptides
containing 19.1% of the total dicarboxylic acids. Concerning the 0.11 and 0.18 moles,
respectively, of monoamino dicarboxylic acids present in preparations 15 and 17
per mole galactosamine, their presence is probably due to the formation of the
calcium salts of their free carboxyl groups during the enzymic digestions in a cal¬
cium medium. The low degree of dissociation of the calcium salts may have allowed
some glycopeptides containing dicarboxylic acids to pass the Dowex-i column
(fourth step of preparation).
Treatment of the glycopeptides with 0.5 N NaOH resulted in the liberation
of iV-acetylgalactosamine and a concomitant loss of an approximately equimolar
quantity of a-amino-/S-hydroxycarboxylic acids. This equivalence prevailed in
experiments carried out at o° and at 220. Though at 220 more of the released amino
sugar was destroyed than at o°, 80% of the total hexosamine was liberated under
this condition within a relatively short time (48 h). The slope of the decrease of
bound hexosamine (see Fig. 3) would indicate that with the release of 80% of the
total hexosamine the reaction had not yet reached the end-point. It seems therefore
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likely that the residual 20% of hexosamine would also be split off with a concomitant
loss of serine and/or threonine. Since the glycopeptides contained 50% of the total
hexosamine of OSM, it would appear that at least 50% of the prosthetic groups
are linked O-glycosidically to the hydroxyl groups of serine and threonine residues.
As to the mechanism of the reaction, the observations made by Tanaka
et al.6 and Harbon et al.8 (see introduction") strongly suggest that the liberation of
A'-acetylhexosamine proceeds by /S-carbonyl elimination resulting in the formation
of peptide-bonded a-aminoacrylic acid (from serine) and a-aminocrotonic acid or
isomer (from threonine):
H2C—O—glycosyl i '2C
OH H—C — NH — CO* Pep1 ^ C — NH—CO • Pepi + glycosyl • O" + H20
Pep2 • NH — C=0 Pep2 • NH — C=0
0-substituted peptide- a-omino acrylic
bound serine residue acid residue
The resulting dehydropeptide, on acid hydrolysis with 6 N HC1 at no0 for 24 h,
will yield free amino acids and in addition pyruvic acid instead of serine and a-keto-
butyric acid instead of threonine. Our finding of the increase in absorbancy at
241 mfi on alkali treatment of the glycopeptides would be consistent with this
mechanism, since the strong absorbancy at 241 mu of a-amino acrylic acid deri¬
vatives has been previously23 reported.
As may be seen from Fig. 3, after the release of 56% of Ar-acetylgalactosamine
in 12 h the rate of ^-elimination decreased markedly. This decrease may result from
the terminal positioning of some of the O-substituted seryl and threonyl residues.
When in a C-terminal position, the carboxylate anion of an O-substituted seryl or
threonyl residue will discourage /2-elimination because of its mesomeric effect on the
a-carbon atom. When in an N-terminal position, the inductive effect of the non-
protonated amino group will hinder the expulsion of the proton in a-position.
On keeping native OSM at pH 8.0 and 42° for 120 h 36% of the total A'-
acetylhexosamine was released, half of which was degraded to such an extent that
it did not react with the Ehrlich reagent under the conditions of the Morgan-Elson
and Elson-Morgan tests. It was an unexpected but reproducible finding that the
retentate of the dialvsed reaction mixture contained 8.75 /mioles of material reacting
in the Warren test11 and expressed as NANA (Table VI). When the retentate was
hydrolysed (0.1 N H2S04, 8o°, 60 min) to liberate the bound NANA, the Warren
value of the hydrolysate (27.3 /rmoles) was practically the same as the resorcinol
value (27.0 amoles) of the retentate before hydrolysis, indicating that part of the
bound, non-dialvsable NANA reacted in the Warren test11. Since the chromogen
in the Warren test is formylpyruvic acid24, which is formed only from free N-
acylneuraminic acids and from iV-acetyl-4-O-acetylneuraminic acid, the mild alkali
treatment of OSM has apparently changed some of the bound NANA residues in
such a way that the conditions of the Warren procedure sufficed to cleave the
ketosidic linkage. Assuming deacetylation of part of the NANA residues as the
alkali-induced change, the action of periodate on the changed prosthetic groups
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Fig. 5. Structure resulting from periodatc oxidation of deacetvlated NANA linked ketosidically
to C-6 of a glycosidically-linked A'-acetylgalactosaminc residue.
would result in the structure shown in Fig. 5. This structure contains formylpyruvic
acid in a ketosidic linkage rendered labile by the presence of carbonyl groups in
/(-position to both C-atoms involved in the ketosidic linkage. It is true that methoxy-
neuraminic acid, which on periodate oxidation will also give rise to the glycon
structure ta) shown in Fig. 5, has only '/12th of the molecular extinction coefficient
of NANA. However, the difference in the oxidized compounds is that in the case of
methoxyneuraminic acid only the glvcosidic carbon atom of the glycon (a) has a
carbonyl group in /(-position, whereas in the case of the prosthetic group both C-atoms
involved in the glycosidic linkage are activ ated by /(-carbonyl groups.
Some evidence for the assumed deacetylation of part of the NANA residues
during digestion at pH 8.0 seems to be provided by the resorcinol value (expressed
as NANA) of the retentate (see Table VI). Since in the native OSM the molar ratio
NANA/hexosamine was 0.98, the same ratio may be expected for the isolated
glycoprotein after release of about one-third of the prosthetic groups on keeping
OSM at pH 8 and 420. The observed value of this ratio was, however, 1.18. This
figure would be consistent with a partial deacetylation of the NANA residues; for
it was found that deacetylated NANA, as present in methoxyneuraminic acid,
gives mole per mole 24.3% more colour in the resorcinol test than NANA.
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SUMMARY
OSM prepared from sheep is known to contain O-glycosidic linkages involving
the reducing group of ^-acetylgalactosamine and the hydroxyl groups of serine and
threonine. It is the aim of this paper to establish whether or not in addition to this
linkage another type of alkali-labile linkage, in particular a glycosidic-ester linkage,
is present in OSM.
In the first set of experiments it was found that the release of 35.2% of IV-acetyl-
galactosamine, when OSM was kept at pH 8.0 and 42° for 120 h, was matched by the
loss of an equimolar amount of serine and threonine without a significant change in
the other amino acids. In a second set of experiments it was shown that on treating
OSM with 0.1 N NaOH at 4° the decrease of bound hexosamine with time was linear.
Finally, glycopeptides prepared by trypsin (EC 3.4.4.4) or pronase action on OSM
were treated with LiBH4 in tetrahydrofuran. No significant difference in the di-
carboxylic amino acids before and after such treatment was observed. Only traces of
homoserine and a-amino-Yhydroxy-w-valeric acid were detectable after LiBH4
reduction.
Since the LiBH4 treatment of trypsinized OSM prepared from Australian sheep
resulted in the loss of 35% of the dicarboxylic acid content, the suggestion is made
that the fine structure of the ovine submaxillary glycoproteins may vary with the age
of the animals. In Australia, lambs of an average age of 4 months were used for the
work; in Europe only sheep of three years or more are slaughtered. Similar differences
with age have been described for the fine structure of the chondroitin sulphates
composing human hyaline cartilage.
INTRODUCTION
In previous papers1-2 it was shown that in OSM prepared from German sheep
at least 50% of the prosthetic groups (Y-acetylneuraminyl (2->6) IV-acetylgalactos-
Abbreviations: OSM and BSM, ovine and bovine submaxillary-gland glycoprotein respec¬
tively; NANA, .V-acetylneuraminic acid.
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amine) are linked O-glycosidically to the hydroxyl groups of serine and threonine
residues. The evidence for this type of linkage was that treatment with 0.5 N NaOH
at o° for 96 h or at 220 for 24 h effected the release from short glycopeptides, derived
by pronase digestion of OSM, of two-thirds of the bound IV-acetylhexosamine con¬
comitant with the loss of an equimolar amount of a-amino-/S-hydroxycarboxylic
acids, most probably by the mechanism of /J-elimination. Shortly afterwards and
independently, Harbon et al.3 reported similar results. It was rather surprising to
find that on keeping native sheep OSM at pH 8.0 and 420 for 120 h, about 36% of the
total prosthetic groups were liberated2. Since the susceptibility to such mild alkaline
conditions was suggestive of the existence in OSM of a second type of carbohydrate-
peptide linkage still more sensitive to alkali than the O-glycosidic linkages to serine
and threonine, three sets of experiments were performed. Firstly, native OSM was
kept at pH 8.0 and 42° until about 35% of the prosthetic groups were released. At this
stage a quantitative analysis of the hexosamine still bound to the protein and of the
component amino acids was carried out and compared with the hexosamine and
amino acid analyses of the control (untreated) OSM. Secondly, OSM was dissolved
in 0.1 N NaOH containing 0.3 M sodium borohydride and kept at 40 for various
periods of time; the decrease of bound NANA and hexosamine was determined.
When these conditions were applied to BSM, the kinetics of the decrease of bound
hexosamine indicated the presence of two different types of alkali-labile linkages4.
Thirdly, for the detection of any glycosidic-ester linkages previously reported to be
present in OSM from Australian lambs5, glycopeptides prepared from submaxillary
glands of sheep were treated with lithium borohydride in tetrahydrofuran and their
dicarboxylic acid content was determined before and after such treatment. In these
experiments a search was also made for homoserine and a-amino-<5-hydroxy-w-valeric
acid which would arise from the reduction of esterified /5- and y-carboxyl groups
respectively of aspartyl and glutamyl residues.
experimental
Materials
OSM was prepared from sheep as described previously2. Dry methanol was
prepared from absolute methanol as described by Vogel6. Methanolic hydrochloric
acid was prepared as described previously5. Tetrahydrofuran was purified and dried
according to Crawhall and Elliott7. Lithium borohydride was purified according
to Chibnall and Rees8. Crystalline homoserine was supplied by Sigma Chemical
Company, St. Louis, U.S.A. Trypsin (EC 3.4.4.4), twice recrystallized, was supplied
by Koch-Light Laboratories Ltd., Colnbrook, Bucks, England. Pronase was a
preparation supplied by Sigma Chemical Company, St. Louis, U.S.A.
Cellulose casings (6 cm circumference) for dialysis were obtained from the
Visking Corporation, Chicago. All glassware used for the reduction with lithium boro¬
hydride was dried at 105° for at least 12 h prior to use.
Resins used were Dowex-i X4 (50-100 mesh) and Dowex-5oW X4 (50-100
mesh). Sephadex G-25 was a preparation of Pharmacia, Uppsala, Sweden.
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Methods
Measurements of pH were made with a Radiometer type TTT ib equipped
with a glass electrode type G 222 C.
iV-Acetylneuraminic acid was determined by the resorcinol method of Svenner-
holm9 using crystalline NANA as standard. iV-Acetylhexosamine was determined
according to Morgan-Elson as modified by Reissig, Strominger and Leloir10.
Crystalline IV-acetyl-d-galactosamine was used as standard.
Hexosamine was determined as described previously11. Prior to assay the ma¬
terial was hydrolysed with 3 N HC1 at ioo° for 8 h in a sealed tube. The hydrolysate
was dried in vacuo. On the basis ofmodel experiments a correction for the destruction of
10% galactosamine was applied. As standardcrystalline d-galactosamine • HC1 was used.
Protein was determined by the Lowry-Folin method12 using crystalline serum
albumin as standard.
The quantitative analysis of the individual amino acids in OSM hydrolysates
was carried out with an amino acid analyser, Spinco Model 120.
In the LiBH4 experiments the dicarboxylic acids were separated on a Dowex-i
(acetate form) column from the neutral and basic amino acids and determined with the
ninhydrin reagent ofMoore and Stein13. The fraction containing the neutral and basic
amino acids was the material assayed for homoserine and a-amino-<5-hydroxy-«-valeric
acid.
For the quantitation of homoserine and a-amino-d-hydroxy-M-valeric acid the
same Beckman automatic analyser and the same columns and resins were used as
for the estimation of the ordinary amino acids. However, the temperature was lowered
to 28°; the buffer used was the usual 0.2 N sodium citrate (pH 3.25) and the rate of
elution was 40 ml buffer per h. Under these conditions a good separation of homo¬
serine from serine and of a-amino-<5-hydroxy-w-valeric acid from proline and glutamic
acid was achieved. Homoserine appeared 14 ml and a-amino-d-hydroxy-w-valeric
acid 26 ml behind serine. This separation allows a convenient quantitative evaluation
of homoserine and a-amino-d-hydroxy-w-valeric acid, the valley between their peaks
going down to 0.08 absorbance.
Paper chromatography in various solvents was carried out as described
previously2.
The reducing power of the stock solution of lithium borohydride in tetrahydro-
furan was estimated prior to each reduction by the method of Lyttle, Jensen and
Struck14.
The reduction by LiBH4 in tetrahydrofuran of glycopeptides prepared from
OSM as detailed under results was carried out in a 50-ml conical flask, fitted with a
three-neck adaptor. One neck bore a Liebig condenser fitted with a CaCl2 drying-
tube, another a thermometer and the third one was stoppered, being used for the
addition of the reactants. The flask was heated on a hotplate and the content of the
flask was stirred magnetically. The reduction procedure, the decomposition of excess
LiBH4, the hydrolysis of the reduction products and the separation of the mono-
carboxylic amino acids from the dicarboxylic amino acids on a Dowex-i (acetate
form) column have been described previously5.
Synthesis of a-amino-d-hydroxy-n-valeric acid
y-Methyl glutamate hydrochloride was prepared according to Coleman15,
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except that methanol was used instead of ethanol; m.p. 152-153° (uncorr.). The ester
was reduced under the conditions used by Murphy and Gottschalk16. The a-amino-
<5-hydroxy-n-valeric acid had a melting point of 228-229° (uncorr.).
results
Effect of mild alkali treatment at 42° on the carbohydrate and protein moieties of OSM
About 100 mg of OSM was dissolved in 20.0 ml of 0.01 M CaCl2; 18.0 ml of this
solution was adjusted to pH 8.0 and incubated at 42° in the presence of toluene; the
remainder was kept frozen until used as control. The pH was kept constant by
readjustment from time to time. Aliquots were withdrawn every 48 h, adjusted to
pH 6.0 with 0.1 N HC1 and the progress of the reaction, i.e. the release of prosthetic
groups, was measured by the Morgan-Elson reaction. As was shown in the previous
paper2, about half of the ^-acetylgalactosamine of the released prosthetic groups was
destroyed under the same conditions in 120 h.
When the Morgan-Elson reaction in the assay indicated the release of about
35% °f the total prosthetic groups, the experiment was interrupted by adjusting the
pH to about 6.0. One ml of the assay and 1.0 ml of the control were treated with
6 N HC1 for 24 h at 110° in an atmosphere of nitrogen in sealed tubes. The hydrolysates
were dried in a vacuum-desiccator, dissolved in water, filtered (to remove humin)
and the filtrate plus washings were dried. The dry residue was dissolved in 4.0 ml of
0.2 M sodium citrate buffer (pH 2.2) and an aliquot (1.0 ml) was analysed for neutral
and acidic amino acids.
10.o ml of the neutralized assay (see above) was exhaustively dialysed, with
stirring, against de-ionized water at 40 in the presence of toluene. The content of the
bag was made up to 25.0 ml and a 2.0-ml aliquot was analysed for hexosamine after
acid hydrolysis.
In order to ascertain that no bound hexosamine was lost on dialysis of the
assay, the dialysate was concentrated to a small volume and submitted to paper
chromatography. When the chromatograms were sprayed for the detection of glyco-
peptides with periodate-benzidine and peptide sprays, a weak spot at the base line
reacting with both reagents was seen, indicating the presence in the dialysate of some
glycopeptide material. This did not amount to more than 2.0% of the OSM, as judged
from the colour intensity of the periodate-benzidine spot.
The results of the analyses are shown in Table I.
Effect of alkali treatment at 4° on the carbohydrate moiety of OSM, using the conditions
of Tanaka, Bertolini and Pigman4
About 150 mg of OSM was dissolved with shaking in 30.0 ml of 0.1 N NaOH
containing 0.3 M sodium borohydride; a 5.0-ml aliquot was withdrawn and used as
control. The remainder was kept at 40 and 5.0-ml aliquots were removed after various
time intervals. Assays and control were neutralized and dialysed as described by
Tanaka, Bertolini and Pigman4. The content of the bag was made up to 25.0 ml
and aliquots were analysed for NANA, hexosamine and total protein. The results
are shown in Table II. Since the protein content of the retentates of the assays was
not significantly different from that of the retentate of the control, no correction was
applied to the carbohydrate figures.
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TABLE I
AMINO ACID AND HEXOSAMINE ANALYSES OF SHEEP OSM BEFORE AND AFTER TREATMENT WITH
ALKALI (pH 8.0 AND 420)
Results are expressed in /imoles/96.8 mg OSM.




o 64.2 62.8 50.8 70.4 30.0 44.4 29.1 24.0 12.6 12.1 8.6 23.3 27.4
120 41.6 48.7 41.8 70.4 30.7 46.6 29.3 25.8 13.1 12.0 10.2 24.8 24.8
Change —22.6 —14.1 —9.0 0.0 +0.7 +2.2 +0.2 +1.8 +0.5 —0.1 +1.6 +1.5 —2.6
-231
Effect of LiBH4 treatment on the dicarboxylic amino acid content of enzymatically
fragmentated OSM
A. About 50 mg of OSM, dissolved in 10.o ml of 0.1 M phosphate buffer (pH 8.0)
was digested with 1 mg of crystalline trypsin for 16 h at 37° (in the presence of toluene).
The digest was dialysed against distilled water (saturated with toluene) at 40 for 72 h.
The retentate was made up to 50.0 ml volume. Two aliquots of 22.0 ml each were
transferred to the reduction flasks (see methods) and dried in a vacuum-desiccator.
TABLE II
DECREASE OF BOUND NANA AND HEXOSAMINE OF SHEEP OSM AFTER TREATMENT WITH O.I N
NaOH-0.3 M NaBH4 AT 40
Results are expressed in mg/154.5 mg OSM.
Time of treatment in hours
0 24 72 144 216
Protein 88.5 90-3 89.1 89.6 85.6
NANA 2.5-8 24.1 21.2 18.2 15-3
Hexosamine * 19-5 18.3 15.6 13-2 10.7
*
Expressed as D-galactosamine • HC1.
To one flask was added 15 ml of 0.3 M LiBH4 in tetrahydrofuran and the solution
was refluxed for 6 h. The reaction mixture was then stirred with about 2 ml of 2 N
methanolic hydrochloric acid for 1 h at o° and taken to dryness in a desiccator.
Residual borate was removed by repeated evaporation from methanolic hydrochloric
acid. The dry residue was hydrolysed in 5 ml of 6 N HC1 at no° for 24 h in a sealed
tube. After removal of the hydrochloric acid (see above), the dicarboxyiic acids were
separated on a Dowex-i (acetate) column, eluted with 1 N acetic acid and quantitated
according to Moore and Stein13. The other aliquot of 22.0 ml was treated in the same
manner except that LiBH4 was omitted.
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TABLE III
THE DICARBOXYLIC AMINO ACID CONTENT OF GLYCOPEPTIDES FROM SHEEP OSM BEFORE AN,.
AFTER TREATMENT WITH LiBHt










Trypsin, pH 8.0, 37°, 16 h;
dialysis
Trypsin, pH 8.0, 37", 16 h;
dialysis
Pronase, pH 7.0, 370, 24 h;
fractionation on
Sephadex G-25
Pronase, pH 8.0, 420,
120 h; fractionation on
Sephadex G-25
Pronase, pH 8.0, 370,






' Not corrected for moisture.
The results of the experiments are shown in Table Hi.
B. About 50 mg of OSM was dissolved in 10.o mi of 0.01 M CaCl2 solution and
the pH adjusted to 7.0. This mixture was digested with 2 mg of pronase for 24 h at
370, the pH being kept constant. After concentration to a small volume the digest
was applied to a Sephadex G-25 column and developed with distilled water. The
fractionation of the digest was performed as described previously2. For the reductior
experiments the sialoglycopeptide fraction (Pool B) was taken. Pool C (free amine
acids and short peptides) gave a ninhydrin value equivalen+ to 81 wmoles of L-leucine
indicating a considerable degree of fragmentation.
Pool B was concentrated to a volume of 10.0 mi. An aliquot of 5.0 ml was dried
j.nd submitted to the reduction and subsequent procedures as described under A
As control, the dicarboxylic acid content in an aliquot of the residual concentrate was
ietermined.
In some experiments pronase digestion was carried out as in the previous paper-
vpH 8.0, 42°, 120 h). In one experiment about 50 mg of OSM was treated with 3 addi¬
tions of pronase (totalling 3.0 mg) at pH 8.0 and 37° for 72 h. In this case no fractiona¬
tion of the digest prior to LiBH4 treatment was undertaken; a corresponding amount
of pronase was added to the control immediately before acid hydrolysis.
The results of the pronase experiments are also shown in Table III.
In the pronase experiment at pH 7.0 the glycopeptides, after treatment with
LiBH4, were assayed for homoserine and a-amino-<5-hydroxy-«-valeric acid Only
traces of these reduction products were found, their sum total being o 06 //mole o
rven less, i.e. 0.8% or less of the total dicarboxylic acids present
Neduction by LiBHx of the model ester, y-methyl glutamate
To test the efficiency of the reduction procedure applied. 8.9 ^moles of the
. i:.. lio-bhyr. Acta, 101 (ip6<-> ::r,x-14^
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model ester, '/-methyl glutamate, were submitted to all steps of the procedure de
scribed under A. When the effluent and the eluate from Dowex-i column were
analysed for amino acids, the following results were obtained: effluent, 6.52 //moles;
eluate, 2.48 //moles. It was found in an independent experiment that the colour
value of a-amino-d-hydroxy-M-valeric acid was 96% of that of the l-leucine standard.
By paper chromatography, taking authentic a-amino-^-hydroxy-n-valeric acid as
reference substance, it was ascertained that the effluent contained only a-amino-d
hydroxy-^-valeric acid and the eluate only glutamic acid. These figures would indicate
a reduction of 73.3% of the ester.
discussion
It was the aim of the experiments described in this paper to find out whether
or not in the OSM preparation from German sheep in addition to the O-glycosidic
linkages to serine and threonine known to be present2-3 another type of alkali-labik
linkage, in particular a glycosidic-ester linkage, occurs.
In the first set of experiments 35.2% of the total bound hexosamine wa.
liberated when the OSM preparation was kept at pH 8.0 and 420 for 120 h. For eacl
rig. I. Decrease with time of bound hexosamine and NANA on treatment of OSM anc
BSM with 0.1 N NaOH at a°. Hexosamine bound in sheep OSM (O—O). hexosamine bound ir
BSM (•—«).
tnole of hexosamine released one mole of serine or threonine was lost (Table I). In tfie
>econd set of experiments the decrease with time of bound hexosamine and NANA
on treatment of OSM with 0.1 N NaOH-0.3 M NaBH4 at 4° was determined (Table II)
Under these conditions Tanaka, Bertolini and Pigman4 had observed for BSM a
apid fall of bound hexosamine during the first 24 h, followed by a slow decrease over
the next 192 h. Fig. 1 shows on a comparable scale the results of Tanaka, Bertolin)
and Pigman with BSM and our results with OSM. Whereas the time curve obtained
vith BSM displays a sharp decrease in gradient after 24 h, indicating the presence ot
rwo types of carbohydrate-peptide linkages differing in their degree of alkali lability,
the time curves obtained with OSM are very close to a straight line. Moreover, in the
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BSM preparation the release of hexosamine, on a molar basis, was more than the loss
of serine plus threonine. Thus, after 144-h treatment 68.9 //moles of hexosamine were
liberated for a total loss of 51.5 //moles of a-amino-/J-hydroxycarboxylic acids, indi¬
cating that 17% of the total hexosamine residues are linked to the peptide by a bond
other than a glycosidic linkage to serine and/or threonine. The high sensitivity of this
other bond to alkali would be compatible with a glycosidic-ester linkage, as pointed
out by Tanaka, Bertolini and Pigman4.
In the third set of experiments glycopeptides prepared from OSM by trypsin
or pronase digestion were treated with LiBH4 in tetrahydrofuran and the dicarboxylic
acid content of the protein moiety was determined before and after this treatment.
With the trypsin-pretreated OSM no significant difference was observed after 6-h
LiBH4 treatment. Also the small glycopeptides, resulting from pronase digestion of
sheep OSM at pH 7.0, did not lose more than 10.7% of their dicarboxylic acids on
treatment with LiBH4 for 6 h, a loss too small to be regarded as significant. This is
also evident from the negligible amount of homoserine and a-amino-<5-hydroxy-n-
valeric acid formed in this experiment.
The efficiency of LiBH4 to reduce esters under the conditions applied in the
above experiments is shown by the reduction of 73% of y-methyl glutamate to a-
amino-(5-hydroxy-w-valeric acid. On the other hand, the recovery of 94.6% and
94.9% respectively of the dicarboxylic acids of glycopeptides (prepared from OSM
by pronase action at pH 8.0 and known to contain only O-glycosidic linkages to serine
and threonine2) on LiBH4 treatment for 6 and 10 h would indicate that peptide-
bonded aspartyl and glutamyl residues are not effected by this treatment. This is in
agreement with out previous finding18 that LiBH4 treatment of poly-a-glutamic acid
yielded on hydrolysis only 3.4% less free glutamic acid than did a control similarly
treated, but omitting refluxing with LiBH4 in tetrahydrofuran.
It would thus appear from the three approaches made that the existence in
OSM (German sheep) of a glycosidic-ester linkage or any other linkage more alkali-
labile than is the O-glycosidic linkage to serine or threonine can be excluded.
These results seem to contradict our previous observations with OSM prepared
from Australian sheep. When trypsinized Australian OSM was submitted to LiBH4
treatment under the conditions applied to German OSM, it lost 35% of its dicarboxy¬
lic acids in 7 h.
In a similar manner, the results of hydroxylamine treatment of OSM prepared
from Australian and European sheep differ. Treatment of OSM (Australian sheep)
with hydroxylamine at pH 12.2 and 370 resulted in the release of prosthetic groups
concomitant with the formation of hydroxamates. The released disaccharides were
quantitatively recovered, mainly in form of their oximes. Under similar conditions
of alkalinity but in the absence of hydroxylamine, disaccharides were released at a
much lower rate11. When Harbon, Herman-Boussier and Clauser20 treated their
European OSM at pH 12.8 and 50° for 60 min, the presence of hydroxylamine (1.6 M)
did not alter the rate of release of the prosthetic groups.
Obviously then, the results obtained with Australian OSM and European OSM
are consistent in themselves, but differ from each other. The suggestion is made that
the difference in age of the sheep used for the material may be a contributing factor.
At the Canberra abattoirs (from which the glands were collected for linkage studies)
more than 80% of the sheep slaughtered are lambs at the age of 3 to 9 months
Biochim. Biophys. Acta, 101 (1965) 141-149
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(average 4 months), the reason being that Canberra has a selected population without
industrial workers. In Germany and France practically only adult sheep of three
years or more are killed and the meat sold as mutton. There are also differences in
breed, in pastures and other living conditions between Australian and European sheep.
Kaplan and Meyer21 have shown that costal cartilage of newborn infants
contains only chondroitin 4-sulphate, that of adults mainly chondroitin 6-sulphate.
For human intervertebral discs Buddecke and Sziegoleit22 found similar changes
with age. It is also known23 that the sialic acid of serum of 3-6-month-old calves
consists of about 25 % iV-glycolylneuraminic acid and 75 % iV-acetylneuraminic acid
(disregarding any O-acetylation). In ox serum the sialic acid contains about 65%
iV-glycolylneurammic acid, the rest being the N-acetylated compound. For fetuin,
the main serum protein of fetal calf, Klenk and Uhlenbruck24 and Spiro25 have
shown that Ar-glycolylneuraminic acid contributes but 5-7% to the total sialic acid
content.
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Mucopolysaccharides: N-Acetylglucosamine- and
Galactose-6-Sulfates from Keratosulfate
Abstract. Galactose-6-sulfate and N-acetylglucosamine-6-sulfate were obtained
pure from a partial acid hydrolyzate of corneal keratosulfate by paper chromatog¬
raphy and electrophoretic fractionation. These sugars were also present in
hydrolyzates of skeletal keratosulfate. The distribution of the sulfate groups in
the various keratosulfates might depend upon their source, and this distribution
probably has important biological significance.
Keratosulfate is a sulfated muco¬
polysaccharide composed of equimolar
amounts of d-galactose and N-acetyl-
d-glucosamine and of variable quantities
of methylpentose and sialic acid (/).
It has been isolated from cornea (2),
nucleus pulposus (5), and cartilage of
mammals and lower species (4). In
these tissues keratosulfate is covalently
bound to protein by at least two dif¬
ferent types of bonds, either by N-
glycosyl bonds to the amide groups of
asparagine and glutamine or by O-gly-
cosyl bonds to the hydroxyls of serine
and threonine (/). The O-glycosidic
bonds are alkali-labile and are split by
^-elimination (5). The N-glycosyl
bonds are mainly present in keratosul¬
fate of cornea, the O-glycosyl linkages
in skeletal keratosulfate. The structure
of corneal keratosulfate was deduced
from methylation and enzymatic diges¬
tion of the sulfated and desulfated
polymer as jV-acetyllactosamine-6-sul-
fate, polymerized by 1,3 bonding of
the alternating hexosaminyl and d-ga-
lactosyl moieties (6).
Since the yields of the isolated
methyl ethers were rather low, the
methylation of bovine cornea kerato¬
sulfate was reinvestigated. Improved
methods markedly increased the yields
of methyl ethers, which, in general,
confirmed the proposed structure. How¬
ever, the evaluation of the experiment
suggested that carbon No. 6 of galac¬
tose was partly blocked, indicating ei¬
ther branching at this position or sub¬
stitution by another group.
After searching for optimum condi¬
tions we obtained, on hydrolysis of 1.0
g of keratosulfate for 1 hour with
0.5N H0SO4 at 100°C, two sulfated
monosaccharides, which were isolated
by paper chromatography and electro¬
phoresis. Fraction I (8.0 mg) was ga¬
lactoses-sulfate, the other (fraction II,
13.2 mg) N-acetylglucosamine-6-sulfate.
In addition, a number of sulfated oligo¬
saccharides were present.
The properties of fraction I are as
follows: [a]n as barium salt was +42.5°,
as ammonium salt was +52.0°. In pa¬
per chromatography its migration was
10 percent slower than that of syn¬
thetic glucose-6-sulfate. On paper elec¬
trophoresis at pH 6 it had the same
mobility as glucose-6-sulfate. Its stain¬
ing with aniline phthalate and tetra-
zolium chloride showed that the re¬
ducing group and carbon No. 2 were
free.
The ratio of sulfate to galactose was
1.06. The reducing value (Schales and
Schales) was 84 percent that of galac¬
tose. On infrared spectroscopy the sub¬
stance absorbed at 1240 and 820
cm-1, showing the absence of a sul¬
fate on carbon No. 4. It consumed 3
moles of periodate rapidly in unbuf¬
fered solution and then consumed slow¬
ly an additional mole. Negligible
amounts of formaldehyde were re¬
leased on oxidation in bicarbonate buf¬
fer (pH 7.5) for 24 hours (7).
The properties of fraction II were
as follows: [oln as ammonium salt was
+47.9°. Chromatographically and elec-
trophoretically it had the same mobili¬
ty as authentic /V-acetylglucosamine-6-
sulfate. It stained with aniline phthal¬
ate and gave a positive reaction for
N-acetylhexosamine. The ninhydrin re¬
action was negative. On complete hy¬
drolysis glucosamine was the only car¬
bohydrate present. The ratio of sulfate
to jV-acetylglucosamine was 0.97, that
of sulfate to glucosamine was 0.98. The
reducing value (Schales and Schales)
was 98 percent that of N-acetylglucosa-
mine. On infrared spectroscopy the sub¬
stance absorbed at 1240 and 820 cm-1,
indicating a primary sulfate ester group.
On periodate oxidation in bicarbonate
buffer it liberated formaldehyde only in
traces.
The data strongly indicate that frac¬
tion I is galactose-6-sulfate and that
fraction II is N-acetylglucosamine-b-
sulfate. Paper chromatography and
electrophoresis of a similarly hy-
drolyzed sample of keratosulfate from
cartilage of human rib likewise yield¬
ed galactose-6-sulfate. Judged from the
intensity of the spots, the content of
galactose-6-sulfate in this fraction ap¬
pears to be higher than that of kerato¬
sulfate of cornea. The isolation of N-
acetylglucosamine-6-sulfate is in agree¬
ment with the structure previously pro¬
posed.
The presence of galactose-6-sulfate is
another instance of the variations in
the mucopolysaccharides in general and
in keratosulfate in particular, and is
another example of the apparent ran¬
domness of the biosynthesis of these
compounds.
The isolation of galactose-6-sulfate
from keratosulfate of cornea is note¬
worthy in that the ratio of sulfate to
hexosamine in cornea is always close
to one, while keratosulfate of senile hu¬
man cartilage, as well as that of elasmo-
branch cartilage, is oversulfated; that
is, the ratio of sulfate to hexosamine
is greater than one (J). In these sources
the extra sulfate can be expected to
be in the galactosyl moiety. Galactose
sulfate in mammalian tissue occurs in
the sulfatides of brain and other tis¬
sues (8), and recently galactoses-sul¬
fate was demonstrated in neuraminlac-
tose sulfate from the mammary glands
of rats (9).
The finding of sulfate ester groups
in both galactosyl and hexosaminyl
moieties of keratosulfate may explain
the anomalous behavior of this poly¬
mer toward quaternary ammonium
and pyridinium salts (10), which may
be caused by the proximity of sulfate
groups in neighboring instead of in al¬
ternating glycosyl groups, so that the
compound behaves similarly to
heparin.
In view of our finding, we should
not assume that the keratosulfate frac¬
tions that are isolated from different
normal and abnormal tissues, such as
degenerating cartilage, nucleus pulpo¬
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Studies on Keratosulfates
METHYLATION AND PARTIAL ACID HYDROLYSIS OF BOVINE CORNEAL KERATOSULFATE*
(.Received for publication, May 22, 1967)
V. P. Bhavanandan and Karl Meyer
From the Department of Medicine, College of Physicians and Surgeons, Columbia University, and the Department
of Chemistry, Belfer Graduate School of Science, Yeshiva University, New York, New York%
SUMMARY
Bovine corneal keratosulfate was permethylated in non¬
aqueous solvent after prior peracetylation. The methyl
ethers were isolated after hydrolysis and characterized either
as crystalline derivatives or by their physical and chemical
properties. The main repeating unit is N-acetyllactosamine
polymerized via a 1 -* 3 linkage to galactose, as reported
previously. About 74% Gf the N-acetylglucosaminyl groups
are sulfated in position 6. However, about 40% cf the
galactosyl groups are also substituted in position 6, at least
in the major portion by sulfate ester groups. This was
shown by the isolation and characterization of galactose
6-sulfate from partial acid hydrolysates. In addition, N-
acetylglucosamine 6-sulfate and oligosaccharides sulfated
to varying degrees were also obtained. The polymer con¬
tained about 25% of galactosyl groups in excess of hex-
osamine. This excess is preferentially hydrolyzed and may
indicate branch points. Evidence of N-methylation of
glucosamine was obtained. The color reactions and nuclear
magnetic resonance spectrum of N-methylglucosamine are
compared with those of iV-acetylglucosamine.
The repeating unit of keratosulfate from bovine cornea was
shown by methylation studies (1), to be (1 —► 3)-/3-D-galacto-
pyranosvl-(l —> 4)-2-acetamido-2-deoxy-j3-D-glucopyranosyl 6-
sulfate. However, the yields in these experiments were not
satisfactory, and the presence of 2,4-di-O-methyl-D-galactose in
both methylated native and desulfated polysaccharide indicated
either that the products were grossly undermethylated or that
position 6 of galactose was blocked. It was therefore thought
desirable to reinvestigate the methylation of KS I.1 By carry¬
ing out the methylation in organic solvents it was possible to
* This work was supported by a research grant from the United
States Public Health Service.
+ Present address of both authors.
1 The abbreviations used are: KS I, corneal keratosulfate;
KS II, skeletal keratosulfate; NMR, nuclear magnetic resonance.
increase both the yield and the extent of methylation of the final
product. Examination of the hydrolysate of this product showed
the presence of 2,4-di-O-methyl-D-galactose, which comprised
about 40% of the galactose derivatives. Once undermethylation
or demethylation could be ruled out, it was concluded that about
40% of the galactose was blocked in position 6 either by branch¬
ing or by sulfate groups. Lack of nonreducing end groups makes
a major degree of branching improbable. This lack was shown
by the total absence of 3,4,6-tri-O-methy1-d-glucosamine and
the presence of only trace amounts of 2,3,4,6-tetra-O-methyl-
galactose and 2,3,4-tri-O-methyl-L-fucose in the hydrolysate of
KS I. Further, the presence of sulfate groups on position 6 of
galactose was confirmed by the isolation of galactose 6-sulfate
from partial acid hydrolysates of KS I (2). A full report of this
partial acid hydrolysis studies and the reinvestigation of the
methylation of KS I is presented in this paper.
EXPERIMENTAL PROCEDURE
Materials—Bovine corneas were obtained from Cudahy Com¬
pany, Omaha, Nebraska. KS I was prepared and purified as
described previously (4). The analytical values of the prepara¬
tion were as follows (per cent of dry weight): hexose (anthrone
method), 35.5; hexosamine, 26.1; uronic acid (carbazole method),
1.8; sulfate, 14.9; protein (Lowry), 10.3; methylpentose, 0.8;
sialic acid (direct Ehrlich), 1.0; and [a]„5 +3.0°.
Sugars—We gratefully acknowledge the following gifts of
samples: 2,3,4-tri-O-methyl-iV-phenyl-L-fucosylamine, 2,4,6-
tri-O-methy1-d-galactose, and 2-acetamido-2-deoxy-3,4,6-O-tri-
methy1-d-glucose, from Professor R. Kuhn; 2,3,4,5-tetra-O-
methy1- and 2,4,6-tri-O-methy1-iV-phenyl-D-galactosylamines,
and 2,3,4-tri- and 2,3,6-tri-O-methylgalactoses, from Professor
G. O. Aspinall; 2,3,4,6-tetra-O-methyl-D-galactose, from Dr.
K. O. Lloyd; 2,4-di-0-methyl-3,6-anhydro-D-galactose, from
Dr. B. A. Lewis; and pentaacetyl-iV-methyl-L-glucosamine,
from Merck and Company, Inc.
Analytical Methods—These were the same as cited previously
(3, 4) except for ester sulfate analysis, which was performed by
the method of Antonopoulos (5).
Melting points were obtained on a microscope hot stage and
are uncorrected.
Optical rotations in water solutions were measured with a
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Diagram 1. Methylation and partial acid hydrolysis of KS I
Bendix model 968 automatic polarimeter at room temperature,
about 25°.
Infrared spectra were obtained with potassium bromide pellets
in a Perkin-Elmer model 21 spectrophotometer with sodium
chloride prism. All evaporations were carried out under reduced
pressure and temperatures below 40°. Methylated sugars were
demethylated with hydriodic acid (6) or with boron tribromide
(7). Deionized water was used in all experiments on the isolation
and characterization of sulfated sugars.
Chromatography—Paper chromatograms were developed by
the descending technique on Whatman No. 1 paper. Whatman
No. 3MM paper used for quantitative separation was previously
washed with 0.01 n HC1, followed by distilled water, and finally
with the solvent used in the separation. The following solvent
systems (v/v) were used: A, butan-l-ol-ethanol-water (10:3:5);
B, butan-l-ol-ethanol-water (4:1:5, upper layer); C, benzene-
ethanol-water (169:47:15, upper layer); D, ethyl acetate-pyri-
dine-water (10:4:3); E, ethyl acetate-acetic acid-water (6:3:2);
F, ethyl acetate-pyridine-water (8:2:1); G, butan-l-ol-pyridine-
water (5:3:2); and H, butan-l-ol-acetic acid-ethanol-water
(10:3:1:7). Sugars were detected with aniline phthalate spray
or with alkaline silver nitrate. Ninhydrin and Elson-Morgan
sprays were used for hexosamines, and Morgan-Elson spray for
N-acetvlhexosamines. Rq values of methylated sugars refer to
rates of movement relative to 2,3,4,6-tetra-O-methyl-D-glucose
in Solvent B.
Thin layer chromatography was carried out on plates coated
with Silica Gel G or Silica Gel H according to Stahl (8). The
plates were eluted by the ascending technique with the following
solvent systems (v/v): (a) acetone-water-ammonia (250:3:1.5)2
and (6) benzene-95% ethanol (20:5) (9). Sugars were detected
with aniline phthalate spray.
Electrophoresis was performed on both Whatman No. 1 and
prewashed Whatman No. 3MM paper (for quantitative separa¬
tion) with the following buffer systems: I, 0.1 n acetic acid-
2 P. Stoffyn, personal communication.
pyridine, pH 5.5; II, 0.1 n acetic acid-pyridine, pH 3.5; and
III, 0.05 n acetic acid-pyridine, pH 6.0. The same sprays de¬
scribed for paper chromatography were used for detection.
Cellulose columns were packed dry and washed extensively
with water, followed by the solvent system used for elution until
the washings gave a negative anthrone test. The solvents used
for cellulose columns or for preparative separations on Whatman
No. 3MM sheets were purified as follows. Butan-l-ol was re-
fluxed for 2 hours with potassium hydroxide (1 %, w/v) and dis¬
tilled. Light petroleum was shaken overnight with concentrated
H2SO4 (10%, w/v), washed free of acid with distilled water,
and distilled. Pyridine (Mallinckrodt) was refluxed with po¬
tassium hydroxide (1%, w/v) and distilled. Analytical reagent
grade preparations of other solvents were used without further
purification.
experiments and results
Methylation and partial acid hydrolysis of KS I were carried
out as summarized in Diagram 1.
Methylation (10)
Keratosulfate (1.05 g) was dissolved in freshly distilled form-
amide (8 ml) by shaking for 1 hour in a stoppered flask. Pyri¬
dine (8 ml) and acetic anhydride (4 ml) were added, and the
mixture was shaken overnight. A further portion of acetic
anhydride (6 ml) was added the next day, and the shaking was
continued for 24 more hours. The reaction mixture was poured
with stirring into cold ethanol (400 ml) containing potassium
acetate, and the precipitate was collected by centrifugation.
The precipitate was dissolved in water (50 ml) and reprecipitated
from ethanol; this process was repeated once. The precipitate
was washed twice with ethanol, dissolved in water, and lvophi-
lized to yield 0.97 g (71 %)3 of the acetylated product.
3 The poor yield could at least be partly explained by the
failure to allow enough time for the precipitation of the acetylated
keratosulfate from ethanol. When KS II was acetylated by the
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Table I
Gas-liquid chromatographic examination of methyl glycosides of
methylated neutral sugars from KS I
These experiments were carried out by Professor G. O. Aspinall,
Department of Chemistry, University of Edinburgh.
Retention times0
Compound





2,4,6-Tri-O-methyl-o-galactose... . 3.99; 3.52 3.30; 3.00
2,3,4-T ri-O-methyl-D-galactose 6.95 4.85; 5.58
2,4-l)i-0-methyl-d-galactose 14.58; 13.40 10.5; 9.48
° Retention times relative to that of methyl 2,3,4,6-tetra-O-
methyl-/3-d-glucopyranoside.
6 NPGA, neopentyl glygol adipate.
Table II
Fractionation of hydrolysate from methylated KS I
Fraction Weight RQ Probable identity of sugar
1
mg
5.8 0.90 2,3,4,6-Tet ramethylgalactose
and 2,3,4-trimethvlfucose
2 62.6 0.79 2,4,6-Trimethylgalactose










3-Me t hvl - Ar-me thylgl u cos -
amine
3-Methvlglucosamine
Acetylated keratosulfate (0.91 g) was dissolved in dimethyl-
formamide (30 ml) and maintained in an ice bath under nitrogen
with continuous stirring. Powdered sodium hydroxide (17.5 g)
and dimethyl sulfate (21 ml) were added in seven equal portions
over a period of 48 hours. The mixture was neutralized with
dilute sulfuric acid to pH 7.0 and filtered, and the residue was
repeatedly extracted with chloroform. The filtrate and chloro¬
form extracts were evaporated under reduced pressure to yield
Syrup a. The residue after chloroform extraction was dissolved
in water and dialyzed, first against running tap water and then
against distilled water. On concentration the bag contents
yielded Syrup b, which gave a positive an throne test, showing
that a part of the partially methylated keratosulfate is insoluble
in chloroform. Syrups a and 6 were combined and again treated
with dimethyl sulfate (21 ml) and powdered sodium hydroxide
(17.5 g) as described above. The reaction mixture was neu¬
tralized and dialyzed against running tap water for 48 hours, and
then against two changes of stirred distilled water at 4° for 48
hours. The bag contents were filtered, concentrated to a small
volume, and lyophilized, yielding 0.51 g of partially methylated
same procedure and the reaction mixture, after being poured
into ethanol, was allowed to stand overnight in the refrigerator,
a 97% yield of the product was obtained (unpublished results).
keratosulfate4 (OCH3, 16.9). This product was dissolved in
dimethylformamide (15 ml) and dry methanol (5 ml) and meth¬
ylated by Kuhn's method (11) with BaO (6 g), Ba(OH)2-
8H20(3 g), and methyl iodide (15 ml) to yield a yellow powder
(0.50 g) (OCH3, 17.6). The infrared spectra showed a peak at
3200 to 3500 cm-1 due to hydroxvl or —XH absorption,
or both. The material was finally treated with distilled dry
methyl iodide and freshly prepared silver oxide (12, 13) in puri¬
fied dimethylformamide. A glassy yellow solid (0.44 g, 42%
yield) was obtained, which was only partially soluble in water
and chloroform but was completely soluble in methanol and
dimethylformamide. Calculated: SO4, 13.3; OCH3, 23.8.
Found: [a]? +4(c, 1.0); S04, 11.5; OCH3, 22.7. The Seliwanoff
test (14) for anhydro sugars on this material was practically
negative.
Hydrolysis of Methylated Polysaccharide
The methylated product (400 mg) was dissolved in 2% meth-
anolic hydrogen chloride (30 ml) and refluxed at 100° for 6 hours.
The solution was concentrated to a syrup under reduced pressure
below 35° and further dried over sodium hydroxide pellets in a
desiccator. The mixture of methyl glycosides thus obtained was
dissolved in n H2S04 (45 ml) and heated at 100°. The hydrol¬
ysis was followed by determination of reducing sugar (15) and
stopped after 7 hours, when the maximum reducing value had
been attained. The hydrolysate was neutralized with Ba(OH)2,
followed by BaC'03, and filtered, and the precipitate was washed
with water and then methanol. The filtrates were concentrated
under reduced pressure, yielding a syrup, which was extracted
with dry methanol and centrifuged; the supernatant was dried to
yield 0.39 g of methyl ethers.
Methylotion Results
Preliminary paper chromatograms in Solvents A, B, and C
and thin layer chromatography in Solvents a and b showed
seven methyl ether components and no unmethylated or mono-
methylated sugars, confirming that a fairly high degree of meth-
vlation was obtained. A sample (8 mg) of the methylated mono¬
saccharides was dried under vacuum and converted to the methyl
glycosides by heating at 100° with 3% methanolic hydrogen
chloride in a sealed tube for 6 hours. The product isolated after
neutralization with silver carbonate was applied as a water solu¬
tion on to a column of Dowex 50-H+ (12 X 1.5 cm). The column
was eluted with water until the washings gave a negative reaction
with anthrone. The water eluate, which contained only the
methyl glycosides of methylated neutral sugars, was dried and
examined by gas-liquid chromatography (16). The results are
summarized in Table I.
Fractionation of Methylated Monosaccharides
The syrup (350 mg) was lyophilized on 3 g of cellulose powder,
and this powder was then packed on top of a cellulose column
(51 X 2 cm). The column was successively eluted with light
petroleum (b.p. 110-115°)-butan-l-ol (7:3, later 1:1) saturated
with water; butan-l-ol half saturated with water; and water.
Fractions of about 10 ml were collected every 20 min. Every
fifth fraction was taken to dryness, examined chromatographi-
cally in Solvent B, and appropriately bulked to give five fractions
(see Table II).
4 This material was easily soluble in methanol, chloroform, and
dimethylformamide, but gave a turbid solution in water.
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Fraction 1—The syrup (5.8 mg) had the same mobility as
2,3,4,6-tetra-O-methylgalactose on paper chromatograms in
Solvents A, B, and C. Demethylation (1 mg) with hydriodic
acid followed by chromatography in Solvent D showed galactose
and a trace of a second component with the mobility of fucose.
The sugar (4 mg) was refluxed with redistilled aniline (2 mg) in
absolute ethanol (1 ml) for $ hour. The product resisted all
attempts to crystallize it. The methyl ethers were recovered by
treatment with Dowex 50-H+. Thin layer and gas-liquid
chromatography showed that the main component in this frac¬
tion was 2,3,4,6-tetra-O-methylgalactose.
Fraction 2—The sugar, [o:]D +82.8 (c, 1.20), was chromato-
graphically indistinguishable from 2,4,6-tri-O-methyl-n-galac-
tose in Solvents A, B, and C. Demethylation with hydriodic
acid gave only galactose. A portion (20 mg) was refluxed for 30
min with redistilled aniline (10 mg) in absolute ethanol (2 ml)
with exclusion of light. On removal of the solvent, a partially
crystalline material was obtained which recrystallized twice
from ethyl acetate; m.p. and mixed m.p. with authentic 2,4,6-
tri-O-methyl-iV-phenyl-D-galactosylamine, 195-197°. The rest
of the sugar crystallized after prolonged desiccation and was
recrystallized from ethyl acetate-light petroleum; m.p. 98-99°;
mixed m.p. with authentic 2,4,6-tri-O-methyl-d-galactose,
97-100°.
Fraction 3—The syrup, [a]D +78.0 (c, 0.91), was chromato-
graphically pure and identical with 2,4,di-0-methyl-d-galactose
in Solvents A, B, and C. The demethylated product showed
only galactose on paper chromatograms run in Solvents B and D.
The syrup crystallized on desiccation and was recrystallized
from ethyl acetate; m.p. 94-97°. The aniline derivative was
prepared as described above for Fraction 2; m.p. 210-212°;
mixed m.p. with authentic 2,4-di-O-methyl-iV-phenyl-d-galac-
tosylamine, 212-214°.
Fraction 4—The syrup (30.8 mg) was fractionated on Whatman
No. 3MM paper in Solvent B into three fractions.
Fraction 4®—(5.3 mg) was chromatographically indistinguish¬
able from Fraction 5 in Solvents B and D, and the two fractions
were therefore combined.
Fraction 4b—This fraction (14.1 mg; Ra 0.39; RF in Solvent
B, 0.36) gave only one spot on paper chromatography in Solvents
A, B, and D. This spot gave positive reactions with aniline
phthalate and ninhydrin sprays, but did not react with the
Morgan-Elson spray, even after a long time. Paper electro¬
phoresis in Buffer I at 500 volts for 2 hours gave only one spot
with the same mobility as i)-glucosamine. Demethylation with
hydriodic acid followed by treatment with ninhydrin (17) showed
mainly arabinose in a paper chromatogram run in Solvent D.
Direct ninhydrin treatment of the fraction gave a sugar which
had the same mobility on paper and thin layer chromatograms as
the sugar obtained by ninhydrin treatment of Fraction 4c (see
"Discussion"). The s\'rup (5 mg) was iV-acetylated (1) to give
a product which had a chromatographic mobility identical with
that of authentic 2-acetamido-2-deoxy-3,6-di-O-methyl-d-glu-
cose. The product gave a positive reaction with the Morgan-
Elson reagent.
Fraction 4c—This fraction (10.4 mg; Ra 0.54; RF 0.49 in
Solvent B) also gave only one spot on paper chromatograms de¬
veloped in Solvents A, B, and D. The spot reacted strongly
with aniline phthalate, rather faintly with ninhydrin, and very
slowly with the Morgan-Elson spray, showing a reddish violet
color after about 30 min (18). Paper electrophoresis in Buffer
I as above (Fraction 4c) gave one spot with the same mobility
as d-glucosamine. Demethylation followed by ninhydrin
treatment gave mainly arabinose. Direct ninhydrin treatment
of this fraction gave a sugar with a mobility corresponding to
that of a dimethylarabinose on paper and thin layer chromato¬
grams. Complete .Y-acetylation (1) of Fraction 4c was dif¬
ficult to attain; even after two treatments the product showed
two spots on paper electrophoresis, one with the mobility of n-
glucosamine and the other staying at the origin (see "Discus¬
sion").
Fractions—The syrup (72.4 mg) was fractionated on Whatman
No. 3MM paper into three fractions in Solvent B.
Fraction 5a—This fraction (40.2 mg; RG 0.18; RF 0.17 in
Solvent B) gave a single spot on paper chromatography in
Solvents B and D. The spot reacted with aniline phthalate,
alkaline silver nitrate, and ninhydrin sprays, but not with the
Morgan-Elson spray even after a long time. Paper electrophore¬
sis in Buffer I gave only one spot with the mobility of glucosa¬
mine. Demethylation followed by ninhydrin gave only arabi¬
nose on paper in Solvents B, D, and G. The syrup (30 mg) was
iV-acetylated. The product, [a]D +28 (c, 0.2), had the same
Morgan-Elson and RF values as an authentic sample of 2-aceta-
mido-2-deoxy-3-0-methyl-d-glucose. The .V-acetylated product
was recrystallized from methanol-ether; m.p. 158°.
Fraction 5b—This fraction (16.2 mg) was a mixture of Frac¬
tions 5a and 5c and was not further investigated.
Fraction 5c—This fraction (10.3 mg; RG 0.26; RF 0.22 in
Solvent B) gave only one spot in Solvents B and D and reacted
strongly with aniline phthalate and alkaline silver nitrate sprays,
but only faintly with ninhydrin. The sugar reacted very slowly
with the Morgan-Elson spray, giving a reddish violet spot after
about $ hour. Paper electrophoresis in Buffer I gave only one
spot, with the mobility of glucosamine. Demethylation followed
by ninhydrin treatment gave mainly arabinose, as shown by
paper chromatography in Solvents B, D, and E. Direct ninhy¬
drin treatment of Fractions 5a and 5c gave mainly one product,
presumably a monomethylarabinose, which had similar mobili¬
ties on paper and thin layer chromatography.
Partial Acid Hydrolysis of KS I
Trial hvdrolyses were carried out with n acetic acid and 0.5 n
H2SO4 for various lengths of time. The products were examined
chromatographically in Solvents E and F and electrophoretically
in Buffer I at 300 volts for 14 hours, with aniline phthalate and
ninhydrin sprays. It appeared that the best yield of sulfated
and nonsulfated oligosaccharides were obtained on hydrolysis
with 0.5 n H0SO4 at 100° for 1 hour. Accordingly, KS I (1.0 g)
in 0.5 n H2SO4 (100 ml) was hydrolyzed for 1 hour at 100°. The
cooled solution was neutralized with Ba(OH)2 and BaC03 and
centrifuged, and the precipitate was washed twice with water.
The supernatant and washings were concentrated to a small
volume, some precipitate that formed was filtered, and the clear
solution was dried (756 mg). This material was redissolved in
water (50 ml) and dialyzed with stirring against two changes of
distilled water (400 ml each) at 4° for 48 hours. The dialysates
(Fraction A) and bag contents (Fraction B) were separately con¬
centrated and lvophilized, yielding 440 mg and 280 mg, respec¬
tively.
Partial Hydrolysis Results
Fraction .1—Fraction A was fractionated by electrophoresis on
Whatman No. 3MM sheets in Buffer III at 25 volts per cm for
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Fig. 1. Electrophoretic fractionation pattern of partial acid
hydrolysate of KS I.
Table III
Sulfated oligosaccharides from partial acid
hydrolysis of KS I
All fractions gave a positive aniline phthalate reaction and a
negative ninhydrin reaction. After total hydrolysis (n hydro¬
chloric acid, 16 hours, 100°), all gave only galactose and glucos¬
amine on paper chromatograms. After sodium borohydride re¬
duction, hexosamine was practically unchanged in the last three
fractions; in the first fraction, 57.2% of hexosamine was destroyed.
Sodium salt Weight












A2c 7.8 0.34 1.00 0.95 0.92 10.6
A4a 4.7 0.38 0.09 2.00 0.96 0.99 51.5
A4b 1.8 0.53 0.18 1.00 0.96 2.64 80.8
A4c 4.1 0.75 0.24 1.00 0.94 0.89 89.5
105 min into six fractions (see Fig. 1). After elution from paper
with deionized distilled water, Fractions A1 through A4, which
were acidic (sulfated) sugars, were neutralized with dilute
NH4OH and taken to dryness. Fraction A5, which contained
the neutral sugars and amino acids, and Fraction A6, containing
the basic sugars, were also concentrated to dryness.
Fraction A2—The sample (64.6 mg) was further fractionated
into three subtractions on thick filter sheets in Solvent E, and
the sugars were isolated as their barium salts.
Subfraction A2a—This subtraction (13.2 mg) was chromato-
graphically (Solvent E) and electrophoretically (Buffer III)
identical with A'-acetylglucosamine 6-sulfate. It gave a positive
reaction with aniline phthalate and Morgan-Elson sprays, but
not with ninhydrin. A sample (100 /xg) on hydrolysis with n
hydrochloric acid at 100° for 6 hours gave only glucosamine on
paper chromatography. The infrared spectrum was identical
with that of an authentic sample of iV-acetylglucosamine 6-
sulfate potassium salt. This fraction had the following analysis:
.V-acetylglucosamine (Morgan-Elson), 18.70 /im; n-glucosamine
(Elson-Morgan), 18.4-0 /zm; sulfate, 18.05 pM; and reducing
sugar value (14), 18.28 /xm. For periodate studies, a portion of
the barium salt was passed through a small column of Dowex
50-H+, eluted with deionized water, neutralized with dilute
NH4OH to pH 7.0 and evaporated to dryness under reduced
pressure; [q:3d +47.9 (c, 0.06, ammonium salt). A solution of
the ammonium salt (0.3 mg/0.5 ml) was mixed with 0.5 ml of
0.03 m sodium metaperiodate and set aside in the dark at room
temperature. Aliqtiots (0.1 ml) were pipetted at various inter¬
vals, and the reduction of periodate was determined according to
Aspinall and Ferrier (19) (see Table IV). After 144 hours, the
reaction mixture was tested for formaldehyde with ehromotropic
acid (20). Only insignificant amounts of formaldehyde were
detected. Subfraction A2a (0.94 /zm) was oxidized with 0.012 m
sodium metaperiodate in 5 ml of sodium bicarbonate solution
(0.04 m, pH 7.5). iV-Acetyl-D-glucosamine (0.84 aim) was also
oxidized under the same conditions. Blanks of Subfraction A2a
and inactivated sodium metaperiodate were also included.
Aliquots (1 ml) were withdrawn after 24 and 46 hours, and
formaldehyde was estimated as before. After 46 hours, 1 mole
of A2a liberated only 6% formaldehyde compared to the amount
liberated by 1 mole of V-acetyl-D-glucosamine.
Subfraction A2b—The sugar (12.3 mg) had [a]D +42.5 (c, 0.11)
and a mobility of 0.90 relative to glucose 6-sulfate in Solvent E.
Electrophoresis in Buffer III gave a single spot with a mobility
identical with that of authentic glucose 6-sulfate. The fraction
gave a positive reaction with aniline phthalate and triphenyl-
tetrazolium salt (21) sprays. Paper chromatography in Solvents
E and G of a hydrolyzed (n hydrochloric acid, 100°, 6 hours)
sample showed only galactose. A portion of the fraction was
converted to the ammonium salt as described for Fraction A2a;
[a]D +52.0 (c, 0.09, ammonium salt). The fraction had a degree
of polymerization (22) of 0.84 and a molar ratio of sulfate to
galactose of 1.06. The infrared spectrum showed a strong ab¬
sorption at 1240 and 820 cm-1. The ammonium salt (0.325 mg)
was oxidized with sodium metaperiodate as described for Frac¬
tion A2a (see Table IV). A test for formaldehyde (20) at the
end of 144 hours was negative. Periodate oxidation in sodium
bicarbonate buffer for 46 hours liberated about 4% of the form¬
aldehyde liberated by an equal amount of n-galactose.
Subfraction A2c—This subfraction (30.7 mg) was a mixture of
several components as shown by chromatography in Solvents
E, G, and H. One major component (7.8 mg; mobility relative
to glucose, 0.29, in Solvent H) was isolated by preparative chro¬
matography in Solvent G. This component was chromatograph-
ically (Solvents E, G, and H) and electrophoretically (Buffer
III) homogeneous. Complete hydrolysis with n hydrochloric
acid for 6 hours at 100° gave galactose and glucosamine. Mild
hydrolysis (0.5 n sulfuric acid, 1 hour, 100°) followed by chroma¬
tography and electrophoresis showed, in addition to galactose
and glucosamine, some unhydrolyzed material, an unidentified
sugar, and a small amount of galactose 6-sulfate. A portion
was reduced with potassium borohydride, hydrolvzed (0.5 n
hydrochloric acid, 9 hours, 100°), and examined by chromatog¬
raphy. Galactose, glucosamine, glucosaminitol, and a trace of
galactitol were detected. The analysis of the compound before
and after borohydride reduction is given in Table III.
Fraction A4—This fraction (105 mg) was fractionated on a
Bio-Gel P2 column (95 X 3 cm). The fractions were screened
for an throne, and then every fifth fraction was taken to dryness
and examined chromatographically in Solvents E and G. By
combining appropriate tubes, nine fractions were obtained. The
three major fractions were purified further on paper to give
chromatographically and electrophoretically homogeneous Frac¬
tions A4a, A4b, and A4c, which were isolated as their sodium
salts. Some of the analyses of these fractions are summarized
in Table III.
Fraction A^a—Yeast /3-galactosidase, which almost completely
digested lactose5 in 15 hours, did not have any effect on this
5 The rruyn products were galactose and glucose; however,
some unchanged lactose and two slower moving components,
presumably trisaccharides, were present. This suggests the
occurrence of a transglycosidase in yeast 0-galactosidase.
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fraction. Mild acid hydrolysis (0.25 n sulfuric acid, 1 hour,
100°) followed by paper chromatography showed N-acetyllactos-
amine, galactose, and Y-acetylglucosamine, among other prod¬
ucts.
DISCUSSION
In the earlier investigation (1), keratosulfate was methylated
by four successive treatments with Haworth's reagents. A
product with a methoxyl content of about 80% of the theoretical
value was obtained, which, on account of its insolubility in
organic solvents, could not be further methylated with the con¬
ventional Purdie reagent (12). In general, the small amounts
of keratosulfate available limit the choice of methylation tech¬
niques. Methylation in nonaqueous solvents appears in general
to be more efficient than the classical Haworth technique. The
latter, which is carried out in aqueous media, even though mild
(e.g. it is not known to cause iV-methylation), requires repeated
treatments, sometimes up to six or seven times, to approach full
methylation. This method was not applied here, since poor
yields could be expected as a result of the losses from the repeated
treatments. In the present investigation, the procedure of
Bouveng, Kiessling, Lindberg, and McKay (10) was used.
Keratosulfate was acetylated in order to obtain products soluble
in organic solvents in which they were methylated. This proce¬
dure, in addition to giving a high degree of methylation, keeps the
alkaline degradation to a minimum. The methylation according
to Hakamori (23), even though now widely used, was not utilized
here because of the strongly alkaline nature of the methylsulfinyl
carbanion. This strong alkalinity could cause extensive degra¬
dation, especially in the case of a polysaccharide such as kerato¬
sulfate, which has 1 —♦ 3-linked sugars.
The acetylation procedure was also expected to iV-acetylate
any amino groups present in the polymer. It is known that
free amino groups are iV-methylated by dimethyl sulfate and
sodium hydroxide (24), whereas iV-acetylhexosamine is not
affected by these reagents (25). Our methylation procedure
caused at least partial iV-methylation of <V-acetvlhexosamine,
which most probably occurred during the treatment with Kuhn's
reagent. This was also suspected by Venkata Rao, Buchanan,
and Baddiley (26), who used Kuhn's procedure for methylation.
The method of Hakamori causes complete iV-methylation of
iV-acety lhexosamine.6
The acetylated keratosulfate was first methylated in dimethyl-
formamide with the use of dimethyl sulfate and sodium hydrox¬
ide. It was found that a part of the methylated keratosulfate
remained insoluble in chloroform. This is not unexpected, be¬
cause of the presence of sulfate groups. Hence, after the second
treatment, the product w as isolated by dialysis. This was found
desirable, even at the expense of the yield, on account of loss of
degradation products of low molecular weight. Dialysis also
removed dimethylformamide and the small amounts of impurities
which are contained even in the purified solvent. Dimethyl¬
formamide otherwise is difficult to remove even by repeated
evaporation with solvents such as 1-propanol, with which it is
known to form a low boiling azeotrope. The nondialyzable prod¬
uct had 71 % of the theoretical methoxyl content. After one
treatment by Kuhn's procedure, the value increased by 2%.
The infrared spectrum at 3200 to 3600 cm-1 showed only a small
peak compared to that of the unmethylated polysaccharide. It
is not known whether this peak is due to hvdroxyl or —N—H
6 S. I. Hakamori and R. W. Jeanloz, personal communication.
absorption. Hydrolysis and chromatographic examination of a
small sample at this stage showed traces of free (unmethylated)
galactose and glucosamine. The methoxyl value after treatment
with methyl iodide and silver oxide was 86.5% (w/w) of the
theoretical value, the latter on the basis of a monosulfated N-
acetyllactosamine repeating unit. This product gave a cloudy
solution in water and had [a]D +4.0 (c, 1.0). The high peptide
content (10.3%) of the starting material and the balance of
sugar, sulfate, and peptide analysis, which do not add up to
100%, probably explain the methoxyl value. No further treat¬
ments were attempted since methylation appeared complete.
Some desulfation did occur during methylation, as indicated by
the decreased sulfate value (86.5% of theory). This is not sur¬
prising in view of the alkali lability of sulfate esters. The
Seliwanoff test for anhvdro sugar, such as 3,6-anhydrogalactose,
was negligible. If, as is concluded below, all galactose residues
are 3-linked, then no 3,6-anhydrogalactose could be formed,
except from nonreducing 6-sulfated galactose end groups. On
the other hand, iV-acetylglucosamine is mainly 4-linked and
could, under alkaline conditions, form 3,6-anhydro-.V-acetyl-
glucosamine. It is not known whether this sugar gives a positive
Seliwanoff test.
The methylated keratosulfate was first methanolyzed, and the
water-soluble mixture of methyl glycosides was further hydro-
lyzed with n sulfuric acid until the reducing sugar value did not
increase. A small portion of the hvdrolysates was reconverted
to methyl glycosides, and the methyl glycosides of the methylated
neutral sugars obtained free of amino sugars (on Dowex 50-H+)
were examined by gas-liquid chromatography (16). The results
indicated that the two major components were 2,4,6-tri-O-
methylgalactose and 2,4-di-O-methyl-o-galactose. In addition,
small amounts of two unknowns and trace amounts of 2,3,4,6-
tetra-O-methylgalactose and 2,3,4-tri-O-methylfucose were
present. The two major sugars were characterized by prepara¬
tion of crystalline derivatives. Fraction 4b was identical in its
properties with 3,6-di-O-methylglucosamine. Fraction 4c,
which had a slightly faster mobility on paper than 4b, reacted
rather differently with ninhydrin. In the Morgan-Elson reac¬
tion, this fraction reacted slowly and gave a reddish violet color
in about 1 hour. As a model compound, iV-methyl-L-glucosa-
mine was prepared by hydrolysis (2 n hydrochloric acid, 4 hours,
100°) of pentaacetyl-iV-methyl-L-glucosamine. This sugar
(mobility relative to glucosamine of 1.37 in Solvent G) reacted
with aniline phthalate spray and rather faintly with ninhydrin.
Whereas glucosamine does not give a color in the Morgan-
Elson reaction, V-methylglucosamine gave a reddish violet
color which developed rather slowly (30 to 60 min). N-Acetyl-
glucosamine, however, develops a violet color in 5 min. On
paper electrophoresis in Buffer III, .V-methylglucosamine had
almost the same mobility as glucosamine, whereas V-acetyl-
glucosamine stayed at the origin. On ninhydrin oxidation (17),
.V-methylglucosamine was partly converted to arabinose (about
60% as judged by paper chromatography). The NMR spectra
of pentaacetyl-/3-D-glucosamine and pentaacetyl-iV-methyl-L-
glucosamine in CDCI 3 solutions were recorded with a Varian
A-60A NMR spectrometer.7 A single sharp absorption (area,
3 hydrogens) is observed; r = 7.09 (tetramethylsilane was used
7 We are grateful to Dr. I. J. Borowitz for the use of the NMR
spectrometer, purchased through Grant A1-07455-01 from the
National Institutes of Health, and to Dr. Karl Untch for running
the spectra.
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Table IV
Reduction of periodate by Fractions A2a and A2b
Reduction of periodate in
Fraction
1 hr ; 4 hrs 24 hrs 48 hrs 96 hrs 144 hrs
moles/mole of fraction
A2a 0.85 I 1.15 3.85 1 4.24 5.18 1 5.26
A2b 2.94 3.53 3.64 | 3.83 j 3.90 3.92
Table V
Analysis of nondialyzable Fraction B after
partial hydrolysis of KS I
Material Anthrone Hexos¬amine Sulfate Protein Orcinol
Carba-
zole
% % % % % %
KS I 35.3 26.1 14.9 10.3 8.0 1.8
Fraction B 26.9 27.4 7.1 15.8 8.4 1.4
as internal standard) in the case of the Y-methyl derivative.
This value of the chemical shift for the iV-methyl group of the
latter compound is distinctly different from those due to the
0- and Y-acetylmethyl groups (r = 7.80 to 8.10) (27). Thus,
this method appears to be extremely useful and direct for the de¬
tection of Y-methylated hexosamines.
It thus appeared that Fraction 4c is an Y-methylglucosamine
derivative. Ninhydrin oxidation of Fractions 4b and 4c gave the
same dimethylarabinose derivative. This strongly indicates that
Fraction 4c is 3,6-di-O-methyl-Y-methyl-d-glucosamine. Even
after two Y-acetylations, this fraction gave two spots on paper
electrophoresis: one with the mobility of d-glucosamine (pre¬
sumably 3,6-di-0-methyl-xV-methyl-i>-glucosamine), and one at
the origin (3.6-di-O-methy1-xV-methyl-xV-acety1-d-glucosamine).
This indicated that the conditions used for complete Y-ace-
tylation of n-glucosamine are not sufficient to cause complete
-V-acetvlation of iV-methylglucosamine. Fraction 5a was char¬
acterized as 3-O-methyl-d-glucosamine by preparation of crys¬
talline 3-O-methyl-iV-acety1-d-glucosamine. A set of reactions
similar to those described above suggested that Fraction 5c is 3-
O-methyl-Y-methyl-n-glucosamine.
Partial hydrolysis of the polysaccharide following electropho-
retic separation of the dialyzable fragments gave the pattern
shown in Fig. 1. Fraction A5 consisted of the expected neutral
sugars (galactose, .Y-acetylglucosamine, and four oligosaccha¬
rides) together with amino acids and peptides. Glycopeptides
were present in this fraction. Fraction A6 was mainly glucosa¬
mine, with at least two basic oligosaccharides which gave galac¬
tose and glucosamine on hydrolysis. Fractions A1 to A4 con¬
sisted of the acidic sugars, the main fractions being A2 (64.6 mg)
and A4 (105.0 mg). Fraction A2, after further fractionation on
filter paper sheets, gave three compounds, A2a, A2b, and A2c.
A2a and A2b were characterized as Y-acetylglucosamine 6-
sulfate and galacto.se 6-sulfate, respectively. Characterization
was made by chromatographic and electrophoretic mobility, hy¬
drolysis products, color reactions, infrared spectra, and periodate
oxidation (Table IV). The fast reduction of 2.94 moles, followed
by a slow reduction of 1 mole of periodate and liberation of only
a negligible amount of formaldehyde, is in accordance with the
expected values for galactose 6-sulfate (28). In the case of Y-
acetylglucosamine 6-sulfate, however, even though the formalde¬
hyde liberated was negligible as expected, the reduction of
periodate did not agree with the theory. The reduction kept
steadily increasing and even after 96 hours did not stop com¬
pletely. Jeanloz and Forchielli (29) showed that the iV-acetyl
group does not prevent the cleavage of adjacent —C'(OH)—
C(NH2)— and that Y-acetylglucosamine consumes 5 moles of
periodate under ideal conditions. Fraction A2c was a complex
mixture. The major component (mobility relative to glucose,
0.29, in Solvent H) was isolated after fractionation on Whatman
No. 3MM paper. The ratio of galactose to hexosamine to sulfate
was approximately 1:1:1. On sodium borohydride reduction,
57.2% hexosamine and 10.6% galactose were destroyed. Thus
it appeared that Fraction A2c is a tetrasaccharide with a hexosa¬
mine at the reducing end. The tetrasaccharide would have two
sulfate groups, at least one on galactose, since some galactose 6-
sulfate was detected in the partial hydrolysate of A2c. From
Fraction A4, three sulfated oligosaccharides (A4a, A4b, and A4c)
were obtained in pure form. Fraction A4a is a sulfated tri-
saccharide with galactose at the reducing end. The ratio of
galactose to hexosamine to sulfate was approximately 2:1:1.
Roughly half the galactose was destroyed, whereas hexosamine
was unchanged after sodium borohydride reduction. Two struc¬
tures, namely Gal-GlcNAc-Gal and GlcNAc-Gal-Gal, are
possible for this trisaccharide. Since Y-acetyllactosamine was
detectable among the partial acid hydrolysis products of A4a,
the probable structure is Gal-GlcNAc-Gal. Yeast /3-galacto-
sidase was without effect on this trisaccharide. This mav indi¬
cate that galactose at the nonreducing end is sulfated. Sulfation
of glycosyl group in general causes resistance to glycosidases (30).
Not enough material was available for a desulfation followed by
/3-galactosidase digestion. Fraction A4b is Y-acetyl-n-gluco-
saminy1-d-galactose. The ratio of galactose to hexosamine was
1:1. Sodium borohydride reduction caused destruction of
81% of galactose, with no change in hexosamine. The high
sulfate content of A4b could at least be partly explained by a
disulfated disaccharide fraction. Fraction A4c appears from the
analysis to be .V-acetylglucosaminyl-d-galactose with a sulfate
group substituted on position 6 of one of the sugar residues.
The methylation and partial hydrolysis results are in general
agreement with the structure proposed previously (1, 31) for
KS 1, namely, a chain made up of the repeating unit (1 -» 3)-
/?-d-galactopyranosyl-(l —► 4)-2-acetamido-2-deoxy-/3-i)-gluco-
pyranose. In the earlier work it was suspected that all the
sulfate was substituted at position 6 of Y-acetylglucosamine.
This conclusion was arrived at on the assumption that the
dimethylgalactose from the methylated native polymer was due
to undermethylation. In this reinvestigation undermethylation
seemed highly improbable. Thus, approximately 40% of the
galactose residues and 74% of the Y-acetylglucosamine groups
are sulfated in position 6. The exact distribution and sequence
of the sulfate groups cannot be evaluated from these studies.
The substitution may be random or systematic and consequently
coded. In any event, the isolation of disulfated .V-acetyl-
lactosamine from a polymer with a sulfate to hexosamine ratio
no greater than 1 requires the presence in the polymer of regions
of nonsulfation. These could be present as nonsulfated side
chains in the proteinpolysaccharide or as a nonsulfated repeating
unit in the same polysaccharide side chain. A trace amount of
2,3,4-trimethylgalactose detected only by gas-liquid chromatog¬
raphy presumably arises from 6-substituted terminal galactose
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residues. The presence of 2,3,4,6-tetramethylgalactose and
2,3,4-trimethylfucose indicates nonreducing galactose and
fucose residues in the molecule. These residues could arise
either from different chains where they are the terminating end
groups, or, more likely, from the same chain where one (pre¬
sumably galactose) is the chain-terminating sugar and the other
(fucose) is a single branch unit. In either case, fucose could be
attached to position 6 of either galactose or iV-acetylglucosamine.
Final proof of the structure is expected from isolation of fucosyl-
oligosaccharides from enzymatic digests. KS I, in any event,
seems to have little branching as compared to its skeletal counter¬
part.8 The nondialyzable fragment from partial hydrolysis
(Fraction B) of the polysaccharide had a galactose to hexosamine
ratio of 1.00:1.03 (Table V) as compared to 1.00:0.75 in the
original polysaccharide. The excess of galactose over hexos¬
amine, which amounts to approximately 25%, and its preferen¬
tial loss by mild hydrolysis and methanolysis during catalytic
desulfation8 are difficult to explain. The excess of galactosyl
groups could be present as blocks on the nonreducing ends of the
polysaccharide chains or as branches. If present as branches,
the galactosyl groups would have to be substituted in position
3, possibly by sulfate. Unsubstituted galactosyl end groups
would have resulted in a larger amount of tetramethylgalactose.
On the other hand, the infrared spectrum gave no evidence for
the presence of galactose 3-sulfate in the polysaccharide. From
Table V it is obvious that 55% of the protein in the original
polymer became dialyzable as a result of the very mild acid
hydrolysis. This was also evident by the detection of amino
acids or peptides, or both, in Fraction A5 of the dialyzable
fragments.
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THE KERATOSULFATE-LIKE MUCOPOLYSACCHARIDE
OF CHICK ALLANTOIC FLUID*
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Communicated, August 1967
A family of sulfated uronic acid-free mucopolysaccharides which was named
keratosulfate has been isolated after proteolytic digestion from cornea, nucleus
pulposus, and cartilage of mammals, birds, and fishes. These mucopolysaccharides
were composed of D-galactose and hexosamine in a ratio of somewhat greater than
1, contained variable amounts of sialic acid and fucose, and had a ratio of sulfate to
hexosamine of 1 or greater. The mucopolysaccharide fractions were covalently
linked to proteins or peptides and in fact were highly resistant to proteolytic diges¬
tion. Thus they could either be regarded as sulfated mucopolysaccharides or sul¬
fated glycoproteins resembling blood group substances. The latter, however, have
never been found to occur as sulfate esters.
In the last few years a group of Norwegian authors reported the isolation of a
uronic acid and sialic acid-free sulfated mucopolysaccharide1 from the allantoic
fluid of embryonated eggs, either normal or infected with influenza virus.1-3 This
mucopolysaccharide, termed "host factor" (HF), was obtained without proteolytic
digestion, and proved to be antigenic in man and in rabbit.1-4 Attempts to produce
antibody to keratosulfates have thus far failed.5 In fact, a substance immuno¬
logically identical with HF was shown to be present as a component of the influenza
virus envelope.6 Since the chemical structure of keratosulfate both of cornea and
of cartilage has been determined in our laboratory,8' "• 12 it seemed of interest to
study the substances present in allantoic fluid and if possible to determine why, in
contrast to keratosulfates, they are antigenic. This report deals with the isolation
and chemical properties of the chick allantoic fluid saccharide (CAFS). The
fractions isolated, while immunologically similar or identical with the Norwegian
material, showed chemical differences, the most important being a high sialic acid
content.
Materials and Methods.—The mucopolysaccharide of chick allantoic fluid infected
with influenza virus (Japan/170/62A2) was isolated by methods analogous to those
used in this laboratory for the isolation of keratosulfate. After removal of the
virus, the supernatant fluid was precipitated with acetone. (We thank Eli Lilly
and Co., Indianapolis, for the generous gift of this material.) Aliquots of the dry
powder, corresponding to 16 liters of fluid, were digested with activated papain at
65° for two days, followed after neutralization by repeated digestion with Pronase,
dialysis, removal of residual protein, and fractionation by free-flow electrophoresis
and by Biogel. The final yield of material was 12.6 mg per liter, i.e., about six to
seven times larger than that reported by Haukenes et alA
A second batch was purified in a similar fashion. After Biogel P2 fractionation
it was furl her fractionated on DEAE Sephadex and eluted with a linear gradient of
0.3-1.5 M NaCl. The main fraction was eluted in a fairly sharp peak from 0.55 to
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0.85 M NaCl. A small amount (~8%) of a sialic acid and sulfate-free glycoprotein
appeared at the start of the gradient.
Results.—Tables 1 and 2 give analytical values for the two samples of CAFS.
For comparison, values are also given for typical fractions of cornea keratosulfate
(KSI) and human cartilage keratosulfate (KSII).
Compared to KSI and KSII, CAFS contained a high proportion of galactos-
amine, a considerably lower sulfate and a higher sialic acid content. Noteworthy
also are the differences in the amino acids between CAFS and the keratosulfates.
In the case of CAFS, serine and threonine constituted about 50 per cent of the amino
acids and proline about 16 per cent.
Electrophoresis on Sepraphore at pH 5.0 showed one sharp spot staining both
with Alcian Blue and with Procion Brilliant Blue (for protein).7 Electrophoresis
at pH 1.8 (4% formic acid) showed an additional smaller spot of lower mobility.
A sample obtained from Norway gave two spots at pH 1.8 with mobilities identical
to those of our preparations; in addition there was an immobile fraction at the
origin.
Our preparations were nondialyzable and were excluded by Biogel P2 and P4.
TABLE 1
Composition op Two Preparations op CAFS, KSI, and KSII
Chicken Allantoic Fluid Saccharide Keratosulfate •
Preparation Preparation
Analysis A(%) B(%) KSI(%) KSII(%)
Anthrone 26.0 28.1 35.3 28.7
Hexosamine*
GlcN 12.0 11.9 25.1 21.4
GalN 8.6 8.8 1.1 2.7
Total 20.6 20.7 26.2 24.1
Sulfate 6.9 6.0 17.7 18.9
Sialic acid 13.0 12.7 Trace 3.4
Fucose 1.0 N.d.f Trace 2.7
Mannose — N.d. + +
Protein (Lowry) 6.0 4.1 2.5 6.6
Protein J 12.4 11.1 2.6 6.0
Carbazole§ 3.7 N.d. 3.4 2.4
[u]d (Water) -6.8 -3.2 + 0.5 -7.2
S04 /GalN(molar) 1.06 0.94 1.31 1.65
GalN/GlcN(molar) 2.17 2.36 1.40 1.34
♦Not corrected for destruction during hydrolysis,
t Not determined,
j By amino acid analyzer.
§ The color has a different absorption than uronic acid.
TABLE 2
Amino Acids of Two Preparations of CAFS, KSI, and KSII








Aspartic acid 2.68 0.78 39.93 13.34
Threonine 23.65 26.96 6.55 13.00
Serine 25.38 27.91 8.21 10.72
Glutamic acid 8.05 4.57 13.86 23.35
Proline 15.56 17.58 0.00 14.11
Glycine 1.51 0.73 9.64 8.80
Alanine 6.39 5.91 5.65 5.73
Valine 4.21 3.84 12.05 4.14
Methionine 1.01 0.90 0.00 0.28
Isoleucine 2.80 2.63 2.18 2.07
Leucine 6.67 6.59 1.13 1.37
Tyrosine 0.52 0.34 0.00 0.86
Phenylalanine 1.51 1.26 0.75 1.88
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On Biogel P6 they were partly excluded and partly held, showing polydispersity.
Analysis of the excluded and retarded fractions did not show significant differ¬
ences.
On treatment with 0.5 N NaOH at room temperature for 48 hours, 242 /jM of
serine and 205 /tM of threonine were selectively destroyed concomitant with 92 jiM
of glucosamine (or 13.3%) and 335 ,uM of galactosamine (65.9%). Thus the sum of
serine and threonine destroyed (447 pM.) was equivalent to the total hexosamines
destroyed (427 pM).
In another experiment 30 per cent of glucosamine was destroyed when treated
with alkali and borohydride. In this experiment, the galactosamine value could
not be calculated since reduced hexosamines coincide with the galactosamine peak
in the amino acid analysis.
Electrophoresis, at pll 5.0, of the alkali-treated preparation showed two spots
which stained with Alcian Blue. Alkali treatment in the presence of borohydride
followed by fractionation on Biogel P6 showed markedly increased polydispersity
of the carbohydrate fraction. The main carbohydrate was eluted just prior to the
salt peak and was free of peptide, whereas KSII after similar treatment retained its
peptide chains. The approximate molecular size of this fraction corresponded to
that of a hexasaccharide. A reduced chromogen (peak 3 in the amino acid analyzer)
after acid hydrolysis was absent in contrast to the pattern with KSII.8 The pro¬
tein-free fraction, on mild acid hydrolysis, failed to show the unsaturated component
demonstrated by Lloyd et al. in blood group substances.9 As with KSII, an increase
of alanine and the appearance of a-aminobutyric acid were demonstrated after
treatment with alkali and borohydride.
The only hexose detected after acid hydrolysis was galactose. Sialic acid by the
Svennerholm method was 13.0 per cent and by the Warren method, 11.8 per cent.
After digestion with sialidase (CI. perfringens) and dialysis, sialic acid in the dialy-
sate determined by the Warren method was 14.0 per cent. The infrared spectra of
our samples were very similar to those of keratosulfate. However, the spectrum of
our preparation of CAFS has an additional peak at 1400 cm-1 which was not present
in the Norwegian sample of HF. The latter preparation showed two additional
peaks at 920 and 850 cm-1, both absent in our preparations and KS. The above
two peaks are typical for axial secondary sulfate groups (galactosamine or galactose-
4-sulfate).10 After acid hydrolysis with 0.5 N H2SO4,11 paper chromatography and
electrophoresis revealed a main spot for N-acetyl glucosamine-6-sufate and a minor
spot of galactose-6-sulfate similar to those obtained with KSI and KSII. No evi¬
dence was obtained for sulfated galactosamine.
At different stages of purification, our materials were compared immunologically
with purified HF obtained from Norway. In double-diffusion analysis (Ouchter-
lony) with antisera to HF, our samples showed two components which gave reaction
of identity with HF; their reactivity in this system was not significantly altered by
prior enzymatic removal of sialic acid. The same samples, however, showed only
5-10 per cent of the capacity of HF to block inhibition, by anti-HF, of viral hemag¬
glutination.3' 4 In quantitative precipitin analysis, CAFS exhibited approximately
20-30 per cent of the potency of purified HF in precipitating anti-HF. The sole
exception to the foregoing was the protein-free oligosaccharide after treatment with
alkaline borohydride. This material, even in relatively high concentration in
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double-diffusion analysis, gave but one line identical with one component of HF,
and was entirely inactive in the hemagglutination-inhibition-blocking test.
Discussion.—CAFS, although similar, is clearly distinct from the keratosulfates.
Like keratosulfate it consists of a peptide backbone to which multiple short car¬
bohydrate chains are attached by O-glycosidic linkages to serine and threonine.
As in the case of KSII,8 the sugar linking the carbohydrate chains to the peptide
appears to be mainly a nonsulfated N-acetyl galactosamine. In contrast to KSII
the absence of reduced chromogen on borohydride treatment of CAFS indicates
the absence of 3-substitution of the galactosamine in the latter. The separation
of at least the major portion of the carbohydrate covalently linked to peptide also
contrasts with KSII. The larger proportion of galactosamine in CAFS as com¬
pared to KSII (Table 1) and its selective destruction during alkaline treatment
would indicate that the carbohydrate chains are much shorter than those of KSII.
The carbohydrate chains of both CAFS and KS consist of galactose and N-acetyl
glucosamine and contain sialic acid and some methylpentose as nonreducing end
groups. It is remarkable that the sulfate content of CAFS is only 6-7 per cent, as
opposed to the 17-18 per cent of keratosulfate. Partial hydrolysis and infrared
spectra data indicate that the sulfate ester is mainly N-acetyl glucosamine-6-sul-
fate. In fact, the molecular ratio of sulfate to glucosamine is close to 1.00. Since
in addition to N-acetyl glucosamine-6-sulfate, a small amount of galactose-6-sulfate
was detected after acid hydrolysis, the above value indicates that almost all glu¬
cosamine groups are monosulfated while galactosamine appears not to be sulfated.
In contrast to KSI and KSII, CAFS is antigenically active.
The mucopolysaccharide is nondialyzable and by Biogel filtration has an ap¬
parent molecular weight greater than 4,000. The fraction isolated in this labora¬
tory is similar but not identical with the fraction (HF) described by the Norwegian
authors. The main differences lie in the yields obtained from allantoic fluid, the
sialic acid content, and immunologic reactivity. Since our yield was six to seven
times higher than that reported by the Norwegian authors, it seems possible that
they isolated a minor fraction of the total having a lower sialic acid content and a
higher immunological activity. The fractionation procedures used in the present
study, including free flow electrophoresis, ion exchange, gel filtration, and electro¬
phoresis on cellulose acetate at acid and nearly neutral pH, excluded the presence
in our preparation of a nonsulfated sialic acid containing glycoprotein. The anti¬
genicity and higher immunologic reactivity of the Norwegian material may perhaps
be ascribed in part to its higher molecular weight, or to the presence of more com¬
plete peptide chains than remained in our preparations after exhaustive digestion
with proteolytic enzymes.
It seems most significant in this connection, however, that the protein-free oli¬
gosaccharide fraction was still immunologically active, although only at a concentra¬
tion approximately 20 times that at which other CAFS fractions reacted specifically
with anti-HF. While the native protein polysaccharides of cartilage are antigenic,
this property is abolished after proteolysis.
Chemically, CAFS is certainly very similar to keratosulfates. A further kerato-
sulfate-like mucopolysaccharide, obtained from the organ of Lorenzini, was re¬
cently described and named lorenzan sulfate.13 The latter, like KSII, did not react
immunologically and probably is more closely related chemically to KSII than to
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CAFS. CAFS as well as lorenzan sulfate presumably are epithelial products in
contrast to the mesodermal origin of KSI and II. The former may represent a
class of compounds widely distributed in epithelial mucins and cellular membranes.
We wish to express our appreciation to Dr. A. Harboe, Oslo, Norway, for a sample of his prepara¬
tion of CAFS and anti-CAFS sera and to Dr. J. Doyle, Isle of Cumbrae, Scotland, for a sample of
lorenzan sulfate.
Abbreviations used: CAFS, chick allantoic fluid saccharide; KSI, corneal keratosulfate; KSII,
human cartilage keratosulfate; GlcN, glucosamine; GalN, galactosamine.
* This work was supported in part by grants AM-00570 and AI-03168 from the National Insti¬
tutes of Health, U.S. Public Health Service.
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SUMMARY
The structure of the carbohydrate moiety of old human rib
cartilage keratosulfate (KS II) was investigated by methyla-
tion of the mucopolysaccharide and its desulfated analogue.
The methods used were identical with those used previously
for cornea keratosulfate. The methyl ethers were charac¬
terized either as crystalline derivatives or by paper, thin
layer, or gas-liquid chromatography. The data are inter¬
preted as a repeating unit of iV-acetyllactosamine polymerized
via 1 —» 3-linkages to the galactose. Position 6 of N-acetyl-
glucosamine or d-galactose, or both, is esterified with sulfate.
The polysaccharide appears to be more highly branched than
that from cornea. Furthermore, d-mannose was isolated
from KS II and characterized. Mannose was also found
in corneal and other keratosulfates. Catalytic desulfation
in methanol yielded two high molecular weight desulfated
products, one insoluble in aqueous solvents but soluble in
formamide, and the other soluble in water. In addition to
sialic acid and L-fucose, some d-galactose was released
by methanolysis during the desulfation.
Keratosulfate is a sulfated mucopolysaccharide composed of
approximately equimolar quantities of D-galactose and iV-acetyl-
D-glucosamine and variable amounts of sulfate, L-fucose, sialic
acid, and .V-actyl-D-galactosamine. It has been isolated from
cornea (1), cartilage (bovine, human, and shark) (2-4), and
nucleus pulposus (5). The keratosulfates of bovine cornea and
of human rib cartilage are known to differ mainly in their linkage
between carbohydrate and peptide (6). The structure of the
* This work was supported by United States Public Health
Service Grants AM 00570 and HD 02646. A preliminary report
on this work was presented at the Fifty-first Annual Meeting of
the Federation of American Societies for Experimental Biology,
Chicago, April 1967, Fed. Proc., 26, 150 (1967).
t Present address of both authors.
carbohydrate portion of KS I1 was shown by Hirano, Hoffman,
and Meyer (7) to be a linear molecule made up of the repeating
unit (1 —> 3)-/3-D-galactopyranosyl-(l —► 4)-2-acetamido-2-deoxy-
/3-D-glucopyranosvl 6-sulfate. This structure was further
modified by us after reinvestigation of the methylation and on the
basis of studies of partial acid hydrolysis (8, 9).
KB II has been assumed to have basically the same carbohy¬
drate structure as KS I. The studies presented in this paper
support this assumption. The basic structure appears to be
similar for both polysaccharides, but differences were noticed
mainly in the average length of the chains and in the occurrence
of a greater degree of branching in KS II. In the course of the
studies on methylation of the native and desulfated polysaccha¬
rides, it was discovered that this kerotosulfate preparation con¬
tained a sugar with the chromatographic mobility of mannose.
This sugar was isolated after total acid hydrolysis of KS II and
characterized as D-mannose. Keratosulfates of different origin
were tested for mannose, and all of them contained small
amounts, roughly 1 to 2%, of this sugar. From the total acid
hydrolysate, a disaccharide tentatively identified as glucosa-
minyl-(l —► 3)-galactose was also isolated. In addition, the
catalytic removal of sulfate ester groups of keratosulfate was
studied. Desulfation was carried out in such a way as to obtain
a maximum yield. However, surprisingly, more than half of the
desulfated product became water-insoluble.
EXPERIMENTAL PROCEDURE
Materials—Rib cartilage of people over 60 years old was
collected, and the keratosulfate was prepared by the procedure
used in this laboratory (6). The fractions, which still had a
fail* amount of chondroitin sulfate and about 11% protein, were
digested with testicular hyaluronidase, followed by Pronase, and
fractionated with ethanol. The fraction having the following
1 The abbreviations used are: KS I, bovine cornea keratosulfate;
KS II, old human rib cartilage keratosulfate. MX, methylated
neutral sugars; MH, methylated hexosamines; MDN, methylated,
desulfated neutral sugars; MDH, methylated, desulfated hexos¬
amines; DKS, desulfated keratosulfate; Rt, retention time rela¬
tive to methyl tetramethvl-a-D-glucoside.
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analysis was used for the present studies: hexose (anthrone
method), 31.4%; hexosamine, 28.6%; uronic acid (carbazole
method), 2.1%; sulfate, 18.7%; protein (Lowry), 6.0%; methyl
pentose, 2.5%; [a]f —7.2°. About 11% of the hexosamine was
galactosamine, and the rest was glucosamine, as determined with
the amino acid analyzer.
Sugars—We gratefully acknowledge the following gifts of
samples: 2,3.4-tri-O-methyl-iV-phenyl-L-fucosylamine, 2,4,
6-tri-O-methyl-D-galactose, and 2-acetamido-2-deoxy-3,4,6-tri-
O-methyl-D-glucose, from the late Professor R. Kuhn; 2,3,4,fi¬
let ra-O-methyl- and 2,4,6-tri-0-methyl-A"-phenyl-D-galactosyl-
amine and 2,3,4-tri- and 2,3.6-tri-O-methylgalactose, from
Professor G. 0. Aspinall; 2,3,4,6-tetra-O-methyl-D-galactose,
from Dr. K. 0. Lloyd; 2,4-di-0-methyl-3,6-anhydro-D-galactose,
from Dr. B. A. Lewis; and pentaacetyl-.V-methyl-L-glucosamine,
from Merck and Company.
Analytical Methods—These were the same as cited previously
(9).
Chromatography—Paper chromatograms were developed by the
descending technique on Whatman No. 1 paper. Whatman No.
3MM paper used for quantitative separation was washed with
0.01 x HC1, followed by distilled water, and finally with the
solvent used in the separation. The following solvent systems
(v/v) were used: A, butan-l-ol-ethanol-water (10:3:5); B,
butan-l-ol-ethanol-water (4:1:5, upper layer); C, benzene-
ethanol-water (169:47:15, upper layer); D, ethyl acetate-pyri-
dine-water (10:4:3); E, ethyl acetate-acetic acid-water (6:3:2);
F, ethyl acetate-pyridine-water (8:2:1); G, butan-l-ol-pyridine-
water (5:3:2); H, butan-l-ol-acetic acid-ethanol-water (10:3:
1:7); I, ethyl acetate-pyridine-acetic acid-water (5:5:1:3).
Sugars were detected with aniline-phthalate spray or with alka¬
line silver nitrate. Ninhydrin and Elson-Morgan sprays were
used for hexosamine, and Morgan-Elson spray for iV-acetyl-
hexosamines. Ro values of methylated sugars refer to rates of
movement relative to 2,3,4.6-tetra-O-methyl D-glucose in
Solvent B. The butan-l-ol and pyridine used for preparative
separations on Whatman No. 3MM sheets were purified by
refluxing for 2 hours with KOH (1%, w/v) and distilling. Ana¬
lytical reagent grades of other solvents were used without further
purification.
Thin layer chromatography was carried out on plates coated
with Silica Gel G or H as described previously (9). The plates
were eluted by the ascending technique with the following solvent
systems (v/v): (a) acetone-water-ammonia (250:3:1.5); (6)
benzene-95% ethanol (20:5); (c) ethyl acetate-propan-l-ol-water
(65:23:12). Sugars were detected with aniline-phthalate spray
or by spraying with 25% H2SO4 and heating the plate for 30 min
at 100°.
Electrophoresis was performed on both Whatman No. 1 and
prewashed Whatman No. 3MM (for quantitative separation)
paper with the following buffer systems: I, acetic acid-pyridine,
pH 5.5; II, acetic acid-pyridine, pH 3.5; III, 0.05 x acetic acid-
pyridine, pH 6.0. The same sprays as those described for paper
chromatography were used for detection.
EXPERIMENTS AND RESULTS
Methylotion
Nondialyzable keratosulfate (2.0 g) was initially acetylated as
described for KS I (9). The dark brown liquid was poured with
stirring into a large excess of ice-cold ethanol. The mixture was
Table I
Analysis of native and desulfated KS II used for methylation













left in the refrigerator overnight, and the precipitate was sep¬
arated by centrifugation. The precipitate was dissolved in
water, dialyzed, and lvophilized, yielding 2.64 g (97%) of the
acetylated product. This product was methylated twice with
dimethyl sulfate and powdered NaOH in dimethylformamide
(2.03 g; OCH3, 16.4%) and once by Kuhn's procedure as de¬
scribed previously (9), and yielded 1.65 g (73.3%) of fully
methylated KS II; [a]^0 +5.9° (c, 1.73).
CisHsiOuNSNa
Calculated: SO4 16.6, OCH3 23.8
Found: S04 17.6, OCH3 22.2
Hydrolysis of Methylated KS II
The methylated product (1.50 g) was methanolyzed and then
hydrolyzed with x H2SO4 for 7 hours. The hydrolvsate after
neutralization and concentration (9) yielded 1.64 g of methyl
ethers.
Preparation of Desulfated Polymer
Keratosulfate (200 mg) was desulfated as described under "De-
sulfation of Keratosulfates." The cloudy suspension was lvoph-
ilized without separation of the insoluble desulfated polysac¬
charide from the soluble fraction, to yield the desulfated product
(103 mg; 68.7%) (Table I).
Methylation of Desulfated Polysaccharide
The desulfated KS II was acetylated (125 mg) a id methylated
with dimethyl sulfate and powdered NaOH by the same pro¬
cedure as that used for the native polysaccharide. The final
product in this case was isolated by chloroform extraction, since
the methylated, desulfated product was soluble in chloroform as
opposed to the partial solubility of the methylated sulfated
material. Yield, 52 mg; OCH3, 26.4%. The partially methyl¬
ated product (50 mg) was then methylated by Kuhn's procedure,
extracted with chloroform, and precipitated by addition of light




Hydrolysis of Methylated Desulfated KS II
Trial hydrolysis was carried out with two 1-mg portions for
optimal hydrolysis. The first portion was methanolyzed and
then hydrolyzed with x H2S04 for 6 hours at 100°. The second
portion was added to 0.2 ml of ice-cold 72% H2SO4 and shaken
for 1 hour at room temperature. The dark syrup was diluted
with 1.6 ml of water to a final concentration of 3 x H2S04 and
heated at 100° until the reducing sugar value became constant
(10, 11). The product was isolated after neutralization with
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BaC(>3. Paper and thin layer chromatographic examination of
the two products showed that the first procedure had caused
some degradation. Hence the methylated, desulfated poly¬
saccharide (39.5 mg) was hydrolyzed by the second procedure
and yielded 36.3 mg of methyl ethers.
Paper chromatography in Solvents B and C and thin layer
chromatography in Solvents a and b indicated that methyl
ethers from methylated native KS II contained as major com¬
ponents 2,4,6-tri- and 2,4-di-O-methylgalactose and 3,6-di-
and 3-O-methylglucosamine. The minor components were
2,3,4-tri-O-methylfucose and 2,3,4,6-tetra- and 2,3,4-tri-O-
methylgalactose. In the case of the desulfated polymer, the
methyl ethers were composed entirely of 2,4,6-tri- and 2,3,4,6-
tetra-O-methylgalactose and 3,6-di-O-methylglucosamine.
Initial Separation
The separation of neutral methylated sugars from methyl
ethers of hexosamines was accomplished by passing an aqueous
solution of the mixture of methyl ethers through a Dowex 50-H+
column (30 X 2.5 cm). The eluate was recycled, and the column
was washed with distilled water until the washings gave a nega¬
tive anthrone test. The effluent was passed through an Amber-
lite IR-45 (CO3-) column, evaporated to a small volume, filtered,
and dried. It yielded 654 mg of methylated neutral sugars.
The Dowex 50 column was washed with an excess of 5% NH4OH.
The eluate was aerated to remove most of the ammonia, con-
Table II
Gas-liquid chromatographic examination of methyl glycosides of
methylated neutral sugars from methylated native and
desulfated KS II
The results given here were obtained 011 a polyphenyl ether
column at 185°. The samples were also analyzed on butanediol
succinate ester at 190°; identical results were obtained.
Table IV
Fractionation of hydrolysate from methylated KS II
Sugar
Retention times




































MN2 18.6 0.77 2,3,4-Trimethylgalactose and
unknown
MN3 132.6 0.80 2,4,6-Trimethylgalactose° and
2,3,4-trimethylfucosea
MN4 17.2 0.92 2,3,4,6-Tetramethylgalactose0
MH1 30.8 0.17 3-0-MethyIglucosaminett
MH2 15.2 0.27 3-O-Methyl-iV-methylglucos-
amine
MH3 2.8 0.27 + 0.31 Mixture of MH2 and unknown
MH4 23.1 0.35 3,6-Di-O-methylglucosamine
MH5 6.9 0.52 SjO-Di-O-melhyl-iV-methylglu-
cosamine
MH6 3.1 0.60 Unknown
0 These compounds were characterized as crystalline deriva¬
tives.
centrated under reduced pressure to a small volume, filtered, and
dried, to yield 542 mg of methylated hexosamine.
Similar fractionation of methyl ethers (32 mg) from the
methylated, desulfated polysaccharide on a Dowex 50-H+
column (20 X 1.5 cm) yielded methylated neutral sugars (11.5
mg) and methylated hexosamines (10.8 mg). The methylated
neutral sugars from methylated native and methylated desulfated
polysaccharides were converted to their methyl glycosides and
examined by gas-liquid chromatography.2 The results are sum¬
marized in Table II. The neutral sugar fractions (Fractions
MN and MDN) and the methylated hexosamine fractions
(Fractions MH and MDH) were examined by paper chromatog¬
raphy (Solvents A, B, and C) and thin layer chromatography
(Solvents a and b). The results are given in Table III. The
molar proportions of the sugars given for the native polysaccha¬
ride were approximated from the weights of the sugars isolated
and, in the case of the desulfated polysaccharide, from paper,
thin layer, and gas-liquid chromatography.
Isolation of Methylated Monosaccharides
The mixture (400 mg) of methylated neutral sugars from
native KS II (Fraction MN) was applied to a charcoal-Celite
column (30 X 2.5 cm), which was prepared as follows. Darco
A-60 charcoal and Celite 535 were separately washed with
concentrated HC1, followed by tap water, and finally with boiling
distilled water. A water slurry of charcoal-Celite (1:1) was
packed into a column which had a porous plate at the bottom and
a pad of glass wool on the top. The methyl sugars were eluted
with a gradient from 50% ethanol (750 ml) to water (750 ml).
Fractions of about 10 ml were collected every hour. Aliquots of
every third fraction, sometimes after concentration, were ex¬
amined by paper chromatography. The appropriate tubes were
combined to yield four fractions (MN1 to MN4) (Table IV).
Fraction MNl—The syrup, [a]D +73.2° (c, 1.0), was indis¬
tinguishable from 2,4-di-O-methyl-d-galactose by paper and
thin layer chromatography. Demethylation of a portion gave
2 We are grateful to Dr. K. O. Lloyd of the Department of
Microbiology, Columbia University College of Physicians and
Surgeons, for carrying out these analyses.
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galactose as the only monosaccharide. The syrup crystallized
in the desiccator and was recrystallized from ethyl acetate; m.p.
96°. The aniline derivative was prepared by refluxing equimolar
amounts of the sugar and redistilled aniline in absolute ethanol,
with exclusion of light, for 30 min. The crystalline material
after removal of the solvent was recrystallized from ethyl acetate;
m.p. and mixed m.p. (with authentic 2,4-di-0-methyl-Ar-phenyl-
d-galactosylamine) 213-214°.
Fraction MN2—Paper and thin layer chromatographic
examination showed as the main component of this fraction
2,3,4-tri-O-methyl-d-galactose. In addition, small amounts of
2,4-di-O-methyl-d-galactose and an unknown (RG 0.79 in Solvent
C) were present. Demethylation of a portion with boron tri-
bromide followed by paper chromatography in Solvents G and I
showed galactose as the main component. A small amount of a
second component with the same mobility as that of mannose
(#Gai 1.21 and 1.34 in the above two solvents) was present. It
was difficult to decide whether this component was mannose or
whether it was a monomethyl galactose from incomplete de¬
methylation. A portion (1 mg) of the fraction was converted to
the methyl glycosides and examined by gas-liquid chromatog¬
raphy. The main peaks corresponded to those of the glycosides
of 2,3,4-tri-O-methyl galactose, in addition to a trace of an
unknown peak.
Fraction MN3—The syrup (132.6 mg) was separated on What¬
man No. 3MM sheets in Solvent C to give Fractions MN3a
(109.4 mg) and MN3b (13.2 mg). MN3a, [a]D +80.5° (c, 0.96),
was indistinguishable from 2,4.6-tri-O-methyl-D-galactose by
paper and thin layer chromatography. Demethylation with
boron tribromide gave only galactose. The sugar (30 mg), con¬
verted to the aniline derivative and recrystallized as described for
Fraction MNl, had a melting point of 197° and a mixed melting
point (with authentic 2,4,6-tri-O-methyl-AT-phenyl-d-galactosyl-
amine) of 196-198°. MN3b, [a]D —99.3° (c, 0.60), was identical
with 2,3,4-tri-O-methvl-l-fucose on paper and thin layer
chromatography. After conversion to its methyl glycoside, it
gave a single peak identical with methyl 2,3.4-tri-O-methyl-
fucoside on gas chromatographic analysis. Demethylation of a
portion yielded fucose as the only monosaccharide. The sugar
was finally converted into the aniline derivative; m.p. and mixed
m.p. (with authentic 2.3.4-tri-O-methyl-W-phenyl-L-fucosyl-
amine) 134-135°.
Fraction MNJ+—The main component of this fraction was
2,3,4,6-tetra-O-methyl d-galactose; traces of two other sugars
were also present. The main sugar (14.6 mg), [a]D +117.0°
(c, 0.73), was obtained in pure form by fractionation on What¬
man No. 3MM paper with Solvent C. After demethylation,
galactose was the only monosaccharide detectable on paper
ehromatograms. Gas-liquid chromatography of its methyl
glycosides on two different columns gave peaks identical with
those of the methyl glycosides of authentic 2,3,4,6-tetra-O-
methylgalactose. The syrup was converted to its aniline deriva¬
tive and recrystallized from ether-petroleum ether; m.p. and
mixed m.p. (with authentic 2,3.4,6-tetra-O-methyl-AT-pheny1-d-
galactosylamine) 186-188°.
Fractionation of Methylated Hexosamines
The mixture of methyl ethers of hexosamine (methylated
hexosamines) (542 mg) from methylated native KS II was a dark
syrup which streaked heavily on paper chromatograms. The
syrup was dissolved in methanol and decolorized with active
carbon to yield 402 mg of the purified sugars. A portion (300 mg)
of this syrup was Ar-acetylated with acetic anhydride according to
the method of Hirano, Hoffman, and Meyer (7), yielding 255 mg
of product. Paper electrophoresis in System III revealed that
Ar-acetylation was incomplete, since part of the sugar had the
same mobility as that of glucosamine and the rest stayed at the
origin as did A'-acetylglucosamine. Hence the mixture was
treated a second time with acetic anhydride. The resulting
syrup was still incompletely Ar-acetylated and consisted of a
variety of components (see ''Discussion"). Hence the identifica¬
tion of the methylated hexosamines was carried out with the
remaining one-quarter of the sample (102 mg). It was frac¬
tionated without N-acetylation on Whatman No. 3MM paper in
Solvent B, and the six fractions (MH1 to MH6) were eluted from
the paper with water and concentrated to syrups.
Fraction MHl—This fraction (30.8 mg; RG 0.17 in Solvent B)
gave a single spot on paper chromatography in different solvent
systems. Paper electrophoresis in Buffer III gave only one
spot, with the mobility of glucosamine. The sugar reacted with
aniline phthalate and ninhvdrin spray but not with Morgan-
Elson spray. Demethylation followed by ninhydrin gave only
arabinose on paper chromatograms. A portion of the syrup was
N-acetylated. The product had the same Rp value as authentic
2-acetamido-2-deoxy-3-0-methyl-D-glucose. The A'-acetylated
product was crystallized from methanol and petroleum ether;
m.p. and mixed m.p. (with crystalline 2-acetamido-2-deoxy-3-0-
methyl-D-glucose obtained from KS I (9)) 156-158°.
Fraction MH2—This fraction (15.2 mg; Ra 0.27 in Solvent B)
also gave only one spot on paper chromatograms in Solvents B,
D, and H. It reacted with aniline phthalate and alkaline silver
nitrate and only faintly with ninhydrin spray. In contrast with
Fraction MHl, it reacted slowly with the Morgan-Elson spray,
giving a color characteristic of N-methylglucosamine (9).
Ninhydrin treatment (12) of the fraction gave the same mono-
methyl arabinose as that obtained by similar tratment of
Fraction AIH1. On this basis, this fraction is 3-0-methyl-N-
methylglucosamine.
Fraction MH3—This fraction (2.8 mg) gave two spots, with
Ro 0.27 and 0.31 in Solvent B. Thus it appeared to be a mixture
of Fraction MH2 and an unknown. Demethylation of a portion
followed by ninhydrin treatment gave arabinose, but no lyxose,
as detected on paper chromatograms.
Fraction MHJ+—This fraction (23.1 mg; RG 0.35 in Solvent B)
gave only one spot on paper chromatograms in Solvents B. D, and
H. It reacted strongly with aniline-phthalate and ninhydrin,
but not with Morgan-Elson spray, even after a long time.
Demethylation with hydriodic acid followed by treatment with
ninhydrin gave mainly arabinose, as seen by paper chromatog¬
raphy. Direct ninhydrin treatment of the fraction gave di¬
methyl arabinose (paper and thin layer chromatography), which
was identical with that obtained by ninhydrin treatment of
3,6-dimethylglucosamine (obtained from methylated KS I).
The product obtained by AT-acetylation had the same mobility as
authentic 2-acetamido-2-deoxv-3,6-di-O-methyl d-glucose.
Fraction MH5—This fraction (6.9 mg; RG 0.52 in Solvent B)
was chromatographically and electrophoretically pure. It
reacted with aniline-phthalate and alkaline silver nitrate, and
faintly with ninhydrin spray; with Morgan-Elson spray it gave
the characteristic reaction for an A'-methvlated hexosamine.
Ninhydrin treatment of the fraction gave dimethyl arabinose,
identical with that obtained from Fraction MH4. From these
1056 Carbohydrate Structure of Human Rib Cartilage Keratosulfate Vol. 243, Xo. 5
reactions this fraction appears to be 3,6-di-O-methyl-iV-methyl-
glucosamine.
Fraction MH6—This fraction (3.1 mg; RG 0.60 in Solvent B)
gave a single spot on paper chromatograms and paper electro¬
phoresis. Its color reaction was similar to that of Fractions
MH1 and MH4. Demethylation with hvdriodic acid followed by
ninhydrin gave mainly arabinose; no lyxose was detectable on
paper chromatograms. Thus this is a methylated glucosamine
and not a galactosamine derivative.
Examination of Methylated Sugars (Methylated, Desulfated
Neutral Sugars and Hexosamines) from Desulfated KS II
The methylated desulfated neutral sugars were examined by
paper chromatography in Solvents B and C. In the former
solvent, 2,4.6-tri-methyl galactose (RF 0.65) was the main sugar,
with a smaller spot of 2,3,4,6-tetramethylgalactose (RF 0.77).
In addition, traces of 2,4-dimethylgalactose and an unknown
were present. In Solvent C, 2,4,6-trimethylgalactose (Rr 0.20),
2.3,4,6-tetramethyl galactose (Rr 0.60), and a trace of a spot
with Rr 0.05 were detected. Thin layer chromatography in
Solvent a confirmed the presence of 2,3,4,6-tetramethyl-
galactose, 2,4,6-trimethylgalactose, traces of 2,4-dimethyl¬
galactose, and an unknown with the .same mobility as 2,3,
4-trimethylgalactose. A sample of 2,4-dimethyl-3,6-anhydro-
galactose was used on both paper and thin layer chromatograms
as reference. In methylated, desulfated neutral sugars this
sugar was absent.
Gas-liquid chromatography of the methylglycosides of methyl¬
ated, desulfated neutral sugars was carried out with a butanediol
succinate ester column at 190° and with a polyphenol ether
column at 185° (13, 14). This analysis confirmed the presence
of 2,4,6-trimethylgalactose (major), 2,3,4,6-tetramethyl¬
galactose (minor), and 2,4-dimethvlgalactose (trace). In
addition, two very small peaks with RT 1.40 and 2.00 were
detected in the first system. After demethylation of methylated
desulfated neutral sugars (1 mg), galactose was the only free
hexose detected on paper chromatograms run in Solvents G and I.
Paper chromatography of the methylated, desulfated hexos-,
amines in Solvent B gave a strong spot of 3,6-dimethylglucos-
amine (Rr 0.38), a smaller spot of S^-dimethyl-A'-methylglucos-
amine (Rr 0.46), and a trace of 3-O-methylglueosamine (Rr 0.18).
These spots gave characteristic color reactions with the aniline-
phthalate, ninhydrin, and Morgan-Elson sprays. Paper chroma¬
tography in Solvent C gave only one very slow spot (Rr 0.02).
Similarly, on thin layer chromatography in Solvents a and 6, this
fraction was very slow and gave no useful information. The
main product after ninhydrin oxidation was a dimethyl arabinose,
paper chromatographically identical with that obtained by
ninhydrin treatment of Fraction MH4. Arabinose was the
only pentose detectable on paper after demethylation followed
by ninhydrin oxidation.
Total Acid Hydrolysis of KS II
Fraction MN2 from methylated native polysaccharide yielded,
on demethylation, sugar with the chromatographic mobility of
mannose, as stated earlier. Total acid hydrolysis of KS II
followed by chromatography confirmed the presence of this
sugar in the original preparation. Hence KS II (500 mg) was
dissolved in 2 x H.SO4 (250 ml) and hydrolyzed by refluxing for
15 hours at 100°. The cooled solution was neutralized with a
saturated solution of Ba(OH)2, followed by addition of BaC03,
and centrifuged. Concentration of the supernatant furnished a
syrup (437 mg). A solution of this syrup was passed through
successive columns of Dowex 50-H"1" and Amberlite IR-45
(CO3"). The columns were washed with water until the wash¬
ings gave a negative test with anthrone. The effluent and water
eluate were concentrated to a syrup, which was then fractionated
into four fractions (A through D) on prewashed Whatman No.
3MM paper with Solvent A. The basic components were
eluted from the Dowex column with 2 x NH4OH. The eluate
was aerated to remove ammonia and concentrated to a syrup.
The two main components (Fractions E and F) were obtained in
pure form by fractionation of this syrup on Whatman No. 3MM
paper with Solvent G.
Fractions A and F were D-galactose and D-glucosamine,
respectively, and were not investigated further. Fraction C
(10.6 mg) was chromatographically (Solvents E, G, H, and I) and
electrophoretically (borate buffer, pH 10.0) indistinguishable from
fucose. The identification of L-fucose in KS II has been re¬
ported by Bray, Lieberman, and Meyer (15).
Fraction B—This fraction (7.7 mg; [ajfinai +15.3° (c, 0.1)) was
chromatographically identical with mannose in Solvents B, E, G,
H, and I. Paper electrophoresis in borate buffer at pH 10.0 gave
a single spot identical with mannose. The sugar (1.0 mg) was
reduced with sodium borohydride, and the product was divided
into two portions. One portion, examined paper chromato¬
graphically in Solvents G and I, showed spots identical with
mannitol. The second portion of the reduced material was
acetylated with acetic anhydride and pyridine, and the product
was examined by gas-liquid chromatography on a column of
ethylene glycol succinate combined with a cyanoethyl silicone
column (16, 17) at 180° and 200°. The main peak (ftgiucitoi
0.75) corresponded to that of mannitol hexaacetate. The sugar
was finally converted to its phenylhydrazone (18); m.p. 193-195°;
mixed m.p. (with an authentic sample of D-mannose phenyl¬
hydrazone) 196-198°.
Fraction D—This sugar (7.6 mg; Ra 1.11, 1.62, and 1.24
in Solvents E, G, and I, respectively), on paper electrophoresis in
Buffer I, stayed at the origin. It gave a brown spot, fluorescent
in ultraviolet light, resembling the hexoses. The anthrone
spray (19) specific for ketoses was positive. The identity of this
fraction is unknown.
Fraction E—This fraction (18.2 mg; [a]D,final +13.3° (c, 0.2);
#Gai 0.35 and 0.45 in Solvents G and I, respectively) gave a
positive reaction with ninhydrin and aniline-phthalate sprays.
Hydrolysis of this sugar (10 mg) with 4 x HC1 for 6 hours at
100°, followed by chromatography in Solvent I, showed galactose
and glucosamine, while the major part of the fraction remained
unhvdrolyzed. Sodium borohydride reduction, followed by
strong acid hydrolysis of the derived glycitol, gave 110 galactose
but yielded glucosamine, galactitol, and some glucosaminitol.
This sugar thus appeared to be a disaccharide of glucosamine
and galactose, with the latter at the reducing end. A sample of
the sugar was treated with a saturated solution of lime water for
27 hours at room temperature in an atmosphere of nitrogen. It
was heated in a boiling water bath for 1 min. The cool solution
was neutralized with phosphoric acid, calcium phosphate was
removed by centrifugation, and the supernatant was concentrated
to dryness. Paper chromatographic examination of the resulting
syrup showed mainly glucosamine, with possibly a trace of
mannosamine. Under the same conditions laminaribiose (G
1 3 G) gave glucose and a trace of mannose, and cellobiose
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(G 1 4 G) gave only a little glucose and was mostly un¬
changed.
The sugar (2.0 mg) was converted to the methyl glycosides and
oxidized with sodium periodate at room temperature for 6 hours.
After addition of the calculated amount of ethylene glycol to
destroy the excess periodate, it was hydrolyzed with x H2SO4
for 4 hours at 100°. The hydrolysate was neutralized with
BaCC>3, concentrated, and examined by paper chromatography
in Solvents G and I. Galactose was the only sugar detected on
these chromatograms with silver nitrate and aniline-phthalate
sprays.
Desulfation of Keratosulfates
KS II (500 mg) was shaken with anhydrous methanol (50 ml) in
a stoppered flask for 3 hours. Dry Dowex 50-X8 (H+) (5 g) and
dry NaCl (1 g) were added, and the heterogeneous mixture was
shaken for 48 hours at room temperature. Distilled water
(approximately 200 ml) was added to the flask, and the solution
was stirred for 18 hours in the cold. The cloudy suspension was
filtered through a pad of glass wool, and the resin remaining in
the glass wool was washed twice with water, with stirring. The
combined filtrates were dialyzed in the cold for 48 hours against
stirred, distilled water. The contents of the bag were concen¬
trated to a small volume and centrifuged. The precipitate was
dispersed in distilled water and lyophilized to yield the water-
insoluble Fraction DKS Ha (161 mg). The supernatant was
lyophilized to yield the water-soluble Fraction DKS lib (123 mg).
The dialvsate was concentrated to a syrup (Fraction DKS lie).
Similarly, KS I (500 mg) was desulfated to yield the water-
insoluble Fraction DKS la (212 mg) and the water-soluble
Fraction DKS lb (82 mg). The analyses of native and desulfated
polysaccharides are given in Table V. Infrared spectra of the
desulfated samples showed practically 110 sulfate peaks (1240
cm-1, 850 cm-1, and 820 cm-1)- Fractions DKS la and DKS Ila
were insoluble also in dilute acid, alkali, borate buffer, 6 m urea,
ethylene glycol, and 1-butanol. They swelled in formamide and
dimethyl sulfoxide and dissolved 011 shaking. They were also
soluble in strong acids (25% H2SO4, 4 x HC1). Fractions DKS
la and DKS lb did not cause any deepening in color of a dilute
iodine solution. The amino acid compositions of KS I, DKS la,
and DKS lb were very similar. Digestion of Fraction DKS lb
with Pronase reduced the total amino acid content only slightly.
About 44% of the remaining amino acid was aspartic acid,
strongly supporting the proposed aspartyl linkage in I\S I (6).
Retreatment of a portion (50 mg) of the soluble Fraction DKS
lib with Dowex 50-H+ and NaCl in methanol gave no additional
insoluble Fraction DKS Ila. Gel filtration of DKS Ila and DKS
lib was carried out on a Sephadex LH-203 with 66% formamide
as the eluent, in which both samples are soluble. Both samples
were eluted in the void volume.
Examination of Dialyzable Fragments
Fraction DKS lie—This syrup was dissolved in water and
desalted by passage through Dowex 50-H+ and Amberlite IR-45
(C03~) columns. The water eluate of the columns was concen¬
trated to dryness, and the resulting syrup, on paper and thin
layer chromatography, showed a number of spots reacting with
silver nitrate, in addition to traces of free galactose and fucose.
After total acid hydrolysis galactose, fucose, and glucosamine
3 Sephadex LH-20 was a gift from Pharmacia, Piscataway, New
Jersey.
Table V
Desulfation of KS I and KS II
Small amounts of mannose were detected in the total acid hy-
drolysates of both the water-soluble and water-insoluble frac¬
tions.





% % % % % %
KS II -10.6 18.9 28.7 24.1 2.7 N.D.6
DKS Ila 42.9 -11.1 1.0 34.5 29.4 <1.0 N.D.
DKS lib 32.6 +9.6 1.5 30.4 27.4 1.1 N.D.
KS I +1.12 17.7 35.3 26.2 N.D. 2.57
DKS la 56.4 -6.6 0.6 45.0 42.4 N.D. 2.38
DKS lb 21.8 —5.9 1.5 35.9 27.7 N.D. 3.17
° By amino acid analysis.
6 N.D., not determined.
were detected in that order of intensity. Three fractions (DKS
IIcl through 3) were obtained by fractionation of 45 mg of DKS
lie on Whatman No. 3MM paper with Solvent B.
Fraction DKS IIcl—This fraction (32.5 mg), after initial
examination on paper and thin layer chromatography, was
further purified by thin layer chromatography on Silica Gel H
plates with Solvent c. The sugar (9.2 mg) was identical with
methyl fucoside on paper and thin layer chromatography. After
hydrolysis with x H2SO4 for 3 hours, only fucose was detected on
paper in Solvents D, E, F, and G.
Fraction DKS IIc2—Chromatography of 3.2 mg of Fraction
DKS IIc2 in Solvent B with silver nitrate and aniline-phthalate
sprays showed a spot with the mobility of fucose. However,
after acid hydrolysis, fucose and some galactose were detected on
paper. On paper chromatography in Solvent E, this fraction
gave a double spot with mobilities corresponding to those of
fucose and methyl galactoside. Thin layer chromatography in
Solvent c showed two distinct spots with mobilities of fucose and
methyl galactoside. Chromatography after sodium borohvdride
reduction and acid hydrolysis gave galactose and fucitol.
Fraction DKS IIcS—This fraction (2.5 mg) had the same
mobility as Ar-acetvllactosamine 011 paper chromatograms and
reacted with aniline-phthalate and silver nitrate sprays. On
acid hydrolysis (2 x H2SO4, 7 hours, 100°), it gave only galactose
and glucosamine. Sodium borohydride reduction followed by
acid hydrolysis yielded galactose as the only reducing sugar.
discussion
Old human rib cartilage keratosulfate used in the present
studies was prepared by the usual procedure and was further
purified by digestion with testicular hyaluronidase, followed by
Pronase. The preparation had a low peptide content and was
substantially free of chondroitin sulfate. It has been previously
reported from this laboratory that KS II has a low molecular
weight range and is partly dialyzable. The procedures used by
us to isolate the methylated and desulfated polysaccharides in¬
cluded dialysis. The KS II preparation was dialyzed against
stirred, distilled water for 48 hours in the cold room, and the non-
dialyzable portion (approximately 90%) was used for the methyl-
ation and desulfation studies. KS II was acetylated and then
methylated as described for KS I (9). The methylated KS II had
a methoxvl content of 22.2%, which is 93% of the theoretical
value expected on the basis of a monosulfated iV-acetyllactos-
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amine repeating unit. The yield of final product, 73%, was
much better than the 42% yield obtained in the case of KS I.
It is interesting that the methylated KS II had a positive optical
rotation (+5.9°) as opposed to the starting material, which had
a negative rotation (—7.2°). The desulfated KS II was methyl¬
ated by the same method as for the native polysaccharide.
Preliminary paper and thin layer chromatography indicated
that the hydrolysates from methylated native and methylated
desulfated polysaccharides contained 3,6-dimethylglucosamine,
2,4,6-trimethylgalactose, and some 2,3,4,6-tetramethyl-
galactose. The hydrolysate from methylated native poly¬
saccharide contained, in addition, 3-methylglucosamine, 2,4-
dimethylgalactose, and some 2,3,4-trimethylgalactose. The
methylated neutral sugars were separated from the methylated
hexosamine by passing the mixture through a cation exchange
agent. The methylated neutral sugars from both polymers were
converted to their methyl glycosides and examined by gas-
liquid chromatography in two different columns. The results
were in full agreement with the paper and thin layer chromatog¬
raphy; i.e. the neutral sugar from methylated desulfated poly¬
saccharide was mainly 2,4,6-tri-O-methyl-D-galactose, with
some 2,3,4,6-tetra-O-methyl-D-galactose and only a trace of
2,4-di-O-methyl-n-galactose. The methylated native poly¬
saccharide yielded 2,4,6-tri- and 2,4-di-O-methyl-D-galactose as
the main components, in addition to smaller amounts of 2,3,6-
tri-O-methvl-L-fucose and 2,3,4,6-tetra- and 2,3,4-tri-O-
methyl-D-galactose. The mixture of methylated neutral sugars
from the native polymer was fractionated on a carbon-Celite
column. The following sugars were characterized by preparation
of crystalline derivatives: 2,3,4,6-tetra-, 2,4,6-tri-, and 2,4-
di-O-methyl-n-galactose, and 2,3,4-tri-O-methyl-L-fucose. The
composition of additional fractions is given in Table IV.
The major portion of the methylated hexosamines from the
native polymer was V-acetylated by repeated treatment of the
free bases with acetic anhydride. The product obtained ap¬
peared to be a complicated mixture, and fractionation proved
difficult. The reason for this difficulty was probably the un¬
suspected presence of iV-methylhexosamines in the mixture. As
was shown earlier (9), Ar-methylhexosamines are not easily V-
acetylated. This neces utated the repeated acetylations, which
might even have caused some O-acetylation, thus giving rise to a
wide variety of products. The methylated hexosamines were,
however, identified after fractionation of the rest of the syrup on
Whatman Xo. 3MM paper into six fractions.
One of the main components, 3-O-methyl-D-glucosamine, was
characterized by its crystalline derivative. The others, 3-0-
methyl-Ar-methyl-D-glucosamine, 3,6-di-O-methyl-D-glucosamine
and 3.6-di-O-methyl-V-methyl-D-glucosamine, were identified by
their chromatographic and electrophoretic behavior and by their
color reactions. In addition, smaller amounts of two unidentified
derivatives were also present. These components appeared to be
glucosamine derivatives, rather than galactosamine, since both
gave only arabinose after demethylation and ninhydrin treat¬
ment. The identities of the methylated sugar components from
the desulfated polysaccharide are based on paper and thin layer
chromatography, electrophoresis, and their reactions with spray
reagents. The methylated neutral sugars were further identified
by gas chromatography, and the methylated hexosamines by the
products obtained on ninhydrin treatment. The results are sum¬
marized in Table III.
The desulfated polysaccharide appears to be a linear polymer
of 3-linked galactose and 4-linked V-acetylglucosamine, probably
in an alternating sequence. The nonreducing end groups are
composed entirely of galactose residues, and the average chains
appear to be made up of approximately 20 disaccharide units
(Table III). In the case of the native polysaccharide, roughly
60% of the glucosamine derivatives are 3-methyl glucosamine
and about 50% of the galactose derivatives are 2,4-dimethyl
galactose. It thus appears that approximately half the galactose
residues and about 60% of the glucosamine residues are sub¬
stituted in position 6. The major portion of these substituents is
sulfate. Since, during desulfation, fucose, sialic acid, galactose,
and a minor quantity of glucosamine were lost due to methanol-
ysis, it cannot be ruled out that the substituents at position 6 are
carbohydrates. Xo methyl ether of fucose was found in the
methylated, desulfated product. In the methylated native poly¬
saccharide one fucose derivative, namely 2,3,4-trimethylfucose,
was found. This indicates that all the fucose residues in KS II
are present as terminal nonreducing groups. In spite of the fact
that more galactose than glucosamine was lost during desulfation,
2,3,4,6-tetramethylgalactose is still present in the methylated,
desulfated polysaccharide. This, together with the fact that no
3,4,6-trimethylglucosamine was detected either in the methyl¬
ated native or methylated desulfated polysaccharide, indicates
the presence of galactose branch points or consecutive galactose
units in the main chain. The small amount of 2,3,4-trimethyl¬
galactose in the methylated native polymer arises from terminal
nonreducing galactose residues substituted at position 6. Again,
the substituent could be sulfate or a sugar residue. Whichever
is the case, the substituent must be acid-labile because it was
removed during desulfation and no 2,3,4-trimethyl galactose was
detected in the methylated, desulfated polysaccharide. The
unknown fraction from methylated native polysaccharide gave,
on demethylation, a sugar with the chromatographic mobility of
mannose. However, the i)eaks on gas chromatography of the
methyl glycoside of this fraction did not correspond to any of the
known methylated mannose derivatives.
Complete characterization of methylated hexosamines was
handicapped by the lack of reference sugars and also by the oc¬
currence of partial .V-methylation. However, the major com¬
ponents have been, at least tentatively, identified. About one
third of the hexosamines was N-methylated (see Table III). _V-
Methylglucosamine can be determined quantitatively by analysis
in the amino acid analyzer, where it appears between glucosamine
and galactosamine under the conditions of hexosamine analysis at
pH 5.28. The 6 n HC1 hydrolysate of a fraction of methylated
KS II showed almost 60% of the total hexosamine as Ar-methyl-
glucosamine (uncorrected) by this method.
It is now well established (4, 6) that roughly about 10% of the
hexosamine in KS II is ^-acetylgalactosamine. Methylated
galactosamine derivatives were not detected among the hydrol¬
ysis products of either the methylated native or the methylated
desulfated polysaccharides. Bray, Lieberman, and Aleyer (15)
found that ^-acetylgalactosamine in KS II is sensitive to alkali
and that it is lost as the Kuhn chromogen, concomitant with the
loss of serine and threonine, under very mild alkaline conditions.
Hence it is very likely that the Ar-acetvlgalactosamine was con¬
verted to the chromogen during the methylation (owing to the
alkalinity) and destroyed on hydrolysis.
The isolation and identification of D-mannose from KS II was
a surprise, since D-mannose has been considered typical of
glycoproteins. Total hydrolysis of keratosulfates from different
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sources, such as cornea, shark, nasal septum, and rib cartilage of
Marfan's syndrome, also yielded mannose, as detected by paper
chromatograms. Preparations purified by techniques such as
free flow electrophoresis (20) still had mannose, thus eliminating
the possibility of a contaminating glycoprotein in keratosulfate
preparations, unless a contaminating glycoprotein was also
sulfated. A KS II preparation reisolated after alkali treatment
still contained mannose, which would exclude the possibility of
its forming a glycosidic bond to the hydroxyamino acid. A
disaceharide composed of galactose and glucosamine was also
isolated from the total acid hvdrolysate. This disaccharide was
very resistant to acid hydrolysis and had galactose at the reducing
end. Glucosamine was identified after alkaline elimination,
suggesting a 1 -» 3-linkage to galactose. This was further con¬
firmed by the identification of only galactose after periodate
oxidation and hydrolysis of the methyl glycoside of the disaccha¬
ride. The A"-acetylated derivative of this disaccharide, with a
sulfate group possibly in position 6 of the galactose, has been
isolated by enzymic digestion of keratosulfate.4 The isolation of
these disaccharides and the isolation of sulfated .V-acetyllactos-
amine (9) support the earlier propositions (7, 9) that d-galactose
and d-glucosamine are linked in an alternating sequence in
keratosulfate. The total hydrolysate also gave the expected
galactose, glucosamine, and fucose. An unidentified trace com¬
ponent was present which had a faster chromatographic mobility
in basic solvent as compared to acidic solvents and gave a positive
reaction with a spray specific for ketose.
The procedures (21, 22) used for desulfation of sulfated poly¬
saccharides such as chondroitin sulfate have been unsuitable for
keratosulfate on account of extensive degradation and low yields.
Hirano, Hoffman, and Meyer (7) modified these methods by using
dry Dowex 50-H+ and NaCl and succeeded in getting reasonable
yields. However, when this experiment was repeated, it was
found that part of the desulfated polysaccharide was insoluble in
water.5 The water-insoluble fraction was also insoluble in dilute
acids, alkali, and a series of solvents listed in "Experimental
Procedure." No significant difference in the carbohydrate or
amino acid analysis was found that would explain the difference
in the solubility of the two fractions. The slightly higher sulfate
content (1.5%) of the water-soluble fraction probably does not
explain its solubility, since further treatment of this fraction with
the desulfating agent failed to produce the insoluble fraction.
These fractions may differ in their molecular weights. The
insolubility of one of the fractions prevented the conventional
molecular weight determinations. On gel filtration on Sephadex
LH-20, both fractions were excluded; however, Sephadex LH-20
has a very low exclusion limit.
In addition to the removal of sulfate ester groups, sialic acid,
l-fucose, and, surprisingly, some galactose and iV-acetyllactos-
amine were also cleaved by methanolysis during desulfation.
Among the dialyzable fragments methyl fucoside, methyl
galactoside, A'-acetyllactosamine, and traces of galactose and
fucose have been identified by chromatography. Sialic acid and
l-fucose probably occupy terminal nonreducing positions in the
4 R. Lieberman and K. Meyer, unpublished results.
5 Carragenan, a natural sulfated polygalactan, on desulfation
remained entirely water-soluble.
carbohydrate chains, and the acid lability of such groups is not
surprising. The preferential removal of galactose was surprising.
Galactofuranose residues, which are acid-labile, could not be
demonstrated in keratosulfate. The nature of the acid-labile
galactosyl groups, probably at branch points, is at present un¬
known.
The main carbohydrate chains of both KS I and KS II are
similar, namely, A~-acetyllactosamine units polymerized through
1 —» 3-linkages to galactose. In both cases the sulfate goups
appear to be distributed in a random manner between positions 6
of d-galactose and .V-acetyl-d-glucosamine, with the larger share
of the sulfate groups on glucosamine. That branching occurs to a
slightly greater extent in KS II is indicated by the presence of
larger amounts of 2,3,4-trimethyl fucose and 2,3,4,6-tetra-
methyl and 2,3,4-trimethyl galactose in methylated KS II as
compared to the traces of these components in methylated KS I
(see "Discussion" in Reference 9). The actual size of the
branches or the number of branches present is difficult to ascer¬
tain at this time. Our prediction is that sialic acid, fucose, and
some galactose are present in the branches either individually or
in small groups. Information along these lines is expected from
the study of the oligosaccharides obtained by partial hydrolysis,
acetolysis, and enzymatic hydrolysis of KS II.
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SUMMARY
The bulk (60 to 65%) of the neuraminidase activity present
in rat liver homogenates was found in the M + L (mito¬
chondria plus lysosomes) fraction. The patterns of subcellular
distribution were essentially identical whether disialoganglio-
sides or neuramin-lactose (2-+3') were utilized as sub¬
strates.
A new neuraminidase, which hydrolyzes sialyl trisac-
charides but which does not act upon glycoproteins and
gangliosides, was detected in Golgi apparatus. Unlike the
other particulate neuraminidases of rat liver, the Golgi
enzyme is stimulated by prior incubation and by the addition
of Ca2+ or Zn2+ at 1 mM concentration.
Although plasma membrane-rich fractions are often con¬
taminated by Golgi membranes the marked differences in
their enzymic properties allowed a clear distinction between
the neuraminidases present in these two types of mem¬
branes.
Rat liver contains soluble (2) and particle-bound neuramini¬
dases (3). The soluble enzyme is a component of the cytosol (4),
whereas the particulate enzyme was first found in lysosomes
(3-7) and more recently in plasma membrane-rich fractions
(8, 9). The observation that most of the particulate neuramini¬
dase with specificity toward gangliosides appears to be asso¬
ciated with plasma membrane (8) whereas most of the neur¬
aminidase activity measured with neuramin-lactose appears to
be lysosomal (6) prompted distribution studies with both sub¬
strates. In addition, since plasma membrane preparations are
often contaminated by Golgi membranes, neuraminidase activity
was also investigated in highly purified Golgi preparations.
* This work was supported in part by United States Public
Health Service Grant NS09176. A preliminary report has been
published (1).
t Present address, Department of Molecular Biology, Vander-
bilt University, Nashville, Tennessee 37232.
§ Present address, Department of Biological Chemistry, The
Milton S. Hershey Medical Center, The Pennsylvania State Uni¬
versity, Hershey, Pennsylvania 17033.
MATERIALS AND METHODS
Neuramin-lactose (2—»3') and neuramin-lactose sulfate (potas¬
sium salts) were prepared from rat mammary glands (10), while
the 2—*6' isomer of neuramin-lactose was isolated from cow colos¬
trum (11). Ovine submaxillary glycoprotein was kindly provided
by the late Professor Alfred Gottschalk, Max Planck Institute for
Virus Research, Tubingen, West Germany. Disialogangliosides
were prepared from bovine brains as described by Winterbourn
(12). The preparation utilized for this work contained 35.1% of
AT-acetylneuraminic acid (13); it had a molar ratio of N-acetyl-
neuraminic acid to iV-acetylgalactosamine (14) of 2.1 and 46% of
its total sialic acid was released upon treatment with neuramini¬
dase from Clostridium perfringens. Mixed gangliosides from bovine
brain type II, 5'AMP, iV-acetvlneuraminic acid,1 UDP-galactose
(sodium salt), iV-acetylglucosamine, glucose 6-phosphate, and
neuraminidase type VI from Clostridium perfrivgens were products
of Sigma. UDP-[MClgalactose (274 mCi per mmol) was obtained
from New England Nuclear. Fetuin from fetal calf serum and p-
nitrophenyl thymidine 5'-phosphate were purchased from Calbio-
chem. All of the other chemicals utilized were of the highest purity
commercially available.
Female Sprague-Dawley albino rats (220 to 260 g) fed ad libitum
on a commercial pellet diet (Teklad Mills) were used for these
studies.
The animals were stunned and killed by decapitation. The livers
were quickly excised and chilled in ice-cold homogenizing solu¬
tion; tissue homogenates were prepared and fractionated follow¬
ing published procedures as follows.
The method of Touster et al. (15) was adopted for the initial
preparation of crude subcellular fractions and for the subsequent
isolation of purified plasma membranes from the microsomal frac¬
tion.
Purified lysosomes were prepared by differential centrifugation
as described by Ragab et al. (16).
For the isolation of Golgi apparatus, the method followed was
essentially that of Leelavathi et al. (17). The Golgi fraction thus
obtained was purified further by repeating the step of ultracentrif-
ugation in discontinuous sucrose gradient. This procedure is
similar to the one recently recommended by Dewald and Touster
(18). The purified Golgi suspension was then diluted with distilled
water to a sucrose concentration of 0.25 m and centrifuged for 30
min at 78,000 X g. The final Golgi pellet was gently suspended in
glass-distilled water (1.8 mg of protein per ml) for neuraminidase
assay. The Golgi marker enzyme, UDP-galactose: iV-acetylgluco-
samine galactosyltransferase was assayed on a portion of the pellet
suspended in a 0.5% (v/v) solution of Triton X-100.
The incubation mixture for the neuraminidase assay consisted
of 135 pi of Golgi suspension, 15pi of 1 M acetate buffer, pH 4.2, and
50 pi of substrate solution containing 200 nmol bf bound sialic acid.




Subcellular distributioji of rat liver neuraminidase and of lysosomal and plasma membrane marker enzymes
Liver fractions" Protein%"





RSAe % RSA % RSA % RSA % RSA %
Nuclear 20.6 0.91 18.7 1.02 21.1 0.66 13.6 0.83 17.2 1.04 21.4
M + L 28.0 0.35 9.7 0.64 17.8 1.86 52.1 2.11 59.2 2.36 66.1
Microsomal 21.6 2.99 64.5 2.58 55.7 0.77 16.6 0.77 16.6 0.42 9.1
Soluble 29.7 0.24 7.1 0.18 5.4 0.60 17.7 0.23 6.9 0.11 3.3
0.54' 15.9 0.39* 11.7
" Isolated by differential centrifugation (15).
6 All percentages are based on total recovery. Actual over-all recoveries were within 10% of the values obtained with the unfrac-
tionated liver homogenate.
e RSA, relative specific activity: percentage of total activity divided by percentage of total protein of each fraction.
d Assayed using as substrate disialoganglioside (DSG) or neuramin-lactose 2 —* 3' (NL). Since all fractions contained 0.25 m sucrose,
the incubation mixtures were fractionated by ion exchange chromatography prior to the determination of free iV-acetylneuraminic
acid.
• Values for the soluble neuraminidase assayed at pH 5.8.
The system was incubated for 2 hours at 37°. The reaction was
stopped by the addition of 0.1 ml of periodate reagent (19) and the
free sialic acid was assayed by a modification (20) of the thiobarbitu-
ric acid method of Warren (19). Alternatively, the enzyme reaction
was stopped by quick freezing of the incubation mixture. After
thawing, the samples were immediately subjected to ion exchange
chromatography on columns (0.5 X 6 cm) of Bio-Rad AG 1-X2
(formate). The columns were first-washed with distilled water and
then eluted with 25 column volumes of 0.3 m formic acid. The
eluates were lyophilized and free sialic acid was then assayed in
the residue dissolved in distilled water. Enzyme and substrate
controls were incubated concurrently and their values subtracted
from the experimental values. Neuraminidase assays in other
particulate fractions and in the soluble fraction were done by the
same procedure but at their pH optima, 4.4 and 5.8, respectively
(4).
All other enzyme assays were done by published methods
as follows. UDP-galactose: V-acetylglucosamine galactosyltrans-
ferase was assayed by the methods of Fleischer and Fleischer (21)
and of Morre et al. (22); 5'-nucleotidase and phosphodiesterase I
were determined as described by Touster et al. (15); acid phospha¬
tase was measured according to Berthet and de Duve (23); a-d-
mannosidase was assayed at pH 5.5 by the method of Dewald and
Touster (18) and glucose-6-phosphatase was determined according
to de Duve et al. (24).
Protein was determined according to Lowry et al. (25) using
crystalline bovine serum albumin as the standard.
For ultrastructural studies, the pelleted Golgi fractions were
fixed in 2% glutaraldehyde and postfixed with osmium tetroxide.
After washing with buffered normal formalin, the material was de¬
hydrated in graded ethanol and embedded in Araldite 6005. Sec¬
tions of these pellets were examined in a Hitachi HU-11B electron
microscope.
RESULTS
The enzyme content of liver subcellular fractions obtained by
differential centrifugation (15) shows that the bulk of the neur¬
aminidase activity and the highest relative specific activity was
recovered in the combined mitochondria plus lysosomes (M -+■ L)
fraction (Table 1) whether disialogangliosides or neuramin-
lactose (2—were used as the substrate. The distribution of
neuraminidase resembles that of the lysosomal marker enzyme,
acid phosphatase, while the plasma membrane marker enzymes,
5'-nucleotidase and phosphodiesterase I, appeared concentrated
in the crude nuclear and microsomal fractions as expected. The
microsomal pellet was fractionated by discontinuous sucrose-
gradient centrifugation (15) and the same four enzymes were
Table II
Neuraminidase activity in rat liver plasma membrane
Fraction P2 isolated from the microsomal pellet (15) and sus-






" All incubation mixtures were fractionated by ion exchange
chromatography.
6 Membrane fraction incubated at 37° for 90 min in 0.1 m ace¬
tate buffer, pH 4.4, and centrifuged for 30 min at 105,000 X g.
Supernate used to measure sialic acid released from endogenous
substrates.
assayed in the isolated subfractions P2, P3, and P4. In general
agreement with a previous report (8), all of the enzymes ex¬
hibited their highest relative specific activity in the plasma
membrane-rich fraction (P2), which collects at the 0.25 m-34%
sucrose interface. This fraction was the only one that consist¬
ently gave measurable levels of neuraminidase activity towards
both neuramin-lactose and disialogangliosides (Table II).
Release of sialic acid from endogenous substrates (8) was also
demonstrated; the product of this hydrolysis was characterized
as N-acetylneuraminic acid by paper chromatography (26).
Since it was recently reported that plasma membranes pre¬
pared by this method are contaminated by variable amounts of
Golgi membranes (18), plasma membranes (P2) and Golgi-rich
fractions were prepared and assayed for neuraminidase and
several marker enzymes. The results obtained for the marker
enzymes (Table III) are in close agreement with those reported
in the literature (18).
The specific activities of neuraminidase and of the Golgi
marker enzymes a-mannosidase and galactosyl transferase arc
considerably higher (315%, 337%, and 378%, respectively) in
Golgi than in plasma membrane. Conversely, the specific activi¬
ties of the plasma membrane markers (S'-nucleotidase and
phosphodiesterase I), of the lysosomal marker (acid phospha¬




Comparison of levels of various enzymes in preparations of plasma




Entyme unitse per mg protein
5'-Nucleotidase 1.67 0.26




Acid phosphatase 22.34 10.63
Glucose 6-phosphatase 0.15 0.07
Fig. 1. Electron micrograph of a rat liver Golgi fraction. The
bar represents 1 micrometer.
Golgi are less than 50% of the values found in plasma mem¬
brane. These results provide strong support for the presence of
neuraminidase activity as an integral part of the Golgi mem¬
branes.
Further characterization of the Golgi neuraminidase was con¬
ducted on preparations obtained as described under "Materials
and Methods." The high purity of these preparations was
ascertained by the high specific activity of the galactosyl trans¬
ferase (22) (248 to 343 nniol per hour per mg of protein) and by
occasional examination by electron microscopy (Fig. I). The
specific activity for Golgi neuraminidase usuallv ranged between
a Prepared according to Touster et al. (15); yield 1.48 mg of
protein per g of liver. /
6 Prepared according to Dewald and Touster (18); yield 0.62
mg of protein per g of liver.
6 For 5'-nucleotidase, phosphodiesterase I, and glucose-6-
phosphatase, 1 enzyme unit corresponds to the activity hydrolyz-
ing 1 Atmol of substrate per min; for galactosyltransferase, a-man-
nosidase, and acid phosphatase units are expressed in nanomoles
per min and for neuraminidase in nanomoles per hour.
d Determined by the method of Fleischer and Fleischer (21).
• Determined with neuramin-lactose (2—>3') as the substrate.
Fig. 2. pH versus activity curve of rat liver Golgi neuramini¬
dase. The enzyme activity was measured with neuramin-lactose
(2—»3') as the substrate in the presence of sodium acetate-acetic
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Fig. 3. Effect of the concentration of neuramin-lactose (2—»3')
on the rate of hydrolysis. iV-AN, iV-acetylneuraminic acid.
10 and 25 nmol per hour per mg protein, although values as
high as 150 have been observed.
The pH value versus activity curve of Golgi neuraminidase,
studied with acetate buffer, displayed a broad peak between
pH 4.0 and 4.4 with a maximum at about pH 4.2 (Fig. 2). The
rate of hydrolysis of neuramin-lactose (2-*3') was linear for up
to 2 hours of incubation at 37°. The reaction velocity was also
Linear with increasing enzyme concentrations between 0.06 and
0.55 mg of protein. The effect of substrate concentration (neura¬
min-lactose, 2—»3') on the rate of hydrolysis is shown in Fig. 3;
the Km calculated from the plot [«S]/v versus (5) (27) gave a
value of 2.17 X 10"4 m. Stimulation of the enzymic activity was
noticed upon preincubation at 37° in acetate buffer, pli 4.2, for
1 hour. The magnitude of the stimulation varied (between 50
and 80%) from preparation to preparation. Preincubation of
lysosomes isolated by differential centrifugation (16) or ot
Triton WR-1339-filled lysosonies (4) under similar conditions
resulted in a 30 to 50% loss of neuraminidase activity.
The effect of several divalent cations (as their chloride.-*) on
the enzvme activity was also studied. Addition of C'a2+ or Zn'-+
2G5S
Table IV











° Differential spectrum (complete enzyme system recorded
against enzyme blank) of the chromogens obtained by direct
thiobarbituric acid assay of the incubation mixtures showed an
interfering peak with xmmx at 535 nm. Fractionation of the incu¬
bation mixtures by ion exchange chromatography prior to the
thiobarbituric acid assay (see "Materials and Methods") revealed
absence of free AcNeu, indicating lack of hydrolysis of disialo-
gangliosides.
at 1 mu concentration resulted in about 40% activation, while
Hg24" ions at the same concentration caused 40 to 50% inhibi¬
tion of the enzyme. Cu24" at 1 mM concentration had no effect
on the enzyme activity.
Higher concentrations of chlorides of mono and divalent
cations (Na+, K+, Li+, and Ca2+) were inhibitory to the en¬
zyme. At 200 meq per liter, only 40 to 50% of the initial activity
was detected.
The rate of hydrolysis of different substrates by Golgi neur¬
aminidase was also studied. Neuramin-lactose sulfate was
hydrolyzed much faster than neuramin-lactose (2—>3') which in
turn was a much better substrate than the 2—*6' isomer of
neuramin-lactose. Golgi preparations showed no neuraminidase
activity towards macromolecular substrates such as fetuin,
ovine submaxillary glycoprotein, and gangliosides under the
experimental conditions described (Table IV).
A point still under study, but which nevertheless should be
mentioned at this time, is that Golgi preparations obtained
from the livers of female rats, in general, appear to have higher
neuraminidase activity than those obtained from male rats.
discussion
There are marked discrepancies between the results reported
from different laboratories regarding the relative distribution of
particulate neuraminidase in rat liver subcellular fractions.
Using neuramin-lactose as the substrate, Horvat and Touster
(6) observed that the lysosomal fraction was the richest (47%)
while only 32% of the total activity was recovered in the micro¬
somal fraction. On the other hand, Schengrund et al. (8), using
ganglioside as the substrate, found 54% of the total neuramini¬
dase activity in the microsomal fraction and only 26% in the
combined mitochondrial-lysosomal pellet. In our studies on the
intracellular distribution of neuraminidase, the major portion of
the particulate neuraminidase activity was found in the M + L
fraction, regardless whether neuramin-lactose or disialoganglio-
sides were used as substrates (Table I). The reasons for these
differences are not readily apparent and they are probably due
to the combined effect of differences in the modus operandi and
in the composition of the substrates. Commercial neuramin-
lactose is usually isolated from cow colostrum and it contains a
mixture of the 2—>3' and 2-*6' isomers (11), whereas the neura¬
min-lactose utilized for our studies is pure 2—»3' isolated from
rat mammary glands (10). Differences in the rates of hydrolysis
obtained with these two isomers are quite significant (Table IV)
and variations in the relative proportions of these two compo¬
nents in different specimens might possibly account for the fact
that, while some authors consider neuramin-lactose to be a
relatively poor substrate (8), other investigators find it satis¬
factory (9), and, we found it more sensitive (Table I) than
gangliosides for all of the enzyme preparations assayed in these
studies. The possible effect of variations in the relative propor¬
tions of the individual gangliosides present in commercial mixed
gangliosides and in disialogangliosides is another factor that
needs to be evaluated. A technical point that, unless adhered to
can invalidate the results is that the assay of the sialic acid
liberated by plasma membrane preparations can be conducted
only after fractionation of the incubation mixture by ion ex¬
change chromatography because spectroscopic analysis of the
chromogens obtained by direct thiobarbituric acid assay on the
incubation mixtures gave a differential spectrum (i.e. spectrum
of the complete enzyme system recorded against the enzyme
blank) with Xmax at 535 nm instead of the typical peak at 549
nm (19).
In spite of the differences in enzyme distribution described
above, our findings (Table II) are consistent with previous
reports (8, 9) concerning the presence of neuraminidase activity
toward endogenous and exogenous substrates in plasma mem¬
brane-rich fractions.
The fact that the neuraminidase activity found in plasma
membranes is not due to lysosomal contamination has been
clearly substantiated (9). On the other hand, since plasma mem¬
brane fractions prepared by the method of Touster et al. (15)
are contaminated with Golgi membranes (18), the Golgi neur¬
aminidase described in this paper may contribute, in some
measure, to the neuraminidase activity assayed with neuramin-
lactose in plasma membrane preparations.
The three membrane-bound neuraminidases of rat liver (lyso¬
somal, plasma membrane, and Golgi) differ markedly in some
of their properties, suggesting that they are probably three
different enzymic entities. As indicated above (Table IV), the
Golgi neuraminidase does not hydrolyze gangliosides which in
turn are good substrates for lysosomal (4-6) and plasma mem¬
brane (8-9) neuraminidases. While preincubation of Golgi
preparations causes 50 to 80% stimulation of the activity towards
neuramin-lactose, no such stimulation was observed with plasma
membranes (9) and a marked inhibition was observed with
tritosomes (4) and with lysosomal preparations obtained by
differential centrifugation (16). Using neuramin-lactose as the
substrate, the Km for the Golgi neuraminidase was 2.17 X 10-4
m, whereas the values reported for the lysosomal and plasma
membrane neuraminidases (9) were 1.27 X 10~3 m and 6.86 X
10~4 m, respectively. Marked differences in the behavior of these
three enzyme preparations were also observed in the presence
of 1 mm concentration of several divalent cations. While Ca2"1",
Zn24", and Hg24* had little or no effect on the lysosomal enzyme
(4), Ca2+ and Zn2+ stimulated the Golgi enzyme by 40% while
Hg2+ caused 40 to 50% inhibition. Cu24", on the other hand,
caused more than 90% inhibition of the plasma membrane
neuraminidase (9) but had no effect on either the lysosomal (4)
or the Golgi enzymes.
In addition to neuraminidase, two other glycohydrolases
(a-mannosidase and Ar-acetyl-/3-glucosaminidase) have been
detected (18) in Golgi apparatus. The presence of these degrada-
tive enzymes in an organelle which appears to be the major site
for glycosyltransferases involved in biosynthetic processes is not
to be regarded as an incongruity. Actually, these findings support
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current views concerning the participation of the Golgi apparatus
in the biogenesis of lysosomes. Since the Golgi neuraminidase,
unlike its lysosomal counterpart, does not attack macromolecu-
lar substrates, this form of the hydrolase is compatible with the
presence of newly synthesized sialoglycoconjugates within the
same organelle. The other two glycohydrolases found in Golgi,
i.e. a-mannosidase and iV-acetyl-j3-glucosaminidase, have been
assayed using low molecular weight synthetic substrates, and
hence it would be of considerable interest to establish whether
they are active or inactive toward glycoproteins.
In the case of neuraminidase and a-mannosidase, marked
differences have been observed between the enzymic properties
of the respective Golgi and lysosomal enzymes; no data is yet
available for iV-acetyl-/3-glucosaminidase. These differences in
properties and specificity may be caused by intrinsic structural
changes or by changes in the microenvironment of these enzymes
as the endomembrane differentiation from Golgi vesicles to lyso¬
somes shifts these glycohydrolases from a biosynthetic sub¬
cellular compartment to one committed exclusively to a degrada-
tive function or both. Studies with highly purified hydrolases
from Golgi apparatus and from lysosomes should help elucidate
possible structural and functional interrelationships between
these homologous enzymes.
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A new method for the radioisotopic assay of neuraminidase activity has
been developed. The substrate utilized, a-D-/V-acetylneuraminosyl-(2 —» 3')-
lactit[3h]ol, was prepared by reduction of a-D-/V-acetylneuraminosyl-(2 —* 3')-
lactose with tritiated borohydride and purified by ion-exchange chromatography.
After incubation with neuraminidase, the reaction mixtures were applied to small
columns of AG 1-X2 (formate) in order to remove free sialic acid and unhydro-
lyzed substrate. The lactit[3h]ol released by neuraminidase action was then
recovered by washing the columns with distilled water and quantitated by uti¬
lizing a liquid scintillation spectrometer. Studies with bacterial, avian, and mam¬
malian neuraminidases are described.
Neuraminidases are widely distributed (1) in microorganisms (viruses,
mycoplasmae, and bacteria) as well as in animal tissues (amphibian,
avian, and mammalian). The enzyme activity is usually assayed by
measuring the sialic acid released from natural substrates (oligosac¬
charides, gangliosides, and glycoproteins). The thiobarbituric acid2
methods (2,3), widely used for the estimation of free sialic acids, often
do not give reliable results with crude enzyme preparations. Substances
such as deoxyribose (2), sucrose (from the homogenizing solutions) (4),
lipid peroxides, 3-deoxyaldulosonic acid (5), and unsaturated uronic
acids (6) are some of the compounds known to interfere with this assay.
In addition, and for reasons not quite understood, several compounds
containing bound sialic acids have been reported to give a positive TBA
test (7-9). In some cases, suitable corrections can be calculated from
dichromatic readings (2) but in many instances, isolation of the free
sialic acid must be conducted prior to the TBA assay (4).
1 Present address: Department of Biological Chemistry, The Milton S. Hershey Medical
Center, The Pennsylvania State University, Hershey, Pa. 17033.
2 Abbreviations used: TBA. thiobarbituric acid: NL(2 —> 3'), a-L-iV-acetyl-
neuraminosyl-(2 —* 3')-lactose: NL(2 —> 6'), a-D-V-acetylneuraminosyl-(2 -» 6')-lactose:
NL[3H]ol, «-D-iV-acetylneuraminosyl-(2 -» 3')-lactit[3H]ol.
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The new method described in this communication circumvents these
problems by utilizing as the substrate a sialyl-oligosaccharide with a neu¬
tral radioactively labeled aglycone. Free sialic acid and unhydrolyzed
substrate are removed from the reaction mixture with an anion-exchange
resin and the aglycone released by the enzyme action is then measured
by scintillation spectrometry.
MATERIALS AND METHODS
Neuramin-lactose was isolated from skimmed bovine colostrum by
ion-exchange chromatography, essentially as described by Schneir and
Rafelson (10). It should be pointed out, however, that this method gave
only a partial separation of NL(2 —» 3') from NL(2 —» 6'). In order to
complete the isolation of pure NL(2 —» 3') utilized for these studies, the
intermediate fractions, containing a mixture of the two isomers, were
further fractionated by preparative paper chromatography. This separa¬
tion was performed on prewashed Whatman No. 3MM paper by
descending irrigation with ethyl acetate: pyridine: acetic acid: water
(5 :5 : 1: 3, by volume). 3H-labeled sodium borohydride and Aquasol were
purchased from New England Nuclear. Neuraminidase (type VI) from
Clostridium perfringens and crystalline synthetic /V-acetylneuraminic
acid (type IV) were products of Sigma. All other chemicals were ob¬
tained commercially and they were the highest purity available.
Total sialic acid was determined by the periodate-resorcinol method
(11). Free sialic acid was measured by the TBA assay of Warren (2) as
modified by Yeh et al. (12). Protein was determined by the method of
Lowry et al. (13) with crystalline bovine serum albumin as the standard.
Lactose and lactitol were assayed by the anthrone reaction (14).
Radioactivity was measured in a Nuclear-Chicago Mark I liquid scin¬
tillation system using a mixture of 1 ml of aqueous sample and 12 ml of
Aquasol. The efficiency was about 17%.
RESULTS
Preparation of Tritium-Labeled Neuramin-Lactitol
A solution of NaB[3H]4 (231 ^moles, total activity 7.29 mCi) in 2 ml
of 0.01 n NaOH was added to 67 pimoles of NL(2 —> 3')(potassium
salt) and the reaction was allowed to proceed at room temperature in a
stoppered test tube with occasional shaking. At the end of 2.5 hr,
NaBH4 (20 mg) in 0.5 ml of 0.01 n NaOH was added and the reaction
was allowed to proceed for an additional 4 hr. The reaction was then
stopped by decomposing the excess borohydride by dropwise addition of
acetone (1 ml). The solution was applied to a Bio-Rad AG 50-X2 (H+)
column (0.9 x 7 cm) and eluted with 60 ml of distilled water. This
operation was done in a cold room (4°C) since earlier experience in-
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TABLE 1
Analysis of a-d-'V-Acetylneuraminosyl-(2 —» 3')-Lactit[3H]ol
Percentage of dry
weight
Component Calculated" Found Method
Total iV-acetylneuraminic acid 43.0 37.7 Periodate-resorcinol (11)
Free iV-acety[neuraminic acid 0.0 2.8 Thiobarbituric acid (2)
Lactit[3H]ol 51.2 45.8 Anthrone4 (14)
Potassium 5.8 n.d.° —
" Calculated from molecular weight of 675.
6 Lactitol was used as the standard.
c n.d., Not determined.
dicated that some hydrolysis of neuramin-lactitol occurred when it was
exposed to this cation-exchange resin at room temperature. The effluent
and washings from the column were evaporated to dryness under re¬
duced pressure at temperatures under 30°C. Borate was eliminated as
volatile methyl borate by subjecting the residue to repeated evaporation
(about five times) with methanol under reduced pressure. In order to
remove the "acid-stable" radioactive impurities (15) the final residue
was dissolved in 2 ml of distilled water and applied to a Bio-Rad AG
1-X2 (formate) column (1.3 x 23 cm) at 4°C. The column was washed
with an excess (300 ml) of distilled water and then eluted with 0.01 m
pyridinium formate (16); the eluate was collected in 20-ml fractions. The
fractions corresponding to a sharp peak of material reacting positively
with the resorcinol reagent (11) and showing a high tritium count were
pooled and lyophilized. The syrupy residue was then dissolved in 1 ml
of water and passed through a column (0.6 x 7 cm) of Bio-Rad AG
50-X2 (H+). The effluent and washings were neutralized with 0.05 m
KOH and lyophilized to yield 45.3 mg of the potassium salt of
NL[3H]ol with a specific radioactivity of 0.73 /u.Ci//rmole. The chemical
analysis (Table 1) indicated a recovery of 59 /u-moles of product with a
purity of 90% and small amounts of TBA-reacting material. A single
Spot (/?.v-acetyl neuraminic acid 0.59; R\l(2—3') 0.89, Rjactitol 0.50) Was observed
on paper chromatograms developed for 40 hr with the solvent system
described under methods. The spot could be visualized with periodate-
benzidine (17) or with alkaline silver nitrate (18) but, as expected, it
failed to react with the aniline-oxalate (19) spray reagent for reducing
sugars. When a 4-ju.mole sample was subjected to mild acid hydrolysis
(0.1 n H2S04, 80°C, 1 hr) and the hydrolysate was neutralized with
BaC03, centrifuged, and passed successively through coupled columns
(0.9 x 7 cm) of AG 50-X2 (H+) and AG 1-X2 (formate), the anthrone-
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positive material and the tritium counts were quantitatively recovered in
the water eluate. Elution of the AG 1-X2 (formate) column with 0.3 N
formic acid yielded the free sialic acid and less than 1% of the initial
radioactivity.
The potassium salt of NL[3H]ol appears to be as stable as its parent
compound NL(2 —* 3'), since essentially no decomposition was ob¬
served after storage for 11 months at — 20°C.
Neuraminidase Studies
The incubation system utilized for the neuraminidase assay (12) con¬
sisted of 135 yu.1 of enzyme preparation, 15 /xl of 1m sodium acetate-
acetic acid buffer (pH value indicated in each experiment) and 200
nmoles (ca. 3.2 x 10s dpm) of tritium-labeled neuramin-lactitol dissolved
in 50 p.\ of distilled water. The mixtures were incubated at 37°C for
various lengths of time (from 30 to 180 min). Control tubes containing
heat-inactivated enzyme, substrate, and buffer were incubated concur¬
rently. At the end of the incubation, the reaction mixtures were quantita¬
tively transferred to columns (0.6 x 7 cm) of AG 1-X2 (formate). After
washing the column with an excess (20 ml) of distilled water, the com¬
bined eluate was lyophilized and the residue was dissolved in 2 ml of
water. An aliquot, usually 1 ml, was mixed with Aquasol for radioac¬
tivity measurements. One unit of neuraminidase activity is defined as the
amount of enzyme that hydrolyzes 1 nmole of substrate per hour under
the conditions of the assay. Specific activities are expressed as units of
neuraminidase activity per milligram of protein.
For initial enzymic studies, a dilute (500 jug/ml) aqueous solution of
Clostridium perfringens neuraminidase was utilized and the incubations
were conducted for 1 hr at pH 5.0. The radioactive lactit[3H]ol was
isolated from the incubation mixture by the anion-exchange column
described above, by paper chromatography, and by paper elec¬
trophoresis (0.1 m ammonium acetate-acetic acid buffer, pH 4.65,
375 V for 4 hr, on Schleicher and Schuell paper No. 598). In the last
two experiments, the lactit[3H]ol position was detected by spraying
strips containing duplicate samples run concurrently, and the paper
areas containing the lactit[3H] ol spot were cut out, placed in vials with
Aquasol and counted. The enzyme activity was also estimated by the
assay of the sialic acid released by direct TBA assay of the incubation
mixture or by assay of the sialic acid eluted with 0.3 n formic acid from
the same columns utilized for the isolation of radioactive lactitol. As
shown in Table 2, the results obtained agreed closely among themselves
and with the results obtained by the usual procedure, i.e., direct TBA
assay using NL(2 -* 3') as the substrate.
TABLE2
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pH
Fig. 1. pH vs activity curves of human leukocyte neuraminidase. The enzyme activity
was measured by the release of lactit['H]ol (O-O) from NL[3H]ol and by the release of
N-acetylneuraminic acid (#--#) from NL(2 —» 3'), respectively. The pH values shown
were obtained with sodium acetate-acetic acid buffers (final concentration, 75 dim).
1 2
Time (hours)
Fig. 2. Progress curve of human leukocyte neuraminidase. The incubations were con¬
ducted at pH 4.0 for the lengths of time indicated, using NL[3H]ol (O-O) and
NL(2 -» 3') (#—#) as the substrates.
Protein (mg)
Fig. 3. Effect of protein concentration on the rate of hydrolysis. The incubations were
done at pH 4.0 for 3 hr. using NL[3H]ol (O-O) and NL(2 -» 3') (#--•) as the substrates.
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TABLE 3
Assay of Neuraminidase Activity in Preparations of Chick Liver and Rat


















cytoplasmic 1.73 1.90 1.53
extract
Rat-liver
plasma membrane 0.23 2.38 1.54
For experiments with leukocyte neuraminidase, mixed human leuko¬
cytes were isolated by dextran sedimentation (20) from heparinized
blood, freshly drawn from a healthy male donor. A cell suspension
(8.9 mg of protein per ml) in glass distilled water (12) was utilized for
these studies, and, unless stated otherwise, the incubations were done
for 3 hr at 37°C. The pH versus activity curves (Fig. 1) showed a pH
optimum of 4.0 whether using this isotopic method or our previous
method (12) with NL(2 —» 3') as the substrate and direct TBA assay.
The enzymic activities (nanomoles hydrolyzed per milligram of protein
in 3 hr) at pH 4.0 were 4.41 by the isotopic method and 4.81 by the
TBA assay, respectively; these values are similar to those previously
reported from our laboratory (21). The rate of hydrolysis of both sub¬
strates is linear at least for 3 hr (Fig. 2) and a linear relationship was also
observed between protein concentration and enzyme activity (Fig. 3).
Neuraminidase activity was also assayed in an aqueous suspension
(1.92 mg of protein/ml) of rat liver plasma membrane (fraction P,) pre¬
pared according to Touster et al. (22) and in the cytoplasmic extract ob¬
tained from a chick-liver homogenate (1:4 v/v) in 0.154 m KC1 (23).
These preparations were incubated for 3 hr at 37°C, pH 4.0, in presence
of NL[3H]ol and the enzyme activity was determined by direct TBA
assay, by TBA assay after ion-exchange chromatography, and by mea¬
surement of the lactit[3H]ol released (Table 3). The strong interference
by spurious colors in the direct TBA assay was quite impressive for this
preparation of plasma membrane and these results illustrate the
problems and pitfalls often encountered in the assay of neuraminidase
activity in animal tissues.
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DISCUSSION
Several approaches have been utilized for the measurement of neur¬
aminidase activity by methods that avoid the TBA reaction. Radioac-
tively labeled sialo-glycoproteins have been recently utilized for studies
with bacterial and mammalian neuraminidases (24,25). In these experi¬
ments, the tritiated seven- and eight-carbon analogs of /V-acetyl-
neuraminic acid, released by the enzyme action, are assayed by mea¬
suring the radioactivity present in the acid-soluble fraction obtained
from the incubation mixtures. However, the observation that these
modified glycone moieties are released by neuraminidase action at a
slower rate than intact /V-acetylneuraminic acid from native sialoglyco-
proteins (26) and the possibility that proteases present in lysosomal
preparations or in crude tissue extracts may cause the release of acid-
soluble labeled sialoglycopeptides (26), indicate that the use of these
substrates should be undertaken with some caution.
Synthetic substrates with chromogenic aglycones, such as the phenyl
(27) and 3'-methoxyphenyl (28) a-ketosides of )V-acetylneuraminic acid
have been tested successfully with purified neuraminidase preparations.
However, since the Folin-Ciocalteau reagent utilized for the assay of
the released phenolic aglycone also reacts with phenolic amino acids in
proteins (13), these methods are not suitable for neuraminidase assay in
crude tissue preparations (1). Substrates with aglycones which produce a
chromophore by simple pH adjustments, such as nitrophenols and phen-
olphthalein, would circumvent some of these problems and hence at¬
tempts to prepare these compounds were undertaken in our laboratory3.
Unfortunately, efforts to prepare o-nitrophenyl and p-nitrophenyl ke-
tosides of A-acetylneuraminic acid by methods similar to those de¬
scribed by Tuppy and his associates (27,28) for the synthesis of phenyl
glycosides were unsuccessful. There was apparently no reaction
between o-nitrophenol and aceto-chloro-neuraminic acid (4,7,8,9-tetra-
0-acetyl-Al-acetyl-2-chloro-2-deoxy-D-neuraminic acid) while with p-ni-
trophenol although a product was isolated, the yields, under various
experimental conditions, were too low (<5%) to warrant further work.
Attempts to prepare the phenolphthalein ketoside of N-acetylneuraminic
acid by a method similar to that used by Marsh and Reid (29) for the
synthesis of phenolphthalein-glucuronide yielded small amounts of a
compound which contained equivalent amounts of N-acetylneuraminic
acid and phenolphthalein. However, since this compound was not hy-
drolyzed by bacterial neuraminidase, there is a strong possibility that it
may be the /3-ketoside.
A method based in the colorimetric assay of the lactose released by
3 Bhavanandan, V. P., and Carubelli, R., unpublished observations.
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the action of neuraminidase on neuramin-lactose was developed by
Holmquist (30). A drawback of this method is that other sugars interfere
with the determination of the lactose released by neuraminidase, while in
the method described in this paper the radioactivity measured can only
originate from the aglycone moiety of the substrate.
The observation that NL[3H]ol and its parent compound NL(2 -» 3')
are hydrolyzed at the same rate was fully expected since both substrates
have identical composition, configuration and conformation (i.e., a-D-N-
acetyl neuraminosyl-(2 —» 3')-/3-D-galactopyranosyl) at the level of the
neuraminidase susceptible linkage, and the difference between their
molecular weights is negligible.
The results presented here show that the method is operational and
suggest that reduction of NL(2 -» 6') and of the prosthetic group of
various sialoglycoproteins with tritiated borohydride should also provide
suitable substrates for this assay. Glycoproteins with sialic acid-con¬
taining prosthetic groups linked by O-glycosidic linkage to seryl and
threonyl residues would be particularly suited for this purpose since
these glycoproteins release their prosthetic groups by a mechanism of /3-
elimination (7). For example, treatment of ovine submaxillary glycopro¬
tein with mild alkali in the presence of NaB[3H]4 would yield a-D-N-
acetylneuraminosyl-(2 -*■ 6')-iV-acetylgalactosaminit[3H]ol, which could
substitute for NL[3H]ol in the assay system described.
In addition to its usefulness for work with crude enzyme preparations,
the special features of this method make it particularly valuable for the
assay of neuraminidase activity in the presence of /V-acetylneuraminic
acid-utilizing enzymes, such as N-acetylneuraminic acid aldolase, as
well as in the presence of high concentrations of free sialic acid (inhibi¬
tion studies).
Although this method in its present form has some time-consuming
steps, the use of substrates with higher specific radioactivity should
allow a reduction in the volumes of the incubation mixtures, columns,
and effluents thus shortening and simplifying the whole operation.
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ABSTRACT Mucopolysaccharides have been isolated,
fractionated, and characterized from the nuclei of cultured
B16 mouse melanoma cells grown in the presence of [3H]-
glucosamine and [35S]sulfate. Digestion of the nuclei with
DNase followed by Pronase gave a mixture of complex car¬
bohydrates from which the mucopolysaccharides were iso¬
lated by precipitation with cetylpyridinium chloride.
After fractionation by differential salt extraction and chro¬
matography on controlled pore glass bead columns, the
components were identified by chemical and enzymatic
methods. The major polysaccharide components were a
family of high-molecular-weight chondroitin sulfates
with different degrees of sulfation; a minor component
has been characterized as heparan sulfate.
The production of mucopolysaccharides by cultured cells and
the effect of virus transformation on this has been demon¬
strated for several cell lines (1-5). A major portion of the
mucopolysaccharide synthesized by the cells can be detected
in the culture media and as intercellular material, not a
surprising result, since mucopolysaccharides are considered to
be extracellular components. In addition, mucopolysaccharide
is detectable in cell pellets, although the nature of the associa¬
tion of this material with the cell has not been fully estab¬
lished. The presence of heparan sulfate as a surface component
of several cell lines has been reported (3) but it is not clear
whether the heparan sulfate-protein complex is an integral
part of the plasma membrane of cells or is present as a cell
coat (fuzz) immobilized by ionic interaction with cell mem¬
brane proteins.
In this paper we present evidence for the presence of muco¬
polysaccharides associated with cell nuclei. The presence of
anionic saccharides in the nucleus of mammalian cells may
have considerable significance. While cell surface complex
carbohydrates can be involved in determining antigenicity,
intercellular recognition and adhesion, contact inhibition, and
other surface-related phenomena, anionic saccharides of the
nuclei are more likely to be involved in controlling nuclear and
cytoplasmic events. Alternatively these components may have
a common function in all membranes as structural elements
maintaining organellar integrity or regulating membrane
properties, such as transport of nutrients.
MATERIALS AND METHODS
B16 mouse melanoma cell line 3 and an amelanotic clone were
propagated as described previously (5). Cells utilized for the
isolation of nuclei were harvested in the late-log phase of
growth at a density of about 15 X 106 cells per 16 oz (0.5
liter) bottle. In experiments requiring labeling of complex
Abbreviations: CPC, cetylpyridinium chloride; CPG, controlled
pore glass.
carbohydrates, the cells were cultured for 48 hr prior to
harvest in sulfate-free medium containing per milliliter 10 gCi
of [3H]glucosamine-HC1 (New England Nuclear, 7.3 Ci/-
mmol) and 50 pCi of Na235S04 (New England Nuclear, 738
mCi/mmol).
Cells were harvested by pouring off the media, washing the
cell layer three times with serum-free medium, and treating
with 0.01 M EDTA in calcium, magnesium-free phosphate-
buffered saline (10 ml) at 37° for 5 min. Serum-free medium
(10 ml) was added, and the cells were collected by centrifuga-
tion and washed three times with the buffered saline by re-
suspension and centrifugation. The viability of the cells was in
the region of 85-95% as determined by trypan blue exclusion.
Nuclei were prepared by two methods: one utilized 0.05%
Triton X-100 in the buffer as described by Alwine et al. (6);
the other method was essentially as described by Sakiyama
and Burge (7) except that the nuclear pellet after the first
gradient centrifugation was suspended in 4 ml of 0.2 M
sucrose in buffer and layered on top of the gradient, and the
centrifugation was repeated. The purification of nuclei was
routinely monitored by phase contrast microscopy.
Protein was determined according to Lowry et al. (8) with
crystalline bovine serum albumin as the standard. DNA and
RNA were determined by the modified Schmidt-Thannhauser
method as described by Munro and Fleck (9) with calf thymus
DNA and yeast RNA as standards, respectively.
5'-Nucleotidase was assayed by the method of Dewald and
Touster (10) and acid phosphatase as described by Appelmans
et al. (11). Succinic dehydrogenase was assayed by determining
the reduction of cytochrome c (12) or of 2-p-iodophenyl-3-(p-
nitrophenyl)-5-phenyl-2H-tetrazolium chloride (13).
The isolation of the complex carbohydrate components
was achieved by suspending the washed nuclei pellet in 0.01 M
Tris-HCl buffer, pH 7.4, containing 0.01 M MgCl2 and digest¬
ing with DNase. The digestion was carried out at 37° for a
period of 24 hr with addition of 50 pg of DNase at time 0 and
again after 12 hr. The digest was exhaustively dialyzed against
distilled water and the nondialyzable portion was centrifuged
(2000 X g, 10 min) and the radioactivity in an aliquot of the
supernatant was measured. The pellet was resuspended in the
supernatant (pH adjusted to 8.0) and digested with Pronase
for 48 hr at 40° in the presence of toluene. The digest was
centrifuged and the supernate was extensively dialyzed against
0.2 M NaCl followed by distilled water.
Hyaluronic acid, chondroitin-4-sulfate, and heparin (0.5 mg
each) were added as carriers to the dialyzed digest and, after
the solution was made 0.04 M in Na2S04, 2% cetylpyndinium
chloride (CPC) in 0.04 M Na2S04 was added at 1 ml/10 ml,
and the solution was mixed and allowed to stand at room tem-
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perature overnight. The precipitate was collected by centri-
fugation (10,000 X g, 10 min) and washed three times with
0.2% CPC in 0.04 M Na2S(>4 by resuspension and centrifuga-
tion. The CPC precipitate was then fractionally extracted
with 0.2, 0.4, 0.8, 1.2, 2.0 M NaCl utilizing 2 ml once and 1
ml four times for each extraction. The CPC in the extracts
was removed by dialysis at 40-45° against 0.1 M NaCl fol¬
lowed by distilled water at 4° and the solutions were lyophi-
lized.
Cellulose acetate electrophoresis was carried out as de¬
scribed earlier (5) but using pyridineacetic acid buffer, pH 3.5,
at 10 mA for 20 min or 0.2 M calcium acetate, pH 7.0, at
5 mA for 3 hr. Paper electrophoresis was done on Whatman
3MM sheets in 0.5 N pyridineacetic acid buffer, pH 5.0, at
10 V/cm for 2-3 hr. Hexosamine in isotopically labeled com¬
ponents was determined as described earlier (5).
Sources of enzymes, isotopes, standard mucopolysac¬
charides, and chemicals were as previously described (5).
DNase was the electrophoretically purified grade from Worth-
ington and was free of hyaluronidase and chondroitinase
activities. Testicular hyaluronidase digestion was performed
in 0.1 M sodium acetate buffer, pH 5.0, and 8 mM EDTA in
the presence of toluene and chloroform at 37° for 24 hr.
Bacterial hyaluronidase digestion was performed in 0.1 M
sodium acetate buffer, pH 5.0, at 37° for 24 hr. Chondroitinase
and chondrosulfatase digestions were according to Suzuki and
coworkers (14). Nitrous acid degradation was done by treating
the sample in 160 /xl of water with 20 /A of 3 M NaN02 and
20 /d of glacial acetic acid at room temperature for 80 min.
Excess nitrite was destroyed by addition of 50 /zl of 3 M glycine
and after 60 min at room temperature, the product was
lyophilized.
Liquid scintillation counting was performed on an Inter-
technique model SL36 spectrometer. Usually 1 ml aqueous
samples were mixed with 10 ml of the counting liquid con¬
taining xylene and Triton X-114 (15).
RESULTS
The recoveries of protein and radioactivity in the nuclei were
5-10% of the total cellular protein and between 4 and 9% of
the cell-associated 3H and activity. The DNA and RNA
contents of the nuclei were 398 and 59 /xg/mg of protein,
respectively. The nuclei had less than 1% of the 5'-nucleotid-
ase, a plasma membrane marker enzyme, detected in the
original cell homogenate. There was no detectable activity of
acid phosphatase (lysosomal enzyme marker) and succinic
dehydrogenase (mitochondrial enzyme marker) in the nuclear
preparations, with about 0.5 mg of protein per assay. Although
high concentrations of detergent are known to solubilize the
outer nuclear membrane (16), the concentration employed by
us did not appear to affect the morphology of this structure.
Nuclei prepared by the alternative procedure did not appear
as clean as those prepared with 0.05% Triton but the incor¬
poration patterns of radioactivity into mucopolysaccharide
and glycoprotein were similar for preparations obtained by the
two methods.
After treatment of the nuclei with DNase and centrifuga-
tion, about 90-95% of the radioactivity (3H and ^S) sedi-
mented with the pellet. Pronase digestion of the pellet
solubilized the labeled components; between 75 and 80% of
the 3H and activities in the nuclei were recovered in the
soluble fraction after the treatment. Thus the sulfated and
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Fig. 1. Fractionation of Pronase-digested nuclear membrane
pellet on a 1.5 X 115 cm controlled pore glass (CPG) 10-240 glass
bead column with 0.5 M CaClj as the eluting solvent. Fractions (4
ml) were collected and 50 ^1 aliquots were analyzed for radioac¬
tivity. Fractions 30-39 (Na), 40-47 (Nb), and 48-62 (Nc) were
combined, dialyzed against water, and lyophilized.
nonsulfated complex saccharides of the nuclei may be mainly
associated with the nuclear membrane, which has been re¬
ported to contain glycoproteins (17-19). The possibility that
a minor portion of the complex carbohydrate of the nuclei is
associated with lipids (glycolipids) cannot be excluded by
these studies.
Chromatography of the Pronase digest on a preparative
glass bead column gave the results illustrated in Fig. 1. The
majority of the sulfate radioactivity and a small percentage
of the tritium label appeared in the fast-moving higher
molecular weight peak (Na) and represents components
derived primarily from proteoglycans. The low-molecular-
weight fraction (Nc) contains the bulk of the tritium label
and is predominantly glycopeptide in nature. Analytical data
of these two fractions are given in Table 1.
The distribution of 3H and MS radioactivity in the different
Table 1. Analytical data of various 3H- and 35S-labeled
macromolecular fractions from nuclei*
Chondroi¬
tinase ACf
Fraction Mol. wt. 3H GlcN GalN 3H MS
Na 35,000+ — 46.0 54.0 64.3 89.5
Nc ~15,000 — 88.3 11.7 ND ND
4a 35,000+ 4.3 4.9 95.1 81.8 92.0
4c 10,000 1.4 60.5 39.5 ND ND
8a 35,000+ 9.3 0 100 100 100
8b ~15,000 6.9 48.6 51.4 56.0 60.0
12a 35,000+ 24.7 ND ND 85.4 86.2
12b ~15,000 8.0 18.8 81.2 ND ND
ND is not determined.
* Summary of analytical data for the different fractions de¬
scribed in the text. The molecular weight values are based on the
behavior of the labeled components relative to standard muco¬
polysaccharides during chromatography on CPG columns. The
amino sugar values are as percentages of tritium label found for
glucosamine and galactosamine.
t Percentage radioactivity eluting in the low-molecular-weight
region on a CPG column after incubation with chondroitinase AC.
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Fig. 2. (a) Fractionation of the 0.8 M NaCl extract of CPC-
precipitable material from Pronase-digested nuclear membrane
on a 0.9 X 95 cm column of CPG 10-240 glass beads. Fractions (1
ml) were collected and 50 /xl was analyzed for radioactivity. The
peak elution position of marker saccharides (HA, vitreous humor
hyaluronic acid; CSA, porcine rib cartilage chondroitin-4-sulfate;
and GlcUA, glucuronic acid) are indicated by the arrows. Frac¬
tions 29-35 and 36-55 were separately combined as peaks 8a and
8b, respectively. Figures (b) and (c) are elution patterns of peaks
8a and 8b after rechromatography on the same column; 700 /xl of
1 ml fractions were analyzed.
CPC fractions is given in Table 2. Oyer 90% of and about
5% of 3H activity are in salt extracts of molarity greater than
0.4 M and constitute the mucopolysaccharide content of nuclei.
The CPC supernatant and the washings of the precipitate
contain about 90% of the 3H activity and represent glyco-
peptide components. A further 3% of the 3H activity present
in the 0.2 M NaCl eluate is a sialoglycopeptide comparable
to that isolated from the culture media of the cells (5). Char¬
acterization of these glycopeptides will be described in a
subsequent report.
Chromatography of the 0.8 N NaCl fraction which con-
Table 2. CPC precipitation and salt elution of 3H and 3SS
radioactivity in Pronase digest of nuclei*
CPC-
solublej
Molarity of NaCl for eluate
0.2 0.4 0.8 1.2 2.0
3H 1548.3 58.3 28.8 28.3 5.9 2.5
(91.6) (3.4) (1.7) (1.7) (0.3) (0.15)
3SS 5.3 3.1 16.9 96.6 21.0 1.0
(3.5) (2.1) (11.3) (64.4) (14.0) (0.67)
* Values are expressed in dpm X 10~3; the numbers within
parentheses are the percentages. Results of a duplicate experi¬
ment were identical. Recovery of radioactivity w(u> essentially
quantitative.
t Material present in the CPC supernate combined with washes
of the original CPC precipitate.
tained about */* of the sulfated polysaccharide associated
with the nuclei is illustrated in Fig. 2a. Rechromatography of
Fractions 8a and 8b gave the patterns shown in Fig. 2b and
c. The hexosamine contents of these fractions are given in
Table 1.
Fraction 8a. The chromatographic elution profiles of 8a after
treatment with testicular and bacterial hyaluronidases and
with chondroitinase AC are shown in Fig. 3. Control digestion
of 8a with buffer alone and rechromatography gave a profile
identical to that in Fig. 2b. The presence of galactosamine as
the only hexosamine in this fraction and its complete suscep¬
tibility to testicular hyaluronidase and chondroitinase AC
suggests that it consists of chondroitin-4 and/or 6-sulfate.
This fraction was also susceptible to bacterial hyaluronidase
but the fragments obtained were larger than tetrasaccharides,
implying that the degree of sulfation is greater than 50%,
since a polysaccharide with significantly less sulfation would
give rise to di- and tetrasaccharides. The electrophoretic
mobility of this component, in the two buffer systems tested,
was consistent with that of a chondroitin sulfate having 0.5-
1.0 sulfate residues per disaccharide unit. Chondroitinase AC
and chondroitinase AC plus chondro-4-sulfatase digestion of
this fraction followed by paper chromatography indicated that
the sulfate ester group is predominantly in the 4-position of the
galactosamine moiety.
After mild acid hydrolysis (0.04 N HC1, 100°, 90 min) of
the 8a fraction, about 45% of the 35S radioactivity migrated
with inorganic sulfate on paper electrophoresis as well as on
a Bio-Gel P2 column. It was also evident from these experi¬
ments that the polymer underwent considerable degradation.
Both cartilage chondroitin-4-sulfate and hyaluronic acid
treated in the same manner are degraded to fragments ranging
from tetra-(major) to octa-saccharides, an observation not
previously recorded. Previous findings from this laboratory
(20) have established that about 35% of 35S042- was released
from chondroitin-4-sulfate on hydrolysis with dilute acid
under conditions comparable to those used in the present
study.
The possible presence of iV-sulfate residues in this fraction
was considered even though the results of the chondroitinase
AC and chondro-4-sulfatase digestions were not consistent
with this. Treatment of the 8a fraction with nitrous acid, a
reagent that causes deaminative cleavage of mucopolysac¬
charides containing sulfated amino groups (21), followed by
chromatography on a CPG 10-240 column gave a profile
identical to that in Fig. 2b, indicating that there were no such
residues in this fraction. Gel filtration of Fraction 8a on the
CPG 10-240 column indicated that this component has a
molecular weight of 35,000 or greater, since it elutes in the void
volume coincident with vitreous humor hyaluronic acid of
molecular weight 35,000, whereas cartilage chondroitin-4-
sulfate of molecular weight 15,000 elutes differently (Fig. 2).
A high-molecular-weight chondroitin fraction isolated from
the culture media of the same cells (B16 mouse melanoma)
has been estimated to have a molecular weight of 97,000 ±
8,800 by ultracentrifugation. (Bhavanandan and Davidson,
unpublished results.) In order to determine whether the high
molecular weight of Fraction 8a was due to incomplete
Pronase digestion resulting in proteoglycan fragments rather
than polysaccharide chains, we digested Fraction 8a with
Pronase (two additions of 250 ng each at time 0 and 24 hr)
for a total period of 72 hr and rechromatographed the product
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on a CPG 10-240 column. The elution profile was identical to
that of the untreated sample (Fig. 2b), indicating that the
high-molecular-weight nature of this fraction is probably not
due to incomplete Pronase digestion. Soluble pig cartilage
proteoglycan is completely degraded to polysaccharide chains
of molecular weight about 15,000 on digestion with Pronase
(22).
Fraction Sb. The labeled hexosamine content of this fraction
was 51% galactosamine and 49% glucosamine (Table 1).
Chromatography on CPG 10-240 gave the heterogenous
elution profile shown in Fig. 2c; high-molecular-weight mate¬
rial is absent and the major portion of the fraction eluted in
the 15,000-10.000 range. On treatment with chondroitinase
AC and rechromatography on the same column, about 60%
of the MS activity eluted in the low-molecular-weight region.
Mild acid hydrolysis followed by paper electrophoresis of this
fraction also gave results similar to those obtained with
Fraction 8a; about 52% of radioactivity migrated with
inorganic sulfate. Nitrous acid treatment of this fraction
followed by chromatography on the CPG 10-240 column
showed that 57.5% of activity eluted in the low-molecular-
weight region. These results suggest that this fraction is a
mixture of heparan sulfate and chondroitin (4 or 6) sulfate of
molecular weight similar to that of the cartilage polysaccha¬
ride.
Chromatography of the 0.4 M and 1.2 M NaCl eluates on
the CPG 10-240 column gave the profiles shown in Fig. 4.
Hexosamine and chondroitinase susceptibility data on Frac¬
tions 4a, 4c, 12a, and 12b are summarized in Table 1. Fractions
4a and 12a are high-molecular-weight chondroitin sulfate
components, apparently the undersulfated and more fully
sulfated homologs of Fraction 8a (see KS/3H in Table 1).
Fraction 4c contains lower molecular weight material com¬
posed of both amino sugars and sialic acid and is presumably
sialoglycopeptide similar to that present in the 0.2 M NaCl
eluate. There was insufficient material for complete charac¬
terization.
DISCUSSION
This study provides direct biochemical evidence for the
association of anionic polysaccharides with mammalian cell
nuclei. In the system investigated, a family of high-molecular-
weight chondroitin-4-sulfates were the major nuclear muco¬
polysaccharides. The other mucopolysaccharides identified
were heparan sulfate and a chondroitin sulfate of lower
molecular weight.
The presence of glycoproteins in cell nuclei has been pre¬
viously reported by several workers (17-19) and is confirmed
by our results. Based entirely on the tritium incorporation
data (Table 2), it would appear that mucopolysaccharides
are a minor component compared to glycoproteins; however,
definitive information on the carbohydrate composition of
nuclei must await mass analytical data. It is also essential to
establish whether the association of mucopolysaccharides
with the nuclei is a feature common to all mammalian cells.
The physical properties and chemical architecture of the
anionic polysaccharides with heterogeneity of size and dis¬
tribution of functional groups (O-SCh; .V-SO4; COOH) make
them excellent candidates for a range of regulatory functions,
including control of cationic environment at the nuclear
membrane, transport selectivity into the nuclei, regulation of
















Fio. 3. Chromatography of Fraction 8a on a 0.9 X 95 cm glass
bead column after digestion with testicular hyaluronidase (upper),
chondroitinase AC (middle), or bacterial hyaluronidase (lower).
Fractions (1 ml) were collected and 700 m1 analyzed for radioac¬
tivity. Abbreviations are as in Fig. 2.
chromatin. Several'recent reports have suggested involvement
of anionic polysaccharides in nuclear functions. Anionic poly¬
saccharides such as gum tragacanth (23) and dextran sulfate
(24) have been shown to inhibit mitosis in vitro and in vivo.
Heparin has been used to prepare nuclear membranes from
nuclei, apparently because of its ability to interact with
histones, thus solubilizing chromatin (25). Cook and Aikawa
(26) have demonstrated the activation of endogenous DNA
polymerase, of rat liver nuclei by heparin. Another possible
function of acidic polysaccharides in regulating DNA synthesis
is indicated by the studies of Robbins et al. (27). Kinoshita has
presented evidence (28) for a heparin-like polysaccharide
which is released within the cytoplasm during cleavage of sea
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Fig. 4. Chromatography of 0.4 M (upper) and 1.2 M (lower)
fractions on the CPG column. Fractions (1 ml) were collected and
50 m1 was analyzed for radioactivity. Fractions 29-35 (4a) and
44-55 (4c) of the upper figure and Fractions 29-35 (12a) and 36-55
(12b) of the lower figure were combined, dialyzed, and lvophilized.
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urchin embryos and is suspected to induce changes in em¬
bryonic nuclei, such as loosening of chromatin and the initia¬
tion of RNA synthesis.
The accumulation of dermatan sulfate and/or heparan
sulfate in lvsosomes of fibroblasts from patients with muco¬
polysaccharidoses is well established (29). There is a strong
possibility that the lysosomal pool of polysaccharides may in
part arise from nuclei by disruption of the nuclear membrane
during the mitotic phase of the cell cycle. Information on this
is expected from studies on the relationship between the
nuclear polysaccharides and turnover of polysaccharides in the
lysosomes during the cell cycle.
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SUMMARY
A human melanoma cell line established in our laboratory
was characterized in terms of tyrosinase activity and ahionic
polysaccharide production. Tyrosinase levels were diluted
during the growth phase and increased after the cell culture
became confluent. The anionic polysaccharides produced
included hyaluronic acid, heparitin sulfate, and a high-mo¬
lecular-weight chondroitin 4-sulfate. In contrast, a primary
culture of human melanocytes derived from embryonic iris
produced much greater amounts of hyaluronic acid, about
30-fold less heparitin sulfate, and a mixture of chondroitin
4-sulfate and dermatan sulfate. Saccharides secreted into
the culture medium were generally identical to those remain¬
ing cell associated except for the melanoma heparitin sul¬
fate, wherein the latter fraction appeared to be of lower
molecular weight.
INTRODUCTION
Human melanoma cells bear a common antigen, cross-
reactive between different patients, and unique antigen(s)
that are specific for each individual tumor (4, 9, 11, 12).
Some preliminary attempts have been made to isolate and
characterize membrane-associated melanoma antigens.
Partially purified, soluble protein fractions have been ob¬
tained from homogenized tumors by gel filtration (6) and
electrophoresis (12). It is probable that membrane-associ¬
ated glycoproteins contribute to the immunogenicity of hu¬
man melanoma cells.
Melanoma cell cultures provide an opportunity to con¬
duct studies on the characterization of membrane-associ¬
ated glycoproteins upon a consistent cell population. Hu¬
man melanoma lines have been established in a number of
laboratories (7, 14) including our own.
The present study is a description of some of the biologi¬
cal properties of one of our lines (HM7) and the biochemical
characterization of the oronase- and alkali-stable cell-as¬
sociated and extraceiiuiar glycosaminoglycans and glyco¬
proteins labeled by inclusion of tritiated glucosamine and
35S05~ in the culture media. The components will be com¬
pared with those produced by a population of normal mela¬
nocytes derived from an embryonic human iris explant. A
preliminary report has been presented (2).
1 This work was supported in part by Grants CA15483 and CA11097-06
from the NIH. USPHS.
7 Career Development Award. 7-K4-CA38.809.
5 To whom all correspondence should be addressed.
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MATERIALS AND METHODS
Establishment of Melanoma Cell Culture Line. The hu¬
man melanoma cell line, HM7, was obtained from an exci-
sional biopsy of an axillary nodal metastasis in April, 1974.
Chips (1 x 1 mm) of tumors were partially dried onto the
surface of a plastic culture flask, incubated with medium for
1 week, and then refed 3 times each week. After a confluent
monolayer was obtained, the cells were suspended with
0.04% EDTA and passaged. They have since been passaged
at about 2-week intervals in 16-oz prescription bottles.
Establishment of Human Iris Cultures. Human iris mela¬
nocytes were obtained from a therapeutically aborted fetus
utilizing methodology analogous to that described earlier
(19). After aseptic excision, the 2 irises were cultured as
explants for 49 hr in 7 ml of complete media containing
PHlglucosamine and Na,MSO., 20 /xCi/ml each, in a 60-mm
plastic Petri dish (Falcon Plastics, Oxnard, Calif.). At the
end of this time the media were decanted, the cells were
harvested by centrifugation, and each fraction was pre¬
pared for analysis. Cell counts on the iris explant were not
performed due primarily to technical difficulties. In view of
the significant saccharide synthesis observed, it seems
probable that the bulk of the explant cell population was
viable under the conditions of the experiment, although
significant cell death cannot be ruled out.
Propagation of Cultures. HM7 cells were routinely propa¬
gated in MEM* with Earle's balanced salt solution supple¬
mented with heated (56° for 30 min) fetal calf serum to 10%
final concentration, sodium pyruvate, nonessential amino
acids, 2x vitamins, and 100 units penicillin G per ml and 100
M9 streptomycin sulfate per ml. All components, with the
exception of the antibiotics and.the fetal calf serum, were
obtained from Grand Island Biological Co., Grand Island, N.
Y. Cells were incubated at 36° in a humidified 5% CO,:95%
air atmosphere and were propagated in 16-oz glass prescrip¬
tion bottles (Brockway Glass Co., Inc., Brockway, Pa.). The
cells became confluent at approximately 6 x 106 cells/ bottle
and were routinely subcultured to approximately 1 x 10*
cells/bottle by suspension with 0.02% ethylene glycol bislfl-
aminoethyl ether)-W,/V'-tetraacetic acid in calcium- and
magnesium-free phosphate-buffered saline, 0.15 m
Na+:0.005 m 1^:0.14 M Cl":0.009 M P04, pH 7.2. Cultures
were routinely tested for bacterial contamination by the use
of thioglycolate and tryptose phosphate broth and for yeast
4 The abbreviations used are: MEM, Eagle's minimum essential medium;
CPC, cetyl pyridinium chloride; HS. heparitin sulfate; ha, hyaluronic acid;
CPG, controlled porous glass; H.I.M., human iris melanocytes; C4S.
chondroitin 4-sulfate.
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and mold contamination with Sabouraud's medium. No con¬
tamination was observed. The possible presence of myco¬
plasma was not assessed in the cells used for labeling
studies although other lines carried in our laboratory have
been routinely assayed and found to be free of contamina¬
tion.
Examination of Karyotype. Petri dishes (60 mm) were
seeded with 10" dye-excluding cells 3 to 5 days before
karyotyping experiments. The cultures were treated with
colchicine, 0.25 p.g/ml (Calbiochem, San Diego, Calif.), for
2 hr, resuspended with 0.25% trypsin in phosphate-buffered
saline, and washed twice with MEM. The cell pellet was
resuspended in a hypotonic (0.6% sodium citrate:0.06 M
KCI) solution, incubated for 30 min at 37°, and then washed
twice with MEM. The cell pellet was fixed with metha-
noliacetic acid (3:1, v/v), refrigerated for 20 min, and
washed twice in the fixative. The pellet was broken up with a
Pasteur pipet and 2 to 3 drops were placed on a microscope
slide. The fixative was evaporated on a warm hotplate and
the preparation was stained with 2% Giemsa.
Implantation of Cells into Nude Mice. Human melanoma
cells grown to confluency in 16-oz prescription bottles were
suspended with 0.1% EDTA, washed, and counted, and 5 x
10" trypan blue-excluding cells were inoculated s.c. into the
backs of 10 CRL-HO nude mice (Drug Research and Devel¬
opment Branch, National Cancer Institute, Bethesda, Md.).
The mice were housed under ordinary ambient laboratory
conditions but with tetracycline added to the drinking wa¬
ter.
Cell Labeling and Sizing. Two confluent bottles (16 oz) of
human melanoma cells were fed with 25 ml of complete
media containing ["HJglucosamine, 5 /xCi/ml, and Na.^SOj,
25 /xCi/ml, for 48 hr and then were prepared for analysis. To
increase the labeling of the cellular components, confluent
cultures were labeled for 48 hr in media containing no
inorganic sulfate and one-third the glucose concentration
of complete media. Essentially similar results were obtained
using either labeling procedure. Separate experiments con¬
ducted with early- and late-passage logarithmically growing
cells gave essentially identical results. No attempt was
made to evaluate specific saccharide synthesis as a func¬
tion of the cell cycle, although other results suggest that the
saccharide pattern seen is independent of cell density (J.
Banks and E. A. Davidson, unpublished results).
Cell sizing was done utilizing a Model B Coulter counter.
Ragweed pollen and previously calibrated B16C3 mouse
melanoma cells grown in parallel were used for calibration.
Analysis of Anionic Polysaccharides. Saccharide frac¬
tions were isolated from culture: medium and cell-associ¬
ated material by fractional salt elution from CPC precipi¬
tates of pronase-dicested and alkali-treated samples as de¬
scribed by Satoh et al. ^19).
Liquid chromatography in 0.5 m CaCI. utilizing previously
calibrated 10-240 80'120 beads (Electro-Nucleonics, Inc.,
Fairfield, N.J.) was done as described previously (19) and in
the indicated figures. Recoveries for these runs were
greater than 90% and standards were always included.
Amino sugar analyses of 5,000 to 20,000 3H dpm of the
labeled samples were done by hydrolysis in 6 n HCI for 24 hr
at 100° in a vacuum. Recovery was 70 to 80% for polysaccha¬
ride samples with the losses occurring during hydrolysis.
The hydrolysates were dried in a vacuum over P2Os and
NaOH and were then chromatographed on a Beckman 120C
amino acid analyzer using a stream-splitting attachment.
For liquid scintillation counting of samples, the volume of
the sample was brought to 1 ml, and 10 ml of a scintillation
cocktail (1) were added. The counting efficiency of tritium in
this system was 15 to 16% and, of 35S, was 46%, utilizing an
Intertechnique SL36 liquid scintillation spectrometer. Cross¬
over of MS counts into 3H window was usually 13.5%, while
3H count crossover into the 35S window was negligible and
was not corrected. No additional quenching was observed
with any of the solvents at the concentration used for the
experiments. For stream-splitting analyses, 4-ml fractions
were collected and counted utilizing 10 ml of 3a40 complete
scintillation cocktail (Research Products International
Corp., Elk Grove Village, III., 60007).
o-Glucosamine-6-FH]hydrochloride, 7.3 Ci/mmole, and
carrier-free Na,MS04, 80 to 800 mCi/mmole, were obtained
from New England Nuclear, Boston, Mass.
The enzymes and other components were obtained from
previously described sources (19) with the exception of
leech hyaluronidase, which was obtained from Biotrics,
Arlington, Mass. Heparitinase and heparinase were isolated
from an adapted Flavobacterium heparinum strain obtained
from Dr. A. Linker. The enzyme purifications were followed
through the initial hydroxylapatite column elution (15). At
this point, contamination of the heparinase and hepariti¬
nase peaks by glucuronidase and chondroitinase was con¬
sidered low enough to pool appropriate tubes for enzyme
assays.
Conditions for the enzyme assays were 0.25 unit chondroi¬
tinase ACII or ABC, 24 hr at 37° in 0.1 M phosphate buffer,
pH 7.8, or in 1 to 5 diluted enriched Tris buffer (18). The total
volume for the enzyme digest was 500 p.l; 250 pg of a
chondroitin 4:6 chondroitin sulfate mixture was completely
hydrolyzed when run in parallel with the sample that con¬
tained less than 15,000 3H dpm. These enzymes had no
significant heparitinase activity. For the heparitinase as¬
says, the samples with HS or heparan sulfate were digested
for 24 hr in 0.1 M sodium acetate buffer, pH 7, containing 1
mM calcium acetate. The temperatures for incubation were
30° for heparinase and 43° for heparitinase. Contaminating
chondroitinase accounted for less than 10% of the activity.
Samples for leech hyaluronidase digestion were incubated
in Mcllvaine's standard buffer at 37° for 6 hr in a 400-/H
volume. Leech hyaluronidase, 125 pg, was added every hr
for the 1st 3 hr to ensure complete digestion of HA.
For paper chromatography of chondroitinase ACII- and/or
ABC-digested samples, the volume of the enzyme digest
was 50 /xl in enriched Tris buffer as described by Saito et al.
(18). Chondroitin 4-sulfate and chondroitin 6-sulfate stand¬
ards were digested with the enzymes to detect any sulfatase
activity. No significant activity was found. Radioactive chro-
matograms were cut into 1-inch strips after drying and
added to a counting vial containing 2 ml of deionized H20.
After overnight shaking, 15 ml of a scintillation cocktail
were added, and after thorough mixing the samples were
counted. Elution of applied 3H and 35S dpm under these
conditions was greater than 90%.
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Tyrosinase Assay. Tyrosinase activity in situ of living
cells in culture was determined by a recent modification (16)
of the Pomerantz method (17). Briefly, tritiated L-tyrosine
(New England Nuclear) was added to the cultures at a final
concentration of 1 nCi/'ml. After 24 hr, a 200-/xl aliquot of
supernatant was removed. The aliquot was adsorbed with
Norit A and the soluble fraction was counted in Aquasoi
(New England Nuclear) in a liquid scintillation spectrome¬
ter.
Cellulose acetate electrophoresis was carried out in 0.2 m
calcium acetate, pH 7.0, at 5 ma for 3 hr or in pyridine
formic acid buffer, pH 3.0, at 10 ma for 30 min.
RESULTS
Characteristics of HM7 Cell Monolayers. The doubling
time of the HM7 cells after 20 passages decreased to approx¬
imately 40 hr from a mean value of 84 hr after 5 passages but
has not changed significantly in several recent experiments.
This is somewhat longer than the average value reported by
Liao et al. (14) for several human melanoma lines, but, since
our growth medium and substratum differ, direct compari¬
son cannot be made. Viability, as measured by trypan blue
exclusion, was better than 80%. The cells of the HM7 line
were considerably variable in size. Relatively small cells
with scanty cytoplasm predominated, but there were also
occasional cells 6 to 10 times the diameter of the smallest
cells. The large cells were amelanotic and contained single
nuclei. The observed morphological heterogeneity may in
part derive from the fact that this line has not been cloned.
However, we believe that some of the differences noted may
be related to the maturational state of the cells.
With continued growth and the attainment of confluency,
theHM7 monolayer developed multilayered foci characteris¬
tic of transformed cell lines. Cells in these foci sometimes
presented amber-brown pigmented granules, similar to
those described in other melanotic human melanoma cell
lines (14).
A frequency distribution of cell volume was obtained with
the Coulter counter and showed a mean cell volume of 1980
cu iim (Chart 1).
Implantation of HM7 Cells into Nude Mice. Nude mice
inoculated with HM7 cells developed small (2 to 3 mm),
plaque-like, s.c. nonpigmented nodules. The nodules were
not elevated and did not spread beyond the injection sites.
Microscopic sections of the nodules demonstrated pleo¬
morphic amelanotic cells with conspicuous nucleoli and
nuclear cytoplasmic evaginations. Death of all animals oc¬
curred as a consequence of intercurrent bacterial infection.
Relationship of Cell Pooulation Density and Tyrosinase
Activity. The production of -H.0 is a measure of the in situ
functional activity of tyrosinase (16). During the replicative
phase of culture growth, the tyrosinase activity progres¬
sively decreased each day until the 9th culture day, when
the monolayer became confluent and tyrosinase levels were
minimal (Chart 2). With the attainment of confluency, tyro¬
sinase activity increased until it was restored to its former
level by the end of the experiment at 17 days.
Evaluation of HM7 Karyotype, An enumeration of the
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Chart 1. Cell volume measurement. Cells in the logarithmic phase of
growth were harvested with phosphate buffered saline:0.02% ethylene glycol
bis(/3-amino ether)-A/,/V'-tetraacetic acid solution and resuspended in Isoton
(Coulter Electronics. Inc., Hialeah, Fla.) at approximately 1 x 10s cells/ml.
The same mean volume was obtained when the experiment was repeated
several passages later.
Chart 2. Growth curve of cells used for tyrosinase assay and results of
tyrosinase assay.
very broad distribution of values. However, about two-thirds
of the metaphase cells contained 40 to 60 chromosomes.
Although the chromosomes could not be paired in consist¬
ent patterns, most of those studied were metacentric, a
characteristic of human chromosomes.
Saccharide Fractionation and Characterization. Sum¬
mary data of :'H and 35S incorporation at the final stages in
the standard workup procedure (19) are shown in Table 1.
From 6.6 to 26% of the incorporated 'H and 35S is found in
CPC-precipitable material (Table 2). After dialysis to remove
residual CPC, the nonprecipitable human melanoma media
fraction was examined by high voltage electrophoresis for
the presence of keratan sulfate; none was found. The un¬
labeled material migrated only slightly from the origin,
whereas the 'l5S-labeled material little of which remained,
migrated completely from the strip in a manner identical to
that of inorganic sulfate.
The 0.4 m NaCI Eluate. Fractionation of the 0.4 M NaCI
eluates from the media on CPG-10 240 80/120 glass beads
resulted in the patterns shown in Chart 3. Incubation of the
samples from the melanoma or the iris culture with bacterial
or leech hyaluronidase resulted in complete degradation of
the media saccharides and degradation of about 90% of the
material in the cell-associated fraction. These results indi¬
cate that both the cell and media fraction contained HA
almost exclusively. The cell-associated fraction from the
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° Stage refers to labeled nondialyzable material remaining in solution after addition of
CPC to 0.2% CPC (final concentration) in 3 mM NaCI and addition of carrier mucopolysac¬
charides (19) and celite. This material appears to be mainly glycopeptide in nature.
Table 2
Summary of CPC elution results
Results for the elution values presented in Part A are in dprrvTO1 cells. For Parts B and C the values presented are expressed as dpm x
10-3.
Salt eluate fraction
0.4 0.8 1.2 2.0 Totals % precipitated"
3H MS 3H 35S 3H MS 3H MS 3H MS 3H 33S
A. HM7" media 22.8 1.5 26.0 18.6 30.6 25.5 36.9 28.6 116.3 74.2 6.6 16.8
HM7 cell associated 16.2 .2 27.2 3.6 11.7 4.8 3.2 1.1 58.3 9.7 17.7 26.0
B. H.I.M. media 656.7 • .17 47.5 1.4 45.8 3.6 99.4 12.5 849.4 17.7 20.4
H.I.M. cell associated 111.1 1.9 25.5 1.6 13.0 .9 24.7 5.3 174.3 9.7 11.8
,c. HM7 media 160.9 10.3 183.6 131.4 215.9 179.6 260.9 201.7 821.3 523.0 6.6 16.8
Cell associated 114.4 1.4 191.5 25.7 82.7 33.8 22.3 7.9 410.9 68.8 17.7 26.6
' 3H and MS dpm in the CPC-precipitated fraction divided by the sum of the non-CPC-precipitated and the CPC-precipitated dpm.
' The number of HM7 cells used was 7.05 x 10® in two 16-oz bottles.
human melanoma was resolved by preparative chromatogra¬
phy on a glass bead column. The lower-molecular-weight
fraction contained both glucosamine (80%) and galactosa-
mine (20%) as well as sialic acid. The latter component
contained somewhat more than one-half of the radioactivity
in this fraction and indicates that the major if not exclusive
materials present are sialoglycopeptides. These results
were confirmed by electrophoresis and are summarized in
Table 3.
The 0.8 m NaCI Eiuate. Fractionation of the 0.8 M NaCI
eluates on CPG-10 240 80/120 glass beads resulted in the
patterns shown in Charts 4 and 5. Incubation of the human
melanoma media fraction with heparitinase resulted in
digestion of 80% of the ''H dpm and 95% of the 35S dpm
(Chart 4). The remaining 20% of the :'H dpm was a 1:1
mixture of chondroibn Axhondroitin S sulfate and HA based
on amino sugar ccrtent, cellulose acetate electrophoresis,
and susceptibility to leech hyaluronidase and chondroitin-
ase ACII. Following digestion of the media fraction with
chondroitinase ACII, 9% of the3H and 7% of the 35S radioac¬
tivity migrated in the disaccharide region after chromatogra¬
phy on a Bio-Gel P2 column. The excluded peak contained
glucosamine exclusively and had a mobility on the CPG
column somewhat slower than the C4S standard. This
change in apparent molecular weight may arise from con¬
tamination of the enzyme preparation or the existence of a
hybrid molecule containing both HS and C4S. The bulk of
the human iris media fraction contained a mixture of HA and
chondroitin 4:chondroitin 6 sulfate as well as small amounts
of HS and dermatan sulfate (Chart 5). The composition of
the cell-associated and media fractions for both the mela¬
noma and iris were very similar. However, the melanoma
heparan sulfate from the medium appeared to have a higher
molecular weight than that which was cell associated. Re¬
sults are summarized in Table 4.
The 1.2 m NaCI Eluate. Fractionation of the melanoma 1.2
M NaCI eluate on a CPG-10 240 80/120 glass bead column
resulted in the patterns shown in Chart 6. Incubation of the
melanoma fraction with chondroitinase ACII resulted in hy¬
drolysis of approximately 58% of the^H dpm and 87% of the
,5S dpm; incubation with heparitinase resulted in hydrolysis
of 52% of the 3H dpm. These results agree well with the
amino sugar analyses indicating a 1:1 mixture of glucosa¬
mine and galactosamine and were confirmed by cellulose
acetate electrophoresis. The human iris sample differed in
that 90% of the material was a chondroitin sulfate, presum¬
ably chondroitin 4-sulfate. The presence of a small amount
of dermatan sulfate could not be ruled out since dermatan
sulfate was present in both the 0.8 and 2.0 M NaCI eluates.
The identification of the glucosamine-containing compo-
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Chart 3. Results of the chromatography on CPG-10 240 80020 glass
beads of the 0.4 m NaCI eluates of the human melanoma (upper) and iris
media (lower) fractions. Left, material before bacterial hyaluronidase diges¬
tion. Right, material after bacterial hyaluronidase digestion. CSO,. chondroi-
tin 4-sulfate; GA. glucuronic acid.
Table 3
Properties of 0.4 M NaCI fraction
Chromatography of the samples was done on a 0.9 x 60 cm
column of CPG-10 240 8(yi20 glass beads. The eluting solvent was
0.5 m CaCI2 and each fraction was approximately 1 ml. The flow rate




M.W. % GluNH2 % GalNHv dase" (%)
HM7 media 35,000+ 99 100
H.I.M. media 35,000+ 100 100
susceptibility by the dialysis assay. However, when incuba¬
tion with the enzyme was followed by product analysis by
Bio-Gel P2 or paper chromatography, it was obvious that
the bulk of the material was incompletely hydrolyzed. The
maximum amount of chondroitinase ACII-susceptible mate¬
rial was 52% by these methods. Following chondroitinase
ABC incubation, however, the sample was completely di¬
gested to disaccharides; the main unsaturated disaccharide
present was A-disaccharide-4-sulfate (18). These results
agree well with the amino sugar analyses, and it may be
concluded that this fraction contains both chondroitin 4-
sulfate and dermatan sulfate (Table 6).
A summary of the incorporation data for the melanoma
and iris melanocyte anionic saccharides and their relative
amounts is given in Table 7.
DISCUSSION
The HM7 line was composed of a morphologically hetero¬
geneous population of cells including a preponderance of
small amelanotic cells and occasionally much larger forms.
We observed similar changes in the B16C3 melanoma cell
line and produced evidence supporting the conclusion that
the heterogeneity was the result of the murine B16 mela¬
noma cells maturation and differentiation pattern (13). Al¬
though a similar interpretation for the heterogeneity of the
I50(
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Chart 4. Results of chromatography as described for Chart 3 of the 0.8 m
NaCI eluate of the human melanoma media fraction before (left) and after
(right) heparitinase/heparinase digestion. CS04, chondroitin 4-sulfate; GA.
glucuronic acid.
0 Susceptibility to digestion assayed by exclusion chromatogra¬
phy on glass beads or Bio Gel P2.
nent as HS was not confirmed due to the small number of 3H
dpm incorporated into this sample. The cell-associated com¬
ponents were identical tc me media fractions (Table 5).
The 2.0 m NaCI Eluate. Fractionation of the 2 m NaCI
eluates on the CPG-10 240 80/120 glass bead column
showed both the melanoma and iris to contain a single
high-molecular-weight fraction. Incubation of the human
melanoma media fractions with chondroitinase ACII, fol¬
lowed by paper chromatography (Chart 7) of the digested
material, indicated the presence of chondroitin 4-sulfate
only since the A-disaccharide-4-sulfate was obtained after
enzyme hydrolysis in 88% yield. Incubation of the human iris
media fraction with chondroitinase ACII resulted in 85%
20 40 60 20 40 60
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Chart 5. Results of chromatography as described for Chart 3 of the 0.8 m
NaCI eluate of the human iris media fraction before (left) and after (right)
bacterial hyaluronidase digestion. CSO«, chondroitin 4-sulfate; GA. glucu¬
ronic acid.
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Table 4
Properties of 0.8 u NaC! fractions
Hyalu¬ Chron-
roni¬ droiti- Hepariti¬
dase nase ACII nase
M.W. GluNHs GalNH2 (%) (%) (%)
HM7 media 35,000-14,000 90 10 10" 10 80
H.I.M. media 35,000-14,000 54 46 606 21 7
" After heparitinase, heparinase, and chondroitinase digestion and extensive dialysis
the remaining material was subjected to leech hyaluronidase digestion, and after lyophili-
zation the sample was chromatographed on a calibrated CPG-10 240 80/120 with marker
mucopolysaccharides (19) (unlabeled). A molecular weight range of 35,000 to 14,000
daltons indicates the material was intermediate in molecular weight to the HA (M.W.
35,000) and CS04 (M.W. 14,000) markers used.
6 Bacterial hyaluronidase susceptibility.
600?
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Chart 6. Results of chromatography as described for Chart 3 of the 1.2 m
NaCI eluate of the human media fraction before (left) and after fright) chon¬
droitinase AC digestion. CSO,. chondroitin4-sulfate; GA. glucuronic acid.
HM7 line is heuristically appealing, we have not yet exam¬
ined this possibility.
The activity of tyrosinase in this system is dependent
upon the replicative activity of the cells. This observation is
similar to that which we found in B16C3 cells (J. W. Kreider,
unpublished observations) but with some important differ¬
ences. In the B16C3 line, tyrosinase activity was not detecta¬
ble during the replicative phase and appeared only after
confluency was attained. In the HM7 line, tyrosinase activity
was present at the time of cell planting and declined in
inverse proportion to replicative activity. Such dilution of
tyrosinase activity with cell replication has been observed in
chick melanocyte cultures and has been interpreted as the
result of the redistribution of a fixed amount of preformed
tyrosinase among an increasing number of newly produced
melanocytes (25). This seems to be a reasonable explana¬
tion for the results we have described here for the HM7 line.
With the attainment of confluency, additional tyrosinase
activity is demonstrable and continues to increase each day
in a relatively fixec -u-Per of cells. This suggests de novo
enzyme synthesis, out we have not directly examined this
point. In contrast, in the B16C3 mouse melanoma cell line,
tyrosinase activity appears only after confluency and rapidly
diminishes to 0 within a few days. The loss of activity in the
B16C3 may be due to a saturation of the melanosomes with
accumulated melanin (22). Since the HM7 cells produce
very little melanin, such saturation of the melanosomes
probably does not occur within the duration of the experi¬
ment.
Implantation of HM7 cells into athymic nude mice pro¬
duced small plaque-like nodules of persistent tumor cells
that did not grow progressively. Although a number of
human neoplastic cell lines have formed tumors in athymic
mice (7), failure to do so cannot be interpreted as evidence
that the lines are not neoplastic since other human tumor
cell lines implanted in nude mice have also failed to pro¬
duce progressive growths (23). This could be attributable to
inadequate nutritional conditions for these human tumor
cells in the athymic mice. Microscopic examination of the
persistent nodules in our experiment demonstrated cells
with typical human melanoma morphology that were ac¬
tively invading between the muscle bundles of the underly¬
ing panniculus carnosus.
It is not probable that the HM7 line has been contami¬
nated by admixture with murine melanoma cells. The kinet¬
ics of growth in vitro is very different. The doubling time of
the B16C3 line is 19 to 29 hr, while that of the HM7 line is 40
to 72 hr. The kinetics of tyrosinase activation also is remark¬
ably distinctive, the mean cell volumes are at least 2-fold
different, and the morphology of both lines is unique. Mela¬
nin produced by the B16C3 cells is coal-black in color, while
that produced by the- HM7 is amber-brown. The chromo¬
somes of murine cells generally are predominantly acrocen¬
tric, while those of the HM7 line are metacentric.
The polysaccharides produced by the HM7 human mela¬
noma line differ in several ways from those made by human
embryonic iris melanocytes. The percentage of HA made by
the HM7 cells is significantly reduced, while the proportion
of HS and C4S is significantly increased, and the HM7 cells
contain no detectable dermatan sulfate while the human iris
melanocytes produce significant quantities. It is not possi¬
ble to attribute these differences to the neoplastic state
alone, as the comparisons are not just between neoplastic
versus normal melanocytes. The cells studied also differ as
adult versus embryonic, integumentary versus ocular, and
established cell line versus primary explant. There are no
control cell culture lines of normal adult melanocytes. The
use of primary explants of human embryonic iris, while
inadequate in the respects detailed above, provides the only
available control for these studies.
The HS secreted into the medium by the melanoma is
apparently incorporated in molecules of higher molecular
weight than those previously observed in mouse melanoma
(19). The significance of this is not clear and may be a
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Table 5
Properties of the 1.2 m NaCI fractions
Chondroi- Heparin-
M.W. GluNH2 GalNH.. tinase ACII nase
HM7 media 35,000+ 50 50 58 52
H.I.M. media 35.000-14.000 10 SO 90
20001
MIGRAT'ON
Chart 7. Results of chondroitinase AC digestion and paper chromatogra¬
phy of the 2 m NaCI eluate of the human melanoma media fraction and of
chondroitinase ABC digestion of the human iris media fraction 2 w NaCI
eluate. 4D16S, d-disaccharide-6-sulfate; AOnlS. A-disaccharide-4-sulfate;
ADiOS, A-disaccharide-O-sulfate.
Table 6
Properties of the 2 m NaCI fractions
Chondroitinase
M.W. GluNH., GalNHo ACII ABC
HM7 media 35,000+ 100




Saccharide products of melanocytes
HA C4S Heparan-S04
Melanoma 21.8 47.2
Normal iris" 79.3 19.0''
31.1
1.0*
" About 10% of thel'HlGlcNH, counts in the 0.8 M rnecia and cell-
associated fraction could not be completely characterized due to
the small number present.
6 Includes dermatan-SO., 5.6%.
c Figure given assumes that all of the RHIGlucNH. counts in the
1.2 n media fraction are in HS.
species difference or may reflect the existence of hybrid
polysaccharide structures. The overall results are similar to
those previously reported on the B16 mouse melanoma
1921), indicating a reduction in the amount of HA and an
increase in the percentage of high-molecular-weight C4S
and HS. The major differences between the lines are the
lack of dermatan-SO. croc jction by the mouse iris melano¬
cytes, the presence of a iower molecular weight HS in the
mouse melanoma, and the complete absence of HA produc¬
tion by the mouse melanoma. Similar effects indicating the
reduction of HA synthesis by transformation have been
shewn for SV40-transformed mouse or human fibroblasts
(8, 10), but the opposite effect has been shown to occur for
hamster cells transformed by herpes simplex virus (20).
The biological function of the^complex saccharide mole-
cuies described and their intracellular iocation are not
known. Lectin-binding sites increase in number after hyalu-
ronidase treatment of Rous sarcoma virus-transformed CEF
cells (5). Treatment of HeLa cells with chondroitinase ABC
produced a marked reduction in electrophoretic mobility,
indicating that these molecules are associated with the cell
surface (24). However, it is difficult to determine if these
molecules are anchored into the plasma membrane and/or
are cell surface associated through ionic or protein core
interactions. In addition, the presence of polysaccharides in
the nucleus has been reported (3).
The reduction of HA synthesis and the increase in HS and
CSO, synthesis may represent compensatory responses.
These molecules (HS, CSO.) are markedly different from HA
in physical parameters, and one might reasonably expect
some changes in surface properties to occur, especially if
the amount associated with the cell surface changes signifi¬
cantly. The distribution of these components on the surface
as well as their variation during the cell cycle are also of
interest.
The recent report of an alkali-stable common melanoma
antigen being excreted by the majority of human melanoma
patients (6) raises the possibility that the protein component
of 1 of the saccharide proteoglycans functions as an anti¬
gen; alternative sources may be glycoproteins shed from
the cell surface.
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SUMMARY: The glycopeptides produced by B16 mouse melanoma cells grown in
the presence of [^H]glucosamine were isolated and fractionated into two
classes (I and II) with cetyl pyridinium chloride. The class I glyco¬
peptides were of higher molecular weight and of higher negative charge
(sialic acid content) than those in class II. Class I glycopeptides con¬
tained N-acetyl neuraminic acid, galactose and N-acetylgalactosamine and
on treatment with alkaline-borohydride were degraded to apparently tri-
and tetrasaccharides. The presence of this mucin-type glycoprotein on
the cell surface was detected by mild trypsinization of intact cells.
Examination of proteins and glycoproteins of control and transformed
cells by gel filtration or by gel electrophoresis has shown numerous
differences of a quantitative nature. These include a sialoglycopeptide
derived from membranes (1,2) and a high molecular weight surface protein
that disappears on transformation (2-4).
While studyinq the polysaccharides produced by B16 mouse melanoma
cells it was discovered that cetyl pyridinium chloride (CPC)"^ was capable
of precipitating a sialoglycopeptide from the pronase digested cells and
from spent media in which these cells were grown. Markedly reduced amounts
of this sialoglycoprotein were produced by a control population of mouse
iris melanocytes (5).
This study describes the partial characterization of this sialoglyco¬
peptide. Its properties are compared with those of the glycopeptides
which are not precipitated by CPC and remain in the supernatant.
Abbreviations used: CPC, cetyl pyridinium chloride; TPCK-trypsin, L-(l-
tosylamido-2-phenyl)-ethyl chloromethylketone treated trypsin; GalNAc, N-
acetyl galactosamine.
Copyright © 1976 by Academic Press, Inc.
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MATERIALS AND METHODS
B16 mouse melanoma cells were grown and the complex saccharides labeled
with [-^H] glucosamine and Na^-^SO^ as described previously (5,6).
The glycopeptides were isolated from labeled cells as well as the spent
media by exhaustive digestion with pronase and fractionation of the solubilized
components with CPC (6). For isolation of cell surface complex saccharides,
cells were cultured for 48 hours prior to harvest in medium containing 1/3 the
usual amount of glucose and 0.5 yCi ml--'- of D- ["-^C] glucosamine (New England
Nuclear, 51.5 mCi mmole--'-). The cells were subjected to short-term successive
incubations with TPCK-trypsin (Worthington Biochemical Corp.) according to
Codington et al (7) and the resulting trypsinates digested with pronase to
yield cell surface glycopeptides.
Hexosamine determinations on isotopically labeled glycopeptides were
carried out on acid hydrolysates (4 N HC1, 8 hr, 100°C) on a Beckman 120C amino
acid analyzer employing a stream-splitting attachment. Unlabeled and ["-^cl-
labeled glycine, glucosamine and galactosamine were used as markers. To
identify hexosaminitols, the citrate-borate buffer system as described by
Bella and Kim (8) was used. Labeled sialic acid in glycopeptides was deter¬
mined either by acid hydrolysis (0.1 N H2SO4, 8P°C, 1 hr) or neuraminidase
treatment followed by separation of sialic acid from asialoglycopeptide on a
BioGel P2 200-400 mesh column (0.9 x 70 cm) by elution with 0.1 M pyridine
acetate, pH 5.0. Radioactivity in column fractions was determined as described
previously (6). To locate radioactivity on paper chromatograms, 1 cm paper
strips were extracted with 1 ml water in counting vials prior to addition
of scintillation liquid and counting. Paper chromatography was done on
Whatman No. 1 paper using the following solvents: A, N-butyl acetate:glacial
acetic acid:water (3:2:1); B, N-butyl alcohol:pyridine:water (6:4:3); C,
ethylacetate:pyridine:water (9:3:2). Marker sugars were detected by a silver
nitrate stain.
Vibrio cholerae neuraminidase (Calbiochem) digestion was done in 0.1 M Na
acetate buffer, pH 5.6 containing 0.001 M CaCl2 with 188 milliunits of enzyme
in a total digest volume of 200 yl; incubation was performed at 37°C. Influ¬
enza virus neuraminidase (Calbiochem) digestion was carried out in 0.05 M Tris-
maleate buffer, pH 6.5 containing 0.001 M CaCl2 with 174 milliunits of the
enzyme in a volume of 200 yl. Incubation with 6-galactosidase from Jack bean
(9) was performed in 0.05 M citrate-buffer, pH 4.0 in a volume of 50 yl using
0.1 units enzyme for 24 hr at 37°C. Digestions with 8-N-acetyl hexosaminidase
and with a-N-acetyl galactosaminidase both from Charonia lampus (Miles Labora¬
tories) were also done under the above conditions using 0.1 unit or 10 milli-
unit of the enzymes respectively. The released labeled sugars were estimated
by chromatography of the digest on BioGel P2 columns as described above.
RESULTS AND DISCUSSION
The labeled glycopeptides synthesized by the mouse melanoma and present
in the pronase digest of the cells or media were fractionated into two classes
on the basis of their interaction with CPC. The Class I glycopeptides were
selectively eluted from the CPC precipitate with 0.2 M NaCl, whereas the
Class II glycopeptides which remain in the CPC supernate were isolated
after precipitation of CPC with potassium thiocyanate and extensive
dialysis. The Class I glycopeptides contained 4-5% of the incorporated
tritium label and those in Class II about 90%; the balance of the tritium
140
91
Vol. 70, No. 1, 1976 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
FRACTION NUMBER
Fig. 1: Chromatography of mouse melanoma glycopeptides (a) on CPG 10-240
glass bead column (0.9 x 90 cm). Elution was with 0.5 M CaCl^ at 30 ml per hr.
The peak elution positions of marker saccharides (HA; vitreous humor hyaluronic
acid; C4S porcine rib cartilage chondroitin-4-sulfate and G1CUA, glucuronic
acid) determined by the oricinol reaction are indicated by arrows. (b) On
Sephadex G-50 column (0.9 x 140 cm) eluted with 0.1 M pyridine acetate pH 5.0.
The peak elution positions of markers BD, blue dextran 2000; YD, yellow dextran
and B12, vitamin B^2 are indicated by arrows. One (1) ml fractions were col¬
lected and aliquots analyzed for radioactivity. Class I ( O 0 ) and
Class II ( 9 ♦ ) glycopeptides were run in separate experiments and the
elution patterns superimposed.
label and virtually all of the non-dialyzable label were in mucopoly¬
saccharides.
The Class I glycopeptides were of higher molecular weight (Fig. 1) and
higher negative charge (Fig. 2) than those in Class II. The former appeared
relatively homogenous on the basis of size and charge whereas the latter
was obviously a complex mixture. The tritium label in these glycopeptides
was distributed between sialic acid and hexosamines. Class I glycopeptides
had about 38% of their label in sialic acid, the balance being in galacto-
samine. The label in Class II glycopeptides was distributed between sialic
acid (25%), glucosamine (66%) and galactosamine (9%). The sialic acid of
glycopeptide I was identified as [~*H] -N-acetyl neuraminic acid by co-chroma-
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FRACTION NUMBER
Fig. 2: Chromatography of Class I and IX glycopeptides from mouse
melanoma cells on DEAE cellulose column (0.9 x 70 cm). Elution was with a
linear gradient of 0.01 M to 0.5 M pyridine acetate buffer, pH 5.1 (fractions
1-140), followed by 1 M pyridine acetate of same pH. Rate of flow was 30 ml
per hr. Fractions of 2.5 ml were collected and aliquots analyzed for radio¬
activity. Class I ( 0 0 ) and Class II ( • • ) were analyzed on
separate runs and the results are presented by superimposing the elution
patterns.
solvent A and by paper electrophoresis (3 MM paper, pyridine acetate buffer,
pH 3.5, lOV/cm, 3 hr). Further evidence that the hexosamine of glycopeptide
I is galactosamine was obtained by ninhydrin oxidation (10) followed by
identification of [3H]-lyxose as the only labeled component by paper chroma¬
tography (solvent C). [^H]-galactose was the only neutral sugar detected by
paper chromatography of a total acid hydrolysate of Class I glycopeptides
isolated from cells grown in the presence of [^H]glucose (V. P. Bhavanandan,
J. Umemoto, J. Banks and E. A. Davidson, unpublished results).
Vibrio cholerae neuraminidase digestion of Class I glycopeptides re¬
leased virtually 100% of the labeled sialic acid in 24 hr, indicating that
all the sialic acid was present as terminal residues. However, influenza
virus neuraminidase released only about 50% of the sialic acid in 24 hr,
suggesting that sialic acid may be involved in more than one type of
linkage. It has been reported that whereas Vibrio cholerae neuramini¬
dase acts equally on both 2-K3 and 2->-6 linked sialic acid, influenza virus
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enzyire acts preferentially on 2-K3 and only weakly on 2->-6 linkage (11).
Incubation of the asialoglycopeptide (prepared by Vibrio cholerae
neuraminidase treatment) with Charonia lampus B-hexosaminidase, Charonia
lampus a-N-acetyl galactosaminidase or Jack bean b-galactosidase followed
by b-hexosaminidase failed to release any labeled sugar. However, when the
asialoglycopeptide was treated with Jack bean b-galactosidase followed by
a-N-acetyl galactosaminidase, a component with 27% of the label was released
and was identified as N-acetyl galactosamine by paper chromatography in sol¬
vents A and B. This suggests the presence of the sequence Gal——> [3H]GalNAc
in the asialoglycopeptide.
In order to examine the nature of the linkage between carbohydrate and
peptide, the Class I glycopeptides were treated under nitrogen with 0.3 M
NaBH. - 0.1 N NaOH for 90 hr at 37°C in sealed tubes in the dark. The excess
4
borohydride was destroyed by careful addition of 1 N acetic acid and the
neutralized solution chromatographed on controlled pore glass bead column.
The radioactive material now migrated in the low molecular weight region
with the peak elution position at fraction 48 (Fig. la). On BioGel P2 and
P4 columns, about 90% of the radioactive material was included whereas the
untreated sample was entirely excluded. Paper chromatography of the alkali
degraded product gave two spots, the major one having R 0.34 and
Lactose
0.09 and the minor one 0.79 and 0.56 in solvent systems A and B respectively.
On hydrolysis of the b-elimination products, only [3h]galactosaminitol was
detectable with virtually no [^H]galactosamine indicating that only one
galactosamine per prosthetic group was present and that this was involved
in an alkali-labile O-glycosidic linkage apparently to serine and/or threonine.
The class I glycopeptide is rich in sialic acid and galactosamine, free
of glucosamine and of higher molecular weight than the other glycopeptides
produced by melanoma cells. It is distinct from the peak A glycopeptides
described by Warren and co-workers (1,12) since these glycopeptides have
been shown to have the serum-type N-glycosidic linkage (13). Even though an
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accurate estimation of the size of the prosthetic group has not been made,
its mobility on BioGel columns and paper chromatograms indicate a mixture of
tetra- and trisaccharides. The enzymatic digestion data are consistent with
B ol
the sequence Gal >GalNAc—^ Ser/Thr. To this core, one or two sialic acid
residues are probably attached, forming tri- or tetrasaccharide units. In
the case of the later, the two sialic acid residues are most likely attached
by two types of linkages (e.g. 2-K3 and 2-*6) . The glycopeptide appears to be
of molecular weight 10-15,000 on the basis of its behavior on controlled pore
glass and Sephadex G-50 columns in comparison with standard anionic sac¬
charides. Thus it is conceivable that several oligosaccharides are present
in a cluster attached to the peptide core resulting in a molecule resistant
to further proteolytic digestion.
When the mouse melanoma ^H-glycopeptides isolated from the media were co-
chromatographed together with the [-^C]-glucosamine labeled components isolated
from the surface of intact mouse melanoma cells, strikingly similar profiles
were obtained both on molecular sieve (CPG; Sephadex G-50) as well as ion
exchange (DEAE cellulose) columns (not illustrated). This suggests that the
Class I and II glycopeptides are located at least partly at the cell surface.
These components may be anchored in the membrane or they may reside only tem¬
porarily in the glycocalyx (cell coat) in the process of being shed into the
medium.
The production of this glycoprotein by melanoma cells but not by control
melanocytes (5) is of extreme interest. Mucin-type glycoproteins have been
isolated from the membranes of mammalian erythrocytes (14,15) and of cancerous
cells grown in ascites form (16-18) , whereas solid tissue controls (19) did
not make comparable glycopeptides. The production of this class of glyco¬
proteins by substratum grown mouse melanoma as well as human melanoma cells
(20; V. P. Bhavanandan, J. Banks and E. A. Davidson, unpublished results) seems
to indicate that this may be a more general characteristic of cancer cells.
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SUMMARY: Evidence is presented for the presence in filtrates of Diplococ¬
cus pneumoniae of an endo-glycosidase capable of acting on the O-glycosidic
linkage between N-acetyl galactosamine and serine or threonine residues.
The glycosidase was partially purified by chromatography on Affi-Gel 202.
The resulting preparation acted on glycopeptides from mouse melanoma, fetuin
and pig submaxillary mucin to release a disaccharide characterized as
galactosyl-N-acetyl galactosamine. The enzyme had no action on phenyl a-
N-acetyl-D-galactosaminide, asialo ovine submaxillary mucin or monosialo-
ganglioside. A similar activity was detected in a commercial preparation
of Clostridium perfringens neuraminidase.
Endo-glycosidases would be extremely useful tools for structural
studies on glycoproteins and for investigating the nature and function of
cell surface complex carbohydrates. Endo-B-N-acetyl glucosaminidase
activity, first demonstrated by Muramutsu (1) in Diplococcus pneumoniae,
has since been isolated from various microorganisms (2-4). This enzyme
hydrolyzes the di-N-acetyl-chitobiose linkages in glycoproteins having a
glucosaminyl asparagine bond; the exact substrate specificity depends on
the source of the enzyme (2-4). The presence of a-N-acetyl galactosaminyl
oligosaccharase in a crude enzyme preparation from Clostridium perfringens
has been reported (5). The present report describes some of the properties
of such a glycosidase obtained from D. pneumoniae.
Chromatographic fractionation of glycosidases from D. pneumoniae gave
a preparation of neuraminidase with very high specific activity. However,
on digesting a labelled sialoglycopeptide from mouse melanoma cells with
this enzyme fraction, it was discovered that in addition to sialic acid, an
oligosaccharide was released. Structural analysis of this oligosaccharide
Copyright © 1976 by Academic Press, Inc.
All rights of reproduction in any form reserved.
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resulted in the identification of an endo-glycosidase which in contrast to
the enzyme described by Muramutsu acts on the O-glycosidic linkage between
a-N-acetyl galactosamine and serine or threonine in glycoproteins.
MATERIALS AND METHODS
The crude preparation of enzymes isolated from the culture filtrates
of Diplococcus pneumoniae type 1 and having neuraminidase, B-N-acetyl hex¬
osaminidase, B-galactosidase and endo-8-N-acetyl glucosaminidase activities
but no proteases was generously provided by Dr. Gilbert Ashwell. ^
Mouse melanoma sialoglycopeptides (class I) were isolated from [ H]-
glucosamine labelled cells as described (6,7). The tritium label in this
preparation was distributed between sialic acid (40%) and galactosamine
(60%) . Pig submaxillary mucin (PSM)-2 isolated from pooled glands was a
gift from Dr. M. de Salegui. Glycopeptides from this glycoprotein were
isolated as described (8), except that the pronase digest was ultrafiltered
through a UM2 membrane (Amicon) before chromatography on Sephadex G-50.
The anthrone positive material consisting of the mixed glycopeptides was
used in these studies. Fetuin was purchased from Gibco and the 0-glycosid-
ically linked glycopeptides from it were prepared as described by Spiro and
Bhoyroo (9), with the following modification: the pronase digest was ultra-
filtered using a UM0.5 "membrane (Amicon) and directly fractionated on a
Sephadex G-25 (2.6 x 128 cm) column. The glycopeptides corresponding to
Fraction C of Spiro and Bhoyroo were used in these studies; 36 mg was ob¬
tained from 1 g fetuin. Ovine submaxillary mucin and asialo ovine sub¬
maxillary glycopeptides were isolated as described previously (10).
Neuramin- (2-*-3)-lactose was isolated from skimmed bovine colostrum as de¬
scribed previously (11) .
Activities of B-galactosidase and B-N-acetyl hexosaminidase were
measured using O-nitrophenyl-B-D-galactopyranoside and p-nitrophenyl-N-
acetyl-B-D-glucosaminide (both from Calbiochem) respectively, as described
(12). a-N-acetyl-D-galactosaminidase was assayed using either phenyl-N-
acetyl-a-D-galactosaminide (Nakarai Chemicals,. Japan) or asialo ovine sub¬
maxillary glycopeptides as substrate. The incubation mixtures were assayed
for N-acetyl galactosamine by the Morgan-Elson reaction (13) and in the
case of the former substrate also by Folin-Ciocalteu reaction for phenol.
The incubation mixture for the neuraminidase assay consisted of 25 yl of
0.1 M phosphate-citrate buffer, pH 6.5 (12), 50 yl of a 5 mM solution of
Neuramin- (2-K3)-lactose and enzyme in a final volume of 200 ul. One unit
of neuraminidase activity is defined as the amount of enzyme that causes
the release of 1 umole of NANA per 30 min. After incubation at 37°C for
30 min, the released sialic acid was measured by a modification of the
thiobarbituric acid method (14). Incubation with the endo-a-N-acetyl
galactosaminidase was done under the same conditions as for neuraminidase
using the appropriate substrates. After the incubation, aliquots of the
mixture were assayed for Morgan-Elson positive material. The product was
further identified by gel filtration on BioGel P2 <400 mesh columns (0.9 x
64 cm) and by paper chromatography.
Paper chromatography was done on Whatman No. 1 paper using the fol¬
lowing solvents: A, N-butyl acetate:glacial acetic acid:water (3:2:1); B,N-
butyl alcohol:pyridine:water (6:4:3). Radioactivity in column fractions
and on paper chromatograms was determined as described previously (6,7).
Abbreviations used: PSM, pig submaxillary mucin; GalNAc, N-acetyl
galactosamine, NANA, N-acetyl neuraminic acid.
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Figure 1. Chromatography of Diplococcus pneumoniae crude enzyme
preparation on Affi-Gel 202 at 4°C. The column (1.2 x 26 cm) was eluted
with 0.02 M Tris-HCl buffer, pH 7.0 and fractions of 1.5 ml were collected.
The eluant was changed to 0.5 M NaCl in the same buffer at fraction 62.
The fractions were analyzed for ultraviolet absorbance at 280 (—■—■—) ,
B-N-acetyl-D-hexosaminidase (—•—•—), B-galactosidase (—4—*—) and neuramin¬
idase (—O-O—) as described under "Methods". The scale for neuraminidase
activity is 1/20 of that of the other enzymes.
Figure 2. Fractionation of enzyme fraction II digests of a) [ H]—
asialoglycopeptides from B16 mouse melanoma; b) fetuin glycopeptide
fraction C on BioGel P2 <400 mesh columns. The columns were eluted with
0.1 N pyridine acetate at the rate of 30 ml per hr and fractions of 1 ml
were collected. Aliquots were analyzed for tritium radioactivity
(—■—■—) , Morgan-Elson reacting material (—•-•—) , free sialic acid
(—O—O—) and total sialic acid after acid hydrolysis ( 4 A—). Void volume
(Vo) and peak elution positions of standard sugars and inorganic sulfate
are indicated by arrows.
Isolation of the endo-enzyme: The crude enzyme was placed on a
column of Affi-Gel 202 (BioRad) and the column eluted with 0.02 M Tris-HCl
buffer, pH 7.0 followed by 0.5 M NaCl in the same buffer in the cold room,
4°C. The result of the fractionation is illustrated in Figure 1.
The designated fractions in Figure 1 were combined and concentrated
by ultrafiltration. The concentrated enzyme fractions I and II were tested
for glycosidases and proteases. Fraction I had B-galactosidase, 8-N-acetyl
hexosaminidase and neuraminidase activities. The only detectable exo-
glycosidase activity in fraction II was neuraminidase; the protein in this
fraction was very low and there was no protease activity when tested
against Azocoll (Calbiochem).
Treatment of mouse melanoma class I [3H]-sialoglycopeptide with enzyme
fraction II followed by chromatography on a BioGel P2 column released
RESULTS AND DISCUSSION
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Figure 3. Paper chromatography of low molecular weight material
isolated by BioGel P2 column chromatography of enzyme fraction II digests.
The position of the labelled oligosaccharide from mouse melanoma asialo-
glycopeptides (fractions 33-37, Figure 2a) is indicated by the shaded
area. After treatment with Jack bean B-galactosidase the labelled
material (unshaded area) has the same mobility as GalNAc. The low
molecular weight material from fetuin glycopeptide (fractions 29-33,
Figure 2b) before (lane A) and after (lane D) acid hydrolysis (3N HC1,
100°C, 6 hr). Lanes B and C are standards.
about 90% of the radioactivity as low molecular weight material. This was
unexpected since only about 40% of the radioactivity was in sialic acid was
determined by mild acid hydrolysis (0.1 N H^SO^, 80°, 1 hr). Treatment of
[^H]-asialoglycopeptide, prepared by Vibrio cholerae neuraminidase digestion,
with fraction II for 24 hrs, released 73% of the radioactivity (Figure 2).
Paper chromatography in solvent A of the low molecular weight material re¬
leased from the sialoglycopeptide showed two spots, one with the mobility
of N-acetyl neuraminic acid and the other with a lower was apparently
an oligosaccharide (Figure 3). The material released from the asialogly¬
copeptide showed only the oligosaccharide on paper chromatography. On re-
chromatography of the product from asialoglycopeptide, after treatment
with Jack bean B-galactosidase, a labelled spot with the mobility of N-
acetyl galactosamine was detected (Figure 3). These results indicated that
an enzyme in fraction II was releasing an oligosaccharide with the
structure (Gal) 1 »GalNAc. The class I mouse melanoma glycopeptide has
a mucin type structure in which the prosthetic group is linked to serine
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and/or threonine through a-N-acetyl galactosaminyl residues (7); therefore,
it appeared that an endo-glycosidase in fraction II was cleaving this
linkage. In order to confirm this finding the action of this enzyme on
O-glycosidically linked glycopeptides from fetuin and PSM was tested.
Digestion of fetuin glycopeptide fraction C with this enzyme resulted
in the production of a Morgan-Elson positive material. In order to
identify this product the incubation mixture was chromatographed on a Bio-
Gel P2 column (Figure 2). Two peaks were obtained; fractions in the second
peak reacted with Morgan-Elson and thiobarbituric acid reagents, whereas
fractions in the first peak reacted with neither but reacted with the
latter reagent after acid hydrolysis (0.1 N H^SO^, 80 °C, 1 hr). Chroma¬
tography of a control digest, without enzyme, on the same column gave only
the first peak. The material eluting in the second peak was isolated and
on paper chromatography (solvents A and B) showed two silver nitrate
staining components with the same mobilities as N-acetyl neuraminic acid
and the oligosaccharide from mouse melanoma glycopeptide (Figure 3). The
oligosaccharide was separated from sialic acid by chromatography on an AG1
(formate) resin column. Acid hydrolysis (3 N HC1, 100°, 6 hr) of the oli¬
gosaccharide gave galactose and galactosamine, identified by paper chroma¬
tography (Figure 3). Quantitative analysis indicated the presence of equi-
molar amounts of these sugars in the hydrolysate; galactose was determined
by anthrone reaction (15) and galactosamine by the Elson-Morgan reaction
(16). Reduction of the oligosaccharide with sodium borohydride followed
by acid hydrolysis gave galactose and galactosaminitol as identified by
chromatography on borate treated paper in solvent A. These results prove
that an enzyme activity in fraction II is capable of releasing the disac-
charide galactosyl-(l->-3) N-acetyl galactosamine from fetuin glycopeptide
fraction C.
Submaxillary glycopeptides on digestion with the enzyme fraction II
gave a Morgan-Elson positive product which was isolated by BioGel P2
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column chromatography and identified as the disaccharide, galactosyl-N-
acetyl-galactosamine, as described above. The same product was obtained
when PSM glycopeptides from which fucose and sialic acid had been removed
by mild acid hydrolysis (1 M HCOOH, 100°C, 1 hr) and the galactosamine re-
N-acetylated (17) was used as substrate. The PSM preparation was from
pooled glands and thus probably has both blood group A+ and A active
components. The isolation of only a disaccharide and not higher oligosac¬
charides from digests of the PSM glycopeptides indicates that the enzyme
might require an unsubstituted galactose for activity. It will be interest¬
ing to determine whether this enzyme is capable of releasing sialo-oligo-
saccharides, such as sialyl-N-acetyl galactosamine from ovine submaxillary
glycopeptides. This can be determined once the enzyme is purified free of
neuraminidase.
The enzyme also released the same disaccharide from intact PSM and
PSM from which fucose and sialic acid had been removed and the galactosamine
re-N-acetylated. It is thus capable of acting on intact glycoproteins, a
property which will be very valuable in structural studies on glycoproteins.
The enzyme fraction II did not have any action on the following: phenyl-
a-N-acetyl galactosaminide, asialo ovine submaxillary glycoprotein and its
glycopeptides, monosialoganglioside (GM^) and asialo GM^ prepared by acid
treatment (1 M HCOOH, 100°, 1 hr). It is thus apparent that it has no exo-
N-acetyl galactosaminidase activity and the endo activity is specific for
the a-linkage, since in. GM^ (Gal->GaINAc) is linked B to galactose.
Using class I [3H]-sialoglycopeptides from mouse melanoma we were
able to detect the same endo-glycosidase activity in a commercial prep¬
aration (Worthington) of Clostridium perfringens neuraminidase.
The evidence reported in this communication firmly establishes the
presence of an endo-glycosidase, identified as endo-a-N-acetyl galactos¬
aminidase, in a fraction obtained from D. pneumoniae culture filtrates.
The only other detectable enzyme activity in this fraction is neuraminidase.
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The binding of neuraminidase and the endo-enzyme to Affi-Gel 202 followed
by their elution with NaCl is of interest. Affi-Gel 202 is an agarose gel
NH
I
bead to which the spacer arm -CO NH(CH^)(CH^)^NHCO(CH^)^COOH is attached.
This support is used for immobilizing ligands for affinity chromatography.
D. pneumoniae neuraminidase also bound to Affi-Gel 202 to which p-amino-
benzyl-l-thio-2-acetamido-2-deoxy-B-D-glucopyranoside was coupled (J. Um-
emoto, V. P. Bhavanandan and E. A. Davidson, unpublished results). This
indicates that the neuraminidase is bound to the Affi-Gel 202 by non¬
specific (hydrophobic) interaction with the spacer arm, and not to the
carboxyl group.
In preliminary experiments the crude enzyme preparation was chromato-
graphed on a Sepharosyl-glycyltyrosyl-[N-(p-aminophenyl)]oxamic acid column
(0.8 x 2.8 cm) as described by Den et al. (18). The neuraminidase activity
was separated from 8-galactosidase and 8-N-acetyl hexosaminidase but the
endo-enzyme was detected in the neuraminidase containing fraction. It was
noticed that on storage, the activity of the neuraminidase in the fraction
obtained from Affi-Gel 202 column decreased more rapidly than that of the
endo-enzyme. Partial separation of the neuraminidase and endoenzyme
activities was also obtained when the crude preparation was chromatographed
on Affi-Gel 202 using a NaCl gradient for elution. These results indicate
that neuraminidase and the endoenzyme activities are two separate enzymes.
The possibility of using these properties to separate the two enzyme
activities is being explored. Purification of the endoenzyme as well as the
properties of this enzyme, such as pH optimum and the exact substrate
specificity, will be reported in a subsequent publication.
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Interaction Between the Soluble and Particulate Neuraminidases of Chick Liver1
D. R. P. Tulsiani2, V. P. Bhavanandan3 and R. Carubelli
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Summary. The sum of the neuraminidase activities found in the isolated soluble and particulate fractions of chick
liver was considerably higher than that observed in the cytoplasmic extract from which these fractions were obtained.
Addition of increasing amounts of particulate neuraminidase to a constant amount of the soluble preparation resulted
in a progressive loss of enzyme activity.
Chick liver, as the liver of other vertebrates, contains
both a soluble and a particle-bound neuraminidase4.
Unlike the situation observed with rat liver5, the chick
liver neuraminidases have rather close pH optima: 3.8
for the particulate and 4.4 for the soluble enzyme4.
While investigating the intracellular distribution of
this enzyme, it was observed that the sum of the neura¬
minidase activities found in the isolated soluble and
particulate fractions was more than 50% higher than
that of the cytoplasmic extract from which these fractions
were derived. In order to further investigate this obser¬
vation, chick liver homogenates (1:4 w/v) were prepared
in 0.154 M KC1 and nuclei and debris were removed by
low speed centrifugation (10 min at 800 g). Neuraminidase
activity was then measured in this cytoplasmic extract
as well as in the soluble fraction and in the sedimentable
fraction (resuspended in 0.154 KC1) obtained from it by
centrifuging for 1 h at 105,000 g. All neuraminidase
assays were conducted at pH 4.0; at this pH, about 95%
of the maximum activity for the soluble and particulate
fractions can be detected4. The N-acetylneuraminic acid
(NANA) released by the action of the enzyme was
measured by the thiobarbituric acid method6.
In a series of determinations conducted using as
substrates various sialyltrisaccharides isolated from rat
mammary gland7 and from cow colostrum8, the neura¬
minidase activity in the cytoplasmic extract was con¬
sistently lower than the sum of the values obtained for the
soluble and particulate fractions (see table).
Addition of increasing amounts of the particulate
neuraminidase to a constant amount of the soluble pre¬
paration resulted in a progressive loss of neuraminidase
activity (see figure). When the two enzymes are present
in the mixture in the same proportion found in the original
tissue, the activity of the mixture is usually 50-70% of
that given by the soluble neuraminidase by itself. Heat
inactivated (15 min at 100 °C) particulate neuraminidase
was less effective but, nevertheless, clearly inhibitory.
Several possible mechanisms that could account for
this inhibition were investigated arid the results are sum¬
marized below.
Addition of ashes from 1 g of whole fresh liver to the
soluble fraction from 1 g of liver caused much less in¬
hibition (less than 20%); at least one half of the inhibition
caused by the ashes is probably due to the inhibitory
effect of chlorides on the soluble neuraminidase4.
1 This investigation was supported in part by U. S. Public Health
Service Grant NS09176 from the National Institutes of Health.
2 Present address: Department of Molecular Biology, Vanderbilt
University, Nashville (Tennessee 37232, USA).
3 Present address: Department of Biological Chemistry, The Milton
S. Hershey Medical Center, The Pennsylvania State University,
Hershey (Pennsylvania 17033, USA).
4 D. R. P. Tulsiani and R. Carubelli, Biochim. Biophys. Acta
284, 257 (1972).
5 R. Carubelli and D. R. P. Tulsiani, Biochim. Biophys. Acta
237, 78 (1971).
• L. Warren, j. Biol. Chem. 234, 1971 (1959).
7 H. U. Choi and R. Carubelli, Biochemistry 7, 4423 (1968).
8 M. L. Schneir and M. E. Rafelson, Jr, Biochim. Biophys. Acta
130, 1 (1966).
Neuraminidase activity in the soluble and particulate fractions and in the unfractionated cytoplasmic extract prepared from the livers of
8-day-old white leghorn chicks
Substrate: type of
linkage and source






















































The set of values on the left corresponds to the results obtained from a single representative experiment conducted with the various substrates
listed. The mean i S. D. from seven different experiments with neuramin-lactose, and three experiments with neuramin-lactose sulfate,
are shown on the right side of the table. Figures in parentheses represent the sum of the activities of the soluble and particulate fractions.









Inhibition of soluble chick-liver neuraminidase by increasing con¬
centrations of active and heat-inactivated particulate neuraminidase.
A constant amount of soluble enzyme was present in all incubation
mixtures. Ordinate values represent the activity of the mixtures
expressed as percent of the activity given by the soluble fraction by
itself. Abcissa values indicate percent of active (•) and heat in¬
activated (■) particulate fraction added to the mixture; at 100%,
soluble and particulate fractions are present in the same proportion
found in the original fresh tissue. All assays were conducted using
neuramin-lactose (2—>-3') as the substrate; the data shown cor¬
responds to the average of two separate experiments. Theoretical
values, calculated by adding the activities of the soluble and par¬
ticulate enzymes assayed separately, are included for mixtures con¬
taining active (O) and heat-inactivated ( ) particulate preparations.
No destruction of free NANA (NAN A-aldolase activity),
or interference with the thiobarbituric acid assay, by the
particulate fraction could be detected.
No marked differences were observed in the pH-versus
activity curves of the cytoplasmic extract, soluble and
particulate enzymes.
No abnormal behavior was observed upon determin¬
ation of neuraminidase activity with increasing substrate
concentrations. The Km values for neuramin-lactose
(2-*y) were of the same order of magnitude: soluble
neuraminidase 1.20 x 10~3 M; particulate neuraminidase
2.72 x 10-3 M and cytoplasmic extract 1.97 x 10-3 M.
Experiments with [14C]-U-neuramin-lactose9 indicated
absence of irreversible binding of the substrate by the
particulate fraction and ruled out possible transfer (trans-
glycosylation) of NANA (cleaved from the substrate.by
neuraminidase action) to endogenous or exogenous
acceptors.
Since the cytosolic neuraminidase of chick liver ex¬
hibits very low activity towards macromolecules4, our
data suggests the possibility that binding of this enzyme
to sialyl groups on the surface of the native, and of the
heat-inactivated, particulate fraction may account for
the loss of activity observed in these experiments. It is
tempting to speculate that a similar phenomenon may
also play a role in the regulation of neuraminidase
activity in vivo.
9 R. Carubelli, B. Taha, R. Li. Trucco and R. Caphtto, Bio-
chim. Biophys. Acta 83, 224 (1964).
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RELEASE OF O-SULFATE GROUPS UNDER MILD ACID HYDROLYSIS
CONDITIONS USED FOR ESTIMATION OF N-SULFATE CONTENT
V.P. BHAVANANDAN, D. BREINDEL and E.A. DAVIDSON
Department of Biological Chemistry, The Milton S. Hershey Medical Center,
The Pennsylvania State University, Hershey, Pa. 17033 (U.S.A.)
(Received December 20th, 1976)
Summary
The treatment of chondroitin sulfate isolated from cultured B16 mouse
melanoma cells with 0.04 M HC1 at 100° C for 90 min released up to 45% of
O-sulfate residues as free inorganic sulfate. In addition to the release of inor¬
ganic sulfate, extensive degradation of this polysaccharide as well as of cartilage
chondroitin sulfate, pig rib cartilage proteoglycan, heparin and hyaluronic acid
was also evident under these conditions. The above hydrolysis conditions are
used for characterizing 35S-labeled heparan sulfates synthesized by cultured cells
and to calculate ratio of N- and O-sulfates in these molecules. Our results
suggest that caution is necessary in interpreting the results of mild acid hydrol¬
ysis of glycosaminoglycans.
Introduction
Sugar sulfates, like most esters, are easily hydrolyzed by both alkalis and
acids. The rate of release of sulfate from sulfated sugars during acid hydrolysis
depends on the nature of sugar ester linkage. The ester groups on equatorial
secondary hydroxyl are more readily hydrolyzed than those on axial secondary
hydroxyl which in turn are more readily hydrolyzed than sulfate ester groups
on primary hydroxyl groups [1], Compared to these O-sulfate ester groups, the
N-sulfate (sulfoamino) groups are much more acid labile [2].
The differential rate of hydrolysis of sugar sulfates has been used to distin¬
guish between N-sulfate and O-sulfate [2] as well as to obtain information on
the position of attachment of O-sulfate (for example, 4-sulfate vs. 6-sulfate)
groups [3], At best, such determination can be expected to give only tentative
Abbreviations: CPG column, controlled-pore glass beads column.
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information, since when two or more types of sulfate groups co-exist in a
molecule the rate of hydrolysis determined would be a composite of the differ¬
ent reaction rates.
In studies characterizing glycosaminoglycans synthesized by cultured cells,
the release of inorganic sulfate on mild acid hydrolysis has been used as evi¬
dence for the presence of AI-sulfate, and to calculate ratio of N- and O-sulfates
in the molecule [4—7], During our studies on the sulfated polysaccharides
associated with the nuclei of mammalian cells, it was noticed that considerable
release of inorganic sulfate occurred on mild acid hydrolysis of a fraction
devoid of V-sulfate groups [8]. This finding prompted a re-examination of the
effect of mild acid hydrolysis of some standard glycosaminoglycans, the results
of which are reported in this publication.
Experimental
Heparin sodium salt was from Sigma. Vitreous humor hyaluronic acid was
purchased from Worthington. Protein polysaccharide light fragments (PPL) and
chondroitin 4-sulfate were isolated as described [9]. Octa-, tetra- and disac-
charides of chondroitin sulfate were prepared by hydrolysis of chondroitin
sulfate [10].
A high molecular weight chondroitin sulfate was isolated from the spent
media, whole cells and nuclei of B16 mouse melanoma cells grown in the
presence of [3H]glucosamine and Na235S04 as described previously [8,11].
Hydrolyses of polysaccharide samples were done in capillary tubes prepared
from disposable Pasteur pipettes. The sample (0.5—2.0 mg) was dissolved in
50—200 m 1 water, an equal volume of 0.08 M HC1 was added and the tube
sealed. Hydrolysis was carried out in a boiling water bath for 30 or 90 min. The
capillary tubes were cooled, centrifuged to collect all the solution to the
bottom and kept frozen until analyzed on columns. The samples were thawed,
neutralized by the addition of NaOH and fractionated on a controlled-pore
glass (CPG) or BioGel P2 column or used for paper electrophoresis. Controlled-
pore glass beads (CPG 10-240 80/120 mesh) were treated with polyethylene
glycol and packed in columns as a slurry with application of constant vibration.
The columns were equilibrated with 0.5 M CaCL and eluted with the same solu¬
tion. BioGel P2 column (0.9 X 70 cm) was equilibrated and eluted with 0.1 M
pyridine acetate. Rates of flow of both columns were maintained constant at
30 ml /h by means of a Milton Roy minipump in order to obtain reproducible
fractionations. Fractions of about 1 ml were collected using an ISCO fraction
collector equipped with a drop counter.
Fractions were analyzed for uronic acid by the orcinol reaction [12] or for
radioactivity by scintillation counting on an Intertechnique Model SL36 spec¬
trometer using 1 ml of aqueous sample and 10 ml of the counting liquid con¬
taining xylene and Triton X-114 [13].
Results and Discussion
The results of paper electrophoresis before and after mild acid hydrolysis of
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Fig. 1. Paper electrophoresis of mouse melanoma chondroitin sulfate before (upper) and after (lower)
hydrolysis with 0.04 M HC1, 100"C for 90 min. Electrophoresis was done on Whatman No. 3 paper
in 0.5 M pyridine acetic acid buffer, pH 5.0, at 10 V/cm for 2—3 h. Positions of markers 1V-[14C]-
acetylneuraminic acid ([1 '*C]NANA) and [35S]sulfate were determined by scanning 1.5 inch wide
strips on Packard Model 7201 radiochromatogram scanner. Tritium activity (solid line) and 35S activity
(broken line) of samples were detected by extracting 1 cm strips and counting.
mouse melanoma cells is illustrated in Fig. 1. After hydrolysis with 0.04 M HC1
at 100° C for 90 min, about 45% of the 35S radioactivity migrated as inorganic
sulfate. This was surprising since this fraction has been characterized as having
only O-sulfate residues by its complete susceptibility to chondroitinase AC and
chondro-4-sulfatase [8]. The resistance of this component to HN02 treatment,
FRACTION NUMBER
Fig. 2. Fractionation of mouse melanoma chondroitin sulfate (o-.--.-o, 35g and • •, ^H) and
cartilage chondroitin sulfate (* *) after hydrolysis with 0.04 M HC1, 100°C for 90 min. The elution
of cartilage chondroitin sulfate after hydrolysis for 30 min (■ ■) is also illustrated. Chromatography
on BioGel P2 column (a) and on controlled-pore glass (CPG) column (b). The peak elution positions of
marker saccharides (HA, vitreous humor hyaluronic acid; C4S, porcine rib cartilage chondroitin 4-sulfate;
GlcUA, glucuronic acid; SO^~, inorganic sulfate; octa-, tetra- and disaccharides, respectively, from chon¬
droitin sulfate) are indicated by the arrows.
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0.3 M HN02 at room temperature for 80 min, further confirmed the absence
of iV-sulfate residues. It was also apparent in the above experiment that in addi¬
tion to the release of O-sulfate, the hydrolysis degraded the molecule to oligo¬
saccharides. The results of chromatography of the acid hydrolysis products on
BioGel P2 column (Fig. 2a) confirmed this finding. About 42% of the 35S
eluted in the position of inorganic sulfate while most of the remaining 35S activ¬
ity and all of the 3H activity eluted in the area of chondroitin tetrasaccharide.
The elution profiles of cartilage chondroitin sulfate hydrolyzed for 30 and
90 min are also shown in Fig. 2a. It is clear that after 90 min hydrolysis the
major portion of this polysaccharide is degraded to fragments eluting in the
position of chondroitin 4-sulfate tetrasaccharides. The balance eluting at the
void volume are octasaccharide size or larger. The elution pattern on CPG
columns of cartilage and melanoma chondroitin sulfates after acid hydrolysis
further illustrates the degradation of these molecules (Fig. 2b). Whereas, the
unhydrolyzed melanoma chondroitin sulfate co-elutes in the void volume with
vitreous humor hyaluronic acid, the hydrolysis products are eluted entirely in
the low molecular weight region of the column. When hydrolyzed for only 30
min, the extent of degradation of cartilage chondroitin sulfate is less as illus¬
trated by the peak elution position at fraction 51 (Fig. 2b).
The elution profiles of hyaluronic acid and heparin after mild acid hydroly¬
sis for 90 min on BioGel P2 and CPG columns are shown in Fig. 3. The results
suggest that hyaluronic acid is completely degraded to fragments of octasac-
charides or larger. In the case of heparin, the degradation appears to be minimal;
before hydrolysis heparin eluted from CPG column in a very broad peak with
maximum at fraction 47 and after hydrolysis the peak maximum shifted to
fractions 49—50 (Fig. 3b).
FRACTION NUMBER
Fig. 3. Chromatography of hyaluronic acid (A •*) and heparin (■ ■) after hydrolysis with 0.04
M HC1, 100°C for 90 min on a, BioGel P2; b, CPG columns. Abbreviations are as in Fig. 2.
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Cartilage proteoglycan light fraction (PPL) when hydrolyzed for 90 min and
chromatographed on CPG and BioGel P2 columns showed extensive degrada¬
tion of the polysaccharide chains.
Heparan sulfate appears to be a ubiquitous component of the mammalian
cell surfaces and has been implicated in control of cell growth [11,14,15].
Labeling with [35S]sulfate and chromatographic techniques are widely used to
facilitate the identification and characterization of sulfated polysaccharides
synthesized by mammalian cells in culture. One of the criteria used to distin¬
guish the IV-sulfate heparan sulfate from other O-sulfated polysaccharides (chon-
drotin sulfate, dermatan sulfate, keratan sulfate) is the ease of release of sulfate
from the former on mild acid treatment. It is clear from our results that this
distinction is unreliable because of the unexpected ease of hydrolysis of
O-sulfate.
The degradation of glycosaminoglycans by the mild acid hydrolysis is of
interest and is in general agreement with the findings of Cifonelli [16]. The
glycosaminoglycans (hyaluronic acid, chondroitin sulfates and chondroproteo-
glycan) containing iV-acetylhexosamines were all degraded to oligosaccharides
in the range of tetra- to octasaccharides. However, heparin having mostly
ALsulfated hexosamines did not undergo detectable degradation under these
conditions. This may be related to the very rapid cleavage of the AZ-sulfate
bonds and the resistance to further hydrolysis of the generated hexosaminidic
bond.
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ABSTRACT
The mucopolysaccharides produced by B16 mouse melanoma cells have been
isolated in milligram quantities from the spent media in which the cells were grown in
the presence of 2-amino-2-deoxy-D-glucose-t and [35S]-sulfate. The mucopoly¬
saccharides obtained by precipitation with cetylpyridinium chloride from the
Pronase digest of the media were further purified by gel filtration, ion-exchange
chromatography, and treatment with nucleases. The major components were
identified as chondroitin-4-sulfates by identification of the hexosamine as 2-amino-2-
deoxy-D-galactose, and by digestibility with hyaluronidases, chondroitinase AC, and
chondro-4-sulfatase. The o.r.d. curve and i.r. spectra of these components also
confirmed their similarity to chondroitin-4-sulfate from cartilage. The molecular
weight of the polysaccharide chains was estimated to be in the range 90,000-120,000
by sedimentation equilibrium analysis.
INTRODUCTION
Mucopolysaccharides are associated with the surface of a wide variety of
cultured normal and cancer cells1 '2. They are thought to play a role in a variety of cell
properties such as adhesion, contact inhibition, masking of receptors, and interaction
with antigens. In addition, due to their high negative charge and their large size, they
are also likely candidates for regulating macromolecule and cation access to the cell
plasma membrane. This class of macromolecule is also associated with the nuclei3-5,
mitochondria6, and plasma membrane7. Neither the nature of the association of
mucopolysaccharides with these cell organelles nor their function is clearly under¬
stood.
A prior study of the complex saccharides produced by B16 mouse melanoma
ceils8 showed the presence, both in the cells and spent media, of a family of chon-
•Dedicated to the memory of Sir Edmund Hirst, C.B.E., F.R.S.
174 v. p. bhavanandan, e. a. davidson
droitin sulfates having properties distinct from those of typical chondroitin sulfates
of cartilage. This class of polymer was also the major mucopolysaccharide associated
with the nucleus of these cells3.
We now report on the chemical and physical characterization of the chondroitin
sulfates produced by B16 mouse melanoma cells in culture.
experimental
Materials. — Fetal calf serum and antibiotic solution were obtained from Flow
Laboratories, Rockville, MD, and other components for culture media from Grand
Island Biological Company, Grand Island, N.Y. Pronase CB was obtained from
Calbiochem; controlled-pore glass beads (CPG 10-240) and glyceryl-CPG 240 were
from Electronucleonics, Fairfield, NJ; Sepharose 4B-200 and diethylaminoethyl
(DEAE) Sephadex were from Sigma; Chondroitinases ACII (EC 4.2.2.5) and ABC
(EC 4.2.2.4) and chondro-4-sulfatase (EC 3.1.6.9) were from Miles Laboratories;
testicular hyaluronidase (EC 3.2.1.35) (400 units per mg) was from Worthington,
Inc.; bacterial hyaluronidase (EC 4.2.99.1) from Organon; and leech hyaluronidase
(EC 3.2.1.36) from Biotrics, Arlington, MA. Heparitinase was isolated from an
adapted Flavobacterium heparinum strain provided by Dr. A. Linker9,10. Bovine
pancreas deoxyribonuclease DN-EP (EC 3.1.4.5) was from Sigma, and bovine
pancreas ribonuclease (EC 2.7.7.16) from Boehringer.
Vitreous humor hyaluronic acid was obtained from Worthington; proteoglycan
and chondroitin-4-sulfate were isolated from pig-rib cartilage; and reference heparan
sulfate was a gift from Dr. A. Linker. Streptococcal hyaluronic acid was a gift from
Dr. Karl Meyer.
Column chromatography. — Glyceryl CPG-240 or CPG 10-240 beads (80-
120 mesh) treated with polyethylene glycol were packed in silicone-coated columns
with constant vibration according to the instructions of the manufacturers. The
columns were equilibrated with 0.5m KC1 and eluted with the same solution; a pump
was used to maintain a constant flow rate of 30 ml/h. Columns (0.9 x 70 cm) of Biogel
P2 were equilibrated and eluted with 0.1m pyridine acetate (pH 5.0). Sepharose 4B
and Sephadex G200 were packed in columns (2 x 60 cm) and equilibrated with 50 mM
Tris-HCl buffer (pH 8.0).
DEAE Sephadex A-25-120 was swollen in m sodium acetate for 48 h, filtered
off, and washed with 0.01m pyridine acetate buffer (pH 5.1) on a Buchner funnel until
the filtrate gave a negative test for chloride. A suspension of the beads in the same
buffer was packed in a column (13x1 cm).
Cellulose acetate electrophoresis was performed in a Beckman R-101 microzone
electrophoresis cell with 0.2m calcium acetate (pH 7.0) at 5 mA for 3 h, or pyridine-
formic acid buffer (0.1m in formic acid, pH 3.0) at 10 mA for 20 min. Staining with
Alcian Blue (0.1% in 0.5% acetic acid) was used for detecting acidic components
(mucopolysaccharides and mucin-type sialoglycoproteins).
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Unless specified otherwise, all dialysis was performed at 4° in the presence of
toluene and chloroform.
Hexosamine determinations on isotopically labeled components were carried
out, after acid hydrolysis, by ion-exchange chromatography on an automated amino
acid analyzer; the stream-splitting technique described earlier8,11 was used. The
samples were hydrolyzed with 6m HC1 at 110° in vacuo for 24 h; on the basis of
control experiments, a correction for the destruction of 28.5% of 2-amino-2-deoxy-
glucose and 25.5% of 2-amino-2-deoxygalactose was applied. G.l.c. identification of
neutral sugars was performed, following hydrolysis as described in the text, by the
alditol acetate procedure12. A Packard gas-liquid chromatograph was used13 with a
glass column (6 ft x 0.125 in.) of 3% of ECNSS-M on Gas Chrom Q (100-120 mesh).
Uronic acids were identified as the trimethylsilyl derivatives14 [15% of Apiezor. M on
Gas Chrom CLZ (80-100 mesh)]. Marker polysaccharides run on gel columns were
assayed by the orcinol reaction15. Liquid scintillation counting was performed on an
Intertechnique Model SL36 spectrometer; usually, 1-ml aqueous samples were mixed
with 10 ml of the counting liquid containing xylene and Triton X-l 1416. Efficiencies
for 3H and 35S were ~ 16 and ~47%, respectively, with a crossover of ~ 13-14% of
35S into the 3H channel. The citrate buffer fractions (4 ml) from the amino acid
analyzer were mixed with 10 ml of 3a40 counting fluid (Research Products Inter¬
national Corporation) and counted. The efficiency for tritium in this system was 15%,
using the same settings for minimal crossover of 35S as above. Radioactivity on
cellulose acetate or paper strips was estimated by extracting cut pieces with 1 ml of
water in counting vials. After shaking for at least 6 h on a reciprocating shaker,
counting liquid was added, and the solution was mixed and counted.
Cell cultures. — BI6 mouse melanoma cell lines (B16C2 and B16C3) and an
amelanotic clone were grown in 16-oz prescription bottles and subcultured at
confluency by suspension with 0.02% of EGTA [ethylene glycol bis(/?-aminoethyl
ether)-A,yV'-tetraacetic acid] in calcium- and magnesium-free phosphate buffered
saline. The cells were cultured in Eagle's medium17 containing twice the recom¬
mended concentration of vitamins and supplemented with non-essential amino acids
(each at O.imm), sodium pyruvate (mm), and 10% heat-inactivated (56° for 30 min)
fetal-calf serum. Cultures were routinely tested for bacterial contamination by the use
of thioglycolate and tryptose phosphate broth18, and for yeast and mold contamina¬
tion with Sabouraud's medium19. The spent media at each medium change, and at
subculturing, were decanted, centrifuged to remove floating cells, and stored in the
freezer. We are grateful to Mr. John Banks for help in cell culture and for collecting
media used in these studies. Spent medium containing labeled complex saccharides
was prepared by culturing the cells for 48 h prior to harvest in medium containing
(per mi) 10 ^Ci of 2-amino-2-deoxy-d-glucose-r (New England Nuclear, 755 mCi per
mmol) and 50 ^Ci of Na23 5 S04 (New England Nuclear, 755 mCi per mmol).
Treatment of media and offetal-calf serum with Pronase and alkali. — Pooled,
frozen, spent media (~5 1, MI) was thawed and dialyzed at 4° against 0.9% NaCl for
2 days, and then against water for 5 days. The dialyzed material was concentrated by
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ultrafiltration and lyopliilization to ~600 ml and combined with 100 ml of dialyzed,
labeled media. Calcium acetate was added (to 0.01m Ca2+) and the pH was adjusted
to 7.8 with 10m NaOH. Pronase (100 mg) was stirred in, toluene (2 ml) added, and
the solution incubated in a stoppered flask at 40° for 72 h with further additions of
100 mg of enzyme and toluene after 24 and 48 h; the pH was maintained at 7.8-8.0
during the incubation by the addition of NaOH. The digest was centrifuged, the
residue discarded, and the supernatant solution dialyzed against 0.9% NaCl overnight,
and then against deionized water for 4 days. The contents of the dialysis bag were
adjusted to pH 12.5 and, after 18 h at 20-25°, dialyzed for 5 days against several
changes of deionized water. A second batch of spent media Mil (3 1) was worked up
in an identical manner, except that the treatment at pH 12.5 for 18 h was omitted.
As a control, heat-inactivated fetal-calf serum (300 ml) was digested with
Pronase as described above for the second batch of media, and then dialyzed against
0.9% NaCl followed by deionized water for a total of 5 days.
Precipitation of digested media and serum with cetylpyridinium chloride. — The
Pronase- and alkali-treated material was adjusted to 0.03m in NaCl and 0.15% in
cetylpyridinium chloride (CPC). After 48 h at room temperature, the precipitate was
collected by centrifugation (15,000 g, 30 min) and washed three times with 0.15% of
CPC in 0.03m NaCl by resuspension and centrifugation. CPC was added to the
supernatant solution and washings to a final concentration of 1 %. The small amount
of precipitate formed was collected and washed as above. The precipitates were
combined and fractionally extracted by stirring with 0.2, 0.4, 0.6, 1.0, 1.2, and 2.0m
NaCl, utilizing 1x20 ml and 3x10 ml for each extraction; at least one of the
extractions at each molarity was done overnight. The CPC in the extracts was
removed by dialysis at 40-45° against 2m NaCl followed by distilled water at 4°; the
solutions were then filtered and lyophilized.
Enzyme digestions. — The labeled samples (10,000-25,000 d.p.m., 3H) were
mixed with 500 pg of carrier mucopolysaccharide (hyaluronic acid, chondroitin
sulfate, or heparan sulfate) and digested with hyaluronidase, chondroitinase, or
heparitinase as described below. The carrier mucopolysaccharides were completely
degraded under the conditions employed. Testicular hyaluronidase digestion was
performed in 700 pi of 0.1m sodium acetate buffer (pH 5.0) and 8mM EDTA in the
presence of toluene and chloroform at 37° for 24 h, using 80 units of enzyme.
Bacterial hyaluronidase digestion was performed in 0.1m sodium acetate buffer
(pH 5.0) at 37° for 26 h, using 150 units of enzyme in a total volume of 150 p\. Leech
hyaluronidase digestion was carried out by dissolving the sample in 100 pi of
Mcllvaine's buffer (pH 5.6) and incubating at 37° for 6 h with the addition of 125 pg
of enzyme in 25 pi of buffer at 0, 1, and 2 h. Heparitinase digestions9 were done in
300 pi of 0.1m sodium acetate buffer (pH 7.0) containing mm calcium acetate at 43°
for 24 h. Chondroitinase and chondrosulfatase digestions were performed according
to the method of Saito et al.20.
Nitrous acid degradation was done by treating the sample in 100 pi of water
with 20 pi of 3m NaNOz and 20 pi of glacial acetic acid at room temperature for
115"
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80 min. Excess of nitrite was destroyed by addition of 50 /d of 3m glycine and, after
60 min at room temperature, the product was lyophilized.
The molecular weights (M„) of standard saccharides and unknown samples
were determined by sedimentation equilibrium on a Beckman Model E analytical
ultracentrifuge by using Rayleigh interference optics. Samples dissolved in an
electrolyte, usually 0.5m NaCl, were run at 25° in a three-channel cell at three different
concentrations21. The fringe patterns were recorded photographically, and the data
were read and analyzed directly by a computer-operated system22.
O.r.d. data were obtained on a Cary Model 60 Spectropolarimeter with samples
dissolved in m NaCl; a 10-mm cell was used. Infrared spectra (KBr pellets) were
recorded on a Perkin-Elmer 267 spectrophotometer.
results
Table I presents the results of CPC fractionation of the Pronase digest of the
two lots of spent media (MI, 5 1; and Mil, 3 1) and of fetal-calf serum (S). Fractions
MI 0.2 and Mil 0.2, which were eluted from the CPC precipitate with 0.2m NaCl,
consisted mainly of a mucin-type sialoglycopeptide which has been characterized11.
0.4m NaCl Fractions. — MI 0.4 (5.5 mg) was fractionated on a CPG column
(1.5 x 115 cm), as illustrated in Fig. 1 (middle). The fractions were combined as
indicated, dialyzed, and lyophilized to yield MI 0.4a (1.8 mg) and MI 0.4b (3.2 mg).
The distribution of [3H]-activity in the hexosamine component of these fractions is
given in Table II. The major portion of MI 0.4b was identified as a mucin-type
sialoglycopeptide similar to that present in the 0.2m NaCl eluates. Cellulose acetate
electrophoresis of MI 0.4a was done in the two buffer systems; the result in calcium
acetate buffer is shown in Fig. 2. Two components were detected with Alcian Blue,
but the radioactivity was associated entirely with the spot having the higher mobility.
Separation of the labeled component from the unlabeled contaminant was
achieved by chromatography of MI 0.4a on a column (1x13 cm) of DEAE Sephadex.
After loading of the sample, the column was eluted with a linear gradient of
0.01 -» 1.0m pyridine acetate (pH 5.1). Fractions (180 x1ml) were collected and
aliquots assayed for radioactivity; none was detected in these fractions. The labeled
component was recovered from the column by. elution with 2m NaCl, dialysis, and
lyophilization (MI 0.4a2). The fractions (1-180) were also combined, concentrated,
and recovered (MI 0.4al). The results of cellulose acetate electrophoresis of these
two fractions are illustrated in Fig. 2. Fraction (MI 0.4a2) gave only one spot and
was free of the unlabeled component (MI 0.4al). Component MI0.4al was hydrolyzed,
and analyzed on a Beckman model 121 amino acid analyzer (60-cm column). In
addition to amino acids, both 2-amino-2-deoxyglucose and 2-amino-2-deoxy-
galactose were present in approximately equal amounts; the component was ap¬
parently derived from serum and was not further examined.
The molecular weight of MI 0.4a2 was determined by equilibrium sedimentation
to be 92,500; a partial specific volume (v) for chondroitin sulfate23 of 0.57 was used
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for the calculation (Table II). The sample recovered after molecular weight deter¬
mination was used for o.r.d. measurements. The results are shown in Fig. 3. The
sample was then dialyzed against water, KBr (300 mg) was added, and the solution
was lyophilized. The resulting powder was dried in a desiccator over P205, and
pressed into a pellet, and the i.r. spectrum was recorded (Fig. 4).
O.r.d. measurements and i.r. spectra were also done on cartilage proteoglycan,
hyaluronic acid, and cartilage chondroitin-4-sulfate standards.
Chromatography of the fraction MI 0.4a2 before and after treatment with
alkaline borohydride (m NaBH4-0. 1m NaOH, 37°, 72 h) gave the results shown in
Fig. 5. There was very little change in molecular size on treatment with alkaline
borohydride.
Fraction Mil 0.4 was also separated into Mil 0.4a and Mil 0.4b on a CPG
column (Fig. 1). Mil 0.4a (1.69 mg), consisting of mucopolysaccharide of high
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Fig. i. Fractionation of 0.4m or 0.8m NaCl fractions on a column (l.5x 115cm) of CPG 10-240
beads; fractions (3 ml) were collected and analyzed for radioactivity FH). The peak-elution position
of marker saccharides (FIA, vitreous humor hyaluronic acid; C4S. porcine rib-cartilage chondroitin-4-
sulfate, and GlcUA, glucuronic acid) are indicated by the arrows. MI0.8 (upper); fractions 29-38
and 39-52 were separately combined and recovered to yield MI0.8a and M 10.8b, respectively.
M10.4 (middle); fractions 26-32 and 33-45 were recovered to yield M 10.4a and M 10.4b. respectively.
MI 10.8 (lower); fraction, 27-33 and 34-52 were combined and recovered to yield MI 10.8a and
Ml 10.8b. respectively.
Fig. 2. Cellulose acetate electrophoresis in calcium acetate buffer of M 10.4a before and after (M10.4a I
and MI0.4a2) fractionation on a column of DEAE Sephadex; details are given in the text. Shaded
spots stained more intensely with Alcian Blue than the dotted spots.
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TABLE II
ANALYTICAL DATA FOR VARIOUS MEDIA SUBFRACTIONS
Fraction Weight (mg) GlcN* GalN' Mot. Wt."
MI0.4a 1.80 2.8 97.2 47,400
MI0.4b 3.21 8.8 91.2 ~15,000
MI0.4al' 0.42 n.d." n.d. n.d.
MI0.4a2' 1.17 0 100.0 92,500'
MII0.4a' 1.69 n.d. n.d. 120,600
MI0.8a 1.38 5.8 94.2 80,000
MI0.8b 1.53 71.5 29.5 ~15,000
MII0.8a" 0.80 3.5 96.5 121,000
MII0.8b 1.40 67.5 32.5 ~15,000
"The hexosamine values are as percentages of the tritium label found for 2-amino-2-deoxy-glucose
and -galactose. 'Based on the behavior of the labeled components relative to standard mucopolysac¬
charides during chromatography on CPG (MI0.4b, MI0.8b, and MII0.8b) or by sedimentation
equilibrium analysis (others). 'Obtained by fractionation of MI0.4a on DEAE Sephadex; see Results
for details. dn.d., Not determined. 'Average of two separate determinations (88,000 and 97,000).
determined after purification on Sepharose 4B. "Determined after treatment with DNase, RNase,
and Pronase, and purification by chromatography on Sephadex G200 and Sepharose 4B.
X (nm)
Fig. 3. O.r.d. curves for fractions of mouse melanoma chondroitin sulfate: —O—, MI0.4a2; and
—, MI0.8a.
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Fig. 4. Infrared spectrum for fraction MI0.4a2 of mouse melanoma chondroitin sulfate.
Fig. 5. Gel filtration of mouse melanoma fraction MI0.4a2 before (—•—) and after (—O—)
treatment with m NaBH4.-O.lM NaOH (37° for 72 h) on a column of Sepharose 4B (2 x 60 cm).
Hlution positions of calibration standards are indicated by arrows: BD, blue dextran; YD, yellow
dextran; Vit. Bl2> vitamin B12; and Strep. HA, streptococcal hyaluronic acid. The fractions were
analyzed for 3H activity.
fig. 6. Molecular moments for fraction MII0.4a of mouse melanoma mucopolysaccharide in
0.5m NaCl: r.p.m. = 15,000; loading concentration channel A (•), 0.5 mg/ml; channel B (A),
0.25 mg/ml; and channel C (O), 0.125 mg/ml.
below for Mil 0.8a, and the main peak was used for determination of molecular
weight. A molecular weight (MJ of 120,600 +5800 was estimated (Fig. 6); a two-
species plot24 showed the presence of aggregates up to trimers.
0.8m NaCl Fractions. — Fractionation on a CPG column gave the elution
pattern shown in Fig. 1 (upper); MI 0.8a (1.38 mg) and MI 0.8b (1.53 mg) were
obtained. Hexosamine analyses of these fractions are given in Table II. Cellulose
acetate electrophoresis of MI 0.8a was done in two buffer systems. In pyridine formate
buffer, the major spot moved slightly ahead of hyaluronic acid, and the second spot,
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present only in trace amounts, had a mobility similar to that of heparan sulfate
(Fig. 7). O.r.d. measurements were done on MI 0.8a (Fig. 3), which had [a]28o — 120°;
porcine rib-cartilage chondroitin sulfate has [a]28o —219°, and vitreous humor
hyaluronic acid — 520°. This fraction was digested with Pronase for 48 h at 40°, with
two additions of the enzyme at 0 and 24 h. The gel-filtration pattern on CPG of the
digested material was the same as that of the undigested fraction. This indicates that
the molecule does not consist of several saccharide chains attached to a Pronase-
susceptible peptide, in agreement with earlier observations on material isolated from
the nuclei of melanoma cells3.
MI0.8a ■ I t
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Fig. 7. Cellulose acetate electrophoresis of mucopolysaccharide fraction MI0.8a from mouse
melanoma in pyridine acetate (left) and calcium acetate (right) buffers. The unknown sample was
run in two lanes; after electrophoresis, one lane was assayed for radioactivity (see Methods) and the
remainder of the strip was stained with Alcian Blue.
This fraction was digested with testicular hyaluronidase and chondroitinase AC,
and the digests were examined by chromatography on CPG columns. The material
was completely susceptible to both of these enzymes. The fraction was also susceptible
to bacterial hyaluronidase, but the fragments obtained were larger than tetrasac-
charides and disaccharides, as illustrated for the nuclear material3. These results are
in agreement with a polysaccharide having 50% or less of the disaccharide repeating-
units sulfated, more or less at random. Chondroitinase AC and chrondroitinase AC
plus chondro-4-sulfatase digestion of this fraction, followed by paper chromatography
as illustrated in Fig. 8, indicates that the sulfate ester group is mainly at position 4 of
the 2-amino-2-deoxygalactose moiety.
In order to identify the uronic acid and neutral sugars by g.l.c., and the
hexosamine by the ninhydrin-degradation method, this fraction was hydrolyzed under
two different conditions and the products were separated as shown in Fig. 9. The
uronic acid was identified as glucuronic acid; there was no evidence for the presence of
iduronic acid, thereby eliminating the possibility of a chondroitin sulfate-dermatan
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Fig. 8. Paper chromatography (1-butanol-acetic acid-M ammonium hydroxide, 2:2:1; 18 h) of
chondroitinase AC (lower) and chondroitinase AC and chondro-4-sulfatase (upper) digests of
fraction MI0.8a. The positions of reference compounds are indicated: A4S, 2-acetamido-2-deoxy-3-
0-(4-deoxy-ot-L-rAreo-hex-4-enopyranosyluronic acid)-4-0-sulfo-D-galactose; A6S, 2-acetamido-2-
deoxy-3-0-(4-deoxy-a-L-/7treo-hex-4-enopyranosyluronic acid)-6-0-sulfo-D-galactose; AOS, 2-ace-
tamido-2-deoxy-3-0-(4-deoxy-a-L-f/fra?-hex-4-enopyranosyluronic acid)-D-galactose.
there were several unidentifiable peaks. However, small peaks of xylose and galactose
were detectable, but their stoichiometry could not be assessed; the presence of these
sugars needs to be confirmed by independent methods. Polysaccharide chains of
molecular weight ~ 120,000, if synthesized via glycosyl-serine initiation, would be
expected to have only one xylose residue per 600 monosaccharide residues. Thus,
larger amounts of samples are needed for quantitation of the neutral sugars. The
hexosamine fraction was degraded with ninhydrin26, and the products were examined
by paper chromatography (ethyl acetate-pyridine-water. 9:3:2) with arabinose and
lyxose as reference sugars. The labeled material had a mobility identical to that of
lyxose, confirming the identity of the hexosamine as 2-amino-2-deoxygalactose;
arabinose was not detected.
A major portion of MI 0.8b was susceptible to nitrous acid treatment. As 72%
of the hexosamine in this fraction was 2-amino-2-deoxyglucose, it can be concluded
that heparan sulfate is the major constituent of MI 0.8b. The remainder is apparently
chondroitin sulfate3 of molecular weight, 10-15,000. When MI 0.8b was treated with
heparitinase and chromatographed on CPG, ~60% of the 3H-radioactivity was
eluted in the region of low molecular weight, a result in agreement with the nitrous
acid degradation.
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MIO- 8a
(a) m HCI . 100*, 3h
or
(b) AG50W X2 (H+) resin in 0.05 m HCI, sealed tube, 100*, 24 h
AG 50W X2 (H ) resin
Water eiution













AG50W X2 (H + ) resin in 0.05 m HCI




Sample hydrolyzed under condition (b) was directly trimethylsilylated.
Fig. 9. Scheme for degradation and isolation of neutral sugars, uronic acids, and hexosamines from
mouse melanoma fraction MI0.8a.
Fraction Mil 0.8 was separated into fractions of higher and lower molecular
weight on a CPG column (1.5x115 cm) (Fig. 1, lower). The fraction of higher
molecular weight (Mil 0.8a, 2.2 mg) was further purified as follows. It was dissolved
in 50mM Tris-HCl buffer (pH 7.4) containing 10mM Mg2 + , and treated with deoxy-
ribonuclease I and ribonuclease at 37° for 48 h. The product, recovered by dialysis
and freeze-drying, was then dissolved in 50mM Tris-HCl buffer (pH 8.0) containing
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10mM Ca2+, and digested with Pronase at 40° for 3 days in the presence of toluene;
enzyme was added at time 0 and at 24 h. The digest was chromatographed on a
column of Sephadex G-220, and the peak containing all the radioactivity was re¬
covered and chromatographed on a column of Sepharose 4B (Fig. 10). The component
in the sharp portion of the peak (fractions 26-39) was recovered (0.72 mg). Cellulose
acetate electrophoresis of this peak in calcium acetate buffer gave a single Alcian
Blue-staining spot of mobility intermediate between that of hyaluronic acid and
chondroitin-4-sulfate. The molecular weight of this purified material was estimated to
be 121,000 by sedimentation equilibrium analysis; a two-species plot gave evidence
for the presence of aggregates (trimers). Digestion of a portion of this fraction with
leech hyaluronidase, with chromatography on a CPG column, gave the results shown
in Fig. 11a. In parallel experiments, it was found, as expected, that the enzyme
digested hyaluronic acid, but had no action on chrondroitin-4-sulfate from porcine
rib-cartilage. The action of leech hyaluronidase on proteoglycan is illustrated in
Fig. lib. There is a slight change in the molecular size distribution, suggesting there
may be a few leech hyaluronidase-susceptible bonds in proteoglycan.
Serum fraction S 0.8. — This fraction was also digested with deoxyribonuclease,
ribonuclease, and finally Pronase, as described above. The digested sample was
chromatographed on a column of Sepharose 4B, and the fractions (26-39) correspon¬
ding to the peak in Fig. 10 were combined, dialyzed, and lyophilized to yield 0.59 mg
of material. Similarly, fractions 16-25 and 40-70 were also recovered, yielding 0.12
and 1.80 mg, respectively. Cellulose acetate electrophoresis of these fractions ir,
pyridine acetate and calcium acetate buffers did not show any Alcian Blue-staining
spots when spotted in the usual concentrations. When fifteen times the usual amount
was subjected to electrophoresis, very diffuse areas were stained with Alcian Blue.
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Fig. 10. Chromatography of MI10.8a (—•—) on a column (2 x 60 cm) of Sepharose 4B after treat¬
ment with deoxyribonuclease, ribonuclease, and Pronase. Elution pattern of vitreous humor hyalu¬
ronic acid (—O—) and the peak-elution positions of other standards (see Figs. 1 and 5) are shown.
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Fig. 11. (a) Chromatography of fraction MIIO.8a (—•—) and hyaluronic acid (—O—) on a column
(0.9x61 cm) of controlled-pore glass (CPG) 10-240 beads after digestion with leech hyaluronidase.
Abbreviations are as in Fig. 1. Before treatment, both samples were eluted at the position indicated
by HA. (b) Elution patterns of cartilage proteoglycan, before (—•—) and after (—O—) digestion
with leech hyaluronidase, on the same CPG column.
responding fractions from Mil 0.8a. Fractions 40-70 from serum, however, gave a
streaky spot with the mobility of rib-cartilage chondroitin-4-sulfate.
DISCUSSION
The purity of the labeled polyanionic components isolated from culture media
was established by the criteria that the radioactivity and Alcian Blue-staining
material co-migrated on cellulose acetate electrophoresis in two different buffer
systems. Chemical characterization of the components is based mainly on the
distribution of radioactivity in hexosamines, and on the susceptibility of the labeled
component to enzymes. In addition, the charge properties, as determined by the
elution from the cetylpyridinium chloride precipitate, and by the behavior on
electrophoresis, confirm the identity of the components. The identification of the
major mucopolysaccharide components as a family of chondroitin-4-sulfates of high
molecular weight, and the minor components as heparan sulfate and chondroitin
sulfates, is in agreement with previous results3,8.
The susceptibility of the chondroitin sulfate of high molecular weight to leech
hyaluronidase (Fig. 11) was surprising. This enzyme is an endo-glucuronidase, and is
considered specific for linkages between 2-acetamido-2-deoxy-D-glucose and
D-glucuronic acid27. It is possible that the melanoma chondroitin sulfate may have a
few 2-acetamido-2-deoxy-D-glucose residues in the chain. Cleavage of only a few
bonds in the molecule could cause the change in molecular size observed on CPG
columns, whereas the presence of 2% of 2-amino-2-deoxy-D-glucose (3-4 residues)"
might not be detected by the analytical techniques described. There was insufficient
material to further investigate this possibility.
Physical measurements were carried out on the chondroitin of high molecular
weight, and the chondroitin-4-sulfate having ~50% sulfation, which eluted from the
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CPC precipitate with 0.4 and 0.8m NaCl, respectively. Fig. 6 shows the results of a
representative sedimentation-equilibrium analysis of these samples. The sample
shows considerable polydispersity in molecular weights, as each concentration gave a
different curve. The weight-average molecular weights {Mw) calculated from several
experiments were in the range of 80,000-120,000. The elution pattern of the labeled
component from a column of Sepharose 4B (Figs. 5 and 10), in relation to streptococ¬
cal and vitreous humor hyaluronic acids, is in agreement with the above values28. The
lower values of 80,000-95,000 may be due to the presence of contaminants of low
molecular weight in these samples. For example, the sample MI 0.4a, which still had
a serum component (MI 0.4al) of low molecular weight as a contaminant, had Mw
47,000. The apparent polydispersity of the molecules could be partly due to associative
interactions. A two-species plot indicated the presence of aggregates (monomer-
trimer systems) of these polyanionic molecules, in agreement with earlier observations
on cartilage proteoglycan24. It can be concluded that the molecular size of the
melanoma chondroitin sulfate is in the range of 90,000-120,000, compared to 13,000
for the rib-cartilage product24. As the melanoma product was not susceptible to
further Pronase digestion or to degradation with alkaline borohydride, it is more
likely to be a single polysaccharide chain and not several smaller chains attached to a
common peptide.
O.r.d. of the melanoma component (Fig. 3) was characteristic of mucopoly¬
saccharides with a trough at 210-215 nm. The o.r.d. spectrum of chondroitin-4-
sulfate chains from cartilage showed a trough at 220 nm, and that of vitreous humor
hyaluronic acid at 215 nm. The infrared spectrum of MI 0.4a2 resembled that of
cartilage chondroitin-4-sulfate, except for the absence of absorption in the sulfate
region between 1230-1250 cm" 1. The lack of sulfate absorption is expected, as the
fraction eluting with 0.4m NaCl from the CPC precipitate is low in sulfate. The
35S/3H ratio in MI 0.4 is 0.037, compared to 0.098 for MI 0.8 (Table I). The infrared
spectra of hyaluronic acid and of cartilage proteoglycan were distinguishable from
that of the melanoma component.
It has been reported that fetal-calf serum contains acid mucopolysaccharides
in addition to large quantities of glycoproteins29. The chondroitin sulfate of high
molecular weight identified above was metabolically labeled with 2-amino-2-deoxy-
d-glucose-t and 35SC>4~ as illustrated, for example, by the production of disaccharides
labeled with 3H and 35S on digestion of MI 0.8a with chondroitinase AC (Fig. 8).
This, together with the fact that it was also isolated from the cell pellet8 and nuclei3,
is inconsistent with its being a serum component. The possibility of a serum con¬
taminant co-purifying with the melanoma chondroitin sulfate and leading to mis¬
interpretation of the physical data was tested by carrying out a control experiment
with fetal-calf serum. The fractions eluting with 0.4 and 0.8m NaCl were isolated from
fetal-calf serum by procedures identical to those used for spent media. However, on
fractionation of the 0.8m fraction on Sepharose 4B, the major portion was eluted
in the region of low molecular size and behaved in cellulose acetate electrophoresis
like cartilage chondroitin sulfate. The material (~0.6 mg) eluted in the same region
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as the melanoma chondroitin sulfate may not be a polyanionic component because,
even at fifteen times the usual concentration, it failed to stain with Alcian Blue when
examined by cellulose acetate electrophoresis.
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Isolation and Partial Characterization of Sialoglycopeptides Produced
by a Murine Melanoma1"
Veerasingham P. Bhavanandan,* Junji Umemoto, John R. Banks, and Eugene A. Davidson
abstract: The glycopeptides produced by B16 mouse mel¬
anoma cells grown in the presence of [3H]glucosamine and
[35S]sulfate were isolated from the cells and from spent media.
Treatment of the media and cells with pronase gave a mixture
of isotopically labeled glycopeptides and glycosaminoglycans.
One class of sialoglycopeptides was fractionated from this
mixture by precipitation with cetylpyridinium chloride and
purified by porous glass bead chromatography and ion ex¬
change chromatography. It possessed greater molecular weight
and charge than those glycopeptides which are not precipitated
with cetylpyridinium chloride. This sialoglycopeptide has tetra-
and trisaccharide moieties which contain sialic acid, IV-
acetylgalactosamirie, and galactose attached O-glycosidically,
apparently in clusters, to the peptide core. A notable feature
was that this sialoglycopeptide, which is devoid of iV-acetyl-
glucosamine, was adsorbed on a wheat germ agglutinin-
Sepharose column and also had a strong inhibitory activity on
the wheat germ agglutinability of the B16 melanoma cells. The
interaction between this sialoglycopeptide and wheat germ
agglutinin was found to be due to the presence of several sialyl
oligosaccharides attached to the same peptide backbone in the
molecule. This mucin-type sialoglycopeptide, which has fea¬
tures common with human erythrocyte membrane glycopro¬
tein, appears to be produced by several malignant cell lines,
including the one investigated in the present studies.
(Circumstantial evidence has implicated surface carbohy¬
drates in cellular functions such as cell-cell recognition, ad¬
hesion, maintenance of membrane integrity, regulation of cell
growth, and receptor sites. Recently, there have been a number
of reports that a "cell-surface" glycoprotein of 200 000-
250 000 daltons is present on several normal cells but is absent
or diminished in the corresponding transformed cells (Hynes,
1973; Gahmberg et ah, 1974; Yamada and Weston, 1974;
Graham et ah, 1975). Such changes of cell-surface carbohy¬
drate have been attributed to increased proteolytic activity
manifested at the surfaces of transformed cells (Schnebli and
Burger, 1972; Ossowski et ah, 1973), but definitive proof for
tnis hypothesis is lacking. However, if this were the case, one
would expect to detect glycopeptides arising from the high-
molecular-weight and other cell-surface glycoproteins in the
spent media in which transformed cells are grown. In the an¬
imal, a large amount of these glycopeptides may be shed by the
neoplastic cells into the circulation. Such shedding may be a
possible mechanism by which these cells escape the immuno-
surveillance of the host or it may be a factor in the poor ad¬
herence of these cells and their consequent metastasizing po¬
tential (Sjogren et al., 1971; Kim et al., 1975).
Antigens associated with B16 melanoma which appear to
be secreted or shed by the cells have been isolated from spent
media in which cells were grown in the presence of [3H]leucine
(Bystryii et al., 1974; Bystryn, 1976). Biochemical charac¬
terization of these antigens has not been done, but they appear
to be glycoproteins.
In earlier reports we have discussed the nature of glycosa¬
minoglycans produced by several cell lines (Satoh et al., 1973,
1974; Banks et al., 1976; Bhavanandan and Davidson, 1975,
1977). This study describes the isolation and structural char-
' From the Department of Biological Chemistry, The Milton S. Hershey
Medical Center, The Pennsylvania State University, Hershey, Pennsyl¬
vania 17033. Received April II, 1977. This investigation was supported
by research grants (CA 15483 (E.A.D.) and 17686 (V.P.B.)) from the
National Cancer Institute and the National Institutes of Health, United
States Public Health Service.
acterization of one class of sialoglycopeptides produced by
mouse melanoma cells. A preliminary report has been pub¬
lished (Bhavanandan and Davidson. 1976).
Experimental Procedure
Materials. The B16 melanotic melanoma cell lines studied
were the second and third clones (B16C2 and B16C3) se¬
quentially isolated by Kreider et al. (1973). An amelanotic
clone isolated from stock B16 tumor maintained by the Jackson
laboratory, Bar Harbor, Maine, was also used. Both the
melanotic and amelanotic cell lines produce similar glyco-
conjugates (Satoh et al., 1974). Components for culture media,
with the exception of antibiotic solution and fetal calf serum,
were obtained from Grand Island Biological Co., Grand Island,
N.Y. Pronase and neuraminidases (Vibrio cholerae and in¬
fluenza virus) were obtained from Calbiochem; controlled pore
glass beads (CPG1 10-240) were from Electronucleonics,
Fairfield, N.J.; Sephadex G-50 was from Pharmacia; Sepha-
rose 4B, DEAE'-Sephadex, 8-galactosidase (E. coli), oval¬
bumin, and fetuin were from Sigma; cyanogen bromide was
purchased from Eastman Kodak; DEAE-cellulose (DE-52)
was from Reeve Angel; mixed giycosidases, a-A'-acctylga-
lactosaminidase, and (3-hexosaminidase (all from Charonia
lampis) were purchased from Miles Laboratories; Tos-
PheCHyCl-trypsin was obtained from Worthington Bio¬
chemical Corp. enrfo-a-A'-Acetylgalactosaminidase and u-
hexosaminidase from Diplococcus pneumoniae were isolated
as described (Bhavanandan et al., 1976; Umemoto et al.,
1977). Jack bean /3-galactosidase was a gift from Dr. Y. T.
Li.
1 Abbreviations used are: Con A, concanavalin A; RCA1, Ricinus
communis agglutinin (mol wt 130 000): RCA1I. Ricinus communis
agglutinin (mol wt 60 000); CPC. cetylpyridinium chloride; Tos-
PheCH.Cl-trypsm. L-(l-tosylamido-2-phenyl)ethyl chloromethy! ketone
treated trypsin; NANA, A'-acetylneuraminic acid; Tris-HCl. 2-amino-
2-hydroxymethyl-l,3-propanedioi hydrochloride; DEAE, diethylami-
noethyl; CPG, controlled pore glass beads: WGA, wheat germ agglutin¬
in.
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Wheat germ agglutinin (WGA) was isolated from crude
wheat germ according to Nagata et al. (1974), except that after
the second ammonium sulfate fractionation an affinity column
of ovaibumin-Scpharose was used for purification (Marchesi,
1972). The preparation gave a single band on polyacrylamide
gel electrophoresis and had an apparent molecular weight of
29 000. Concanavalin A (Con A) was prepared from Jack bean
meal (Sigma) as described by Agrawal and Goldstein (1972).
The agglutinins RCAI (120 000 mol wt) and RCA11 (60 000
mol wt) from Ricinus communis were isolated as described by
Nicolson and Blaustein (1972), except that the seeds were first
crushed, defatted with cold acetone (-20 °C) and air-dried
before extraction with phosphate buffer. Soybean agglutinin
was isolated from defatted soybean meal according to the
procedure of Allen and Neuberger (1975); it should be noted
that several commercial batches of soybeans and soybean meal
that were tested did not have any activity. Conjugation of the
lectins to Sepharose 4B was done essentially as described by
Allan et al. (1972); the remaining active groups were blocked
by treatment with 0.1 M ethanolamine hydrochloride in 1 M
NaCl-0.1 M NaHC03, pH 8.0, by stirring for 8 h at 4 °C. The
product was packed in a column and washed successively with
0.1 MNaHCO3;0.1 MNaHC03-l M NaCl, pH 8.0:0.1 M
sodium acetate-1 M NaCl, pH 4.0; distilled water: 0.1% bovine
serum albumin in 0.05 M Tris-HCI, pH 8.0; and finally with
0.05 M Tris-HCI with 10 mM Ca2+, 1 mM Mg:+, 1 mM
Mn2+. pH 7.0, for the Con A column and 0.05 M Tris-HCI,
pH 8.0, for all other lectin columns.
Column Chromatography. Controlled pore glass 10-240
beads of 80/120 mesh were treated with polyfethylene glycol)
and packed with constant vibration according to the instruction
of the manufacturers. The columns were equilibrated with 0.5
M CaCL or 0.5 M KC1 and eluted with the same solution using
a pump to maintain a constant flow rate of 30 ml/h. Sephadex
G-50, Bio-Gel P2 (200-400 mesh), and P4 and P6 columns
were equilibrated and eluted with 0.1 M pyridine acetate, pH
5.0. DEAE-cellulose (DE-52 microgranular) was degassed by
suspending in 1.0 N acetic acid (pH 3.0). neutralized with
pyridine to pH 5.2, and filtered through a sintered glass funnel.
The ion exchanger was then equilibrated by washing exten¬
sively with 1.0 M pyridine acetate and packed in a column (0.9
X 70 cm). The sample was applied in 0.01 M pyridine acetate
and the column eluted with a linear gradient of 0.01 M pyridine
acetate, pH 5.1, in the mixing chamber and an equal volume
of 1.0 M pyridine acetate, pH 5.1. in the reservoir. Cellulose
acetate electrophoresis was carried out in a Beckman R-101
microzonc electrophoresis cell using 0.2 M calcium acetate,
pH 7.0. at 5 mA, for 3 h or in 0.1 M pyridine-formic acid
buffer. pH 3.0. at 10 mA for 20 min. Alcian blue (0.1% in 0.5%
acetic acid), periodate-Schiff reagent, and Ponceau-S were
used for staining.
Paper chromatography was carried out on Whatman no. 1
paper by the descending technique. The following solvent
systems were employed: (A) 1-butyl acetate-acetic acid-water
(3:2:1). (B) 1-butanol-pyridine-water (6:4:3), (C) pyridine-
ethyl acetate-water-acetic acid (5:5:3:1) with pyridine-ethvl
acetate-water (11:40:6) in the bottom of the chromatography
tank, (D) 1-butanol-aceticacid-water (4:1:5, upper phase).
Sialic acids were detected by the thiobarbituric acid spray
(Warren, 1960). Neutral sugars, hexosamines, and oligosac¬
charides were located by the silver nitrate staining procedure
(Trevelvan et al., 1950) and sugar alcohols by the periodate-
benzidene technique (Gordon et al., 1956).
Hexosamine determinations on isotopicallv labeled com¬
ponents were carried out on acid hvdrolysatcs on the amino
acid analyzer by the stream-splitting technique described
earlier (Bhavanandan and Davidson, 1976). Total sialic acid
in isotopically labeled glycoproteins was determined either by
acid hydrolysis (0.1 M H5SO4, 80 °C, 1 h) or neuraminidase
treatment followed by separation of sialic acid from asialo-
glycoprotein on a Bio-Gel P2 column. Total sialic acid was
determined by the periodate-resorcinol method (Jourdian et
al., 1971). Marker polysaccharides run on gel columns were
assayed by the orcinol reaction (Davidson, 1966). Liquid
scintillation counting was performed on an Intertechnique
Model SL36 spectrometer. Usually, 1-mL aqueous samples
were mixed with 10 mL of the counting liquid containing xy¬
lene and Triton X-l 14 (Anderson and McCiure, 1973). Ef¬
ficiencies for 3H and 35S were about 16 and 47%, respectively,
with a crossover of about 13-14% 33S into the 3H channel. The
4-mL citrate buffer fractions from the amino acid analyzer
were mixed with 15 mL of 3a40 counting fluid (from Research
Products International Corp.) and counted. The efficiency for
tritium in this system was 15%, using the same settings for
minimal 33S crossover as above. Radioactivity on cellulose
acetate or paper strips was estimated by extracting cut pieces
with 1 mL of water in counting vials. After shaking for at least
6 h on a reciprocating shaker, counting liquid was added and
the solution mixed and counted.
Digestion with Glycosidases. Vibrio cholerae neuraminidase
digestion was done in 0.1 M sodium acetate buffer, pH 5.6,
containing 0.001 M CaCU using 0.1-1.0 unit of enzyme in a
total digest volume of 200 pL; incubation was performed at 37
°C for the specified time. Influenza virus neuraminidase di¬
gestion was carried out in 0.05 M Tris-maleate buffer, pH 6.5,
containing 0.001 M CaCL using 0.1-0.2 unit of the enzyme
in a volume of 200 pL incubated as above. The released product
was determined by the modified thiobarbituric acid method
(Yeh et al., 1971) in experiments using unlabeled oligosac¬
charide substrates. In experiments with labeled sialogly-
copeptide, the released sugar was estimated either by separa¬
tion on Bio-Gel P2 columns or by loss of radioactivity on di¬
alysis.
Incubation with /3-galactosidase from Escherichia coli or
Jack Bean was done in citrate-phosphate buffer, pH 6.5, using
5 units of enzyme or citrate buffer, pH 4.0, using 0.2 unit en¬
zyme, respectively, 37 °C for 48 h in a total volume of 150 pL.
The E. coli enzyme had no action on p-nitrophenyl cr-D-
galactopyranoside, p-nitrophenyl-A'-acetyl-/J-D-galactosam-
inide, or p-nilrophenyl-A'-acetyl-/?-D-glucosaminide. Digestion
with fJ-zV-acetylhexosaminidase from Charonia lampus was
done as for E. coli 0-galactosidase but using 0.1 unit of enzyme:
incubation with the ^-hexosaminidase from D. pneumoniae
was performed for 6 h at pH 5.3 with 100 milliunits of enzyme.
The enzyme from Charonia lampus had ten times more ac¬
tivity toward p-nitrophenyl-A'-acetyl-/3-D-glucosaminide as
compared to p-nitrophcnyl-.V-acetyl-0-D-galactosaminidc.
Digestion with a-A-acetylgalactosaminidase from Charonia
lampus was done in 0.05 M citrate buffer, pH 4.0. using 5-10
milliunits of enzyme in a total volume of 100 uL at 37 °C for
24 h. Treatment with e«r/o-«-A'-acetylga!actosaminidase from
D. pneumoniae (Bhavanandan et al., 1976) was done in Tris-
malcate buffer, pH 7.0, or citrate phosphate buffer, pH 6.5,
al 37 °C for 6-24 h in a total volume of 50 pL.
Alkaline Borohydride Treatment ofGlycopeptides. Alka¬
line borohydride treatment of the glycopqptides was done with
1.0 M NaBH4 or 0.3 M NaBH4 in 0.1 N NaOH for 3-4 days
at 37 °C under nitrogen in sealed tubes in the dark. The re¬
action mixture was cooled in an ice bath and the excess bor¬
ohydride destroyed by careful addition of 1 N acetic acid.
Isolation of tetra- and trisaccharides from fetuin by treatment
with alkaline borohydride was as described by Spiro and
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SCHEME I: Isolation of Glycopeptides Produced by Murine Melanoma Cells
Dialyzed spent media; pellet from cells after treatment with DNase
(1) Pronasc digestion
(2) Dialysis













(1) Wash with 0.15% CPC
in 0.03 M NaCl
(three times)
(2) Fractional extraction
with 0.2 to 2.0 M NaCl
MOM
Gel filtration on CPG column
(Figure 1)
Fractions MO.2a, MO.4a





Cell Cultures. B16 mouse melanoma cell lines (B16C2 and
B16C3) and an amelanotic clone were routinely grown in 16-oz
prescription bottles in minimum essential medium with Earle's
salt solution supplemented with nonessential amino acids (0.1
mM), sodium pyruvate (1 mM), twice the recommended
concentration of vitamins (Eagle, 1959), 10% heat-inactivated
fetal calf serum, and 10 units per mL of penicillin G and 10 ug
per mL of streptomycin sulfate. The particular clone has been
screened for mycoplasma contamination and its tumorigenicity
established by ability to develop tumors in appropriate host
mice. Cells were subcultured at confluency by suspension with
0.02% EGTA ([ethylenebis(oxyethylenenitrilo)]tetraacetic
acid) in calcium magnesium free phosphate buffered saline.
The spent media at each medium change and at subculturing
were decanted, centrifuged to remove floating cells, and stored
in the freezer until used. Labeled complex saccharides were
prepared from cells and spent medium after culturing the cells
for 48 h prior to harvest in medium containing 10 iiCi of
[3H]glucosamine per ml. (New England Nuclear, 755 mCi/
mmol). For the identification of the neutral sugars, ceils were
grown in the presence of [3H]glucose (New England Nuclear.
34 mCi/mmol) at 40 /iCi per mL in Fl2 media (Ham, 1965)
containing 1% bovine serum albumin (Banks et al., 1977).
Isolation of Labeled Glycopeptidesfrom Spent Media and
Cells (refer to Scheme I). Pooled frozen spent medium, about
5 L, was thawed and dialyzed at 4 °C against 0.9% NaCl for
2 days, followed by water for 5 days in the presence of toluene
and chloroform. The dialyzed material was concentrated by
ultrafiltration and lyophilization to about 600 mL and com¬
bined with 100 mLof dialyzed labeled media. Calcium acetate
was added to a concentration of 0.01 M Ca2+ and the pH ad¬
justed to 7.8 with 10 N NaOH. Pronase (100 mg) was stirred
in, 2 mL of toluene added, and the solution incubated in a
stoppered flask at 40 °C for 72 h with further additions of 100
mg of enzyme and toluene after 24 and 48 h. The pH was
maintained at 7.8-8.0 during the incubation by addition of
NaOH. The digest was centrifuged, the residue discarded, and
the supernatant dialyzed against saline followed by deionized
water for 4 days. The contents of the dialysis bag were adjusted
to pH 12.5 and after 18 h at room temperature (20-25 °C)
were dialyzed for 5 days against several changes of deionized
water. A second batch of spent media (3 L) as well as the media
from the [3H]glucose experiment were worked up in an iden¬
tical manner except that the treatment at pH 12.5 was omit¬
ted.
For isolation of cell-associated complex saccharides, the cells
were first treated with DNase, and the insoluble pellet obtained
digested with pronase to yield a mixture of soluble complex
saccharides. The pronase digests were dialyzed and subjected
to CPC precipitation.
The pronase- and alkali-treated material was adjusted to
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TABLE 1: Results of CPC Precipitation and Salt Elution of
Pronase-Digcstcd Spent Media.
Expt 1 Expt II
dpm X 3H dpm X 3H
Fraction 10"6 % Wt (mg) 10"6 % Wt (mg)
CPC 46.85 89.7 32.80 89.0
supernatant
0.2 M NaC! 2.28 4.4 7.4 0.64" 1.7 1.9°
0.4 M NaCl 0.40a 0.8 7.8° 2.40 6.5 7.1
0.8-2.0 M 2.68 5.1 16.3 1.01 2.7 8.3
NaCl
a Some of these fractions were lost accidentally during dialysis.
0.03 M in NaCl and 0.15% in CPC. After 16-48 h at room
temperature, the precipitate was collected by centrifugation
(15 OOOg, 30 min) and washed three times with 0.15% CPC
in 0.03 M NaCl by resuspension and centrifugation. In some
experiments, further CPC was added to the supernatant and
washes to a final concentration of 1%, and the small amount
of precipitate formed was collected and washed as above. The
precipitates were combined and fractionally extracted with 0.2,
0.4,0.8, 1.2, and 2.0 M NaCl utilizing 1 X 20 mL and 3X10
mL for each extraction. The CPC in the extracts was removed
by dialysis at 40-45 °C against 2 M NaCl followed by distilled
water at 4 °C: the solutions were filtered and lvophilized
(Table 1).
The CPC in the combined supernatant and washings was
precipitated by addition of KCNS. The precipitate was re¬
moved by centrifugation and washed with water, and the fil¬
trate and washings were extensively dialyzed against distilled
water. Lyophilization of the dialyzed solution gave a mixture
of glycopeptides (class II). In the case of fractions from media,
the mixture also consisted of a large proportion of glycopep¬
tides arising from fetal calf serum.
Treatment ofCells with Tos-PheCH2CI-Trvpsin. For the
isolation of cell-surface complex saccharides, cells were cul¬
tured for 48 h prior to harvest in medium containing one third
the usual amount of glucose and 0.5 nCi per ml. of D-[l-
,4C]glucosamine hydrochloride (New England Nuclear, 51.5
mCi/mmol). The cells were harvested and washed with bal¬
anced salt solution three times by resuspension and centrifu¬
gation and subjected to short-term successive incubations with
Tos-PheCHiCl-trypsin (Codington et al., 1972). In prelimi¬
nary experiments with unlabeled cells, it was noticed that
considerable cell death and clumping occurred after the third
incubation. In subsequent experiments, DNase (Sigma, elec-
trophoretically purified) was included at 10 jig per mL of in¬
cubation mixture in order to prevent the clumping. Control
incubations were done simultaneously with DNase and bal¬
anced salt solution. After each incubation period, the mixture
was centrifuged (200g, 10 min) and the supernatant collected
and cells resuspended in fresh solution and incubation repeated.
All incubations were carried out in the cold room (4 °C) on a
rotary table (100 rpm) for 20 min.
Agglutination of Cells by Plant Lectins. Cells were har¬
vested by pouring off the media, washing the cell layer with
calcium magnesium free phosphate buffered saline three times,
and treating with 0.01 M ethylenediaminetetraacetic acid in
the same buffer at 37 °C for 5-15 min. The cells were pelleted
and washed with balanced salt solution three times by resus¬
pension and centrifugation and finally suspended at 2 X 106
cells per mL in phosphate-buffered saline, pH 7.2. Lectin so¬
lutions also in phosphate-buffered saline were serially diluted




FIGURE 1: Fractionation of 0.2 (broken line) and 0.4 M (solid line) NaCl
fractionson a 1.5 X 115 cm column ofCPG 10-240 glass beads using 0.5
M CaClj as the eluling solvent. Four-milliliter fractions were collected
and 50-mL aliquots analyzed for radioactivity. The peak elution positions
of marker saccharides (HA, vitreous humor hyaluronic acid; C4S, porcine
rib cartilage chondroitin 4-sulfatc; GlcUA, glucuronic acid) are indicated
by arrows. Fractions 26-31 (M0.2a), 32-42 (M0.2b), 26-33 (MO.4a),
and 34-44 (M0.4b) were combined, dialyzed against water, and lyophi-
lizcd.
mL/well) in a plastic agglutination plate was incubated with
0.1 mL of the above cell suspension for 20 min at room tem¬
perature (20-25 °C) on a rotary table at 70 rpm. Controls
without lectins and with lectins plus inhibitor saccharides
(A'-acetyl-D-glucosamine for WGA, methyl a-D-mannoside
for Con A and lactose for RCA1) were included in order to
check the specificity of the agglutinins. The agglutination was
scored as; +++, heavily clumped; ++, moderately clumped;
+, slightly clumped; —, not clumped.
Results
Table I presents the results of NaCl fractionation of the
CPC precipitate. Fractions M0.8 to M2.0 contain glycosa-
minoglycans which have been characterized (Satoh et al., 1974;
Bhavanandan and Davidson, 1977).
Sialoglycopeptides in M0.2 and M0.4—Class I Sialogly-
copeptides. Chromatography of M0.2 and M0.4 on a CPG
column produced the pattern illustrated in Figure 1. M0.2a,
M0.4a, M0.2b, and M0.4b were isolated by pooling the indi¬
cated fractions, dialyzing to remove the salts in the eluent and
lyophilizing. M0.2a and M0.4a were identical to the major
component of M0.8 which was identified as a high-molecu¬
lar-weight chondroitin (Bhavanandan and Davidson, 1977).
M0.2b and M0.4b consisted of similar glycopeptides, referred
to in the rest of the text as class I giycopeptides. Chromatog¬
raphy of class I glycopeptides (M0.2b) on CPG andSephadex
G-50 columns (Bhavanandan and Davidson, 1976) indicated
that this fraction is relatively homogeneous on the basis of size.
However, cellulose acetate electrophoresis in two different
buffer systems showed two Alcian blue positive components,
only one of which was labeled. This indicated that the labeled
glycopeptide was contaminated by an acidic nonlabeled
component apparently derived from serum. Further purifi¬
cation of the labeled component was achieved by chromatog¬
raphy on a DEAE-cellulose column using a linear gradient of
0.01 to 1.0 M pyridine acetate (Figure 2). The single peak
obtained was isolated by preparative chromatography. Cel¬
lulose acetate electrophoresis in two buffer systems of the
purified material is illustrated in Figure 3. The labeled gly-
copeptidc was coincident with the major Alcian blue staining
spot in both buffer systems; a trace of the unlabeled contami-
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FIGURE 2: Chromatography of class I and II sialoglycopeptides on a
DEAE-cellulosc column (0.9 X 70 cm). Elution was with a linear gradient
of 0.01 to 1.0 M pyridine acetate buffer, pH 5.1. Rate of flow was 30
mL/h. Fractions of 2.5 mL were collected and aliquots analyzed for ra¬
dioactivity. Classes I (O) and II (•) were analyzed on separate runs and
the results are presented by superimposing the elution patterns.
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FIGURE 4: Paper chromatography of -'H-labelcd neutral sugars isolated
from class I sialoglycopeptides in solvent system B. Standard saccharides
















FIGURE 3: Cellulose acetate electrophoresis of class I sialoglycopeptide.
Upper, in 0.2 M calcium acetate, 5 mA. 3 h; lower, in 0.1 N pyridine for¬
mate. pH 3.0: 10 mA. 20 min. Strips were stained with Alcian blue.
Marker saccharides used were HA and C4S (see Figure 1), Hep-S04,
heparan sulfate, and mouse melanoma chondroitin.
nant was still evident in one buffer system, 0.2 M calcium ac¬
etate.
Sialic Acid and Hexosaniine Analysis. The distribution of
3H counts in sialic acid (38?^) and hexosamine (62%) in class
I glycopeptides and identification of these sugars as N-
acetylneuraminic acid and A'-acetylgalactosamine has been
published (Bhavanandan and Davidson. 1976).
Neutral Sugars in Class I Glycopeptides. Class 1 glyco¬
peptides isolated from cells and spent media obtained by
growing the cells in the presence of [3H]glucose were used in
this experiment. The fractions obtained by 0.2 M NaCl ex¬
traction of the CPC precipitate were extracted with
CHCI3-CH3OH (2:1) and the component insoluble in the
organic solvent was purified by chromatography on CPG and
a WGA-Sepharosc 4B column to yield class I glycopep¬
tides.
To determine the neutral sugar content, the glycopeptides
were hydrolyzed (1 N HC1. 100 °C. 6 h) and after drying in
a vacuum desiccator over NaOM and P2O5 the residues were
dissolved in water and passed through AG50 (H+) and AG I
(formate) columns. The water eluates of the columns were
lyophilized and examined by paper chromatography (Figure
4). The AG50 column was eluted with 1 N HC1, and the cluatc
was dried and hydroly/cd with 6 N FIC1 and examined on the
amino acid analyzer by the stream-splitting technique
3000
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FIGURE 5: Gel filtration of class 1 sialoglycopeptide on a Bio-Gel P2
column »0.9 X 70 cm) after treatment wi.h Vibrio cholerae neuraminidase
(O) or treatment with neuraminidase followed by pronasc (•). The low-
molecule-weight material with peak position at fraction 31 had an elution
profile identical to that of NANA.
employing 14C-labeled glucosamine and galactosamine as
internal standards. In addition to [3H]galactosamine, the
following 3H-labeled amino acids were detected: glycine, al¬
anine (the label corresponding to these two amino acids was
not completely resolved), serine, aspartic acid, glutamic acid,
proline, valine, and leucine, in this order of abundance.
Neuraminidase Susceptibility of Sialic Acid in Class I
Glycopepticies. Vibrio cholerae neuraminidase released 50.9%
sialic acid in 30 min, 84.5% in 3 h. and 97.4% after 24 h,
whereas with influenza virus neuraminidase about 48.6% had
been released in 1 h and 59.1% after 2 h with no further release
up to 24 h. The labeled sialic acid released by acid hydrolysis
was taken as 100%. The radioactive component released by
Vibrio cholerae enzyme was identified as /V-acctylneuraminic
acid by paper chromatography and cochromatography on a
Bio-Gel P2 column.
Retreatmcnt of the asialo class 1 glycopeptides with pronase
did not cause appreciable degradation of the molecule as il¬
lustrated in Figure 5.
Treatment ofSialo and Asialo Class I Glycopeptides with
Various Glvcosidases. The glycopeptides and the asialo gly-
copeptide prepared by treatment with Vibrio cholerae neu-
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TABLE H: Action of Glycosidases on Sialo and Asialo Class I Glycopeptidcs.
% Tritium-labeled components released
Treatment Sialoglycopeptide Asialoglycopeptide Remarks
/3-Hexosaminidase (Ch. lampus; D. Not determined 0 (Ch. lampus). D. pneumoniae hexosaminidase product elutcd
pneumoniae) 3.6 (D. pneumoniae) on a Bio-Gel P2 column at the same position
as Gal 1 —»(3H]Gal/YAc
a-ZV-Acetylgalactosaminidase (Ch. 0 0
lampus)
/3-Galactosidase (Jack bean) followed Not determined 0
by /3-hexosaminidase (D. pneumoniae)
/3-Galactosidase (Jack bean) followed 2 (Jack bean 27 (Jack bean Product from asialoglycopeptide was identified
by o-A'-acetylgalactosaminidase (Or. /?-galactosidase) /3-galactosidase) as Ar-acetyl[3H]galactosamine
lampus)
Mixture of glycosidases (Ch. lampus) Not determined 48 Product identified as A-acetyl[3Hj-
galactosamine
emfo-a-A'-Acetylgalactosaminidase (D. 0 80 Product from asialoglycopeptide was identified
pneumoniae) as Gal 1—[3H]GalNAc
raminidase or mild acid (0.1 N H2SO4) followed by fraction¬
ation on a Bio-Gel P2 column were digested with various gly¬
cosidases singly or in combinations. The incubation mixtures
were analyzed for release of 3H-labeled components by gel
filtration on a Bio-Gel P2 column. The results are summarized
in Table II. When a labeled component was released, it was
characterized by chromatographic techniques.
The labeled product from digestion with endo-a-N-
acetylgalactosaminidase was isolated by chromatography on
a Bio-Gel P2 column and identified as Gal 1()3)—[3H]Gal7VAc
by paper chromatography (Figure 6). The disaccharide mi¬
grates with a mobility close to that of GalNH2, whereas after
treatment with Jack bean /3-galactosidase the labeled product
has a mobility identical to that of GalA'Ac. The identity of this
disaccharide was further confirmed by reduction with NaB3H4
followed by acid hydrolysis and detection of [3H]galacto-
saminitol on the amino acid analyzer using the citrate-borate
buffer system (Bella and Kim, 1970). However, only 38% of
the label in the hydrolysate eluted with gaiactosaminitol. A
large portion of the balance eluted at the beginning of the
chromatogram before aspartic acid; this arises from an acid-
resistant contaminant in NaB3H4 (McLean ct al., 1973). Some
labeled material cluted after galactosamine and is apparently
due to reduced chromogen derived from terminal A'-acetyl-
galactosamine (Bray et al., 19t>7) (cf. results in Figure 10).
Action of Alkaline Borohydride on Class I Glycopeptides.
Theelution profile of the glycopeptide on a CPG column before
and after treatment with alkaline borohydride showed clear
evidence of complete alkali elimination. The gel-filtration
profiles on Bio-Gel P4 and P6 columns of the products of al¬
kaline borohydride treatment of class 1 glycopeptides together
with markers including tetra- and trisaccharides obtained by
similar treatment of fetuin are illustrated in Figure 7. The la¬
beled material eluting in peaks 1 (25-31) and II (32-37) on
the Bio-Gel P4 column was recovered by lyophilization and
treated three times with methanol to remove borate. Paper
chromatography in solvent systems A (Figure 8) and C showed
that the major labeied components in peaks I and II had
mobilities similar to the tetra- and trisaccharides obtained by
treatment of fetuin with alkaline borohydride. In both solvents
other minor unidentified spots were detected. The major peak
I (47-52) from the Bio-Gel P6 column gave a single sharp spot
coincident with fetuin tetrasaccharide when examined by paper
chromatography using solvent system C.
Hydrolysis of the ^-elimination products of class 1 glyco¬
peptides followed by stream-split analysis on the amino acid
analyzer employing the citratc-borate system gave only
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FIGURE 6; Paper chromatography of the low-molecular-weight material
obtained by digesting asialo class 1 glycopeptide with endo'Cr-iV-acetyl-
jlalactosaminidase before (shaded) and after (unshaded) treatment with
Jack bean d-galactosidase. The chromatogram was developed in solvent
system A and the standard sugars were detected with silver nitrate re¬
agent.
[-'Hjgalactosaminitol with no detectable [3H]galactosam-
ine.
The distribution of label in the tetra- and trisaccharides from
class I glycopeptide (peaks 1 and II, respectively, from the
Bio-Gel P4 column) is 73 and 27%. If it is assumed that the
specific activity of the three (two from tetra and one from tri)
residues of sialic acid are the same and also the specific ac¬
tivities of two residues of GalNAc are the same, then the ratio
of tetra- to trisaccharide is 3.24, since 38% of the label in the
class I glycopeptides is in sialic acid.
The class 1 glycopeptide isolated from cells grown in the
presence of [3H]glucose was treated with alkaline borohydride,
neutralized with acetic acid, and passed through an AG50
(H+) column. The column was washed with water and the
/3-eliminated oligosaccharides were recovered by lyophilization
and subjected to periodate oxidation (Spiro and Bhoyroo.
1974). Periodate-oxidized sodium borohydride reduced
products were neutralized with HCI and passed through cou¬
pled AG50 (H+) and AG1 (formate) columns. The sialylated
oligosaccharides were eluted from the AG1 column, concen¬
trated to dryness, and hydrolyzed with 4 N HCI. 100 °C for
4 h. The hydrolysis products, together with the products from
a control sample treated similarly but with destroyed pcriodate.
were examined on paper chromatograms (Figure 9).
In order to determine the amino acids involved in the O-
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FIGURE 8: Paper chromatography of /3-eliminateci oligosaccharides from
class I glycopeptides isolated by Bio-Gel P4 fractionation; peak 25-31,
solid line; and peak 32-37, broken line. Chromatography was in solvent
system-A. The dotted area shows the mobility of neuramin[3H]Iactitol.





figure 7: Gel filtration of class i siaioglycopeptidcs before (•) and after
(O) treatment with alkaline borohydride on a (a. top) Bio-Gel P4 column
(0.9 x 70 cm) and a (b, bottom) Bio-Gel P6 column (0.9 x 104 cm). The
treated samples were mixed with tctrasaccharides and trisaccharides
isolated from alkaline borohydride treatment of fetuin prior to chroma¬
tography. The elution pattern (A) of these oligosaccharides was detected
by analyzing aliquots of the fractions for sialic acid (Jourdiari et al., 1971).
The peak elution of blue dextran (Vo) and other standards on the same
columns arc indicated by arrows.
glycosidic linkage to ^'-acetylgalactosamine, the class I gly-
copeptide was treated with NaB3H4. The NaB3H4 (New En¬
gland Nuclear specific activity 276 mCi/mmo!) was dissolved
in lOO^LofO.! N NaOH to give a solution of 0.9 M NaB3H4
concentration. The sample was dissolved in 20 nL of the above
N'aB3H4 and incubated for 48 h at 37 °C in the dark under an
N!2 atmosphere. A solution of 1 M NaBH4-0.1 N NaOH (100
mL) was added and the incubation continued for a further 24
h under the same conditions. Acetone was added to destroy
NaB3H4 and the 2-[3H]propanol distilled off. The residue was
repeatedly dissolved in water and lyophilized to remove ex-
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FIGURE 9: Paper chromatography of acid hydrolysates of sialyl oligo¬
saccharides from class I gKcopeptidcs before (broken line) and after (solid
line) periodatc oxidation. Chromatography was in solvent system D. The
standards (GalNHs and Gal) and the products obtained by similar
treatment of fetuin trisaccharidc (unmarked spots) were visualized by the
periodatc -benzidine reagent.
changeable tritium. An aliquot was hydrolyzed (6 N HC1, in
vacuo sealed tube at 110 °C for 20 h) and the hydrolysate. after
drying, analyzed by the stream-splitting technique on the
amino acid analyzer using labeled and unlabeled standards.
A control using 20 of the same solution NaB3H4 was
treated identically. The results are illustrated in Figure 10. The
tritium activities derived from the treated sample correspond
to alanine (fractions 56-58), a-amino butyric acid (fractions
64-67), galactosaminitol (114-120) which elutes in the same-
position as galactosamine in the buffer system used, and an
unknown (fractions 126-133) which is apparently the reduced
Kuhn's chromogen (Bray et al.. 1967). Tritium activity eluting
in the position of glycine was detected both in the sample and
in the NaB3H4 control. The control also had large quantities
of label eluting before aspartic acid. In another experiment.
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FIGURE 10: Analysis on the amino acid analyzer using a stream-splitting technique of the 6 N HC1 hydrolysate of alkaline borotritide (B}H.t) treated
class I glycopeptides. The elution of tritium activity from the sample is shown by the black area and from the NaB3H4 control by the shaded area. The
radioactivities of internal standards [l4C]threonine, [14C]!eucine, and [|,4C)glucosamine are shown by the unshaded areas.
the product from NaB3H4 treatment was applied on the AG50
(H+) column and, after washing with deionized water, the
peptides were eluted with 1 N NHaOH.The NH3 in theeluate
was removed by a stream of Ny and the solution lyophilized
to yield the 3H-labeled peptides. Hydrolysis followed by amino
acid analysis gave results similar to those above.
Affinity Chromatography of Class I Glycopeptides on
Lectin-Sepharose Columns. The class I sialoglycopeptide and
theasialoglycopeptide prepared by neuraminidase treatment
were not retained on Con A-Sepharose. The activity of the Con
A column was demonstrated by the binding of ovalbumin
glycopeptides to the lectin ar.d their eiution with 0.1 M methyl
a-mannoside solution.
The sialogiycopeptide, however, bound to a WGA-Sepha-
rose column and was eluted with 0.1 M A'-acetylglucosamine
in buffer. Asialoglycopeptides prepared either by mild acid
hydrolysis as well as partially (46%) or totally (100%) dcsia-
lylated glycopeptide obtained by Vibrio choleras neuramin¬
idase treatment were not adsorbed on this lectin column,
whereas a preparation dcsialylated to 16% was retained on the
WGA column. In order to determine whether the retention of
thesialoglycopqitide on the WGA-Scpbarose column was due
to an anion-exchange effect, the following experiment was
done. The sialoglycopeptide was applied to the lectin column
and after washmg with buffer the column was eluted with 0.05
M NaCl in buffer prior to elution with 0.1 M /V-acetylgluco-
samine. The results, illustrated in Figure 11, show that only
a trace of the ghcopeptidc eluted with 0.05 M NaCl. whereas
the major portion was displaced only with the sugar. A sample
of 3H-iabe!ed hyaluronic acid applied on the WGA-Sepharose
column was not retained. The oligosaccharides prepared by
/3 elimination from the glycopeptide were not retained on the
column, illustrating that the carbohydrates must be attached
to the peptide core for interaction with WGA.
The asialoghcopcptide bound to RCAII-Sepharose col¬
umns and was specifically eluted with 0.1 M lactose; it also
bound partially to the RCA i-Sepharose column, about 13-33%
in different experiments. The sialoglycopeptide did not bind
to either RCA.'- or RCAII-Sepharose columns.
Molecular Weight Determination of Class I Sialogly¬
copeptide. The class 1 sialogiycopeptide (1.84 mg) isolated
from media was further purified as follows. It was dissolved
in 50 mM Tris-ilCI buffer. pH 7.6, containing 10 inM Mg2+
apd treated wish dcoxyribonuclease I (Sigma DN-EP) and
ribonuclease (Boehringer) at 37 "C for 48 h. The sample was
recovered by dialysis and freeze-drying. It was then dissolved
in 0.1 M NaOAc, pH 5.0, containing 0.15 M NaCl and di¬
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I Kit Kti II: Affinity chromatography of class I sialoglycopeptidcs on
a WGA Scpharose column. Elution was with 0.05 M Tris-HCI. pH S.0,
followed by 0,05 M NaCl in buffer, and finally .\'-acelylg!ucosamine. One
milliliter fractions were collected and analyzed for radioactivity.
was dialyzed against Tris-HCI buffer, pH 7.6, containing 10
mM Ca23" and treated with pronase at 40 °C for 3 days in the
presence of toluene; enzyme was added at 0, 24, and 48 h. The
treated sample was purified by chromatography first on a CPG
column and then on a DEAE-cellulose column. The labeled
material (1.2 mg) was recovered and used for sedimentation
equilibrium analysis and for gas-liquid chromatography.
The molecular weights of this purified material determined
by sedimentation equilibrium analysis as described previously
(Bhavanandan and Davidson, 1977) were 6600 and 8800 when
run at two different speeds. A partial specific volume (d) of
0.66 was assumed in the calculation of molecular weights.
Codington et al. (1972) calculated the d of epiglycanin, a
mucin-type glycoprotein from TA3Ha cells, to be 0.66.
Gas-Liquid Chromatographic Analysis of Class I Glyco¬
peptides. The purified class I glycopeptides were methanolyzcd
and analyzed by gas-liquid chromatography as described
(Clamp et al., 1971), except that re-N-acetylation was done
in the presence of pyridine instead of silver carbonate (Etchison
and Holland, 1975). The analysis showed the presence of ga-
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TABLE 111: Agglutination of B16C3 Mouse Melanoma Cells by
Wheat Germ, Con A, and Ricinus communis I Lectins,"
Lectin concn Peg of agglutination
(Mg/mL) WGA Con A RCAI
50 +++ +++ +++
25 ++.+ +++ ++ +
12.5 +++ +++ ++(+)
6.25 ++ ++ ++
3.13 + ++ ++
1.56 (+) +(+) +
0.78 - + (+)
0.39 — + -
0.19 - (+) -
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FIGURE t2: Cochromutography of l4CTabeted Tos-PheCFLCI-lrypsinate
components (•) and class II sialoglycopeptides (O) on a DEAE-cellulosc
column. Elution was with a linear gradient of 0.01 M pyridine acetate (300
mL) to 1.0 M pyridine acetate (300 mL). Fractions of 3.5 ml were col¬
lected and 1-mL aliquols assayed for radioactivity.
lactose, /^-acetylgalactosamine, and sialic acid in the ratio of
1.0:0.86:1.63. Another sample which was purified on a
DEAE-cellulose column but not digested with nucleases and
hyaluronidase showed A'-acetylglucosamine in addition to the
above sugars in the ratio of 1.0:0.71:2.0:1.04 (GlcNAc). In
addition to these sugars glucose was also detected (see Dis¬
cussion).
Class II Glycopeptide (Glycopeptides not Precipitated with
CPC). The glycopeptides were isolated from the CPC super¬
natant of the pronase digest of spent media and ceils obtained
by cultivation of cells in the presence of [3H]glucosamine (B16
media). A representative distribution of the radioactivity in
sialic acid and hexosamine is sialic acid (25%), glucosamine
(66%), and galactosamine (9%). Gel filtration on CPG and
Sephadex G-50 columns indicated that these glycopeptides
were smaller in molecular weight than the class 1 glycopeptides
(Bhavanandan and Davidson, 1976). Chromatography on
DEAE-cellulose column (Figure 2) resulted in resolution into
a number of components. The characterization of these gly¬
copeptides will be reported in a subsequent publication.
Agglutination of BI6 Melanoma Cells by Plant Lectins.
The results of agglutination experiments on B16 mouse mel¬
anoma cells using WGA, Con A. and RCAI are given in Table
111. All three lectins agglutinated these cells strongly, whereas
soybean agglutinin was inactive even at a concentration of 500
ng/mL. Treatment of the cells with Vibrio cholerae neuram¬
inidase for 30 inin rendered them agglutinable by soybean
lectin. The agglutination by Con A was inhibited by methyl
rr-D-mannoside and that by RCAl by lactose but not by N-
ucetyl-D-galactosamine. Both A'-acetyl-D-glucosamine and
/V-acctylneuraminic acid inhibited agglutination by wheat
germ lectin, the former at 40 mM and latter at 80 mM. Class
1 glycopeptides purified by DEAE-cellulose column chroma¬
tography also inhibited the wheat germ induced agglutination
of melanoma cells at a concentration of 74 jtg/mL, 0.1 mM
or less.
Isolation ofSurface Components from 14C-Labeled Cells.
The results of a typical experiment are given in Table IV. The
release of considerable |4C-!abe!ed material in the absence of
trypsin was unexpected. The supernatants from the first three
trypsin incubations were combined for further investiga¬
tions.
After centrifugation at 15 000 rpm for 20 min to remove any
cell debris, the supernatant was dialyzed against deionized
" See Experimental Procedure for details about scoring of agglut¬
ination.
TABLE IV: Complex Saccharide Release on Successive Incubation
of (,JC]G!ucosamine-Labeled B16 Melanoma Cells with
I4C dpm released
Treatment Incubation % Viable cells per 106 cells
Tos-PheCHiCl- 0 92
trypsin/' and I 92 15 443
DNase' 2 91 10 275
3 91 7 928
4 87 9 738
5 82 6 963
DNasef 0 92
1 91 4 969
2 90 4 628
3 88 2 925
4 83 4 259
5 83 3 105
" All incubations were at 4 °C for 20 min. b 20 eg/mL in balanced
salt solution. *' 10 gg/mL in balanced salt solution.
water and lyophilized. The lyophilized material was dissolved
in 0.5 mL of 50 mM Tris-HCl buffer, pH 8.0, containing 0.01
M Ca24 and incubated at 37 °C for 60 h with pronase (0.5 mg
at time 0, 20, and 40 h) in the presence of toluene. The mixture
was dialyzed against deionized water and lyophilized to yield
[l4C]glucosamine-labeled complex saccharides.
Cochromatography of Tos-PheCH^Cl-trypsinization
Products and Media Glycopeptides. The [,4C]glucosamine-
labeled material obtained by pronase treatment of Tos-
PhcCFLCl-trypsinate was chromatographed together with
[3H]glucosamine-labeled class II glycopeptides obtained from
media on CPG, Sephadcx G-50. and DEAE-cellulose columns.
The elution profiles of both isotopes from each of these columns
were remarkably similar. The profile on the DEAE-cellulose
column, which was the most complex, is illustrated in Figure
12. The similarity of the profiles is striking up to about fraction
75. The difference in the pattern beyond this fraction may be
at least partly due to the fact that Tos-PheCFGCI-trypsinate
was not treated with CPC and would thus include the glycos-
aminoglycans which are absent in 3H-labeled class II glyco¬
peptides isolated from media. Chromatography of pronase
digested Tos-PheCFDCI-trypsinate on a WGA-Scpharose
column showed the presence of class I glycopeptide in this
material.
Discussion
It is evident from the results of the present investigation that
cultured B16 mouse melanoma cells synthesize several gly-
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coproteins which can be detected both at the cell surface as well
as in the growth medium. The nondialyzable glycopeptides
derived by pronase digestion of the cells or spent media were
fractionated into two groups on the basis of their interaction
with CPC. Sialoglycopeptides which apparently formed a weak
complex with CPC were selectively eluted from the precipitate
with 0.2-0.4 M NaCl, whereas the complexes between the
strongly anionic glycosaminoglycans and CPC required higher
concentrations of NaCl for dissociation. These class I sialo¬
glycopeptides which constitute about 4-6% of the nondialyz¬
able 3H activity incorporated into the complex saccharides
were purified to apparent homogeneity by gel filtration on CPG
columns and by anion-exchange chromatography on DEAE-
cellulose columns. A trace amount of a serum-derived nonla-
beled component staining with Alcian blue was still detectable
by cellulose acetate electrophoresis (Figure 3). The labeled
sugar components were NANA and tV-acetylgalactosamine.
The identity of the former was based on cochromatography
with standard on a Bio-Gel P2 column, by paper chromatog¬
raphy, and paper electrophoresis. The galactosamine was
identified on the amino acid analyzer and by ninhydrin oxi¬
dation followed by paper chromatography.
The neutral sugar (galactose) was identified using cells
grown in the presence of [3H]glucose. The isotope yield of the
class I glycopeptide in the experiment was poor but this was
expected due to the incorporation of glucose into various
metabolic components. However, the neutral sugars isolated
from purified class I glycopeptide on paper chromatography
showed only [3H]ga!actose: some slower moving labeled ma¬
terial apparently represents oligosaccharides arising from in¬
complete hydrolysis. Again, the only hexosamine obtained
from those glycopeptides was [3H]gaiactosamine: several la¬
beled amino acids were also detected.
Analysis by gas-liquid chromatography of the class I gly¬
copeptide isolated from spent media purified on a DEAE-
cellulose column showed galactose. A'-acetylgalactosamine,
sialic acid, glucose, and A'-acetvlgiucosamine. The first three
sugars were expected on the basis of the analysis of metabolic
labeled products; the presence of the latter two sugars sug¬
gested contamination by unlabeled components. A'-acctyl-
glucosamine was not detected in a sample which was pretreated
with hyaluronidase; thus, a hyaluronic acid contaminant could
be responsible for this sugar. Glucose was still present and
would be due to glucose containing macromolecular contam¬
inants from DEAE-cellulose or Sephadex G-50 columns, or
dialysis tubings (Codington ct al.. 1972).
The action of neuraminidase on the purified glycopeptide
showed that all sialic acid was present as terminal residues.
However, the differential action of Vibrio cholerae and in¬
fluenza virus neuraminidases suggested that this sugar may
be involved in more than one type of linkage (Bhavanandan
and Davidson, 1976). Information on the sequence of the other
sugars was obtained by treatment of the asialoglycopeptide
with various glycosidases (Table II). The only treatment which
released labeled monosaccharide, identified as 7V-[3H]-
acetylgalactosamine, was the combination of Jack bean 0-
galactosidasc and a-A'-acetylgalactosaminidase. This sug¬
gested the presence of the sequence (Ga!).v((})—[3H]Gal-
A'Ac(a)-* in the asiaio class 1 glycopeptide. This was con¬
firmed by the release of the disaccharide Gal 1((3)—[3H]-
GaliYAe on digesting the asiaio glycopeptidc with endo-ct-
A'-acetylgalactosaminidase. The disaccharide was released
in a yield of about 80% by the endo enzyme.
Treatment of the glycopeptides with alkali in the presence
of borohydride resulted in complete degradation to low-mo¬
lecular-weight labeled components. The detection of only
[3H]galactosaminitol after hydrolysis of the ^-elimination
products indicated that there was only one galactosamine per
prosthetic group which was involved in an alkali-labile linkage
to the peptide. This together with the isolation of the disac¬
charide Gal—GalA'Ac from emfo-galactosaminidasc treat¬
ment of asiaio class I glycopeptides suggested that the glyco¬
peptide had a mucin-type structure in which several oligo¬
saccharides of the type NANA* [Gal — GalA'Ac] were at¬
tached to the protein. The two major alkaline borohydride
degradation products of this glycopeptide and that of fetuin
(Spiro and Bhoyroo, 1974) cochromatographed on Bio-Gel P2,
P4, and P6 columns and on paper in two different solvent
systems. This together with the similarity of the composition
of the oligosaccharides from the two sources suggests that the
melanoma class 1 glycopeptides may have prosthetic groups
similar, if not identical, to those found in fetuin. The identity
of the two other oligosaccharide peaks (minor components)
detected on the Bio-Gel P6 column was not investigated further
due to insufficient material. The detection of [3H]galactose
after periodate oxidation of (3-eliminated oligosaccharides
suggests that position 3 of galactose is substituted. Preliminary
results from periodate oxidation of the native class 1 sialogly-
copeptide indicate that the GalA'Ac is also substituted on po¬
sition 3. Confirmatory evidence for the linkages in these oli¬
gosaccharides will have to be obtained by methylation analysis;
this will be feasible using glycopeptides isolated from solid
tumor.
Evidence for the involvement of both serine and threonine
in O-glycosidic linkages to iV-acetylgalactosamine was ob¬
tained by the detection of both [3H]alanine and a-[3H]ami-
nobutyric acid after 0 elimination in the presence of NaB-'Hs.
Even though the ratio of the two amino acids was 8:7, this may
not reflect the relative proportion of serine and threonine
residues involved in the O-glycosidic linkage, since the un¬
saturated amino acids obtained by elimination (dehydroalanine
and a-aminocrotonic acid) are not reduced by NaBHj to the
same extent (Tanaka and Pigman, 1965).
It is thus apparent that oligosaccharide units, mostly te-
trasaccharides [NANA—3Gal—(NANA—(?))3GalA'Ac)
and some trisaccharides, are attached O-glycosidically to
threonine and serine in the class 1 glycopeptide. The presence
of trisaccharides may reflect incomplete sialylation during
biosynthesis or enzymatic or chemical breakdown during iso¬
lation. The molecular weight of this glycopeptide was estimated
to be about 12 000-15 000 on the basis of its mobility on the
CPG column, since it had an elution profile identical to that
of cartilage chondroitin 4-sulfate chains. Equilibrium sedi¬
mentation analysis suggested a value in the range of 6500 to
9000. The estimate obtained by gel filtration using a poly-
anionic polysaccharide as reference is probably more reliable
than the results from sedimentation analysis. Low-molecu¬
lar-weight unlabeled contaminants will lower the estimated
molecular weight of the sialoglycopeptide; further, the partial
specific volume (0.66) used in the calculation is an assumption
(see Results). In either case the apparent molecular weight of
the pronase-resistant glycopeptide seems high. Since the mo¬
lecular weight of the tetra- and trisaccharide units would be
about 1000 and 700, respectively, it may be estimated that 7-9
such units are present in the pronase corestructure. This gly¬
copeptide was resistant to further digestion by pronasc. Even
removal of sialic acid does not alter the susceptibility to pronase
very much, since the asialoglycopeptide was only minimally
degraded by this enzyme (Figure 5). This suggests that the
saccharides may be clustered in groups on the peptide chain.
In this aspect, as well as in the structure of the tetra- and tri¬
saccharides, the class I glycopeptide of mouse melanoma has
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an apparent similarity to the major glycoprotein of the eryth¬
rocyte membrane (Thomas and Winzler, 1969; Tomita and
Marchesi, 1975). The structure of the trisaccharide is similar
to the short-chain-type oligosaccharide of the TAj-Ha cell
surface glycoprotein (Codington et al., 1975). The glycopep-
tides containing O-glycosidically linked carbohydrate units
obtained by pronase digestion of fetuin were found to be in¬
cluded in Sephadex G-50 and G-25 columns in agreement with
the results of Spiro and Bhoyroo (1974) and, therefore, are of
lower molecular weight than the class 1 glycopeptide which is
excluded on a Sephadex G-50 column (Bhavanandan and
Davidson, 1976). The absence of clustered O-glycosidically
linked carbohydrate units in fetuin was advantageous in pu¬
rifying the class I glycopeptide from the spent media containing
fetal calf serum.
Affinity chromatography of glycopeptides on lectin columns
of defined specificities might be expected to provide structural
information on the molecule (Sharon and Lis, 1972) in addition
to yielding data on the homogeneity of the preparations. Class
I glycopeptide interacted with WGA as shown by the retention
of the labeled component on a WGA-Sepharose column and
its subsequent elution by Af-acetylglucosamine (Figure 11).
Since this fraction does not contain any labeled A'-acetylglu-
cosamine, the sugar generally believed to be the ligand for this
lectin (Sharon and Lis, 1972), the observed affinity was
probably due to sialic acid. This conclusion is consistent with
the observations by other workers that WGA also has an af¬
finity for sialic acid (Greenaway and LeVine, 1973) and si-
aloglycopeptides (Adair and Kornfeld, 1974). Confirmation
of this hypothesis was obtained by the failure of the desialy-
lated fraction to bind to WGA-Sepharose and by the inability
of NaCI of the same ionic strength as of the A'-acetylglucos-
amine solution to displace the bound sialoglycopcptide from
the lectin column. The polyanion hyaluronic acid was not re¬
tained on this column, excluding an ion-exchange effect. Even
though WGA is able to interact with sialic acid and sialogly-
copeptides, it apparently binds oniy to those molecules with
a jiigh sialic acid content and having specific structural fea¬
tures. The class II sialoglycopeptides and the partially desia-
lylated class I glycopeptides were not retained by the WGA-
Sepharose column. Most interestingly, the oligosaccharides
prepared from class I by 0 elimination had no affinity to the
WGA-Sepharose 4B column, suggesting that several con¬
current sialyl oligosaccharides attached to a peptide backbone
are essential for the binding process. It is possible that the
binding site for the sialic acid is the same as that for N-
acetvlglucosaminyl residues, or that it is conformational^
affected by the hexosamine binding site. Sialoglycopeptides
obtained from erythrocyte membrane also showed a similar
interaction with WGA (Bhavanandan, unpublished results).
The sialoglycopeptide did not bind either to RCAI or
RCAII-Sepharose columns, but the asialogiycopeptide bound
to the latter completely. This is in agreement with the sequence
Gal—GalAhAc in the asiaiogiycopeptide (Bhavanandan, un¬
published results).
In contrast to the class I sialoglycopeptide which formed a
precipitate with CPC, the material which remained unpre-
cipitated was a complex mixture of 3H-labeled glycopeptides
(class II). Preliminary evidence indicates that this class consists
mostly of serum-type glycopeptides in which the carbohydrate
units are linked to peptide through A'-glycosidic linkages be¬
tween /V-acetylglucosaminc and asparagine (unpublished re¬
sults).
The agglutination studies using different lectins indicate that
the BI6 mouse melanoma cells have receptor sites on their
surface for WGA, Con A, and RCAI lectins. The WGA
agglutinability of the cells as well as the inhibition of this
agglutination at very low concentration by class I glycopeptide
seems to indicate that this large mucin-type sialoglycoprotein
is located on the cell surface. In order to obtain further infor¬
mation on the relationship between the class I and II glyco¬
peptides isolated from spent media and those present on the
cell surface, we isolated the surface glycopeptides by mild
treatment of [l4C]glucosamine-labeled cells with Tos-
PheCHjCl-trypsin. It was observed that an unexpectedly large
amount of labeled material was released by cells in the absence
of trypsin, suggesting a natural rapid shedding or turnover of
surface components. It is then conceivable that the use of ex¬
ogenous proteolytic enzymes only accelerates a natural turn¬
over of cell-surface components and that the molecules shed
by the natural process, possibly nonproteolytic, would be larger
in size than those released by exogenous proteolysis. In this
context, it is interesting to note that Cooper et al. (1974) found
appreciable molecular-size differences in the epiglycanin iso¬
lated by Tos-PheCHzCl-trypsin treatment of TA3 cells and
that shed by these cells in vivo into the ascites fluid and serum
of host mice. The material released from B16 melanoma cells
by mild Tos-PheCFhCl-trypsin treatment was digested with
pronase and cochromatographed with 3H-labeled fractions
from media in several different systems. Marked similarity
between the cell surface (IJC-labeled) and media (3H-labeled)
components was evident, suggesting that the class I and II si¬
aloglycopeptides detected in the media have their origin at the
cell surface. The actual nature of this association is difficult
to elucidate. The comparison between the cell surface and
media components mentioned above is based solely on the
shape, size (CPG, Sephadex G-50). and charge (DEAE-cel-
lulose); structural differences between these two classes of
components cannot be excluded from our results.
We have demonstrated the ability of these cells to make class
I and II sialoglycopeptides when grown in a chemically defined
media containing 1% bovine serum albumin but devoid of
serum (Banks et ah, 1977). The class I sialoglycopeptides have
also been isolated from solid melanoma tumors grown in syn¬
geneic mice (V. S. Fareed el ah, unpublished results). These
findings rule out the possibility of the products described in this
paper as being artifacts due to the in vitro culture system.
The synthesis and shedding (or secretion) of the class 1
(mucin-type) glycoprotein by mouse melanoma cells which are
of neural origin are of interest. Evidence for the production and
shedding in vitro and in vivo of mucin-type glycoproteins by
other cancerous cells, particularly those grown in Ascites form,
has been presented by several investigators (Adams, 1965;
Langley and Ambrose, 1967; Molnar et ah, 1965; Codington
et ah, 1972, 1975; Funakoshi et ah, 1974). Human melanoma
and breast cancer cells also produce galactosamine-rich si¬
aloglycopeptides with affinity for WGA-Sepharose columns
(V. P. Bhavanandan et ah, unpublished results). In contrast,
normal tissues, such as mouse iris melanocytes (Satoh et ah,
1974), normal and regenerating rat liver (Akasaki et ah, 1975),
human fetal iris melanocytes (Banks et ah, 1976), and a normal
human mammary cell line (E. V. Chandrasekaran et ah, un¬
published results), either do not produce such or produce
comparable glycoproteins in markedly reduced amounts. It
is also of interest that the immediate precursor of blood group
MN determinants, which is believed to have the structure
Gal—Gal/VAc—Ser/Thr, has been detected in the cell
membranes of breast cancers but not in healthy mammary
glands or benign tumors by immunological methods (Springer
et ah, 1974). The reason for the capacity of malignant cells to
synthesize and shed mucin-type sialoglycoproteins is not clear
even though several hypotheses may be put forward. For ex-
4436 BIOCHEMISTRY, VOL. 16, NO. 20, 1977
SIALOGLYCOPEPTIDES OF MURINE MELANOMA
ample, the inucin-type class I sialoglycoprotein of mouse
melanoma could be involved in masking tumor antigens present
on the cell surface as proposed for epiglycanin of TA}Ha cells
(Codington et ah, 1973). Alternatively, the protein part of these
glycoproteins is itself antigenic and the clustered negatively
charged sialyl oligosaccharides function in masking the anti¬
genic sites of the protein. The relationship between the mela¬
noma-associated antigen (Bystryn ct ah, 1974) and the class
1 and 11 giycopeptides produced by the mouse melanoma is
currently under investigation.
Acknowledgments
We express our appreciation to the following: Jeffrey
Kemper, Anne Katlic, Debora Breindel, and Ellen Goldberg
for technical assistance; Dr. Jan Tkacz for providing the first
Con A-Sepharose and WGA-Scpharose preparations used
in these studies; Mord Moore for amino acid and hexosamine
analyses: and Dr. Y.-T. Li for Jack bean d-galactosidase.
References
Adair, L. W„ and Kornfeld, S. (1974), J. Biol. Chem. 249.
4696-4704.
Adams, J. B. (1965), Biochem. J. 94, 368-376.
Agrawal, B. B. L., and Goldstein, I. J. (1972), Methods En-
zymol. 28. 313-318.
Akasaki, M., Kawasaki, T.. and Yamashina, I. (1975), FEBS
Lett. 59. 100-104.
Allan, D., Auger, J., and Crumpton, M. J. (1972), Mature
(Loudon). New Biol. 236. 23-25.
Allen, A. K., and Neuberger, A. (1975), FEBS Lett. 50.
362-364.
Anderson, L. E., and McClure, W. A. (1973), Anal. Biochem.
51. 173-179.
Banks, J., Biiavanandan, V. P., and Davidson. E. A. (1977),
Cancer Res. (in press).
Banks, J., Kreider, J. W., Bhavanandan, V. p., and Davidson,
E. A. (1976), Cancer Res. 36. 424-431.
Bella, A. M„ Jr., and Kim, Y. S. (1970), J. Chromatogr. 51.
314-315.
Bhavanandan. V. P., and Davidson, E. A. (1975). Proc. Natl.
Acad. Sci. U.S.A. 72. 2032-2036.
Bhavanandan, V. P., and Davidson. E. A. (1976). Biochem.
Biophys. Res. Contmun. 70. 139-145.
Bhavanandan, V. P., and Davidson. E. A. (1977), Carbohydr.
Res. (in press).
Bhavanandan, V. P., Umemoto, J., and Davidson, E. A.
(1976). Biochem. Biophys. Res. Commun. 70. 738-745.
Bray, B. A., Licberman, R., and Meyer, K. (1967). J. Biol.
Chem. 242. 3373-3380.
Bystryn, J.-C. (1976),./. Immunol. 116. 1302-1305.
Bystryn, J.-C., Sehenkein, L, Baur, S..and Uhr. J. W. (1974),
J. Natl. Cancer Inst. 52. 1263-1269.
Clamp. J. R.. Bhatti, T„ and Chambers, R. E. (1971), Meth¬
ods Biochem. Anal. 19. 229-344.
Codington, J. F., Linsley, K. B., Jeanloz. R. W.. Irimura, T.,
and Osawa, T. (1975), Carbohydr. Res. 40. 171-182.
Codington, J. F., Sanford, B. H., and Jeanloz. R. W. (1972),
Biochemistry II, 2559-2564.
Codington, J. F„ Sanford, B. H., and Jeanloz, R. W. (1973),
J. Natl. Cancer Inst. 51, 585-591.
Cooper, A. G., Codington. J. F„ and Brown, M. C. (1974),
Proc. Natl. Acad. Sci. U.S.A. 71. 1224-122$.
Davidson. E. A. (1966), Methods Enzymol. 8. 52-60.
Eagle, H. (1959), Science iSO. 432-437.
Etchison, J. R., and Holland, J. J. (1975), Anal. Biochem. 66.
87-92.
Funakoshi, 1., Nakada, H., and Yamashinha, I. (1974), J.
Biochem. (Tokyo) 76. 319-333.
Gahmberg, C. G., Kiehn, D., and Hakomori, S. (1974), Nature
(London) 248. 413-415.
Gordon, H. T., Thornberg, W„ and Wcrum, L. N. (1956).
Anal. Chem. 28. 849-855.
Graham, J. M., Hynes, R. O., Davidson, E. A., and Bainton.
D. F. (1975), Cell 4, 353-365.
Greenaway, P. J., and LeVine, D. (1973), Nature (London).
New Biol. 241. 191-192.
Ham, R. (1965), Proc. Natl. Acad. Sci. U.S.A. 53. 288-
293.
Hynes, R. O. (1973), Proc. Natl. Acad. Sci. U.S.A. 70.
3170-3174.
Jourdian, G. W., Dean, L., and Roseman, S. (1971), J. Biol.
Chem. 246, 430-435.
Kim. U., Baumler, A., Carruthers, C., and Bielat, K. (1975),
Proc. Natl. Acad. Sci. U.S.A. 72. 1012-1016.
Kreider, J. W., Rosenthal, M., and Lengle, N. (1973), J. Natl.
Can. Inst. 50. 555-558.
Langley, O. K., and Ambrose, E. J. (1967), Biochem. J. 102.
367-372.
Marchesi, V. T. (1972), Methods Enzymol. 28, 354-356.
McLean, C., Werner, D. A., and Aminoff, D. (1973), Anal.
Biochem. 55, 72-84.
Molnar, J., Lutes, R. A., and Winzler, R. J. (1965), Cancer
Res. 25. 1438-1445 and 1860-1866.
Nagata, Y., Goldberg, A. R., and Burger, M. M. (1974),
Methods Enzymol. 32, 611-615.
Nicolson, G. L., and Blanstein, J. (1972), Biochim. Biophys.
Acta 266. 543-547.
Ossowski. L., Quigley, J. P., Kellerman, G. M., and Reich, E.
(1973), J. Exp. Med. 138. 1056-1064.
Satoh, C., Banks, J., Horst, P., Kreider, J. W„ and Davidson,
E. A. (1974), Biochemistry 13. .1233-1241.
Satoh, C., Duff, R., Rapp, F., and Davidson, E. A. (1973),
Proc. Natl. Acad. Sci. U.S.A. 70. 54-56.
Schnebli. H. P., and Burger. M. M. (1972), Proc. Natl. Acad.
Sci. U.S.A. 69. 3825-3827.
Sharon, N.. and Lis, H. (1972), Science 177. 949-959.
Sjogren. H. O., Hellstrom, I., Bansal, S. C., and Hellstrom.
K. E. (1971), Proc. Natl. Acad. Sci. U.S.A. 68. 1372-
1375.
Spiro, R. G., and Bhoyroo. V. D. (1974), J. Biol. Chem. 249.
5704-5717.
Springer. G. F., Desai. P. R., and Bantawala, I. (1974),
Nalurwissenschaften 61. 457-458.
Tanaka, K.. and Pigman. W. (1965), J. Biol. Chem. 240,
1487-1488.
Thomas. D. B., and Winzler, R. J. (1969), J. Biol. Chem. 244,
5943-5946.
Tomita, M., and Marchesi, V. T. (1975), Proc. Natl. Acad.
Sci. U.S.A. 72, 2964-2968.
Trevelyn, W. E., Proctor. D. P., and Harrison, J. S. (1950),
Nature (London) 166. 444-445.
Umemoto, J., Bhavanandan, V. P., and Davidson, E. A.
(1977). J. Biol. Chem. (in press).
Warren. L. (1960), Nature (London) 186, 237.
Yamada, K. M., and Weston, J. A. (1974), Proc. Natl. Acad.
Sci. U.S.A. 71. 3492-3496.
Yeh, A. K.. Tulsiani, D. R. P., and Carubelli, R. (1971), J. Lab.
Clin. Med. 78. 771-778.
BIOCHEMISTRY. VOL. 16, NO. 20, 1977 4437
Thk Journal or Biological Chkmistry
Vol. 252, No. 23, Issue of December 10, pp. 8609-8614, 1977
Printed in U.S.A.
Purification and Properties of an Endo-a-iV-acetyl-D-
galactosaminidase from Diplococcus pneumoniae*
(Received for publication, December 6, 1976)
Junji Umemoto, Veerasingham P. Bhavanandan, and Eugene A. Davidson
From the Department of Biological Chemistry, The Milton S. Hershey Medical Center, The
Pennsylvania State University, Hershey, Pennsylvania 17033
An enzyme that hydrolyzes the O-glycosidic linkage be¬
tween a-iV-acetyl-d-galactosamine and serine or threonine
in mucins and mucin-type glycoproteins was purified by
chromatography on an Affi-Gel 202 column or isoelectric
focusing from filtrates of Diplococcus pneumoniae cultures.
The final preparations were free of protease and a wide
range of other glycosidase activities. The preparation ob¬
tained by isoelectric focusing was shown to consist of a
single protein by gel filtration and sodium dodecyl sulfate-
gel electrophoresis. This preparation had an apparent mo¬
lecular weight of about 160,000, determined by gel filtration,
an optimum pH of 7.6, and an isoelectric point in the range
pH 8 to 9.
The enzyme releases the disaccharide Gal-GalNAc from a
variety of glycopeptide and glycoprotein substrates and
appears to have a specific requirement for an unsubstituted
galactose in the nonreducing terminus and an a linkage
between ^-acetylgalactosamine and the aglycone. This is
the only endoenzyme known capable of cleaving the linkage
between a carbohydrate and serine or threonine residues in
glycoproteins.
The ability of this enzyme to act on macromolecular
substrates and its pH optimum makes it ideally suited to
explore the distribution and function of mucin-type glyco¬
proteins on normal and cancer cell surfaces.
During an investigation of the carbohydrate structure of
sialoglycopeptides produced by mouse melanoma cells, we
found that a partially purified neuraminidase from Diplococ¬
cus pneumoniae liberated the disaccharide galactosyl-N-ace-
tylgalactosamine in addition to sialic acid. Preliminary results
identifying the enzyme responsible for this as an endo-a-iV-
acetyl-d-galactosaminidase cleaving the O-glycosidic linkage
between iV-acetylgalactosamine and serine or threonine resi¬
dues have been published (1). Endo and Kobata (2) have
independently described this activity. An endogalactosamini-
dase has been described which cleaves GalN-GalN linkages
in an oligogalactosaminoglycan but has no action on the N-
acetylated oligogalactosaminoglycan (3).
* These studies were supported by Contract 1 HR 52954 and
Grant CA 15483 from the United States Public Health Service. The
costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby
marked "advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
The endoglycosidase described in this paper together with
the endo-/3-N-acetyl-d-glucosaminidases (4, 5) and the endo-
/3-d-galactosidases (6) isolated from various sources provide
valuable tools for the investigation of the structure and
function of glycoproteins.
In this paper we report the purification and characteriza¬
tion, including detailed studies on the substrate specificity, of
an endo-a-iV-acetyl-d-galactosaminidase isolated from culture
filtrates of D. pneumoniae.
experimental procedures
Materials — AfTi-Gel 202 and Bio-Gel P-2 (<400 mesh) were pur¬
chased from Bio-Rad Laboratories. Sephadex G-25 (Fine), G-200
(Fine), and marker proteins for molecular weight determination
were purchased from Pharmacia. [l-14C]Acetic anhydride (0.25 mCi/
4.7 mg), [3H]acetic anhydride (50 Ci/mmol), and NaB3H., (204.8
mCi/mmol) were purchased from New England Nuclear.
p-Nitrophenyl derivatives of a-l-fucoside, a-d-mannoside, /3-d-iV-
acetyl-d-glucosaminide, 0-nitrophenyl-/3-d-galactoside, and azocas-
ein were purchased from Sigma Chemical Co. Phenyl-a-N-acetyl-d-
galactosaminide was obtained from Nakarai Chemicals (Japan).
Neuramin-a2 —» 3 lactose was prepared from skimmed bovine
colostrum as described (7). Monosialoganglioside (GM,) was pro¬
vided by Dr. C.-L. Schengrund of this department and asialo (GM,)
was prepared by acid hydrolysis in 1 m HCOOH for 1 h at 100°.
Porcine submaxillary mucin was generously provided by Dr. M. de
Salegui, New York University Medical School. Antifreeze glycopro¬
tein was kindly donated by Dr. R. E. Feeney, University of Califor¬
nia at Davis. GalNAc al —» 3(Fuc al —* 2)Gal /31 —* 4 GlcNAc /31 —*
3 hexene-l,2,5,6-tetrol and Gal al —► 3 (Fuc al —*■ 2)Gal >31 —» 4
GlcNAc >31 —» 3 hexene-l,2,5,6-tetrol were kindly donated by Dr. E.
A. Kabat, Columbia University. Mouse melanoma sialoglycopeptide
(Class I) was isolated from [3H]glucosamine-labeled cells as de¬
scribed (8, 9). Human melanoma sialoglycopeptides were isolated
by procedures similar to those used for the mouse melanoma glyco-
peptides.1 Human bronchial glycoprotein was isolated from bron¬
chial secretions.2 Fetuin and ovalbumin were purchased from Gibco
and Sigma Chemical Co., respectively.
Asialoglycoproteins and glycopeptides were prepared by mild acid
hydrolysis (0.1 n H2S04, 80°, 1 h) or by neuraminidase digestion
under the conditions described (8), followed by resolution of the
products by exclusion chromatography on Sephadex G-25.
Ovalbumin asparaginyl oligosaccharide with the composition
(Man)5(glcNAc)2-Asn was prepared according to the method of
Huang et al. (10). This glycopeptide was labeled in the asparagine
moiety by N-acetylation with [l-HC]acetic anhydride as described
by Koide and Muramatsu (4). 3-Hexene-l,2,5,6-tetroyl oligosaccha¬
rides were labeled by oxidation with galactose oxidase followed by
1 V. P. Bhavanandan, J. R. Banks, and E. A. Davidson, unpub¬
lished results.
2 P. A. FeldhofT, V. P. Bhavanandan, and E. A. Davidson,
unpublished results.
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reduction with NaB3H4 according to the procedure reported by
Takasaki and Kobata (6). The 3H-labeled oligosaccharides were
purified by chromatography on a column of Amberlite AG 50W-X8
(H"*") followed by gel filtration on a Bio-Gel P-2 column.
Enzymes - Partially purified preparations of Diplococcus pneumo¬
niae glycosidases were generously provided by Dr. G. Ashwell,
National Institutes of Health, Bethesda, Md. Neuraminidase (EC
3.2.1.18) from Vibrio cholerae and Pronase CB were purchased from
Calbiochem; galactose oxidase (EC 1.1.3.9) was from Sigma Chemi¬
cal Co.; horseradish peroxidase (EC 1.11.1.7) was from Worthington
Biochemical and a-L-fucosidase (EC 3.2.1.51) was from Miles Labo¬
ratories.
Analytical Methods — Neutral sugar was determined by the an-
throne reaction of Trevelyan and Harrison (11). The hexosamine
and amino acid contents of the glycopeptides were assayed by amino
acid analysis after hydrolysis with 4 n HC1 at 100° for 6 h or in 6 n
HC1 at 110° in vacuo for 24 h, respectively. Sialic acid was assayed
by a modification of Warren's thiobarbituric acid method (12) and
bound sialic acid was determined after acid hydrolysis (0.1 n H2S04,
80°, 1 h) by the same procedure.
Paper electrophoresis was performed at a potential of 39 V/cm for
2.5 h in 0.1 n pyridine acetic acid buffer, pH 5.4. The radioactivity
on paper strips was detected using a Packard Radiochromatogram
scanner, model 7201. When the activity was too low, particularly in
the case of tritium-labeled materials, the position of the components
on paper were determined by extraction and measurement as de¬
scribed (8).
Preparation and Properties of Fetuin Glycopeptides — Fetuin gly¬
copeptides were prepared as described earlier (1) according to the
method of Spiro and Bhoyroo (13). The glycopeptides in Fraction C
were freed from a small amount of contaminating peptides by
chromatography on Dowex 1-X2 (formate) and eluted with 0.1 n
pyridine acetic acid buffer, pH 5.2. The yields of glycopeptide
Fractions A, B, and C were 190 mg, 141 mg, and 49 mg, respectively,
starting with 4 g of fetuin. The carbohydrate and amino acid
compositions of these fractions were in.general agreement with
those published by Spiro and Bhoyroo (13).
Asialoglycopeptide Fraction C had the following composition;
numbers in parentheses represent micromoles per 100 mg of asialo¬
glycopeptide (galactose (134.8), iV-acetylgalactosamine (115.2), threo¬
nine (32.4), serine (102.6), proline (118.8), glycine (59.4), alanine
(84.0), and valine (19.2)). Glycopeptide Fraction A was composed
mostly of N-glycosidically linked carbohydrates since 97% of the
hexosamine was glucosamine; the sialic acid content of this fraction
was 83.4 /xmol/100 mg.
Preparation and Properties ofPorcine Submaxillary Mucin Glyco¬
peptides — The glycopeptides from porcine submaxillary mucin (0.5
g) having both blood group A+ and A- active components were
prepared by pronase digestion (14). The glycopeptide obtained after
Sephadex G-25 chromatography was ultrafiltered through a UM-2
membrane (Amicon) and the retained glycopeptides further fraction¬
ated on Sephadex G-50 (1). The filtrate consisting of the smaller
glycopeptides was separated into two fractions (PSM3 UM-A and
PSM UM-B) by gel filtration on Sephadex G-25 using 0.1 n pyridine
acetic acid buffer, pH 5.2, as eluant. The higher (PSM UM-A; 32.4
mg) and lower (PSM UM-B; 21.4 mg) molecular weight fractions
were found to have galactosamine/galactose ratio of 2.08:1 and
1.54:1, respectively. The former consists of A+ PSM, glycopeptide
and the latter is a mixture of both A+ and A- glycopeptides.
Fucose and sialic acid residues from the PSM UM-A and PSM
UM-B glycopeptides were removed by acid hydrolysis in 1 m HCOOH
at 100° for 1 h and the galactosamine re-N-acetylated (15) to yield
the asialo-afuco-PSM glycopeptides.
Enzymatic release of fucose or sialic acid from the PSM glycopep¬
tides was achieved by incubation with a-L-fucosidase or neuramini¬
dase at the optimum pH at 37° for 24 h. The glycopeptide was
recovered by gel filtration on a column of Sephadex G-25.
Preparation of 3H-labeled PSM (A*) Glycopeptides (PSM UM-
A) — The sialic acid and/or fucose-free PSM (A+) glycopeptides
were labeled by treatment with galactose oxidase followed by
NaB3H< reduction according to the method of Morell et al. (16).
The reaction mixture, after labeling, was adjusted to pH 5, freed
from borate by repeated evaporation with methanol and purified by
gel filtration on Sephadex G-25 and, finally, by paper electrophore¬
sis. The product gave a single radioactive band on paper chromatog-
3 The abbreviations used are: PSM, porcine submaxillary mucin;
dansyl, 5-dimethylaminonapththalene-l-sulfonyl.
raphy and on paper electrophoresis. The product was hydrolyzed (4
n HC1, 100°, 6 h) and examined by paper chromatography. It was
found that 90% of the tritium label was in galactosamine and the
rest in galactose.
Enzyme Assays — The standard assay for endo-a-N-acetyl-n-galac-
tosaminidase was performed in a reaction mixture composed of 1
/imol of Tris/maleate buffer, pH 7.6, 115 nmol (based on N-acetyl-
galactosamine) of asialofetuin glycopeptide Fraction C and an appro¬
priate amount of enzyme in a total volume of 50 pi. After incubation
at 37° for 3 h, 50 pi of water was added and the mixture was
assayed for the released disaccharide (Gal 1 —► 3 GalNAc) by the
Morgan-Elson reaction (17) using one-fifth volume. Under these
conditions, the reaction was linear with time (to 6 h) and enzyme
amount. The identity of the released product as galactosy1-/3-1 —* 3-
AT-acetylgalactosamine and not free iV-acetylgalactosamine was con¬
firmed by gel filtration on a Bio-Gel P-2 column followed by paper
chromatography (1). One unit of the enzymatic activity is defined
as the amount of enzyme that hydrolyzes 1 pmol of substrate/min.
Exo-a-iV-acetyl-d-galactosaminidase and neuraminidase were as¬
sayed as reported previously (1), except that in some experiments
fetuin glycopeptide Fraction A was used as substrate for neuramin¬
idase instead of neuramin-a-2 —* 3 lactose. /3-o-Galactosidase were
assayed using 0-nitrophenyl-/3-D-galactosidase (18).
Endo-/3-N-acetyl-d-glucosaminidase activity was determined by
incubation with 3H-labeled ovalbumin glycopeptide followed by gel
filtration on a Bio-Gel P-2 column to identify GlcNAc-Asn (4).
Endo-/3-D-galactosidase activity was determined using 3H-labeled
hexene-l,2,5,6-tetroyl oligosaccharides. The released 3H-trisacchar-
ides were identified by gel filtration on a Bio-Gel P-4 column (6).
/3-N-Acetyl-D-glucosaminidase and other exoglycosidases were as¬
sayed by using the corresponding p-nitrophenylglycosides at the
optimum pH as described (18). Proteases were assayed by incubating
azocasein (1 mg) with the enzyme preparation in 220 pi of 0.1 m
Tris/HCl buffer, pH 7.6, at 37° for 3 h. The reaction was terminated
by addition of 780 pi of 8% trichloroacetic acid, and the absorbance
of the supernatant measured at 350 nm. Appropriate controls with
trypsin were also carried out.
Isoelectric Focusing — Analytical and preparative isoelectric focus¬
ing was done with an LKB apparatus using Ampholine carrier
ampholytes according to the manufacturers instructions.
RESULTS
Purification of Endo-ot-N-acetyl-D-galactosaminidase was
Achieved by Two Independent Methods
Method I — Fig. 1 illustrates the purification of the endoen-
zyme on an Affi-Gel 202 column; the endoenzyme was eluted
just before neuraminidase. The pooled fractions, after the
addition of bovine serum albumin to 0.01% to prevent inacti-
FRACTION NUMBER
Fig. 1. Chromatography of the endo-a-N-acetyl-d-galactosamini-
dase on an Affi-Gel 202 column. A partially purified (18) mixture of
Diplococcus pneumoniae glycosidases (300 /il) was applied to a
column of Affi-Gel 202 (2.0 x 25 cm) equilibrated with 0.02 m Tris/
HC1 buffer, pH 7.5. The column was washed with 35 ml of the above
buffer and then eluted by a concave NaCl gradient with a system
composed of 45 ml each of the above buffer in the two mixing
vessels and 45 ml of the same buffer containing 0.5 m NaCl in the
reservoir. Fractions of 1.7 ml were collected. ■ ■, endo-a-N-
acetyl-D-galactosaminidase; O O, neuraminidase; • •, /3-N-
acety l-D-glucosaminidase.
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vation, were concentrated to about one-tenth their original
volume using a PM10 membrane (Amicon). This preparation
is stable for at least 6 months when stored at 4°.
Method II — Isoelectric focusing in polyacrylamide gels was
carried out on the partially purified glycosidases using Am-
pholine of pH range 3.5 to 10. The results of a typical
experiment are illustrated in Fig. 2. The endo-a-iV-acetyl-d-
galactosaminidase migrated to the high pH region and was
well separated from other endo- and exoglycosidases present
in the original mixture (Fig. 2a). The results of a preparative
experiment are illustrated in Fig. 26; the endoenzyme mi¬
grated to the pH region of 8 to 9 (see "Discussion"). The
fractions having endoenzyme activity were pooled, the pH
adjusted to 7.5 with 0.2 m Na2HP04 and the solution concen¬
trated to about one-tenth the original volume by dialysis
against polyethylene glycol 20,000. The last traces of Ampho-
line were removed by gel filtration on a column of Sephadex
G-25. The recovery of the endoenzyme activity was quantita¬
tive.
In a third method tested, chromatography of the mixture of
glycosidases on a DEAE-Sephadex A-25 column was per¬
formed using a linear NaCl gradient as described by Endo
and Kobata (2). The neuraminidase co-eluted with the endoen¬
zyme and as such this method was not suitable for the
separation of these two enzymes.
Purity ofEnzyme
The endo-a-AT-acetyl-d-galactosaminidase preparations ob¬
tained by Methods I and II were free from neuraminidase,
exo-a-iV-acetyl-d-galactosaminidase, a-l-fucosidase, /3-iV-ace-
tyl-d-glucosaminidase, /3-d-galactosidase, a-d-mannosidase,
endo-/3-AT-acetyl-d-glucosaminidase, and proteases. The prep¬
aration by Method II was also free of endo-/3-d-galactosidase;
the preparation by Method I was not assayed for this activity.
Some preparations obtained by Method I, however, had trace
amounts of neuraminidase and endo-/3-N-acetyl-d-glucosa-
minidase. In separate experiments, endo-a-iV-acetylgalactos-
aminidase was obtained completely free of neuraminidase
from a preparation of culture filtrate of D. pneumoniae which
had very low initial levels of neuraminidase and /3-D-galacto-
sidase.4
The purity of the endoenzyme was also examined by gel
filtration on Sephadex G-200 and sodium dodecyl sulfate-
polyacrylamide electrophoresis after labeling with [3H]acetic
anhydride. The endo-a-AT-acetyl-d-galactosaminidase ob¬
tained by isoelectric focusing was concentrated about 140-fold
by dialysis against polyethylene glycol 20,000 with retention
of 70% of the enzyme activity. The enzyme solution was
treated with [3H]acetic anhydride (5 mCi) in 1 m sodium
acetate at room temperature for 30 min. At this time, 10 /xl of
unlabeled acetic anhydride was added and the reaction was
continued for 30 more min. The enzyme was freed from
[3H]acetic acid by dialysis against 0.05 m sodium phosphate
buffer, pH 7.5, followed by gel filtration on a Sephadex G-25
column. The 3H-labeled preparation obtained was apparently
denatured as it was devoid of endoenzyme activity.
Gel filtration of the [3H]acetyl endoenzyme on Sephadex G-
200 gave the results shown in Fig. 3. A single major peak was
obtained which was located at nearly the same position as
that of the endoenzyme activity. Two minor peaks are either
degradation and aggregation products of the endoenzyme or





Fig. 2. Isoelectric focusing of the endo-iV-acetyl-d-galactosamini-
dase (a) in a polyacrylamide gel and (6) in a column, (a) Twenty
microliters of the enzyme preparation were applied to a 5-mm
square of filter paper which was placed on the gel containing
Ampholine of pH 3.5 to 10 and focused for 2.5 h at a constant power
of 20 watts. At the end of the run, the gel was sliced longitudinally
into 1-cm-wide strips and each strip further sectioned into 4-rnm
pieces. Pieces from a blank strip were suspended in 0.75 ml of
distilled water and after overnight incubation at room temperature;
the pH of the solutions were determined using a pH meter. Pieces
from the sample strips were added to test tubes containing the
appropriate enzyme assay mixtures and enzyme activity determined
as described under "Experimental Procedures," except that Gal-
GalNAc-a-p-nitrophenyl4 was used as a substrate. ■ ■, endo-a-
N-acetyl-D-galactosaminidase; ▲ ▲, /3-D-galactosidase; O O,
neuraminidase; • #, /3-AT-acetyl-D-glucosaminidase; • • • ■, pH.
(6) Seven milliliters of the enzyme preparation were applied to a
110-ml column LKB 8108 containing 0.1% Ampholine of pH range
3.5 to 10 and focused at 300 V. The initial current of 5 mA dropped
to 0.5 mA at the end of 50 h. At 72 h, the experiment was stopped
and fractions of 2 ml were collected. After the pH was measured,
enzyme activity was determined on suitable aliquots. ■ ■, endo-
a-iV-acetyl-D-galactosaminidase; , A280; • • • •, pH.
other contaminating proteins.
Polyacrylamide gel electrophoresis of the [3H]acetyl endoen¬
zyme on a 10% gel in the presence of 0.1% sodium dodecyl
sulfate was done according to the method of Laemmli (19). At
the end of the run, the gel was sliced into 2-mm wide segments
and solubilized by incubation with 0.2 ml of 60% perchloric
acid and 0.4 ml of 30% hydrogen peroxide at 60° for 4 h before
measuring radioactivity. The results illustrated in Fig. 4
shows that enzyme migrated as a sharp band very close to a
cytochrome c standard. Similar results were obtained on a 7%
gel. The acetylated enzyme, when examined on a 6% gel at
pH 4.3 but in the absence of sodium dodecyl sulfate, failed to
enter the gel. The apparently low molecular weight of the
acetylated enzyme on the sodium dodecyl sulfate gel suggests
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Fig. 3 (left). Sephadex G-200 filtration of [3H]acetyl-endo-a-/V-
acetyl-d-galactosaminida8e. 3H-labeled preparation (1.5 ml) contain¬
ing 1.5 x 10s dpm was applied to a Sephadex G-200 column (2.6 x 95
cm). The column was eluted with 0.01 m Tris/HCl buffer, pH 7.5,
containing 0.1 m KC1 at a flow rate of 25 ml/h; fractions of 5.3 ml
were collected. Aliquots were analyzed for radioactivity. The native
endoenzyme was located by its enzyme activity, the peak position is
indicated by an arrow.
Fig. 4 (center). Radioactivity profile of [3H]acetyl-endo-a-N-ace-
tyl-n-galactosaminidase after sodium dodecyl sulfate polyacrylamide
Properties of Endo-a-N-acetyl-D-galactosaminidase
The activity of the enzyme with asialofetuin glycopeptide
Fraction C as substrate at different pH in Tris/maleate buffer
is shown in Fig. 5. The optimum pH is approximately 7.6; the
same pH optimum was shown when 0.1 m sodium phosphate
buffer, pH 5.6 to 8.1, was substituted for the 0.1 m Tris/
maleate buffer. About 50% inhibition of activity was observed
when Tris/HCl buffer was used, apparently due to chloride
ions.
The molecular size of endo-a-iV-acetyl-d-galactosaminidase,
was estimated from its chromatographic mobility on a Sepha¬
dex G-200 column according to the method of Andrews (20).
An apparent weight of 160,000 was obtained based on a series
of standard proteins. The positions of the standards were
determined by absorbance at 280 nm and that of the enzyme
by its activity against asialofetuin glycopeptide Fraction C.
The effect of various cations and other reagents on the
enzyme activity are summarized in Table I. Since inhibition
by excess chloride ions was noted when Tris/HCl was used,
the effect of cations on the enzyme was determined using
acetate salts. The effect of galactose and sialic acid on the
activity of the endoenzyme was measured by using asialofe¬
tuin glycopeptide Fraction C as substrate. The assay was
performed under standard condition using 1.2 mM substrate
and a 100 mM concentration of the monosaccharide. Sialic
acid did not inhibit the enzyme but galactose gave a 70%
inhibition.
The effect of varying substrate concentrations on the reaction
rate with asialofetuin glycopeptide Fraction C was measured
at 37° using 0.1 m Tris/maleate buffer, pH 7.6. The apparent
Michaelis constant (Km) was determined from the Lineweaver-
Burk plot to be 1.0 mm.
The action of the endo-cr-AT-acetyl-d-galactosaminidase on
saccharide, glycopeptide, glycoprotein, and glycolipid sub-
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gel electrophoresis. Electrophoresis was performed in a 10% gel in
the presence of 0.1% sodium dodecyl sulfate. The gel was sliced into
2-mm-wide segments. Each gel slice was solubilized and radioactiv¬
ity was determined as described in the text. The marker proteins
were located by Coomassie Blue G staining. BSA, bovine serum
albumin; Cyt. C, cytochrome c.
Fig. 5 (right). pH optimum of the endo-a-iV-acetyl-d-galactosa-
minidase. The ezyme reaction was performed under standard condi¬
tions using 0.1 m Tris/maleate (• •) or Tris/HCl (O O)
buffer of varying pH.
Table I
Effect of added substances on activity of endo-a-N-
acetylgalactosaminidase
Enzyme assay was performed under the standard condition in the












strates is summarized in Table II. When 3H-labeled substances
were used as substrate, the reaction products were detected
by determination of the radioactivity after fractionation on
Bio-Gel P-2 column, as described (1). In case of unlabeled
substrates, the products were detected by color formation in
the Morgan-Elson reaction (17). In both cases, the identity of
the product was confirmed by paper chromatography.
discussion
In our preliminary publication (1), we reported on the
partial purification of the endo-a-iV-acetyl-d-galactosamini-
dase on the Afli-Gel 202 column. The endoenzyme and neura¬
minidase eluted together from this column. Attempts to sepa¬
rate these enzymes by chromatography on Sepharosyl-glycyl-
tyrosyl[N-(p-aminophenyl)]oxamic acid, an affinity ligand for
neuraminidase (21), were not successful since the endoenzyme
also bound to this column and eluted with the neuraminidase.
Fractionation of the enzyme mixture on DEAE-Sephadex did
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Table II
Substrate specificity of endo-a-N-acetyl-D-galactosaminidase
Substrates Structure Hydrolyzed
Asialofetuin glycopeptide Fraction C




Antifreeze glycoprotein* Gall^GalNAc^Thr+Protein +






B16 Mouse melanoma glycopeptide Class I Gal^[JH]GalNAc+Ser(Thr) -
[^H]NeuAc
Fetuin glycopeptide Fraction B







Asialo Afuco PSM(A+) glycopeptide [3H] GalNAcl-^3Gall^3GalNAc—Ser (Thr)
1
-





Asialo mouse melanoma glycopeptide Gall^3 [3H] GalNAc^Ser (Thr)
1
+
Asialo human melanoma glycopeptide +
Asialo human bronchial glycoproteint +
Asialo PSM +
Asialo Fetuin +
Asialo GM^ ganglioside Gall^3GalNAcl^4Gall^-4Glcl-*-lCeramide -
Ovine submaxillary mucin NeuAc 2+6 GalNAc(Ser/Thr)Protein -
*
Extent of hydrolysis was 30% after 24 hr incubation as determined by analysis of the
galactose and galactosaraine of the product.
^Seven percent of the galactosamine in the macromolecule was released as the disaccharide
Gal-K3alNAc after 24 hr incubation.
not succeed in separating the neuraminidase and endoenzyme
activities. Purification of the endoenzyme was achieved by
the two methods discussed under "Results."
In order to assess the absence of other proteins in the
endoenzyme, preparations obtained by Affi-Gel 202 were dan-
sylated (22), treated with fluorescamine (23), or [3H]acetylated
prior to electrophoresis on polyaerylamide gels in presence or
absence of sodium dodecyl sulfate. These attempts were gen¬
erally not successful in demonstrating the homogeneity of the
protein due to insufficient material and because of denatura-
tion during dansylation or aggregation of the apparently
hydrophobic enzyme protein. The isoelectric focusing method
yielded the endoenzyme in excellent yield and high purity.
Using this preparation, we were successful in labeling the
protein with [3H]acetic anhydride without concomitant insol-
ubilization. Gel filtration on Sephadex G-200 and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis of this
preparation demonstrated the absence of other major extra¬
neous proteins in our preparations. The slight shift in the
peak positions of the enzyme activity and the [3H]acetyl-
labeled protein may be due to conformational effects arising
as a result of the derivatization of basic residues. Sodium
dodecyl sulfate-gel electrophoresis indicated that the endoen¬
zyme may be composed of several subunits of relatively low
molecular weight. The isoelectric focusing data illustrated in
Fig. 2b show at least two peaks of activity. In some prepara¬
tions of the endoenzyme, in addition to these peaks at the
unusually high isoelectric point, a peak with an apparent pi
of 5.0 was also detected. The enzyme with the lower pi seems
to have a greater molecular weight than the high pi form.
The exact relationship between the two forms of the enzyme
is not clear and is under investigation. It is possible that the
lower pi form is an association product formed during the
isolation procedure. The enzyme has a rather high optimum
I
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pH, (7.6), relative to that of other glycosidases, whether Tris/
maleate, Tris/HCl, or phosphate buffers were used. Endo and
Kobata (2) report a pH optimum of 6.0 in phosphate buffer for
their enzyme preparation; the reason for this discrepancy is
not clear but may be a function of the substrate employed and
the time of incubation.
The hydrolysis of asialofetuin glycopeptide Fraction C by
the purified endoenzyme was linear for more than 6 h. The
extent of hydrolysis after 6 h was 45% and after 24 h, it was
94.3%. When mouse melanoma asialoglycopeptide Class I was
used as substrate, the enzyme released 75% of the disaccharide
in 24 h. This substrate has Gal —* GalNAc linked to serine
and threonine apparently in clusters (8, 9) similar to that
found in glycophorin (24). This suggests that the enzyme is
capable of hydrolyzing the O-glycosidic linkage between Gal
—* GalNAc and serine or threonine even when they occur
sequentially on the polypeptide chain.
Antifreeze glycoprotein (25) was also a good substrate for
this enzyme. In this glycoprotein, the disaccharide, Gal —*■
GalNAc, is linked entirely to threonine. These results to¬
gether with the fact that almost 95% of Gal —* GalNAc linked
to serine and threonine in asialofetuin glycopeptide Fraction
C was released suggests that the enzyme can act on both
serine and threonine linkages. Preliminary results indicate
that the enzyme can also efficiently hydrolyze the synthetic
substrate Gal —* GalNAc-a-p-nitrophenyl.4 Thus it is possible
that the nature of the aglycone is not critical for the activity
of the enzyme.
The inability of the enzyme to hydrolyze substrates such as
NeuAc —* Gal —* GalNAc-Ser/Thr, GalNAc —*■ Gal —*■ GalNAc
—> Ser/Thr, GalNAc —* (Fuc) —► GalNAc-Ser/Thr, NeuAc —*
GalNAc-Ser/Thr together with the fact that galactose is an
inhibitor of the enzyme suggests that a nonreducing galactose
terminus is necessary for the recognition of the substrate by
the enzyme. It is possible that galactose is involved in the
binding of the substrate to the active site. Whether the
enzyme has strict specificity for a GalNAc residue in the
penultimate position is not clear from the present studies.
The glycopeptide Gal —► (NeuNGc) —* GalNAc —* Ser/Thr
was not hydrolyzed by the enzyme; therefore, it seems that
the GalNAc has to be unsubstituted, at least in position 6.
The enzyme failed to release Gal —*■ GalNAc from asialo
(GM,) ganglioside suggesting that the /3-ZV-acetylgalactosa-
minyl linkage is not recognized by the enzyme.
The availability of endo-/3-iV-acetyl-D-glucosaminidases (4,
5) which cleave the chitobiose unit of the saccharide core of
serum-type glycoproteins has facilitated the removal of the
bulk of carbohydrate units linked ZV-glycosidically to protein.
A most useful property of the endoenzyme described in this
paper is its ability to hydrolyze macromolecular substrates.
The enzyme released the disaccharide Gal —> GalNAc from
mouse melanoma asialoglycopeptide Class I (Mr = 10,000 to
12,000), antifreeze glycoprotein, asialofetuin, asialo-PSM, and
asialo human bronchial mucin (Afr = about 2 x 106).2 This
should be of utility in both structural and biosynthetic studies.
In addition, the ability of the endo-a-ZV-acetyl-D-galactosamin-
idase to act on macromolecular substrates coupled with a pH
optimum close to physiological should be extremely valuable
in investigating the distribution of O-glycosidically linked
oligosaccharides on cell surfaces.
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SUMMARY
The addition of 1% (w/v) bovine serum albumin (BSA) to
the F12 medium utilized for the growth of the B16 mela¬
noma cells significantly stimulated the growth of this cell
line. The synthesis of mucopolysaccharides and sialogly-
copeptides in this medium is identical with that in Eagle's
minimal essential medium with Earle's balanced salt solu¬
tion supplemented with 2mii L-glutamine, twice the recom¬
mended concentration of vitamins, nonessential amino
acids, sodium pyruvate, and 10% (v/v) fetal calf serum.
Cell volume and morphology did not change significantly
under the different growth conditions and tumorigenicity,
as assayed by injection of cultured cells into syngeneic
animals, was not decreased. Analysis of the BSA used in¬
dicated the presence of a sialoglycoprotein contaminant.
This sialoglycoprotein contaminant was present in all lots
examined and contains W-acetyl- and W-glycolylneuraminic
acid, mannose, galactose, and glucosamine. The sialogly¬
coprotein can be removed by chromatography on acetate
form anion-exchange resin at pH 4.3. F12 media containing
the purified BSA plus selenite and the sodium salts of pal¬
mitic, oleic, and linoleic acids supported growth of the
melanoma cells to the same extent as did the media con¬
taining unpurified BSA, indicating that the sialoglycopro¬
tein has no role in sustaining the growth of the cells.
INTRODUCTION
Previous reports from this laboratory have described the
anionic saccharides (sialoglycopeptides and mucopolysac¬
charides) made by human (2) and mouse (19) melanoma
cells, SV40- and herpes simplex virus-transformed hamster
cells (20), and suitable controls. These studies and those
by other groups involved the characterization of radioiso-
topically labeled molecules that had been synthesized by
cells during their growth in vitro and in vivo from radiola¬
beled precursors such as glucosamine, fucose, sulfate,
glucose, and acetate (9, 12, 23). The prior investigations
were often of a comparative nature and were subject to
uncertainties due to differences in the dilution or pool size
' Supported in part by USPHS Grant CA15483 and Grant 1 P30 CA18450-
01, awarded by the National Cancer Institute. Department of Health, Educa-
tion, and Weifare. *
2 To whom requests for reprints should be addressed.
Received February 10, 1977; accepted August 30. 1977.
of a labeled precursor, entrapment by serum components
(1), carbohydrate concentration, and other variations in the
culture media. Thus, it is highly desirable to confirm incor¬
poration data by direct mass analysis. This has been done
in several instances (8, 9), but not in all.
The cell surface anionic saccharides of the mouse mela¬
noma B16 are reduced in amounts under growth conditions
that result in the loss of tumorigenicity (21). These same
conditions result in an increased expression of cell surface
antigens (24). The mouse melanoma is useful for immuno¬
logical studies, since it is tumorigenic in syngeneic animals
(21), since it can be cultured in vitro while retaining tumor-
forming ability, and since X-irradiated cells inoculated into
syngeneic mice are capable of protecting the animals
against challenge by viable melanoma cells (6). Therefore,
it seems reasonable that syngeneic mice can develop an
immune response to these cells and that the antigenic
components are associated with the plasma membrane
(18). Soluble components synthesized by these cells have
been studied in an attempt to identify possible tumor-
specific antigens (7).
Prior studies on the B16 mouse melanoma with the use
of labeled precursors resulted in the isolation of 2 complex
saccharide components that are either not produced or are
produced in much reduced quantities by a control popula¬
tion of mouse iris melanocytes. The 2 components have
been characterized as a high molecular weight chondroitin
sulfate (19) and a mucin-type glycoprotein (4, 19). For
examination of their immunological importance, it is nec¬
essary to isolate reasonable quantities of these compo¬
nents. Since our data also showed that large amounts of
these components are present in a soluble form in condi¬
tioned culture medium, the possibility of isolating them
from this source seemed attractive. This would be feasible,
provided these cells could be adapted to grow in a chemi¬
cally defined medium without the loss of their biological
and biochemical properties. In this instance, the properties
would be anionic polysaccharide synthesis, ability to prolif¬
erate, and tumorigenicity. The studies reported in this
paper deal with the effect of medium composition on these
properties of an amelanotic variant of the B16 mouse mela¬
noma.
MATERIALS AND METHODS
Cells. The amelanotic variant of the B16 mouse mela¬
noma cell line described previously was used in these
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experiments (19). The phenotype was not stable, and these
cells produce a small amount of melanin which can be
detected by visual observation.
Media. Cells were routinely maintained in a modified
version of MEM3 (11) containing 10% FCS (Flow Labora¬
tories, Inc., Rockville, Md.), 0.1 mM concentrations of each
nonessential amino acid, 1 mM sodium pyruvate, 2 mM
L-glutamine, twice the recommended concentration of
vitamins, and penicillin (10 units/ml) and streptomycin (10
jig/ml); this is termed MB16 medium with FCS. The medium
was obtained from Flow Laboratories as a dried powder.
The nonessential 100x amino acid solution, 100x sodium
pyruvate solution, 100x MEM vitamin solution and 100x l-
glutamine solution were obtained from Grand Island Bio¬
logical Co. (Grand Island, N. Y.) and added to the liquid
medium prepared from the powder.
F12 medium as described by Ham (13) was used for
growth experiments. This was obtained as a dry powder
from Flow Laboratories. This medium was supplemented
in all cases by addition of 2 mM L-glutamine, 0.11% NaHC03,
penicillin (10 units/ml) and streptomycin (10 ^g/ml) after
filtration through a 0.45-/xm Nalgene filter unit (Fisher
Scientific Co., Pittsburgh, Pa.). The albumin was added to
the F12 medium and filtered immediately after dissolving.
Routine cultures indicated that the medium was not con¬
taminated with bacteria, yeast, mold, or mycoplasmas (19).
Reagents. Tritiated glucosamine (D-glucosamine [6-
3H]hydrochloride, 7.3 Ci/mmole) and Na23SS04 (carrier-free;
specific activity, 800 mCi/mmo(e) were obtained from New
England Nuclear, Boston, Mass. o-Glucosamine (1-,4C]-
hydrochloride (specific activity, 51.5 mCi/mmole) was also
obtained from New England Nuclear.
BSA, Cohn Fraction V, was obtained from Sigma Chemi¬
cal Co., St. Louis, Mo. Lots 55C-0074, 95C-0191, 86C-0140,
and 126C-0199 were used for the experiments; these prep¬
arations contain a-globulins as the principal contaminant.
Pentex BSA Cohn Fraction V, 99% pure, presumably pre¬
pared by the classical Cohn low-temperature alcohol pre¬
cipitation method, was obtained from Miles Laboratories
(Catalog No. 81-003, Lot 234). The defatted BSA was ob¬
tained from Sigma (Catalog No. A-6003, Lot 46C-7450).
Crystalline BSA was obtained from ICN, La Puente, Calif.
(Lot 18008, Catalog No. 1136). Sodium oleate (Catalog No.
0251), sodium linoleate (Catalog No. L5378), and sodium
palmitate (Catalog No. P2010) were all approximately 99%
pure and were obtained from Sigma. Selenous acid (Cata¬
log No. A-286) was obtained from Fisher Scientific Co.
Growth Promotion Protocol. In order to test growth-pro¬
moting ability, we seeded the cells into 16-oz glass bottles
(Brockway Glass Co. Inc., Brockway, Pa.) at 2 x 10® viable
cells in 25 ml of medium. Smaller-scale experiments were
initiated by seeding 7 x 105 viable cells in 4-oz glass bottles
(Brockway) in a total of 10 ml of medium. After the allow¬
ance of 12 to 24 hr in the serum-free medium for the cells
to attach, the culture medium was changed to that to be
3 The abbreviations used are: MEM. Eagle's minimal essential media with
Earle's balanced salt solution: FCS. 56°30-min heat-treated fetal calf serum;
MB16. Eagle's MEM as above supplemented with 2 mM L-glutamine, twice
the recommended concentration of MEM vitamins, nonessential amino
acids, and sodium pyruvate: BSA. bovine serum albumin, CPC. cetyl pyridin-
ium chloride; CPG. controlled-pore glass heads.
tested for growth-promoting ability. The cells grown in the
MB16 were fed every 2 days, while those in F12 medium
were fed daily, since the low concentrations of some com¬
ponents in this medium might become exhausted and limit
growth.
When not used for growth studies, the cells were passed
at biweekly intervals and were harvested using phosphate-
buffered saline-0.02% ethylene glycol bis(/3-aminoethyl
ether)-N,A/'-tetraacetic acid (3). Cell counts were obtained
with the use of a hemacytometer, and the viability of the
cells was determined by trypan blue exclusion.
Tumorigenicity Test Protocol. Each of 10 C57BL/6J mice
was inoculated s.c. with 0, 104, 105, or 10s sixth-passage
melanoma cells grown in F12-1 % BSA medium; a control
group received cells grown in MB16 containing 10% heat-
treated FCS. The cells were injected s.c. in 0.2 ml of BSA-
free F12 or serum-free MB16, respectively.
Cell Sizing Protocol. The cells used for this study were
all in the first passage and were grown under identical
conditions except for the medium. The cells were resus-
pended in Isoton (Scientific Products, Edison, N. J.) at 8 x
104 cells/ml and sized with a calibrated Model B Coulter
counter with frequent agitation of the cell suspension.
Labeling of Complex Saccharides and Their Extraction.
Cells in the logarithmic growth phase were fed with medium
containing [,4C]glucosamine (0.6 ^Ci/ml). Growth was al¬
lowed to proceed for 48 hr in 16-oz glass bottles or in a
690-sq cm roller bottle (Bellco Glass, Inc., Vineland, N. J.).
The complex saccharides were isolated by previously de¬
scribed methods (19).
Complex Saccharide Analysis. After precipitation of
the'4C-labeled material with CPC, the nonprecipitable and
the precipitated materials were analyzed as described pre¬
viously (4, 19). Further characterization of the nonprecipi-
tated fraction was performed after dialysis by chromatog¬
raphy on 0.9- x 70-cm DE-52 (DEAE-cellulose; Whatman
Inc., Clifton, N. J.) column with the use of a 0.01 to 1 m
pyridine acetate, pH 5.2 gradient. The precipitated sialogly-
copeptide that was eluted by 0.4 m NaCI from the precipi¬
tated material was characterized by its ability to bind to a
wheat germ agglutinin :Sepharose 4B column and its elution
from that column with 0.1 M /V-acetylglucosamine (4).
Assays. Sialic acid determinations were performed by
the thiobarbituric acid method (28) or the periodate:
resorcinol procedure (14). N-Acetylneuraminic acid ob¬
tained from Pfanstiehl or Difco was used as standard. N-
Glycolylneuraminic acid was isolated from porcine sub¬
maxillary mucin.
Paper chromatography of sialic acids was carried out
with n-butyl acetate:glacial acetic acid:H20 (3:2:1) (25). and
the sugars were detected by the spray method of Warren
(29).
Paper chromatography of the neutral sugar fraction was
carried out after a 4-hr hydrolysis of the sample in 1 n HCI
(26) and passage through a mixed-bed resin, Dowex 50
(H+):Dowex 1 (formate). The eluate which contained >90%
of the neutral sugar present before hydrolysis was chromat-
ographed in n-butyl alcohol;pyridine;H,0 (6:4:3), and the
sugar present was detected by a AgNOj spray (27).
Hexosamine content was determined after 4 hr at 100°
hydrolysis in 4 n HCI with the use of the Elson-Morgan
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reaction as modified by Boas (5) after Dowex 50 (H+)
chromatography of the hydrolysate and 2 n HCI elution.
Protein concentration was measured according to the
method of Lowry et al. (15) with the use of 8SA as the
standard.
Gas-liquid chromatography of the saccharides as the
trimethylsilyl derivatives of methylglycosides was done as
described previously (4). The appropriate corrections for
detector response and losses during hydrolysis were ap¬
plied.
Chondroitinase ACII and Vibrio cholerae neuraminidase
susceptibility assays were done by molecular size profiles
(19). After a 24-hr incubation in a volume of 500 /xl, the
sample was lyophilized and applied in H.0 to a previously
calibrated CPG 10-240 80 to 120 mesh glass bead column;
individual fractions were assayed for radioactivity. Changes
in molecular weight to a region coincident with authentic
chondroitin sulfate disaccharide or sialic acid indicated
degradation of the species under test.
Chromatographic Purification of BSA. Chromatography
of the Sigma BSA (Lots 95C-0191, 86C-0140, and 126C-
0199) was performed on AG 1-X2 200 to 400 mesh resin
(Bio-Rad Laboratories, Richmond, Calif.) converted to the
acetate form. A 4- x 40-cm column was equilibrated with 1
mM sodium acetate buffer, pH 4.3. The sample (1 g) was
dissolved in water, dialyzed for 24 hr versus 6 liters of
deionized H20 at 4° followed by 6 liters of 1 mm sodium
acetate buffer, and loaded onto the column. The column
was eluted with a linear gradient consisting of 900 ml each
of 1 and 50 mm sodium acetate buffer, pH 4.3 (Chart 1).
Fractions 115 to 205 and 206 to 240 were combined,
dialyzed, and lyophilized to yield 840 and 115 mg, respec¬
tively. The sialic acid contents of these fractions together
with the starting material are given in Table 4. The sialic
acid contaminant present in the BSA was cleanly separated
from the albumin with the use of this method, although the
trailing edge of the peak contained a small amount of
periodate:resorcinol-positive material. The main portion of
the albumin peak was used for the growth studies. This
material was shown to have a molecular weight of 66,000
by gel exclusion chromatography and was readily soluble
in deionized water after dialysis and lyophilization.
Photography and Scanning Electron Micrographs. Pho¬
tographs were taken with the use of a Zeiss inverted
microscope with phase-contrast optics equipped with a 35-
mm semiautomatic camera system.
For scanning electron micrographs, cells were fixed with
0D0 So ' 180 ' 220 260
TUBS NUMBER
Chart 1. Purification of BSA (Sigma) on an AG 1-X2 200 to 400 mesh
column (4 x 40 cm). The column was eluted with a linear gradient of 1 to 50
mM sodium acetate (NaoAc) (A). The fractions were assayed for protein by
measuring absorbance at 280 nm (•).
glutaraldehydeiformaldehyde (by the method of Karnovsky)
for 20 to 30 min at 4°. They were rinsed with 0.1 m
cacodylate buffer, dehydrated in a graded ethanol series,
and then dried at the critical point, with the use of liquid
C02, and coated with 200 A of gold and palladium by ion
sputtering.
RESULTS
Growth data representative of 4 separate experiments for
the various media are summarized in Table 1. The results
demonstrate that the cells survived in both F12 and MB16
media over the course of the experiment (84 hr) with little,
if any, loss of viability. The growth rate is the same in the
F12 or MB16 when the medium is supplemented with 10%
FCS. The cells grow slightly better in 0.5% BSA-F12 medium
than they do in MB16 supplemented with 1% FCS. However.
F12 supplemented with 1% BSA (F12-1 % BSA) provides
significantly better growth than does the MB16-1% FCS
medium.
A typical titration curve for cells grown in F12 medium
plus varying BSA concentrations indicates that optimal
growth is obtained at 1% BSA, and no further effect is
noted by increasing the BSA concentration to 2% (Chart 2).
The growth rate is only slightly slower than that for cells
grown in 10% FCS. The plating efficiency was >50% (typi¬
cally 70%) in this medium, and the growth of single cells
into colonies could be seen with inoculations of 500 cells.
Osmolality determination indicated that the F12 medium
and F12 medium supplemented with 1 or 2% BSA or 10%
FCS had an osmolality of 286 ± 3 mOsmoles/kg, while
the MB16 medium with 10% FCS had an osmolality of 272 ±
3 mOsmoles/kg.
The cell line could be grown for multiple passages in the
F12-1 % BSA medium while showing high viability, high
density, melanin production (Fig. 1), and a fairly reproduci¬
ble growth rate. In a typical experiment, the cells were
Table 1
Growth data for B16 mouse melanoma cells in serum-containing
and serum-free media
The cells were seeded into 16-oz glass bottles at 2 x 108 viable
cells/25 ml medium. After 12 hr, the time of first medium change,
the number of cells was 80 to 100% of that seeded. The apparent
doubling times were calculated on the assumption that growth
started at 12 hr postseeding. The cell numbers listed are those at
84 hr postseeding. Data represent an average of 2 separate experi¬
ments.
Apparent dou-
Media Cell no. x 10-6 bling time (hr)
MB16 2.2 (87)a
MB16 + 0.1% FCS 2.2 (87)
MB16 + 1% FCS 5.0 (87) 54 ± 4 (2)"
MB16 + 10% FCS 21 (97) 22 ± 2 (2)
F12 2.1 (87)
F12 + 0.5% BSA 7.3 (95) 44 ± 4 (2)
F12 + 1% BSA 11 (95) 36 ± 7 (2)
F12 + 2% BSA 11 (97) 36 ± 7 (2)
F12 + 10% FCS 21 (98) 22 ± 2 (2)
" Numbers in parentheses, percentage of viability.
fi Numbers in parentheses, number of samples analyzed.
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Chart 2. Growth of B16 melanoma cells in F12 medium containing 0.25
(A), 0.5% (A), 1 or 2% (•) BSA or 10% FCS (O). Inset, growth with respect
to albumin concentration. The results presented are averages of duplicates.
grown for 6 passages in 16-oz bottles and seeded at 2 x
10s cells/bottle (viable) at each passage. Under these con¬
ditions, when passaged at 7-day intervals, cell densities of
2 to 2.5 x 107 viable cells were obtained. The cells could
also be grown under these conditions in 690-sq cm roller
bottles when seeded at 2 x 107 cells; over a 7-day period,
the cell number increased to 10s cells at 95% viability. The
cells were frozen in 10% dimethyl sulfoxide after the second
passage in F12-1 % BSA and could be revived after 1 year in
a liquid N. freezer.
After 6 passages the cells grown in F12-1 % BSA were
tested for tumor-forming ability as compared to the same
cells grown in MB16 medium containing 10% FCS; the
results (Table 2) indicate no loss of tumorigenic activity.
There was no significant change in cell volume in the
various media tested (B16-10% FCS, F12-1% BSA, F12-10%
FCS; data not illustrated).
Effect of Reduced FCS Concentration or Desialylation
of the FCS on Complex Saccharide Synthesis. Cells were
grown to confluency in B16 media-10% FCS and subse¬
quently labeled for 48 hr with [3H]glucosamine and Na235 S04
in the presence of B16 10, 1, or 0.1% FCS. The incorpora¬
tion of radioactivity into macromolecules was determined
as described under "Materials and Methods"; the results
are shown in Table 3. A decrease in the rate of synthesis of
saccharides extractable into 0.4 or 2 m NaCI with decreas¬
ing FCS concentration can be seen. Analysis of the 0.4 m
NaCI eluate by affinity chromatography on a wheat germ
agglutinin:Sepharose column and eluting with 0.1 n
N-acetylglucosamine indicated the presence of the Class
I sialoglycopeptide (4) in cells labeled in the presence of
reduced amounts of FCS (1 or 0.1%) (Chart 3).
Since one of our aims was to isolate mg quantities of
sialoglycoprotein produced by these cells, the possibility
of growing the cells in desialyzed serum-containing media
was also examined. Desialyzed FCS was prepared by acid
(0.1 n HjSOj, 80°, 1 hr) treatment and extensive dialysis.
Analysis by periodate;resorcinol and thiobarbituric acid
methods showed that between 95 and 99% of the sialic
Table 2
Tumor-forming ability of B16 mouse melanoma cells grown in
serum-containing and serum-free media
Cells were prepared and injected s.c. aseptically in 0.2 ml of the
serum-free or BSA-free medium. The C57BL/6J mice were ob¬
served for 2 months; data are presented as number of tumors
present/number of animals given injections.
Dose
Growth media




acid was removed. The growth of cells in medium contain¬
ing 10% desialyzed FCS showed that the cells could not
attach in this medium but that the medium was capable of
promoting growth if the cells were first seeded in regular
medium and then switched to the test medium.
Cells were grown to confluency in B16 medium-10% FCS
and then labeled for 48 hr with [3H]glucosamine and
Na23SS04 in the presence of the medium or B16 medium-
10% desialyzed FCS. The results showed that there was no
quantitative difference in the incorporation of 35S into
mndialyzable macromolecules, whether the cells were la¬
beled in the presence of FCS or desialyzed FCS. However,
the 3H label incorporated into macromolecules was re¬
duced by about 30% when the cells were labeled in the
presence of desialyzed FCS.
Effect of Growth in F12-1% BSA on Complex Saccharide
Synthesis. Cells grown in F12-1% BSA (Lots 55C-0074 and
95C-0191) were labeled by the use of ['"CJglucosamine,
and the sialoglycopeptides were isolated from the spent
medium as described under "Materials and Methods." The
sialoglycopeptides in the 0.4 m NaCI fraction and in the
CPC supernatant were examined for potential Class I and
II sialoglycopeptides on CPG, wheat germ agglutinin:
Sepharose 4B, and DEAE-cellulose columns. The elution
pattern of the 0.4 m fraction on the CPG column is
similar to that of the Class I (mucin-type) sialoglycopep¬
tides produced by these cells, which elutes at the position
of chondroitin sulfate (13,000 daltons) (4). After treatment
with V. cholerae neuraminidase, about 50% of the radioac¬
tivity moved in the low-molecular-weight region, and the
balance eluted in the original position. The amino sugar
analysis of this fraction indicated that 75% was galactosa-
mine and the balance was glucosamine. The presence of
the Class I sialoglycopeptide in this fraction was confirmed
by chromatography on a wheat germ agglutinin:Sepharose
4B column. The radioactivity that was bound specifically
(61%) was recovered by elution with 0.1 m /V-acetylglucosa-
mine and dialysis; on rechromatography, this fraction
bound completely to the lectin column.
The CPC supernatant fraction was mixed with 3H-labeled
Class II sialoglycopeptides isolated from cells grown in
regular (10% FCS) media and chromatographed on a DEAE-
cellulose column with the use of a gradient of 0.01 to 1.0 m
pyridine acetate, pH 5.2 (Chart 4). The coelution of the 3H-
and ,4C-labeled components illustrates the identity of the
Class II sialoglycopeptides synthesized by cells grown in
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Table 3
Effect of FCS concentration on production of complex saccharides: 0.4 u Nad eluate,
Class I sialoglycopeptides, and 2 u NaCI eluate mucopolysaccharides
Cells were grown to confluency from 2 x 10' cells (initial inoculum) in 16-oz bottles
and labeled with [3H]glucosamine (5 nCi/ml) and Na, 3!S0, (25 *zCi/ml) for 48 hr. The
media fractions were then prepared (19) and analyzed. The final cell counts of 1.1 x 107
cells/bottle indicated that the cells were confluent at the start of the labeling period.
3H 3»S
% concen¬ dpm/
tration of 103 dpm/103
FCS dpm %T" cells dpm %T" cells
0.4 m NaCI eluate
10 1,198,148 100 53 24,438 100 1.1
1 978,324 82 46 12,929 53 0.6
0.1 730,751 61 33 10,595 43 0.5
2 m NaCI eluate
10 2,588,517 100 114 772,872 100 34
1 1,708,050 66 81 647,007 84 31
0.1 1,128,838 44 52 380,695 49 18
" %T, percentage of incorporation of the given serum concentration relative to that




4 8 12 16 20
TUBE NUMBER
Chart 3. Chromatography of Class I sialoglycopeptides produced by mel¬
anoma cells grown in M816-0 1 % or 1% FCS medium on a wheat germ
agglutininiSepharose 4B column. Elution was with 0.05 M Tris-HCI buffer.
pH 7.8. followed by 0.1 M /V-acetylglucosamme (NAcGIc) in the same buffer.
dpm/peak to total recovered 3H dpm divided by ,4C dpm/
peak to total recovered ,4C dpm were, from left to right:
Peak 1, 0.72; Peak 2, 0.98; Peak 3, 1.06; Peak 4, 1.3; and
Peak 5, 0.92. These ratios indicate both qualitative and
quantitative similarities.
Analyses of the 2 n NaCI fraction indicated the presence
of a high-molecular-weight material eluting in the position
of the chondroitin 4-sulfate previously described (19). This
fraction was completely susceptible to chondroitinase ACII.
The low-molecular-weight components could not be com¬
pletely characterized, due to the small amount of material
present but appear to be heparan sulfate.
Analysis of BSA for Growth-promoting Factor(s). The
FRACTION NUMBER
Chart 4. Chromatography of non-CPC-precipitable (Class II) sialoglyco¬
peptides grown in the presence of [,4C]glucosamine in F12-1% BSA medium
(O) and corresponding fractions from cells grown in the presence of [3H]-
glucosamine in MB16-10% FCS medium (•). The samples were mixed,
applied on a DEAE-cellulose column, and eluted with a linear gradient of
0.01 to 1.0 m pyridine acetate, pH 5.2. The fractions were analyzed for 3h
and ,4C activity by scintillation counting.
results reported above are interesting in that the various
lots of BSA promoted growth; it was not known whether
the BSA itself or a contaminant was responsible for sup¬
porting growth. Reports in the literature suggest that the
bound fatty acids of albumin (17) are responsible for the
growth of various cell lines (13, 31). Because a major
reason for the use of this medium is the isolation of cell-
specified sialoglycopeptides and since commercial prepa¬
rations of BSA are only -96% pure, an analysis of the
various BSA samples was undertaken. The perio-
daterresorcinol assay (14) showed the presence of signifi¬
cant amounts of sialic acid (Table 4), which was not dialyz-
able. For further identification of the sialic acid-containing
contaminant, BSA (20 g) was extensively digested with
pronase, and the nondialyzable glycopeptide fraction was
recovered in the supernatant after 5% trichloroacetic acid
precipitation at 4°. The sialic acid content of this glycopep¬
tide mixture was 16%. as determined by the thiobarbituric
acid assay after acid hydrolysis (28) and on the intact
glycopeptide by the periodate:resorcinol method (14). The
absorption spectra of the chromogens obtained by both
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Table 4
Sialic acid content of BSA preparations from various sources
BSA source Sialic acid (mg/g)
ICN crystalline 2 (1)«
Pentex 99% pure 1.8-2 (1)
Sigma Fraction V 1.2-1 A1(5)
Sigma Fraction Va6 0 (4)
Sigma Fraction Vb6 0.05 (2)
" Numbers in parentheses, number of samples analyzed.
* These samples were prepared by chromatography of Sigma
Fraction V on an AG 1-X2 column (Chart 1). Va and Vb are
Fractions 115 to 205 and 206 to 240, respectively.
procedures were identical with those given by standard
N-acetylneuraminic acid, thus excluding the possibility of
spurious color formation due to the presence of deoxy
sugars, lipid peroxidation, etc. (28). Further, sialic acid-free
or fatty acid-free (Sigma) BSA at 10 mg/ml did not suppress
or enhance chromogen formation when mixed with stand¬
ard sialic acid (3 to 6 p.g). The sialic acid present in the BSA
preparations was isolated by acid hydrolysis (0.1 u H,SO„,
80°, 1 hr) followed by chromatography on an AG 1-X8
(formate) column and elution with 0.3 n formic acid. Paper
chromatography (26) showed the presence of both N-acetyl-
and N-glycolylneuraminic acids.
The neutral sugar content of the glycopeptide fraction
was determined by the phenol sulfuric acid method (10)
and was found to be 15% with the use of mannose as the
standard. Galactose and mannose were the neutral sugars
identified by paper chromatography. Hydrolysis with 6 n
HCI in a vacuum, at 100° for 24 hr followed by analysis on
the amino acid analyzer showed the presence of glucosa¬
mine as the only amino sugar; the hexosamine content was
estimated to be 13% after correction for losses during
hydrolysis. Gas-liquid chromatographic analysis of the gly-
copeptides indicated the presence of galactose, mannose,
glucosamine, and sialic acid in the ratio of 3.2, 4.7, 2.7,
and 2, respectively; the protein content was 22%.
The effect of the removal of this sialoglycoprotein from
BSA on the growth of B16 cells was determined with the
use of BSA purified by ion-exchange chromatography
(Chart 1). F12 medium, when supplemented with 1% sialo-
glycoprotein-free BSA, 10 a m sodium selenite, sodium
palmitate (10 to 15 MO/ml), sodium oleate (10 to 15 /xg/ml)
and sodium linoleate (5 to 7.5 Mg/ml) gave identical growth
to F12 media supplemented with 1% untreated BSA of the
same lot (Chart 5); sialoglycopeptide-free BSA without
additional fatty acids also supported growth, but to a lesser
extent. In these experiments, the cells cultured in F12
medium for 4 days immediately prior to the experiment
(during which the cells had a doubling time of 68 hr) were
used. This was done to minimize carry-over of growth-
promoting activity. This cell line also had been growing in
F12-1% BSA medium for 5 passages prior to growth in F12
medium. Supplementation of F12 medium with 1% defatted
BSA (Sigma) and the additional ingredients noted previ¬
ously gave identical results (Chart 6). Dialyzing and lyophi-
lizing of the BSA had no effect on growth-promoting activ¬
ity. Titrations indicated that selenite at 10~8 m in F12
medium is able to stimulate cell growth 27% over that of
F12 medium alone; therefore, in the above experiments
IME
Chart 5. Growth of B16 melanoma cells in F12 medium containing 1%
untreated BSA (▲); 1% sialoglycopeptide-free BSA supplemented with 10"*
m selenite and the sodium salts of the fatty acids (▲) and 1% sialoglyco¬






Chart 6. Growth of B16 melanoma cells in F12 medium supplemented
with fatty acid-free BSA (Sigma) ± 10~8 m selenite (■). in F12 medium
supplemented with fatty acids, fatty acid-free BSA (Sigma), and 10~8 m
selenite or control (1% untreated BSA) (▲), in F12 medium only (□), and in
F12 medium plus 10~8 m selenite (A). The cells used in this experiment
were not adapted to growth in F12 medium.
selenite was added at this concentration to ensure optimal
growth; however, it had no effect when added to medium
containing unpurified albumin.
Isolation of Sialoglycopeptides Produced by Mouse
Melanoma Cells Grown in Chemically Defined Media.
Pooled F12-1 % BSA-spent medium, about 2.5 liters, was
dialyzed extensively, lyophilized, and digested with pro-
nase, and the nondialyzable portion was isolated after
dialysis and lyophilization (350 mg). This material gave the
following analysis: sialic acid, 4.1%; hexosamine, 3.5%;
neutral sugars, 6.0%; and uronic acid, 1.3%. The balance
of the pronase-treated material (337 mg) was dissolved in
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0.04 m Na^O.,, and CPC was added to 0.2% final concentra¬
tion. After incubation for 16 hr at room temperature, the
precipitate was collected by centrifugation and washed 3
times with 0.2% CPC in 0.04 m NaaSO., by resuspension
and centrifugation. The precipitate was then fractionally
extracted with NaCI, dialyzed to remove CPC and NaCI,
and lyophiiized. The fractions corresponding to Class I
sialoglycopeptides and mucopolysaccharides were 3.0 and
2.9 mg, respectively.
The results presented clearly demonstrate the ability of
the mouse melanoma line B16 to make the Class I and II
sialoglycopeptides (4, 19) and the anionic polysaccharide
chondroitin sulfate (19), which is the high-molecular-weight
component, when grown in F12 medium supplemented by
specific lots of commerical BSA.
The biological properties of this line also appear un¬
changed compared to the cells grown in medium contain¬
ing 10% PCS. During the first passage, the cells appear to
grow somewhat more slowly than when serum is present in
the culture medium, but the growth rate is still quite
satisfactory. The cells grow to the same density as those
grown in the FCS-containing media, can be grown in roller
bottles, and do not become contact inhibited. Tumor-form¬
ing ability is not altered by the growth in this medium, and
scanning electron microscope pictures show significant
surface activity (30) (Fig. 2a). The size of the cells is not
visibly altered by growth in serum-free medium, nor is their
volume changed.
Electron Microscopy. Scanning electron micrographs of
this cell line grown in F12-1% BSA medium or MB16-10%
FCS indicated a similar amount of surface activity (Fig. 2).
DISCUSSION
With respect to the parameters of lack of contact inhibi¬
tion, tumor-forming ability, morphology, and volume, the
cells grown in the BSA-containing medium are not detecta-
bly different from cells grown in the presence of serum.
These results, coupled with the fact that the cells retain the
ability to produce melanin and to make characteristic com¬
plex saccharides, indicate that this albumin-containing F12
medium can be substituted for that containing serum.
The Sigma lots of BSA (A4503) all stimulated growth,
whereas more highly purified samples (Pentex, Inc., Kan¬
kakee, III.) did not stimulate growth to the same extent, nor
did fatty acid-free BSA. The factor or factors present in the
BSA that permit growth appear to be partially removed by
chromatography on AG 1-X2 200 to 400 mesh anion-ex-
change resin under conditions that result in essentially
quantitative recovery (95%) of the BSA from the column.
The growth factor may not be the sialic acid-containing
contaminant, as supplementation of F12 medium with
the purified sialoglycoprotein fraction did not stimulate
growth. Pentex BSA prepared by similar methods (Cohn
Fraction V low-temperature alcohol precipitation) does not
have the growth-promoting activity of the lots of Sigma
BSA tested, despite the fact that it has greater amounts of
sialoglycoprotein contamination. Fatty acid-free BSA
(Sigma) also has poor growth-promoting activity, despite
containing 80 to 100% of the sialogiycoprotein present in
the nondefatted BSA, but retains optimal growth-promoting
activity if supplemented with fatty acids and selenite. Chro¬
matography under the conditions described may remove
fatty acids (22), and selenite and different lots of BSA may
vary in fatty acid content (22).
Despite the presence of the sialoglycoprotein contami¬
nant, the unpurified BSA at the concentration used still
contains 17 to 24 times less sialic acid than does the
medium containing 10% FCS. The use of this medium
containing 1% BSA, or preferably the fatty acid-supple¬
mented medium with purified BSA, will facilitate the isola¬
tion, chemical, and immunological characterization of the
complex saccharides elaborated by these cells in culture.
Although this is only an intermediate step to the desired
growth of cells in protein and macromolecule-free medium,
it should facilitate the above objectives. It is possible to
grow the B16 melanoma cells in F12 medium, but the growth
was not of the same magnitude or consistency as with F12
medium supplemented with BSA. This might be due to the
presence of selenite (16) in trace amounts, since not all
lots of the F12 media supported growth to the same extent.
The capability of the cells to grow better in the presence
of serum albumin may be due to the capability of this pro¬
tein to solubilize and transport fatty acids (17) and possibly
cofactorS"such as biotin.
A recent communication (J. Mather and G. Sato, Hor¬
mone Requirements of a Clonal Line of the B16 Mouse
Melanoma, personal communication) has described the
growth of another mouse melanoma line in a serum-free
(Dulbecco's modified MEM) medium. This medium, how¬
ever, contains insulin (5 /xg/ml), testosterone (10~9 m),
luteinizing hormone-releasing factor (10 ng/ml), transferrin
(5 ^g/ml), and follicle-stimulating hormone (0.4 /j.g/ml);
the last 2 are glycoproteins. In this medium, the synthesis
of the normal mucopolysaccharides and (sialo)glycopeptides
has not been examined.
It is of interest that wheat germ agglutinin cytotoxicity is
increased 6-fold in F12-1 % BSA medium over that in 10%
FCS-containing medium for these cells (L. Evans and E. A.
Davidson, unpublished observation).
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Fig. 1. Photomicrograph of cells grown in F12-1% BSA. The dark granules are melanin granules, x 666.
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Fig. 2. Scanning electron micrographs of B16 melanoma cells grown in (A) F12 + 1% BSA medium (x 2250) and (B) MB16 + 10% FCS medium (x 2270).
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SUMMARY
The major glycosaminoglycans isolated from B16 mouse melanoma tumors
after Pronase digestion were shown to be a family of chondroitin 4-sulfates with
different degrees of sulfation and a wide molecular-weight range. Ultracentrifugation
data gave molecular weight values as high as 88 000, in contrast to that of costal
cartilage chondroitin 4-sulfate which is about 14 000. A mucin-type sialoglycopeptide,
isolated from the tumors by cetylpyridinium chloride precipitation of the Pronase
digest, was shown to contain O-glycosylically linked tetra- and tri-saccharides
consisting of sialic acid, galactose, and ^-acetylgalactosamine. The sialoglycoprotein,
which on Pronase digestion gave rise to the glycopeptide, was isolated from the tumor
by extraction with lithium diiodosalicylate and affinity chromatography on a wheat-
germ agglutinin-Sepharose 4B column. It was homogeneous on the basis of gel
filtration on Sepharose 4B and Sephadex G-200 columns, lectin affinity, and ion-
exchange chromatography. The compounds isolated from the B16 mouse melanoma
tumors are similar to those produced by the cultured melanoma cells, which suggests
that the latter compounds are not artifacts of the culture system.
INTRODUCTION
The presence of glycosaminoglycans and glycoproteins in a variety of normal
and cancerous cells has been described. In the case of B16 mouse melanoma cells
grown in culture, the glycosaminoglycans and glycopeptides have been characterized
in some detail: The glycosaminoglycans include a family of chondroitin 4-sulfates
with unusually high molecular weights1,2, and the mucin-type sialoglycopeptide
isolated was shown to contain the structure (NeuAc)2 -►(Gal ->GalNAc) O-glycosyl-
ally linked to seiine and threonine. This glycopeptide had the interesting characteristic
of binding to wheat-germ agglutinin, a characteristic that was dependent on the
proportion of terminal sialic acid groups present3,4. The present study was undertaken
to provide a direct comparison between the macromolecules synthesized by tumor cells
grown in vitro with those obtained from in vivo proliferating tissue. The presence of
similar macromolecular, cell-surface components for both types of growth conditions
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tends to strengthen the biological applicability of results obtained with cultured cell
lines. In addition, the possibility of isolating milligram quantities of specific glyco¬
proteins from the tumors is examined.
experimental
Materials. — Pronase CB was obtained from Calbiochem, La Jolla, CA 92037;
controlled-pore glass from Electro-Nucleonics, Fairfield, NJ 07006; diethylaminoethyl
(DEAE) cellulose and deoxyribonuclease (EC 3.1.4.5) from Sigma Chemical Co.,
St. Louis, MO 63178; ribonuclease (EC 2.7.7.16) from Boehringer Mannheim
Biochemicals, Indianapolis, IN 46850; chondroitinase ABC (EC 4.2.2.4) from Miles
Laboratories Inc., Elkhart, IN 46514; BioGel P-4 from BioRad Laboratories,
Richmond, CA 94804; and lithium diiodosalicylate from Eastman Organic Chemical
Div., Rochester, NY 14650. The tumors were obtained from C57B16/J mice that had
been injected subcutaneously with B16 mouse melanoma cells grown in cultures.
Chromatography. — Exclusion chromatography was performed (a) on glyceryl,
controlled-pore glass-beads CPG-240 (200-400 mesh) packed in columns (0.9 x 60 cm)
with continuous vibration and eluted with 0.1m pyridinium acetate buffer (pH 5.2);
(b) on BioGel P4 columns (0.9x54 cm) eluted with the same buffer; and (c) on
Sephadex G-200 and Sepharose 4B columns (1.5 x 50 cm), and Sepharose 6B columns
(1.5x85 cm) eluted with 50mM Tris-HCl buffer (pH 8.0). Ion-exchange chromato¬
graphy was performed on (diethylamino)ethylcellulose (DE52) packed in a column
(1.2x40 cm) and eluted with a linear gradient of 10mM to m pyridinium acetate
buffer (pH 5.2) or in a column (0.9 x 10 cm) eluted stepwise with 0.5m, 0.8m, and m
pyridinium acetate buffer (pH 5.2) (20 ml each). Wheat-germ agglutinin (WGA) was
isolated and conjugated to Sepharose 4B as described earlier4; after loading of this
sample, the WGA-Sepharose was first eluted with 50mM Tris-HCl buffer (pH 8.0),
and then with Tris buffer containing 0.1m A-acetylglucosamine. Descending paper
chromatography was performed in 2:3:1 (v/v) butanol-acetic acid-m NH4OH.
Methyl glycosides as their per-O-trimethylsilyl derivatives were separated by g.l.c. on
3.8% SE-30 as described by Clamp et al.5, except that A-reacetylation was done
according to Etchison and Holland6.
general methods
Chondroitinase ABC digestions were done according to Saito et al.1 Un¬
saturated disaccharides derived from chondroitin 4-sulfates were quantitatively
determined by measuring their absorbance at 232 nm. Molecular weights of glycos-
aminoglycans were determined by equilibrium sedimentation2,8. Hydrolysis, prior to
amino acid analysis, was carried out in vacuo with 6m HC1 at 110° for 24 h.
Protein was determined according to Lowry et al.9, using crystalline bovine serum
albumin as the standard. Total sialic acid was determined by the periodate-resorcinol
method10.
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Cellulose acetate electrophoresis was carried out in the following electrolytes:
LiCl or 20804", 0.2m butylamine12, and calcium acetate13. Alcian Blue staining
(0.1% in 0.5% acetic acid) was used for detecting glycosaminoglycans and sialo-
glycopeptides.
Reductive /^-elimination was performed with m NaBH4 in 0.1m NaOH for 72 h
at 37°; the digest was neutralized with 4m acetic acid prior to analysis.
Extraction procedure. — The tumors (114 g, weight of wet material) were
cleaned free of connective tissue, homogenized in acetone, and air-dried to yield a
material (20.8 g) containing about 25% of protein and ~0.5% of sialic acid by weight.
A portion (16.6 g) was extracted with 2:1 (v/v) chloroform-methanol, followed by
ether. The resulting, defatted tumor powder (12.9 g) was sequentially digested with
ribonuclease in 50mM Tris-HCl buffer (pH 7.2) for 50 h, with deoxyribonuclease in
50mM Tris-HCl buffer (pH 7.4) containing 10mM MgCl2 for 47 h, and with Pronase
(250 mg added in portions over a period of 7 days) in Tris-HCl buffer (pH 8.0)
containing 10mM MgCl2 and 10mM CaCl2. These digestions were carried out at 37°
in the presence of toluene. The digest was exhaustively dialyzed, and centrifuged to
remove insoluble material, and the supernatant was lyophilized. The resultant
product (392 mg; 14% of sialic acid) was dissolved in water (25 ml), and saturated
cetylpyridinium chloride (CPC) added until no more precipitate was formed. The
CPC precipitate was harvested by centrifugation, and sequentially extracted with
sodium chloride (0.2m, 0.4m, 0.8m, and 2.0m) containing 0.1% of CPC. The salt
extracts were freed of CPC and ionic components by dialysis at 37°, and lyophilized.
The yields were 17.6 mg, 2.0 mg, 7.7 mg, and 4.3 mg, respectively.
The recovery of material in the CPC-precipitable fraction is comparable to that
obtained with in vitro cultured cells which utilize d-[3H]glucosamine as a metabolic
precursor. The bulk of the nonprecipitable material consisted of glycopeptides, most
of which appear to contain /V-linked carbohydrate; they were not studied further.
The CPC precipitate contained ~20% of the total sialic acid content, all of which
being present in the 0.2m salt eluate.
A portion of the acetone powder (4.2 g) was defatted, treated with ribonuclease
and deoxyribonuclease as just described, dialyzed, and extracted with lithium diiodo-
salicylate14: this extract was used for glycoprotein isolation.
results and discussion
The 2.0m Nad Fraction. — Examination of the 2.0m NaCl fraction (4.3 mg)
by cellulose acetate electrophoresis in LiCl buffer gave the results shown in Fig. 1.
The major band had the same mobility as chondroitin 4- or 6-sulfate, and the minor
band had the same mobility as the mucin-type sialoglycopeptide of the 0.2m NaCl
Fraction. Further electrophoretic studies employing ZnS04, calcium acetate, or
butylamine as electrolytes confirmed the identity of the major band as either
chondroitin 4- or 6-sulfate.
Examination by cellulose acetate electrophoresis in butylamine of the material,
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after digestion with chondroitinase ABC, showed that the major band was completely
digested. Descending paper chromatography of the digest in 2:3:1 (v/v) butanol-
acetic acid-M NH4OH showed the presence of the unsaturated disaccharide derived
from chondroitin 4-sulfate; no other unsaturated disaccharide was present. These
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Fig. 1. Cellulose acetate electrophoresis of the 2.0m NaCl Fraction in 50mM LiCl-lOmM HC1, pH 2.0
at 1 mA per cm for 20 min. The components were detected with the Alcian Blue stain. Abbreviations:
Hep, heparin; HS, heparan sulfate; C4S, chondroitin 4-sulfate; C6S, chondroitin 6-sulfate; KS,
keratan sulfate; DS, dermatan sulfate; and HA, hyaluronic acid.
The 2.0m NaCl eluate (2.5 mg) was chromatographed on a controlled-pore
glass column, which had been calibrated with vitreous humor hyaluronic acid,
cartilage chondroitin 4-sulfate, and D-glucuronic acid. Since analytical monitoring
of the column effluent would have been wasteful considering the amount of material
available, fractions were combined according to the profile of the standards as shown
in Fig. 2, dialyzed, and lyophilized. Fractions 21-27 gave 0.73 mg, and Fractions 28-40
1.21 mg; this technique also removed the contaminating pigmented material that was
eluted in Fractions 41-60. Examination of the fractions by cellulose acetate electro¬
phoresis in ZnS04 showed that most of the bands that stained strongly with Alcian
Blue were eluted in the high-molecular-weight region (Fractions 21-27) and that the
area corresponding to a molecular-weight range of 13 000-20 000 (Fractions 28-40)
contained most, if not all, of the weakly staining component. The identity of the
high-molecular-weight fraction as chondroitin 4-sulfate was confirmed by cellulose
acetate electrophoresis in ZnS04, and by paper chromatography of its chondroitinase
ABC digest.
Analysis of the high-molecular-weight fraction by equilibrium sedimentation
showed a mol. wt. range of 34 670 + 2 000 to 69 350 + 8 000. The results for amino
acid analysis of the same fraction are shown in Table I. The major amino acids
present were glycine, serine, glutamic acid, and aspartic acid. The first three amino
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Fraction No.
Fig. 2. Elution profile of vitreous humor hyaluronic acid, cartilage chondroitin 4-sulfate, and
glucuronic acid (GlcUA) on a controlled-pore, glass-bead column (0.9 x 60 cm). The fractions were
analyzed by the orcinol reaction for uronic acid. Abbreviations, see legend to Fig. 1.
TABLE I
amino acid composition of the major components of 0.2m and 2.0m NaCl fractions from
mouse melanoma tumors
Amino acid (molar %)
Peak 2" of 0.2m NaCl Higher mol. wt. component of
fraction 2.0m fraction
Lysine 1.3 n.d.6
Cysteic acid 0.7 0.6
Aspartic acid 6.8 4.6
Threonine 13.7 2.8
Serine 12.2 8.6











"From WGA-column. "Abbreviation: n.d., not detected.
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acids have been observed to be in the vicinity of the linkage between the carbo¬
hydrate chain and the protein core of cartilage proteoglycan15. From the results of
the amino acid analysis, it can be seen that glucosamine is present in minor proportion
relative to galactosamine.
Gas-liquid chromatographic analysis of the high-molecular-weight chondroitin
4-sulfate after methanolysis, A-reactylation, and silylation showed the presence of
xylose, and possibly galactose. Xylose was identified by its retention times and by
cochromatography with the trimethylsilyl derivatives of methyl xylosides. The
sample gave a peak corresponding to one of the four peaks of a d-galactose standard,
but quantitative determination was not performed. Cartilage chondroitin 4-sulfate,
when examined under the same conditions, gave the same xyloside peaks together
with one galactoside peak. The identification of galactose is only tentati've, and it was
not possible to deduce whether the structure Gal -> Xyl -► serine is present in this
fraction.
The 0.8m NaCl Fraction. — Chromatography of the 0.8m NaCl Fraction
(5.0 mg) on a controlled-pore glass column as just described gave fractions of high
(0.61 mg), medium (2.39 mg), and low mol. wt. (1.55 mg). The high-molecular-weight
fraction was examined by cellulose acetate electrophoresis in ZnS04 and showed one
major band (>90%) and two minor bands. The major band had a mobility inter¬
mediate to that of heparan sulfate and chondroitin sulfates. An aliquot of this fraction
was digested with chondroitinase ABC and re-examined by electrophoresis. The major
band was completely digested leaving only the two minor bands. Examination of the
digest by paper chromatography as described for the 2.0m NaCl Fraction showed the
presence of unsaturated disaccharides corresponding to standards of unsaturated
disaccharide 4-sulfate and disaccharides. Quantitative measurements gave a value of
1.0:1.4 for the ratio of sulfated to unsulfated disaccharides. Thus the high-molecular-
weight component of the 0.8m NaCl Fraction is an undersulfated chondroitin 4-
sulfate; its mobility on cellulose acetate electrophoresis is in accordance with this
structure. Examination of this undersulfated chondroitin 4-sulfate by equilibrium
sedimentation showed a mol. wt. range of 44 000 ±2 000 to 88 000 + 8 000. Gas-liquid
chromatographic analysis of the high-molecular-weight fraction from the 0.8m NaCl
Fraction indicated the presence of xylose and galactose. These sugars were identified
by their retention times and cochromatography with standards. Other peaks of
unknown identity were also obtained, presumably due to the impurities present as
shown by the minor bands on cellulose acetate electrophoresis.
The 0.2m NaCl Fraction. — Cellulose acetate electrophoresis of the 0.2m NaCl
Fraction in LiCl buffer gave two distinct bands and a third, diffuse band. After gel
filtration on controlled-pore glass, examination of the fractions of different molecular
weights by cellulose acetate electrophoresis showed that the diffuse band was eluted
in the high-molecular-weight region. The intermediate-molecular-weight fraction gave
two distinct bands in a ratio of 1:3 for the proportion of faster to slower moving
bands, as shown in Fig. 3. Anion-exchange chromatography of this fraction on
DEAE-cellulose and re-examination by cellulose acetate electrophoresis showed that
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Fig. 3. Cellulose acetate electrophoresis of the intermediate-molecular-weight component of the
0.2m NaCl Fraction obtained by fractionation on a CPG column (Lane A). Conditions for electro¬
phoresis were as described for the 2.0m fraction (see Fig. 1). Lane B, the fraction after treatment with
chondroitinase ABC; Lane C, the portion not bound to the WGA-Sepharose; Lane D, the portion
bound to WGA-Sepharose and eluted with GlcNAc; and Lane E, standard hyaluronic acid and
chondroitin 4-sulfate. Abbreviations, see legend to Fig. 1.
the faster band was slightly more acidic than the slower band. Gas-liquid chromato¬
graphic analysis of the intermediate-molecular-weight fraction indicated the presence
of mannose, galactose, ^-acetylgalactosamine, tV-acetylglucosamine, and sialic acid,
suggesting the presence of a mixture of sialoglycopeptides.
The sialoglycopeptides in the 0.2m NaCl Fraction were labeled on the sialic
acid moiety by the periodate-tritiated borohydride technique16. Chromatography of
the labeled sialoglycopeptides on BioGel P-4 before and after hydrolysis (50mM
H2S04, 80°, 1 h) proved that at least 95% of the label was on modified sialic acid
residues (C-7 and -8 analogues). Chromatography on a WGA-Sepharose 4B column
gave two fractions; one being eluted with Tris buffer alone (25%), and the other being
eluted with the buffer containing A-acetylglucosamine (75%). This procedure was
repeated on a preparative scale using the unlabeled material, and the fractions
obtained were examined by cellulose acetate electrophoresis. The WGA-bound
fraction gave only one band, whereas the unbound material contained all of the minor
component and some of the major component, possibly due to overloading of the
WGA-Sepharose column (Fig. 3). The two labeled fractions were examined on a
BioGel P-4 column before and after alkaline borohydride treatment to determine the
nature of the carbohydrate-peptide linkage (see Fig. 4). Before treatment, both
samples were eluted in the void volume of this column. The WGA-bound fraction
showed 81% of ^-elimination, and the reduced oligosaccharides dbtained had the
same mobilities on a BioGel P-4 column as those derived from fetuin sialoglycopeptides
treated similarly11. The material eluted in the void volume of the BioGel P-4 column
did not bind to WGA. These results show that the WGA-bound sialoglycopeptide
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contains mainly 0-glycosyl linkages. By contrast, the unbound material gave 29%
^-elimination, some of which may be derived from sialoglycopeptides that were not
bound to WGA-Sepharose because of overloading. The fraction that did not bind to
WGA-Sepharose was not further studied. The amino acid analysis of the WGA-
bound fraction gave the data shown in Table I. As expected for an 0-glycosyl
sialoglycopeptide, serine and threonine were among the major amino acids present.
Fraction No.
Fig. 4. Chromatography of the WGA-Sepharose subtractions WGA Peak I (material not retained on
the WGA-Sepharose column) and WGA Peak II (material retained and eluted with 0.1m yV-acetyl-
glucosamine) of the 0.2m NaCl Fraction on BioGel P-4 column (0.9 x 54 cm), after treatment with
alkaline borotritide. Aliquots of the fractions were analyzed for tritium activity. Peak positions of
markers are indicated by arrows; Vo, Blue Dextran; Tetra and Tri, tetra- and tri-saccharides obtained
by alkaline borotritide treatment of fetuin; NeuAc, ,V-acetyineuraminic acid.
The reduced oligosaccharides obtained from the 0.2m NaCl Fraction after
^-elimination were purified by gel filtration on BioGel P-4 and examined by g.l.c.;
sialic acid, galactose, and (V-acetylgalactosaminitol were present in the ratio of
1.7:1.0:0.8. Thus, the major glycopeptide of the 0.2m NaCl Fraction is a sialoglyco¬
peptide having O-glycosylically-bound oligosaccharides which consist of terminal
sialic acid groups, and galactose and ^-acetylgalactosamine (peptide-linked) residues;
the carbohydrate chains are possibly 3 or 4 residues long. These characteristics are
identical with those of the mucin-type sialoglycopeptide obtained from B16 melanoma
cells grown in monolayer3'4.
Isolation of the sialoglycoproteins. — In order to isolate the parent glycoprotein
of this sialoglycopeptide, the tumors were extracted with lithium diiodosalicylate14.
The water-soluble sialoglycoproteins were labeled in the sialic acid moiety by the
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Fig. 5. Elution profiles of the sialoglycoproteins, prepared by solubilization of the tumor with
lithium diiodosalicylate, on a Sepharose 4B column. The sialoglycoproteins were labeled with
tritium by modification of the sialic acid groups. The solid line illustrates the profile of the whole









0.2 M NaCI FRACTION
Fig. 6. Chromatography of 3H-labeled sialoglycopeptides on a DEAE-cellulose column (1.2 x 40cm).
Elution was performed with a linear gradient of 10mM to M pyridinium acetate, pH 5.2. Upper part:
glycopeptides obtained by Pronase digestion of peak F3; middle part: the portion of the glycopeptides
which bound to the WGA-Sepharose column (see Fig. 4); lower part: the 0.2m NaCI Fraction obtained
by CPC fractionation of the Pronase-digested tumor.
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periodate-tritiated borohydride technique16. Chromatography of the labeled com¬
ponents on a Sepharose 4B column indicated the presence of several glycoproteins
(see Fig. 5). After fractionation on WGA-Sepharose, the WGA-bound fraction gave
only one peak (F3) when rechromatographed on Sepharose 4B. When F3 was re-
chromatographed on Sepharose 6B, DEAE-cellulose (DE52), or WGA-Sepharose,
only one peak was obtained. Although Fraction F3 appeared homogeneous by these
criteria, it must be remembered that these methods only monitor the presence of
labeled sialoglycoprotein. The location of the label on sialic acid was identified by
hydrolysis and chromatography on BioGel P-4.
Chromatography of Fraction F3, after Pronase digestion, on DEAE-cellulose
showed a mixture of sialoglycopeptides (Fig. 6, upper part). These glycopeptides were
chromatographed on WGA-Sepharose and the WGA-bound sialoglycopeptides,
when examined on DEAE-cellulose, gave a single, broad peak (Fig. 6, middle part)
comparable to that obtained when the 0.2m NaCl Fraction was examined on the same
column (Fig. 6, lower part). When treated with alkaline borohydride, the WGA-bound
sialoglycopeptides obtained from Fraction F3 gave results similar to those obtained
from the major component of the 0.2m NaCl Fraction, 87% of ^-elimination being
observed in comparison to 81 %. The amount of reduced trisaccharide obtained in the
case of the 0.2m NaCl Fraction was higher, possibly because of the lengthier extraction
procedure involved. Gel filtration on glass beads CPG-240 of the WGA-bound
sialoglycopeptides from the 0.2m NaCl Fraction and from Fraction F3 gave identical
profiles. Their behaviors on WGA-Sepharose, DEAE-cellulose, BioGel P-4, after
alkaline-borohydride treatment, and controlled-pore glass all indicate that they are
very similar. Thus, Fraction F3 appears to be the glycoprotein that gives rise to the
sialoglycopeptide isolated in the 0.2m NaCl Fraction after Pronase digestion. It is
interesting that, among the sialoglycoproteins of the B16 tumor, only one (F3) binds
to WGA. Assuming identical incorporation of label per mole of sialoglycoprotein, it
is calculated that Fraction F3 represents 40% (mole/mole) of the total sialoglyco¬
proteins in the lithium diiodosalicylate extract.
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The synthetic glycosides, p-nitrophenyl- and o-nitrophenyl-2-acetamido-2-
deoxy-3-0-/3-D-galactopyranosyl-a-D-galactopyranosides, were found to be ef¬
fective chromogenic substrates for an endo-a-iV-acetyl-D-galactosaminidase. We
did not experience any problems when these substrates were used for the screen¬
ing of column fractions during the purification of the endoenzyme from Diplococcus
pneumoniae culture filtrates. However, it should be pointed out that a combina¬
tion of exo-/3-galactosidase, capable of cleaving /31 —* 3 linkages, and an exo-
a-/V-acetyl galactosaminidase would also liberate nitrophenol from the above sub¬
strates. The enzyme had no action on several other synthetic glycosides tested
indicating the strict specificity of this enzyme for the disaccharide Gal-^> GalNAc
linked via an a-linkage to the aglycone. The enzyme was inactive when the aglycone
was methanol but shows activity against the glycosides of phenol, nitrophenols,
serine, and threonine. The use of p-nitrophenyl-2-acetamido-2-deoxy-3-0-/S-D-
galactopyranosyl-/3-D-galactopyranoside, which is a competitive inhibitor of the
endoenzyme, as an affinity ligand for the purification of the enzyme is described.
The purification and characterization of an endo-a-iV-acetyl-d-galactos-
aminidase isolated from culture filtrates of Diplococcus pneumoniae has
been described by us (1,2). Endo and Kobata (3) and Glasgow et al. (4)
have also described this enzyme activity. In all these studies naturally
occurring glycoproteins or glycopeptides derived from them were used as
substrates. These substrates are either not readily available (antifreeze
glycoprotein) or require extensive isolation procedures (asialofetuin gly-
copeptide Fraction C). The availability of readily obtainable substrates
will greatly facilitate the study of this enzyme as well as the exploration
of other sources (both bacterial and mammalian) for the presence of this
or similar enzyme activities.
The present report describes the use of synthetic substrates for assay¬
ing endo-a-./V-acetyl-d-galactosaminidase. These studies also provide fur-
t To whom requests for reprints should be addressed.
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Gal/31 ->■ 3 GalNAc al OC6H4N02 (p) 100 (5)
Gal/31 —» 3 GalNAc al —» 0CfiH4N02 (o) 100 (6)
Gal/31 —» 3 GalNAc al —» OC6H5 70 (6)
Gal/31 —» 3 GalNAc al —» OCH3 0 (6)
Gal/31 —» 3 Gal al —> 0C6H4N02 (p) 0 (6)
Gal/31 -* 3 GalNAc /31 OC6H4NO, (p) 0 (5)
Gal/31 3 GlcNAc al OCH3 0 (7)
Gal/31 3 Gal >31 -> 0C6H4N02 (p) 0 (6)
Gal/31 3 GlcNAc >31 -► OC6H4N02 (p) 0 (8)
Gal/31 -♦ 6 GlcNAc >31 -» OCfiH4N02 (p) 0 (8)
GlcNAc/31 ->■ 6 Gal /31 -♦ 0C6H4N02 (p) 0 (9)
ther information on the substrate specificity of this enzyme. In addition,
the use of a synthetic glycoside as an affinity ligand for the purification of
this enzyme was investigated.
MATERIALS AND METHODS
Partially purified preparations ofD. pneumoniae glycosidases as well as
the inocula of the bacteria were provided by Dr. G. Ashwell. Endoa-/V-
acetyl-D-galactosaminidase was purified from culture filtrates of D.
pneumoniae by isoelectric focusing as described previously (2).
The following glycosides (see also Table 1) were synthesized as pre¬
viously described: p-nitrophenyl-2-acetamido-2-deoxy-3-0-/3-d-galacto-
pyranosyl-a and /3-d galactopyranosides (5); o-nitrophenyl-2-acetamido-2-





6-G-/3-D-galactopyranosyl-/3-D-glucopyranoside (8); p-nitrophenyl 6-0-(2-
acetamido-2-deoxy-/3-D-glucopyranosyl)-/3-D-galactopyranoside (9); and p-
nitrophenyl-3-0-/3-D-galactopyranosyl-aand /3-D-galactopyranosides (6).
Asialofetuin glycopeptide Fraction C (Gal 1-^3 GalNAc A Ser/Thr
peptide)1 was isolated as previously described (2). This glycopeptide was
labeled by treatment with galactose oxidase followed by NaB3H4 reduc¬
tion according to the method of Morell et al. (10). The labeled glycopep-
1 Abbreviation used: GalNAc. ^-acetylgalactosamine.
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tide was recovered by addition of acetone to destroy excess NaB3H4 and
repeated evaporation with methanol to remove borate. The sample was
then passed through a column of AG 50-X2(H+); the column was washed
with 4 bed vol of 1 n NH4OH and the washings were evaporated to
dryness. Hydrolysis (1 n HC1, 100°C, 6 h) followed by examination of
the products by paper chromatography in «-butyl acetate:acetic acid:
water (3:2:1) showed that 88% of the label was in galactose with the bal¬
ance in galactosamine.
The action of the endoenzyme on the various synthetic glycosides was
determined by incubating 10 p.1 of a 10 mM solution of the substrate
with 20 p.1 of citrate phosphate buffer, pH 6.2. and enzyme in a total vol¬
ume of 50 pi at 37°C for various times. In the case of the chromogenic
substrates, 450 pi of 0.2 m sodium carbonate was added at the end of the
incubation and the absorbance at 420 nm was measured. The hydrolysis of
nonchromogenic substrates was checked by the Morgan-Elson reaction
(11) in order to detect the released disaccharide. Appropriate controls
without enzyme or substrate were also included. The phenol released
from the phenylglycoside was determined by using the Folin reagent.
Preparation of Affinity Columns
Method /. The inhibitor p-nitrophenyl-2-acetamido-2-deoxy-3-0-/3-d-
galactopyranosyl-/3-d-galactopyranoside was reduced with hydrogen using
Raney nickel as catalyst (12). The reduced product was isolated and
coupled to CH-Sepharose in the presence of l-ethyl-3-(-3-dimethylamino-
propyl)-carbodiimide according to Cuatrecasas (13).
Method II. In this method the reduction of p-nitrophenyl-2-acetamido-
2-deoxy-3-0-/3-d-galactopyranosyl-/3-d-galactopyranoside and the cou¬
pling of the p-aminophenyl compound to cyanogen bromide-activated
Sepharose CL6B was carried out as described by Bloch and Burger (14).
RESULTS AND DISCUSSIONS
The action of the endo-aw-acetyl-d-galactosaminidase on various syn¬
thetic substrates is summarized in Table 1. The p-nitrophenyl-, o-nitro-
phenyl-, and phenyl-2-acetamido-2-deoxy-3-0-/3-d-galactopyranosyl-a-d-
galactopyranosides were hydrolyzed by the enzyme. The enzyme was
devoid of activity against methyl-2-acetamido-2-deoxy-3-0-/3-d-galacto-
pyranosyl-a-d-galactopyranoside. This is in agreement with the finding
that methyl glycosides are generally poor substrates for glycosidases.
Previously we have demonstrated the action of the endoenzyme on the
O-glycoside linkage between the disaccharide (Gal 1 3 GalNAc) and
serine or threonine residues in glycoproteins (1,2). The inability of the
enzyme to hydrolyze any of the other substrates listed in Table 1 further







Fig. 1. Paper chromatography of enzyme digests of o-nitrophenyl-2-acetamido-2-
deoxy-3-0-/3-galactopyranosyl-a-d-galactopyranoside and [3H]fetuin glycopeptide Fraction
C. Paper chromatography was performed on Whatman No. 1 paper using ,V-butylacetate:
glacial acetic acid:water (3:2:1) for 24 h. The oligosaccharide from o-nitrophenyl sub¬
strate, marked A, and the reference sugars were detected by the silver nitrate reagent.
The labeled oligosaccharide from [3H]fetuin glycopeptide Fraction C is indicated by the
shaded area.
a-O-glycosidically to the aglycone (2). Of special interest is the inability
of the enzyme to hydrolyze p-nitrophenyl-3-0-/3-D-galactopyranosyl-a-D-
galactopyranoside which indicates that the acetamido group at position 2
of galactose is essential for the activity of this enzyme.
The release of p-nitrophenol or o-nitrophenol from p-nitrophenyl- and
o-nitrophenyl-2-acetamido-2-deoxy-3-0-/3-D-galactopyranosyl-a-D-ga-
lactopyranosides paralleled color formation in the Morgan-Elson reac¬
tion. The product reacting with the Morgan-Elson reagent was identified
as Gal 1-4 GalNAc by paper chromatography as illustrated in Fig. 1.
The release of o- and p-nitrophenols from the chromogenic substrates
was linear with respect to time and the proportion of enzyme added.
The activity of the enzyme on these substrates at different pH using
citrate phosphate buffer is shown in Fig. 2. The optimum pH is in the range
5.5 to 7.0 in the present studies in contrast to an optimum pH of 7.6
for the hydrolysis of asialofetuin glycopeptide Fraction C using Tris/
maleate or Tris/HCl buffers reported earlier (2). Endo and Kobata (4)
reported a pH optimum of 6.0 in phosphate buffer using asialoglycophorin
glycopeptide substrate. Thus, the nature of the substrate, the type of
buffer, and the time of incubation appears to influence the optimum pH for
the activity of this enzyme. The effects of varying substrate concentra¬
tions on the rate of hydrolysis of p- and o-nitrophenyl substrates were
measured and the apparent Michaelis constants (Km) were determined
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Even though the p-nitrophenyl as well as the o-nitrophenyl compounds
are equally efficiently hydrolyzed by the endoenzyme, the sensitivity of
the assay is four fold higher with the former compound due to the higher
extinction coefficient ofp-nitrophenol at 420 nm. The release of the nitro-
phenol from these substrates would generally indicate the presence of
endo-a-iV-acetyl galactosaminidase in the test sample. The only other cir¬
cumstance which would lead to the release of nitrophenol from the above
substrates is the presence of both an exo-/3-galactosidase, capable of acting
on Gal 1 3 GalNAc, and an exo-a-iV-acetyl galactosaminidase. In our
studies on D. pneumoniae glycosidases we are able to use these chromo-
genic substrates for detection of the endoenzyme activity in crude culture
filtrates and for monitoring column fractions throughout the purification
procedure. Exo-/3-galactosidase from D. pneumoniae (4), as well as those
from Jack Bean (15) and Clostridium perfringens (16), either do not hy-
drolyze or hydrolyze only very slowly /31 —* 3-linked galactosides. How¬
ever, in order to prove the presence of endo-a-Af-acetyl-D-galactosamini-
dase activity it will be necessary to examine the products of hydrolysis,
for example, by paper chromatography. Detection of the disaccharide,
Gal 1-^3 GalNAc, as opposed to monosaccharides galactose and N-
acetyl galactosamine, would be confirmatory. In conclusion, it should be
pointed out that both the p-nitrophenyl and the o-nitrophenyl compounds
are excellent chromogenic substrates for the endo-a-/V-acetyl galactos¬
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Fig. 2. pH optimum of the endo-a-/V-acetyl-d-galactosaminidase. The enzyme reaction
was performed under standard conditions using p-nitrophenyl- (•), o-nitrophenyl- (O). and







Fig. 3. Effect of p-nitrophenyl-2-acetamido-2-deoxy-3-0-/3-galactopyranosyl-or-galacto-
pyranoside concentration on the rate of reaction. The enzyme reaction was carried out
under the standard conditions using citrate phosphate buffer, pH 6.4.
The /3-anomer of the p-nitrophenyl substrate, p-nitrophenyl-2-acetamido-
2-deoxy-3-0-/3-d-galactopyranosyl-/3-d-galactopyranoside, was found to
inhibit the hydrolysis by the endoenzyme of the a-anomer as well as of
the asialofetuin Fraction C. A 2 mM concentration of the /3-anomer in¬
hibited the hydrolysis of the a-anomer by 90% and that of fetuin glyco-
peptide by 67%. The inhibition was found to be competitive.
The possibility of using the /3-anomer of the p-nitrophenyl substrate
as an affinity ligand for the endoenzyme was explored. In a representa¬
tive experiment, a partially purified (2) mixture of the D. pneumoniae
glycosidases (400 p.1) was applied to a column (0.9 x 5 cm) of p-amino-
pheny 1 - 2 - acetamido - 2 - deoxy - 3 - 0 - /3 - d -galactopy ranosy 1 - /3- d-galacto -
pyranoside linked to CH-Sepharose (Method I). The column was washed
with 30 ml of 0.01 m citrate buffer pH 6.0 and then eluted with the same
buffer containing 0.5 m NaCl. Fractions of 1.5 ml were collected and
assayed for the various glycosidases. The results indicated that the endo¬
enzyme was bound to the affinity adsorbent and eluted with NaCl; how¬
ever, neuraminidase was also bound to the adsorbent and coeluted with
the endoenzyme. The binding of the neuraminidase may be due to non¬
specific hydrophobic interaction with the spacer arm of CH-Sepharose.
We have previously reported (1,2) that both the endoenzyme and the
neuraminidase interacted with Affi-Gel 202 which has a spacer arm of
about 1.4 nm long. The nonspecific adsorption of neuraminidase was
confirmed by chromatography of the mixture of glycosidases on a column
of CH-Sepharose. Both the neuraminidase and the endo-a-N-acetyl-d-
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galactosaminidase bound to CH-Sepharose and were eluted with NaCl.
This procedure could be used for the purification of the endoenzyme
using gradient elutions with NaCl as in the case of the previously re¬
ported chromatography on Affi-Gel 202 (2).
In an attempt to overcome the nonspecific interaction between the
spacer arm and neuraminidase, p-aminophenyl-2-acetamido-2-deoxy-3-0-
/3-d-galactopyranosyl-/3-d-galactopyranoside was coupled directly to
Sepharose CL6B (Method II). A partially purified fraction of the glyco-
sidases (300 /ul) was applied on a column packed with the ligand-Sepharose
CL6B. The column was washed with 25 ml of 0.01 m sodium cacodylate
buffer, pH 6.0, containing 0.1 m NaCl and then eluted with the same
buffer containing 0.5 m NaCl. The results were practically the same as
before, namely neuraminidase still bound to the affinity adsorbent in addi¬
tion to the endoenzyme. The nature of the interaction between neuramini¬
dase and the affinity absorbent is not clear, since there is no hydrophobic
spacer arm in this support. It is probable that the hydrophobic D. pneu¬
moniae neuraminidase is interacting with the phenyl group of the ligand.
These results suggest that a one-step affinity chromatography purifica¬
tion of the endoenzyme may not be feasible due to the apparently high
hydrophobicity of the D. pneumoniae neuraminidase. However, if the
endoenzyme is first partially purified free of neuraminidase by, for ex¬
ample, chromatography on a column of DEAE-Sephadex as described
by Glasgow et al. (4) further purification could be carried out by using
this affinity adsorbent. The synthetic ligand, p-aminophenyl-2-acetamido-
2-deoxy-3-0-/3-d-galactopyranosyl-/3-d-galactopyranoside is a good al¬
ternative to antifreeze glycoprotein for the preparation ofaffinity adsorbent
(4). An affinity adsorbent prepared from this ligand could be repeatedly
used, unlike the adsorbent prepared from the substrate antifreeze glyco¬
protein, which on repeated use could loose activity due to hydrolysis of
the ligand from the Sepharose.
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Purification, Properties, and Analysis of Human Asthmatic
Bronchial Mucin1,
Pamela A. Feldhoff,1 Veerasingham P. Bhavanandan, and Eugene A. Davidson*
abstract: A high molecular weight, mucin-type glycoprotein
has been isolated from a sample of human bronchial secretion
obtained from an asthmatic patient. The glycoprotein elutes
in the void volume of a Sepharose 4B column, and its mobility
is unchanged in the presence of dithiothreitol. Examination
of the material in the analytical ultracentrifuge under equi¬
librium conditions gave an estimated minimal molecular weight
of 1.8 x 106with aggregation to 10 x 106or greater. Analysis
showed the predominant amino acids to be serine, threonine,
and proline with a low content of methionine and cysteine;
glucosamine and galactosamine were present in approximately
equimolar amounts and comprised 28% by weight of the
glycoprotein. Composition analysis after alkaline borohydride
treatment showed that the saccharide chains were O-
glycosidically linked through ^-acetylgalactosamine to both
serine and threonine residues in the peptide backbone.
Carbohydrate analysis by gas-liquid chromatography iden¬
tified galactose, fucose, glucosamine, galactosamine, and sialic
acid in an approximate molar ratio of 3:3:2:2:1. The sialic
acid is present as /V-acetylneuraminic acid. A portion (7%)
of the saccharides are present as galactosyl—*iV-acetyl-
galactosaminyl residues linked to the protein core. A gly-
copeptide fraction was isolated following pronase digestion and
had a molecular weight of 1.5 x 105. This value was not
significantly changed by either removal of sialic acid or ex¬
posure to guanidinium chloride. These data support the
presence of large clusters of oligosaccharides which are co-
valently linked to the serine and threonine residues of the
peptide.
HuLuman mucosal epithelia from all sources are coated with
mucus. The specific properties of mucus vary among organ
tracts (respiratory, salivary, gastric, and cervical), but the
overall chemical and physical similarities reflect a common
lubricative and protective function. The respiratory mucus
has the additional specific roles of particulate clearance and
maintenance of proper water balance in the tracheobronchial
tract.
The chemical composition of unfractionated human
bronchial secretions from healthy and diseased states has been
generally defined as to total inorganic, protein, lipid, and
carbohydrate content (Basch et al., 1941; Chernick & Barbero,
1959; Matthews et al., 1963; Masson et al., 1965; Schultze
& Heremans, 1966). Physical properties, such as viscosity
and elasticity, have also been examined (Denton, 1960).
An understanding of the relationship between the macro-
molecular components of respiratory mucus and the physi¬
ological functions of this secretory product requires, in part,
isolation and characterization of the individual glycoprotein
components.
In general, fractionation of mucus by gel exclusion chro¬
matography on Sephadex G-200 or Sepharose 4B produces
two major peaks. The high molecular weight excluded
component, commonly referred to as mucin or epithelial
glycoprotein, is carbohydrate rich and is apparently responsible
for the physicochemical structure and rheological properties
of the mucus secretion (Havez et al., 1967). The majority of
studies on the glycoprotein component of bronchial secretion
have been histochemical and autoradiographic (Havez et al.,
1967; Lamb & Reid, 1969; Sturgess & Reid, 1972). The
chemical composition of some preparations has been described
(Werner, 1953; Havez et al., 1968; Roussel et al., 1972, 1975;
f From the Department of Biological Chemistry, The Milton S. Hershey
Medicai Center, Tne Pennsylvania State University, Hershey, Pennsylvania
17033. Received Januarx 16,1979. This study was supported bv Contract
N01-HR-5-2954 and Grant HL 19190-01 from the U.S. Public Health
Service.
'Present address: Department of Biochemistry, School of Medicine,
University of Louisville, Louisville, Kentucky 40202.
Lamblin et al., 1973; Roberts, 1974; Boat et al., 1976; Lafitte
et al., 1977). Bhattacharyya and Lynn have reported on the
saccharide structure of a glycoprotein isolated from the alveoli
of patients with alveolar proteinosis (Bhattacharyya & Lynn,
1977; Bhattacharyya et al., 1976). The carbohydrate in this
macromolecule, however, is of the asparagine-linked, man-
nose-containing type and appears unrelated to the predominant
mucin glycoprotein. This paper deals with the purification,
characterization, and partial structural identification of the
major macromolecular component of bronchial secretion.
There are considerable technical difficulties in collecting
adequate amounts of normal human bronchial secretion.
Accordingly, the high molecular weight glycoprotein com¬
ponent discussed in this report was isolated from the tra¬
cheobronchial secretions of an asthmatic patient. Separate
studies in our laboratory have demonstrated that organ cultures
of human trachea produce a mucin glycoprotein with physical
and chemical properties similar to if not identical with those
described for the bronchial secretion product. In addition,
preliminary analyses of aspirate mucus from pediatric patients
show the presence of comparable components. Thus, this study
should provide background data for comparison with the
structural features of bronchial mucins obtained from healthy
individuals and from individuals with defined pulmonary
pathology. It should be noted that mucus from patients with
cystic fibrosis has been extensively investigated but cannot be
considered representative of normal material (Roussel et al.,
1975).
Experimental Procedures
Materials. Human bronchial secretion obtained by a 4-day
collection (100 mL) from an asthmatic patient was generously
provided by Dr. William Lynn, Department of Biochemistry,
Duke University. The patient was a secretor and the crude
mucus sample had blood group A activity (Morgan &
Watkins, 1951). The crude mucin was examined for microbial
contamination by culturing an aliquot on growth medium. No
microorganisms were observed from this sample or subsequent
[Reprinted from Biochemistry, (1979) 18, 2430.]
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collections from the same patient.
The secretion was promptly frozen and maintained in the
frozen state until workup. The material was thawed, diluted
1 to 10 with H20, and adjusted to 5 mM NaN3 to prevent
microbial contamination during subsequent procedures. The
diluted sample was stirred overnight at 4 °C and centrifuged
at 7000g for 20 min to remove a small amount of cellular
debris. There was no visible gel-like material present in the
pellet. The pellet contained less than 10% by weight of the
starting material was not examined further. The supernatant,
which contained over 90% of the carbohydrate content of the
original material, was applied to a 5 X 92 cm column of
Sepharose 4B (Pharmacia Fine Chemicals). Chromatography
was performed at pH 5.0 as indicated in Figure 1. The high
molecular weight void volume component, identified as the
mucin glycoprotein, was dialyzed against HzO at 4 °C and
lyophilized (150 mg).
Analytical Methods. Analyses for the carbohydrate
components of glycoproteins were carried out as follows:
chromatographic column effluents were screened for neutral
sugar by the phenol-sulfuric acid method (Dubois et al., 1956)
with galactose as a standard, and for sialic acid by the
thiobarbiturate procedure (Aminoff, 1961) with N-acetyl-
neuraminic acid as a standard. Specific sugar components
were identified by gas-liquid chromatography of alditol
acetates (Sawardekar et al., 1965; Lehnhardt & Winzler,
1968) following mineral acid hydrolysis or by methanolysis
of the sugars followed by conversion to the trimethyl silyl ethers
(Clamp et al., 1972) prior to gas-liquid chromatography; the
latter procedure only was employed for sialic acid. Glucos¬
amine and galactosamine were also determined on the amino
acid analyzer after acid hydrolysis in vacuo at 100 °C for 8
h in 4 N HC1; galactosaminitol was determined on the amino
acid analyzer after acid hydrolysis as for the hexosamine
analyses (Cheng & Boat, 1978). Asialoglycoprotein and
asialoglycopeptides were prepared by incubation of the ap¬
propriate material at 37 °C with Vibrio cholerae sialidase
(protease free) (Calbiochem). The incubation was carried out
in 0.1 M sodium acetate, pH 5.6. containing 1 mM CaCl2 and
the material then was chromatographed on Sepharose 4B by
utilizing 0.1 M acetate buffer, pH 5.0. The fractions con¬
taining sialic acid were combined and the identity of the
released product as /V-acetylneuraminic acid confirmed by
comparison with authentic standards employing descending
paper chromatography on Whatman no. 1 paper with /V-butyl
acetate:glacial acetic acid:FI20 (3:2:1) as solvent. In general,
exclusion columns were calibrated with blue dextran (V) or
[l4C]glucose (S).
Protein was determined by the procedure of Lowry (Lowry
et al., 1951) or when screening chromatographic column
effluents by a method employing Coomassie Brilliant Blue G
(Sigma Chemical Co.) (Bradford, 1976). Ninhydrin was used
to assay for free amino groups following Pronase digestion.
Amino acid analyses were performed by ion-exchange
chromatography with a Beckman Model 120C or 121 amino
acid analyzer following hydrolysis of the samples in vacuo for
24 h at 110 °C with 6 N HC1.
Reduction and S-Carboxymethylation. Reduction and
S-carboxymethylation of the glycoprotein were performed
according to a modification of the method of Crestfield
(Crestfield et al., 1963). The glycoprotein (2 mg) was dis¬
solved in 1.4 M Tris-HCl, pH 8.6 (10 mL), containing 10 mM
EDTA, 5.7 M guanidinium chloride, and 0.2 M DTT. The
' Abbreviations used: NaDodS04, sodium dodecyl sulfate; BME,
0-mercaptoethanol: PAS, periodic acid Schiff; DDT. dithiotreitol.
samples were incubated at 25 °C for 4 h and the reduced
glycoprotein was reacted with iodoacetic acid (0.25 g) and 2
M NaOH (200 qL) for 45 min at room temperature in the
dark. The reaction mixtures were then extensively dialyzed
at 4 °C in the dark against H20.
Pronase Digestion. Digestion of 5 mg of glycoprotein in
1.0 mL of 0.1 M borate buffer, pH 8.0, containing 0.01 M
calcium acetate was carried out at 37 °C for 72 h with the
addition of 0.5 mg of Pronase (Calbiochem)/10 mg of gly¬
coprotein at times zero, 24, and 48 h. A trace amount of
toluene was added to prevent microbial contamination. The
Pronase digestion was also carried out in 50 mM Tris buffer,
pH 8.0, 0.01 M calcium acetate and in an independent di¬
gestion, Proteinase K (EM Biochemicals) (Ebeling et al„ 1974)
was used in place of Pronase. Exclusion chromatography of
the protease digest was initially performed at either pH 5.2
in 0.1 M pyridine acetate with Sephadex G-25 (Pharmacia
Fine Chemicals) or at pH 5.0 in 0.1 M acetate buffer by
utilizing Sepharose 4B. The void volume fraction of the G-25
column was assayed for blood group activity (Morgan &
Watkins. 1951). Anion-exchange chromatography was
performed by using a pyridine acetate gradient on DEAE-
cellulose (Whatman Biochemicals, Ltd.).
Eleclrophoretic Studies. Poiyacrylamide gel electrophoresis
was performed on 6% polyacryiamide gels in the presence of
sodium dodecyl sulfate ± d-mercaptoethanol at 7 V/cm of gel
(Weber et al., 1972). Samples (15-20 Mg) were incubated in
NaDodS04 ± BME for 2 h at 40 °C and then applied to the
gels. Electrophoresis was also performed with gels containing
0.5% agarose (Bio-Rad Laboratories) and 1.5% acrylamide
(Bio-Rad Laboratories) at 2.5 mA/tube for 2 h (Holden et
al., 1971). Samples of 200-500 Mg were applied to the
agarose-acrylamide gels. Gels were stained for protein with
Coomassie Brilliant Blue R (Sigma Chemical Co.) and for
carbohydrate by the periodate-Schiff method (Zacharius et
al., 1969).
Sedimentation Equilibrium Studies. The glycoprotein and
the pronase resistant glycopeptide core were examined by
analytical equilibrium ultracentrifugation employing the
meniscus depletion method (Yphantis, 1964). Details of the
conditions used are given in the appropriate figure legend.
Prior to centrifugation, the sample in buffer was dialyzed for
24 h against the same buffer. The partial specific volume was
not explicitly measured for this glycoprotein. Based on the
amino acid analysis and carbohydrate composition, a figure
of 0.60 was estimated; the volume for the glycopeptide was
estimated to be 0.54.
Circular Dichroism. Spectra were recorded at 23 °C from
300 to 205 nm with a Cary Model 60 recording spectropo-
larimeter equipped with a CD attachment. The glycoprotein
or glycopeptide was dissolved at a concentration of 1 mg/mL
in 0.1 M NaCl or H20, respectively. The spectrum of the
solvent was recorded before and after each experiment to
correct for any base-line drift.
Alkaline Borohydride Treatment. A solution of 4 mg of
glycoprotein in 2 mL of 0.05 M KOH-l.O M NaBH4 was
incubated for 72 h at 37 °C (Carlson, 1966). The excess
borohydride was eliminated by adjusting the pH to 4.5 at 4
°C by addition of 4 M acetic acid. The solution was evap¬
orated three times with methanol and the resulting material
examined by chromatography on a P10 column (Bio-Rad
Laboratories) in 0.1 M pyridine-acetate buffer, pH 5.2. In
some experiments, NaB3H4 (NEN) was employed to permit
labeling of the oligosaccharide chains.
endo-a-Acetylgalactosaminidase Digestion of the Glyco¬
protein. Treatment of 2.0 mg of the desialylated glycoprotein
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FIGURE 1: Sepharose 4B chromatography of the supernatant from
the diluted human bronchial secretion. The column (5 X 92 cm) was
operated with a pressure head of 50 cm at a flow rate of 100 mL/h.
The eluting buffer was 0.1 M sodium acetate, pH 5.0. Representative
aliquots were analyzed for neutral sugar (•), protein (■), and sialic
acid (A). Absorbance data are at 490, 660, and 550 nm. respectively.
The bars show the fractions that were combined for further study.
Table I: Amino Acid Analysis of Bronchial Secretion after




amino acid I II core)
Lys 29 64 17
His 21 22 26
Arg 40 40 28
Asp 70 115 35
Thr 170 59 302




Pro 103 79 105
Gly 72 63 72
Ala 86 75 92
'/2-cystine 15 35 trace
Val 69 66 33
Met 10 11
He 29 22 9
Leu 63 85 36
Tyr 11 27 6
Phe 21 41 9
glucosamine0 14.4% 5.1% 19.1%
galactosaminea 13.3% 1.0% 17.7%
a Data are expressed as percent by weight of the total glyco¬
protein.
with an enr/o-a-fV-acetylgalactosaminidase isolated from
Diplococcus pneumoniae (Bhavanandan et al„ 1976) was
carried out at 37 °C for 24 h in 1 mL of 0.1 M Tris-maleate
buffer, pH 7.6. After the incubation, aliquots of the mixture
were assayed for Morgan-Elson positive material by using
authentic Gal/31—*3GalNAc as standard (Reissig et al„ 1955).
The released oligosaccharide product was further identified
by paper chromatography on Whatman no. 1 paper by using
/V-butyl acetate:glacial acetic acid:H,0 (3:2:1) as a solvent.
End-Group Analysis. Amino-terminal end-group analysis
was performed by utilizing dansyl chloride (Gray, 1967).
Following hydrolysis with 6 N HC1 for 18 h, the products were
examined by two-dimensional thin-layer chromatography on
polyamide sheets (Woods & Wang, 1967).
Results
Purification and Physical Properties of the Mucin- Type
Glycoprotein. After the low-speed centrifugation (7000g) of
FELDHOFF, BHAVANANDAN, AND DAVIDSON
was operated in 0.1 M sodium acetate buffer, pH 5.0, at a pressure
head of 30 cm and a flow rate of 9 mL/h. The column fractions were
assayed for neutral sugar; absorbance data are at 490 nm.
the bronchial secretion, 93% of the neutral sugar and 88% of
the sialic acid (thiobarbituric acid analysis) remained in the
supernatant. This supernatant was analyzed by exclusion
chromatography on a Sepharose 4B column. The mucin-type
glycoprotein emerged in the void volume (Figure 1) which also
contained nearly all of the blood group A activity. The amino
acid analysis of the void volume (500-700 mL) is presented
in Table I; the total amino sugar content comprised 28% by
weight of the glycoprotein; sulfate content was 4.5%. Fraction
II (1300-1500 mL), when analyzed for amino acids, gave a
profile more characteristic of serum-type glycoproteins (Table
I). In addition, the presence of mannose, alkali stability of
the peptide-oligosaccharide linkage, and extensive reactivity
with anti-human serum following Immunoelectrophoresis
identified the components present as primarily circulating
glycoproteins. The possibility exists that lung cell specified
macromolecules are also to be found in this mixture. However,
this fraction was not further studied.
Sepharose 4B gel filtration of the mucin-type glycoprotein
preincubated with DTT and run in its presence showed no
change in the elution pattern. This result suggests that re¬
duction of disulfide bridges does not lead to a large decrease
in molecular size. The peak I material from the Sepharose
4B column was subsequently chromatographed on a Bio-Gel
A-150 M (Bio-Rad Laboratories) column (1.5 X 55 cm) by
utilizing pH 5.0, 0.1 M acetate buffer. The elution pattern
showed some retention of the glycoprotein (Figure 2), but
substantial material was still present in the void volume. The
heterogeneous profile seen in the Bio-Gel A-150 M column
elution pattern may represent aggregation, entrapment, peptide
and/or saccharide polydispersity, or some combination of these.
End-group analysis of fraction I revealed no measurable
amino-terminal residue. This result is compatible with the
properties of some glycoproteins where the N-terminal amino
acid is found to be blocked, e.g., uq-acid glycoprotein (Schmid,
1954). Additionally, based on the amount of material em¬
ployed and the detection sensitivity of the analytical technique,
the results indicate the absence of significant contamination
by proteins with accessible termini.
The molecular weight of fraction I was examined by
equilibrium sedimentation ultracentrifugation at three different
concentrations in 0.5 M NaCl (Figure 3). Employing a partial
specific volume of 0.60, a minimum molecular weight of 1.8
X 106 can be estimated, although variation in the frequency
of saccharide chains as well as their nature introduces an
uncertain level of heterogeneity. The upward displacement
of the plot of ctw vs. concentration is indicative of the presence
of species of higher molecular weight. An evaluation of the
data by means of a two species plot (Roark & Yphantis, 1969)
gave no indication of specific association stoichiometry, al¬
though components with A/w of 10' or higher are apparently
present. These are likely to be aggregates but may arise in
HUMAN BRONCHIAL MUCIN
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figure 3: Equilibrium sedimentation analyses of the void volume
peak described in Figure I. The sample was run at 20 °C, 2000 rpm,
and at three different loading concentrations: 0.25 (•), 0.5 (▲), and
1.0 mg/mL (O). Data were obtained 8 h after equilibrium was
reached, 36 h after the initiation of the run. The molecular weight
parameters were calculated by a computer program from fringe
displacement patterns obtained after equilibrium was reached.
part from the heterogeneity present in the minimal species.
The mucin-type glycoprotein fraction recovered from the
Sepharose 4B chromatography was completely excluded from
6% polyacrylamide gels when analyzed by NaDodS04-
polyacrylamide gel electrophoresis (± /3-mercaptoethanol).
These results combined with those from the ultracentrifugation
study indicated a high "native" molecular weight. The
limitations of this type of molecular weight estimation,
however, preclude any statements regarding the role of di¬
sulfide bonds in the macromolecule. Accordingly, the gly¬
coprotein was reduced with dithiothreitol in the presence of
guanidinium chloride and any -SH groups generated by
reduction were carboxymethylated with iodoacetamide. The
bulk of the material, approximately 80%, still appeared at the
void volume of a Sepharose 4B column, although a minor
component may be slightly included. The native and re-
duced-carboxymethylated glycoproteins were further examined
by electrophoresis in 0.5% agarose-1.5% polyacrylamide gels.
The native glycoprotein did not enter this gel and no lower
molecular weight protein or carbohydrate components were
detected after loading the gels with 500 qg of glycoprotein.
The reduced glycoprotein showed two components corre¬
sponding in proportion to those observed on Sepharose 4B
chromatography. The included component stained weakly,
but detectably, with the periodic acid-Schiff reagent and is
presumably a glycoprotein.
Chemical Composition. The carbohydrate analysis of the
material in the void volume of the 4B column is presented in
Table II. The overall carbohydrate content was estimated
to represent 70% by weight of the glycoprotein. The sialic acid
was identified by paper chromatography as /V-acetylneur-
aminic acid and was completely susceptible to Vibrio cholerae
neuraminidase. The fact that mannose was absent indicated
that the material was free of glycoproteins wherein the car¬
bohydrate moiety is attached via the amide nitrogen of as-
paragine.
The linkage of the oligosaccharides to the peptide core was
concluded to be O-glycosidic based on the results of treatment
with alkaline borohydride. The data indicate that two-thirds
of both the serine and threonine residues are substituted.
Chromatography of the reaction products on a P-10 column
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Table II: Carbohydrate Composition of the Glycoprotein before
and after Alkaline Borohydride Treatment
molar ratioa
glyco¬ OH-NaBH4




yV-ace ty1- D-glucosamine 2.0 1.8
sialic acid 1.0 1.0
yV-acetyl-D-galactosaminitol 0.0 1.0
a Relative to sialic acid.
figure 4: Bio-Gel P-10 chromatography of bronchial secretion
(Sepharose 4B-pk I, Figure 1) which has been treated with
NaBH4-KOH. The column (1 X 50 cm) was run in 0.1 M pyri-
dine-acetate buffer at a flow rate of 8 mL/h. Fractions were assayed
for neutral sugar.
showed that essentially all of the neutral sugar was included
(Figure 4); the peptide product of this reaction was not studied.
Based on the chromatographic mobility of known oligo¬
saccharides, the size of the eliminated products ranged from
2 to about 9 monosaccharides with the majority containing
5 to 7 sugars. About 85% of the ^-acetylgalactosamine was
reduced to galactosaminitol, indicating that GalNAc is the
linkage sugar (Table II). The stoichiometry of the mono¬
saccharides, the blood group A reactivity of the starting
glycoprotein, and the heterogeneity shown on P-10 chroma¬
tography clearly indicate that several types of oligosaccharides
are present.
Purification and Physical and Chemical Characterization
of the Glycopeptides. Preliminary fractionation of the Pronase
digest was performed on a Sephadex G-25 column. Over 90%
of the material which was positive for neutral sugar eluted at
the void volume and accounted for virtually all (96%) of the
starting carbohydrate content. The column fractions contained
no detectable protein based on the colorimetric procedure,
although amino acids and small peptides were readily detected
in a second peak eiuting near the included volume. The
glycopeptide material was excluded from both G-50 and
controlled pore glass (10-240) columns. However, it was
included on a Sepharose 4B column in sharp contrast to the
starting material (Figure 5). The void volume fraction of the
G-25 column was found to exhibit blood group A activity. This
result was expected since the A determinants are in the
carbohydrate structure. Quantitation of the A activity was
not attempted on this fraction.
A second Pronase digestion performed in Tris buffer or
digestion with proteinase K yielded material which failed to
enter the G-25 gels but was included on Sepharose 4B. In¬
cubation of the Pronase digest with dithiothreitol and chro¬
matography on Sepharose 4B in the presence of dithiothreitol
did not change the profile of carbohydrate reactive material.
The amino acid composition of the glycopeptide (Table 1)
shows a significant enrichment in threonine and serine (nearly
50% of the total), indicating that the large molecular weight
of this fragment is due to clusters of serine and threonine
17^
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ELUTION VOLUME
figure 5: Sepharose 4B chromatography of a 72-h Pronase digest
of human bronchial secretion (Sepharose 4B-pk I, Figure 1). The
column (2 X 66 cm) was operated at a pressure head of 50 cm at a
flow rate of 15 mL/h with 0.1 M sodium acetate buffer, pH 5.0.
Fractions were analyzed for neutral sugar (•) and free amino groups
(A). Absorbance data are at 490 and 570 nm, respectively.
ELUTION VOLUME (ml)
figure 6: Chromatography on DEAE-cellulose of the pooled void
volume fractions from G-25 chromatography of the Pronase
digested material (Figure 5). The material was eluted with a linear
gradient from 10 mM to 1 M pyridine-acetate, pH 5.2. Fractions
were analyzed for neutral sugar (•) and sialic acid (A). Absorbance
data are at 490 and 550 nm, respectively.
residues protected from further proteolytic digestion by
carbohydrate side chains.
The Pronase digestion material from the void volume of the
G-25 was pooled, concentrated, and run on a DEAE-cellulose
column. The material was eluted with a linear gradient from
10 mM to 1 M pyridine-acetate, pH 5.2. As illustrated in
Figure 6, all of the material was eluted between 0.2 and 0.5
M pyridine-acetate but no clear fractionation was obtained.
This result suggests that a distinction between sulfated and
nonsulfated components may not be present.
NaDodS04-polyacrylamide gel electrophoresis (10 cm; 6%
polyacrylamide gels ± 0-mercaptoethanol) was carried out
with the Pronase digested material (void volume of the G-25).
There was no detectable protein (Coomassie Blue stain) but
two bands contained carbohydrate and reacted with the PAS
reagent. One of the bands was comprised of material which
did not enter the gel, and the second band migrated about 1
cm. The results were identical whether or not /3-mercapto-
ethanol was present.
Since the high carbohydrate content of glycopeptides makes
molecular weight estimation unreliable by gel electrophoretic
methods, the glycopeptide obtained after Pronase digestion
was examined by ultracentrifugation. Fractions from the
major peak of the Sepharose 4B chromatography of the
unreduced glycopeptides were combined, dialyzed, lyophilized,
resuspended in 50 mM Tris, pH 8.0, or 50 mM Tris, pH 8.0,
200 250 300
WAVELENGTH (nm)
figure 7: Circular dichroic spectrum of intact bronchial secretion
(Sepharose 4B-pk I, Figure 1) (—) compared with the spectrum of
the glycopeptide (—) core after Pronase digestion. Concentration
was 1 mg/mL.
+ 4 M guanidinium chloride, and dialyzed against the ap¬
propriate buffer. This material was examined in the analytical
ultracentrifuge under equilibrium conditions. Based on a
partial specific volume of 0.54, the estimated molecular weight
for the glycopeptides was 1.5 X 105; there was negligible
polydispersity.
In an attempt to eliminate any aggregation of the glyco¬
peptides which might be due to terminal sialyl residues, the
Pronase digest was treated with sialidase and rechromato-
graphed on Sepharose 4B. All detectable sialic acid was
removed from the glycopeptides, but the elution profile was
essentially unchanged. An ultracentrifugation study of the
major glycopeptide peak following sialidase digestion gave an
estimated molecular weight of 1.4 X 105, a value only slightly
less than that for the starting glycopeptides. A further
centrifugation study of the desialylated glycopeptide in the
presence of 4 M guanidinium chloride gave similar results.
The conformation of the glycoprotein and the Pronase core
were examined by circular dichroic measurements. The
spectrum (Figure 7) for the intact glycoprotein shows a
negative absorption trough at 225 nm; the glycopeptide ob¬
tained after Pronase digestion showed a shift in the absorption
trough to 210 nm.
Discussion
Chemical characterization of the bronchial glycoproteins
present in gel-like secretions requires a solubilization step prior
to analysis. In order to prepare material as nearly native as
possible, a mild procedure of isolation was used and neither
detergent nor reducing agent was employed. Since nearly all
of the carbohydrate was recovered in the soluble fraction, it
may be concluded that the analytical data obtained are
representative. Following solubilization, chromatography on
Sepharose 4B separated the mucin type glycoprotein from
lower molecular weight protein components. This was sub¬
stantiated by the absence of lower molecular weight proteins
upon NaDodS04 gel electrophoresis (±BME) of the mucin
in 6% polyacrylamide gels. These data combined with the
agarose-acrylamide electrophoresis results support the
minimum molecular weight of 1.8 X 106 calculated for the
mucin glycoprotein from the sedimentation equilibrium study.
Hill et al. have proposed aggregation of subunits to account
for the high molecular weight of native and asialo ovine
submaxillary mucin. They attribute the aggregation to
noncovalent interactions dependent upon the carbohydrate
moieties of the mucin (Hill et al., 1977). The presence of
disulfide bonds in bronchial mucin has also been suggested
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by several investigators (Boat et al., 1976; Roberts, 1976;
Creeth et al., 1977). The agarose-acrylamide electrophoresis
indicates that a small portion (approximately 20%) of the
native material is associated via disulfide bonds. However,
the minimal size of the reduced product is estimated at 1 X
106, based on gel electrophoresis studies with submaxillary
mucins (Holden et al., 1971).
An amino acid analysis of the mucin showed that serine and
threonine comprise about one-third of the residues and together
serine, threonine, proline, glycine, and alanine constitute more
than 50% of the total amino acid content. These analytical
data are somewhat lower than those reported for other mucins
or from bronchial glycoproteins obtained from a patient with
cystic fibrosis (Roussel et al., 1975). In the latter case, the
amino acid composition was comparable to that of the gly-
copeptide obtained after Pronase digestion in this study. The
carbohydrates galactose, fucose, glucosamine, galactosamine,
and sialic acid are present in a molar ratio of 3:3:2:2:1. Sulfate
is presumably esterified to the galactose moieties (Havez et
al., 1968; Roussel et al., 1972, 1975; Boat et al., 1976) but
detailed localization of the sulfate ester groups was not
achieved in this study. Mannose and uronic acid which are
constituents of serum glycoproteins and proteoglycans, re¬
spectively, were not present. The mucin was found to exhibit
blood group A activity (Watkins, 1972). A number of ad¬
ditional bronchial mucus samples have been obtained from
pediatric patients hospitalized for surgery or other reasons not
involving the pulmonary system. These have all reflected the
blood group status of the donor and presumably are char¬
acteristic epithelial cell products of secretors.
The carbohydrate-protein linkages were shown by 0
elimination to involve /V-acetyl-D-galactosamine attached to
serine and threonine via O-glycosyl bonds. Approximately
two-thirds of the serine and threonine residues were substituted;
thus approximately one of every five amino acids has a
saccharide chain attached. The structures of the carbohydrate
prosthetic groups have not been fully defined but the results
of the P-10 chromatography indicate a heterogeneous size
distribution (2-9 sugars). A small portion (7%) of the oli¬
gosaccharides are present as galactosyi-dl—3-lV-acetyl-
galactosaminyl disaccharides linked to the protein core through
serine and threonine residues. This conclusion is based on the
results of digestion of the glycoprotein with an endo-a-N-
acetylgalactosaminidase from Diplococcus pneumoniae
(Umemoto et al., 1977). Since the enzyme preparation
employed was free of sialidase, exo-acetylhexosaminidase,
galactosidase, and fucosidase activities and acts only on
unsubstituted disaccharidyl substrates, it may be inferred that
this structural entity arises from incomplete chains. The
Gai-KJalNAc disaccharide is commonly present in mucin type
glycoproteins.
Due to the blood group A activity, some of the oligo¬
saccharides should have the sequence
a(l—3) a
^-acetylgalactosamine * galactose —-
t
L-fucose
at their nonreducing end.
The results of the Pronase digestion indicate that the entire
carbohydrate content is localized in a serine-threonine rich
region of the polypeptide. It may be estimated that the
polypeptide moiety of the glycopeptide obtained after Pronase
digestion contains about 100 amino acids of which about half
are substituted with saccharide chains. Reconciling these data
with the molecular weight estimates of the native mucin
requires either noncovalent associative behavior of the sac-
charide-free domains or the presence of several sections of high
sugar content and spacer regions completely free of carbo¬
hydrate; composite structures are also feasible. Glycoprotein
structural models composed of two types of regions have been
proposed for blood group substances (Dunstone & Morgan,
1965; Kristiansen & Porath, 1968; Donald, 1973; Goodwin
& Watkins, 1974) and for the epithelial secretions of bovine
(Bhushana Rao & Masson, 1977) and human (Roberts, 1976)
origin. Additionally, the clustering of serine and threonine
amino acid residues has been observed in the regions of the
blood group substances carrying the carbohydrate chains
(Goodwin & Watkins, 1974).
The high molecular weight of the glycopeptide fraction is
not due to aggregation caused by the presence of the negatively
charged terminal sialic acid residues, to ionic interactions or
to hydrogen bonding.
A distinctive characteristic of the circular dichroic spectra
of both the intact mucin and the glycopeptide fraction was a
negative trough at 210 mM for the glycopeptide fraction,
similar to the results reported for milk oligosaccharides (Kabat
et al., 1969). The intensity of the negative absorption observed
after Pronase digestion of the mucin indicates that the
spectrum is largely dependent on the carbohydrate moiety of
the glycopeptide.
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The role of sialic acid in the interaction of sialogly¬
coproteins with wheat germ agglutinin was investi¬
gated by using several well characterized saccharides
and sialoglycoconjugates. iV-Acetylneuraminic acid
and neuramin 2 —> 3 lactose, in addition to iV-acetyl-D-
glucosamine and its /?1 —► 4 oligomers were found to be
inhibitors ofwheat germ agglutinin-induced hemagglu¬
tination. Neuraminic acid-/?-methyl ketoside, iV-glyco-
lylneuraminic acid and several other acidic sugars were
noninhibitors. Both glycophorin and ai-acid glycopro¬
tein were excellent inhibitors, whereas the correspond¬
ing asialo compounds were either very poor or nonin¬
hibitors. Among the mucins tested, all except porcine
submaxillary mucin, which has iV-glycolylneuraminic
acid, were potent inhibitors. The results of double dif¬
fusion experiments, in which the ability of the glyco-
conjugates to form precipitin line with wheat germ
agglutinin was tested, were in agreement with the ag¬
glutination inhibition data.
Affinity chromatography of labeled glycoconjugates
on wheat germ agglutinin-Sepharose 4B columns con¬
firmed that iV-acetylneuraminyl residues play an im¬
portant role in the binding of sialoglycoconjugates to
this lectin. The results suggest that the binding of a
glycoprotein to a wheat germ agglutinin-Sepharose 4B
column may be influenced both by the density of the
binding sugar residues (iV-acetyl-D-glucosamine and N-
acetylneuraminic acid) on the glycoprotein and by the
density of the lectin molecules on the gel beads. In cell
affinity chromatography, the cells interacted irrevers¬
ibly with wheat germ agglutinin-Sepharose 6MB beads;
this binding was partially lost on treatment of the cells
with neuraminidase. Models for the interaction of
wheat germ agglutinin with N-acetylneuraminic acid
and polysialoglycoconjugates are presented.
Wheat germ agglutinin is also able to interact with
glycoproteins containing multiple nonreducing termi¬
nals of iV-acetylgalactosamine as are present, for ex¬
ample, in asialo ovine and bovine submaxillary mucins.
In recent years, wheat germ agglutinin (WGA) has been
used extensively as a tool for the isolation and characterization
of a variety of glycoconjugates, including cell surface compo¬
nents (1-4). Further, the cytotoxic properties of WGA1 have
* This investigation was supported by Research Grants CA 17686
and CA 15483 from the National Cancer Institute, United States
Public Health Service. The costs of publication of this article were
defrayed in part by the payment of page charges. This article must
therefore be hereby marked "advertisement" in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
' The abbreviations used are: WGA, wheat germ agglutinin; NaCi/
P., phosphate-buffered saline (0.14 m Na\ 0.1 m K+, 0.006 m P04~3,
pH 7.2); GlcNAc, N-acetylglucosamine; NeuNAc, iV-acetylneuraminic
been utilized for selecting cells with altered cell surface oli¬
gosaccharide units (5, 6). In other studies, immunization of
mice against the WGA receptor has been tried in an attempt
to elicit an immune response in mice against possible wheat
germ agglutinin specific tumor antigens (7). Even though a
large number of such studies have been carried out with WGA,
the true specificity of this lectin remains unclear.
Wheat germ agglutinin, a pure protein with a molecular
weight of 36,000, is composed of two similar polypeptide
chains, each possessing two binding sites for sugars (8, 9). The
binding site consists of three subsites in an extended arrange¬
ment rather than in a single deep pocket in the protein (10).
WGA is a very stable protein and its stability has been
attributed to the presence of a large number of disulfide
bridges (8). Several papers have been published on the sugar
binding specificity of this lectin (9). It is generally accepted
that this lectin binds specifically to 2-acetamido-2-deoxy-D-
glucose (GlcNAc) and its /?-l,4-linked oligomers (8, 10-12). In
addition, recent studies have provided either direct or indirect
evidence for the interaction of sialic acid with WGA (13-20).
However, there is no agreement regarding the nature of the
interaction between sialic acid or sialyl glycoconjugates and
WGA (9, 21). Since WGA is a basic protein, three out of four
isolectins having an isoelectric point of 8.7 ± 0.3 (22), the
possibility exists of electrostatic interaction between sialic
acid and WGA.
While investigating the glycoconjugates produced by mu¬
rine melanoma cells, we isolated a sialoglycopeptide devoid of
GlcNAc but capable of specifically interacting with WGA. It
was shown that the interaction of this glycopeptide with WGA
was due to the presence of clustered sialyl oligosaccharide
groups on the peptide backbone (20). In order to obtain a
better understanding as to the real specificity of WGA, a
systematic study was undertaken using a large number of
simple and complex model saccharides. The results of these
investigations are presented in this paper. A preliminary re¬
port has been presented (23).
EXPERIMENTAL PROCEDURES
Raw wheat germ was obtained from local health food stores and
from Sigma Chemical Co. Crude wheat germ lectin (B grade) was
purchased from Calbiochem.
Ovalbumin (grade III), ovomucoid (trypsin inhibitor), bovine serum
albumin, ceruloplasmin (type III), heparin (grade I), trypsin (type I),
JV-acetylneuraminic acid (type VI), AT-glycolylneuraminic acid, andp-
nitrophenyl-N-acetyl-/8-d-galactosaminide were purchased from
Sigma Chemical Co. Chitin, Vibrio cholerae neuraminidase, pronase-
CB and p-nitrophenyl-N-acetyl-/?-d-glucosaminide were from Calbi¬
ochem. Neuraminic acid-/?-methyl ketoside (methoxyneuraminic
acid) and bovine submaxillary mucin were obtained from Boehringer
Mannheim. Phenyl-N-acetyl-a-d-galactosaminide was from Nakarai
acid; GalNAc, ^-acetylgalactosamine; NeuNGc, iV-glycolylneura-
minic acid.
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Chemicals, Japan. Ribonuclease B, and hyaluronic acid (vitreous
humor) were obtained from Worthington Biochemical. Fetuin (Spiro
method) and colominic acid were obtained from GIBCO and P-L
Biochemicals, respectively. Sugars were mostly from Pfanstiehl.
GlcNAc used for elution of WGA-Sepharose columns was prepared
by N-acetylation (24) of GlcNH2- HC1 purchased from Pfanstiehl.
Sepharose 4B, AH-Sepharose 4B, and cyanogen bromide-activated
Sepharose 6MB were purchased from Pharmacia. All other chemicals
were commercial products of the highest purity available. [1-I4C]-
Acetic anhydride (4.9 mCi/mmol), [3H]acetic anhydride (50 Ci/
mmol), NaB[3H]4 (330 mCi/mmol) and H[uC]HO (45 mCi/mmol)
were purchased from New England Nuclear.
Per-N-acetylated chitobiose and chitotriose were isolated from
chitin by the method of Rupley (25) except that the fractions from
the charcoal-Celite column were further purified by chromatography
on a Bio-Gel P2 column (26). NeuNAc a2 —» 3 lactose and NeuNAc
a2 —* 3 [3H]lactitol were prepared as described previously (27). Ovine
submaxillary mucin was isolated as described (28). Human bronchial
mucin was prepared from bronchial secretions (29). The following
were kindly donated as indicated: ai -acid glycoprotein, (The American
National Red Cross, Washington, D. C., and from Dr. K. Schmid,
Boston University School of Medicine, Boston, Mass.); ovine sub¬
maxillary mucin (Dr. M. Horowitz, New York Medical College, Val¬
halla, N.Y.); bovine submaxillary mucin (Ms. P. Feldhoff, The Milton
S. Hershey Medical Center, Hershey, Pa.); porcine submaxillary
mucin (Dr. M. de Salequi, Mt. Sinai School of Medicine, New York,
N.Y.); heparan sulfate and keratan sulfate II (Dr. M. B. Matthews,
University of Chicago, Chicago, 111.). Gal/?1 —» 6GlcNAc/? —»
CsELNCM/j), Gal/?1 —» 3GlcNAc/?—► CeH»N02(p), and GlcNAc/?l -♦
6Gal/? —* CsH«N02(p) (Dr. K. L. Matta, Roswell Park Memorial
Institute, Buffalo, N.Y.); di- and trisialogangliosides (Dr. C.-L. Schen-
grund, The Milton S. Hershey Medical Center, Hershey, Pa.); dog
tracheal mucin (30) (Drs. R. Carubelli and G. Sachdev, Oklahoma
Medical Research Foundation, Oklahoma City, Okla.); monkey cer¬
vical mucin (31) (Dr. Nasir-ud-din, Massachusetts General Hospital,
Boston, Mass.); N-tosylglucosamine (Dr. M. Miljkovic, The Milton S.
Hershey Medical Center, Hershey, Pa.); Jack bean /J-galactosidase
(Dr. Y.-T. Li, Tulane University, New Orleans, La.); and Diplococcus
pneumoniae /J-galactosidase (Dr. J. Umemoto, The Milton S. Her¬
shey Medical Center, Hershey, Pa.).
Isolation and Purification of Glycophorin
Erythrocytes obtained from the blood bank within 1 week of
outdating were pooled according to blood group types and the ghosts
prepared as described (32). The lyophilized erythrocyte ghosts were
treated with lithium diiodosalicylate and the solubilized glycoproteins
isolated and washed with ethanol and chloroform:methanol (2:1) as
described (33). The major component (glycophorin) was purified by
gel filtration on Sepharose 6B (34) followed by chromatography on
DEAE-Sepharose 6B using a NaCl gradient (0 to 1 m).
Glycophorin Glycopeptides
Glycophorin and [NeulVAc-3H]glycophorin2 were digested with
pronase or TosPheCH2Cl-trypsin and the glycopeptides from all four
digests were purified by chromatography on columns of DEAE-Se-
phacel using a gradient (0.01 to 1.0 n) of pyridine/acetate. Two major
glycopeptide fractions were obtained from each of the pronase and
trypsin digests.
The porcine submaxillary mucin glycopeptides and the fetuin gly¬
copeptide Fractions A, B, and C were isolated as described (35). The
alkaline borohydride-resistant portion and the tetra- and trisaccha-
rides from fetuin were isolated also as described previously (20, 36).
Asialoglycoproteins were prepared either by acid hydrolysis (0.1 n
H2SO4, 80°C, 1 h) or by Vibrio cholerae neuraminidase digestion at
37°C for 24 to 48 h in 0.1 m sodium acetate buffer, pH 5.6, containing
0.001 m CaCl2 using 1.0 to 5.0 units of enzyme in a total volume of 200
ML
Labeling of Glycoproteins and Glycopeptides2
On Sialic Acid—The sialic acid residues of sialoglycoproteins and
sialogiycopeptides were modified to the 7- and 8-carbon analogs and
labeled as described by Van Lenten and Ashwell (37).
2 [NeuNAc-3Ul ([3H]galactose), [3H]- or [,4C]acetyl and ['^di¬
methyl glycoproteins refers to labeling in sialic acid, galactose, protein
by acetylation and protein by reductive methylation, respectively.
On Terminal Galactose—Asialoglycoproteins and asialoglycopep-
tides were labeled on the terminal galactose residue by treatment
with galactose oxidase and NaB[3H]4 (38). Acid hydrolysis followed
by paper chromatography showed, as expected, that a major portion
of the label was in galactose.
On Protein—Radioactive label on the protein was introduced
either by acetylation with [UC]- or [3H]acetic anhydride or by reduc¬
tive methylation using H[l4C]HO and sodium cyanoborohydride (39,
40).
On hydrolysis (6 n HC1,110°C, 18 h) of the reductively methylated
samples followed by analysis on the amino acid analyzer by stream-
splitting, about 85% of the label eluted with lysine. In the buffer
system used monomethyllysine and dimethyllysine do not separate
from lysine (39).
The labeled high molecular weight components were isolated after
extensive dialysis, to remove low molecular weight contaminants,
followed by lyophilization. The labeled low molecular weight glyco¬
peptides were purified by gel filtration on columns packed with the
appropriate supports, generally Sephadex G-25.
Isolation of Wheat Germ Agglutinin
Wheat germ agglutinin was isolated from crude wheat germ by a
combination of methods described by Nagata et al. (41) and Marchesi
(42) with slight modifications. Essentially, the method consisted of
extracting the crude wheat germ (200 g) with light petrol (b.p., 38-
50°C) twice, using 1 liter each time for 24 h. The air-dried residue
was then extracted with 0.05 n HC1, fractionated with ammonium
sulfate, and butanol-treated (41). The lectin was purified by affinity
chromatography on an ovomucoid or ovalbumin-Sepharose 4B col¬
umn (42). To understand the process of elution of the lectin from the
ovomucoid-Sepharose 4B column, we tested 0.1 m sodium acetate and
10 mM mercaptoethanol in phosphate buffer, pH 7.0, both of which
failed to elute the lectin even though small amounts of inactive
protein were eluted. Purified WGA purchased from Boehringer Mann¬
heim was also used in our studies.
Conjugation of Lectins and Glycoproteins to Sepharose 4B
Wheat germ agglutinin, ovalbumin, and ovomucoid were coupled
to Sepharose 4B which was activated by cyanogen bromide by one of
two methods (43, 44). WGA was reacted with the activated Sepharose
in the presence of 0.1 m IV-acetylglucosamine. The remaining active
groups were blocked and the gels were washed as described previously
(20). The amount of protein bound to Sepharose was determined by
estimating the unbound protein in the supernatant and washes. WGA-
Sepharose 6MB purchased from Pharmacia was also used in some of
our experiments.
Affinity Chromatography of Glycoproteins on WGA-Sepharose 4B
Columns
The sample, usually radioactively labeled, was applied in a volume
of 100 to 500 id to a lectin column (2 to 5 ml of gel) equilibrated with
the elution buffer (50 mM Tris-HCl, pH 8.0, with or without 0.1%
Triton X-100). The sample was washed twice into the column with
about 0.5 ml of buffer and allowed to incubate for about 15 min. The
column was then eluted with the above buffer followed by 0.1 m N-
acetylglucosamine in the same buffer and fractions of 1 ml were
collected. The flow rate of the column was controlled to about 10 to
15 ml/h. The radioactivity in the eluted fractions was measured after
mixing with 10 ml of scintillation counting liquid. The total radioac¬
tivity recovered from the columns was better than 85% unless other¬
wise mentioned. The columns were routinely regenerated by washing
with a minimum of 10 bed volumes of the starting buffer. Occasionally
the columns were cleaned, particularly when the recoveries have been
poor, by washing the column with 6 m urea, followed by buffer
containing 0.1% Triton X-100 and finally the starting buffer.
The columns were stored between experiments at 4°C in 0.1 m N-
acetylglucosamine in buffer containing 0.02% sodium azide; most of
our WGA-Sepharose 4B preparations have remained active over
periods of 6 months to 1 year.
Other buffers, including those containing between 0.1 to 0.5 m
NaCl, were also tried but had no significant effect on the results (45).
Agglutination and Agglutination-Inhibition Assays
Human blood group (O)H erythrocytes were washed and a 2%
suspension of cells in Ca2+- and Mg2+-free NaCl/Pi was prepared. For
the titration of lectin activity, serial 2-fold dilutions of the stock lectin
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solutions were prepared in siliconized microtest slides (A. H. Thomas,
Philadelphia) in a volume of 50 /xl of NaCl/Pj. An equal volume of the
erythrocyte suspension was added to each well and the slide was
incubated on a shaker at room temperature for 20 min. The degree of
hemagglutination was scored on a serological scale from 0 (no agglu¬
tination) to +4 (maximum agglutination).
For agglutination inhibition assays, the inhibitors dissolved in
NaCl/Pj and pH adjusted to 7.0 if necessary, were serially diluted in
the plates in a volume of 40 /xl. The minimum amount of WGA (for
untreated erythrocytes, 1 /xg in 10 /il of NaCl/Pi giving a final concen¬
tration of 10 /xg/ml) required to give complete agglutination in the
absence of inhibitor was then added to each well and mixed, and 50
/xl of the erythrocyte suspension was added and once again mixed.
After shaking the mixture on a rotary shaker at room temperature
for 20 min, the plates were examined under a microscope and the
degree of agglutination in each well was assessed to determine the
concentration of the inhibitor causing 50% inhibition. As pointed out
by Allen et al. (10), such an assay involving visual scoring is only
semiquantitative and is liable to give an error of ±20%.
Precipitation Analysis by Diffusion in Gel
Double diffusion was carried out in immunodiffusion plates (Miles)
using 2% agar in 0.15 m phosphate buffer, pH 7.2 (46). The center well
was filled with 20 /xl of a solution of WGA, 2 mg/ml in NaCl/Pi and
outer wells were filled with glycoprotein solutions at 2 mg/ml in water
or NaCl/Pij certain glycoproteins were also tested at higher concen¬
trations. The diffusion plates were incubated in a humid chamber for
18 to 48 h. Some plates were washed, dried, and stained with Amido
black prior to visualization (47).
results
Further Purification of WGA
Attempts to purify further the lectin by a second chroma¬
tography on the same affinity column always resulted in
extremely poor recovery. In a typical experiment, 186 mg of
WGA was applied to an ovomucoid-Sepharose 4B column;
elution with 0.1 n HOAc yielded only 25 mg of protein which
had the same hemagglutinating activity as the original lectin.
Elution of the column with 1 m acetic acid, 0.05 n HC1, or 0.1
m GlcNAc did not yield any additional protein. In another
experiment, 200 mg of a crude wheat germ lectin preparation
(Calbiochem, B grade, Lot 430031) having an activity equiv¬
alent to at least 50 mg of pure lectin yielded 3 mg of active
protein after affinity chromatography using an ovomucoid
column. Similar results were also obtained when repurification
was attempted on a column of Sepharose substituted with p-
aminophenyl-2-acetamido-2-deoxy-d-glucopyranoside3 (48).
Hemagglutination-Inhibition Assays
The results of the hemagglutination-inhibition experiments
are summarized in Tables I to III. The results reported were
reproducible in several experiments. There were no significant
differences in the inhibitory effect of the saccharides using
either our WGA preparations or those obtained from Boeh-
ringer Mannheim. The glycoconjugate inhibitors listed in
Tables II and III did not cause agglutination or lysis of human
group O erythrocytes in the concentration range used in our
experiments. Our results on hexosamines (Table I) are in
agreement with published results that N-acetylglucosamine
and its derivatives are in general good inhibitors, whereas N-
acetylgalactosamine and N-acetylmannosamine are poor in¬
hibitors (8, 10). The p-nitrophenyl glycosides of GlcNAc and
its oligosaccharides are all better inhibitors than GlcNAc. Of
major interest to this study was the inhibitory activity of
neuraminlactose and NeuNAc, the former being a better
inhibitor than GlcNAc, whereas lactose was noninhibitory up
to 200 mm. It is not clear why neuraminlactose is a more
3 J. R. Banks, V. P. Bhavanandan, and E. A. Davidson, unpublished
results.
Table I
Inhibitory effect of simple and complex saccharides on the
agglutinating activity of wheat germ agglutinin
Compounds





GlcNAc/81 — 4GlcNAc 0.15
GlcNAc/31 -> 4GlcNAc/81 — 4GlcNAc 0.03
GlcNAc/3 — C6H,N02(p) 0.10
Gal/81 — 6 GlcNAc/3 — CelLNOzlp) 0.125
Gal/81 -» 3 GlcNAc/8 CJLNCMp) 2.0
GlcNAc/81 -* 6Gal/8 -» CelLNCMp) 0.125
ManNAc 200
GalNAc 200
GalNAca —* phenyl >4.0°
GalNAc/3 —» CJLNCM p) >3.2°
NeuNAc a2 —* 3 lactose 6.25
NeuNAc 25







" Higher concentrations could not be tested due to poor solubility.
Table II
Inhibitory effect ofglycoconjugates on the agglutinating activity of
wheat germ agglutinin
Compounds Concentrationi needed for 50% inhibi¬tion
HM fig/ml
ai-Acid glycoprotein" 1.4; 4.5 62.5; 200
Asialo ai-acid glycoprotein >20.8 >800
Fetuin 20.8 1000
Asialo fetuin >52.7 >2160
Fetuin glycopeptides A >200 >800
Fetuin glycopeptides B and C >400




Ribonuclease B (Worthington) >54.4 >800
Ribonuclease B (purified)6 4.25 62.5
"Two different preparations, one from Dr. Karl Schmid and the
other from the American Red Cross, gave two different values.
6 The fraction bound on concanavalin A-Sepharose 6B column and
eluted with a-methylmannoside.
potent inhibitor than NeuNAc. The effect was specific for
NeuNAc, since NeuNGc, neuraminic acid-/?-methyl ketoside
and other acidic sugars, such as muramic, glucuronic, and
glucosaminic acids, were noninhibitory. Of the glycoproteins
with mainly N-glycosidically linked carbohydrates (Table II),
the inhibitory activity of ovomucoid, ovalbumin, and ribonu-
clease B is due to GlcNAc residues in these molecules. On the
other hand, the inhibition by ai-acid glycoprotein is probably
due to the terminal NeuNAc residues since the asialo com¬
pound was not inhibitory at 4 times the concentration. Fetuin
was a weak inhibitor compared to an-acid glycoprotein and
ovomucoid. Various derivatives of fetuin including asialo fe¬
tuin were all noninhibitors. The weak inhibition by fetuin was
surprising in view of the fact that all other results indicate an
efficient interaction between fetuin and WGA. For example,
WGA could be isolated using a column of fetuin-Sepharose
4B4 (50), fetuin gave a precipitin line with WGA and labeled
fetuin bound to affinity columns of WGA-Sepharose 4B (Ta¬
ble IV).
* V. P. Bhavanandan and A. Katlic, unpublished results.
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The most powerful inhibitors of WGA agglutinations are
mucins or glycophorin, which has a mucin-type structure
having several clustered sialyl oligosaccharides linked O-gly-
cosidically to the peptide backbone (51) (Table III). Ovine
submaxillary mucin and glycophorin were 50,000 and 70,000
times more potent than GlcNAc in inhibiting WGA. Of the
mucins tested, the only one which did not show inhibition was
pig submaxillary mucin. This is interesting since about 90% of
the sialic acid in this mucin is iV-glycolyl (52). Glycopeptides
isolated from glycophorin were also inhibitory, but it is not
possible to compare their potency against glycophorin and
GlcNAc because of the lack of information on their molecular
weights. The noninhibitory nature of polyanions such as hy-
Table III
Inhibitory effect of glycoconjugates on the agglutinating activity of
wheat germ agglutinin
Compounds
Concentration needed for 50% inhibi¬
tion
HM yg/ml
Glycophorin (MM)" 0.16 5
Glycophorin (NN)a 0.32 10
Glycophorin glycopeptides (tryp¬ 100
sin)
Glycophorin glycopeptides (pro- 200
nase)
Asialoglycophorin 16.3; >32.5 400"; >800c
Ovine submaxillary mucin* 0.23 35
Bovine submaxillary mucin' 0.32-0.61/ 50-100
Porcine submaxillary mucin >0.52/ >800
Porcine submaxillary mucin gly¬ >800
copeptides
Asialo ovine submaxillary mucin 1.85; 0.23 200"; 25c
Asialo bovine submaxillary mucin 0.32; 0.92' 50"; 100'
Human bronchial mucin 25
Dog tracheal mucin 50
Monkey cervical mucin 30
Hyaluronic acid >2000
Heparan sulfate >2000
Keratan sulfate II >2000
Colominic acid >800
Di- and trisialogangliosides >1000
° MM and NN designate human blood group type O(MM) and
O(NN).
6 Asialo compound prepared by acid hydrolysis.
c Asialo compound prepared by treatment with V. cholerae neur¬
aminidase.
* Our preparation; the sample donated by Dr. Horowitz gave com¬
parable results.
'
Preparation gifted by Ms. Feldhoff. Preparation from Boehringer
Mannheim gave a value of 50 /ig/ml.
1 These values are approximate since the exact molecular weight of
these mucins are not known. A value of 154,000 reported (49) for
ovine submaxillary mucin was used for these mucins as well.
aluronic acid, heparan sulfate, and keratan sulfate (all
GlcNAc-containing) confirms the specific nature of the inhi¬
bition by NeuNAc-containing polyanionic mucins. The nona-
cidic desulfated keratan sulfate has been shown to form a
precipitate with WGA (53). This is attributable to the alter¬
nating 1 —* 4-linked GlcNAc in this polysaccharide; desulfa-
tion would also remove the NeuNAc from this polymer (54).
A sialic acid polymer, colominic acid, was also noninhibitory.
Colominic acid is a linear polysaccharide of sialic acid linked
a2 —^ 8; it is possible that such a polymer would be unable to
interact effectively with sugar binding subsites of WGA (see
"Discussion"). A mixture of di- and trisialogangliosides did
not inhibit WGA-induced hemagglutination.
Asialo ovine submaxillary mucin and asialo bovine submax¬
illary mucin also inhibited agglutination by WGA, although
at a slightly higher concentration than the native mucins (see
also Ref. 21). These results would tend to suggest that
NeuNAc has no role in the inhibition of WGA agglutination
by these mucins. On the other hand, it is likely that the large
numbers of nonreducing terminal GalNAc in these asialo
mucins are responsible for inhibition. It should be pointed out
that GalNAc is an inhibitor, even though only at higher
concentrations (200 mM) compared to NeuNAc (25 mM) and
GlcNAc (12.5 mM). Thus, a peptide with multiple, some
clustered, GalNAc would be expected to be a good inhibitor.
In order to confirm the role of GalNAc in the asialomucin in
the interaction with WGA, in preliminary experiments,4 we
tested bovine submaxillary mucin and ovine submaxillary
mucin which were deglycosylated by treatment with hydrogen
fluoride (55). It was found that these preparations free of sialic
acid and about 90% of the GalNAc did not inhibit WGA
agglutination up to about 7 [iM. Higher concentrations could
not be tested due to the poor solubility of the deglycosylated
samples.
Asialoglycophorin was a poor inhibitor compared to the
asialo mucins. This is consistent with the fact that the non-
reducing terminals in this compound are galactose. The weak
inhibition by this compound could be due to the internal
GlcNAc residues present in the N-glycosidically linked pros¬
thetic group, even though the possibility of contribution from
the terminal galactose residues to the interaction cannot be
completely discounted (19). Interaction between the internal
GlcNAc in carcinoembryonic antigen and WGA was suggested
by Goldstein et al. (12).
Double Diffusion Experiments
The results of a few typical double diffusion experiments
using wheat germ agglutinin and various glycoproteins are
shown in Fig. 1.
Table IV
Interaction of labeled glycoproteins with different preparations of WGA-Sepharose 4B





Per cent radioactivity specifically bound





























a WGA isolated by affinity chromatography on immobilized ovomucoid was used in the preparations. Based on the estimations of the
protein not bound to Sepharose, the Preparations 1, 2, and 3 should have approximately 1, 2, ancf 5 mg of bound protein/ml of gel. WGA-
Sepharose 6MB purchased from Pharmacia and containing 5 mg/ml of gel gave results comparable to Preparation 3.
6 N.T., not tested.
c Ten times more sample applied.
d Fifty times more sample applied.
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Fig. 1. Double diffusion reaction of WGA in the center well against
various glycoconjugates in the outer wells. A: 1, ceruloplasmin; 2, ox¬
acid glycoprotein; 3, fetuin; 4, ovomucoid; 5, ovalbumin; 6, asialo-
fetuin. B: 1 and 5, glycophorin MM; 2, asialoglycophorin MM; 3,
glycophorin glycopeptides (trypsin); 4, glycophorin NN; 6, glyco¬
phorin glycopeptides (pronase). C:l, porcine submaxillary mucin (a
weak band was visible soon after development); 2, di- and trisialogan-
gliosides; 3, asialo ovine submaxillary mucin; 4, ovine submaxillary
mucin; 5, asialo bovine submaxillary mucin; 6, bovine submaxillary
mucin. Other details are given under "Experimental Procedures."
At concentrations of 2 mg/ml, ovine submaxillary mucin,
bovine submaxillary mucin, human bronchial mucin, dog tra¬
cheal mucin, monkey cervical mucin, glycophorin, and glyco¬
phorin glycopeptides all showed strong precipitin bands. In
the case of glycophorin, a band was detectable even at a
concentration of 200 jag/ml. Glycoconjugates which gave weak
bands at 2 mg/ml include porcine submaxillary mucin, asialo
submaxillary mucins, and asialoglycophorin. Ovalbumin and
fetuin gave strong bands at 15 mg/ml and very weak bands at
5 mg/ml; in comparison, ovomucoid and ai-acid glycoprotein
formed strong bands at 5 mg/ml and weak bands at 2 mg/ml.
Several other components failed to produce a precipitin
band against WGA at concentrations as high as 15 mg/ml.
These include asialo fetuin, bovine serum albumin, hyaluronic
acid, chondroitin 4-sulfate, heparin, and di- and trisialogan-
gliosides.
Affinity Chromatography of Glycoconjugates on WGA-
Sepharose Columns
Except for those experiments reported in Table IV, all
others were carried out using fully active WGA-Sepharose 4B
columns, comparable to Preparation 3 in Table IV.
Glycophorin—Glycophorin isolated from human erythro¬
cytes of blood group MM or NN and labeled either in sialic
acid or in the protein was completely retained on various
WGA-Sepharose columns (Table IV and Fig. 2). The results
obtained when a typical column was eluted with various
solutions prior to elution with 0.1 m GlcNAc is shown in Fig.
3. Asialoglycophorin preparations isolated either by neura¬
minidase or acid treatment of the glycophorin were only
partially (35 to 50%) retained on the WGA columns (Table IV
and Fig. 2). All four major glycopeptides isolated from
[iVew/VAc-3H]glycophorin by pronase or trypsin digestion
were retained on the WGA column (Fig. 2). When [NeuNAc-
3H]glycophorin was treated with alkaline borohydride and
chromatographed on a Bio-Gel P6 column, a large included
peak was obtained eluting in the position of tetrasaccharides
isolated from fetuin by similar treatment (36). These tetrasac¬
charides were not retained on the WGA column.
Fetuin—Different proportions of fetuin labeled in the pro¬
tein either by reductive methylation or acetylation were re¬
tained on different WGA-Sepharose 4B columns as can be
seen from Table IV. Once again prior elution of the column
with salts or acetic acid did not displace a significant portion
of the fetuin (Fig. 3). Fetuin glycopeptides A, B, and C labeled
by reductive methylation were not bound to the WGA column
which completely retained the native fetuin labeled by the
same method. The alkaline borohydride-resistant portion of







Fig. 2. Affinity chromatography of [3H]acetyl glycophorin
(• •), [3H]acetyl asialoglycophorin (A A), and a [NeuNAc-
'Hjglycophorin glycopeptide isolated by pronase treatment of
[NeuNAc-3H]glycophorin (O O) on a WGA-Sepharose 4B column.
Elution was with 50 mm Tris-HCl, pH 8.0, followed by 0.1 m GlcNAc
in buffer. One-milliliter fractions were collected and analyzed for
radioactivity. One other glycopeptide isolated by pronase treatment
and the two glycopeptides isolated by trypsin treatment of [NeuNAc-
3Hlglycophorin were also completely retained on this column.
fetuin prepared by neuraminidase treatment was not bound
on any of the WGA columns tested (Table IV). This com¬
pound, however, was completely bound to and eluted from a
Ricinus communis Agglutinin I-Sepharose 4B column, indi¬
cating the presence of terminal galactose residues. Treatment
of the asialo fetuin with either D. pneumoniae /Tgalactosidase
for 2 h or with jack bean /Tgalactosidase for either V6 or 6 h
abolished its ability to bind to the Ricinus communis Agglu¬
tinin I column, but the products still were not retained on the
WGA column.
Other Glycoconjugates—Ovine and bovine submaxillary
mucins labeled on sialic acid were completely retained on
WGA-Sepharose columns. Ovomucoid labeled in the protein
moiety was retained on different WGA columns to different
degrees as shown in Table IV. ai-Acid glycoprotein labeled
either on sialic acid or protein behaved similarly (Table IV).
Asialo ai-acid glycoprotein prepared by neuraminidase treat¬
ment of the [3H]acetyl ai-acid glycoprotein was not retained
on any of the WGA columns tested. On affinity chromatog¬
raphy of [14C]acetyl porcine submaxillary mucin 9 and 34%
were retained on two different WGA columns (Table IV).
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Table V





Fig. 3. Chromatography of [3H]acetyl fetuin (O- - -O) and
[3H]acetyl glycophorin (• •) on WGA-Sepharose 4B columns.
After application of the sample and a 15-min incubation, the columns
were sequentially washed with 50 mm Tris-HCl buffer, pH 8.0, 1 m
NaCl in buffer, 0.1 m NaOAc, pH 8.1, 0.1 m acetic acid, and finally 0.1





Washed with Eluted with 0.1 m
buffer GlcNAc \
dpm
MDA-231 cells (un¬ 50,000 3,050 (6.1%) 2,500 (5.0%)
treated)
HBL-100 cells (un¬ 57,000 2,533 (4.4%) 716 (1.3%)
treated)
MDA-231 cells 20,065 10,377 (51.7%) 2,175 (10.8%)
treated with
neuraminidase
MDA-231 cells 20,758 10,883 (52.4%)
mixed and ap¬




Fig. 4. Affinity chromatography of [14C]acetyl fetuin (O O)
and [3H]acetyl glycophorin (• •) on a WGA-Sepharose 4B col¬
umn. The mixed samples were applied on the column and eluted with
50 mm Tris-HCl, pH 8.0, followed by a linear gradient ( ) of buffer
alone (10 ml) to 0.1 m GlcNAc in buffer (10 ml). Fractions of 1 ml (1
to 25) and 0.5 ml (26 to 65) were collected and analyzed for radioac¬
tivity.
Chondroitin sulfate and heparan sulfate, isolated from human
melanoma HM7 cells grown in the presence of [3H]glucosa-
mine,4 were not retained on the WGA columns. NeuNAc 2
—* 3 [3H]lactitol was also not retained on the WGA column.
[14C]Dimethyl ribonuclease B, purified on concanavalin A-
Sepharose 4B column, was partially (35%) retained on the
WGA column. [3H]Acetyl ovalbumin glycopeptides were not
bound to this column.
Elution of the WGA-Sepharose 4B Columns with GlcNAc
Gradient
Since the various glycoproteins appeared to interact differ¬
ently with the immobilized WGA, the possibility of separating
these glycoproteins by affinity chromatography using a gra¬
dient (0 to 100 mm) of GlcNAc was tested. Fetuin and ai-acid
glycoprotein appeared to elute at the same position (45 mm
GlcNAc) in the gradient. Glycophorin, however, appeared to
elute a few fractions after fetuin and a i-acid glycoprotein. The
result of a mixed experiment using [14C]acetyl fetuin and
[3H]acetyl glycophorin is shown in Fig. 4.
Cell Affinity Chromatography
In an attempt to find out whether cultured cells could be
fractionated, cell affinity chromatography was carried out
using a K9/15 column with 80-,um nylon net (Pharmacia)
packed with 2 ml of WGA-Sepharose 6MB gel. Human breast
cells (HBL-100 and MDA-321) (56) grown in the presence of
[3H]thymidine were harvested, washed three times with
NaCl/Pj and fixed with formaldehyde (10% HCHO in NaCl/
Pi 1 h at room temperature). A suspension of the cells in
NaCl/Pi was applied to the column, and the column was
washed with NaCl/Pi and eluted with 0.1 m GlcNAc. The
recoveries were extremely low as can be seen in Table V. The
cells recovered from the column increased more than 5-fold
when the fixed MDA-231 cells were treated with V. cholerae
neuraminidase (37°C, 24 h) prior to affinity chromatography.
This suggested that the binding of the cells to the WGA-
Sepharose gels was probably mediated by cell surface sialyl
residues. On applying formaldehyde fixed MDA-321 cells to
the column which was pre-equilibrated with 0.1 m GlcNAc,
52% of the radioactivity was not retained. Similar results were
obtained with unfixed cells.
discussion
Wheat germ agglutinin was isolated by affinity chromatog¬
raphy on ovomucoid (or ovalbumin) Sepharose 4B columns.
The yields of lectin varied from batch to batch of crude wheat
germ. Usually between 50 to 200 mg of the lectin/200 g of
wheat germ were obtained; however, certain batches of crude
wheat germ gave extremely poor yields (<10 mg). The length
of storage of the crude wheat germ prior to use may be one of
the reasons for this variation in yield since one batch of raw
wheat germ which initially gave about 100 mg of lectin/200 g
after storage for about a year at 4°C yielded only 7 mg. In
addition to this, it is not clear whether the strain of the wheat,
condition, and length of storage of wheat before isolation of
the germ, and other unknown factors influence the yield. A
most puzzling aspect of WGA isolation was the loss of material
incurred during attempted repurification. On rechromatogra-
phy of the isolated lectin on affinity columns, the protein
apparently bound to the ligand irreversibly and could not be
displaced. This aspect was not further investigated.
WGA has been purified by affinity chromatography on
immobilized ovomucoid, fetuin, synthetic GlcNAc-based ad¬
sorbents or on chitin (9, 50). We found that immobilized
bovine submaxillary mucin (which lacks GlcNAc but contains
NeuNAc) was also effective for the isolation of WGA.4 In
control experiments,4 WGA did not bind to columns packed
with immobilized bovine serum albumin confirming the spec¬
ificity of the interaction between WGA and GlcNAc or
NeuNAc-containing ligands, or both.
The inability of sodium acetate to elute the WGA from
affinity columns indicates that even though iV-acetyl groups
of the hapten sugars (GlcNAc, NeuNAc, and.GalNAc) are
important for the interaction, acetate ions are not capable of
disrupting the complex between WGA and the ligand. Mer-
captoethanol, which was expected to reduce the large number
of —S—S— bonds in WGA, also failed to disrupt the inter-
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action between the lectin and the ligand under the conditions
used.
The hemagglutination inhibition experiments, while con¬
firming earlier reports that GlcNAc-containing compounds
are good inhibitors of WGA-induced hemagglutination, pro¬
vide clear evidence for the inhibitory ability of NeuNAc-
containing compounds. Nonspecific interaction between
NeuNAc and WGA could be excluded by the inability of
several other acidic sugars to inhibit agglutination. The im¬
portance of the N-acetyl group in NeuNAc (and NeuNAc 2
—* 3 lactose) is shown by the lack of inhibition by neuraminic
acid yS-methyl ketoside with a free NH2 group and by NeuNGc.
In double diffusion experiments, the macromolecular gly-
coconjugates which were good inhibitors of hemagglutination
were also the ones which gave precipitation lines with WGA.
Previous studies with sialoglycopeptides isolated from
mouse and human melanoma cells (20, 57) indicated that
glycopeptides having clustered O-glycosidically linked sialyl
oligosaccharides were capable of interacting specifically with
WGA. It was also apparent that the interaction was through
sialic acid residues since the removal of sialic acid abolished
the interaction. The major sialoglycoprotein of the human
erythrocyte membrane is known to have 15 O-glycosidicaily
linked sialyl tetrasaccharides in addition to 1 iV-glycosidically
linked oligosaccharide (51). Fetuin has three each of iV-gly-
cosidically and O-glycosidically bound oligosaccharides (36).
Therefore, in order to confirm our previous findings, we chose
these and other well characterized glycoproteins for further
studies using affinity chromatography. The results obtained
with fetuin, glycophorin, and a 1-acid glycoprotein confirm the
role of NeuNAc in the binding of these components to WGA.
Asialo fetuin and asialo ai-acid glycoprotein were not retained
on the lectin column; thus, the terminal sialic acids are the
sites of interactions. The specificity of the binding is illustrated
by the inability of sodium chloride, acetic acid, or sodium
acetate to displace the bound fetuin or glycophorin (Fig. 3).
The necessity for the presence of several sialyl oligosaccha¬
rides on a peptide backbone for stable binding is shown by
the failure of neuraminyl lactitol, sialyl tetrasaccharide (iso¬
lated by alkaline borohydride treatment of glycophorin or
fetuin), and fetuin glycopeptide Fractions A, B, and C to bind
to the affinity column. It should be noted that, whereas
neuraminyl lactitol and sialyl tetrasaccharide have 1 and 2
NeuNAc residues, respectively, fetuin glycopeptide Fraction
A could have up to 3 terminal NeuNAc residues and 5 internal
GlcNAc residues (58). In contrast, the glycopeptides isolated
from glycophorin all bound to the WGA column in agreement
with the fact that these glycopeptides would have multiple
sialyl oligosaccharides (51). These results indicate clearly the
requirement of the macromolecular structure and the poly¬
valent binding sites of the glycoconjugates for their stable
binding to WGA-Sepharose column. Further work is necessary
before the minimum valency required for stable interaction
can be defined.
The role of internal GlcNAc residues in the interaction
between glycoconjugates and WGA columns is not clear since
asialo fetuin and asialo ai-acid glycoprotein were not retained
on WGA columns but asialoglycophorin was partially re¬
tained. The failure ofasialo agalactofetuin having nonreducing
termini of GlcNAc and GalNAc to be retained on WGA
columns was unexpected and difficult to understand. One
possible explanation for this finding is that the spacing of
GlcNAc and GalNAc terminals on the protein is unsuitable
for stable binding to the WGA immobilized on Sepharose
beads.
In agreement with the results from agglutination inhibition
experiments, porcine submaxillary mucin was only partially
retained on the lectin column probably because of the N-
glycolylneuraminic acid present on this glycoprotein. The
retained portion may be molecules with human blood group
A activity and thus having nonreducing GalNAc terminals.
Contributions from the NeuNAc residues, 10% of the total
sialic acid, to this binding is also possible. The porcine sub¬
maxillary mucin used in these studies was from pooled pig
submaxillary glands.
The finding that the proportions of fetuin, ai-acid glycopro¬
tein, and ovomucoid binding to different WGA-Sepharose 4B
preparations varied, in contrast to glycophorin which bound
completely to all the preparations, is difficult to interpret
(Table IV). Since applying 10 and 50 times more of the
samples to the lectin columns 1 and 2 did not alter the results,
it is clear that the partial binding of fetuin and ovomucoid
was not due to overloading the columns. The variation in the
concentration of the lectin on the gel could be a factor influ¬
encing the binding of different proportions of glycoproteins to
different preparations. In other words, the interaction between
a sialoglycoprotein and immobilized WGA could be influenced
by both the density of GlcNAc or NeuNAc residues on the
glycoprotein and the density of WGA molecules on the gel
bead. Thus, a WGA-Sepharose 4B preparation with high
density of lectin on the gel beads is capable of binding several
glycoproteins completely, including those with a low density
of NeuNAc or GlcNAc on the protein (fetuin, ai-acid glyco¬
protein, and ovomucoid). In contrast, an affinity gel prepara¬
tion with a low density of lectin on the gel will bind completely
those glycoproteins with a high density of NeuNAc, such as
glycophorin, and interact only partially with the other glyco¬
proteins. The proportions of fetuin and ovomucoid retained
on these columns apparently reflects the heterogeneity of
these molecules with regard to distribution of terminal
NeuNAc and GlcNAc available for interaction. Further inves¬
tigation of this aspect is necessary to test this hypothesis.
The results of this study indicate that the interaction of
glycoproteins with WGA is complex. A well recognized feature
of this interaction is the role of GlcNAc and its /II —* 4-linked
oligomers in glycoproteins which bind to subsites postulated
by Allen and co-workers (10). These workers also reported
that, for efficient binding, the equatorial acetamido group at
position 2 and the equatorial hydroxy group at position 3 of
the hexosamine are essential. In an analogous manner,
NeuNAc could interact at the same site via the acetamido
group at position 5 and the hydroxy group at position 4 as
illustrated in Fig. 5. Since the sialoglycopeptides labeled by
modifying the NeuNAc residues to 8- and 7-carbon analogs
still interacted with WGA, the side chains involving carbon
atoms 7, 8, and 9 in NeuNAc are most probably not involved
in the binding and in fact may even hinder efficient binding.
In the case of sialoglycoproteins, up to 3 sialyl residues present
in a suitable arrangement could interact at the sugar binding
regions, thus leading to the formation of an eventually stable
complex between the glycoprotein and WGA as illustrated in
Fig. 6. It is not clear whether 3 sialic acid residues as presented
by the oligosaccharides attached to consecutive amino acids,
for example, as in glycophorin, or the terminal sialic acids
present in the branched iV-glycosidically linked oligosaccha¬
rides could interact at three consecutive subsites without
hindrance. If such an interaction is prevented due to the larger
size of the NeuNAc residue, compared to the GlcNAc residue,
than a stable complex could still be formed by the interaction
of only 1 or 2 NeuNAc residues at each receptor region of
WGA. Further studies are needed to obtain additional infor¬
mation as to the exact mechanism of the interaction between
sialoglycoconjugates and WGA.
If the above mentioned postulate is correct, it would be
Interaction ofSialic Acid with Wheat Germ Agglutinin 4007
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Fig. 5. Structures of NeuNAc and GlcNAc in the 1C and CI
conformations, respectively. The similar (trans) relationship between
the acetamido (position 5 of NeuNAc and 2 of GlcNAc) and the
hydroxyl (position 4 of NeuNAc and 3 of GlcNAc) groups in both
structures is evident.
S11 OGIycosidicaily Linked Oligosaccharides
^ N-Gycosidically Linked Oligosaccharides
£3 Wheat Germ Agglutinin Monomer
Fig. 6. Illustration representing the multivalent interaction of a
glycoprotein with WGA. The WGA molecule is depicted as a dimeric
protein with four carbohydrate-binding regions, each capable of in¬
teracting with up to 3 NeuNAc or GlcNAc residues. The glycoprotein
molecules have oligosaccharides linked both O-glycosidically and N-
glycosidically to the protein. The model is not drawn to scale; only
some of the sugar residues are indicated by • (terminal NeuNAc
residues) and by O (internal GlcNAc residues in the iV-glycosidic
linkage region interacting with WGA). Maximum interaction is shown,
however, this may not be possible always due to stereochemical
reasons. For example, interactions of only 1 sugar residue (NeuNAc
or GlcNAc)/binding region may be sufficient to lead to a stable
complex.
possible to explain how a glycoprotein having only GalNAc,
such as asialo ovine submaxillary mucin or asialo bovine
submaxillary mucin, could lead to the formation of a stable
complex with WGA. It is known that the configuration at
position 4 of an iV-acetylhexosamine is important for the
interaction with WGA (10). When the 4-hydroxyl group is
equatorial with or without substitution, as in GlcNAc and its
4-substituted derivatives, favorable binding occurs. Replace¬
ment by an axial 4-hydroxyl group as in GalNAc leads to
weak binding, since GalNAc had Vie of the potency of GlcNAc
(Table I). Asialo ovine submaxillary mucin having several
GalNAc on the protein backbone (on an average one in six
amino acids are substituted (52)) will interact through these
sugar residues, leading to a favorable stable complex. Thus, it
is clear that the specificity of WGA and of course of other
lectins is relative rather than absolute. In the case of WGA, at
the present at least three sugars (GlcNAc, NeuNAc, and
GalNAc) commonly found in glycoconjugates appear capable
of interacting with different affinities. Depending on several
other factors glycoconjugates containing these sugars could
form stable complexes. The situation of WGA binding to the
cell surface would thus be more complicated consisting for
example of low and high affinity binding sites as suggested
earlier (4, 6).
Four forms (isolectins) of WGA having similar properties
have been isolated (10, 22). It will be interesting to determine
whether these isolectins have different specificities with re¬
spect to GlcNAc, NeuNAc, and GalNAc.
In preliminary experiments, we have observed that the
recovery of labeled glycoproteins is usually poor from lectin
columns with a high (>5 mg/ml) concentration of lectin on
the gel (compare the 6% recovery of WGA receptor activity
from erythrocytes (4)). This suggests the possibility of strong
irreversible interaction between glycoproteins and gels with a
very high density of lectin molecules. The multivalent inter¬
action between a glycoprotein and WGA will vary from very
weak to very strong, depending on the factors discussed above
and the possible cooperativity of the interaction. Positively
cooperative binding of 125I-WGA to fat cells has been reported
by Cuatrecasas (14). Thus, a monovalent hapten inhibitor,
such as GlcNAc, would not be capable of interrupting a strong
interaction between a polyvalent glycoprotein and WGA, thus
explaining the poor recovery mentioned above. The results of
the cell affinity chromatography are in agreement with this;
the very high density of sialyl and or N-acetylglucosaminyl
receptor sites on the cell surface will lead to an extremely
strong interaction with the WGA immobilized on gel beads
which will be difficult to break up by GlcNAc, whereas treat¬
ment of the cells with neuraminidase, thereby removing some
of the binding sites or application of the cells in the presence
of the inhibitor GlcNAc, improved the recovery of the cells
from the columns considerably (Table V).
If the forces of interaction between glycoproteins and WGA
are variable, then depending on the nature of the glycoprotein,
it may be possible to fractionate mixtures of various glycopro¬
teins on WGA column by elution with a gradient of the hapten
sugar. We were able to obtain partial separation between
fetuin or ovomucoid and glycophorin, since fetuin and ovo¬
mucoid apparently have weaker interactions with WGA in
contrast to glycophorin as discussed above. This is another
aspect which needs further investigation before developing it
as a possible method for fractionation of cell membrane gly¬
coproteins.
Greenaway and Levine (13) noted that approximately 9 mol
of NeuNAc and 1 mol of GlcNAc were bound/mol of agglu¬
tinin when a 50-fold molar excess of the hapten over WGA
was used. They concluded that, at this concentration, WGA
had a higher affinity for binding NeuNAc than GlcNAc. Under
optimum conditions, a maximum of 12 mol of NeuNAc would
be expected to bind/mol of WGA, since it is proposed that
WGA has four binding sites/mol, each of which has three
subsites. Jordan et al. (18) investigated the binding of GlcNAc
and NeuNAc to WGA by proton magnetic resonance and
found that was 238 M"1 for GlcNAc and 560 M_1 for
NeuNAc. Adair and Kornfeld (4) provided evidence indicating
that sialic acid residues are a component of the WGA receptor
on human erythrocytes. Several studies (14, 15, 59) have
indicated that treatment of cells with neuraminidase de¬
creased their binding affinity for WGA and also abolished
WGA-induced agglutination. Not all cells are affected this
way since neuraminidase digestion had no effect on WGA-
induced agglutination of Novihoff tumor cells (60). WGA-
resistant clones isolated from Chinese hamster ovary cells
have shown defects in the sialylation of surface glycoproteins
(5, 6). These and other reports (16, 17, 19) are consistent with
our results.
In conclusion, the data provided in this paper clearly show
that the N-acetylneuraminic acid residues of sialoglycopro-
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teins are directly involved in specific interaction with WGA.
Thus, it is likely that, in the interaction between the cell
surface and WGA, the nonreducing terminal NeuNAc residues
of glycoproteins and glycolipids play a more important role
rather than the usually internal GlcNAc residues. Further, it
is clear from our data that the topography of the NeuNAc
and GlcNAc residues on the glycoconjugates and the cell
surface is important for the formation of a stable association
between the lectin and the glycoconjugates or the cell.
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STUDIES ON THE AGGLUTININ AND ON ENZYMIC PROTEINS ISOLATED FROM WHEAT
GERM. V.P. Bhavanandan and Anne W. Katlic, Department of Biological
Chemistry, The Milton S. Hershey Medical Center, The Pennsylvania State
University, Hershey, PA 17®33.
We have previously reported the involvement of N-acetyl neuraminic
acid in the interaction of wheat germ agglutinin (WGA) with sialoglyco-
proteins (1).
Multivalent nature of the interaction between sialoqlycoconjuqates and WGA;
In the present studies we purified WGA by affinity chromatography on
a column of Fetuin glycopeptide Fraction C-Sepharose 4B. Fetuin glycopep-
tide Fraction C has the structure (NeuNAc+Gal-KlalNAc-O-Ser/Thr peptide) (2)
and does not inhibit hemagglutination by WGA and does not bind to WGA-
Sepharose 4B columns (1). Thus the binding of WGA to this glycopeptide
immobilized on Sepharose 4B gels is of interest and supports our postulate
of the requirement of multivalent interaction between the ligands and WGA
for the formation of stable complexes. To determine the minimum valency
required for stable interaction between sialyl glycoconjugates and WGA,
the binding of glycopeptides A and B isolated by CNBr treatment of glyco-
phorin (3) was tested. The larger glycopeptide B containing the bulk of
the sialic acid is completely bound, but only about 60% of the smaller
glycopeptide A was bound;the balance is retarded (Figure). Of all the
glycoconjugates so far tested the glycophorin CNBr glycopeptide A is the
smallest molecule that bound to WGA affinity columns. Glycopeptide A is
expected to contain 8 amino acids, 2 tetrasaccharides (NeuNAc-KSal-*-(NeuNAc)--*
GalNAc) and one trisaccharide (NeuNAc-*Gal-*Gal) (3) . However, it is pos¬
sible that the retarded portion of glycopeptide A has less sialic acid
than the portion that bound to the column.
Role of internal GlcNAc residues affinity binding to WGA-Sepharose 4B:
^ Affinity chromatography of [ C]dimethyl a^-acid glycoprotein and
[ C] dimethyl asialoagalacto a..-acid glycoprotein on a WGA column resulted
in the specific binding of 100% and 36% of the radioactivities, respec¬
tively. Previously, we have observed that whereas [ H]acetyl- and [ C]di¬
methyl fetuin were bound completely to WGA column, the corresponding
asialo- and asialoagalacto fetuin preparations failed to bind to the same
column. These results suggest that internal GlcNAc residues play only a
minor role, if any, in contrast to terminal NeuNAc residues in the inter¬
action of fetuin and a^-acid glycoprotein with WGA-Sepharose 4B.
Elution of glycoprotein bound to WGA-Sepharose 4B:
We demonstrated that glycoproteins bound to WGA columns could not be
displaced by 1 M NaCl, 0.1 M NaOAc, pH 8.1 or 0.1 M acetic acid. In
preliminary experiment^, we observed that 10 mM NaOH (pH 11.7) was capable
of displacing [NeuNAc- H]glycophorin from WGA columns. The significance
of the elution by NaOH is not clear at the present.
However, 0.1 M GlcNAc was the eluant routinely used to recover
glycoproteins (even those lacking GlcNAc) from WGA columns. If sialic
acid is one of the residues on glycoproteins for which WGA has affinity,
then it should be possible to use this hapten inhibitor instead of GlcNAc
to elute glycoproteins off a WGA column. Since column elution with sialic
acid did not appear feasible due to economical reasons, we tested this pos¬
sibility by batchwise elution in test tubes. The results showed that
NeuNAc is capable of displacing glycoproteins from WGA-Sepharose gels even
though batchwise elution by either NeuNAc or GlcNAc turned out to be very
inefficient compared to the column elution technique.
Studies on Succinyl-Wheat germ agglutinin:
WGA is a basic protein, the isoelectric point of three of its iso-
lectins being 8.7. We tested succinyl-WGA and found that it was in¬
capable of agglutinating human and rabbit erythrocytes at concentrations
698
of 250 yg and 500 ug per ml respectively,
whereas native WGA agglutinated both
erythrocytes at 3 yg per ml. Removal of
sialic acid and some of the surface nega¬
tive charge by neuraminidase treatment
rendered human erythrocytes agglutinable
by succinyl-WGA at 62.5 yg per ml. In
fact, treatment with trypsin which will
remove sialoglycopeptides and peptides
from the surface is even more effective in
that trypsinized human and rabbit erythro¬
cytes are agglutinated by succinyl-WGA at
1.0 yg and <2.0 yg per ml, respectively.
Succinyl-WGA, at 5 mg per ml, failed
to produce a precipitin band with a large
number of glycoconjugates in double dif¬
fusion experiments. Compounds tested
included glycophorin and its glycopeptides,
a^-acid glycoprotein, bovine and ovine sub¬
maxillary mucins, human lung mucin, fetuin
all of which gave a precipitin line with
native WGA at 2 mg per ml.
Succinyl-WGA-Sepharose 6MB was pre¬
pared by treatment Of WGA-Sepharos^ 6MB
with succinic anhydride. [NeuNAc- H]-
glycophorin and [ H]acetyl ovomucoid were
not retained on the succinyl-WGA-Sepharose
6MB column. These results suggest that
succinylation of the lectin, which converts
it to an acidic protein, probably causes conformational changes, dis¬
sociation of the subunits etc., leading to the alteration of the carbo¬
hydrate binding capability of the lectin.
The isolation of an endochitinase from wheat germ extracts by affinity
chromatography on chitin followed by gel filtration on Sephadex G-50 was
reported by Molano et al. (4). Our attempts to separate chitinase from .
WGA on a Sephadex G-50 column were unsuccessful. However, we were able to
separate an exo-8-hexosaminidase from endochitinase and WGA by the proce¬
dure described by Molano et al. (4). The endochitinase was isolated free
of WGA by successive chromatography on columns of fetuin-Sepharose 4B, N-
acetylated chitosan and finally Bio-Gel P30.
The relationship of the exo-6-hexosaminidase, the endochitinase and
WGA are currently under investigation.
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Glycosaminoglycans and Sialoglycopeptides Associated with
Mammalian Cell Nuclei
Veerasingham P. Bhavanandan
The characterization of the glycosaminoglycans associated
with the nuclei of B16 mouse melanoma cells has been described
previously (1). The major nuclear glycosaminoglycan component
is a chondroitin 4-sulfate, which was further characterized
by use of the milligram quantities isolated from spent media.
The o.r.d. curve and i.r. spectrum of the melanoma chondroitin
sulfate resemble those of cartilage chondroitin 4-sulfate.
However, the mol. wt. of the melanoma chondroitin sulfate was
estimated to be in the range of 90 000-120 000 by sedimenta¬
tion equilibrium analysis, whereas the corresponding values
for rib cartilage chondroitin sulfate is 12 000-15 000 (2). ^
The minor nuclear glycosaminoglycans were characterized as
heparan sulfate and chondroitin sulfate of lower mol. wt.
The sialoglycopeptides associated with the mouse melanoma
nuclei were fractionated into two classes (I and II) by use
of cetylpyridinium chloride (Scheme 1). The class I glyco-
peptides differed from those of class II, which are not
precipitated with cetylpyridinium chloride, in greater
molecular size and charge (sialic acid content) and affinity
for wheat germ agglutinin. The distribution of the radio¬
activity in these glycopeptides was as follows: sialic acid
(50%) , galactosamine (43%) , and glucosamine (7%) for class I;
and sialic acid (36%) , galactosamine (23%) , and glucosamine
Copyrigfit © 1979 by Academic Press, Inc
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(41%) for class XI. About 85% of the radioactivity was in
alkali-labile oligosaccharides in class I compared to 43% in
class IX. The sialoglycopeptides isolated from nuclei had
a higher percentage of label in sialic acid than the sialo¬
glycopeptides isolated from spent media. These preliminary
data indicate that the nuclear sialoglycoproteins are richer
in sialic acid and galactosamine as compared to the sialo¬
glycoproteins present in the medium.
The nuclei isolated in our studies were free of obvious
contamination by other organelles, as judged by phase-contrast
and electron microscopy and by assays for marker enzymes
(5'-nucleotidase, acid phosphatase, and succinic dehydroge¬
nase) . The nuclei, which were freed of the outer, membrane,
and therefore also of nonnuclear membrane contaminants, by
treatment with 2.0% Triton X-100 (3), still retained between
70 to 80% of the initial radioactivity. Further, chromatin
isolated from 3jj- and 35s-iabeled mouse melanoma nuclei
yielded, on digestion with Pronase, the same complex saccha¬
rides as those obtained from the intact nuclei. These
results indicate that glycosaminoglycans and sialoglyco¬
proteins are integral components of the nuclei. In other
control experiments, soluble glycoconjugates and membrane
fractions prepared from cells labeled with [%]glucosamine
and Na235S04 were added to unlabeled cells prior to homo-
genization and isolation of nuclei. The results show that
there was negligible adsorption of soluble glycoconjugates
on the purified nuclei and that the contribution from
nonnuclear membrane contaminants could not account for more
than 10% of the radioactivity associated with the nuclei
isolated by our procedures. —
In preliminary studies, evidence for the presence of
glycosaminoglycans associated with the nuclei of rat liver,
Morris hepatoma 7777, human breast cells, and human breast
cancer cells has been obtained. The presence of glycosamino¬
glycans associated with the nuclei of HeLaSj cells (4), rat
brain (5), and human skin fibroblasts (6) has been reported.
Although the significance of these findings remains to be
determined, the present evidence strongly suggests that the
association of glycosaminoglycans with the cell nuclei may
be a general phenomenon.
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PURIFICATION AND PARTIAL CHARACTERIZATION OF HUMAN TRACHEOBRONCHIAL MUCIN
GLYCOPROTEINS. V.P. Bhavanandan, B. Horsey and E.A. Davidson, Department
of Biological Chemistry, The M.S. liershey Medical Center, The Pennsylvania
State University, Hershey, PA 17033.
The purification, characterization and partial structure of a high
molecular weight glycoprotein from the bronchial secretions^ of an asthmatic
patient has been described (1). In the present study we have examined a
number of tracheal secretions from patients in pediatric and neonatal
wards who have undergone surgery for non-pulmonary illness. The bronchial
secretions were collected by sterile aspiration and the soluble components
prepared as described previously (1). The high molecular weight glycopro¬
teins, eluting at the void volume of Sepharose CL-4B columns, were isolated
by gel filtration. The unfractionated samples and the high molecular
weight fractions were analyzed for protein and carbohydrate contents. The
analyses of a number of samples did not vary significantly. For detailed
studies, the bronchial secretions of two patients (K.W. and C.L.), diag¬
nosed as suffering from viral encephalitis (K.W.) and Guillain-Barre
Syndrome (C.L.) were selected. The mucin glycoproteins from these secre¬
tions were isolated by gel filtration on Sepharose CL-4B (K.W.) or by
precipitation with cetyl pyridinium chloride (C.L.). The carbohydrate and
amino acid analyses of the isolated fractions are shown in the Table. The
composition of K.W. peak I and C.L. 0.4 M NaCl fractions are typical of
mucin glycoproteins. The fraction included in Sepharose 4B (K.W. peak II)
and that remaining in the cetyl pyridinium chloride supernatent had analy¬
ses characteristic of serum glycoproteins. In double diffusion experiments,
K.W. peak II gave precipitin lines with antisera against whole human serum,
a^-acid glycoprotein and IgG.
&The minimum molecular weight of K.W. peak I was estimated to be 1.4-3
x 10 by equilibrium sedimentation ultracentrifugation. The results
obtained indicate the presence of higher molecular weight species appar¬
ently resulting from aggregation of lower molecular weight components.
The role of disulfide bonds as well as that of carbohydrate in the un¬
usually high molecular size of the mucin glycoprotein was studie^after
labelling of the protein moiety by reductive methylation using H CHO and
NaBH^CN (2). The labeled glycoprotein was purified by rechromatography on
Sepharose CL-4B. This removed low molecular weight contaminants, which
were probably small amounts of proteins previous^ trapped in the aggre¬
gates of the mucin glycoprotein. The purified [ C]dimethyl mucin glyco¬
protein was treated twice with dithiothreitol and iodoacetamide to reduce
and block disulfide bridges. In a different approach, the labeled glyco¬
protein was treated with performic acid to oxidize the half-cystines to
cysteic acid. The analysis of the performic acid treated sample is given
in the Table. Chromatography of the reduced and carboxymethylated or the
performic acid oxidized [ C]dimethyl glycoprotein on Sepharose CL-4B
columns showed that the molecular size was drastically reduced. In both
cases the radioactive material was included in the column and major por¬
tions eluted in single peaks. Since the radioactivity in the treated
samples was non-dialysable and eluted at the void volume of Sephadex G-50
columns, it was clear that label was still associated with macromolecules.
These results indicate that disulfide bridges are one of the factors in¬
volved in the formation of the high^ijolecular aggregate mucins.
The unlabeled as well as the [ C]dimethyl labeled glycoproteins were
treated with anhydrous hydrogen fluoride to cause deglycosylation without
degradation of the peptide (3). The amino acid and hexosamine composition
of the treated sample is shown in the Table. The amino acid composition
was not significantly changed and >90% of the hexosamines^vpra removed by
the HF treatment. Gel filtration of the deglycosylated [ C]dimethyl
35
glycoprotein on a Sepharose CL-4B column gave a well included single peak;
on a Sephadcx G-50 column the radioactive material cluted at the void
volume. These results indicate that in addition to disulfide bridges, the
carbohydrate residues of the mucin play an important role in the main¬
tenance of the macromolecular structure and rheological properties of the
mucin and hence of the bronchial secretion.
TABLE: Carbohydrate (% by dry weight) and amino acid (mole %) analysis of
various fractions derived from bronchial secretions of two patients
(K.W. and C.L.)












GlcNH2 10.0 0.6 7.2 16.0 12.0
GalNH2 4.0 0.0 4.0 8.0 5.0
Neutral Sugars* 34.0 n. d. n.d. 39.0 42.0
Sialic Acid+ 4.0 n.d. n.d. 2.0 3.0
Cyst. Acid 0 3.3 4.4 0.43 0.22
Asp 6.7 7.0 8.4 5.2 6.4
Thr 17.2 20.5 14.4 22.4 19.1
Ser 15.0 12.2 13.2 20.8 10.6
Glu 7.9 6.3 10.1 6.9 7.6
Pro 7.6 10.2 10.0 9-2 10.3
Gly 8.3 8.3 9.3 8.8 12.0
Ala 10.0 10.8 10.1 8.6 9.3
Half-Cys 5.4 0 0 2.6 5.5
Val 6.4 7.2 6.9 3.4 5.2
Met 1.9 0 0 1.5 0.88
lie 3.5 4.5 3.5 2.3 2.4
Leu 6.0 5.8 7.2 4.7 6.8
Tyr 2.2 1.6 0 1.4 1.7
Phe 2.2 2.2 2.5 1.6 ^9
i
* Determined by Phenol-Sulfuric acid Assay using galactose.
+ Determined by Thiobarbituric Acid method.
It is very likely that in general the high carbohydrate content of
mucins,usually of the order of 80% by weight, play a similar role in
maintaining the characteristics of mucus from such varying sources as sub¬
maxillary glands, gastro-intestinal, uro-genital and tracheo-bronchial
tracts. The findings of Hill et al. (4) on the subunit structure of ovine
submaxillary mucin are in support of this hypothesis.
Acknowledgement: This work was supported in part by U.S.P.H.S. Grant
HL19190.
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A murine B16 melanoma-associated antigen was de¬
tected and partially purified from spent culture medium
and intracellular material. The antigen was also puri¬
fied and partially characterized from the detergent ex¬
tract of cells cultured in the presence of [3H]glucosa-
mine alone or together with [l4C]leucine. During puri¬
fication, the melanoma-associated antigen activity was
monitored by a double antibody antigen binding assay
(Bystryn, J.-C., Schenkein, L, Baur, S., and Uhr, J. W.
(1974) J. Nat Cancer Inst 52, 1263). A radiochemical^
pure preparation of this glycoprotein antigen was ob¬
tained by gel filtration on Sepharose CL-4B and Seph-
arose CL-6B, ion exchange chromatography on DEAE-
Sepharose, and chromatography on concanavalin A-
Sepharose. Gel filtration on a calibrated Sepharose CL-
6B column in the presence of detergent gave an appar¬
ent molecular weight of 375,000. Prolonged treatment
with sodium dodecyl sulfate and 2-mercaptoethanol
followed by gel filtration or acrylamide gel electropho¬
resis in the presence of sodium dodecyl sulfate indi¬
cated a subunit molecular weight in the range of 44,000
to 52,000. The tritium label in the antigen was distrib¬
uted mainly between sialic acid and /V-acetylglucosa-
mine, with a small amount in iV-acetylgalactosamine.
Pronase digestion of antigen followed by fractionation
on a Bio-Gel P-10 column yielded several glycopeptides.
The results of the action of exo- and endoglycosidases
on these glycopeptides and their behavior on lectin
affinity columns suggested the presence of both com¬
plex (TV-acetyllactosaminyl type) and simple (oligoman-
nosyl type) oligosaccharides linked via JV-acetylgluco-
samine to asparagine. The glycopeptide fractions iso¬
lated after proteolytic digestion were devoid of anti¬
genic activity. Significant antigen activity was detected
in the nuclei isolated from the labeled cells.
It is widely believed that tumors possess unique tumor-
associated antigens that are absent in normal adult tissues
and which play an important but as yet not properly under¬
stood role in tumor growth. The isolation, purification, and
characterization of these antigens is of paramount importance
if their influence on tumor growth is to be elucidated.
The B16 murine melanoma has been extensively investi¬
gated (1-15), and it has been proposed as a model for human
* This investigation was supported by Research Grants CA 17686
and CA 13844 from the National Cancer Institute, National Institutes
of Health, United States Public Health Service. The costs of publi¬
cation of this article were defrayed in part bv the payment of page
charges. This article must therefore be hereby marked "advertise¬
ment" in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
malignant melanoma (16, 17). Previous publications from our
laboratories have reported on the nature of the glycosamino-
glycans and glycopeptides isolated from B16 melanoma cells,
culture media, and tumors (5-7, 18, 19). In addition, the
presence of melanoma-associated antigens on the cells and
their release into culture medium by viable cells was reported
(8,10). We have also shown that the partially purified antigens
retained their biological activity since it was possible to im¬
munize syngeneic mice with these antigens and inhibit the
subsequent growth of otherwise lethal numbers of melanoma
cells (11).
This study describes further purification and partial char¬




The B16 mouse melanoma cell line described previously was used
in these studies (7). Sepharose CL-4B and CL-6B and DEAE-Seph-
arose CL-6B were from Pharmacia. Bio-Gel P-2 and Bio-Gel P-10,
both 200 to 400 mesh, and protein standards for gel electrophoresis
were obtained from Bio-Rad. Pronase CB and Vibrio cholerae neur¬
aminidase were from Calbiochem; leech hyaluronidase from Biotrics,
Arlington, Mass.; endoglycosidase D and H (endo-/?-/V-acetylgluco-
saminidases), concanavalin A-agarose (glycosylex A), and protein
standards for gel filtration were from Miles. Neuraminidase, endo-a-
N-acetylgalactosaminidase, /^-hexosaminidase, and /Tgalactosidase
from Diplococcus pneumoniae were isolated as described (20, 21).
Concanavalin A, wheat germ agglutinin, Ricinus communis agglutinin
120 and 60 were isolated and conjugated to Sepharose 4B essentially
as described (7). Concanavalin A-polyacrylamide was prepared as
described by Lotan et al. (22).
Tritiated glucosamine (D-[6-'H]glucosamine hydrochloride, 10 to
30 Ci/mmol) and Na2,5S04 (carrier-free; 10 to 1000 mCi/mmol) were
obtained from New England Nuclear. L-[U-14C]Leucine (330 mCi/
mmol) was from Amersham. [ 'H]Acetylovalbumin glycopeptides were
isolated as previously reported (21, 23).
Isotopically labeled and unlabeled glycophorin, a \ -acid glycopro¬
tein, fetuin, and ovomucoid were prepared by published procedures
(24).
Methods
Cell Cultures—The conditions of cell culture and of labeling of the
complex saccharides produced by the cells have been described (7).
For simultaneous labeling of saccharides and proteins, the cells were
grown for 48 h in the presence of ['Hjglucosamine at 10 /xCi/ml and
[MC]leucine at 1.5 /iCi/ml of media.
The cultured cells were harvested at confluence by treatment with
0.02% EGTA1 in NaCl/Pj. The cells were pelleted by centrifugation
1 The abbreviations used are: EGTA. ethylene glycol bis(/?-amino-
ethyl ether)/V,N,/V',/V'-tetraacetic acid; MAA, melanoma-associated
antigen; MAA-M, melanoma-associated antigen isolated from culture
medium; MAA-C, melanoma-associated antigen isolated from cells;
NP-40, Nonidet P-40 from Shell Chemical Corp., N. Y.; SDS, sodium
dodecyl sulfate; WGA, wheat germ agglutinin; Con A, concanavalin
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(200 x g, 10 min) and washed thrice with serum-free media by
resuspension and centrifugation.
Antisera—Rabbit antiserum to freshly excised murine B16 mela¬
noma cells and rabbit IgG were prepared as described previously (8,
11). Prior to use, rabbit antimelanoma serum and normal rabbit serum
were exhaustively absorbed with pooled normal syngeneic tissues
(11).
The specificity of absorbed antimelanoma serum was examined by
several methods (11, 25). The binding activity of the antiserum was
reduced over 85% by quantitative absorption with increasing numbers
of melanoma cells, whereas, it was reduced only 10% by equal numbers
of syngeneic spleen cells under the same conditions. This finding
indicates that the antiserum was not directed to H-2 or la antigens,
which are strongly expressed on normal lymphoid cells. This was
confirmed by the finding that binding activity was reduced by only
5% by absorption with a pool of normal allogeneic spleen cells pre¬
pared from different strains of mice which expressed most of the
known murine transplantation antigens. B16 melanoma tissue pre¬
pared from surgically excised tumors absorbed binding activity as
effectively as did cultured B16 melanoma cells, indicating that the
antiserum was not directed to neoantigens, fetal calf serum, or other
artifacts of cultured cells. By radioimmunoassay, the antiserum was
shown not to react to the major structural protein.
Assay for MAA—MAA were identified and quantitated by a double
antibody antigen binding assay. The assay is based on the coprecipi-
tation by anti-Ig of immune complexes formed between excess anti¬
melanoma antibodies and radiolabeled MAA (9). Briefly, triplicate
0.1-ml aliquots of material to be tested for MAA activity were diluted
Va in NaCl/Pi and incubated with 0.1 ml of antimelanoma or normal
rabbit serum diluted in NaCl/P,. The assay was performed in the
presence of 0.1 ml of fetal calf serum to reduce nonspecific binding of
proteins. After 30 min of incubation at 37°C, antigen-antibody com¬
plexes were precipitated by the addition of goat anti-rabbit IgG. After
an additional 30 min of incubation, 0.1 ml of normal rabbit serum
diluted Vw in NaCl/Pi was added to all tubes to provide carrier
immunoglobulin, and the incubation continued for 30 min at 37°C
and then for 18 h at 4°C. The precipitates were collected by centrif¬
ugation and washed three times with 3 ml of NaCl/Pi, dissolved in 0.5
ml of 0.25 n acetic acid, mixed with 10 ml of Beckman scintillation
fluid and radioactivity was determined. Specific binding is defined as
the radioactivity (counts/min) bound by antimelanoma serum less
that bound by normal serum. The results are expressed as the
percentage of added radioactivity bound specifically. In some cases
the ratio of radioactivity bound by antimelanoma serum to that
bound by normal serum, the binding index, was also calculated. Prior
experiments have shown (9) that under these conditions there is a
linear relationship between the amount of radioactivity bound specif¬
ically and the amount of labeled MAA present, indicating that the
assay provides a quantitative measure of MAA concentration.
Column Chromatography—Sepharose CL-6B and CL-4B columns
were equilibrated and eluted with Tris-HCl buffer, pH 8.0, with or
without 0.1% Triton X-100. In preparative experiments 0.01% sodium
azide and 0.1 mM of phenylmethane sulfonyl fluoride were included
in the elution buffers. The elution profiles obtained in the presence of
the protease and bacterial inhibitors were identical with those ob¬
tained in their absence. Bio-Gel P-2 and P-10 columns were equili¬
brated and eluted with 0.1 m pyridine acetate, pH 5.0. DEAE-Seph-
arose CL-6B was packed according to the manufacturer's instructions
and regenerated to either the acetate or chloride form. After appli¬
cation of the sample, the column was eluted with a linear gradient of
pyridine acetate, pH 5.0 (acetate form); NaCl or LiCl in Tris-HCl
buffer, pH 8.0, containing 0.1% Triton X-100 (chloride form). The
recovery of radioactivity from the columns was between 80 and 100%
unless otherwise specified.
Lectin Affinity Columns—The sample was applied and washed
into the column which had previously been equilibrated with the
elution buffer (50 mM Tris-HCl buffer, pH 8.0, containing 0.1% Triton
X-100). After being allowed to stand for about 15 min at room
temperature, the column was eluted with the buffer followed by a
solution of hapten sugar in the same buffer; the flow rate was
controlled to about 10 to 15 ml/h. Fractions of 1 ml were collected
and portions analyzed for radioactivity. The hapten sugar solution for
A; RCA-120 or RCA-60, Ricinus communis agglutinin molecular
weight 120,000 or 60,000; NaCl/Pi, phosphate-buffered saline (0.14 m
Na+, 0.1 m K+, 0.006 m POr', pH 7.2); NeuAc, N-acetylneuraminic
acid; GlcNAc, N-acetylglucosamine.
the Con A column was methyl-a-mannoside (0.1 m unless otherwise
indicated); for the WGA column, 0.1 m N-acetylglucosamine and for
the RCA-120 and RCA-60 columns, 0.1 m lactose. The use of buffers
containing 10~3 m CaCl2, MgCl2, and MnCl2 (26) for the Con A column
did not alter the results obtained.
Determination of [3H]Sialic Acid and [3HJHexosamines—Total
(3H]sialic acid was determined either by acid hydrolysis (0.1 m H^O*.
80°C, 1 h) or V. cholerae or D. pneumoniae neuraminidase treatment,
followed by separation of sialic acid from asialoglycoprotein on a Bio-
Gel P-2 column. In instances where the recovery of the asialoglyco¬
protein was poor on the Bio-Gel P-2 column, a Sepharose CL-4B
column or a DEAE-Sepharose CL-6B column was used for the
separation. An internal standard of unlabeled NeuAc or [l4C]NeuAc
was included to establish the identity of product released by the acid
or by the enzyme.
Hexosamine determinations on isotopically labeled compounds
were carried out on acid hydrolysates (4 N HC1, 100°, 8 h) on an
amino acid analyzer by a stream-splitting technique (5). Alternatively
the hydrolysates were mixed with standard hexosamine and [MC]-
hexosamines and then chromatographed on a column of AG 50W-X8
according to Gardell (27); aliquots of the fractions were analyzed for
hexosamine (28) and radioactivity.
Paper chromatography was carried out on Whatman No. 1 paper
by the descending technique. The following solvent systems were
employed: A, 1-butyl acetate/acetic acid/water (3:2:1); B, 1-butanol/
pyridine/water (6:4:3). The standard sugars were detected as de¬
scribed previously (7). Radioactivity on paper strips was estimated
by extracting cut pieces with 1 ml of water in counting vials followed
by scintillation counting. Liquid scintillation counting was performed
on an Intertechnique model SL-36 spectrometer equipped with a
DPM calculating module (7).
Digestion with Glycosidases—Digestions with neuraminidase (V.
cholerae or D. pneumoniae), D. pneumoniae /3-galactosidase, /?-hex¬
osaminidase, and endo-a-N-acetylgalactosaminidase were all done as
described (7, 21). Treatment with endoglycosidase D or H was done
in 50 mM citrate/phosphate (D, pH 6.5; H, pH 5.0) buffer at 37°C for
20 h (23).
Pronase digestion was performed in 50 mM Tris-HCl buffer, pH 8.0,
containing 10 mM Ca2+ at 37°C for 120 h, in the presence of toluene
and chloroform. Enzyme dissolved in the buffer was added at 0, 24,
48, and 96 h.
Gel Electrophoresis—Polyacrylamide gel electrophoresis was per¬
formed on 6.5%, 5.0%, and 4.0% gels in the presence of 0.1% sodium
dodecyl sulfate as described by Weber and Osborn (29). Gel electro¬
phoresis under nondenaturing conditions was performed similarly
except that sodium dodecyl sulfate was omitted from the gels and in
the buffers.
results
Isolation of Melanoma-associated Antigen from Culture
Medium—The medium (200 ml) was dialyzed at 4°C against
0.2 m NaCl for 2 days, followed by distilled water for 5 days,
and then lyophilized. The powder was dissolved in NaCl/Pi
(200 ml), an equal volume of saturated (NH4)2S04 added and
the pH adjusted to 8 with 1 m Tris base. After allowing the
suspension to stand for 4 h at 4°C, the precipitate was col¬
lected by centrifugation, dissolved in 20 ml of 50 mM Tris-
HCl, pH 8.0, and the resulting solution made 52% saturated
by addition of solid (NH4)2S04. After standing overnight at
4°C the precipitate was recovered by centrifugation, washed
with 52% saturated (NHULSCL by resuspension and centrifu¬
gation, and dissolved in 10 ml of 50 mM Tris-HCl buffer, pH
8.0. The percentage of radioactivity in the (NH4)2S04 precip¬
itate specifically bound by antimelanoma serum varied from
2.1 to 7.4% in different preparations; the binding index was
between 1.5 and 3.0.
Purification of MAA-M—The fractionation of the
(NH4)2S04 precipitate of the culture medium on columns of
Sepharose CL-4B is illustrated in Fig. 1. The material from
each peak was tested for MAA activity with highest activity
present in the void peak (Peak I). When the fractionation was
repeated using buffer containing 0.1% Triton X-100, only
negligible radioactivity eluted in the position of peak I (void




Fig. 1. Fractionation of glycoproteins from media. Fraction¬
ation of the glycoproteins isolated by ammonium sulfate precipitation
from culture media on a column (2.7 X 110 cm) of Sepharose CL-4B
using 50 mM Tris-HCI buffer, pH 8.0; 4.5-ml fractions were collected.
Aliquots were analyzed for radioactivity. Fractions were combined as
indicated to yield the numbered peaks. The combined fractions were
concentrated to 2 to 10 ml in an Amicon concentration cell with a
UM-10 membrane and dialyzed against 50 mM Tris-HCI buffer, pH
8.0, in the same cell. The peak elution positions of blue dextran (V0)
and yellow dextran (YD) are indicated by arrows.
volume). The elution profile was similar to that subsequently
obtained with cell extracts (cf. Fig. 26). Material with high
MAA activity eluted in areas designated peaks II and III in
Fig. 26. Chromatography of peak II material on a Sepharose
CL-6B column using Tris buffer containing 0.1% Triton X-100
resulted in further purification of MAA-M. Of the radioactiv¬
ity in the main peak from the Sepharose CL-6B column 63%
was specifically bound by antimelanoma serum and the bind¬
ing index of this fraction was 38.2. The results of gel filtration
in the presence of Triton X-100 suggest that the antigens
found in peak I (Fig. 1) in the absence of detergent are
aggregates. In agreement with this, when the glycoprotein
from peak I (Fig. 1) was rechromatographed on Sepharose
CL-4B using 50 mM Tris-HCI buffer, pH 8.0, containing 0.1%
Triton X-100, the radioactive antigenic material was essen¬
tially all included in the column, whereas if the rechromatog-
raphy was carried out in buffer without Triton, then a portion
of the material eluted at the void volume and the rest as a
continuous trail (no sharp peaks).
Detection of MAA in the Intracellular Material—The
EGTA supernatant obtained during harvesting of cultured
labeled cells was exhaustively dialyzed at 4°C against 0.1 m
NaCl for 2 days and against water for 5 days. The dialyzed
solution was lyophilized, dissolved in Tris buffer, and tested
for MAA activity. The percentage of radioactivity specifically
bound by antimelanoma serum was 3.6%. Chromatography of
the above material on a Sepharose CL-4B column gave an
elution profile identical with that subsequently obtained with
material in the NP-40 extract of cells (cf. Fig. 26). The
percentages of radioactivity specifically bound by antimela¬
noma serum were 9.0, 9.5, and 0.6% and the binding indices
were 2.2., 2.3, and 1.3 for the material eluting in positions
corresponding to peaks I, II, and III, respectively, in Fig. 26.
The melanoma antigens in the EGTA supernatant were not
further investigated.
Isolation of MAA from Cells—The cell pellet was sus¬
pended in 3 m KC1 (1.4 to 2.0 x 10' cells/ml) and stirred at
4°C for 24 h. The resulting suspension was centrifuged at
64,000 X g for 60 min at 4°C, and the supernatant (KC1
supernatant) saved. The pellet was then extracted with 0.5%





60 80 100 120
FRACTION NUMBER
Fig. 2. Fractionation of glycoproteins from cells. Fractiona¬
tion of the glycoproteins extracted by (a) 3 m KC1 and (6) 0.5% NP-
40 from B16 mouse melanoma cells metabolically labeled with
[3H]glucosamine and [l4C]leucine. The extracts were dialyzed against
50 mM Tris-HCI buffer, pH 8.0, containing 0.1% Triton X-100 and
chromatographed in the same buffer on a column of Sepharose CL-
4B (2.7 x 120 cm). F-actions of 4.2 ml were collected and aliquots
analyzed for radioactivity. Fractions were combined as indicated to
yield the numbered peaks, concentrated, and dialyzed against the
elution buffer as described in Fig. 1. Peak elution positions of blue
dextran (V0) and yellow dextran (YD) are indicated by arrows.
centrifuged as above. The KC1 and NP-40 extracts were
separately dialyzed against 6 liters of 50 mM Tris-HCI buffer,
pH 8.0, containing 0.1% Triton X-100 at 4°C, the buffer was
changed at 24 h and the dialysis stopped at 48 h. The dialyzed
material was assayed for MAA activity. In a typical experi¬
ment, the percentage of radioactivity specifically bound by
antimelanoma serum in the NP-40 extract was 2.8% compared
to 0.7% for the KC1 extract; the binding indices were 1.6 and
1.2, respectively.
Purification ofMAA-C—Since Triton X-100 prevented the
aggregation of MAA, all further chromatographic procedures
were carried out using buffers containing 0.1% Triton X-100.
The protease inhibitor, phenylmethane sulfonyl fluoride (0.1
mM), was also included in the buffer.
The KC1 and NP-40 cell extracts were fractionated on
Sepharose CL-4B columns, and individual fractions tested for
MAA activity (Fig. 2 and Table I). Since the peak II material
obtained from the NP-40 extract had the highest antigenic
activity, it was further purified by sequential chromatography
on columns of Sepharose CL-6B and DEAE-Sepharose CL-
6B. The percentage of radioactivity in the purified material
5148 Mouse Melanoma Antigen
Table I
Properties ofglycoproteins isolated from murine melanoma cells





















'H MC 'H UC
% %
0.5% NP-40 extract 2.8 1.7 1.6 1.5 ND° 53
After fractionation on Seph¬
arose CL-4B
Peak I 0.5 1.3 1.1 1.2 ND ND
Peak II 27.4 16.2 19.4 17.7 4.6 90
Peak III 6.8 4.0 6.7 5.8 9.0 58
Peak IV 0.6 0.4 1.6 1.4 49.0 12
3 m KC1 extract 0.7 2.7 1.2 1.5
After fractionation on Seph¬
arose CL-4B
Peak I 2.9 1.2 2.6 2.2 ND ND
Peak II 2.1 0.6 2.0 1.5 ND ND
Peak III 0.5 0.1 1.5 1.1 ND ND
NP-40 Sepharose CL-4B 76.8 68.7 70.7 29.6 14.0 92
Peak II after purifica¬
tion on Sepharose CL-
6B and DEAE-Sepha¬
rose
" ND, not determined.
which was specifically bound by the antimelanoma serum, as
well as the binding index, increased severalfold (Table I). This
suggests that the combination of the chromatography on
Sepharose 6B and DEAE-Sepharose may have removed some
labeled nonantigenic contaminants and perhaps unlabeled
contaminants capable of binding to the antibody. The material
after gel filtration on Sepharose 6B but before chromatogra¬
phy on DEAE-Sepharose was not assayed for MAA activity.
The percentage of label specifically bound by antimelanoma
serum and the binding index of other purified preparations of
MAA-C varied between 70 to 85 and 21 to 54, respectively.
Nature of Labeled Contaminants in MAA and Attempts
at Further Purification—Chromatography of MAA-C on a
calibrated column of DEAE-Sepharose CL-6B gave a single
peak eluting at a concentration of 0.50 M LiCl. The peak
elution positions of standards on this column were as follows:
glycophorin, 0.505 M LiCl; hyaluronic acid, 0.55 M LiCl; hep¬
aran sulfate, 0.78 M LiCl; chondroitin sulfate, 1.05 M LiCl; and
heparin, 1.25 m LiCl.
Since the antigen eluted close to the position of hyaluronic
acid and had a high glucosamine content, the preparation was
examined for the presence of hyaluronic acid. Treatment of
the antigen fraction with leech hyaluronidase (phosphate/
citrate buffer, pH 5.6, 37°C, 24 h) followed by examination of
the digest on controlled pore glass (6) and Sepharose CL-4B
columns indicated that less than 5% of the radioactive material
was degraded. The low molecular weight material produced
eluted close to the position of glucuronic acid on the Sepharose
4B column and was not further characterized, but is presum¬
ably hyaluronic acid oligosaccharides. In an attempt to remove
the glycosaminoglycans in the antigen preparations, MAA-C
(Sepharose 4B Peak II in Fig. 26) was treated with cetylpyr-
idinium chloride in the presence of carrier anionic polysaccha¬
rides (6). Greater than 90% of the labeled glycoprotein mate¬
rial remained in the cetylpyridinium chloride supernatant but
showed only 1.3% MAA activity, suggesting that the cetylpyr¬
idinium chloride treatment caused denaturation of the anti¬
gen.
On treatment of MAA-C with 8% trichloroacetic acid at
4°C, 82% of the radioactivity was precipitable. The precipitate
showed only 6% MAA activity compared to about 60% in the
starting material, suggesting inactivation of the antigen.
Chromatography of MAA-C on Immobilized Lectins—
Chromatography on various concanavalin A-Sepharose or
concanavalin A-acrylamide columns as described under "Ex¬
perimental Procedures", results in recoveries varying from 22
to 32%. The reason for these poor recoveries is not clear.
However, chromatography on a concanavalin A-acrylamide
column at 37°C, instead of 25°C, and elution with a 5%
solution of methyl-a-mannoside improved the recovery to
about 80%. About 72% of the applied material passed through
the column and was antigenically active.
Chromatography of MAA-C on WGA-Sepharose 4B and
Ricinus communis agglutinin 120-Sepharose 4B columns re¬
sulted in 92 and 82%, respectively, of the radioactivity binding.
However, the material eluted from these columns did not
show any increase in MAA activity. Asialo-MAA, prepared by
treatment of the purified material with neuraminidase, was
poorly bound by the WGA-Sepharose (25%) but still inter¬
acted well with RCA-120 or RCA-60; 85% and 82% bound.
Estimation of the Molecular Size ofMAA-C—Gel filtration
of the purified MAA on a calibrated Sepharose CL-6B column
using buffer with 0.1 or 1.0% Triton X-100 gave a single
homogeneous peak (not illustrated). A semilogarithmic plot
of molecular weights versus Kav (= (Ve — V0)/(V, — V0)) for
glycoproteins with carbohydrate contents greater than 20% is
linear (Fig. 3). Standards with lower carbohydrate contents
(<10%) fall on a different straight line. Even though our
results indicate that MAA-C is a sialoglycoprotein, we have
no information on the percentage of carbohydrate in this
molecule. If it is assumed that MAA-C has a carbohydrate
content comparable to the glycoprotein standards falling on
the linear plot, then MAA-C would have an apparent molec¬
ular weight of 375,000, whereas, if the carbohydrate content is







Fig. 3. Molecular weight of MAA-C. Estimation of the molec¬
ular weight of the purified MAA-C by gel filtration on a column (1.5
x 36 cm) of Sepharose CL-6B using 50 mM Tris-HCl buffer, pH 8.0,
containing 0.1% Triton X-100. The column was calibrated by chro¬
matography of protein and glycoprotein standards together
with [14C]glucose as internal reference. Fractions were analyzed for
protein (30) or radioactivity. Standards containing either no or low


















Fig. 4. Gel filtration of MAA-C. Gel filtration of MAA-C
(• •) after prolonged treatment with SDS and 2-mercaptoetha-
nol (see text for conditions) and of [l4C]glucose (O O) on a Seph-
arose CL-6B column (1.5 X 36 cm) using 50 mm Tris-HCl buffer, pH
8.0, containing 1% SDS and 10 mm 2-mercaptoethanol. The inset
illustrates the calibration curve obtained with glycoprotein standards
chromatographed under identical conditions. The peak elution posi¬
tion of asialo-MAA-C on the same column is also indicated.
Since gel filtration of MAA-M in aqueous buffer resulted in
elution as an aggregate, we examined the possibility of further
dissociating MAA-C. When the sample was treated with 1%
sodium dodecyl sulfate and 10 mM 2-mercaptoethanol at 25°C
for 30 min and rechromatographed on the Sepharose CL-6B
column using buffer containing 1% SDS and 10 mM 2-mercap-
toethanol, there was no significant alteration in its elution
position or its Kav. However, prolonged incubation (64 h or
more) with 1% SDS at 50°C followed by a 4-h incubation with
10% 2-mercaptoethanol as described by Kawasaki and Ashwell
(31) resulted in dissociation of MAA into smaller subunits
(Fig. 4). The apparent subunit molecular weight was 44,000
based on a calibration curve obtained by running the reference
glycoproteins in buffer containing 1% SDS and 2-mercapto-
ethanol. It is known that glycoproteins behave anomalously
in SDS systems (32) and this may be the reason for the four
points of the standards not lying on a straight line (Fig. 4). In
this system, glycophorin gave two peaks, a major one appar¬
ently corresponding to the dimer with Kav 0.34, and a minor
peak which is probably the monomer (33). A value of 23,500
was obtained for the apparent molecular weight of asialo-
MAA, indicating that MAA has about 47% sialic acid. How¬
ever, since it is known that sialoglycoproteins behave anom¬
alously in the presence of SDS (32) and on gel filtration (34),
other independent confirmations of the subunit molecular
weight and sialic acid content are needed.
Electrophoresis of MAA-C using 6.5% or 5% acrylamide gels
resulted in the sample failing to enter the gel; on 4% polyacryl-
amide gel the major portion of MAA-C entered the gel and
had a mobility comparable to that of thyroglobulin. The
samples, however, trailed instead of giving a sharp band.
Polyacrylamide gel electrophoresis of MAA in 5% gels in
the presence of sodium dodecyl sulfate is illustrated in Fig. 5.
A radioactive band was obtained corresponding to a molecular
weight of 52,000 or 97,000 based on glycoprotein or pure
protein standards, respectively, provided the sample was sub¬
jected to prolonged incubation with SDS and 2-mercaptoeth¬
anol. Shorter treatment with SDS (for example, heating for
10 min at 100°C) gave a band of radioactivity diffused over 6
cm of the gel (Fig. 5a).
Sialic Acid and Hexosamine Analysis of MAA-C—The
proportion of sialic acid in the carbohydrate moiety of MAA-
C was estimated by assessing the percentage of incorporated
radioactivity released by mild acid hydrolysis (0.1 M H>S04,
80°C, 1 h) or neuraminidase digestion followed by separation
of the cleaved product by exclusion or ion exchange chroma¬
tography. The values ranged from 23 to 33%, probably reflect¬
ing some methodological variation. The identity of the mon¬
osaccharide released by neuraminidase treatment was con¬
firmed as N-acetylneuraminic acid by chromatography on
Dowex 1 (formate) followed by paper chromatography utiliz¬
ing Solvent A.
The ratio of radioactivity in glucosamine to that in galac-
tosamine was found to be 14.0, whereas NP-40-extracted
Sepharose CL-4B peak II material had a ratio of 4.6 (Table I)
suggesting the removal of galactosamine-rich contaminants.
Isolation and Characterization of Glycopeptides from
MAA-C—The MAA-C was treated with pronase, the digest
frozen and thawed three times, centrifuged at 1000 x g for 10
min and the glycopeptides in the supernatant fractionated by
gel filtration on a Bio-Gel P-10 column (Fig. 6). The distri¬
bution of radioactivity in the major glycopeptide fractions is
given in Table II.
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Fig. 5. Gel electrophoresis of MAA-C in presence of SDS. a,
gel electrophoresis of MAA-C on a 5.0% polyacrylamide gel in the
presence of SDS after treatment of the sample with 1% SDS at 100°C
for 10 min ( ) or at 50°C for 72 h ( ). See text for further
details. The gels were sliced into 2-mm segments, solubilized bv
incubation in glass vials with 0.2 ml of 60% perchloric acid and 0.4 ml
of 30% hydrogen peroxide at 60°C for 4 h. Scintillation counting fluid
was added to the solubilized gel and the radioactivity determined.
The marker proteins were located by Coomassie blue G staining, b,
calibration curves obtained with protein (A) and glycoprotein (•)
standards on 5% polyacrylamide gels in the presence of SDS. The
standards were treated with 1% SDS at 100°C for 10 min before
electrophoresis.
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These glycopeptides as well as glycopeptides produced by
the treatment of antigen with trypsin did not have appreciable
antigenic activity. In agreement with this, the Class I and II
glycopeptides isolated from culture medium and cells (7) were
also devoid of antigenic activity.
Sialic Acid and Hexosamine Analysis of the Glycopep¬
tides—This distribution of tritium activity in sialic acid and
hexosamines in the various glycopeptides is shown in Table
II.
The chromatographic elution profiles of the asialoglycopep-
tides II and III on the Bio-Gel P-10 column are illustrated in
Fig. 6.
Treatment of Glycopeptides with Glycosidases—The asi-
aloglycopeptide III on treatment with D. pneumoniae yS-ga-
lactosidase and /?-N-acetylhexosaminidase released a labeled
compound which was isolated by chromatography on a Bio-
Gel P-2 column and desalted by passage through Dowex 50
(H+) and Dowex AG-1 (formate) columns. On a paper chro-
matogram the major product had a mobility identical with
that of GlcNAc. A minor product had a mobility similar to
that of lactose and is probably the product of the endoglyco-
sidase D activity present in trace amounts in the /?-galactosid-
40 60 80 100
FRACTION NUMBER
Fig. 6. Fractionation of MAA-C glycopeptides on Bio-Gel P-
10. Fractionation of Pronase digest of MAA-C (• •) on Bio-Gel
P-10. The column (0.9 x 134 cm) was equilibrated and eluted with 0.1
m pyridine acetate, pH 5.0. Fractions of 1.0 ml were collected and
aliquots analyzed for radioactivity. Numbered areas designate frac¬
tions which were combined and lyophilized to yield glycopeptides I to
VII. Elution profiles of asialoglycopeptide II (O O) and III
(A A) prepared by treatment with neuraminidase are superim¬
posed. The peak elution positions of blue dextran (Vo), glucose (V,-),
and fetuin glycopeptides A, B, and C (A, B, and C) are indicated by
arrows.
Table II
Properties ofglycopeptides isolated from purified f*H]MAA from
cells by treatment with Pronase
Glyco- Tritium activity in
Radioactivity spe¬
cifically bound to
fraction dioactiv-ity Sialicacid GlcNH, GalNH2 WGA Con A
% %
I 4.0 45 41 14
II 19.0 50 14 36 0 ND"
III 36.0 28 66 6 0 0
IV 16.0 ND 98 2 ND 0
V 5.0 ND
VI 14.0 0 94 6 0 82
VII 6.0 ND 85
ase used. The major product was further characterized as
[3H]GlcNAc by acid hydrolysis (3 N HC1 at 100°C for 8 h)
followed by detection of [3H]GlcNH2 on a paper chromato-
gram developed in Solvent System B. In control experiments
treatment of asialoglycopeptide III with the hexosaminidase
failed to release any labeled products.
The treatment of glycopeptide VI and standard [3H]ace-







" ND. not determined.
FRACTION NUMBER
Fig. 7. Gel filtration of glycopeptides treated with endogly¬
cosidase H. a, gel filtration of [:1H]ovalbumin glycopeptides after
treatment with endoglycosidase H on a column of Bio-Gel P-4 (0.9
X 108 cm) using 0.1 m pyridine acetate. Untreated ovalbumin glyco¬
peptides gave only the first peak. The elution position of the second
peak was coincident with that of reference GlcNAc -» Asn. b, gel
filtration of MAA-C glycopeptide VI before (O O) and after
(• •) treatment with endoglycosidase H under conditions iden¬
tical with a. c, gel filtration of glycopeptide III which was first treated
with neuraminidase, /?-galactosidase, and /?-hexosaminidase; reiso-
lated and then treated with endoglycosidase H, on the same column
as in a. Fractions of 1 ml were collected and analyzed for radioactivity
in all cases. Peak elution positions of markers blue dextran (Vo),
vitamin Bi2 (£12), and glucose (Glc) are indicated by arrows.
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by gel filtration on a Bio-Gel P-4 column gave the results
shown in Fig. 7. The treatment of asialoagalactoaglu-
cosaminoglycopeptide III (see above) with endoglycosidase H
gave several peaks, but only a minor peak eluted in the
position of GlcNAc —*■ Asn (Fig. 7c). Treatment of glycopep-
tide VI with endoglycosidase D did not result in the release of
significant label.
Affinity Chromatography of the Glycopeptides on Lectin-
Sepharose Columns—Glycopeptides VI and VII bound to a
Con A-Sepharose 4B column and were specifically eluted with
a 2% solution of methyl-a-mannoside. None of the glycopep¬
tides showed affinity to a WGA-Sepharose 4B column, in
contrast to the parent glycoprotein which was bound by this
column (Tables I and II).
Asialoglycopeptide III bound to both Ricinus communis
agglutinin 60- and 120-Sepharose 4B columns and was specif¬
ically eluted with 0.1 m lactose. The asialoglycopeptide III
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Fig. 8. Chromatography of glycopeptides after hydrazino¬
lysis. Chromatography of asialoglycopeptide III (•—-—•) and
[ HJNeuAc ai-acid glycoprotein (O O) on a Bio-Gel P6 column
(0.9 x 105 cm) after hydrazinolysis. Fractions of 1.0 ml were collected
and analyzed for radioactivity. Peak elution positions of references
are indicated. Prior to treatment with hydrazine asialoglycopeptide
III and ai-acid glycoprotein gave single peaks with peak positions at






Fig. 9. Gel filtration of MAA-C and glycopeptide II after
borohydride treatment. Gel filtration of MAA-C (• •) and
glycopeptide II (O O) after treatment with alkaline borohydride
on a Bio-Gel P6 column (0.9 x 105 cm). Fractions of 1.0 ml were
collected and analyzed for radioactivity.
raphy on a Bio-Gel P-6 column; results are shown in Fig. 8.
Treatment of glycopeptide II with alkaline borohydride (1
m NaBH4-0.1 n NaOH, 37°C for 72 h) followed by neutrali¬
zation and gel filtration on a Bio-Gel P-6 column indicated
the presence of some oligosaccharides linked O-glycosidically
to the peptide (Fig. 9). This is in agreement with the higher
proportion of galactosamine in this glycopeptide fraction.
Similar treatment of MAA-C resulted in the release of insig¬
nificant quantities of oligosaccharides (Fig. 9).
Subcellular Location of MAA—To obtain information on
the localization of MAA in the cells, plasma membranes and
nuclei were isolated from [3H]glucosamine-labeled cells. The
isolation procedure involved differential and sucrose gradient
centrifugation which has been shown to yield plasma mem¬
branes and nuclei free of significant contamination by other
organelles.2 The membrane and nuclear pellets were then
sequentially extracted with 3 m KC1 and NP-40 detergent and
dialyzed as described under "Isolation of MAA from Cells."
The extracts were tested for MAA activity and the percentage
of radioactivity specifically bound by the melanoma antisera
were as follows: plasma membrane KC1 extract, 3.9; plasma
membrane NP-40 extract, 0.0; nuclei KC1 extract, 5.8; and
nuclei NP-40 extract, 6.3.
discussion
Earlier studies indicated that some mouse melanoma-asso¬
ciated antigens are glycoproteins which were detectable both
on the cells and in the culture medium (8, 10). We have now
partially purified one of these antigen (s) and studied its bio¬
chemical properties.
Initial studies were conducted on the [ JH]glucosamine- and/
or [14C]leucine-labeled macromolecules released into the me¬
dium. A partially purified MAA was isolated by ammonium
sulfate precipitation followed by gel filtration on Sepharose
CL-4B and CL-6B. Column chromatography in the presence
of detergents resulted in a marked shift of the antigenic
material to lower molecular weight regions, suggesting that
the MAA aggregated in the absence of detergents.
Examination of the material isolated from cells showed that
the KCl-solubilized components were of lower molecular size
and also had lower antigenic activity than the material sub¬
sequently extracted with NP-40 (Fig. 2 and Table I). It is
possible that the material solubilized by KC1 may have un¬
dergone partial proteolysis, since it has been demonstrated by
Mann (36) that the release of histocompatibility antigens from
lymphoid cells by 3 m KC1 requires the presence of cell sap
proteases. The 3 m KCl-extracted material was not further
investigated. Subsequent treatment of the cell pellet after KC1
extraction with 0.5% NP-40 solubilized over 90% of the labeled
macromolecules in the pellet. The NP-40 extract was chosen
for detailed studies of MAA because it had high quantities of
the antigenic material and also was expected to have less fetal
calf serum contaminants. Even though unlikely, we cannot
completely exclude the possibility that the membrane-bound
proteases in the cell pellet may have been active during the
extraction with 0.5% NP-40 at 4°C and subsequent operations.
Mann (36) found that only 3 to 6% of histocompatibility
antigen was solubilized when the lymphoid cell membranes,
free of cell sap, were extracted with 3 m KC1 at 4°C for 24 h.
Further, the treatment of MAA with Pronase or trypsin (see
"Results") or with papain (8) completely abolishes its anti¬
genic activity. Whereas MAA exhibited a macromolecular
structure with a tendency to precipitate in the absence of
detergents, the glycopeptides derived from MAA were easily
2 J. Umemoto, J. G. Kemper, and V. P. Bhavanandan, unpublished
results.
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soluble in water and had molecular weights ranging from 4,000
to 12,000 (7). These data indicate that the MAA-C purified
and characterized in this study has not been extensively
degraded by proteolysis. The requirement of a detergent for
solubilization from cells and aggregation behavior in the ab¬
sence of detergents suggests that this macromolecule may be
membrane-associated. However, MAA-C may not be the na¬
tive form of the antigen present in the cell organelles (nuclei,
membrane), and further studies are needed to resolve this
problem.
Sequential chromatography of NP-40-extracted material
having the highest MAA activity (Peak II, Fig. 26) on Seph-
arose CL-6B, DEAE-Sepharose, and concanavalin A-Sepha-
rose 4B columns gave apparently homogenous peaks of la¬
beled material with increased specific antigenic properties.
Attempts to further purify the antigen were unsuccessful
due to loss of antigenic activity. It was apparent from these
results that both high pH (about 8.0) and detergent (0.1%
Triton X-100) are essential to protect the antigenic properties
of the isolated glycoprotein. Conditions of low pH, as encoun¬
tered during chromatography using acetate buffer of pH 5.0,
trichloroacetic acid precipitation, preparative isoelectric fo¬
cusing, or desialylation with acid all resulted in the loss of
antigenic activity.3 Recognition by antibody was also signifi¬
cantly reduced in the absence of detergent probably dqe to
precipitation of the antigen.
The MAA-C preparations appeared radiochemically ho¬
mogenous when chromatographed on Sepharose CL-4B,
Sepharose CL-6B, and DEAE-Sepharose (not illustrated).
After prolonged treatment (72 h at 50°C) with SDS followed
by gel electrophoresis in the presence of SDS a single but
broad radioactive band was obtained. The band covers about
2 cm of the gel; however, 79 and 53% of the radioactivities fall
within 1.0 and 0.6 cm of the gel, respectively. This diffuse
band of 2 cm may be due to incomplete dissociation or partial
reassociation of subunits. Electrophoresis of samples treated
with SDS for shorter periods (10 min at 100°C (Fig. 5a) or 24
h at 50°C (not illustrated)) gave diffuse radioactive areas over
6 and 5 cm of the gel, respectively. An additional contribution
to the gel behavior may be introduced by microheterogeneity
in the carbohydrate moiety of the glycoprotein. The bulk (75
to 85%) of the labeled material in the purified MAA-C was
specifically precipitated by an antiserum that reacted selec¬
tively with melanoma cells. These data suggest that our
preparations consist of either a single glycoprotein exhibiting
microheterogeneity or a group of antigenically related glyco¬
proteins not separated by the above techniques. The presence
of trace amounts of unlabeled material cannot be excluded
even though other components were not detectable in column
fractions (30) or gels (Coomassie blue staining). Since the
characterization of MAA is based on the behavior of the
labeled material, trace contaminants (if present) should not
alter the major findings.
The antiserum used for monitoring the antigen had been
raised to freshly excised B16 melanoma cells, a procedure
which obviated the possibility of generating antibodies to
neoantigens or other artifacts of cultured cells. On the basis of
the specificity studies conducted to date with this antiserum
(11, 25), the possibilities that the antigens it identifies are
histocompatibility antigens, tissue-specific antigens of mela¬
nocytes, or one of the major type C viral proteins can be
excluded. However, as in all studies of tumor antigens, the
possibility that the purified antigen is simply one which is
expressed to a greater degree on melanoma as opposed to
1 V. P. Bhavanandan. J. G. Kemper, and J.-C. Bystrvn, unpublished
results.
unrelated cells cannot be completely discounted.
The molecular weight of MAA based on its mobility on a
Sepharose CL-6B column in buffer containing 0.1 or 1.0%
Triton X-100 was estimated to be about 375,000. Evidence for
a strong association of monomer subunits even in the presence
of 1.0% Triton X-100 was obtained when the sample was
subjected to prolonged treatment with sodium dodecyl sulfate.
Provided the MAA has a carbohydrate composition compa¬
rable to the glycoprotein standards used, values of 375,000
and 44,000 to 52,000 may be assumed for the native and
subunit molecular weight, respectively. B16 mouse melanoma
antigens having molecular weight in the range of 20,000 to
25,000 have been reported by Poskitt et al. (14). A more
accurate determination of the molecular weight will be possi¬
ble only after isolation of sufficient quantities of MAA for
sedimentation equilibrium study and for quantitation of the
carbohydrate content.
Some problems were experienced in determining the per¬
centage of radioactivity present as sialic acid in MAA probably
because of the insolubilization of the asialo-MAA in H2S04
and/or the effect of the low pH (5.0) of the pyridine acetate
buffer used to elute the column. Based on several experiments,
we conclude that approximately 30% of the 'H radioactivity
in the MAA isolated from cells is in sialic acid and that
virtually all of it is released as N-acetylneuraminic acid by V.
cholerae neuraminidase. The balance of the radioactivity was
distributed between glucosamine (64%) and galactosamine
(6%).
The glycopeptides obtained by fractionation of a Pronase
digest were investigated to obtain some information on the
structure of the parent glycoprotein. Seven fractions were
isolated, three of which contained significant levels of radio¬
activity in sialic acid; the 5H-label in other glycopeptides was
mainly in GlcNH2. Glycopeptides VI and VII interacted with
concanavalin A-Sepharose and were cleaved by endoglycosi-
dase H to release [3H]GlcNAc —* Asn (Fig. 7). This indicated
the presence of an oligomannosyl core saccharide attached to
the peptide backbone.
The results of the chromatography of the asialoglycopep-
tides II and III on a Bio-Gel P-10 column (Fig. 6) suggest that
the differences between these two and the other glycopeptides
were due to reasons other than different degrees of sialylation.
This was further apparent in the high proportion of GalNH2
(GalNH2/GlcNH2 = 2.5) in glycopeptide II compared to III.
The release of oligosaccharides on treatment of glycopeptide
II with alkaline borohydride was consistent with the high
GalNH2 content of this glycopeptide. However, the failure of
the sialoglycopeptide II to interact with WGA-Sepharose 4B
indicates the absence of clustered sialooligosaccharides (O-
glycosidically linked to peptide via serine and threonine) such
as those present in the Class I glycopeptides isolated from B16
mouse melanoma cells (7, 24).
The release of GlcNAc on treatment of asialoglycopeptide
III with yS-galactosidase and /3-N-acetylhexosaminidase but
not with /?-iV-acetylhexosaminidase alone indicates the se¬
quence Gal —* GlcNAc —► in this glycopeptide. The presence
of this sequence was also suggested by the interaction of the
asialo-glycopeptide III and of the asialo-MAA itself with
Ricinus communis agglutinin.
The release of oligosaccharide from the asialoglycopeptide
III on hydrazinolysis and the susceptibility to endoglycosidase
H of glycopeptide III which has been pretreated with neura¬
minidase, y3-galactosidase, and /?-N-acetylhexosaminidase in¬
dicated the presence of GlcNAc —*■ Asn in this glycopeptide,
as well.
In summary, we have succeeded in isolating an antigen
associated with B16 mouse melanoma cells and purifying it to
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apparent homogeneity. The isolated antigen is a glycoprotein
with a heterogenous population of oligosaccharides, which
consist mainly of those terminating with the sequence NeuAc
—► Gal —*• GlcNAc—»; some are terminated with mannosyl
residues. These oligosaccharides, because of their susceptibil¬
ity to endoglycosidase H and to hydrazinolysis, are presum¬
ably linked via iV,iV'-diacetylchitobiose to asparagine residues
of the peptide chain. The presence of a few GalNAc-containing
O-glycosidically linked oligosaccharides is indicated. The an¬
tigen was also partially purified from culture medium and
some activity was associated with nuclei.
The information obtained in this study on the characteris¬
tics of MAA would enable us to isolate milligram quantities of
this antigen from solid tumors (19) or from serum-free spent
culture medium (18). Future studies will be directed toward
the complete immunological and chemical characterization of
this antigen.
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Glycosaminoglycans of Cultured Human Fetal Uveal Melanocytes and
Comparison with Those Produced by Cultured Human Melanoma Cells*
V. P. Bhavanandan
abstract: The glycosaminoglycans produced by human fetal
uveal melanocytes and by human melanoma cells were exam¬
ined. The cells were grown in the presence of [3H]glucosamine
and [35S]sulfate, and the labeled glycosaminoglycans were
isolated from the cells, spent medium, and intracellular ma¬
terial. The distribution of the glycosaminoglycans was similar
in both cells and spent media, which together accounted for
95% of the total. Of the total 3H-labeled glycosaminoglycans
produced by the melanocyte culture, 42% was in chondroitin
Several investigators have reported alterations in the gly¬
cosaminoglycans (Dietrich & Armelin, 1978; Dunham &
Hynes, 1978; Hopwood & Dorfman, 1977; Glimelius et al.,
1978; Keller et al., 1980; Klagsbrun, 1976; Muto et al., 1977;
Vannucchi et al., 1978; Winterbourne & Mora, 1978) pro¬
duced by malignant cells compared to normal cells. We have
previously described the partial characterization of the gly¬
cosaminoglycans produced by cultured HM71 human mela¬
noma cells and by a primary culture of human embryonic iris
(Banks et al., 1976).
The subject of the present investigation is the study of the
glycosaminoglycans produced by two established cell lines of
human fetal melanocytes (Giovanella et al., 1976). In contrast
to the primary explant of human embryonic iris, this system
is a better control for the rapidly growing human melanoma
cells. Even though the cells under comparison are of adult
(melanoma) and fetal (normal melanocytes) origin, this is not
undesirable since the detected differences would exclude the
fetal antigens which are common to both tumor and fetal cells.
We describe below the characterization of the glycos¬
aminoglycans produced by the cultured normal melanocytes.
Additional characterization of the glycosaminoglycans isolated
from human melanoma cells and culture media is also de¬
scribed. As in previous studies, the cell cultures were divided
into three compartments: (i) the spent medium (medium),
(ii) the intracellular material released by EGTA (EGTA su¬
pernatant), (iii) the material which remains associated with
the viable cells (cell associated). The glycosaminoglycans of
the normal fetal cells (iris and melanocytes) are compared to
those produced by tumorigenic human melanoma cells. A
preliminary report has been presented (Bhavanandan et al.,
1979).
Experimental Procedures
Materials. The human melanoma cell line, HM7, was
isolated by Dr. John W. Kreider as described (Banks et al.,
1976). The normal human uveal melanocyte cell lines FeMel
6 and FeMel 13 derived from embryonic tissues were kindly
donated by Drs. McCormick and Giovanella, Cancer Research
r From the Department of Biological Chemistry and The Specialized
Cancer Research Center, The Milton S. Hershey Medical Center. The
Pennsylvania State University, Hershey, Pennsylvania 17033. Received
November 10, 1980. This investigation was supported by Research
Grants CA15483 and CA17686 from the U.S. Publich Health Service.
4-sulfate, 25% in heparan sulfate, 16% in chondroitin 6-sulfate,
and 17% in hyaluronic acid. In contrast, HM7 human me¬
lanoma cultures produced no chondroitin 6-sulfate, increased
quantities of heparan sulfate, and less hyaluronic acid. A
heparan sulfate fraction obtained from melanocytes required
both heparitinase and heparinase for complete degradation,
indicating the presence of heparin-like molecules in this
fraction. The corresponding fraction from melanoma cells was
totally degraded by heparitinase alone.
Laboratory, St. Joseph Hospital, Houston, TX (Giovanella
et al., 1976). Components for culture media and fetal calf
serum were obtained from Grand Island Biological Co. (Grand
Island, NY) and Flow Laboratories (Rockville, NY), re¬
spectively. Pronase CB was from Calbiochem. Vitreous hu¬
mor hyaluronic acid was obtained from Worthington (Free¬
hold, NJ); chondroitin 4-sulfate was isolated from pig rib
cartilage, and reference heparan sulfate was a gift from Dr.
A. Linker (Salt Lake City, UT). Leech hyaluronidase (EC
3.2.1.36) was from Biotrics, Arlington, MA; bacterial chon-
droitinases ABC (EC 4.2.2.4), ACII (EC 4.2.2.5), and the
unsaturated reference disaccharides ADi-4S, ADi-6S, and
ADi-OS were from Miles Laboratories (Elkhart, IN). He¬
paritinase and heparinase were isolated from a Flavobacterium
heparinum strain provided by Dr. A. Linker (Linker & Ho-
vingh, 1972). All the above enzymes were free of contami¬
nating mucopolysaccharidases when tested with isotopically
labeled glycosaminoglycans as substrates. Glyceryl-controlled
pore glass beads (glyceryl-CPG) were obtained from Elec-
tronucleonics (Fairfield, NJ). d-[6-3H]Glucosamine hydro¬
chloride (10-13 Ci/mmol) and Na235S04 (carrier free; 80-800
mCi/mmol) were obtained from New England Nuclear
(Boston, MA). Sources of other materials used in this study
are given in the preceding paper in this issue (Bhavanandan
et al., 1981).
Methods. Column Chromatography. Glyceryl CPG-240
beads of 80/120 mesh were packed with constant vibration
and then equilibrated and eluted with 0.5 M KC1 by using a
pump to maintain a constant flow rate of 30 mL/h. For
fractionation of glycosaminoglycans, DEAE-Sepharose CL-6B
generated in the chloride form was used, and the column was
eluted with a linear gradient of 0 -» 1.5 M LiCl in 50 mM
Tris-HCl buffer, pH 8.0.
Enzyme Digestions. Pronase digestion was performed in
50 mM Tris-HCl buffer, pH 8.0, containing 10 mM Ca2+ at
37 °C for 120 h, in the presence of toluene. Pronase CB
dissolved in the buffer was added at 0, 24, 48. and 72 h. The
1 Abbreviations used: glyceryl-CPG, glyceryl controlled pore glass
beads; CPC. cetylpyridinium chloride; AcNeu, .V-acetylneuraminic acid;
DEAE. diethylaminoethyl; EGTA, [ethylenebis(oxyethylenenitrilo)]-
tetraacetic acid; FM6 and FM13, normal human uveal melanocyte cell
lines FeMel 6 and FeMel 13; HM7. human melanoma cell line; Tris,
tris(hydroxymethyl)aminomethane.
Reprinted from Biochemistry, 1981,20, 5595.
Copyright © 1981 by the American Chemical Society and reprinted by permission of the copyright owner.
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enzyme preparation used was free of contaminating exo-
glycosidases and endo-iV-acetylhexosaminidase when assayed
with p-nitrophenyl glycosides and [3H]acetylovalbumin gly-
copeptides, respectively (Umemoto et al., 1977).
The labeled samples (10000-25 000 dpm, 3H) were mixed
with 500 ug of carrier glycosaminoglycans (hyaluronic acid,
chondroitin sulfate, heparan sulfate, or heparin) and digested
with the mucopolysaccharidases as described below. The
carrier glycosaminoglycans were completely degraded under
the conditions employed. Leech hyaluronidase digestion was
carried out by dissolving the sample in 100 pL of Mcllvaine's
buffer (pH 5.6) and incubating at 37 °C for 6 h with addition
of 125 Mg of enzyme in 25 pL buffer at 0, 1, and 2 h.
Chondroitinase digestions and paper chromatography of the
products were performed according to the method of Saito et
al. (1968). Heparitinase and heparinase digestions were done
in 300 mL of 0.1 M sodium acetate buffer, pH 7.0, containing
1 mM calcium acetate for 24 h at 30 (heparinase) and 43 °C
(heparitinase) (Linker & Hovingh, 1972). Blanks prepared
as above but using heat-inactivated enzymes did not degrade
the reference glycosaminoglycans.
Nitrous acid degradation was done by treating the sample
in 100 tiL of water with 20 uL of 3 M NaN02 and 20 ph of
glacial acetic acid at room temperature (20 °C) for 80 min.
Excess nitrite was destroyed by addition of 50 pL of 3 M
glycine, and after 60 min at room temperature, the product
was Iyophilized.
The enzyme and nitrous acid degradation products were
assessed by gel filtration on glyceryl-CPG-240 or Bio-Gel P-4
or P-6 columns.
Liquid scintillation counting was performed on an Inter-
technique Model SL-36 or Model SL-4000 spectrometer
equipped with disintegration per minute calculating modules.
Usually 0.3-1.0-mL aqueous samples were mixed with 3-10
mL of counting liquid (ACS obtained from Amersham) in
minivials or regular plastic counting vials, respectively. Ef¬
ficiencies for 3H and 35S were about 25% and 65%, respec¬
tively, with a crossover of about 10% 35S into the 3H channel.
When the external standard method was used, quenching was
not detectable with any of the buffers.
Cellulose acetate electrophoresis was performed in a
Beckman R-101 microzone electrophoresis cell by using 0.2
M calcium acetate (pH 7.0) at 5 mA for 3 h or pyridine/0.1
M formic acid bufer (pH 3.0) at 10 mA for 20 min. Reference
giycosaminoglycans were detected by staining with Alcian blue
(0.1% in 0.5% acetic acid). Radioactivity on cellulose acetate
strips was estimated by dissolving cut pieces in 1 mL of glacial
acetic acid in glass vials. After incubating at 37 °C for 3-6
h and cooling to room temperature, scintillation counting liquid
was added, and the solution was mixed and counted. The
recovery of the applied 3H and 35S radioactivities was between
80% and 90%.
Other methods used in this study are described in the
preceding paper in this issue (Bhavanandan et al., 1981).
Cell Culture. The cells were propagated in 16-oz glass
prescription bottles as described (Banks et al., 1976). When
confluent, the cells were subcultured by using about 2 x 106
cells per bottle. The cultures were routinely tested for bacterial
and yeast contamination as described previously (Banks et al.,
1976). The cells were also tested for the presence of myco¬
plasma (Russell et al., 1975). No contamination was detected
in the cells used in these studies.
Metabolic labeling of the glycoconjugates was accomplished
by growing the cells in a medium containing isotopic precursors
but no inorganic sulfate and one-third the usual glucose con¬
centration. The FM6 and FM13 cells were labeled at the 17th
and 20th passages, respectively. The isotopes used were
[3H] glucosamine and 35S042- at 5 and 20 jiCi/mL, respec¬
tively. The isotope-containing medium (25 mL) was added
to logarithmically growing cells (4-8 bottles per experiment),
and after 48 h, when confluency was reached, the cells were
harvested. Exposure to labeled precursor for this time period
is sufficient to provide an accurate estimate of mass ratios from
incorporation levels. The medium was decanted, and the cell
layer was rinsed 3 times with NaCl/Pj buffer and then treated
with 0.02% EGTA in NaCl/P; buffer, pH 7.2, at 37 °C for
10-20 min. The EGTA supernatant was removed after cen-
trifugation, and the cell pellet was washed 3 times with the
NaCl/Pj buffer. The combined medium plus washings of the
monolayers and the combined EGTA supernatant plus the
washing of the cell pellet were again centrifuged to remove
residual cells. The supernatants, referred to as spent medium
and EGTA supernatant, respectively, and the cells were all
separately examined for their labeled glycoconjugates.
The establishment and isotopic labeling of the human fetal
iris explant were described previously (Banks et al., 1976). The
labeled spent medium and the tissue (iris) were treated sep¬
arately and analyzed for glycoconjugates. This system did not
yield an EGTA supernatant fraction (extracellular material).
Processing of the Cells, Spent Media, and the EGTA Su¬
pernatants. The cells were extracted with chloroform/meth¬
anol (2:1 and then 1:2) as described by Hakomori & Mura¬
kami (1968). The pellet was treated with Pronase. The spent
media and the EGTA supernatants were dialyzed at 4 °C
against 0.15 M NaCl for 2 days, followed by distilled water
for 4 days in the presence of toluene and chloroform. The
nondialyzable materials were recovered by lyophilization and
digested with Pronase.
Separation of Glycopeptides and Glycosaminoglycans in
the Pronase Digests by Treatment with Cetylpyridinium
Chloride (Refer to Scheme /). The Pronase digests were
subjected to cetylpyridinium chloride precipitation as described
(Bhavanandan et al., 1977). The giycosaminoglycans were
recovered in the 0.2, 0.4, 0.8, 1.2, and 2.0 M NaCl extracts
of cetylpyridinium chloride precipitate. The mixed glyco¬
peptides present were isolated from the cetylpyridinium
chloride supernatant by precipitation of the cetylpyridinium
with KCNS followed by dialysis and lyophilization of the
nondialyzable material. Table I presents the distribution of
the radioactivity in the glycosaminoglycan and glycopeptide
fractions.
Fetal CalfSerum-[3H]Glucosamine Control Experiment.
This experiment was designed to determine the contribution,
if any, to the glycoconjugate pool of spent medium, of artifacts
arising from the interaction of [3H]glucosamine with fetal calf
serum components. Fetal calf serum (100 mL) from the same
batch used for metabolic labeling of cells was mixed with 400
pL of [3H]glucosamine containing 400 pd, and the mixture
was incubated at 37 °C for 48 h. Triplicate aliquots were
taken for determining radioactivity, and the balance was
dialyzed at 4 °C against 0.15 M NaCl followed by water, two
changes of 6 L each for a total of 8 days. When no further
radioactivity was detectable in the dialysate, the dialysis was
stopped. The nondialyzable material contained 0.76 uCi of
radioactivity, which is 0.19% of the original. Two 2-mL al¬
iquots were hydrolyzed (6 N HC1, 110 °C, 24 h), and the
hydrolysate was purified on a column of Dowex 50 (H+) (Boas,
1953) and analyzed on an amino acid analyzer by the
stream-splitting technique. About 68% of the radioactivity
coeluted with standard glucosamine. The balance of non-
213
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Scheme I: Isolation of Glycosaminoglycans Produced by HM7 Human Melanoma Cells
Cell pellet after CHCl^CH^OH extraction
Dialyzed spent media
Dialyzed EGTA supernatant
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GAG 0.2 GAG 0.1 GAG 0.8 GAG 1.2 GAG 2.0
Table I: Distribution of 3H- and "S-Labeled Glycoconjugates Produced by Human Fetal Uveal Melanocyte and Melanoma Cell Culture0
human fetal uveal melanocytes HM7 human melanoma
cell spent medium EGTA supernatant cell spent medium EGTA supernatant
glycopeptides
3H 26.52(95.8) 14.63 (56.2) 16.61 (70.5) 54.18(94.9) 34.78(85.6) 4.79 (92.2)
35S 0.13 (8.0) 0.84 (4.4) 0.80 (8.7) 0.13 (6.1) 0.44 (5.7) 0.03 (10.0)
glycosaminoglycans
3H 1.17 (4.2) 11.38 (43.7) 6.95 (29.5) 2.91 (5.1) 5.85 (14.4) 0.39 (7.8)
35S 1.49 (92.0) 18.32(95.6) 8.41 (91.3) 2.04 (93.9) 7.32(94.3) 0.26 (90.0)
° The results are expressed as 3H and 3SS radioactivity (10"# dpmlQ7 cells) incorporated into the clycoconjugates. The numbers within par¬
entheses are percentages relative to the total radioactivity which is the sum in the glycopeptides and the glycosaminoglycans in the respective
culture compartments. The cells were grown in the presence of [3H] glucosamine and Na533S04 for 48 h during log phase of growth. The
culture compartments (cell, medium, and EGTA supernatant) were digested with Pronase and dialyzed. The Pronase digests were treated
with CPC to fractionate the glycopeptides and glycosaminogiycans. For details see Methods and Scheme I.
dialyzable material was digested with Pronase, and the digest
was dialyzed exactly as for Pronase-digested spent medium.
The nondialyzable material after Pronase digestion contained
only 10.2% of the radioactivity present before the treatment.
The nature of this radioactive material (108000 dpm), 0.019%
of the original, was not further investigated.
Results
Culture Characteristics of the Fetal Melanocytes. The
FM6 and FM13 cells grew as nonpiling monolayers of elon¬
gated cells compared to the multilayered foci growth of the
HM7 human melanoma cells (Figure 1). A brown-black
pigmentation was observed in the confluent monolayers of the
melanocytes, which is indicative of the production of melanin
by these cells. The doubling time of FM6 cells was determined
to be 58 h whereas the HM7 cells had a doubling time of 40
h. The doubling times of three other human fetal uveal me¬
lanocytes are reported to be 62 (Mel IB), 52 (Me 7-2A), and
108 (Mel 9) by Giovanella et al. (1976). In contrast to the
HM7 cells which have been maintained in culture for over 4
years (>120 passages), both the normal melanocyte cell
cultures, FM6 and FM13, failed to grow after about 30
passages.
Tumorigenicity in Athymic (Nude) Mice. Whereas HM7
cells produced large black tumor masses when 106 cells were
inoculated into nude mice, FM6 cells failed to produce tumors
even when 10' cells were inoculated. In an earlier work, HM7
cells produced only small nodules in nude mice; the reason for
EStfcfcSftft- ..:
figure 1: Photomicrograph of normal human uveal fetal melanocytes
(top) and of HM7 human melanoma cells (bottom). Cultures grown
to saturation. Phase contrast 100X.
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Table II: Characteristics of GAG 0.81 Fractions0
% low mol wt 3H after treatment with
[3H]GlcNHj [3H]GalNH2 leech chondroitinase
(%) (%) hyaluronidase heparitinase AC nitrous acid
cell
GAG 0.8 100 0 8 83 NT 96
spent medium
GAG 0.8 88 12 NT NT NT NT
GAG 0.8a 100 0 6 81 4 80
GAG 0.8c 91 9 0 88 10b 89
EGTA supernatant
GAG 0.8 97 3 0 100 NT 88
° Percent of radioactivity in the hexosamines was determined by hydrolysis (6 M HC1, 110 °C, 20 h) of the glycosaminoglycans followed by
analysis by a stream-splitting technique on an amino acid analyzer as described previously (Bhavanandan & Davidson, 1976). The recovery of
radioactivity was between 65 and 75%. The samples were treated as described under Methods with enzymes or nitrous acid, and the mixture
was analyzed on Bio-Gel P-4 or P-6 columns. The percentage of radioactivity included in the column is given; the untreated samples were ex¬














figure 2: Cellulose acetate electrophoresis of human melanocyte
glycosaminoglycan fractions GAG 0.8 and GAG 1.2. The human
fetal melanocyte glycosaminoglycan fractions GAG 0.8 and 1.2 isolated
from the spent medium of cultures labeled with [JH]glucosamine and
Na235S04 were subjected to electrophoresis on cellulose acetate strips.
Electrophoreses were carried out in 0.2 M calcium acetate, pH 7.0,
at 5 mA for 3 h (top panels) and in pyridine/0.1 M formic acid buffer,
pH 3.0, at 10 mA for 20 min (bottom panels). The radioactivity [!H
(—) and 35S (---)] and the reference glycosaminoglycans (HA,
hyaluronic acid; HS, heparan sulfate; C4S, chondroitin-4-sulfate; and
Hep, heparin) were detected as described under Methods.
this is not clear (Banks et al., 1976). FM13 cells were not
tested for tumorigenicity. Another fetal melanocyte cell line
(Mel 7-2A) is also reported not to have yielded tumors when
107 cells were injected subcutaneously and mice were observed
throughout their life spans of 1-2 years (Giovanella et al.,
1976).
Characterization of the Glycosaminoglycans from Mela¬
nocytes'. GAG 0.2 and GAG 0.4 Fractions. These fractions
from the three culture compartments all contained only
[3H] glucosamine and were totally excluded from the CPG
column. Treatment with leech hyaluronidase followed by
rechromatography on the CPG column indicated that the
labeled material in these fractions was completely degraded.
Ion-exchange chromatography on DEAE-Sepharose column,
using a LiCl gradient for elution, of the GAG 0.2 (medium)
and the GAG 0.4 (cell fractions) gave single peaks which
coeluted with vitreous humor hyaluronic acid. Heparitinase
had no effect on the fractions derived from the medium.
Fraction Number
figure 3: Fractionation of human melanocyte glycosaminoglycan
fractions GAG 0.8 and GAG 1.2 on DEAE-Sepharose. The human
fetal melanocyte glycosaminoglycan fractions GAG 0.8 and GAG
1.2 isolated from the spent medium of cultures labeled with [3H]-
glucosamine and Na235S04 were chromatographed on a DEAE-Se¬
pharose column (1X16 cm). The column was eiuted with a linear
gradient (total volume 100 mL) of 0.5-1.2 M LiCl. Fractions of 1
mL were collected and aliquots analyzed for radioactivity [3H (•)
and 35S (O)]. Material eluting in the area indicated by horizontal
arrows marked a, b, and c were recovered by dialysis and lyophilization
and designated GAG 0.8a, GAG 0.8b, etc. The GAG 1.2 fraction
isolated from the EGTA supernatant was also similarly fractionated.
Cellulose acetate electrophoresis of the GAG 0.2 (medium),
GAG 0.4 (medium), and GAG 0.4 (EGTA) fractions gave
single bands with mobilities identical with that of reference
hyaluronic acid. Ion-exchange chromatography, heparitinase
treatment, and cellulose acetate electrophoresis were not done
on the other fractions due to insufficient material. However,
on the basis of the results obtained, it was concluded that 0.2
and 0.4 M NaCl fractions from all three compartments con¬
tained essentially only hyaluronic acid.
GAG 0.8 Fractions. These fractions contained both 3H and
35S radioactivities. Cellulose acetate electrophoresis of the
medium fraction in two buffer systems showed that the major
component in this fraction had a mobility similar to that of
heparan sulfate (Figure 2). The hexosamine composition
(Table II), however, indicated the presence of both glucos¬
amine- and galactosaminoglycans. The GAG 0.8 (medium)
fraction was fractionated on a DEAE-Sepharose column
(Figure 3), and three subfractions (a, b, and c) were obtained.
The hexosamine composition of subfractions 0.8a and 0.8c is
given in Table II; the minor intermediate fraction 0.8b was
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Table III: Characteristics of GAG 1.2 Fractions0
9fo low mol wt 3H after treatment with
heparitinase
[3H]GlcNH, [3H]GalNHj and chondroitinase
(%) (%) heparitinase heparinase AC nitrous acid
ceil
GAG 1.2 38 62 NT 36 68 NT
spent medium
GAG 1.2 24 76 NT NT NT NT
GAG 1.2a 100 0 80 100 4 94
GAG 1.2c 0 100 0 NT 100b-c 0
EGTA supernatant
GAG 1.2 21 79 NT NT NT NT
GAG 1.2a 100 0 63 98 NT 100
GAG 1.2c 0 100 NT 8 93 c NT
° Details are as described in Table II. b Paper chromatography showed the presence of both ADi-4S (70%) and Al)i-6S (30%). c Chon-
droitinase ABC digestion gave identical results.
FIGURE 4: Chromatography on Bio-Gel P-6 of 3H-labeled glycos-
aminoglycan fractions from human fetal melanocytes after treatment
with nitrous acid. The 'H-labeletl glycosaminoglycan fractions GAG
0.8c (•) and GAG 1.2a (O) from spent medium of human fetal
melanocyte cultures were treated with nitrous acid (see Methods for
details) and chromatographed on a Bio-Gel P-6 column (0.9 X 105
cm). The column was eluted with 0.1 M pyridine/0.1 M acetic acid
(pH 5.0) at 20 mL/h; 1-mL fractions were collected and analyzed
for radioactivity. The void and included volumes of the column
determined by the elution of blue dextran (VQ) and glucose (Glc) are
indicated. The untreated glycosaminoglycans eluted at the void volume
of the column. The results of the treatment of the various melanocyte
glycosaminoglycan fractions with nitrous acid are summarized in
Tables II and III.
not analyzed. The results of the treatment of GAG 0.8a and
0.8c (medium), GAG 0.8 (cell), and GAG 0.8 (EGTA) with
leech hyaluronidase, heparitinase, chondroitinase, and nitrous
acid are summarized in Table II. Typical results of the nitrous
acid treatment are illustrated in Figure 4.
On the basis of the results, the major component of the
GAG 0.8 fractions from all three compartments is charac¬
terized as heparan sulfate. The medium fraction, in addition,
contained hyaluronic acid (2%) and chondroitin sulfate (12%),
and the cell-associated GAG 0.8 contained about 8% hyal¬
uronic acid. The galactosamine component (3%) of GAG 0.8
(EGTA) was not directly identified but is presumed to be
chondroitin sulfate.
GAG 1.2 Fractions. These fractions had the largest per¬
centage of 35S radioactivity, and the hexosamine analysis
(Table III) suggested that they were mixtures of glucosamino-
and galactosaminoglycans. Chromatography on a CPG col¬
umn indicated components in the molecular weight range
15 000-40 000. Cellulose acetate electrophoresis of GAG 1.2
(cell) showed sulfated material moving as a broad band in the
area of heparan sulfate and chondroitin sulfate (Figure 2). The
medium and EGTA fractions were fractionated on DEAE-
Sepharose to yield two major (a and c) and one minor (b)
fraction each (Figure 3). The major fractions were found to
have either glucosamine or galactosamine (Table III). The
results of the action of nitrous acid, chondroitinase, and he¬
paritinase (or heparitinase followed by heparinase) on these
fractions are summarized in Table III. Typical results of
chondroitinase treatment and the paper chromatographic
pattern of the products are illustrated in Figure 5. Thus the
components of the GAG 1.2 fractions from cell, medium, and
EGTA supernatant are chrondroitin 4-sulfate (50%, 53%, and
59%), heparan sulfate (38%, 24%, and 21%) and chondroitin
6-sulfate (12%, 23%, 20%), respectively.
GAG 2.0 Fractions. The medium fraction on hydrolysis
gave only galactosamine. It gave single peaks on both CPG
and DEAE-Sepharose columns. On the basis of its mobility
on the CPG column, the molecular weight of the component
was estimated to be about 25 000. Chondroitinase AC and
ABC completely digested the labeled material. The product
was isolated by chromatography on a column of Bio-Gel P-4
and identified as ADi-4S by paper chromatography; no ADi-6S
was detectable in contrast to the GAG 1.2 fraction (Figure
5, bottom). The GAG 2.0 (medium) fraction was not sus¬
ceptible to either heparitinase or heparinase and was thus
identified as chondroitin 4-sulfate. Insufficient material from
the cell-associated and EGTA fractions was available for
complete characterization. The 100% galactosamine compo¬
sition of these two fractions, however, suggested that they
consisted of chondroitin sulfate(s).
Characterization of the Glycosaminoglycans from Mela¬
noma. Fractions GAG 0.4-2.0 which contain the glycos¬
aminoglycans (hyaluronic acid, chondroitin sulfate, and he¬
paran sulfate) have been partially characterized (Banks et al.,
1976). Additional characterization of the melanoma glycos¬
aminoglycans was carried out after further fractionation by
chromatography on DEAE-Sepharose CL-6B columns and
controlled pore glass as described above. Fraction GAG 0.2
from cell and medium was carefully examined since the cor¬
responding fractions obtained from B16 mouse melanoma
consisted mainly of a mucin-type sialoglycopeptide (Bhava-
nandan & Davidson, 1976; Bhavanandan et al., 1977).
Flowever, the human melanoma GAG 0.2 fractions on
treatment with neuraminidase or mild acid released insig¬
nificant quantities of [3H] sialic acid; further, the labeled
material in these fractions did not interact with WGA-Se-
pharose 4B. Greater than 90% of the radioactivity in this
fraction was identified as [3H]glucosamine after acid hy¬
drolysis; on treatment with leech hyalnuronidase, the labeled
material was degraded to oligosaccharides. These results as
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Table IV: Summary of the 3H-Labeled Glycosaminoglycans Produced by Human Fetal Uveal Melanocytes and Melanoma in Culture0
human fetal uveal melanocytes human melanoma
glycan cell
spent medium
(48 h) EGTA supernatant cell
spent medium





























a The results are expressed as 3H radioactivity (1CT1 dpm) incorporated into the various glycosaminoglycans obtained from the culture com¬
partments cell, spent medium, and EGTA supernatant. The numbers within parentheses are the percentages relative to the total radioactivity
present in glycosaminoglycans, in the separate culture compartments (vertical columns). Individual species of glycosaminoglycans were iden¬













FIGURE 5: Chromatography of 3H- and 35S-labeled glycosaminoglycan
fraction GAG 1.2c from human fetal melanocytes after digestion with
chondroitinase AC on Bio-Gel P-4 (top) and paper (bottom). (Top
panel) The 3H- and 3!S-labeled glycosaminoglycan fraction GAG 1.2c
isolated from human melanocytes was mixed with carrier chondroitin
4-sulfate treated with chondroitinase AC (see Methods for details)
and chromatographed on a Bio-Gel P-4 column (0.9 X 110 cm). The
column was eluted with 0.1 M pyridine/0.1 M acetic acid (pH 5.0)
at 20 mL/h, and 1-mL fractions were collected. After the fractions
were assayed for unsaturated disaccharides by measuring absorbance
at 232 nm (▲), aliquots were analyzed for radioactivity [3H, (•) and
35S, (O)]. Untreated GAG 1.2c and chondroitin 4-sulfate or controls
prepared by treatment of the glycosaminogiycans with heat-inactivated
enzyme eluted at the void volume (K0). The peak elution positions
of ;V-acetylneuraminic acid (AcNeu) and glucose (Glc) are indicated
by arrows. The radioactive material eluting in the area marked by
horizontal arrows A and B were recovered by lyophilization and
examined by paper chromatography. (Bottom panel) The radioactive
materials A [3H, (—)] and B [3H (—) and 35S (---)] were chroma¬
tographed on paper together with standard unsaturated disaccharides
(ADi-4S, ADi-6S, and ADi-OS) by using the solvent system 1-bu-
tanol/acetic acid/1 M NH40H (2:3:1 v/v). The migration positions
of the standard unsaturated disaccharides were detected by examining
the paper in UV light. Radioactivity on paper strips was estimated
by extracting 1-cm cut pieces with 1 mL of water in counting vials
followed by scintillation counting. The results of the treatment of
the various melanocyte glycosaminoglycan fractions with chondroi¬
tinase AC followed by paper chromatography are summarized in
Tables II and III.
well as those from cellulose acetate electrophoresis and
DEAE-Sepharose chromatography confirmed that the human
melanoma GAG 0.2 fractions from cells and spent medium
were similar to the GAG 0.4 fractions which comprise hyal¬
uronic acid.
The results of the characterization of the glycosamino¬
glycans produced by the human fetal uveal melanocyte and
human melanoma cultures are summarized in Table IV.
Discussion
The long-term cultures of the uveal melanocytes used in this
study were derived from therapeutically aborted, 6-12-week
human embryos by Giovanella et al. (1976). The cells were
characterized as normal melanocytes on the basis of their
ability to produce melanin and by their morphological char¬
acteristics (Giovanella et al., 1976). In our laboratory, we
confirmed these observations on the FM6 and FM13 cultures.
Further, in our studies, the FM6 cells failed to produce tumors
in athymic mice under conditions which produced charac¬
teristic tumors from HM7 human melanoma cells. This to¬
gether with the limited culture life (number of passage in
culture) of the FM6 and FM13 cells compared to the virtual
immortality of the HM7 human melanoma cells under iden¬
tical culture conditions substantiates the nonmalignant nature
of the fetal melanocytes.
[3H]Glucosamine and Na23SS04 were employed as radio¬
active precursors to label the newly produced glycoconjugates.
The possibility of labeled glucosamine interacting with fetal
calf serum components of the culture medium leading to the
formation of artifacts (Angello & Hauschka, 1974; Herrmann,
1974) was investigated in a control experiment. After [3H]-
glucosamine was mixed and incubated with fetal calf serum,
exhaustive dialyses removed 99.81% of the radioactive mate¬
rial. The balance, identified as glucosamine, was apparently
trapped or nonspecifically interacting with serum components
since 90% of this dialyzed out following Pronase digestions.
Thus the artifactual contribution to the pool of glycopeptides
and glycosaminoglycans in the Pronase digest of the spent
media in our experiments could be shown to be negligible (at
the most, 0.019% of the added radioactivity). It should be
noted that in the control experiment we used 10 times more
glucosamine per milliliter of serum than that employed in the
cell labeling experiments.
The total nondialyzable 3H radioactivity in the Pronase
digests of the melanocytes and melanoma cells did not differ
significantly, but large differences were noted in the extra¬
cellular pools (the spent medium and EGTA supernatant). For
example, the melanocytes incorporated 3.5 times more sulfate
label into the extracellular (medium and EGTA supernatant)
glycosaminoglycans than did the melanomas (Table I). A
similar difference was noted in the synthesis of sulfated gly¬
cosaminoglycans by Balb/c 3T3 and SV40 Balb/c 3T3 cells
(Klagsbrun, 1976). Further, the percent of CPC precipitable
3H label (glycosaminoglycans) in the Pronase digests of the
spent medium and EGTA supernatant was 14.4% and 7.8%
for the melanoma culture and 43.8% and 29.5% in the case
of the melanocyte culture (Table I). This indicates an in¬
creased secretion (or shedding) of glycosaminoglycans by the
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melanocytes into the external environment, most of which was
recovered in the GAG 1.2 fractions.
Whereas both melanocyte and melanoma cultures produced
hyaluronic acid, chondroitin 4-sulfate, and heparan sulfates,
only the melanocyte culture produced chondroitin 6-sulfate
(Table IV). The cell, medium, and EGTA supernatant com¬
partments of the melanocyte culture contained 5.3%, 18.3%
and 13.5% of glycosaminoglycan-associated 3H radioactivity
in chondroitin 6-sulfate. Dermatan sulfate and keratan sulfate
were not produced by either culture. There were quantitative
differences in the production of hyaluronic acid, chondroitin
4-sulfate, and heparan sulfate by the two cell cultures. The
distribution of 3H in hyaluronic acid, heparan sulfate, and
chondroitin 4-sulfate were 11.6%, 36.0%, and 52.4% for the
melanoma culture and 16.5%, 24.5%, and 42.2% for the me¬
lanocyte culture (Table IV). An increased production of
sulfated glycosaminoglycans, specifically heparan sulfate, with
a concomitant decrease in hyaluronic acid production by
malignant cells compared to normal counterparts has been
previously observed (Goggins et al., 1972; Satoh et al., 1974;
Chandrasekaran & Davidson, 1979). The glycosaminoglycans
produced by the iris explant were markedly different from
those produced by both of the continuous cell cultures (FM6
and HM7). In this case, about 79% of the 3H radioactivity
in the glycosaminoglycans was accounted for by hyaluronic
acid, 14% by chondroitin 4-sulfate, 1% by heparan sulfate, and
5% by dermatan sulfate (Banks et al., 1976).
Several forms of heparan sulfate and chondroitin 4-sulfate
appear to be present as indicated by the detection of these
components in the 0.8, 1.2, and 2.0 M NaCl eluates of the
CPC precipitate. Both heparinase and heparitinase were re¬
quired to digest completely the heparan sulfate in the GAG
1.2 fractions (Table III) whereas heparitinase alone fully
degraded the GAG 0.8 heparan sulfate (Table II). In com¬
parison, the heparan sulfates produced by human melanoma
culture were always completely degraded by heparitinase alone
[Banks et al., (1976) and present results). These data suggest
that the heparan sulfate in the GAG 1.2 fractions of the
melanocyte culture may have structural features resembling
heparin, for example, a higher degree of N- or O-sulfation.
The faster mobility on cellulose acetate electrophoresis of the
glycosaminoglycans in GAG 1.2 compared to GAG 0.8
(Figure 2) and the nitrous acid degradation patterns of GAG
0.8c and GAG 1.2a (Figure 4) further supports this possibility.
It has been shown that heparan sulfate isolated from normal
Swiss 3T3 mouse cells contains 8% more O-sulfate than that
isolated from SV40 transformed Swiss 3T3 cells (Keller et al.,
1980).
Glycosaminoglycans which are major constituents of the cell
surface and extracellular matrix are believed to be important
in modifying the growth of cells both in vitro and in vivo.
These molecules may be involved in the adhesion of cells to
each other and to the substratum or membranes (Roblin et
al., 1975; Culp et al., 1978; Turley & Roth, 1980).
A role of masking tumor antigens has also been postulated
for the cancer cell surface glycosaminoglycans (Takeuchi et
al., 1977). However, thus far the studies on the production
of glycosaminoglycans by a wide variety of cultured cancer
cells have given inconsistent results. For example, whereas
increased sulfated glycosaminoglycan production by virus
transformed fibroblasts has been reported by Goggins et ai.
(1972), Satoh et al. (1973), Makita & Shimojo (1973), and
Hopwood & Dorfman (1977), others have reported a decrease
in the production of these molecules by virus transformed cells
(Saito & Uzman, 1971; Terry & Culp, 1974; Roblin et al.,
1975). Similarly, both an increase (Temin, 1965; Satoh et
al., 1973; Hopwood & Dorfman, 1977) and a decrease
(Hamerman et al., 1965; Satoh et al., 1974) in the production
of hyaluronic acid by malignant cells have also been recorded.
In the present studies, we have grown the cells in the same
medium, labeled them at comparable cell densities and growth
phase, and used the same concentration of isotopes in order
to minimize the influence of external factors. Accordingly,
the observed changes between the malignant and control (fetal)
cultures should be considered characteristic of the cell type
rather than due to artifactual reasons.
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Partial Characterization of Sialoglycopeptides Produced by Cultured
Human Melanoma Cells and Melanocytes1,
V. P. Bhavanandan,* Anne W. Katlic, John Banks, Jeffrey G. Kemper, and Eugene A. Davidson
abstract: The sialoglycopeptides produced by HM7 human
melanoma and fetal uveal melanocyte cultures grown in the
presence of [3H] glucosamine and [35S] sulfate were isolated
from the Pronase digests of cells, spent media, and intracellular
material. From the melanoma culture, six sialoglycopeptides,
accounting for 43% of the total 3H radioactivity in the non-
diffusible cell-associated glycopeptides, were purified. A major
glycopeptide (GPIb) having an apparent molecular weight in
the range 12000-15000 showed specific sialic acid dependent
interaction with wheat germ agglutinin (WGA). It was found
to contain mainly O-glycosidically linked oligosaccharides
having the Structure (AcNeu)—►0.2[Gal—GalNAc]; some
N-giycosidically linked saccharides were also present. A
second WGA-binding glycopeptide (GPIa) was smaller and
less anionic and had a higher proportion of N-glycosidically
linked saccharides than GPIb. The normal fetal cultures
yielded either no (iris) or markedly reduced (melanocytes)
quantities of the WGA-binding glycopeptides. The four
WGA-nonbinding sialoglycopeptides purified from melanoma
were shown to have complex (A-acetyllactosaminyl type)
oligosaccharides linked via W-acetylglucosamine to asparagine
with either no or insignificant amounts of O-glycosidically
linked saccharides. The corresponding glycopeptides from
melanocytes were of smaller molecular size and lower anionic
charge, reflecting an overall lower degree of glycosylation.
D ifferences in the glycoproteins produced by malignant cells
compared to normal cells have been reported (Bramwell &
Harris, 1978; Buck et al., 1979; Ceccarini & Atkinson, 1977;
Codington et al., 1979; Glick, 1979; Muramatsu et al., 1979;
Takasaki et al., 1980; van Beek et al., 1977). A molecular
description of these alterations is of importance because it will
help to understand the biological properties of malignant cells.
We have investigated in some detail the glycoproteins and
glycopeptides isolated from B16 mouse melanoma cells grown
in culture and in vivo. The characterization of a mucin-type
sialoglycopeptide (Bhavanandan & Davidson, 1976; Bhava¬
nandan et al., 1977; Fareed et al., 1978) and a melanoma-
associated antigen (Bhavanandan et al., 1980) have been re¬
ported. The characterization of a malignancy-related mu¬
cin-type sialoglycopeptide produced by human breast cancer
cell lines has also been reported (Chandrasekaran & Davidson,
1979).
We report here the purification and partial structures of the
major glycopeptides isolated from cultured human melanoma
cells and from the culture media. These are compared to those
t From the Department of Biological Chemistry and The Specialized
Cancer Research Center, The Milton S. Hershey Medical Center, The
Pennsylvania State University, Hershey, Pennsylvania 17033. Received
November 10, 1980. This research was supported by Research Grants
CA15483 and CA17686 from the U.S. Public Health Service.
produced by normal fetal melanocytes in culture. The gly¬
copeptides obtained from the highly tumorigenic (in athymic
mice) human melanoma cells are markedly different from
those obtained from nontumorigenic human fetal uveal me¬
lanocytes. A preliminary report of these results has been
presented (Bhavanandan et al., 1979).
Experimental Procedures
Materials. The cells and culture conditions used are de¬
scribed in the following paper in this issue (Bhavanandan,
1981). Neuraminidase (Vibrio cholerae) was from Calbio-
chem. Bio-Gel P-2, P-4, P-6, and P-10 were obtained from
Bio-Rad Laboratories (Richmond, CA). DEAE-Sephacel,
DEAE-Sepharose CL-6B, Sephadex G-50, and Sephacryl
S-200 were purchased from Pharmacia (Piscataway, NJ).
/J-Galactosidase, /3-W-acetylhexosaminidase, and endo-a-W-
acetylgalactosaminidase from Diplococcus pneumoniae culture
filtrates were prepared in this laboratory. These enzymes were
free of contaminating glycosidases as tested with p-nitrophenyl
glycosides and isotopically labeled natural substrates (fetuin
or pig submaxillary mucin glycopeptides) (Umemoto et al.,
1977). Endo-/3-JV-acetylglucosaminidase D (Muramatsu et
al., 1978) and endo-d-W-acetylglucosaminidase H (Tarentino
& Maley, 1974) were purchased from Miles (Elkhart, IN).
Highly purified exo-d-galactosidase from jack bean (Li et al.,
1975) and endo-/3-galactosidase from Escherichia freundii
GLYCOPEPTIDES OF HUMAN MELANOMA AND MELANOCYTES VOL. 20, NO. 19, 1981 5587
(Nakagawa et al., 1980) were kindly provided by Dr. Y.-T.
Li of Tulane University (New Orleans, LA). Wheat germ
agglutinin, concanavalin A, Ricinus communis agglutinins of
molecular weights 120000 and 60000 (RCA12o and RCA^),1
and soybean agglutinin were isolated and conjugated as de¬
scribed (Bhavanandan & Katlic, 1979a; Bhavanandan et al.,
1977). [[3H]AcNeu]glycophorin and its Pronase and tryptic
glycopeptides were prepared as described (Bhavanandan &
Katlic, 1979a). Fetuin glycopeptide fractions A, B, and C were
isolated and labeled by reductive methylation with Hl4CHO
(Umemoto et al., 1977; Bhavanandan & Katlic, 1979a).
Cyanogen bromide fragment A from [[3H]AcNeu]glycophorin
was prepared according to Blumenfeld & Puglia (1979).
Methods. Column Chromatography. Columns of Sephadex
G-50 (fine), Bio-Gel P-2 (minus 400 mesh), P-4, P-6, and P-10
(200-400 mesh) were equilibrated and eluted with 0.1 M
pyridine/0.1 M acetic acid, pH 5.0. DEAE-Sepharose CL-6B
and DEAE-Sephacel columns were generated in the acetate
form, packed in columns, and extensively washed with 0.1 M
pyridine/0.1 M acetic acid, pH 5.0. The columns were finally
equilibrated in 0.01 M pyridine/0.01 M acetic acid, pH 5.0,
prior to application of the sample and elution with a linear
gradient of 0.01 M pyridine/acetic acid, pH 5.0, in the mixing
chamber and an equal volume of 1.0 M or 0.5 M pyridine-
acetic acid, pH 5.0, in the reservoir. Affinity chromatography
on lectin-Sepharose columns was done as described (Bhava¬
nandan & Katlic, 1979a). The WGA-Sepharose columns
used had about 2 mg of lectin per mL of Sepharose. The
recovery of radioactivity and standards from the columns was
greater than 80% unless otherwise specified. The distribution
of radioactivity in the peaks is reported as percentages of the
total recovered.
Paper chromatography was carried out on Whatman No.
1 paper by the descending technique. The following solvent
systems were employed: (A) 1-butyl acetate/acetic acid/water
(3:2:1 v/v), (B) 1-butanol/pyridine/water (6:4:3 v/v), (C)
pyridine/ethyl acetate/water/acetic acid (5:5:3:1 v/v) with
pyridine/ethyl acetate/water (11:40:6 v/v) in the bottom of
the chromatography tank, and (D) 1-butanol/acetic acid/1
M NH„OH (2:3:1 v/v).
Marker neutral sugars, hexosamines, oligosaccharides, and
oligosaccharide alcohols were located by the silver nitrate
staining procedure (Trevelyan et al., 1950) or by the per-
iodate-benzidine technique (Gordon et al., 1956). Sialic acids
were detected by the thiobarbituric acid spray (Warren, 1960)
and the N-acetylhexosamines and Gal—GalNAc by the
Morgan-Elson reagent (Partridge, 1948).
Determination of [3H]Sialic Acids and [3H]Hexosamines.
[3H]Sialic acid in isotopically labeled glycoproteins was de¬
termined by acid hydrolysis (0.1 M H2S04, 80 °C, 1 h) or by
treatment with Vibrio cholerae neuraminidase followed by
addition of carrier sialic acid (0.5-1.0 mg) and fractionation
on a Bio-Gel P-2 column. Aliquots of the fractions were
analyzed for sialic acid and radioactivity. [3H] Hexosamines
in the labeled glycoconjugates were estimated after acid hy¬
drolysis (4 M HC1, 100 °C, 8 h). Standard hexosamines and
[,4C]hexosamines were added to the dried hydrolysates, and
the mixture was analyzed by a stream-splitting technique on
1 Abbreviations used: glyceryl-CPG, glyceryl controlled pore glass
beads; WGA, wheat germ agglutinin; RCA120 and RCA^, Ricinus com¬
munis agglutinins of Afr 120000 and 60000, respectively; class I and class
II glycopeptides refer to WGA-binding and WGA-nonbinding glyco¬
peptides. respectively; DEAE, diethylaminoethyl; EGTA [ethylenebis-
(oxyethylenenitrilo)Jtctraacetic acid; AcNeu, jV-acetylneuraminic acid;
Tris, tris(hydroxymethyl)aminomethane.
an amino acid analyzer (Bhavanandan & Davidson, 1976) or
on a column of AG50W-X8 (H+) according to Gardell
(1953). The fractions were analyzed for hexosamine by the
ninhydrin or the Elson-Morgan assay (Lewy & McAllan,
1959) and for radioactivity.
Digestions with Enzymes. Vibrio cholerae neuraminidase
digestion was done in 0.1 M sodium acetate buffer, pH 5.6,
containing 1 mM Ca2+ with 1.0 unit of enzyme in a total digest
volume of 200 #tL. Incubations with jack bean or D. pneu¬
moniae d-galactosidase were done in 50 mM citrate buffer,
pH 4.0, or 50 mM citrate/phosphate buffer, pH 7.0, with 0.2
unit of the enzyme at 37 "C for 24 h in a total of 200 mL.
Digestion with D. pneumoniae rf-hexosaminidase was done in
50 mM citrate/phosphate buffer, pH 5.3, with 0.2 unit of the
enzyme. Treatment with endo-a-jY-acetylgalactosaminidase
from D. pneumoniae was done in 50 mM Tris/maleate buffer,
pH 7.6, at 37 °C for 24 h in a total volume of 50 pL (Ume¬
moto et al., 1977). Digestion with endoglycosidase D or H
was done in 50 mM citrate/phosphate buffer (D, pH 6.5; H,
pH 5.0) at 37 °C for 20 h (Koide & Muramatsu, 1974).
Incubation with E. Freundii endo-3-galactosidase was in 0.05
M sodium acetate buffer, pH 5.8, at 37 "C for 24 h (Naka¬
gawa et al., 1980). All digestions were terminated by heating
at 100 °C for 2-5 min. The mixtures were centrifuged and
the supernatants fractionated on a Bio-Gel P-2 column (0.9
X 70 cm) calibrated with known saccharides. In some ex¬
periments, appropriate carrier sugars (GlcNAc, Gal, and
AcNeu) were added to the supernatants prior to chromatog¬
raphy.
Alkaline Borohydride Treatment of Glycopeptides. Al¬
kaline borohydride treatment of the glycopeptides was done
with 1.0 M NaBH4 in 0.1 M NaOH for 72-96 h at 37 °C
under nitrogen in sealed tubes in the dark. The reaction
mixture was cooled in an ice bath, the excess borohydride
destroyed, and the mixture neutralized by careful addition of
1 M acetic acid. The eliminated products were analyzed by
chromatography on calibrated columns of Bio-Gel P-4 and P-6.
Other methods used in this study are described in the fol¬
lowing paper in this issue (Bhavanandan, 1981).
Results
Several experiments were carried out on the melanoma cells
over a period of about 4 years by using early (<20) and late
passage (>100) cells. There was no significant difference
between the results from individual experiments; the results
presented are representative.
The processing of the labeled glycoconjugates from the cells,
spent media, and EGTA supernatants and the cetylpyridinium
chloride fractionation are described in the following paper
(Bhavanandan, 1981). The glycopeptides were recovered from
the cetylpyridinium chloride supernatant. The total radio¬
activity from [3H]glucosamine incorporated into glycopeptides
by the melanoma culture was 93.8 X 106 dpm per 107 cells
compared to 57.8 X 106 dpm for 107 cells of the melanocyte
culture (see Table I, Bhavanandan, 1981).
Gel Filtration Analysis of the Glycopeptides. The mixtures
of glycopeptides obtained from melanoma and melanocytes
were examined on Sephadex G-50 (not illustrated) and Bio-Gel
P-10 (Figure 1) columns. On both columns, the bulk of the
melanocyte glycopeptides were included, and only 1-2% eluted
in the void volume. In contrast, the melanoma glycopeptides
eluting at the void volume of the Bio-Gel P-10 column rep¬
resented 5 times as much material.
Affinity Chromatography of the Glycopeptides on a
WGA-Sepharose Column. The results illustrated in Figure
2 show striking differences in the proportions of the glyco-
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figure 1: Elution profiles if the 3H-labeled glycopeptides from human
fetal melanocytes and human melanoma cells on Bio-Gel P-10.
Human fetal melanocytes labeled with [3H]glucosamine were pro¬
cessed, digested with Pronase, and treated with cetylpyridinium
chloride as described in the text. The 3H-labeled glycopeptides (•)
remaining in the cetylpyridinium chloride supernatant were recovered,
mixed with [14C] glucose, and chromatographed on a Bio-Gel P-10
column (0.9 x 134 cm). The corresponding 5H-labeled glycopeptides
isolated from HM7 human melanoma cells (O) were also mixed with
[,4C]glucose and chromatographed on the same column. The column
was eluted with 0.1 M pyridine/0.1 M acetic acid (pH 5.0) at 20
mL/h, and 1-mL fractions were collected and analyzed for radio¬
activity. The results are presented by superimposing the elution
patterns, using elution of [14C]glucose (A) and the void volume (F0)
as references. The percent of radioactivity of the melanoma and
melanocyte glycopeptides eluting in the area indicated by the horizontal
arrows are given above and below the arrows, respectively.
peptides derived from melanoma, melanocyte, and iris (Banks
et al., 1976) cultures specifically binding to WGA. There is
a significant reduction of the WGA-binding (class I) glyco¬
peptides in the melanocyte culture and the iris explant when
compared to the melanoma culture.
We have previously demonstrated that the binding of
sialoglycopeptides to a WGA-Sepharose column depended not
only on the number and arrangement of the binding sugar
residues (A-acetylneuraminic acid or A-acetylglucosamine)
but also on the density of lectin molecules on the gel beads
(Bhavanandan & Katlic, 1979a). Therefore, in the present
studies, we have used WGA-Sepharose columns having the
Q
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figure 2: Affinity chromatography of glycopeptides on WGA-Se¬
pharose. Glycopeptides isolated from cells, medium, and EGTA
supernatant of cell cultures labeled with [3H]glucosamine, as described
under Experimental Procedures, were chromatographed on a WGA-
Sepharose column (2 X 6.5 cm) containing about 2 mg of WGA
covalently bound per mL of gel. The column was eluted with 0.05
M Tris-HCl, pH 8.0, followed by 0.1 M GlcNAc in the same buffer.
One-milliliter fractions were collected and analyzed for radioactivity.
The results of the elution of melanoma cell-associated glycopeptides
are illustrated. The percentage of glycopeptides which specifically
bound to WGA when about 50 000 dpm of the glycopeptides from
the different cellular compartments of melanoma, melanocytes, and
iris were chromatographed is given in the inset. In preparative ex¬
periments, the WGA-binding and -nonbinding glycopeptides were
recovered by dialysis followed by lyophilization and designated class
I and II glycopeptides, respectively.
same concentration of lectin (about 2 mg/mL). This pre¬
caution was important because in subsequent studies we have
noticed that on WGA-Sepharose columns having a high
density of lectin (10 mg/mL gel), even small serum-type
glycopeptides (such as fetuin glycopeptide A) are partially
retained (V. P. Bhavanandan, unpublished results).
Fractionation of the Glycopeptides from Cell, Spent Me¬
dium, and EGTA Supernatant (Refer to Scheme /). The
glycopeptides were separated into WGA-binding (class I
giycopeptides) and nonbinding (ciass II giycopeptides) portions
by preparative chromatography on WGA-Sepharose (Figure
2).
Characterization of the Melanoma Class I {WGA-Binding)
Glycopeptides. The melanoma class I glycopeptides were
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figure 3: Ion-exchangc chromatography of glycopeptides on
DEAE-Sephacel. (Top) The human melanoma cell-associated gly¬
copeptides (class I (O), class II (•), and asialo class II (a)] isolated
from [3H]glucosamine-labeled cultures were each mixed with
[,4C]AcNeu and chromatographed on a DEAE-Sephacel column (0.9
X 40 cm). The column was eluted with a linear gradient of 0.01-1.0
M pyridine/acetic acid, pH 5.0 (400 mL), at the rate of 20 mL/h.
Fractions of 2.0 mL were collected and 1-mL aliquots analyzed for
radioactivity. The results are presented by superimposing the elution
patterns, using elution of [,4C]AcNeu as an internal reference.
(Bottom) Elution profiles of the human fetal melanocyte cell-associated
glycopeptides [class I (a), class II (•), and asialo class II (O)].
separated into two fractions, GPIa and GPIb, by chroma¬
tography on DEAE-Sepharose CL-6B (Figure 3, top). The
latter fractions were rechromatographed on a DEAE-Sephacel
column and yielded single peaks, as did chromatography on
a glyceryl-CPG column. Both these fractions were excluded
from Sephadex G-50 and Bio-Gel P-10, but on a Sephacryl
S-200 column, these glycopeptides apparently interacted ir¬
reversibly since greater than 90% of the radioactivity was lost.
Affinity chromatography of GPIa or GPIb on immobilized
lectin columns resulted in either binding (WGA) or no binding
(concanavalin A, RCA120, RCA^o, and soybean agglutinin)
of the entire fractions. Polyacrylamide gel electrophoresis of
GPIa and GPIb in 6% gels in the presence of sodium dodecyl
sulfate gave single bands. The result obtained with GPIa is
illustrated (Figure 4).
Characterization of the WGA-Binding Glycopeptides GPIa
and GPIb. The distribution of 3H radioactivity in sialic acid
and hexosamines in the class I glycopeptides is given in Table
I. The results of further experiments on the GPIa and GPIb
obtained from cells are presented below; analogous studies were
also carried out on the fractions isolated from spent medium
and EGTA supernatant with substantially similar results.
The class I asialoglycopeptides (mixture of asialo-GPIa and
-GPIb) prepared by either mild acid hydrolysis or treatment
with neuraminidase did not bind (<5%) to WGA-Sepharose,
confirming the role of sialic acid in the interaction with WGA
(Bhavanandan et al., 1977; Bhavanandan & Katlic, 1979a,b).
The asialoglycopeptides bound to both RCA12o and RCA^
columns, 79% and 78%, respectively, and could be eluted with
0.1 M lactose. Asialo-GPIa and -GPIb were also separately
tested on the RCA^ column, and 100% and 83% of the ra¬
dioactivities were specifically bound, respectively. These results
figure 4: Sodium dodecyl sulfate/polyacrylamide gel electrophoresis
of human melanoma glycopeptide la and glycophorin. The 3H-labeled
glycopeptide la (shaded area) isolated from human melanoma cells
and standard [[3H]AcNeu]glycophorin (unshaded area) were elec-
trophoresed on 6% polyacrylamide gel in the presence of sodium
dodecyl sulfate for 3 h at 70 V as described by Weber & Osborn
(1969). The gels were sliced into 2-mm segments and solubilized by
incubation in glass vials with 0.2 mL of 60% perchloric acid and 0.4
mL of 30% hydrogen peroxide at 60 °C for 4 h. Scintillation counting
fluid was added to the solubilized gel, and the radioactivity was
determined. The results are superimposed by using the migration
position of bromophenol blue as reference. Glycophorin yields two
bands corresponding to the monomer (Mr 31 000) and dimer (Mr
62000).
Table i: Percent Distribution of 3H Activity in Sialic Acid and




glycopeptides hydrolysis neuraminidase GlcNH2 GalNH2
cell
class I 28.4 28.0* 35.it 36.5t
GPIa 26.0 26.0* 45.lT 28.9J
GPIb 40.0 42.0* 10.2t 49.8t
spent medium
class I 27.4 ND 30.5 42.1
EGTA supernatant
class I 28.2 ND 33.7 38.1
GPIa 26.5 ND 41.9 31.6
GPIb 44.4 ND 8.9 46.7
a The sialoglycopeptides were treated with acid or neuramin¬
idase and chromatographed on Bio-Gel P-2 (see Methods for de¬
tails), and the percent of radioactivity coeluting with carrier sialic
acid was estimated. Sialic acids from experiments marked with an
asterisk were recovered and identified as A-acetylneuraminic acid
by paper chromatography in solvent system A. Percent of radio¬
activity in the hexosamines was determined by hydrolyzing (4 M
HC1, 100 °C, 8 h) a separate aliquot of the glycopeptide followed
by analysis on a column of AG50W (H+) (samples marked f) or by
stream-splitting technique on an amino acid analyzer (details and
references are given under Methods). Total radioactivity refers to
the sum in sialic acid (acid hydrolysate), GlcNH2, and GalNH,.
ND = not determined.
indicated the presence of /3-galactosyl or /3-7V-acetyl-
galactosaminyl nonreducing terminals in these asialoglyco¬
peptides (Irimura et al., 1975); however, heterogeneity with
respect to the distribution of oligosaccharides on the peptide
may be present (V. P. Bhavanandan, unpublished results).
Treatment of the asialo-GPIa and -GPIb with endo-a-N-
acetylgalactosaminidase released 25% and 58% radioactivity,
respectively, in a product which coeluted on Bio-Gel P-2
columns with Gall—3GalNAc prepared by treatment of fetuin
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Table II: Percent Distribution of 3H Activity in Sialic Acid and
Hexosamines in the Glycopeptides Produced by Human
Melanocytes in Culture and by Explant Iris Culture0
20 40 60
Fraction Number
FIGURE 5: Elution profiles on Bio-Gel P-6 of human melanoma
glycopeptides after treatment with alkaline borohydride. The human
melanoma cell-associated glycopeptides, GPIa (panel a), GPIb (panel
b), and GPII, i.e., Class II (panel c), were treated with alkaline
borohydride and chromatographed on a Bio-Gel P-6 column (0.9 X
105 cm) as described under Methods. The column was eluted with
0.1 M pyridine/0.1 M acetic acid, 1-mL fractions were collected, and
aliquots were analyzed for radioactivity. The eiution profiles of internal
standards glucose (A) and iV-acetylneuraminic acid (A) and the peak
elution positions of blue dextran (Va), AcNeu -<iai -(AcNeu) -■
GalNAc(OH) (tetra), AcNeu -Gal -GalNAc(OH) (tri), and
Gal-*GalNAc(OH) are also indicated.
asialoglycopeptides (Umemoto et al., 1977) with the same
enzyme. The product from asialo-GPIa and -GPIb was iso¬
lated by gel filtration on a Bio-Gel P-2 column and desalted
by passage through mixed-bed ion-exchange resin. Paper
chromatography in solvent system A showed that it had a
mobility identical with that of reference Gall—^-3GalNAc. The
identity of the disaccharide was further confirmed by treatment
with NaBH4 followed by acid hydrolysis, after which the only
labeled component detected on the amino acid analyzer was
[3H]galactosaminitol (Bella & Kim, 1970). The sialo- and
the asialoglycopeptides la and lb were not degraded by
endo-/3-galactosidase from E. Freundii.
Alkaline borohydride treatment of GPIa and GPIb followed
by gel filtration on a Bio-Gel P-4 or P-6 column indicated that
46% and 88% of the radioactivities, respectively, were released.
On both columns, the major products coeluted with [Ac-
Neu-*Gal—-(AcNeu)—»GalNAcOH], [AcNeu—Gal-*Gal-
NAcOH], and [Gal—"GalNacOH] prepared from fetuin or
glycophorin by alkaline borohydride treatment (Spiro &
Bhoyroo, 1974) (Figure 5). The major elimination products
from GPIa and GPIb were isolated by preparative chroma¬
tography on Bio-Gel P-6, repeatedly evaporated with methanol
to remove borate (when present), and examined by paper
chromatography. In solvent systems A and C, they comigrated
with the tetra-, tri-, and disaccharide alcohols isolated from
fetuin (Figure 6). Acid hydrolysis of the total /3-eliminated
oligosaccharides from GPIb followed by stream-split analysis
on the amino acid analyzer employing the citrate-borate buffer
system (Bella & Kim, 1970) gave only [3H]galactosaminitol,
with no detectable [3H]glucosamine or [3H]galactosamine.






class I 31.5 43.8 24.7
class II 20.0* 66.0 14.0
class Ila 5.3 90.8 3.9
class lib 10.6 82.1 7.3
class lie 14.3 75.2 10.5
class lid 16.1 71.1 12.8
FM6 spent medium
class I 34.0 39.5 26.5
class II 20.9* 65.6 13.5
FM6 EGTA supernatant
class II 21.3 78.7 <1
iris explant cell 16.0 73.1 10.9
iris explant medium 18.6 76.5 4.9
° Details are as described in Table I.
Table III: Percent Distribution of 3H Activity in Sialic Acids and





hydrolysis neuraminidase GlcNHj GalNH.
cell
class II 19.6 19.1* 68.3 12.1
GPIIC-2a 15.5 14.0* 79.7 4.8
GPIIC-2c 21.5 20.3* 78.5 0.0
GPIID-2b 23.1 21.7* 76.9 0.0
GPIIE-2b 23.0 20.0* 73.8 3.2
spent medium
class II 22.9 ND 72.5 4.6
EGTA supernatant
class II 23.7 ND 63.3 13.0
° Details are as described in Table I.
rasaccharide followed by chromatography on a Bio-Gel P-6
column gave two sharp peaks coincident with reference AcNeu
and Gall-*3GalNAcOH; the radioactivity was distributed
equally between the two peaks. The alkaline borohydride
resistant portions of GPIa and GPIb (55% and 12%, respec¬
tively) eluting prior to the tetrasaccharide peak on the Bio-Gel
P-6 column (Figure 5a,b) were also recovered and examined.
Only minor portions (14% and 11%) of these fractions were
retained on the WGA-Sepharose 4B column. [3H]Glucos-
amine accounted for greater than 90% of the radioactivity
detectable after total acid hydrolysis, in both cases.
Retreatment of GPIa and GPIb with Pronase did not alter
their elution profile on the glyceryl-CPG or Sephadex G-50
columns.
Characterization of the Melanocyte WGA-Binding Glyco¬
peptides. Ion-exchange chromatography on a DEAE-Sephacel
column using a 0.01-1.0 M pyridine/acetic acid gradient gave
one broad peak which eluted after the WGA-nonbinding (class
II) glycopeptides and before the human melanoma class I
glycopeptides la (Figure 3, bottom). The percent distribution
of radioactivity in sialic acid and hexosamines (Table II)
resembles that of melanoma la glycopeptides. Alkaline bo¬
rohydride treatment of WGA-binding glycopeptides from cells
followed by gel filtration on a Bio-Gel P-6 column indicated
that 38% of the radioactivity was released as oligosaccharides.
The hexosamine in the alkaline borohydride resistant portion
was practically all glucosamine.
Studies on the WGA-Nonbinding (Class II) Glycopeptides.
The distribution of radioactivity in sialic acid and hexosamine
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figure 6: Paper chromatography of .^-eliminated oligosaccharides
from human melanoma glycopeptides la (top panel) and lb (bottom
panel). The 3H-labeled oligosaccharides A, B, and C obtained from
GPI a (Figure 5, panel a) and A and B from GPIb (Figure 5, panel
b) were chromatographed by using solvent systems A and C, re¬
spectively. The migration positions of standard sugars detected as
described under Methods are indicated. Tetra and Tri refer to the
tetra- and trisaccharides described in Figure 5.
in the class II glycopeptides is given in Tables II and III.
The elution profiles of the WGA-nonbinding glycopeptides
obtained from melanoma cells and melanocytes on an ion-
exchange column is illustrated in Figure 7. There is a higher
proportion of the less anionic glycopeptides in the melano-
cyte-derived glycoconjugates. For example, 49.7% of the 3H-
labeled glycopeptides from melanocytes elutes in fractions
25-66 as opposed to only 31.6% in the case of the melano¬
ma-derived glycopeptides. Gel filtration on glyceryl-CPG,
Sephadex G-50, and Bio-Gel P-10 indicated that these gly¬
copeptides are heterogeneous and of lower molecular weight
when compared to the class I glycopeptides. The melanoma
cells, however, contained a higher proportion of the larger
glycopeptides than did the melanocytes (cf. Figure 1).
The size of the class II glycopeptides was reduced on de-
sialylation (about 80% of radioactivity was now dialyzable),
and the asialogiycopeptides were still highly heterogeneous.
It was therefore apparent that the heterogeneity of the class
II glycopeptides is not solely due to differences in the degree
of sialylation, even though this may be a factor. This was
further illustrated by chromatography of the untreated and
desialylated glycopeptides on a DEAE-Sepharose column
(Figure 3, top).
Characterization of the Melanoma Class II Glycopeptides.
The melanoma sialo- and asialogiycopeptides on treatment
with endo-a-A-acetylgalactosaminidase or with endo-/3-
galactosidase released insignificant quantities of radioactivity.
The results of alkaline borohydride treatment of the class II
glycopeptides from melanoma cells followed by gel filtration




figure 7: Elution profiles of the 3H-labeled glycopeptides from human
fetal melanocytes and human melanoma cells on DEAE-Sephacel.
The WGA-nonbinding (class II) glycopeptides isolated from [3H]-
glucosamine-labeled human fetal melanocytes (•) and human me¬
lanoma (O) were separately mixed with ['*C]glucose and [l4C]AcNeu
(a) and chromatographed on a DEAE-Sephacel column (1.5 X 22
cm). The column was eluted with a linear gradient of 0.01-0.5 M
pyridine/acetic acid, pH 5.0 (300 mL), at 15 mL/h. Fractions of
2.1 mL were collected and 1-mL aliquots analyzed for radioactivity.
The results are presented by superimposing the elution profiles. The
present of radioactivity of the melanoma and melanocyte glycopeptides
eluting in the area indicated by the horizontal arrows are given above
and below the arrows, respectively.
activities were in the released tetra- and trisaccharides, re¬
spectively.
Attempts to fractionate the class II glycopeptides on WGA-,
Con A-, RCA120-, and RCAjo-Sepharose columns were un¬
successful since these glycopeptides were not retained on these
columns. The asialogiycopeptides also did not interact with
either WGA- or Con A-Sepharose but were partially (77%
and 24%) retained on RCA120- and RCA^-Sepharose col¬
umns. On a RCA12o-Sepharose column, class II asialo¬
giycopeptides separated into three categories: not retained
(excluded from the column), 12%; retarded but eluted with
buffer, 76%; retained and eluted with 0.1 M lactose, 12%.
Fractionation of the Melanoma Class II Glycopeptides
(Refer to Scheme I). The class II glycopeptides from mela¬
noma cells were fractionated on a DEAE-Sepharose column
into six fractions (GPIIA-F) by using a 0.01—1.0 M pyri¬
dine/acetic acid, pH 5.0, gradient. The three major fractions
(GPIIC, GPIID, and GPIIE) were separately rechromato-
graphed on DEAE-Sepharose by using a 0-0.5 M pyridine/
acetic acid gradient, and the material eluting in sharp peak
areas GPIIC-2, GPIID-2, and GPIIE-2 was recovered (Figure
8) and chromatographed on a column (0.9 x 140 cm) of
Sephadex G-50 (fine). Fraction GPIIC-2 yielded two peaks
and fractions GPIID-2 and GPIIE-2 one major peak each.
The material in the major peaks in each case was rechroma-
tographed on the Sephadex G-50 column, recovered, and
designated GPIIC-2a, GPIIC-2c, GPIID-2b, and GPIIE-2b.
These glycopeptides represented 4.0%, 5.4%, 10.5%, and 3.3%
of the total radioactivity in the glycopeptides (cetylpyridinium
chloride supernatant).
Partial Characterization of GPIIC-2a, GPIIC-2c, GPIID-
2b, and GPIIE-2b. The distribution of 3H counts in sialic acid
and hexosamine in these glycopeptides is given in Table III.
All four glycopeptides had a lower proportion of radioactivity
in sialic acid and a much higher proportion in glucosamine
as compared to GPIa and GPIb. This indicated that these may
contain N-glycosidic linkages between GlcNAc and aspara-
gine.
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figure 8: Fractionation of 3H-labeled class II glycopeptides from
human melanoma cells on DEAE-Sepharose. The human melanoma
class II giycopeptides isolated from [3H]glucosamine-labeled cells were
chromatographed on a DEAE-Sepharose column (1.5 X 25 cm). The
column was eluted with a linear gradient of 0.01-1.0 M pyridine/acetic
acid, pH 5.0. The total volume of the gradient was 400 mL, and the
rate of elution was about 20 mL/h. Fractions of 2 mL were collected,
and aliquots of 25 nL were analyzed for radioactivity. The glyco¬
peptides eluting in fractions 42—51, 52-62, and 63-74 were recovered
by lyophilization and designated GPIIC, GPIID, and GPIIE. They
were then individually rechromatographed on the same DEAE-Se¬
pharose column by using a 0-0.5 M pyridine/acetic acid gradient.
In each case, the material eluting in the area indicated by horizontal
arrows (GPIIC-2, GPIID-2, and GPIIE-2) was recovered by lyo-
phiiization.
Asialo-GPIIC-2c and -GPIID-2b, prepared by treatment
with V. cholerae neuraminidase followed by chromatography
on Bio-Gel P-2, interacted specifically with RCAI20-Sepharose
.but not with Con A-Sepharose. Treatment of the asialo-
GPIIC-2c and -GPIID-2b with D. pneumoniae /3-galactosidase
and /3-A-acetylhexosaminidase released a product containing
45% and 55% of the radioactivity, respectively. This product
eluting in the same position as GlcNAc on a Bio-Gel P-2
column was isolated and desalted by passage through Dowex
AG50 (H+) and Dowex AG1 (formate) columns. On paper
chromatography using solvent system B, it was indistin¬
guishable from standard GlcNAc. In control experiments,
treatment of the asialoglycopeptides with either enzyme alone
failed to release any labeled products.
The portion of asialo-GPIIC-2c undigested by the exo-
glycosidases eluting at the void volume of the Bio-Gel P-2
column was recovered by lyophilization. It was not retained
on a Con A-Sepharose column and was resistant to degra¬
dation by endo-N-acetylglucosaminidase H. However, on
treatment with endo-IV-acetylglucosaminidase D followed by
chromatography on a Bio-Gel P-4 column, 32% of the ra¬
dioactivity eluted in the position of reference GlcNAc—Asn.
Hydrazinolysis of GPIIC-2c and GPIID-2b followed by gel
filtration of a Bio-Gel P-6 column gave included peaks, in¬
dicating that these glycopeptides had oligosaccharides linked
N-glycosidically to the peptide.
Fractionation of the Melanocyte Class II Glycopeptides.
The cell-associated class II sialoglycopeptides were prepara-
tively fractionated on the DEAE-Sepharose column into four
fractions (a-d). The distribution of radioactivity in the peaks
marked a, b, c, and d in Figure 3 (bottom) was 23%, 33%, 23%,
and 21%. The fractions were rechromagraphed on a DEAE-
Sephacei column using 0-0.5 M pyridine/acetic acid gradient,
and the material eluting in sharp peaks was recovered and
designated class Ila, class lib, and class lie, and class lid. The
distribution of 3H activity in sialic acid and the significant
quantities of galactosamine in these glycopeptides compared
to the human melanoma class II glycopeptides (Table III) is
of interest. The results suggest that the major portion of the
carbohydrate in these glycopeptides is of the N-glycosidically
linked type. Insufficient material was available for further
purification and characterization of these four subfractions.
Characteristics of Glycopeptides from Human Embryonic
Iris. Chromatography on Sephadex G-50 of the glycopeptides
from both tissue and medium gave patterns very similar to that
of the asialoglycopeptides isolated from cultured melanocytes.
On gel filtration on a calibrated CPG column, the iris gly¬
copeptides eluted as a broad peak, with a maximum two
fractions before glucuronic acid. The elution pattern of the
iris glycopeptides on a DEAE-Sepharose column was unusual
and markedly different from those of the melanocyte and
melanoma glycopeptides. A significant portion (27%) of the
iris glycopeptides eluted in a sharp peak very early; these are
probably uncharged (nonsialylated) or low sialic acid glyco¬
peptides. The overall reduction in sialylation in the iris gly¬
copeptides is also reflected by the low percent of radioactivity
in the sialic acid, 16.0% and 18.6;, for the tissue and medium
derived glycopeptides, respectively. Alkaline borohydride
treatment of these iris medium glycopeptides followed by
chromatography on Bio-Gel P-6 showed that about 12% of
the radioactivity was released as tetra- and trisaccharides. This
is in agreement with the presence of 11% and 5% [3H]-
galactosamine in the iris tissue and medium glycopeptide,
respectively. The elution pattern of the elimination products
on the Bio-Gel P-6 column was very similar to that obtained
for melanocyte glycopeptides after the same treatment. These
O-glycosidically linked oligosaccharides are apparently not
present as clusters and thus fail to bind to the WGA-Se-
pharose.
Discussion
The WGA-binding glycopeptide, GPIb, had a mobility on
a glyceryl-CPG column identical with that of chondroitin
4-sulfate from cartilage and of mouse melanoma class I gly¬
copeptides (Bhavanandan & Davidson, 1976), indicating an
apparent molecular weight in the range of 12000-15 000,
whereas glycopeptide GPIa had an apparent molecular weight
of ~8000-10000. The reason for the anomalous behavior of
GPIa on polyacrylamide gel electrophoresis in the presence
of sodium dodecyl sulfate (Figure 4) is not entirely clear but
is probably dependent on higher carbohydrate content of GPIa
(expected to be greater than 90%) compared to that of gly-
cophorin (55%). The high sialic acid content is likely to be
the primary determinant of the ion-exchange chromatographic
behavior of class I glycopeptides la and lb (Figure 3, top) even
though factors such as amino acid composition and size are
likely to contribute.
Chromatographic and enzymatic data suggest the presence
of the sequence Gall—3[3H]GalNAc in asialo-GPIa and -
GPIb. GPIb has a large portion of tetra- (51%) and tri¬
saccharides (31%) linked O-glycosidically in clusters to serine
or threonine, as suggested by affinity chromatography on
WGA-Sepharose (Bhavanandan & Katlic, 1979a) and re¬
sistance to degradation by Pronase. Thus GPIb has a structure
very similar to that suggested for the mucin-type (class I)
sialoglycopeptides obtained from mouse melanoma (Bhava¬
nandan & Davidson, 1976; Bhavanandan et al., 1977).
However, it differs from the mouse melanoma glycopeptide
in containing a small proportion of N-glycosidically linked
glucosamine-containing oligosaccharides and in not being
precipitated by cetylpyridinium chloride. Since neither gly-
cophorin nor glycopeptides derived from it is precipitated to
any extent by this cationic detergent, the class I mouse me-
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FIGURE 9: Molecular weight estimation of human melanoma gly-
copeptides IIC-2a, IIC-2c, IID-2b, and IIE-2b. The purified H-
labeled human melanoma glycopeptides IIC-2a, IIC-2c, IID-2b, and
IIE-2b were individually mixed with uC-labeled fetuin and (I4CJ-
giucose and chromatographed on the calibrated Sephadex G-50
column. The K„ values are plotted against log molecular weight.
lanoma glycopeptides may contain other anionic groups
(sulfate or phosphate) or a closer spacing of the sialic acid
residues and therefore a higher charge density. Further work
is necessary to resolve this discrepancy.
The higher proportion of glucosamine, the difference in the
ratio of O-glycosidically linked oligosaccharides, and the in¬
ability to convert GPIa to GPlb by treatment with Pronase
excludes the possibility that GPIa is a precursor of GPlb,
although both bind to WGA-Sepharose.
The four substantially homogeneous WGA-nonbinding
(class II) glycopeptides from melanoma cells have apparent
molecular weights of 7000, 3700, 4500, and 3800 based on
their mobilities on a Sephadex G-50 column (Figure 9). The
anomalous behavior of sialoglycopeptides (Alhadeff, 1978;
Santer & Glick, 1979) in gel filtration precludes a more ac¬
curate determination of their molecular weights by this
technique. Glycopeptides IIC-2c and IID-2b were shown to
have Gal—GlcNAc sequences penultimate to sialic acid and
/V,iV'-diacetylchitobiosyl linkages to asparagine residues,
probably with fucose substitution at the internal GlcNAc
residue (Muramatsu et al., 1978). The various class II gly¬
copeptides may differ from each other in monosaccharide
composition and the number and completeness of the branches,
i.e., bi-, tri-, and tetraantennary structures; differences in the
core region are also possible.
N-Glycosidically linked simple (oligomannosyl) type oli¬
gosaccharides were not detected in these studies, probably due
to the isolation procedure which involved extensive dialysis.
In fact, the gel filtration profile on Sephadex G-50 of the total
Pronase digest of the cells before and after exhaustive dialysis
suggests the loss of low molecular weight fragments. Other
glycopeptides which would have been lost by dialysis are those
having nonclustered O-glycosidically linked oligosaccharides
as are present in fetuin. The failure of endo-/3-galactosidase
from E. Freundii to degrade GPIa, GPlb, or class II sialo-
or asialoglycopeptides indicates the absence of repeating
Gal—GlcNAc structures in these fractions (Krusius et al.,
1978; Li et al., 1980). The sialic acid and hexosamine com¬
positions of the partially purified melanocyte class II glyco¬
peptides and of iris glycopeptides (Table II) show that the
major portion of the carbohydrate in these glycopeptides are
N-glycosidically linked N-acetyllactosaminyl type, although
they differ from the analogous melanoma glycopeptides in
having significant quantities of galactosamine.
An increase in the molecular size of N-glycosidic complex
glycopeptides from malignant cells (Warren et al., 1978) was
also observed in this study. The increased production of these
higher molecular weight glycopeptides (referred to as group
A by Warren et al., 1978) has been correlated with the active
growth state and tumorigenicity of cancer cells (Buck et al.,
1971; Glick et al., 1973; Muramatsu et al., 1973; Van Beek
et al., 1977). The purification and partial structure of one of
these larger glycopeptides isolated from Rous sarcoma virus
transformed baby hamster kidney cells were recently reported
(Glick, 1979; Santer & Glick, 1979).
Another difference noted in our studies was a striking in¬
crease in the WGA-binding glycopeptides in the melanoma
culture compared to the melanocyte culture (Figures 1 and
2). Similar increases in the production of WGA-binding
glycopeptides by B16 mouse melanoma cells (Satoh et al.,
1974; Bhavanandan & Davidson, 1976; Bhavanandan et al.,
1977) and by two mammary cancer cells (Chandrasekaran
& Davidson, 1979) compared to their normal counterparts
have also been noted. The relevance of these alterations to
malignancy is not clear, but both alterations noted indicate
a higher degree of glycosylation (specifically sialylation) in
cancer cells. This is in agreement with the overall increase
in the negative charge of the cancer cell as detected by whole
cell electrophoresis (Abercrombie & Ambrose, 1962) and with
the increase in sialyltransferase activities of cancer cells
(Warren et al., 1972; Bosmann & Hall, 1974; Bernacki &
Kim, 1977). Further, studies with malignant cells in vivo have
consistently shown that plasma membrane sialic acid is ele¬
vated relative to control cells (Mabry & Carubelli, 1972;
Bryant et al., 1974; Bosmann et al., 1974; Dristrian et al.,
1977). This increased cell surface sialic acid has been im¬
plicated in reducing the immunogenicity of neoplastic cells by
masking antigenic determinants.
Since the melanocytes were of embryonic origin, the dif¬
ferences noted in our studies may not be entirely related to
the malignant state of the melanoma cells. It is also difficult
to draw conclusions regarding the changes in the individual
glycoconjugates based solely on the results of these studies.
Recently, we succeeded in purifying and partially character¬
izing a mucin-type glycoprotein from HM7 human melanoma
cells (Umemoto et al., 1981).
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ISOLATION AND PARTIAL CHARACTERIZATION OF A MUCIN-TYPE GLYCOPROTEIN FROM PLASMA
MEMBRANES OF HUMAN MELANOMA CELLS
JUNJI UMEMOTO *, V.P. BHAVANANDAN ** and EUGENE A. DAVIDSON **
Department ofBiological Chemistry, and Specialized Cancer Research Center, The Milton S. Hershey Medical Center, The Pen¬
nsylvania State University, Hershey, PA 17033 (U.S.A.)
(Received March 9th, 1981)
Key words: Glycoprotein isolation; Plasma membrane: Mucin; (Human melanoma cell)
Plasma membranes were isolated from HM7 melanoma cells grown in the presence of [3H]glucosamine and
Na|sS04 or [3H]mannose and [14C]glucosamine. The labeled glycoconjugates were solubilized with 0.6 M lithi¬
um diiodosalicylate/0.5% Triton X-100. Fractionation of glycoconjugates by repeated chromatography on col¬
umns of Sepharose CL-6B and DEAE-Sepharose and by affinity chromatography on WGA-Sepharose yielded
three radiochemically homogenous glycoproteins. One of these having an apparent molecular weight of 100 000
was found to contain clusters of (AcNeu)t or 2 -*■ [Gal -> GalNAc] linked O-glycosidically to the protein. One other
glycoprotein contained both O-glycosidically and A-glycosidically-linked oligosaccharides, and the third con¬
tained only jV-glycosidically-linked carbohydrates. Preliminary results indicate that the 100 000 molecular weight
mucin-type glycoprotein is present in significantly reduced quantities in cultured human fetal uveal melanocytes.
Further, the bulk of the glycoproteins from the melanocytes were of lower molecular size compared to those
from the melanoma cells.
Introduction
We recently described the characterization of gly-
copeptides derived from HM7 human melanoma cells
and from human fetal uveal melanocytes [1], The
patterns of glycopeptides obtained from these two
sources were strikingly different. The melanoma cells
produced increased quantities of the two wheat germ
agglutinin (WGA)-binding mucin-type glycopeptides.
These glycopeptides were shown to have highly sialy-
lated oligosaccharides linked O-glycosidically to pro¬
tein, in clusters. On the other hand, for the WGA-
nonbinding glycopeptides, there was a significantly
higher proportion of the smaller molecular size less
* Present address: Maruho Pharmaceutical Co., Osaka, Japan.
** To either of whom correspondence should be addressed.
Abbreviations: WGA, wheat germ agglutinin; AcNeu,
jV-acety [neuraminic acid; GalNAc(OH), V-acetylgalactos-
aminitol.
anionic species derived from melanocytes compared
to those from the melanoma cells. Similar increases
in the size of the rV-glycosidic glycopeptides from
cancer cells and tumors have been reported by several
workers (see review by Warren et al. [2]).
In the present study, we have succeeded in isolat¬
ing three glycoproteins from plasma membranes of
HM7 human melanoma cells. The partial characteri¬
zation of an acidic mucin-type glycoprotein is dis¬
cussed. A preliminary report has been presented [3].
Materials and Methods
Materials
The HM7 human melanoma cells [1 ] and cultured
FM13 human fetal uveal melanocytes [4,5] described
previously were used in these studies. Pronase CB and
Vibrio cholerae neuraminidase (EC 3.2.1.18) were
0005-2736/81/0000—0000/S02.50 © 1981 Elsevier/North-Holland Biomedical Press
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purchased from Calbiochem (La Jolla, CA). Sepha-
rose CL-6B, DEAE-Sepharose CL-6B and Sephadex
G-50 were obtained from Pharmacia (Piscataway,
NJ). Endo-a-7V-acetylgalactosaminidase (EC 3.2.1.97)
from Diplococcus pneumoniae culture filtrates was
prepared in our laboratory [6]. Wheat germ aggluti¬
nin was isolated and conjugated as described [7],
d-[6-3H]glucosamine hydrochloride; [1-14C]glucos¬
amine hydrochloride; Na25S04 and d-[l-3H]mannose
were obtained from New England Nuclear (Boston,
MA). Lithium 3,5-diiodosalicylate was purchased
from Eastman Kodak Co. (Rochester, NY). The oligo¬
saccharides, (AcNeu)0_2 [Gal -*■ GalNAcOH], were
isolated from fetuin by treatment with alkaline boro-
hydride as described [8].
Methods
Column chromatography. Sepharose CL-6B
columns were equilibrated and eluted with Tris-HCl
buffer, pH 8.0 containing 0.1% Triton X-100 and 0.1
mM toluenesulfonyl fluoride;Sephadex G-50, and Bio-
Gel P-2 and P-6 columns were equilibrated and eluted
with 0.1 M pyridine acetate, pH5.0. DEAE-Sepha¬
rose CL-6B columns were packed according to the
manufacturer's instructions and regenerated to the
chloride form. After application of the sample, the
columns were eluted with linear gradients of LiCl
in Tris-HCl buffer, pH8.0, containing 0.1% Triton
X-100 and 0.1 mM toluenesulfonyl fluoride. Affinity
chromatography on a WGA-Sepharose column, con¬
taining about 5 mg lectin per ml Sepharose, was done
as described [7]. The recovery of the radioactivity
from the columns was better than 80%.
Digestions with enzymes. Pronase digestion was
performed for 96 h at 37°C in 50 mM Tris-HCl buf¬
fer, pH 8.0 containing 10 mM Ca2+ in the presence of
toluene. Pronase dissolved in buffer was added at
0, 24, 48 and 72 h. The enzyme preparation used was
free of contaminating exoglycosidases and endo-A-
acetylhexosaminidases when assayed with p-nitro-
phenyl glycosides and [3H]acetylovalbumin glyco-
peptides, respectively [6], Treatment with endo-a-rV-
acetylgalactosaminidase from D. pneumoniae was
done in 50 mM Tris-maleate buffer, pH 7.6 at 37°C
for 24 h in a total volume of 50 pi. V. cholerae
Neuraminidase digestion was done in 0.1 M sodium
acetate buffer, pH 5.6, containing 1 mM CaCl2 using
0.5 unit of enzyme, at 37°C for 24 h. All digestions
were terminated by heating at 100°C for 2—5 min.
Alkaline borohydride treatment of the glycopep-
tides was done with 1.0 M NaBH4 in 0.1 M NaOH
for 72—96 h at 37°C under nitrogen in sealed tubes in
the dark. The reaction mixture was cooled in an ice
bath, the excess borohydride destroyed and the
mixture neutralized by careful addition of 1 M acetic
acid.
All dialysis and concentrations were carried out at
4°C in Amicon Ultrafiltration units using PM-10
membranes.
Liquid scintillation counting was performed on an
Intertechnique Model SL-36 or Model SL-4000 spec¬
trometer equipped with dpm calculating modules.
Usually 0.3- or 1.0-ml aqueous samples were mixed
with 3 or 10 ml of counting liquid in mini- or regular
plastic vials, respectively. Using the external standard
method, quenching was not detectable with any of
the buffers. Radioactivity on paper chromatogram
strips was estimated by extracting cut pieces with
1 ml water in counting vials prior to addition of
counting liquid.
Cell cultures. The conditions of cell culture and of
labeling of the complex saccharides produced by the
cells have been described [ 1,5].
Preparation of plasma membranes. The cultured
cells were treated with 0.02% EGTA in NaCl/Pj and
washed twice with 0.15 M NaCl. The cells were sus¬
pended in 2 mM ZnCl2, at 2 • 108 cells per 10 ml,
and after 15 min at 20°C the suspension was placed
in an ice bath [9]. After 5 min, the cells were homo¬
genized in a tight fitting (Type B) Dounce homogen-
izer until greater than 90% of the cells were broken.
The homogenate was centrifuged at 220 Xg for 15
min and the pellet was washed once with 10 ml 2 mM
ZnCl2.
The membranes were isolated from this pellet by
partition in an aqueous two phase polymer system as
described by Brunette and Till [10], Essentially, the
pellet was suspended in 10 ml of the top phase,
mixed with an equal volume of the bottom phase and
centrifuged at 9 000 Xg for 10 min. The supernatant
containing the membranes at the interface was trans¬
ferred to another tube, mixed and re-centrifuged.
This process was repeated two or three times. The
pellets were combined and used for the isolation of
nuclei. The results of the investigation of the nuclear
glycoconjugates will be reported elsewhere (Bhava-
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nandan, V.P., unpublished data). The material at the
interface after the final centrifugation in the two
phase system was recovered and subjected to dis¬
continuous sucrose-density centrifugation [11]. The
membrane fraction banding between 37% and 41%
sucrose was used in our studies.
Solubilization of plasma membrane glycoconju-
gates. The membranes were delipidated by two
extractions with chloroform/methanol (2:1, v/v)
and then suspended in 5 ml of 0.6 M lithium diiodo-
salicylate and 0.5% Triton X-100 in 0.1 M Tris-HCl
buffer, pH7.5 [12], The suspension was stirred at
4°C for 2h and then centrifuged at llOOOX# for
20 min. This process of extraction and centrifugation
was repeated two more times, with the final extrac¬
tion for 4 h. The combined supernatants, containing
90% and 95% of the 3H- and 35S-labeled components
respectively, were dialysed against 50 mM Tris-HCl
buffer, containing 0.1% Triton and 0.1 mM toluene-
sulfonyl fluoride and concentrated.
Marker enzyme assays. 5-Nucleotidase was assayed
by the method of Dewald and Touster [13] and
succinate dehydrogenase as described by Pennington
[14], (Na+, K^-activated ATPase and NADPH-dia-
phorase were determined by the procedures of Wal-
lach and Kamat [15]. Protein was determined accord¬
ing to Lowry et al. [16] with crystalline bovine serum
albumin as standard. For electron microscopic exami¬
nation the membrane fractions were fixed in 2% glu-
taraldehyde and post fixed with osmium tetroxide.
Sections of the embedded material were examined in
an RCA model EMU-4 electron microscope. We are
indebted to Mr. Barry Hillman for his assistance in
this work.
Results
Plasma membranes were obtained in good yields
by homogenization of cells in the presence of Zn ions
followed by centrifugation in a two phase aqueous
polymer system and sucrose density centrifugation.
The purity of the membrane preparation was estab¬
lished by assay of marker enzymes and by electron
microscopic examination. The membranes obtained
from cells metabolically labeled with [3H] glucos¬
amine and Na35S04 were treated with buffer con-
FRACTION NUMBER FRACTION NUMBER
Fig. 1. Fractionation on Sepharose CL-6B of glycoconjugates from plasma membranes. Fractionation of the glycoconjugates
extracted by 0.6 M lithium diiodosalicylate/0.5% Triton X-100 from plasma membranes of HM7 human melanoma cells meta¬
bolically labelled with [3H]glucosamine and Na3SS04. The extracts were dialysed against 50 mM Tris-HCl buffer, pH 8.0, con¬
taining 0.1% Triton X-100 and 0.1 mM toluenesulfonyl fluoride, concentrated and chromatographed in the same buffer on a
column of Sepharose CL-6B (1.5 X 100 cm). Fractions (1.2 ml) were collected and aliquots analyzed for radioactivity. Fractions
were combined as indicated and concentrated to yield the numbered peaks. Peak elution positions of blue dextran (Kg) and yel¬
low dextran (Y.D.) are indicated by arrows.
Fig. 2. Fractionation of glycoprotein fraction IIB on DEAE-Sepharose. The glycoprotein Fraction 11B from the second gel filtra¬
tion on Sepharose CL-6B was chromatographed on a DEAE-Sepharose column (1.5 X 18 cm). The column was eiuted with a
linear gradient of 0.1 to 1.5 M LiCl in 50 MM Tris-HCl, pH 8.0, containing 0.1% Triton X-100 and 0.1 mM toluenesulfonyl
fluoride. Fractions of 1 ml were collected and aliquots analyzed for radioactivity. The three fractions indicated by horizontal
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Scheme 1: Isolation of Glycoproteins from Plasma Membranes of HM7 Human Melanoma Cells.
taining various detergents, singly or in combinations
[17]. The combination of 0.6 M lithium diiodosalicy¬
late and 0.5% Triton was found to be the best since it
solubilized about 90 and 95% of the 3H- and 35S-
labeled components, respectively.
Fractionation of the solubilized glycoconjugates
The fractionation of the solubilized plasma mem¬
brane glycoconjugates on a column of Sepharose CL-
6B is illustrated in Fig. 1. The five peaks obtained
were designated I, II, III, etc. The material from each
peak was digested with pronase and the resultant
glycopeptides fractionated by gel filtration on a
Sephadex G-50 column into peak A (excluded) and
peaks B and C (included). Hexosamine analysis, affin¬
ity chromatography on WGA-Sepharose and treat¬
ment with alkaline borohydride of the three glyco-
peptide peaks revealed that peak A was enriched in
the Class I (mucin-type) glycopeptides reported pre¬
viously [1]. The Sepharose CL-6B fractions I and II
were both rich in the peak A glycopeptides but frac¬
tion II, containing 22% of the total 3H-radioactivity,
was chosen for further purification since it was low in
35S04 and thus in sulfated glycosaminoglycans. Re-
chromatography of II on Sepharose CL-6B gave a
rather broad peak and the material in fractions 60—
77 was recovered to yield IIB. Chromatography of
IIB on a DEAE-Sepharose column using a 0.1 -*■ 1.5
M LiCl gradient (Fig. 2) resulted in three peaks (IIB 1,
IIB2 and IIB3). Fractions IIB2 and IIB3 were sepa-
a. 33
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rately rechromatographed on the DEAE-Sepharose
column but using a gradient of 0.1 -*0.75 M LiCl
for elution, to yield three fractions IIB2a, IIB2b and
IIB3b. Each of these fractions was chromatographed
once more on DEAE-Sepharose columns using 0 ->
0.5 M LiCl gradients and the material eluting in the
sharp symmetrical areas of the peaks recovered. Addi¬
tional purification of the peak materials was achieved
by affinity chromatography on a WGA-Sepharose
column. The major portion (84%) of IIB2a' which
passed through the column was recovered and desig¬
nated IIB2a' U. In the case of IIB2b' and IIB3b',
88 and 99%, respectively, bound to the WGA-Sepha¬
rose and could be eluted with 0.1 M n-acetylglucos-
amine. The materials recovered by dialysis and concen¬
tration were designated IIB2b'W and IIB3b'W. The
three purified glycoproteins contained about 7% of
the total 3H-radioactivity in the glycoconjugates
(lithium diiodosalicylate extract); see Scheme I.
Characterization of the glycoprotein fractions
Polyacrylamide gel electrophoresis [18] of the
three purified glycoproteins in 6% gel in the presence
of sodium dodecyl sulfate gave single bands. Gel
filtration of the glycoproteins on a Sepharose CL-6B
column using buffer containing 0.1% Triton X-100
gave single homogenous peaks in each case. The
apparent molecular weight of IIB3b'W was estimated
to be about 100 0O0 based on gel filtration on a
column calibrated with glycoprotein standards (Fig.
3).
TABLE 1
DISTRIBUTION OF TRITIUM ACTIVITY IN SIALIC ACID
AND HEXOSAMINES OF PURIFIED GLYCOPROTEINS
The proportions of sialic acid in three purified glycoproteins
were determined by hydrolysis (0.1 N H2SO4, 80°C, 1 h),
neutralization and gel filtration on a BioGel P-2 column. The
tritium activity co-eluting with [14C]AcNeu internal stan¬
dard was estimated. Hexosamine was determined on acid
hydrolysates (4N HC1, 100°C, 8 h) on an amino acid analyser
by a streamsplitting technique (22).
Glycoprotein Sialic Acid G1CNH2 GalNH2
(%) (%) (%)
II B2a'U 20.0 78.8 1.2
II B2b'W 26.3 49.9 23.8
11 B3b'W 37.1 1.9 61.0
The distribution of tritium activity in sialic acid
and hexosamines in the three glycoproteins is given in
Table I.
Elucidation of the nature of oligosaccharides in
IIB3b'W
The glycoprotein was subjected to alkaline boro-
hydride treatment and chromatographed on a cali¬
brated BioGel P-6 column. The 3H-labeled carbohy¬
drate was almost completely (94%) eliminated and
about 55 and 29% eluted in the positions of the tetra-
saccharide [AcNeu -»• Gal -> (AcNeu) -> GalNAc-
(OH)] and the trisaccharide [AcNeu -* Gal -* GalNac-
(OH)], respectively (Fig. 4). When the material from
these two peaks were isolated, treated with V. chol-












Fig. 3. Gel filtration of IIB3b'W on Sepharose CL-6B before
and after pronase digestion. The glycoprotein IIB3b'W before
(• •) or after (o o) pronase digestion was mixed
with [14C]glucose and chromatographed on a Sepharose CL-
6B column (1.5X35 cm). The column was elutcd with 50
mM Tris-HCl, pH 8.0, containing 0.1% Triton X-100 and 0.1
mM tolucnesulfonyl fluoride. 1 -ml fractions were collected
and analyzed for radioactivity. Human melanoma Class I
glycopeptide GPIb (a a) was also similarly chromat¬
ographed. The results are presented by superimposing the
elution patterns using [14C]glucose as an internal reference.
The peak elution positions of blue dextran (K0), AcNeu,




























same column the radioactivity eluted in a single peak
coincident with Gal GalNAc(OH) and AcNeu (Fig.
4). The presence of Gal -* [3H]GalNAc(OH) and
AcNeu in this peak, as well as the identity of the
tetra- and trisaccharides were confirmed by paper
chromatography in two solvent systems; n-butyl-
acetate/glacial acetic acid/water (3:2:1, v/v) and
pyridine/ethyl acetate/water/glacial acetic acid (5 :
5:3: 1, v/v) [1],
The nature of the carbohydrate moieties of this
glycoprotein (IIB3b'W) was further explored by
treating the asialoglycoprotein (prepared by mild acid
hydrolysis) with endo-a-vV-acetylgalactosaminidase.
The released product, consisting of 87% of the radio¬
activity in the asialocompound, co-eluted on a Bio-
Gel P-2 column with Gal(l -* 3)GalNAc prepared
by treatment of asialofetuin glycopeptide with the
same enzyme [19]. The radioactive product was
isolated, desalted by passage through mixed bed ion
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Fig. 4. Gel filtration of IIB3b'W after alkaline borohydride
treatment. The glycoprotein IIB3b'W was treated with
alkaline borohydride (•——•) and chromatographed on a
BioGel P-6 column (0.9 X 90 cm). The column was eiuted
with 0.1 M pyridine/0.1 M acetic acid, pH 5.0, 1-ml fractions
collected and aliquots analyzed for radioactivity. The mate¬
rials eiuting in fractions 47-53 and 57-67 were recovered by
lyophilization and portions examined by paper chromato¬
graphy. Separate portions were treated with Vibrio cholerae
neuraminidase and re-chromatographed on the same column.
In both cases, the radioactivity eiuting in single peaks
(o -o) was recovered by lyophilization. The peak elu-
tion positions of blue dextran (V0) and reference saccharides
are indicated by arrows.
using n-butylacetate/glacial acetic acid/water (3:2:
1, v/v) as solvent [20], The results confirmed the
identity of the product as Gal(l -* 3)[3H]GalNAc.
Isolation and characterization of glycopeptides from
IIB3b'W
The glycoprotein was treated with pronase, centri-
fuged at 1 000 X g for 10 min and the glycopeptides
in the supernatant examined by gel filtration on
Sephadex G-50 and Sepharose CL-6B columns. On
the Sephadex G-50 column, about 90% of the labeled
material eluted at the void volume, indicating the
presence of mostly peak A glycopeptide mentioned
previously. On a Sepharose CL-6B column the mate¬
rial was included and eluted in the same area as the
peak A glycopeptides derived from the crude glyco¬
protein (Fig. 3). The glycopeptide purified by
chromatography on Sepharose CL-6B had no detect¬
able [3H]GlcNH2; the tritium label was entirely in
AcNeu and GalNH2. Treatment of the glycopeptide
with alkaline borohydride gave a mixture of AcNeu -»
Gal (AcNeu) GalNAc(OH) and AcNeu -> Gal ->
GalNAc(OH). The glycopeptide was estimated to
have an apparent molecular weight in the range of
12 000—15 000 by gel filtration and showed sialic
acid-dependent interaction with WGA-Sepharose [7],
Redigestion of the glycopeptide with pronase did not
alter its chromatographic elution profiles or its inter¬
action with WGA.
[3H]Mannose labeling of the HM7 glycoproteins
Plasma membranes were isolated from cells grown
in the presence of [3H]mannose and [14C]glucos-
amine (5 pCi and 1 ;uCi per ml culture medium). The
labeled glycoconjugates were extracted and fraction¬
ated by repeated chromatography on Sepharose CL-
6B and DEAE-Sepharose columns as described above.
The most acidic glycoprotein IIB3b'W, had negligible
incorporation of label from [3H]mannose confirming
the absence of A'-glycosidically-linked oligosacchar¬
ides. The two other glycoproteins purified, IIB2a'U
and IlB2b'W, contained significant quantities of triti¬
um radioactivity indicating the presence of yV-glyco-
sidically-linked oligosaccharides.
Examination ofFM13 human fetal uveal melanocytes
for mucin-type glycoproteins
The glycoconjugates were isolated by extraction of
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FRACTION NUMBER
Fig. 5. Chromatography of glycoconjugates from human
melanoma cells and human fetal melanocytes. Glycoconju¬
gates isolated from HM7 human melanoma cells (• •)
and from FM13 human fetal melanocytes (o -o), meta-
bolically labelled with [3H]glucosamine, were chromatog-
raphed on Sepharose CL-6B column (1.5X100 cm) as
described in Fig. 1. The results are presented by superimpos¬
ing the elution profiles. The materials eluting in the area
indicated by 'II' were recovered and further examined.
whole cells grown in the presence of [3H]glucosamine
with 0.6 M lithium diiodosalicylate/0.5% Triton
X-100. The extracted glycoconjugates were partially
purified by partition in an aqueous three-phase
polymer system consisting of polyethylene glycol,
dextran and Ficoll [21]. This step removes nucleic
acids and separates (glyco)proteins according to
hydrophobicity. The 3H-labeled glycoconjugates in
the upper phase were recovered after dialysis. The
elution profile of these glycoconjugates and of the
glycoconjugates similarly prepared from labeled HM7
melanoma cells on a Sepharose CL-6B column is illus¬
trated in Fig. 5. It is clear that the melanoma cells
produce an increased proportion of glycoproteins
eluting in the higher molecular size region (fractions
61—95) of the column, whereas the bulk of the glyco¬
protein from the melanocytes eluted in the lower
molecular size region of the same column. These
results are consistent with our earlier observation that
the melanoma cultures produced a higher proportion
of the larger glycopeptides than the control cells [ 1 ].
The labeled material eluting in the fractions
marked 'IT was recovered and chromatographed on a
WGA-Sepharose 4B column. In the case of the HM7
Fraction II, 70% of the labeled material bound to the
column and was recovered by elution with 0.1 M
335
GlcNAc. In contrast, only 49% of the labeled material
of the FM13 Fraction II was bound to and eluted
from the WGA-Sepharose. The WGA-interacting
glycoproteins were recovered by dialysis and
chromatographed on a DEAE-Sepharose column (Fig.
6). The elution of the purified 14C-labeled glycopro¬
tein (IIB3b'W) isolated from plasma membranes of
HM7 cells on the same column is also illustrated in
Fig. 6.
A portion of the FM13 Fraction II (glycoproteins)
was digested with pronase and the glycopeptides
examined on a Sephadex G-50 column. Only 8.2%
of the labeled material eluted at the void volume
(peak A glycopeptide), the balance was included. This
is in contrast to the elution of about 28.6% in peak A
when HM7 Fraction II material was subjected to the
same treatment.
Discussion
Our major aim in these studies was the isolation
and characterization of glycoprotein(s) rich in
carbohydrate groups linked via 0-glycosidic linkage
to proteins. Accordingly, the five fractions obtained
by chromatography on Sepharose CL-6B (Fig. 1)
FRACTION NUMBER
Fig. 6. Chromatography of melanoma and melanocyte
glycoproteins (fraction II) on DEAE-Sepharose. The fraction
II glycoproteins from melanoma cells and melanocytes (Fig.
5) were purified by affinity chromatography on WGA-Sepha¬
rose. The WGA-interacting glycoproteins from melanoma
(• •) and melanocyte (o -o) were each mixed
with 14C-labeled glycoprotein IIB3b'W (a a) and
chromatographed on DEAE-Sepharose column (1.5 X 18 cm).
The column was eluted with a linear gradient of 0.1 to 1.0
M LiCl in 50 mM Tris-HCl, pH 8.0, containing 0.1% Triton
X-100 and 0.1 mM toluenesulfonyl fluoride. Fractions of 1
ml were collected and analyzed for radioactivity. The results
are presented by superimposing the elution patterns.
40'
were examined for the presence of WGA-binding
glycopeptides (GPIa and GPIb) previously described
[1 ] -
Purification of fraction II using buffers containing
0.1% Triton X-100 and 0.1 mM toluenesulfonyl fluo¬
ride yielded three apparently homogenous glycopro¬
teins. The recovery of the glycoproteins was poor in
the absence of detergents, apparently due to aggrega¬
tion and precipitation [22]. The molecular weight of
the most acidic glycoprotein (IIB3b'W) was estimated
as 100 000 by gel filtration [22]. The gel electro¬
phoresis data indicate a smaller subunit molecular
weight, but the anomalous behavior of glycoproteins
in the presence of dodecyl sulfate [23] does not per¬
mit an accurate estimation by this technique.
The sialic acid and hexosamine analysis indicated
that the glycoprotein which had the highest affinity
for DEAE-Sepharose (IIB3b'W) had the highest sialic
acid and GalNAc contents, whereas the glycoprotein
(IIb2a'U) with the least affinity had the lowest sialic
acid and highest GlcNAc content. The low sialic acid
content of this glycoprotein is also consistent with its
noninteraction with WGA-Sepharose [7]. The iso¬
lated glycoproteins may be considered as representa¬
tive of three general classes of glycoproteins, con¬
taining only iV-glycosidically linked or only O-glyco-
sidically linked or both types of oligosaccharides
[24]. These macromolecules did not contain detect¬
able 35S radioactivity and therefore, are not hybrid
glycoprotein-glycosaminoglycan molecules of the type
described by Baker et al. [25].
The high galactosamine content of IIB3b'W and
the lack of mannose suggested that this glycoprotein
had a mucin-type carbohydrate structure. The
O-glycosidically-linked oligosaccharide was shown to
be mainly tetra- and trisaccharides of the type
(AcNeu)! or 2 -* [Gal -» GalNac(OH)].
To the best of our knowledge, an intrinsic mem¬
brane glycoprotein having carbohydrate entirely
(9-glycosidically linked to the protein has not been
previously described. Several membrane glycoproteins
rich in mucin-type oligosaccharides but also having
serum-type oligosaccharides are known. These include
glycophorin (Mr 31 000) from human erythrocyte
ghost [26,27], a glycoprotein (Afr about 100 000)
from plasma membranes of ascites hepatoma AH 66
[12,28], bovine [29] and porcine [30] erythrocyte
membrane and thyroid plasma membrane [31] glyco¬
proteins. An extrinsic mucin-type glycoproteii
(epiglycanin) has been isolated from TA3 Ha mous'
mammary carcinoma cells and extensively investi
gated by Codington and co-workers [32,33], In pre
liminary experiments, the human melanoma glycc
protein IIB3b'W failed to complex with rabbit anti
human glycophorin antibodies (Bhavanandan, V.P.
unpublished data).
The FM13 melanocytes produced significantly
lesser proportions of the WGA-binding glycoprotein
identical or similar to IIB3b'W (Fig. 6). This is ii
agreement with our previous results that pronasi
digests of cultured human fetal uveal melanocytes o
spent culture medium yielded markedly reduce<
quantities of the WGA-binding mucin-type glycopep
tides GPIa and GPIb [1],
In future investigations we hope to isolate m]
quantities of the described glycoproteins by extrac
tion of membranes prepared from HM7 tumors growi
in athymic mice for additional biochemical and im
munological characterizations.
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It is generally recognized that events which occur at the surface of eu-
karyotic cells can regulate a variety of phenotypic characteristics. These
include essential functions such as transport of key metabolites and re-
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sponse to external stimuli which may allow a cell to move from a quies¬
cent or resting state through the cell cycle to mitosis. These events are
modulated by a wide variety of receptor molecules which are either inte¬
grally or transiently associated with the plasma membrane and provide
specific recognition sites for appropriate ligand interactions. It is not sur¬
prising, therefore, that cells which have undergone malignant transforma¬
tion or otherwise lost aspects of growth control have associated with their
external membrane, either continually or intermittently, molecules
unique to their particular growth characteristics; (for reviews see Wal-
lach, 1968; Burger, 1973; Emmelot, 1973; Hughes, 1973, 1976; Warren et
ai, 1974; Glick and Santer, 1978; Yamadaand Pouyssegur, 1978; Hynes,
1979). In some situations these serve as do other cell surface molecules, in
a receptor capacity to respond to external signals in such a fashion as to
promote cell division or regulate other metabolic events. The binding of
molecules (such as insulin, steroid hormones, epinephrine, etc.) can in¬
duce either conformational changes within the membrane leading to al¬
tered activities or to internalization of the receptor ligand complex with
eventual targeting for the nucleus of the cell thus regulating expression of
particular genes. The immense diversity of signals to which a cell must
respond requires the presence on its surface, therefore, of a broad variety
of receptor type molecules. Most, if not all, of these are glycoproteins for
reasons which are physiologically and biologically appealing. There are a
diversity of carbohydrate molecules available. The hydrophilic nature of
the sugars provides the necessary directionality for these molecules en¬
suring that the appropriately substituted regions of the polypeptide are
directed toward the outer environment. In addition, there is sufficient op¬
portunity for structural variation to provide the level of selectivity and
specificity necessary to discriminate among a broad variety of external
signals. Normally there are only a few sugars found in mammalian glyco¬
proteins but the opportunities for branching and for differing distributions
on any given polypeptide backbone provide an enormous number of pos¬
sible structures. For a trisaccharide containing three different sugars, for
example, there are well over a thousand possible structures whereas for a
comparable tripeptide only six structures exist.
II. Glycoprotein Structures
In the sense that a genetic control is exerted over the structures of sur¬
face macromolecules, the glycosyl or saccharide portion of these is con¬
structed by addition of mono- or oligosaccharides to a growing polypep¬
tide chain at specific attachment sites. As a rule, only two types of
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carbohydrate-peptide linkage are found in glycoproteins associated with
the plasma membrane (Marshall and Neuberger, 1970; Spiro, 1970; Mar¬
shall, 1974).
The first is linkage between the amide nitrogen of asparagine and a car¬
bohydrate chain wherein the initial sugar attached to the polypeptide is
yV-acetylglucosamine. Such oligosaccharide attachments are formed by a
complex biosynthetic pathway involving the addition of a 14 unit oligosac¬
charide (dolichol-P-P-/V-acetylglucosamine2 mannose9 glucose3) en bloc
to specific asparagine residues within the polypeptide chain (Struck and
Lennarz, 1980). Partial sequence studies have indicated that asparagine
residues are candidates for glycosylation when they are separated from
serine or threonine residues by one amino acid whose structure appears
not to be regulated (Asn-X-Ser). Other asparagine residues are not glyco¬
sylated. and even those meeting sequence requirements may not be glyco¬
sylated; regulation in this area is still a matter of continuing study. Pro¬
cessing of the 14 member oligosaccharide unit takes place first by removal
of the glucosyl moieties followed by trimming of the mannose structure
and subsequent elongation to provide one of two types of final structures:
either an oligomannosyl (so-called simple) type or the lactosaminyl (com¬
plex) types which generally terminate in a sequence of (V-acetylglucosa-
mine-galactose-sialic acid (see Fig. 1). The branching possibilities allow
for the latter group to have as many as four such end terminal units at¬


















Fig. 1. Types of cell surface glycopeptides presently known.
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contain up to about 20 monosaccharide units, with single or multiple an-
tennary structures giving a wide diversity of possible products. As a gen¬
eral rule, sialic acid (and fucose) residues are terminal nonreducing ends
and provide a stop signal for further glycosylation. The diversity of glyco-
syltransferases required for the elongation of processed oligosaccharide
chains is considerable and few of them have been studied in detail. Regu¬
lation is not thoroughly understood and it is believed, at least by some
investigators, that the control is imperfectly established and that consid¬
erable microheterogeneity exists in the end product carbohydrate chains,
especially with regard to completeness of glycosylation at the outer pe¬
riphery.
A second type of carbohydrate peptide linkage that is found in these
glycoproteins is that between the hydroxyl group of either serine or
threonine residues and (V-acetylgalactosamine which serves as the initiat¬
ing residue for oligosaccharide chain assembly. In this case, the glycosyl
transfer appears to take place by sequential addition of monosaccharides
from nucleotidyl sugars with galactose usually the next sugar and sialic
acid commonly present. The structures found for this class of oligosac¬
charides may be rather simple as are present in erythrocyte glycophorin
wherein two sialic acids, one galactose and one ^-acetylgalactosamine,
comprise the entire oligosaccharide unit (Lisowska, 1969; Thomas and
Winzler, 1969), to those found in epithelial secretions of intestinal muco¬
sal cells or lung cells wherein large complex oligosaccharide chains con¬
taining up to 15 sugars are present. It is not uncommon for the O-glycosid-
ically linked carbohydrate chains to bear blood group determinants, espe¬
cially if the individual is a secretor. However, these are less frequently
found on cell surfaces than they are in secretory products. There is little
or nothing known about the regulation of the end product structure for the
O-glycosidically linked glycoproteins. Thus, structural diversity or heter¬
ogeneity is the norm and a single family of molecules may be derived from
a common polypeptide chain with a considerable diversity of carbohy¬
drate substitution. The recognition of appropriate serine and threonine
residues by the glycosyltransferases is not understood nor is the control
of oligosaccharide chain length. It is generally believed that this is a ki¬
netic regulation involving transit time in the Golgi apparatus for the in¬
completely glycosylated protein and availability of the nucleotidyl sub¬
strates to the appropriate membrane-bound glycosyltransferases. Thus, at
a given serine or threonine residue in such a glycoprotein, glycosyl sub¬
stitution may or may not have taken place and the chain may be com¬
pleted to different sizes.
Accordingly, isolation techniques must compromise in terms of purity
criteria, generally accepting overall compositional analyses as representa-
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tive rather than applying the standards usually employed for simple pro¬
teins. Single molecule purity probably does not exist in this class of com¬
pounds and structural analyses represent probability statements rather
than specific details. The methodologic problems involved are discussed
later in this chapter but are formidable in terms of defining both the oligo¬
saccharide and polypeptide structures in detail (see Section VII).
III. Qualitative and Quantitative Changes
Association with the transformed state can be expressed in several
ways. Descriptive changes involving, for example, the interaction of lec¬
tins with cell surfaces provide qualitative or crude information about
some alteration in surface properties (Nicolson, 1974). Whether this rep¬
resents the expression of new molecules, modification of old ones, total or
local bilayer fluidity change, or some cryptic phenomenon whereby pre¬
viously available macromolecules are now physically reorganized within
the membrane structure such that the external probes no longer can find
them has generally not been defined. The same type of problem applies to
surface alterations detected by electron microscopy using, for example,
ferritin-conjugated lectins or antibodies. There is an element of qualitative
information that is definitely available from such studies but it is impossi¬
ble to translate such observations to the presence or absence of specific
molecular species. Similarly, changes in biologic properties have been
correlated with the presence or absence of specific types of macromole¬
cules on the cell surface. A well-studied example is the mouse mammary
carcinoma TA3 system wherein transplantability across species bounda¬
ries is associated with the presence on the cell surface of an unusual gly¬
coprotein (epiglycanin) whose apparent function is to mask otherwise re¬
sponsive cell surface antigens (Codington, 1975; Codington et al., 1978,
1979a,b; Cooper et al., 1979). Properties such as adhesion to substrate,
metastatic potential, and immunogenicity of whole cells as well as mask¬
ing have been correlated with the presence on the cell surface of particu¬
lar types of macromolecules (Hudson and Kunz, 1925; Hynes, 1976;
Codington, 1978). Specific molecules have not been identified and struc¬
tural information not forthcoming to define their nature.
A type of quantitative change that has been widely associated with ma¬
lignancy is the loss of a large glycoprotein from the cell surface. This
macromolecule, originally described about 10 years ago (Hynes, 1973,
1976), has been the subject of intensive study. A variety of names have
been used including fibronectin, LETS (large, external, trypsin or trans¬
formation sensitive), cell surface protein, and galactoprotein A among
others (Yamaaa and Weston, 1974; Vaheri and Ruoslahti, 1975; Hako-
58 V. P. BHAVANANDAN AND E. A. DAVIDSON
mori, 1975; Engvall and Ruoslahti, 1977; Hynes et al., 1979). The near
identity of this material with a previously described circulating glycopro¬
tein, cold insoluble globulin, has also been well documented and the rela¬
tionship between the surface glycoprotein and the circulating form has
been examined in some detail (Mosesson and Umfleet, 1970; Ruoslahti
and Vaheri, 1974; Mosesson et al., 1975; Mosher, 1975). The generality of
the loss of fibronectin from transformed cell surfaces is broad but not total
and may well be related to the generally increased protease activity asso¬
ciated with malignant tumors (Unkeless et al., 1973; Rifkin et al., 1974;
Lang et al., 1975). This field has been extensively reviewed in recent
years and insofar as fibronectin represents a cell surface glycoprotein
marker for neoplasia, it can only be said to represent a negative marker
since it is a normal component of all fibroblastic cells and a number of
other cell types that have been studied.
The specific associations of glycoproteins with discrete types of malig¬
nant cells have been under intensive study for well over a decade. The
literature is frequently and extensively reviewed and the following discus¬
sion does not claim to be exhaustive but rather representative. The topical
subdivision is arbitrary and other means of classification could well have
been employed. We will discuss initially studies with virus-transformed
cells, second, animal cells and animal tumor models, data available from
studies with human systems, and finally the methodology.
IV. Virus-Transformed Cells
The association of viruses with animal tumors has been known since
the description of Rous sarcoma virus nearly 70 years ago (Rous, 1911).
That virus-directed transformation would be an excellent model to study
virtually every event associated with cellular metabolism is also well rec¬
ognized and a wide variety of systems has been studied. Reviews have
been published recently by Montagnier and Torpier (1976) and on RNA
tumor viruses by Kurth (Kurth and Bauer, 1975; Kurth, 1976; Kurth et
al., 1979).
Early studies with Rous sarcoma virus transformed cells indicated that
glycopeptides derived from such cells had increased molecular size pri¬
marily due to either increased fucosylation or increased sialylation and
that there was an increase in sialyltransferase levels associated with the
transformed cell (Warren et al., 1972a,b). At least one glycosyltransferase
was demonstrated to be externally directed as contrasted with the same
activity in nontransformed cells (Bosmann 1972; Bosmann et al., 1974)
suggesting that accessibility of the external glycoproteins to this enzyme
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could result in altered glycosylation patterns. The problem of substrate
availability in terms of nucleotidyl sugars has rarely been addressed in
any of these studies. The loss of LETS glycoprotein from Rous sarcoma
virus-transformed cells has also been studied in some detail. It is gen¬
erally agreed that the levels of this glycoprotein are sharply reduced when
chick embryo fibroblasts are transformed with Rous sarcoma virus
(Hynes and Wyke, 1975; Parry and Hawkes, 1978). In an attempt to de¬
fine tumor-specified cell surface changes more closely, transformed fibro¬
blasts have been examined by both metabolic labeling and labeling of cell
surface components by lactoperoxidase catalyzed iodination (see Section
VII).
Early experiments carried out by Warren with control and Rous sar¬
coma virus transformed BHK 21 cells indicated that although the glyco-
peptides present in the latter cells appeared to be of somewhat larger size,
treatment with sialidase converted these to a size pattern characteristic of
the controls (Warren et al.} 1972a). Accordingly, it was concluded that the
major difference found in the transformed cell population could be
ascribed to the increased sialylation of normally present glycoproteins;
these results were later shown to be due to an increase in multiantennary
saccharide substitution. A number of related experiments have subse¬
quently been carried out along these lines including examinations of fuco-
sylated glycopeptides with comparisons made between the pattern of gly-
copeptides obtained from metabolically labeled material (tritiated sugar
material) and molecules accessible on the cell surface by one of several
labeling procedures such as lactoperoxidase catalyzed iodination, peri-
odate oxidation-sodium borotritide reduction, or galactose oxidase-so-
dium borotritide reduction with or without prior neuraminidase treatment
(Critchley et al., 1976, Gahmberg et al., 1976). The primary observations
can be summarized as follows: in general, the glycopeptides of the trans¬
formed cells appear to be larger. The size differences are attributable in
part to increased sialylation but the fucose-containing glycopeptides ap¬
pear to be somewhat larger as well even after neuraminidase treatment
(Glick, 1979). Both N- and 0-linked glycopeptides appear to be present
with the latter group clearly less prevalent in the untransformed cells
(Santer and Glick, 1979; Hunt et al., 1981). Examination of radiolabeled
material either from metabolic labeling experiments or by cell surface la¬
beling indicates substantially identical patterns although Flowers has re¬
ported some change in molecular size and an increase in a 150,000 molec¬
ular weight glycoprotein (Flowers and Glick, 1980), and new surface
antigens have been described (Phillips and Perdue, 1978). Increased sialic
acid is generally present after transformation but explicit isolation of al¬
tered or modified glycoproteins has rarely been carried out. It is beiieved
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that the virus-transformed cells show an increased turnover of cell surface
glycoproteins, including not only fibronectin but others more tightly asso¬
ciated with the plasmalemma. Rieber has indicated that although the gen¬
eral turnover of cell surface proteins in transformed cells is increased,
there are variations within this group and that the changed rates are not all
uniform (Rieber et al., 1975).
Similar studies have been carried out with a wide variety of virally
transformed cells including polyoma (Chiarugi and Urbano, 1972; Gahm-
berg et al., 1974; Ogata et al., 1976; Koideetal., 1979), SV40 (Wu et al.,
1969; Meezan et al., 1969; Onodera and Sheinin, 1970; Culp and Black,
1972; Sheinin and Onodera, 1972; Ceccarini, 1975; Smetset al., 1976; Lu-
borsky^f a/., 1976; Onodera et al., 1976; Duksin and Bornstein, 1977; Aoi
and Yokota, 1980), and murine sarcoma viruses (Fishman et al., 1976;
Van Nest and Grimes, 1977; Kamm and Grimes, 1978), mouse mammary
tumor viruses (Yanget al., 1977; Teramoto et al., 1977), leukemia viruses
(Smart and Hogg, 1976; Ledbetter and Nowinski, 1977; Troy et al., 1977;
Murray and Rabat, 1979), and Epstein-Barr virus (Strnad et al., 1981). In
virtually every case, some alteration in surface labeling patterns has been
observed including the appearance of viral envelope glycoproteins. Many
of the recent studies depend on surface accessibility of glycoproteins
using either the periodate-borotritide or galactose oxidase techniques. It
should be noted that these procedures, especially the latter, will label only
available surface glycoproteins and that those components which are
masked or rapidly shed may appear to have been altered when in fact their
physical configuration in association with the plasma membrane may be
that which is changed.
Several studies have indicated the obverse of these general conclusions
noted above. It was reported that polyoma virus-transformed BHK cells
have associated with the plasma membrane, glycoproteins which tend to
be less glycosylated than those found in the control population whereas
those released into the medium appear to be more heavily glycosylated
(Chiarugi and Urbano, 1972). Conversely, using the same system and
cells metabolically labeled with mannose, the mannose-containing oligo¬
saccharides were isolated after pronase digestion, separation of glycopep-
tides, and cleavage of the oligosaccharides with endoglycosidase H. It
was concluded that the oligomannosyl fragments were substantially the
same in the normal and transformed cells (Koide et at., 1979).
In a study with polyoma-transformed cells, the differences in the trans¬
formed glycopeptides were shown to involve more than simply sialic acid
as observed by affinity chromatography on Con A-Sepharose (Koide et
al., 1979). The different patterns of affinity chromatographic behavior in-
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dicated that although the core structures of the glycopeptides were simi¬
lar, the outer branches of the transformed cells were more complex. This
result is in keeping with those generally obtained with Rous sarcoma
virus-transformed cells which indicate that the glycosylation pattern
tends to become more complete or extensive yielding glycopeptides
which are both fully sialylated and of a higher molecular size.
A number of investigators have examined SV40-transformed cells uti¬
lizing basic strategies very similar to those employed in other systems.
Two types of studies indicate differences between control (3T3) cells and
their SV40 transformed counterparts: the first involves affinity chroma¬
tography utilizing as ligand antibodies elicited by whole cells or plasma
membranes. As a rule, cells are either metabolically or surface labeled
and glycoproteins that adsorb to the affinity matrix eluted by appropriate
measures and examined by polyacrylamide gel electrophoresis. Glyco¬
proteins have been identified with molecular weights in the 50,000-60,000
range; these appear to be associated with SV40 transcription, although
detailed characterization has not been carried out (Luborsky et al., 1976).
One report has indicated that exposure of SV40-transformed cells to tuni-
camycin affects surface glycosylation patterns resulting in a marked re¬
duction of glycoprotein affinity for Con A-Sepharose. This is not surpris¬
ing since tunicamycin inhibits an early step in the assembly of the dolichol
oligosaccharide which serves as the precursor for all of the N-glycosidi-
cally linked oligosaccharides found on glycoproteins. A second approach
involves genetic analysis. The geneA of SV40 was shown to be related to
a sialyltransferase and thus to associated changes in glycosylation (Ono-
dera et al., 1976). The implication from these data is that the expression of
a new type of sialyltransferase in the transformed cells allows modifica¬
tion of preexisting glycoproteins to take place with associated increased
sialylation—a frequently observed result and one consonant with altera¬
tions in both chromatographic mobility and lectin affinity behavior.
Work with mouse mammary tumor virus-transformed cells has indi¬
cated the presence of a 52,000 molecular weight externally directed glyco¬
protein which appears to be uniquely associated with the transformed cell
(Yang et al., 1977; Teramoto et al., 1977). This glycoprotein has been
identified both by immunologic means and also by direct visualization fol¬
lowing lactoperoxidase catalyzed iodination and gel chromatography. It is
not known if this protein arises as a result of expression of a viral gene or
due to a secondary circumstance wherein a normally quiescent host gene
is expressed following viral transformation. Tumor-specific antigens have
also been described for spontaneous or chemically transformed cells (In-
vernizzi et al., 1977; Natori et al., 1977, 1978).
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V. Animal Tumors and Derived Cell Clones
A. Neuroblastoma
A number of laboratories have studied the C 1300 mouse neuroblas¬
toma in cell culture (Brown, 1971; Glick <?r al., 1976b; Glick, 1976). Differ¬
ences in glycopeptide patterns between more and less differentiated cells
have been indicated using metabolic labeling with tritiated glucosamine
followed by trypsinization of membranes or whole cells, and chromatog¬
raphy on diethylaminoethyl cellulose. A study with cloned C 1300 cells
involved prior induction of neurite expression with dimethyl sulfoxide or
hexamethylene bis-acetamide. The cells were labeled with tritiated fucose
or glucosamine and glycoproteins examined following neurite isolation
from plasma membranes by shearing and discontinuous sucrose gradient
ultracentrifugation. At least one qualitative difference was observed in a
200,000 molecular weight protein which appeared to be reduced in undif¬
ferentiated cell membranes but then appeared in the growth medium. This
was distinct from fibronectin on the basis of molecular weight, trypsin
sensitivity, and lack of growth relatedness but was a glycoprotein since it
was well labeled by carbohydrate and poorly stained with Coomassie
Blue (Littauer et al., 1980). Further characterization of this component
has not been reported.
In analogy to other studies, it has been shown that the turnover kinetics
of plasma membrane components in the neuroblastoma system differ con¬
siderably for individual components (Mathews et al., 1976). These studies
involve carbohydrate labels such as fucose followed by gel chromato¬
graphic examination of products. As a rule, high turnover components ap¬
pear to be more sensitive to protease cleavage from the plasma mem¬
brane. An increased complexity of the neuroblastoma glycopeptides as
compared to those of less differentiated cells has been suggested, and in
addition Glick (1976) has indicated a structural homology between both
mouse and human membrane glycoproteins derived from this type of
cells.
B. Melanoma
A large number of laboratories have studied the B16 mouse melanoma
system as a model for cell surface expression (Warren et al.. 1975; Bha-
vanandan et al., 1977; Evans et al., 1977; Yogeeswaran et al., 1978; Bys-
tryn, 1978; Gersten and Marchalonis, 1979). Early work indicated the
same general pattern for these cells as observed with others in that an in-
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creased content of sialic acid and fucose as well as higher molecular
weight oligosaccharides was found when compared to normal tissues. It
should be noted that finding appropriate controls for melanoma cells is
difficult since primary cultures of readily available melanocytes (e.g.,
from iris), while possessing the characteristic of melanin production are
not identical to the skin melanocytes; established lines of normal melano¬
cytes are generally not available. A study of the glycopeptides produced
by B16 mouse melanoma cells has indicated that an unusual sialoglyco-
peptide is present in these cells which has a molecular weight of approxi¬
mately 10,000-12,000 and an affinity for wheat germ agglutinin-Se-
pharose (Bhavanandan et al., 1977). The saccharide portion of this
glycopeptide is analogous or identical to that found in human glycophorin
and contains galactose, /V-acetylgalactosamine, and sialic acid. The par¬
ent glycoprotein which contains this glycopeptide was also identified both
from cultured cells and from the solid B16 tumor grown in vivo (Fareed et
al., 1978). An interesting feature of this glycopeptide is that its affinity for
the wheat germ agglutinin-Sepharose column is completely dependent on
the presence of sialic acid since digestion with neuraminidase results in
cleavage of the sialic acid with concomitant loss of affinity. This is an ex¬
ample of lectin lack of specificity in that the glycopeptide is free of N-ace-
tylglucosamine which is not only the nominal ligand for wheat germ agglu¬
tinin but also can be used as a haptenic displacer to remove the bound
glycopeptide from a WGA-Sepharose column (Bhavanandan and Katlic,
1979).
The availability of sublines of the B16 with high and low metastatic po¬
tential has prompted a number of studies designed to examine the rela¬
tionship between cell surface components and metastatic behavior. In
general, the more metastatic lines have been found to have increased con¬
centrations of sialoglycopeptides and possibly some additional glycopro¬
teins which are not present in low metastatic lines (Warren et al., 1975;
Nicolson et al., 1977; Raz et al., 1980b). Electron microscopic visualiza¬
tion of high and low metastatic lines of B16 has been carried out using
cationic ferritin derivatives. Qualitative differences were observed al¬
though it was reported in these studies that the same level of sialic acid
was present in both lines (Raz et al., 1980a). The difference between total
sialic acid content and the rather descriptive nature of the electron micro¬
scopic visualization makes it difficult to interpret these data further. As a
rule, the glycoproteins in high and low metastatic lines were similar but at
least one (78,000 molecular weight) sialoglycoprotein was reported to be
related to the ability of these cells to colonize in the lung (Jumblatt et al.,
1980). Glycoproteins from these same cells showed a reduced affinity for
wheat germ agglutinin-Sepharose. There appeared to be no differences in
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membrane fluidity, substrate adhesion properties, or ganglioside patterns.
A directly contrasting report has indicated that increased levels of sialic
acid are well correlated with metastatic potential for these cells and that
this increased level of sialic acid is related to increased lectin affinity. In a
continuation of this type of study, an examination was made of B16 cells
which are resistant to wheat germ agglutinin. Variants were selected by
growth in high concentrations of the lectin and the surface glycopeptide
patterns examined by conventional techniques. There is a reduction in
sialic acid containing glycopeptides both of the N- and 0-glycosidic type
with an apparent increase in fucose-containing glycopeptides (Finne et
al., 1980b). It was concluded that the glycopeptide patterns indicate that
more than one receptor for wheat germ agglutinin is present on the sur¬
face of these cells and that in different variants one or another such recep¬
tor might be present in reduced quantity. In addition, it was suggested
that a certain minimal number of wheat germ agglutinin molecules must
bind to the surface of such cells before a toxic threshold is crossed. Thus,
reduction in a single type of glycoprotein receptor might be sufficient to
render cells resistant to the lectin (Lin and Davidson, 1981). There was
some suggestion that the resistant cells had less metastatic and tumor-
forming potential than did the parent lines but the in vivo studies were in¬
sufficient to allow general conclusions to be drawn. It should be noted
that studies in other laboratories have indicated, at least intermittently,
that alteration of cell surface sialic acid content by pretreatment with
neuraminidase may render such cells either more immunogenic or less tu-
morigenic depending on the nature of the host response (Currie et al.,
1968; Simmons and Rios, 1971).
C. Ascites
Detailed studies have been done on the general profile of plasma mem¬
brane glycoproteins obtained from cells grown in ascites form including
Ehrlich ascites carcinoma (Nachbar et al., 1976), sarcoma 180 (Shin and
Carraway, 1973), and mouse mammary carcinoma (Codington et al.,
1979a,b; Sherblom and Carraway, 1980). As a rule, plasma membranes
have been isolated utilizing the zinc chloride procedure developed by
Warren (Warren et al., 1966; Colombini and Johnstone, 1973) and pro¬
teins solubilized from such preparations with detergents such as deoxy-
cholate, lithium diiodosalicylate, or by sequential extraction with high salt
followed by detergent. The solubilized materials are then subjected to af¬
finity chromatography on lectin Sepharose columns utilizing lectins such
as Ricinus communis, wheat germ agglutinin, concanavalin A, soybean
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lectin, and limulin. Glycoproteins have been identified from Ehrlich
ascites cells ranging in molecular weight from 35,000 to 200,000 (Nachbar
et al., 1976). However, there was no comparison of such material with
any control cell so it is impossible to tell whether any qualitative or even
quantitative changes occurred. A second study with sarcoma 180 cells uti¬
lized lactoperoxidase-catalyzed iodination of plasma membranes followed
by their isolation and solubilization. Glycoproteins were identified which
ranged in molecular weight from 33,000 to 300,000 (Shin and Carraway,
1973). Utilizing the AH 66 hepatoma, proteins were isolated from the
plasma membrane of these by lithium diiodosalicylate extraction followed
by phenol partitioning. A protein was identified with a molecular weight
of 165,000 which had approximately 50% carbohydrate, most if not all of
which was O-glycosidically linked (Funakoshi and Yamashina, 1976; Na-
kajo et al., 1979); it was indicated that the glycoprotein was glycophorin-
like. It should be noted that glycophorin-like macromolecules have now
been reported to be surface components of a number of cells and at least
in the case of the B16 mouse melanoma, the saccharide structures have
been sufficiently well identified to confirm this similarity (Bhavanandan et
al., 1977). The immunologic reactivity of cell surface glycoproteins with
antiglycophorin antibodies has been examined and our group has indi¬
cated the presence of reactive surface molecules using indirect immuno-
fiuorescent techniques (Barsoum and Bhavanandan, 1981, unpublished
results).
D. Hepatoma
A number of hepatoma lines have been examined for glycoprotein al¬
terations; most studies relied on general descriptions. In Reuber and
Novikoff hepatoma cells, neuraminidase-sensitive sialic acid is increased
in these cells as compared to control liver cells, as is the overall level of
sialic acid and glycopeptide size (Glenney and Walborg, 1979). These data
are generally consistent with reports from other cell studies. An early re¬
port indicated that treatment of AH 62 hepatoma cells with either concan-
avalin A or neuraminidase affected the electrophoretic mobility of these
cells (Yamada and Yamada, 1973). This simply indicates that charged
moieties responsible for electrical migration are either available to the lec¬
tin and thus masked by its presence or susceptible to enzymatic cleavage,
since removal of sialic acid from cell surface macromolecules would be
expected to influence mobility.
In studies with Novikoff hepatoma cells, descriptive profiles have been
developed following lactoperoxidase-catalyzed iodination and lectin affin-
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ity chromatography. More detailed studies were performed following la¬
beling of sialic acid residues by periodate treatment and borotritide reduc¬
tion followed by examination of detergent solubilized glycoproteins on
SDS-polyacrylamide gels. A variety of proteins ranging in molecu¬
lar weight from 25,000 to 240,000 was detected with representatives at
120,000 and 92,000 which contain both sialic acid and N-acetylgalactosa-
mine as indicated by affinity of those macromolecules for soybean lectin
following neuraminidase treatment (Glenney et al., 1979).
Morris hepatoma cells in contrast to normal liver have increased
plasma membrane fucose (4-fold) as well as an increase in the number of
fucose-labeled glycoproteins (Vischer and Reuter, 1978). Specific macro-
molecules, however, were not identified in these studies. In still other
hepatoma work, trypsin-sensitive membrane glycoprotein fragments were
isolated from HTC cells following either cell surface labeling with lacto-
peroxidase or metabolic labeling using leucine and fucose. A heavily sial-
ylated product of molecular weight 55,000 was identified and noted to
contain approximately 17 sialic acid residues per mole (Baumann and
Doyle, 1979). This was apparently a fragment derived from an 85,000 mo¬
lecular weight precursor containing about 40% carbohydrate. Although
both of these were purified, further characterization was not carried out.
The relation of these to specific surface markers of hepatoma remains to
be defined. In related work, AS 30D hepatoma cell glycoproteins were ex¬
amined by several labeling techniques followed by affinity chromatogra¬
phy on Ricinus communis lectin-Sepharose and two-dimensional gel
electrophoresis. Three galactoproteins were identified which possess
charge heterogeneity due to varying levels of sialic acid. One of these was
cleaved to a 63,000 molecular weight fragment by papain but the relation¬
ship, if any, of this to the above mentioned 55,000 molecular weight com¬
ponent was not defined (Glenney et al., 1980).
E. Mammary Carcinoma
A detailed study of the surface properties of a mouse mammary carci¬
noma (TA3) system has been carried out by Codington and co-workers.
Two variants of this mammary carcinoma differ in their ability to be trans¬
planted into allogeneic hosts. It has been found that the transplantable
form contains on its cell surface, a carbohydrate-rich glycoprotein called
epiglycanin which is not present in the nontransplantable line. This pro¬
tein has a molecular weight of approximately 500,000 and contains about
80% carbohydrate, essentially all of which is O-glycosidically linked.
There are approximately 500 to 600 carbohydrate substitution sites on the
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polypeptide chain with most of the subsituents being disaccharide units.
The apparent function of this macromolecule, which is broadly distrib¬
uted over the cell surface, is to mask surface antigenic structures which
may permit immune response of the host and thus rejection of the tumor
cells. The saccharide units are free of fucose and it has been shown that
removal of sialic acid results in a decrease in transplantability of the
tumor cells (Sanford, 1967). This is probably the best studied of the cell
surface glycoprotein markers and its function is reasonably well estab¬
lished. There is some saccharide heterogeneity so that structural data rep¬
resent composite information but the overall features are quite clear and
have been confirmed by direct electron microscopic visualization (Slayter
and Codington, 1973; Miller et al., 1977).
A related study using a rat mammary carcinoma (13762) grown in
ascites form has focused on membrane glycoproteins solubilized either by
detergent extraction or by treatment with guanidine hydrochloride. Purifi¬
cation included cesium chloride density gradient centrifugation and led to
the isolation of one mucin type glycoprotein which may serve a masking
function as does epiglycanin in the mouse system (Sherblom et al., 1980).
It was noted that within the membrane system, this component and a sec¬
ond glycoprotein were associated to give a complex with a molecular
weight of approximately 600,000 (Sherblom and Carraway, 1980). One
subunit bound to concanavalin A and one did not. The nature of the asso¬
ciation was not covalent since the two species were separable in the pres¬
ence of guanidinium chloride; the overall data suggest that the association
is primarily hydrophobic.
F. Lung Carcinoma
Studies with a murine lung carcinoma revealed the presence of a sur¬
face glycoprotein with a molecular weight of 180,000 which is not present
on normal cells (Kennel, 1979; Kennel et al., 1980). The protein was iden¬
tified by metabolic labeling, isolated, and a radioimmunoassay developed.
The data suggest that the protein is shed from the surface of the cells at
some regular rate and eventually appears in the serum as the tumor bur¬
den in the animal increases. Lactoperoxidase-catalyzed iodination of the
cell surface indicated that the molecule was expressed at least transiently
at that locus; comparable macromolecules were identified in several lung
carcinoma lines. There was some suggestion that charge heterogeneity
was present based on isoelectric focusing studies but apparently this was
not due exclusively to variations in sialic acid (Eisinger and Kennel,
1981).
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G. Leukemias and Lymphomas
Mouse leukemia cells (GRSL) were shown to contain a glycoprotein
with apparent /V-acetylgalactosaminyl residues, a conclusion based on in¬
teraction with a lectin from Dolichos biflorus (Muramatsu et al., 1980).
This glycoprotein had a molecular weight of 100,000, contained O-linked
oligosaccharides, and had properties somewhat reminiscent to one de¬
scribed by Bramwell and Harris (Bramwell and Harris, 1978a,b). In a
number of other studies on leukemic cell lines, properties of glycopep-
tides have been described. Increased size and fucose content was gen¬
erally noted and interaction with lectins defined (Hourani et al., 1973).
An interesting report suggested that antigenic determinants of mem¬
brane glycoproteins derived from a mouse plasma cell line may involve
Af-acetylneuraminic acid (Prat et al., 1975; Prat and Comiglio, 1976).
These studies were based on immunologic methods with alterations in im¬
mune reactivity observed following treatment with neuraminidase. In
spite of these observations, the interpretation is unlikely to be correct. As
a rule, sialic acid does not function as an antigenic determinant although
its presence in a molecule can confer specific conformations which make
one or another antigenic determinant site unique and accessible. Thus, al¬
though removal of sialic acid from a given glycoprotein may alter immune
properties (similar to studies carried out with MM and NN glycophorin)
(Springer and Desai, 1975; Lisowska and Wasniowska, 1978; Sadler et
al., 1979) this does not necessarily mean that the sugar itself is recognized
by the antibody but rather that its removal occasions a conformational
change which results in altered immune properties.
H. Viral Glycoproteins
A number of laboratories have been concerned with the possible ex¬
pression of viral glycoproteins on the surface of infected cells (Nilsson et
al., 1977; Snyder and Fleissner, 1980; Kurth et al., 1977; Kurth and
Mikschy, 1978; Krakower and Aaronson, 1978; Krakower et al., 1978;
Mesa-Tejada et al., 1978). Attempts have been made to define such com¬
ponents immunologically as well as by direct analysis of labeled macro-
molecules. Although the results are suggestive, perhaps the clearest data
have come from studies with Epstein-Barr virus glycoproteins. Two
types of glycoproteins have been identified, one on a human lymphoma
line and one as a membrane antigen from infected cells (Nilsson et al.,
1977). The labeling techniques involved either galactose oxidase or neura¬
minidase and then galactose oxidase; glycoproteins of molecular weight
71,000 or 69,000 and 236,000 were identified. The latter was characterized
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on the basis of lectin affinity and subsequently isolated on a preparative
scale by polyacrylamide gel electrophoresis.
I. General Phenomena
A provocative series of studies has been carried out by Bramwell and
Harris on several murine lines, including hybrid lines with suppressed ma¬
lignancies (Bramwell and Harris, 1978a,b). Plasma membranes were iso¬
lated from these cells by treatment with zinc chloride followed by discon¬
tinuous sucrose gradient centrifugation. The membranes were extracted
with Triton and the glycoprotein patterns examined by lectin-binding
properties and gel chromatographic behavior. A membrane-associated
glycoprotein with a molecular weight of approximately 100,000 and an
isoelectric point of approximately 4 was found with high consistency in'
the tumorigenic cells. The level of this component was reduced in the rel¬
atively less malignant hybrid lines. It may be present in the cell membrane
as a dimer; there was some suggestion, not confirmed, that this molecule
is associated with glucose transport.
VI. Human Cells
A number of human cell lines have been examined for specific mem¬
brane-associated glycoproteins (Table I).
A. Melanoma
Early work conducted with a line of melanoma cells adopted the follow¬
ing strategy: rabbits were immunized with inactivated human melanoma
cells and the elicited antibodies used as a primary fractionation tool.
Screening was conducted on extracts of solid tumors and on urine of pa¬
tients for proteins which reacted with the rabbit antibodies. The reactive
molecules were examined by gel electrophoresis and melanoma asso¬
ciated antigens identified in the 40,000-60,000 molecular weight range
(Carrel and Theilkaes, 1973).
Evidence was developed for membrane-associated melanoma antigens
by use of a delayed hypersensitivity reaction utilizing extracts of mela¬
noma cell membranes. A number of active fractions were identified al¬
though none was purified (Hollinshead et al., 1974). In comparable stud¬
ies using immunologic approaches, melanoma patients were screened for
the presence of circulating antibodies directed against cell surface anti-
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TABLE I
Glycoproteins of Human Tumor Cell Surfaces"
Source Methodology Properties
Melanoma cells Immunoadsorbent 20,000-50,000 MW; af¬
(patient serum) finity for Lens culinaris
lectin
Melanoma cells Monoclonal antibody 97,000 MW
Mammary ductal carcinoma Membrane isolation. 20,000 MW; PCA-soluble,
extraction; immuno¬ 38-57% carbohydrate;
adsorbent pi 4.45-5.35
Lung adenocarcinoma Standard biochemical 77,000 MW; cross reacts
with o^-antichymotrypsin
Colon adenocarcinoma Surface labeling,
lectin affinity
Carcinoembryonic antigen
Renal cancer cells Metabolic labeling,
two-dimensional
gels
27,500 MW; p/ 5.7, 5.3, 4.9
Neuroblastoma cells Monoclonal antibody 20,000 MW; fucose, glu¬
cosamine label
Ovarian tumor Immunoadsorbent 70,000 MW; PCA-soluble
" See text for references.
gens of cultured melanoma cells (Carey et al., 1976; Leong et al.,
1977a,b). In one study, a particular patient with a high titer was identified
and serum from that patient utilized as a screening tool for the presence of
melanoma associated cell surface antigens in a variety of cell sources
(Carey et al., 1979). A group of proteins in the molecular weight range of
20,000-50,000 was identified by this technique. An indication that they
were glycoproteins was derived from their interaction with Lens culinaris
lectin. However, structural details were not reported in these studies.
Surface labeling of several lines of cultured melanoma cells indicated
that galactosyl residues were sterically hindered. Common features in¬
cluded proteins with molecular weights of 90,000 and 110,000 as well as
two glycoproteins with the characteristics of la antigens (Lloyd et al.,
1979).
A putative melanoma associated antigen was identified by radioimmu¬
noassay and a molecular weight of 97,000 was assigned (Brown et al.,
1981a). However, the specificity of this to melanoma was not defined, nor
were any structural details reported.
Several laboratories have utilized hybridomas to develop panels of
monoclonal antibodies directed against cell lines derived from human
melanoma and other malignant cells (Carrel et al., 1980; Dippold et al.,
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1980). A number of common antigens have been identified but relatively
few specific components. The release of antigens from melanoma cell
lines has been examined but in contrast to studies with virus-transformed
lines, no apparent change in antigen secretion rate was observed when
data were compared to that from control cell populations (Bystryn et al.,
1981).
B. Mammary Carcinoma
Studies carried out with human mammary tumors utilizing both chemi¬
cal and surface localization techniques have identified tumor-related gly¬
coproteins of approximately 20,000 molecular weight; these were distinct
from carcinoembryonic antigen (Kuo et al., 1973). The glycoproteins are
soluble in perchloric acid and contain between 40 and 60% carbohydrate;
isoelectric focusing identified a pi of 4.45 for one component and 5.35 for
another. It was not known if these were related by differences in sialic
acid content although both components contained sialic acid (Leung et
al., 1978; Leung and Edgington, 1980).
An association of human breast cancer with T antigen which is a pre¬
cursor of the MN blood groups has been described (Springer et al., 1976;
Howard and Batsakis, 1980).
C. Lung Carcinoma
An antigen associated with lung tumor has been identified as a 76,000
molecular weight, sialic acid-containing glycoprotein (Gaffar et al., 1979;
Braatz et al., 1978). The protein was isolated by direct extraction from
lung tumor and was shown to have some structural homology with aj-an-
tichymotrypsin on the basis of immunologic cross reactivity; the two mol¬
ecules were not identical (Gaffar et al., 1980).
D. Colon Carcinoma
The interest in carcinoembryonic antigen has prompted a number of
studies with colonic carcinoma lines. Surface labeling of one such with
galactose oxidase indicated the presence of at least five glycoproteins; the
major one had a molecular weight of 200,000 and properties similar to
those of carcinoembryonic antigen (Tsao and Kim, 1978). Soluble anti¬
gens from colonic carcinomas have been studied by the usual techniques
and a number of glycoproteins identified but other than similarities to
CEA, no structural details have been reported. The appearance of car-
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cinoembryonic antigen on the cell surface of cultured colon adenocarci¬
noma cells requires protein synthesis and can be inhibited by the presence
of bromouracil deoxyriboside (Rosenthal et al., 1980). Internalization of
the surface antigen was accomplished by exposure of the cells to antibody
and the subsequently denuded cells were allowed to recover under condi¬
tions which permit reexpression of the CEA.
E. Ovarian Carcinoma
A perchloric acid-soluble glycoprotein with a nominal molecular weight
of 70,000 has been purified from extracts of human ovarian tumor (Knauf
and Urbach, 1974, 1976). The development of a satisfactory radioimmu¬
noassay has permitted discrimination between this molecule and carcino-
embryonic antigen and the lack of association of this molecule with lung
cancer; cross reactive material was present in colon carcinoma. The gen¬
erality of this particular antigen has yet to be defined but the authors sug¬
gest that it may be common to certain types of cyst adenocarcinomas
(Knauf and Urbach, 1981). Screening for the presence of this macromole-
cule in plasma indicates an association with advanced disease (Knauf and
Urbach, 1977, 1978).
F. Neuroblastoma
Studies on human neuroblastoma glycopeptides have shown that they
have the same general features associated with those found in other trans¬
formed cells in that they tend to be more complex and perhaps more
highly fucosylated (Glick et al., 1976a). An unusual linkage has been iden¬
tified in glycopeptides from these cells with fucose linked 1-3 or 1-4 to N-
acetylglucosamine (Santer and Glick, 1980). At least one membrane gly¬
coprotein with a molecular weight of approximately 20,000 has been iden¬
tified from human neuroblastoma utilizing monoclonal antibodies as the
detecting tool (Momoi et al., 1980). Glycopeptides derived from this gly¬
coprotein had some antigenic activity, although reactivity with glycolipids
was not found. It is of interest to note that there was cross reactivity with
extracts of fetal but not adult brain.
G. Miscellaneous
Physical studies have indicated surface changes in cultured lines of
bladder epithelial cells associated with transformations (Kahan et al..
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1977). A similar analysis compared renal cancer and normal kidney epi¬
thelial cells; protein components of molecular weights 27,500 and isoelec¬
tric points ranging from 5.7 to 4.9 were uniquely present in the malignant
cells (Ogata et al., 1981).
VII. Methodology
The general approaches toward defining the nature of cell surface gly¬
coproteins can be subdivided into metabolic or biochemical procedures as
contrasted to immunologic procedures. In most cases that have thus far
been described, few of the glycoproteins have been isolated in sufficient
quantity to permit detailed biochemical characterization. Most studies
have been performed with either metabolic or chemically labeled material
and identification of unusual products by means of polyacrylamide gel
electrophoresis or more recently, monoclonal antibodies. Considerable
work has been done with proteolytic digests of crude fractions isolated
from plasma membranes or whole cells to examine glycopeptide profiles.
Progress in this field will remain limited until techniques are worked out
for isolating native glycoproteins and providing at least minimal structural
details for them, including immunologic behavior, so that a library of de¬
fined surface glycoproteins can be established. There are many indica¬
tions that malignancies both of animal and human origin have associated
with their cell surfaces glycoproteins that are either immunologically or
otherwise unique; a vast amount of work remains to be done to provide
adequate characterization profiles.
A. Preparation of Cells
A major reason for the relatively slow progress in this field is that the
cells utilized for studies are available in limited quantities. Developments
in cell culture techniques such as growth of cells on microbeads (Levine
et al., 1977), in multi-plate culture systems (Schleicher, 1973), large vol¬
ume fermentors and spinner cultures (Chee et al., 1976), and the use of
serum-free medium (Barnes and Sato, 1980a,b) should alleviate the pri¬
marily economic aspects of this shortcoming. An associated problem is
the requirement of normal cells of the same cell lineage and comparable
cell growth characteristics; these are not always available. When avail¬
able, it is best to carry out the comparative studies of cancer and control
cells at the same cell cycle phase, since growth-dependent changes of cel¬
lular glycopeptides have been documented (Buck et al., 1971; Sakiyama
and Burge, 1972; Muramatsu et al., 1973).
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B. Metabolic Labeling of Cellular Glycoproteins
In this approach, a suitably labeled precursor sugar is added to culture
medium containing metabolically active cells, organs, or tissue slices. The
injection of isotopes into animals is uneconomical because the extensive
dilution results in extremely poor incorporation into the desired tissue
products. A number of precursor sugars can be utilized, the most com¬
monly employed is glucosamine ([6-3H] or [1-14C]). This is the preferred
sugar since all known animal glycoconjugates, with the exception of gly¬
cogen and collagen, contain at least one of the three sugars (N-acetylglu-
cosamine, ^-acetylgalactosamine, sialic acid) biosynthetically derived
from it. Further, the major part of the added precursor is utilized in syn¬
thetic pathways (Kohn et al., 1962). Recent studies in our laboratory,
however, have shown that a significant proportion of glucosamine may be
used by certain cultured cells for energy metabolism (O'Connor and Da¬
vidson, unpublished results).
l-Fucose is another precursor widely used for the metabolic labeling of
glycoproteins. The use of this sugar was suggested by the pioneering stud¬
ies of Bekesi and Winzler (1967) which indicated that it is exclusively in¬
corporated as such into tissue glycoproteins and is not extensively metab¬
olized. However, the subsequent isolation of various fucoglycolipids
(Hakomori, 1975; McKibbin, 1978), fucose-containing glycosaminogly-
cans (Bray et al., 1967), and fucose-free glycopeptides (Tai et al., 1975;
Bhavanandan et al., 1977, 1981; Li and Kornfeld, 1979; Van den Eijnden
et al., 1979), and fucose-free glycoproteins (Spiro, 1973; Kawasaki and
Ashwell, 1976a; Montreiul, 1980), does not support the earlier claim of
exclusivity of fucose incorporation into glycoproteins. Nevertheless, this
sugar as well as isotopically labeled mannose, galactose, and N-acetyl-
mannosamine are useful for obtaining specific information on the carbo¬
hydrate composition and structure of cell surface glycoproteins (Yur-
chenco et al., 1978). Metabolic labeling with a precursor sugar (for
example, [6-3H]glucosamine) and a precursor amino acid ([14C]leucine) or
[35S]sulfate will help in subsequent purification since the second isotope
serves to screen for nonglycosylated proteins or sulfated glycosaminogly-
cans, respectively.
C. In Vitro Cell Surface Labeling of Glycoproteins
All of the carbohydrate moieties of the cell membrane glycoproteins
(intrinsic and extrinsic) and portions of the protein are present on the
outer surface of the intact cell. This arrangement makes it possible to iso¬
topically label these glycoproteins by in vitro techniques and allows their
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visualization after treating with carbohydrate-specific dyes, lectins, or an¬
tibodies (see Section VII,F).
Isotopic labeling of the exposed (available) sugar or amino acid on in¬
tact cells involves chemical modification using isotopic reagents under
conditions that do minimal damage to the cells. The available methods in¬
clude labeling of sialic acid residues by brief periodate treatment and tri-
tiated borohydride reduction (Liao et al., 1973; Gahmberg and Anders-
son, 1977) labeling of galactose residues by galactose oxidase oxidation
followed by reduction with tritiated borohydride (Gahmberg and Hako-
mori, 1973) or coupling with methionine [3SS]sulfone hydrazide (Itaya et
al., 1975); labeling of available tyrosine by iodination with 12SI2 generated
by treatment of Na125I with lactoperoxidase and H202 (Phillips and Morri¬
son, 1971; Hunt and Brown, 1975); and coupling of exposed -NH2 (lysine)
with pyridoxal phosphate to form a Schiff base which is stabilized by re¬
duction with tritiated borohydride (Rifkin et al., 1972). Labeling tech¬
niques including some not widely tested are summarized in Table II.
All of the above procedures attempt, not always successfully, to label
only the surface-exposed molecules by employing either reagents that are
too large (for example, lactoperoxidase, galactose oxidase) or highly
charged (pyridoxal-5'-phosphate, formyl methionylsulfonemethyl phos¬
phate) so that they do not penetrate the hydrophobic interior of the mem¬
brane. The exclusivity of these techniques has been questioned (Schmidt-
Ullrich et al.. 1973; Juliano and Beher-Bennelier, 1975) but they are still
suitable for preliminary studies. The periodate -borotritide labeling pro¬
cedure was initially applied to erythrocytes (Liao et al., 1973) and subse¬
quently extended to lymphoid and other cell systems (Gahmberg and An-
dersson, 1977; Flowers and Glick, 1980; Browner al., 1981b). In our own
preliminary work on various nucleated cultured cells (hepatoma, mela¬
noma), it was found that 60-90% of the cells were permeable to Trypan
Blue at the end of the labeling period (Bhavanandan, unpublished results).
It is thus clear that some of these techniques should be used judiciously
and appropriate controls carried out, particularly if it is essential that only
externally exposed residues are labeled. If it is critical to establish the sur¬
face localization of a glycoprotein, additional evidence should be obtained
by independent criteria involving visualization techniques or by initial iso¬
lation of plasma membranes. Failure to label a molecule does not neces¬
sarily mean that it is absent at the surface since cryptic (sterically unavail¬
able loci) molecules may not be acted upon by enzymes or other reagents.
A serious disadvantage of the in vitro labeling technique is that glycopro¬
teins adsorbed to the cell surface are not distinguished from true cell sur¬
face components. Strong adsorption of fetal calf serum components to the
cell surface has been reported (Phillips and Perdue, 1977).
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TABLE II
Cell Surface Labeling Techniques
Reagents Group(s) labeled Reference
Sodium periodate and Sialic acid Liao et al. (1973); Gahm-
sodium [3H]boro- berg and Andersson (1977)
hydride
Galactose oxidase- Galactose; /V-acetyl- Gahmberg and Hakomori
sodium [3H]borohydride galactosamine (pre¬ (1973)
ferentially non-
reducing terminals)
Lactoperoxidase - H202 Tyrosine Phillips and Morrison (1971);
or glucose oxidase and Hunt and Brown (1975)
glucose and radioactive
iodide
Pyridoxal phosphate and -NH2 (eNH2 group of Rifkin et al. (1972)
sodium [3H]boro- lysine, aminoterminal)
hydride
Galactose oxidase- Galactose, iV-acetyl- Itaya et al. (1975)
methionine [35S]sulfone galactosamine
hydrazide
4,4'-Diisothiocyano-2,2'- -NH2 Cabantchik and Rothstein
ditritiostilbene disulf- (1974)
onate ([3H]DIDS)
[35S]Formylmethionyl -nh2 Bretscher (1971)
sulfone methyl phos¬
phate <[35S]FMMP)
Diazobenzene [35S]sulf- -NH2; Bender et al. (1971)
onate (DABS) tyrosine;
histidine
Despite these limitations the in vitro labeling procedures, particularly
the lactoperoxidase iodination and the galactose oxidase -NaB3H, tech¬
nique in conjugation with prior neuraminidase treatment, are very useful.
At the present time, these techniques are of primary value in providing
radioactive handles for the purification and preliminary characterization
of minute quantities of glycoproteins (Fareed et al., 1978). Improvements
in application as well as development of newer methods can be expected
to broaden the usefulness of this approach to the study of cell surface gly¬
coproteins.
D. Isolation and Purification of Cell Surface
Glycopeptides
Different strategies have been used for the isolation of cell surface gly¬
copeptides of malignant cells. The two types discussed in this chapter are
CELL SURFACE GLYCOPROTEIN MARKERS 77
those involving mild protease treatment of intact cells and exhaustive pro¬
teolysis of isolated plasma membranes.
1. Mild Proteolysis of the Cell Surface Components
Information on the nature of cell surface glycoproteins may be obtained
by limited proteolysis of intact labeled or unlabeled cells resulting in con¬
trolled release of fragments. It is important to choose conditions of pH,
ionic concentration of buffer, time, and temperature of incubation such
that cell viability is not affected. Several investigators have used trypsin
to release glycopeptides (and glycosaminoglycans) from the cell surface
(Langley and Ambrose, 1967; Codington et al., 1972; Saito et al., 1977;
Nakadaand Yamashina, 1978; Debray and Montreuil, 1978). Codington et
al. (1972) were able to release significant quantities of cell surface sialic
acid in the form of glycopeptides from TA3 mammary adenocarcinoma
cells. Using similar conditions, we were able to release mucin-type glyco¬
peptides from B16 mouse melanoma cells metabolically labeled with
[14C]glucosamine (Bhavanandan et al., 1977).
Walborgpt al. (1969) and Robinson et al. (1976) were successful in solu-
bilizing several glycoproteins from rat hepatoma cells by the use of pa¬
pain. Papain seems capable of releasing larger glycoprotein fragments,
which sometimes retain biological activity. Thus, biologically active anti¬
gens have been released from several cell types by treatment with papain
(Shimada and Nathenson, 1969; Baldwin et al., 1973; Viza and Phillips,
1975; Clemetson et al., 1976; Ishii et al., 1980). However since the condi¬
tions for maintaining cell viability are not optimal for papain activity, the
yields of released glycopeptides are poor. Ficin (Langley and Ambrose,
1967) and bromelain are two other narrow spectrum proteases which may
be useful for the release of cell surface components. In contrast to the
above mentioned proteases, Pronase, which is a mixture of broad spec¬
trum proteases, is generally not suitable for the release of surface compo¬
nents without affecting cell viability. The mildest conditions tried resulted
in loss of viability of cultured cells (Bhavanandan, unpublished observa¬
tions). However Ceccarini et al. (1975) and Ceccarini and Atkinson (1977)
were able to isolate mannose-containing glycopeptides from monolayers
of cultured human cells.
Mild proteolysis of intact cells probably results in the release of a selec¬
tive rather than a representative population of surface glycopeptides. This
is illustrated by the preferential release of epiglycanin (a peripheral glyco¬
protein) compared to other intrinsic membrane glycoproteins of TA3
cells. Further, this approach seems to work better on cells grown in sus¬
pension or Ascites form than on detached monolayer cultured cells since
the latter have an already altered surface.
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2. Total Proteolytic Fragmentation of Isolated Membranes
A majority of the studies on cell-associated glycoproteins have been
carried out on limit protease (Pronase) digestion products of isolated
plasma membranes (Meezan et al., 1973; Glick and Buck, 1973; Nakada
etal., 1975; Warren et al., 1978; Glick, 1979) or whole cells (Bhavanandan
et al., 1977, 1981; Muramatsu et al., 1978; Li etal., 1980; Takasaki et al.,
1980). This procedure has the advantage of yielding water-soluble frag¬
ments of membrane glycoproteins most of which have amphiphatic char¬
acteristics rendering them not readily soluble in aqueous systems. In addi¬
tion, it is possible to obtain information on total carbohydrate changes at
the cell surface without concern for the protein moiety; the latter is likely
to influence solubilization, purification, and analytical procedures. Major
disadvantages of this approach are that it does not provide information on
changes of discrete glycoproteins and it is difficult to determine the rela¬
tionship between observed differences and malignancy.
3. Purification of Glycopeptides
Glycopeptides derived from the proteolytic treatment of intact cells or
plasma membranes can be broadly classified as illustrated in Fig. 1.
Within each class, wide structural variations are possible; incompleteness
of chains, mode and number of branches, linkage positions, etc. In addi¬
tion to glycopeptides, glycosaminoglycans are present in digests of
plasma membranes, a fact which has not always been previously consid¬
ered. Several methods are available to separate glycosaminoglycans from
glycopeptides. We have generally used cetyl pyridinium chloride to pre¬
cipitate the glycosaminoglycans from the Pronase digests (Bhavanandan
et al., 1977, 1981; Chandrasekaran and Davidson, 1979). This procedure
works well except for small losses of glycopeptides which occur during
the precipitation of excess cetyl pyridinium chloride with KSCN followed
by dialysis of the supernatant. An alternative technique, used in our stud¬
ies on nuclear glycoconjugates, is fractionation by ion exchange chroma¬
tography on DEAE-cellulose or Sephadex columns (Bhavanandan and
Kemper, unpublished results). This approach was only partially suc¬
cessful due to overlap of the elution of certain sialoglycopeptides and the
non- or low-sulfated glycosaminoglycans (hyaluronic acid, chondroitin).
If information on the nature of the glycosaminoglycans is not required,
then it is possible to use enzymes and/or chemicals to selectively degrade
these molecules. For example, hyaluronic acid and the chondroitin sul¬
fates could be degraded by using hyaluronidases (Meyer, 1971) and chon-
droitinases (Suzuki, 1972), and the heparan sulfates by either heparitinase
(Linker and Hovingh, 1972) or nitrous acid (Cifonelli, 1968). This ap-
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proach has not been widely used apparently due to the difficulty in obtain¬
ing the requisite saccharases free of exoglycosidase activity. A recent
study described the use of Flavobacterium heparinum culture filtrates to
degrade chondroitin sulfates and heparan sulfates (Gill et al., 1981).
Standard techniques such as gel filtration, ion exchange chromatogra¬
phy, and lectin affinity chromatography are then employed to fractionate
the complex mixture of glycopeptides (Smith et al., 1973; Bhavanandan et
al., 1977, 1981; Debray and Montreuil, 1978; Santer and Glick, 1979;
Finne et al., 1980a). In view of the intrinsic microheterogeneity of the oli¬
gosaccharide portion of glycopeptides and because the starting material
consists of a pool of glycopeptides derived from a large number of individ¬
ual glycoproteins, only mixtures of closely related glycopeptides rather
than single species can be expected. For example, in work involving ex¬
tensive purification, apparently homogeneous glycopeptides were ob¬
tained from metabolically labeled RSV-BHK cells (Santer and Glick,
1979) and HM7 human melanoma cells (Bhavanandan et al., 1981). Struc¬
tural investigation of these purified glycopeptides suggested reasonable
homogeneity of the carbohydrate portions. However, it cannot be ex¬
cluded that the isolated fractions contain glycopeptides of near-identical
carbohydrate composition and array derived from several different glyco¬
proteins or different areas of the same glycoproteins. A corollary to this is
that amino terminal analysis cannot be used as a purity criterion for glyco¬
peptides.
E. Isolation of Intact Cell Surface Glycoproteins
To understand the relationship between cell surface glycoproteins and
malignancy, it will be essential to isolate individual components, ideally,
with retention of biological activity. Membrane glycoproteins can be
grouped into two categories: peripheral or extrinsic glycoproteins which
interact minimally with other membrane components and integral or in¬
trinsic glycoproteins which are partly buried in the bilayer. The possibility
of extracting the extrinsic glycoproteins without damaging the intact cell
has not been fully investigated. The only extrinsic protein extracted in
this manner is cellular fibronectin (LETS glycoprotein) which was solubi-
lized by treatment of cell monolayers with urea (Yamada and Weston,
1974).
The solubilization of intrinsic glycoproteins presents technical prob¬
lems due to the partial hydrophobic nature of these molecules. In general,
these amphipathic glycoproteins can be extracted only after prior purifi¬
cation of plasma membranes. The membranes are then treated with deter-
t
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gents to disrupt the lipid bilayer in essence substituting the hydrophobic
lipid surrounding the glycoprotein by hydrophobic detergents.
1. Plasma Membrane Isolation
A variety of techniques are available for the isolation of plasma mem¬
branes; as a rule, procedures are continually being improved in terms of
speed, yield, and purity (Steck and Wallach, 1970; Brunette and Till,
1971; Warren, 1974; Perdue, 1974; Neville, 1976). Some of these methods
have been adapted for zonal centrifugation and therefore can be used for
large scale preparations. A rapid method for the isolation of surface mem¬
branes from tissue culture cells involves cell lysis in hypoosomotic borate
buffer-EDTA followed by differential centrifugation (Thorn et al., 1977).
The method of Barland and Schroeder (1970) involving the stripping of
membrane from monolayer cells with fluorescein mercuric acetate is rapid
and simple but may result in selective loss of some membrane compo¬
nents (Quissel et al., 1977). Two novel methods described for the isolation
of erythrocyte plasma membranes involve (1) the use of polylysine cou¬
pled to glass beads (Jacobson et al., 1978) and (2) the introduction of poly-
deoxythymidylic acid chains to the membrane followed by hybridization
to polyadenylic acid-agarose (Wennogle and Berg, 1978). The applicabil¬
ity of these methods to other cell membranes has not been reported.
2. Solubilization of Plasma Membranes
Prior to solubilization of the glycoprotein, extraction of the membranes
with chloroform-methanol mixtures helps to remove lipids and glyco-
lipids (Hakomori and Murakami, 1968). If this is done, then consideration
should be given to the possibility that certain glycoproteins may partition,
in part, in the organic phase (Watanabe et al., 1980). This could be due to
either an overall hydrophobic nature or to strong binding of lipids. This
treatment is likely to denature many membrane glycoproteins resulting in
the loss of biological activity, if any.
The glycoproteins that are interacting with the lipid bilayer by electro¬
static interactions may be solubilized with suitable changes in the ionic
strength and/or pH of the extracting medium. Sodium chloride of varying
molarity has been used to extract membrane proteins (Rosenberg and
Guidotti, 1969; Fairbanks et al., 1971; Braatz et al., 1978). In these and
other similar extractions involving 3 M KC1 (Reisfeld et al., 1971; Leon¬
ard et al., 1975; Chee et al., 1976) the role of endogenous proteases should
be considered since some activation by salt solutions appears to occur
(Mann, 1972). Therefore, if undegraded glycoproteins are to be obtained,
it is essential to include protease inhibitors such a toluene sulfonyl fluo-
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ride, diisopropyl fluorophosphate, pepstatin, aprotinin, and iodoaceta-
mide in the extracting medium. Extraction of whole cells with 3 M KC1
gave active histocompatibility antigens (Reisfeld et al., 1971) and active
melanoma-associated antigen (Bhavanandan et al., 1980) indicating that
limited autoproteolysis may not always be undesirable. Treatment with
chelating agents such as EDTA (Wise et al., 1975; Dunn et al., 1975) or
with the hydrogen-bond breaking agents, urea (Tanner and Gray, 1971) or
guanidine hydrochloride (Gwynne and Tanford, 1970), are other methods
for extracting extrinsic membrane proteins. If high concentrations (4-
8 M) of urea or guanidine HC1 are used, the effect of the high density of
these solutions should be taken into account in evaluating results. Protein
-lipid complexes are small vesicles and are likely to float during centrifu-
gation of the extracts giving the false impression of effective solubilization
(Maddy and Dunn, 1976).
Solubilization of intrinsic membrane glycoproteins requires the use of
chaotropic agents (potassium or sodium thiocyanate, lithium diiodosalicy-
late) or organic solvents (butanol, pyridine, phenol) or detergents. Lith¬
ium diiodosalicylate introduced by Marchesi and Andrews (1971) for the
purification of glycophorin from human erythrocyte membranes has been
successfully used for the extraction of glycoproteins from plasma mem¬
branes of AH66 rat hepatoma (Funakoshi and Yamashina, 1976; Nakajo
et al., 1979) of BHK cells (Tuszynski et al., 1978) and HM7 human mela¬
noma (Umemoto et al., 1981). The strong affinity of lithium diiodosalicy¬
late to glycophorin and probably other membrane glycoprotein was dem¬
onstrated by Segrest et al. (1979) who recommended the use of sodium
deoxycholate for the purification of glycophorin. Butanol, pyridine, and
phenol have been used by several investigators to solubilize erythrocyte
ghosts (Maddy, 1966; Zwaal and van Deenan, 1968; Blumenfeld and Zvili-
chovsky, 1972; Howe et al., 1972) but have not been applied to other ani¬
mal cell membranes. Extraction with chloroform-methanol to partition
the lipid and protein components of the erythrocyte membrane used by
Hamaguchi and Cleve (1972) was recently adapted for the extraction of
glycoproteins from thyroid plasma membranes (Okada and Spiro, 1980).
The most popular agents for solubilizing membranes are detergents.
Both nonionic (Triton X-100, Nonidet P-40, octyl glucoside, Triton CF-
54, Tween 20) and ionic (sodium deoxycholate, sodium dodecyl sulfate,
sodium dodecyl sarcosinate) detergents have been used (Maddy and
Dunn, 1976). In general, the former category is preferable since these ap¬
pear to cause the least alterations in the structure and conformation of the
glycoproteins as illustrated by the absence of their influence on the activi¬
ties of antibodies (Dimitriadis, 1979) and lectins (Lotan et al., 1977) at
concentrations of about 1%. These detergents can also be expected to
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have minimal effect on enzyme and receptor activities. In contrast, the
ionic detergents bind strongly to proteins (Reynolds and Tanfold, 1970)
and can thus cause irreversible conformational changes. They also inter¬
fere in the interaction of antibodies and lectins with glycoproteins (Lotan
et al., 1977; Dimitriadis, 1979). Although the nonionic detergents have ob¬
vious advantages, the use of ionic detergents is still valuable under special
circumstances because of their ability to cause complete solubilization of
most membrane glycoproteins.
Once the proteins are solubilized the detergents may, in some in¬
stances, be removed without causing precipitation. For example, glyco-
phorin remains in aqueous solution after removal of detergents, probably
due to its high carbohydrate content. However, in most cases this proce¬
dure is likely to cause aggregation or insolubilization of the glycoproteins
(Kawasaki and Ashwell, 1976b; Dorst and Schubert, 1970; Bhavanandan
et al., 1980). Thus, an optimum concentration of the detergent should be
maintained throughout purification and subsequent studies to ensure that
the component of interest remains in solution. The nonionic detergents
are usually removed by extensive dialysis, treatment with resins such as
BioRad Sm-2 (Holloway, 1973), or by extraction with ice-cold ethanol, or
acetone (Funakoshi and Yamashina, 1976; Kawasaki and Ashwell,
1976b). The removal of unbound detergents from proteins is discussed in
a recent review (Furth, 1980).
3. Fractionation of the Solubilized Gycoproteins
Generally it is advisable to include protease inhibitors in the buffers
during purification procedures. The direct and simplest method of puri¬
fying a cell surface glycoprotein is by affinity chromatography on an anti-
body-Sepharose column, a technique obviously dependent on the avail¬
ability of an appropriate antibody directed against the glycoprotein of
interest. In view of recent advances in the production of monoclonal anti¬
bodies, future widespread use of this method can be expected (Goding,
1980; Schlom et al., 1980; Mitchell et al., 1980; St. Groth and Scheideg-
ger, 1980). Several investigators have successfully employed monoclonal
antibodies for the purification of cell surface glycoproteins. Thus, Brown
et al. (1981b) isolated a glycophorin-like molecule from rat thymocytes;
Hellstrom and co-workers (Yeh et al., 1979; Woodbury et al., 1980) iso¬
lated a glycoprotein (P97) from human melanoma cells and Momoi et al.
(1980) isolated a membrane glycoprotein from human neuroblastoma cells
by this technique.
Affinity chromatography on lectin columns is another useful technique
for purifying membrane glycoproteins. Because of the wide carbohydrate
specificities of lectins such as concanavalin A, wheat germ agglutinin, and
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the Ricinus communis agglutinins, affinity chromatography using these
lectins will result in the separation of classes of glycoproteins rather than
individual components. If the glycoprotein under investigation binds to an
immobilized lectin, then this property can be used successfully to remove
all nonglycosylated proteins as well as the nonbinding glycoproteins. In
some cases, a specific glycoprotein may entirely bind to a lectin column,
as in the case of 5'-nucleotidase of pig lymphocyte membrane (Hayman
and Crumpton, 1972). In other cases, it is possible that portions of the
same glycoprotein may bind incompletely to one lectin or to different lec¬
tin columns due to carbohydrate heterogeneity. Subfractionation of the
class of glycoproteins binding to a particular immobilized lectin may be
possible by gradient elution with appropriate sugars. In the case of wheat
germ agglutinin, subfractionation should also be possible by using a series
of columns packed with lectin-Sepharose of varying concentration of lec¬
tin per milliliter gel (Bhavanandan and Katlic, 1979).
A note of caution must be introduced regarding the use of affinity chro¬
matography as a structural tool. The characteristics of affinity chromato¬
graphic behavior will indicate only general structural information and,
within that restriction, only those saccharide moieties which are acces¬
sible to and recognized by the affinity ligand. Affinity will also differ de¬
pending on the nature and preparation of the glycopeptides. For example,
it is quite likely that a fragment with two saccharide units will have quite
different behavior on a given lectin affinity column than one with a single
saccharide unit. Furthermore, the density of the lectin on the supporting
matrix is a critical factor in evaluating chromatographic behavior. Thus,
comparisons from one laboratory to another, even with identical cell sys¬
tems, are very difficult to make.
The nominal structural basis for lectin specificities are often inaccurate.
Adsorption to and elution from a particular lectin column with a haptenic
monosaccharide eluent (for example utilization of A-acetylglucosamine
with wheat germ agglutinin-Sepharose columns) does not at all mean that
such sugars are present in the glycoprotein under investigation (Bhavan¬
andan and Katlic, 1979). This kind of oversimplification is frequently en¬
countered and can lead to mistaken identification of saccharide residues
on glycoproteins. Most lectins have specificities which either encompass
oligosaccharide units or have sufficiently broad specificities that sac¬
charides of more than one structure can be accommodated within the
binding site. Nonetheless, with these caveats in mind, the profile of inter¬
action of glycopetides or glycoproteins derived from given cell lines can
be quite revealing and indicate changes in accessible carbohydrate asso¬
ciated with transformation.
Due to this lack of strict specificity of most lectins and the inherent mi-
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croheterogeneity of the oligosaccharides of glycoproteins, it is essential to
first test the lectin columns used for purification with glycoproteins and
glycopeptides of known structures. In addition it is also important to as¬
sess the yield of the glycoprotein from lectin affinity steps because irre¬
versible interaction between the lectin and the ligand is known to occur.
Affinity chromatography on immobilized antibody or lectin columns can
usually be performed in the presence of a number of detergents (Lotan et
al., 1977; Lotan and Nicolson, 1979).
Purification of cell surface glycoproteins can also be carried out by a
combination of conventional techniques. Gel filtration on several sup¬
ports (Sepharose CL, Sephacryl, Controlled Pore Glass beads) can be
carried out in the presence of nonionic detergents (Triton X-100; Am-
monyx; Nonidet P-40), ionic detergent (sodium dodecyl sulfate), or hy¬
drogen bond breaking solvents (urea, guanidine-HCl). It is necessary,
however, to determine the influence (interference) of the buffer additives
on the spectrophotometric, colorimetric or isotope counting procedures
used for analysis of the fractions. Ion exchange chromatography on
DEAE- or CM-Sepharose is usually carried out by gradient elutions
which NaCl or LiCl in buffers containing nonionic detergents. Volatile
buffers such as pyridinium acetate, widely used for the fractionation of
glycopeptides, are not suitable for membrane glycoproteins because of
their poor solubility. The purification of mouse melanoma-associated anti¬
gen (Bhavanandan et al., 1980) and a 100K glycoprotein from human
melanoma cells (Umemotoer al., 1981) was accomplished by repeated ion
exchange chromatography on DEAE-Sepharose columns using buffers
containing 0.1% Triton X-100. Isoelectric focusing in neutral detergents
and urea (Merzer al., 1972; Zechel, 1977; Baumann and Doyle, 1979) has
also been used for purification of glycoproteins. A limitation of this
method is that the high sensitivity usually results in separation based on
microheterogeneity of the oligosaccharides. Thus, a given glycoprotein
may given rise to several peaks based on single differences in sialic acid or
other charged residues. Preparative polyacrylamide gel electrophoresis in
the presence or absence of sodium dodecyl sulfate has also been used for
the purification of glycoproteins even though the recoveries in such ex¬
periments are usually low (Baldwin et al., 1973; Dunn et al., 1975; Braatz
et al., 1978).
F. Mapping the Organization of Cell Surface Glycoproteins
An evaluation of the role of cell surface glycoproteins in malignancy re¬
quires more than information on individual glycoproteins. It is possible
that the altered properties of cancer cells such as proliferative growth,
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metastasis, altered recognition, and adhesion may not be due to changes
in individual cell surface components but rather to a composite influence
of several "new" components. Thus any study on cell surface glycopro¬
tein should also assess the supramolecular organization of these and of
other related molecules (glycolipids and glycosaminoglycans). Useful
tools for these studies are (1) specific chemical stains, (2) lectins of well-
defined specificities, (3) antibodies produced against known oligosac¬
charide structures, and (4) highly purified exo- and endoglycosidases. The
gross distribution of cell surface carbohydrates can be determined by the
help of light or electron microscopy after treatment of the cells with the
first three classes of the above reagents.
/. Studies with Chemical Stains
Typical chemical reagents used include periodate-Schiff (Rambourg et
al., 1966; Ito, 1969; Martinez-Palamo, 1970; Luft, 1976), ruthenium red
(Vorbradt and Koprowski, 1969; Luft, 1971), and colloidal iron (Hale,
1946; Gasic and Berwick, 1963; Rambourg et al., 1966; Benedetti and Em-
melot, 1967). Treatment of the intact cells with enzymes (neuraminidase,
hyaluronidase) as well as carrying out the staining reactions at varying pH
would help to distinguish between glycosaminoglycans and sialoglycopro-
teins or sialoglycolipids (Gasic and Berwick, 1963; Huet and Herzberg,
1973; Kim et al., 1975). For example, at pH 2.0 only about 10% of the
sialic acid carboxyl is ionized whereas sulfate ester groups are fully disso¬
ciated.
2. Studies with Lectins
Lectins are proteins (or glycoproteins) from plant or other sources
which can bind noncovalently to specific carbohydrate groups but are
known not to be enzymes, transport proteins, or immunoglobulins. Be¬
cause of the abundance of carbohydrates on the cell surface (glycocalyx),
the multivalent lectins are able to cause agglutination of erythrocytes and
other cells, sometimes after prior enzymatically catalyzed modification of
the cells. The findings that wheat germ agglutinin caused differential ag¬
glutination of normal and transformed cells stimulated a great deal of re¬
search on lectins (Aub et al., 1965; Burger and Goldberg, 1967). Subse¬
quently several other lectins (concanavalin A, soybean agglutinin,
Ricinus communis agglutinins) were found to agglutinate cancer cells at
much lower concentrations than control (normal) cells (Brown and Hunt,
1978). It was also noted that mild proteolysis rendered normal cells as
agglutinable as transformed cells (Inbar et al., 1969).
Lectins have been used in several additional ways to explore cellular
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glycoconjugates. The binding of lectins to cell surfaces can be quantitated
by the use of isotopically labeled lectins (see reviews by Nicolson, 1974,
1976), preferably the monovalent subunits such as succinylated Con A
(Gunther et al., 1973). The topographical distribution of sugars can also
be assessed by one of several methods: (1) direct immunofluorescence
using lectin conjugated to fluorescent dyes such as fluorescein isothio-
cyanate or rhodamine (Inbar and Sachs, 1973); (2) indirect immunofluo¬
rescence using lectin and a fluorescein-conjugated antibody to the lectin
(Mallucci, 1971); (3) electron microscopic visualization of lectins conju¬
gated with ferritin (Nicolson and Singer, 1971, 1974; Marchesi et al.,
1972); (4) electron or light microscopic autoradiography using isotopically
labeled lectins (Rapin and Burger, 1974); (5) histochemical studies with
covalent conjugates of lectins and peroxidase (Bernhard and Avramaes,
1971; Huet and Garrido, 1972; Martinez-Paloma et al., 1972).
3. Studies Using Antibodies against Oligosaccharides
Because most lectins lack strict or defined saccharide specificity other,
better defined tools are desired. Antibodies directed against known oligo¬
saccharides have great potential since they can be used to probe cell sur¬
face glycoconjugate organization in the same manner as that discussed
above for lectins. Antibodies against neuramin 2-*3 and 2—>6 lactose and
other sialyloligosaccharides (Smith and Ginsburg, 1980); lacto-N-fuco-
pentaose III, lacto-yV-tetraose, and mannotetraose (Zopf et al., 1975,
1978); galactose and lactose (Pazure? al., 1978); galactose and Lewis-a-b
and -d determinants (Lemieux et al., 1981) have all been prepared. Anti¬
bodies against specific oligosaccharides of both the N-glycosidically and
O-glycosidically linked types known to be present on normal and trans¬
formed cells can be expected as a result of the rapidly expanding technol¬
ogy of monoclonal antibody.
4. Studies Using Glycosidases
The use of glycosidases to probe the cell surface distribution of sac¬
charides has been largely confined to the use of sialidases (Hughes et al.,
1972; Barton and Rosenberg, 1973; Simmons and Rios, 1973; Weiss et al.,
1974). The availability of other highly purified exo- and endoglycosidases
of known substrate specificities which are active at near physiological pH
and ionic conditions should make further studies possible. The applicabil¬
ity of this approach is also limited since most of the presently available
glycosidases do not effectively hydrolyze high-molecular-weight glyco¬
protein substrates (Flowers and Sharon, 1979). The endo /3-(V-acetylglu-
cosaminidases (Muramatsu, 1978; Tarentinoet al., 1978), endo-/3-galacto-
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sidases (Takasaki and Kobata, 1976; Nakagawa et al., 1980), a
glycopeptidase acting on aspartylglycosylamine linkages (Takahashi and
Nishibe, 1978, 1981), and endo-a-/V-acetylgalactosaminidase (Umemoto
et al., 1977; Glasgow et al., 1977) are enzymes which satisfy some of the
above requirements (Fukuda et al., 1979).
It is important to consider the effect of the cell surface glycosaminogly-
cans in these studies. The results of experiments on cells before and after
treatment with hylauronidase, chondroitinase (Nakada et al., 1977), and
heparitinase should be compared. The degradation of cell surface heparan
sulfate by heparitinase was recently reported (Ohkubo et al., 1981).
G. Structural Analysis of the Isolated Glycopeptides and
Glycoproteins
Before embarking on structural studies, it is essential to establish ho¬
mogeneity of the component under investigation. This has proved difficult
because of the heterogeneous nature of the carbohydrate chains
(Horowitz, 1977). In the case of homogeneous preparations of nonglyco-
sylated proteins, techniques such as gel filtration, ion-exchange chroma¬
tography, gel electrophoresis, and isoelectric focusing can be expected to
give single sharp symmetrical peaks or single sharp bands. In contrast, a
pure preparation of glycoprotein, because of variations in the intra- and
intermolecular carbohydrates, cannot be expected to yield similar results.
An additional complication in the case of membrane glycoproteins is the
ability of these molecules to aggregate resulting in either discrete bands as
in the case of glycophorin (Silverberg and Marchesi, 1978) or a broad
spectrum of aggregates (Kawasaki and Ashwell, 1976b; Dorst and Schu¬
bert, 1979; Bhavanandan et al., 1980). This difficulty might be overcome
by determining the homogeneity of the protein which carries the sac¬
charide chains. If sufficient (microgram) quantities are available, NH2 or
COOH terminal amino acid determination may provide this information.
A second approach which can be used at tracer levels provided the pro¬
tein is isotopically labeled (either in vivo for example, [14C]leucine or in
vitro by reductive methylation with H14CHO) is chemical or enzymatic
deglycosylation followed by examination of the resultant polypeptide.
Unfortunately, this method is not widely applicable since complete enzy¬
matic deglycosylation with the available exo- and endoglycosidases can
be seldom achieved. The applicability of chemical deglycosylation with
hydrogen fluoride (Mort and Lamport, 1977; Glassman et al., 1978) as a
general method for all glycoproteins has yet to be established.
Structural studies are usually not carried out on intact glycoproteins.
The presence of more than one type of carbohydrate chain on the same
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molecule makes it difficult to interpret the results and the large quantity of
amino acid interferes in many of the analytical procedures. Thus, glyco¬
proteins are usually subjected to proteolysis with broad spectrum pro¬
teases such as Pronase and the products fractionated by a combination of
techniques (gel filtration, ion exchange chromatography, lectin affinity
chromatography, etc.) to yield individual, homogeneous glycopeptides.
The few amino acids present on Pronase generated glycopeptides mini¬
mally influence fractionation. This is in contrast to differences in sac¬
charide composition, where a difference ofjust one sugar particularly if it
is charged, has a significant effect on chromatographic and electrophore-
tic properties. The aim of the fractionation approach should be to separate
the different classes of glycopeptides (Fig. 1) rather than to separate on
the basis of minor variations. Lectin affinity chromatography appears to be
specifically useful for this purpose (Ogata et al., 1975; Krusius et al.,
1976; Narasimhan et al., 1979; Rasilo, 1980; Bhavanandan et al., 1981).
I. Isolation of Peptide-Free Oligosaccharides
An alternative approach, for the determination of carbohydrate struc¬
ture of glycoproteins involves the release of all carbohydrate chains from
the protein thus totally eliminating the influence of the protein (or peptide)
during fractionation (Finne et al., 1980a). The mild alkaline-borohydride
treatment conditions established for the release of O-glycosidically linked
saccharides with minimum degradation (Carlson, 1968; Spiro, 1972) have
been used extensively for this purpose. The release of the N-glycosidi-
cally linked saccharides without destruction is best achieved by hydra-
zinolysis (Yosizawa et al., 1966). The use of this technique for structural
elucidation has recently been reported by several investigators (Fukuda et
al., 1976; Reading et al., 1978; Takasakiet al., 1980; Yoshimaet al., 1980).
The degradation of the oligosaccharides thus released appears to be mini¬
mal provided strictly anhydrous conditions are used. Strong alkaline-
borohydride treatment recommended for the release of such carbohydrate
chains (Lee and Scocca, 1972) was found to cause extensive degradation
of the released saccharides of o^-acid glycoprotein and fetuin (Bhavana-
dan, unpublished results). On a limited scale, endoglycosidases can be
used to release oligosaccharides from glycoproteins (Flowers and Sharon,
1979; Kobata, 1979).
The oligosaccharides derived from chemical or enzymatic cleavage are
then fractionated into different classes. This can be done by gel filtration
on fine and superfine gels (Etchison et al., 1977; Van den Eijnden et al.,
1979; Natowicz and Baenziger, 1980) ion exchange chromatography
(Finne, 1975; Fukuda et al., 1976), thin-layer chromatography (Holmes
and O'Brien, 1979), paper chromatography (Bhavanandan et al., 1977,
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1981; Fukuda and Hakomori, 1979; Li and Kornfeld, 1979), high voltage
paper electrophoresis (Li and Kornfeld, 1979; Takasaki et al., 1980; Yo-
shimact al., 1980), high-pressure liquid chromatography (Wells and Les¬
ter, 1979), and lectih affinity chromatography (Blake and Goldstein,
1980). Reduction of the oligosaccharide with sodium borotritide facilitates
the fractionation and analysis of trace amounts.
Once homogeneous preparations of glycopeptides or oligosaccharides
are available, one can proceed with the determination of the following: (1)
the nature of linkage of carbohydrate to peptide, (2) the sugar composi¬
tion, (3) the sequence of the sugars, (4) the anomeric configuration of each
of the glycosidic bonds, (5) the linkage positions, that is, which hydroxyl
groups other than the glycosidic hydroxyls are involved in the linkages.
The details of the methods used to obtain this information can be found in
prior reviews (Spiro, 1972; Marshall and Neuberger, 1972a; Montreuil,
1975). Thus, only a brief description of the approach is given below.
2. Nature of Carbohydrate-Peptide Linkage
This information can be obtained by mild alkaline treatment in the pres¬
ence of borohydride, hydrazinolysis, and by the use of glycosidases. The
/3-eiimination reaction with mild alkali, however, is very slow if the glyco¬
sylated amino acid is either NH2 or COOH terminal and can be made
more efficient by prior blocking of these groups (Neuberger et al., 1972).
^-Elimination in the presence of sodium borohydride in addition to identi¬
fying O-glycosidically linked oligosaccharides also permits the determina¬
tion of the proportion of serine and threonine substituted by estimating
the increase in alanine and appearance of a-aminobutyric acid. Further,
by carrying out the elimination reaction in the presence of sodium sulfite
instead of sodium borohydride it is possible to convert the hydroxyamino
acids involved in the linkage to sugar to cysteic acid and a-amino-/3-sul-
fonylbutyric acid (Harbon et al., 1968; Simpson et al., 1972; Spiro and
Bhoyroo, 1974). Use of Na35S03 and sequencing of the peptides would
provide information on the location of the sugar-linked hydroxy amino
acid in the protein (Simpson et al., 1972; Isemura and Ikenaka, 1975).
3. Determination of Sugar Composition
Several colorimetric methods, including modifications for microdeter-
minations, are available for quantitating hexoses, hexosamines, deoxy-
hexoses, and sialic acid (Ashwell, 1966; Spiro, 1966a; Marshall and Neu¬
berger, 1972b). The currently preferred approach however, is gas liquid
chromatographic analysis which is more sensitive and rapid. A very use¬
ful procedure is methanoiysis of the giycopeptide or oligosaccharide foi-
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lowed by trimethylsilylation of the methyl glycosides; this permits deter¬
mination in one analysis of the total sugar composition (Clamp et al.,
1971; Laine et al., 1972; Clamp, 1977). Trifluoroacetylation of methyl gly¬
cosides, instead of trimethylsilylation (Montreuil, 1975) is a good alterna¬
tive since the use of electron capture detection would increase the sensi¬
tivity of the analysis several fold (Pritchard and Niedermeier, 1978).
However, this procedure has not been widely tested. Alternatively one
may analyze the sugars (except sialic acid) as alditol acetates (Lehnhardt
and Winzler, 1968; Sloneker, 1972; et al., 1972). Another technique with
good potential which needs further development is high-pressure liquid
chromatographic separation of underivatized sugars following acid hy¬
drolysis (Tikhomirov et al., 1978; Binder, 1980). This method would per¬
mit the recovery of the sugars for further analysis and confirmation of
identify. For identification and quantitation of hexosamines the amino
acid analyzer has been widely used. The micro amino acid analyzers pres¬
ently available make it possible to analyze picomole quantities of hexosa¬
mines present in hydrolysates of glycopeptides and glycoproteins.
These chromatographic procedures can be adapted to quantitate isotop-
ically labeled sugars by stream-splitting the column effluent and collection
of fractions for scintillation counting. Prehm and Scheid (1978) were able
to quantitate 0.2 nmoles of monosaccharide by gas liquid chromatography
of 3H-labeled alditol acetates. We have made extensive use of this tech¬
nique in conjunction with the amino acid analyzer to quantitate the distri¬
bution of label in glucosamine and galactosamine (Bhavanandan and Da¬
vidson, 1976; Bhavanandan et al., 1977, 1981).
Several other techniques for the determination of trace amounts of
sugars have been published (Takasaki and Kobata, 1974; Knutson, 1975;
Roll and Conrad, 1977; Hase et al., 1978; Haraer al., 1979; Barr and Nor-
din, 1980).
4. Determination of Structure
There is no single method available that will provide information on the
sequence, anomeric configuration, and linkages of sugars in glycoproteins
and glycopeptides. The three widely used techniques are methylation
analysis (Lindberg, 1972; Montreuil, 1975), treatment with glycosidases
and periodate oxidation (Smith Degradation) (Hay et al., 1965; Goldstein
et al., 1965). The enzymatic method provides the most information since
all glycosidases have sugar and anomeric specificity and in addition cer¬
tain glycosidases also have linkage and aglycon specificity. Thus it is pos¬
sible to distinguish (a) between Gal/31 —» 4GlcNAc and Gal/31 —*
3GlcNAc and Gal/31 —► 6GlcNAc by using the appropriate /3-galactosid-
ase (Li et al., 1975; Paulson et al., 1978), (b) between manal —» 2 man,
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manal —* 3 man, and manal —> 6 man using Aspergillus saitei a-manno-
sidase (Yamashita et al., 1980), and (c) between NeuNAc 2 —► 3 Gal and
NeuNAc 2 —*■ 6 Gal using influenza virus neuraminidase (Drzeniek, 1967;
Bhavanandan et al., 1977). It can be hoped that the discovery of addi¬
tional glycosidases (particularly from mammalian sources), the elucidation
of the exact specificity of the existing and newly described glycosidases,
and their ready availability would widen the use of this approach. For in¬
formation on currently available glycosidases and their use in structural
elucidation, readers are referred to recent reviews (Li and Li, 1977; Flow¬
ers and Sharon, 1979; Kobata, 1979).
At present, the most productive approach for structure elucidation is
the combination of sequential degradation of the sugar chain from the
nonreducing end with glycosidases and methylation (Hakomori, 1964) of
the residual portion. This is followed by total hydrolysis and identification
of the methylated sugars by GC/MS analysis (Bjorndal et al., 1970). The
application of this has been described in several recent studies (Kornfeld,
1978; Fukuda and Hakomori, 1979; van den Eijnden et al., 1979; Finne et
al., 1980b; Irimura et al., 1981).
Periodate oxidation is useful in obtaining information on linkage posi¬
tion, branching (Goldstein et al., 1965; Spiro, 1966b), and the substitution
position of N-acetyl hexosaminitols (Spiro, 1972; van den Eijnden et al.,
1976). Because of the differences in the rate of hydrolysis of different gly¬
coside bonds and of different sugars, partial degradation of carbohydrate
chains can be achieved by mild acid hydrolysis (Wolfrom and Franks,
1965; Painter, 1965), acetolysis (Bayard and Montreuil, 1972; Bayard et
al., 1975), or hydrazinolysis followed by nitrous acid treatment (Isemura
and Schmid, 1971; Montreuil, 1975; Aspinall et al., 1980; Strecker et al.,
1981). The resulting fragments can then be sequenced and based on over¬
lapping fragments the structure of the complete carbohydrate chain re¬
duced.
A technique which is being increasingly applied to structural elucida¬
tion of saccharides is high resolution (360 to 500 MHz) 'H NMR spectros¬
copy, as illustrated by the studies of Fournet et al. (1978) and Montreuil
and Vliegenthart (1979).
VIII. General Recapitulation
Insofar as generalizations can be made regarding the presence of un¬
usual glycoproteins on the surfaces of transformed cells, it appears that
such are likely to be found. The most common properties appear to be
related to both increased complexity and increased glycosylation of the
saccharide moieties of the glycoproteins. Studies conducted by utilization
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of tritiated sugar precursors or by labeling of saccharide residues in whole
cells or membrane preparations followed by glycopeptide isolation have
supported the generality of these conclusions. What is much less clear is
the tissue-specific origin of the polypeptide portion of these macromole-
cules. Recent work, which is rather heavily dependent on modern im¬
mune technology (production of monoclonal antibodies by the hybridoma
technique), has provided strong suggestive evidence showing that the
tissue-specific antigen is present in all tumors of a particular type or that it
is not present in a variety of tumors of another cell type, as well as adult
or fetal cells. One difficulty with the immune technique is that alterations
in the carbohydrate moiety of the glycoprotein can easily result in suffi¬
cient conformational changes to evoke new antigenic determinants from
common polypeptide precursors. Thus, even the sophisticated hybridoma
technology may be led astray in presuming that totally new structures are
being formed. Without the essential chemical evidence regarding the pri¬
mary structure of glycoprotein products, it will be impossible to define
them as unique and specific products of tumor cell metabolism. It is quite
likely that the transformation event results in expression of new genes but
it may also result in the modification of preexisting membrane associated
glycoproteins and their subsequent appearance as new bands on gels or
new antigens in immune screening procedures.
Modern genetic technology would presume that appearance of new
phenotypic characteristics would, if associated with a new genotype, be
detectable by appropriate techniques. Thus, the presence of a new mes¬
senger RNA could be detected if an appropriate library of cloned frag¬
ments were available for the necessary hybridization studies. It should be
noted that most of the surface components mentioned are present in ex¬
tremely small quantities, have been detected primarily if not exclusively
by isotopic tracer techniques, and the prospect of fishing out the appropri¬
ate genetic information must be accorded as relatively remote.
A second problem in dealing with tumor-related cell surface glycopro¬
teins involves their length of residence on the cell surface. It has been re¬
ported by a number of laboratories that transformed cells exhibit an ele¬
vated level of surface protease activity. This may well account for the
apparent loss of fibronectin from the surface of fibroblasts following viral
transformation. The altered behavior of the cell surface glycoproteins
may arise from the fact that localized processing of intrinsic membrane
proteins can occur under circumstances where this event would not have
taken place prior to transformation. Furthermore, the putative proteolytic
activity could be responsible for the loss from the cell surface of mem¬
brane components at a much higher rate (observations confirmed by di¬
rect experimentation) than is found in normal cells. As a result of this,
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increased levels of membrane proteins may appear in the circulation. At
least one report has appeared of a circulating glycoprotein associated with
malignancy although its identification with the cell surface has not been
made (Bolmer and Davidson, 1981). The generality of this observation,
that is, the association of this glycoprotein with a variety of malignancies,
suggests that origin within a specific tumor cell is less likely than is modifi¬
cation of a preexisting component by a common feature associated with
cells that have lost growth control.
IX. Prognosis
The general trend in recent years has indicated that a very large variety
of tumor-related glycoprotein antigens will continue to be described.
Most of the descriptive material will rely on either metabolic or surface
labeling approaches followed by identification of unusual components by
gel electrophoretic or immunologic techniques. Sophisticated refinement
such as the use of two-dimensional gels or isoelectric focusing gels and
monoclonal antibodies are likely to improve the number of qualitative
changes that are identifiable but are not likely to provide an understanding
of the nature of these differences or the relationship between the charac¬
teristics of the transformed cell and the expression of the unusual compo¬
nent. By quite a different route, descriptive material will continue to be
acquired based largely on techniques such as lectin affinity chromatogra¬
phy and electron microscopic visualization of surface features utilizing ei¬
ther lectin or other probes derivatized to provide localization information.
Here, differences may well be established, but their chemical nature will
be very difficult to interpret. Thus, changes in lectin affinity chromato¬
graphic profiles can arise from alterations in the carbohydrate composi¬
tion of glycoproteins or loss of one or another component from the cell
surface, and so on. The relationship of these observations to the more ex¬
plicit ones derived by direct biochemical techniques, will rarely be ac¬
complished in the same laboratories. A key problem that remains has
been alluded to above and relates to the explicit chemical definition of ob¬
served alterations. It is necessary to isolate sufficient material from any
system to define the chemistry and the origin of the macromolecule in¬
volved. The next step will be to associate these changes with specific gene
expression and to document the generality of such a change with the
transformed phenotype. The latter is perhaps the most difficult problem
and its solution one that has thus far eluded researchers. The fact remains
that the fundamental biologic problem in malignancy has yet to be defined
in spite of, for example, a complete knowledge of the gene architecture of
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a transforming virus. Those events which result in loss of growth control,
perhaps the initial problem, followed by selection from within that popu¬
lation of cells that have the ability to metastasize, the life threatening
event, is still far from understood. The best information that is likely to
derive from continued studies on cell surface glycoproteins has to do with
either diagnostic or immunologic approaches to the management of the
disease.
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Isolation, Purification, and Properties of Respiratory Mucus Glycoproteins*
Harold Woodward, Barbara Horsey, V. P. Bhavanandan, and Eugene A. Davidson*
abstract: The major glycoprotein from human tracheo¬
bronchial secretions and from primary explant cultures of
human tracheal epithelium has been purified to apparent
homogeneity. Mucin was solubilized in buffer and fractionated
on Sepharose CL-4B, followed by CsBr density gradient
centrifugation of the void volume fraction. High- and low-
density fractions were obtained in ratios ranging from 2:1 to
5:1. The high-density (1.46) fraction appeared homogeneous
by exclusion chromatography and recentrifugation in CsBr and
had an amino acid composition characteristic of a mucin-type
structure (threonine, serine, proline, glycine, and alanine
comprise two-thirds of the amino acid residues). The carbo¬
hydrate, which is nearly 80% by weight, was O-glycosidically
linked via GalNAc, sulfated (5.4% by weight), and contained
fucose, galactose, glucosamine, galactosamine, and sialic acid.
The low-density fraction had an amino acid composition
distinct from that of the high-density fraction (threonine,
serine, proline, glycine, and alanine comprise 51% of the amino
acid residues) and a lower sulfate content. The size distribution
of the saccharides in the low-density fraction was similar to
that of the high-density fraction; the same sugars were present
although the ratios were different. The low-density fraction
contained 3 times more noncovalently associated lipid than
did the high-density fraction. Several distinct classes of lipids
were identified. Neutral lipids (mono-, di-, and triglycerides,
cholesterol, and cholesteryl esters) comprised 56% by weight
of the total lipid. Glycolipids and phospholipids were also
identified. Palmitate (16:0), stearate (18:0), and oleate (18:1)
were the major fatty acids in all classes of lipids.
Human tracheobronchial secretions consist of a heteroge¬
neous population of macromolecules, salts, and water. Re¬
spiratory mucus, as well as mucus from other sources (e.g.,
gastric, salivary, and cervical mucus), serves as a lubricative
and protective barrier and, in addition, provides a clearance
mechanism for particulate matter from the respiratory tract.
Human tracheobronchial mucus ha^been characterized in
terms of total protein, carbohydrate, lipid, and inorganic salts
(Basch et al., 1941; Masson et a!., 1965; Chernick & Barbero,
' From the Milton S. Hershey Medical Center, The Pennsylvania State
University, Hershey, Pennsylvania 17033. Received July 14,1981. This
work was supported in part by U.S. Public Health Service Grant
HL19190.
1959). Rheological properties have also been studied (Mit-
cheil-Heggs, 1977; Charman & Reid, 1972, 1973).
The major glycoprotein present in tracheobronchial se¬
cretions is a large, carbohydrate-rich glycoprotein whose
macromolecular structure regulates the viscoelastic properties
of mucus. Isolation and characterization of the individual
components from mucus are required to understand struc¬
ture-function relationships.
Mucus contains several components in addition to the major
mucin glycoprotein, most of which are lower molecular weight
proteins and serum-type glycoproteins (Havez et al., 1968;
Roussel et al., 1975; Boat et al., 1976; Feldhoff et al., 1976,
1979; Rose et al., 1979). Resolution of these components often
involves the use of exclusion chromatography (Boat et al..
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1976; Feldhoff et al., 1979; Rose et al., 1979) or ion-exchange
chromatography (Lamblin et al., 1977; Roussel et al., 1975)
to separate the high molecular weight, polyanionic mucin
glycoprotein from lower molecular weight serum components.
Another separation technique which has proved quite valuable
is density gradient centrifugation in CsBr/CsCl solutions. This
technique has been used preparatively for bronchial mucin
glycoproteins (Creeth et al., 1977) as well as for blood group
substances (Creeth & Denborough, 1970), pig gastric and
intestinal mucus (Starkey et al., 1974; Mantle & Allen, 1981),
and human gastric mucus (Pearson et al., 1980). Studies on
these types of secretions have shown the presence of tightly,
but noncovalently bound, protein and have provided detailed
information on the macromolecular organization of mucus
components.
Detailed studies on "normal" human tracheobronchial se¬
cretions, however, are often incomplete because of difficulties
in collecting adequate amounts of secretions for chemical
characterization. Previous studies from our laboratory have
accordingly reported on mucin glycoproteins isolated from the
tracheobronchial secretions of an asthmatic patient (Feldhoff
et al., 1979). This paper describes the isolation, purification,
and characterization of mucin glycoprotein from bronchial
secretions of patients who have undergone surgery for non-
pulmonary illness and from primary explant organ cultures
of human tracheal epithelium.
Materials and Methods
Collection of Bronchial Aspirate Material. Mucus was
collected every 8 h by sterile aspiration at room temperature
from seven different patients who had undergone surgery for
nonpuimonary illness. Blood group status of these patients
was determined by hemagglutination inhibition using anti-A
and anti-B serum and a 2% suspension of red blood cells
(Morgan & Watkins, 1951). Three patients exhibited blood
group A activity, one patient blood group B activity, and three
patients no detectable blood group A or B activity. Samples
were stored in the freezer if not used immediately. Samples
used immediately were diluted 1:1 with phosphate-buffered
saline (PBS)1 containing 0.02% NaNj and stirred at 4 °C for
24 h and then centrifuged at 10 000 rpm (12000g) for 20 min
to remove a small amount of cellular debris. No visible gellike
material was present in the pellet. This pellet contained less
than 10% by weight of the starting material and was not
examined further. The resulting supernatant which contained
90-95% of the carbohydrate content of the original material
was dialyzed against distilled H20 at 4 °C for 48 h and then
lyophilized.
Primary Explant Culture of Tracheal Epithelium. Seg¬
ments of trachea were obtained from one subject at autopsy
within 4 h after death and were cultured on the basis of the
procedure of Boat et al. (1977). Epithelial cells were removed
from the segments by gentle scraping with a scalpel and
tweezers and then transferred to Gibco medium 199 + glut-
amine (685 qM) in culture plates (2-3 mL of medium/plate).
[3H]Glucosamine (100 qCi; New England Nuclear, specific
activity = 20.2 Ci/mmol) and [14C] leucine (10 uCi; Amers-
ham, specific activity = 35 mCi/mmol) were added to each
plate. The plates were incubated at 37 °C in a 5% COj/95%
air atmosphere, and medium (containing isotope) was changed
every 24 h. The epithelial cells were cultured for 3-4 days.
1 Abbreviations: PBS, phosphate-buffered saline; MeOH, methanol;
DPC, dipalmitoylphosphatidylcholine; NaDodSO,, sodium dodecyl sul¬
fate; dME, d-mercaptoethanol; HOAc, glacial acetic acid; TLC. thin-
layer chromatography.
Pooled, spent medium was dialyzed against H20 at 4 °C for
3 days and then lyophilized.
Analytical Methods. Chromatographic column effluents
and CsBr density gradient fractions were screened for neutral
sugar by the phenol/H2S04 method (Dubois et al., 1956) with
galactose as a standard and for protein by measuring the
absorbance at 280 nm. Specific sugar components were
identified by gas-liquid chromatography of their alditol ace¬
tates after hydrolysis in either 2 N HC1 or 2 N trifluoroacetic
acid (Sawardekar et al., 1965; Lehnhardt & Winzler, 1968)
or by methanolysis of sugars in 1.4 N methanolic HC1 at 85
°C for 24 h, followed by conversion to the trimethylsilyl de¬
rivatives prior to chromatography (Clamp et al., 1971).
Glucosamine and galactosamine were also determined on the
amino acid analyzer after hydrolysis for 8 h at 100 °C in 4
N HC1.
Protein was determined by the method of Lowry et al.
(1951) with bovine serum albumin as a standard. Samples
for amino acid analysis were hydrolyzed in sealed ampules for
24 h at 110 °C with 6 N HC1. Analyses were performed on
a Beckman 120C or 121 amino acid analyzer or on a Dionex
amino acid/peptide analyzer MBFSS kit.
Sulfate was determined by the method of Spencer (1960)
after hydrolysis for 12 h at 110 °C in 6 N HC1. Uronic acid
was determined by a modified carbazole method (Davidson,
1966).
Ouchterlony Immunodiffusion of Sepharose CL-4B In¬
cluded Fractions. Ouchterlony immunodiffusion was per¬
formed according to the procedure of Williams (Williams &
Chase, 1971). Two samples of unfractionated bronchial mucus
(samples C.L. and K.W.) and one sample of fractionated lower
molecular weight components (C.L.) in 0.15 M phosphate
buffer, pH 7.2, were placed in the immunodiffusion wells,
covered, and incubated in a humid atmosphere at room tem¬
perature for 24 h. Gels were stained with Buffalo Black for
2-6 h and destained with 2% acetic acid.
The antisera used were from commercial sources. Rabbit
anti-whole human serum, rabbit anti-oq-acid glycoprotein (lot
78M), and goat anti-human serum albumin (lot G389) were
from Miles Biochemicals. Goat anti-IgG (lot 231-78-13), goat
anti-IgA (lot 231-78-21), and goat anti-whole human serum
(lot 231-74-7) were from Bionetics.
Electrophoretic Studies. NaDodS04-polyacrylamide gel
electrophoresis was performed in 5% polyacryiamide gels
according to the method of Weber & Osborn (1969). Mucin
(100-200 qg) was incubated in NaDodS04 JME at 110 °C
for 3 min and then applied to the gels. After electrophoresis,
gels were stained for protein with Coomassie Brilliant Blue
and for carbohydrate by the periodate-Schiff method (Fair¬
banks et al., 1971).
CsBr Density Gradient Centrifugation. Sepharose CL-4B
void volume material from fractionation of crude bronchial
aspirates or spent culture medium was subjected to CsBr
density gradient centrifugation on the basis of the procedure
of Creeth et al. (1977). Void volume material was suspended
in phosphate buffer (16.7 mM Na2HP04-7H20, 16.7 mM
NaH2P04-H20, 33 mM NaCl, and 0.02% NaNj) containing
42% (w/w) CsBr at a loading density of 1.43 g/cm1 and stirred
for 24 h at 4 °C. After the mixture was stirred, it was pre-
centrifuged at 5000 rpm (3000g) for 5 min at 4 °C, and then
the supernatant was transferred to 1 in. X 3.5 in. cellulose
nitrate centrifuge tubes. After this centrifugation, 97% of the
total neutral sugar remained in the supernatant. Tubes were
filled to the top and capped. The samples were centrifuged
for 67 or 85 h at 14 °C and 42000 rpm in a Beckman 60Ti
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rotor. After centrifugation, tubes were punctured and 1-mL
fractions collected and assayed (after diluting 1:10 with H20)
for protein and for neutral sugar. Fractions from centrifu¬
gation of labeled materials were counted in ACS II (Am-
ersham). Densities were determined by weighing a 100-yL
aliquot of each fraction.
In some cases, centrifugation was performed in 0.625 in.
x 2.5 in. tubes in a Beckman type 50 rotor. All other con¬
ditions were identical with those described above except that
0.7-0.8-mL fractions were collected.
Alkaline Borohydride Treatment. High- and low-density
fractions were treated with 1 M NaBH4 in 0.1 N NaOH
according to the procedure^/Carlson (1966). A 0.1% solution
of mucin in 1 M NaBH4 in"1 N NaOH was incubated for 72
h at 37 °C in the dark under N2- Following incubation,
mixtures were neutralized with 4 N HOAc and evaporated
to dryness by rotary evaporation. The residue was washed
repeatedly (5 times) with 1000:1 MeOH:concentrated HC1,
evaporating to dryness by rotary evaporation after each
washing. The residue was then analyzed by chromatography
on a Bio-Gel P-10 column (column dimensions 1 X 30 cm)
in 0.1 N pyridinium acetate, pH 5.1.
Lipid Extraction. Mucin samples (50 mg) were extracted
sequentially for 12 h at 4 °C in 30-mL Corex test tubes with
20 mL of 2:1 CHCl3:MeOH, 10 mL of 2:1 CHCl3:MeOH,
and finally 5 mL of 1:2 CHCl3:MeOH, based on a procedure
discussed by Esselman et al. (1972). After each extraction,
samples were centrifuged at 10000 rpm (12000g) for 20 min,
and the supernatants were removed with a Pasteur pipet.
Addition of a small volume of methanol (usually 5 mL) aided
in pelleting the insoluble glycoprotein. The combined su¬
pernatants were filtered through coarse-grade filter paper and
evaporated to dryness by rotary evaporation at 25 °C. Lipid
residues were dried for 24 h in vacuo over P205 and then
weighed. The delipidated mucins were suspended in H20 and
then lyophilized.
Silicic Acid Column Chromatography. Lipid extracts were
chromatographed on a Bio-Sil A (200-400 mesh) silicic acid
column (Esselman et al., 1972). Heat-activated silicic acid
(100 °C, 8 h) was equilibrated in CHC13, and then a 4-mL
(1X5 cm) column was poured. The column was washed
sequentially with 10 column volumes of CHC13, 10 column
volumes of 9:1 acetone:MeOH, 10 column volumes of MeOH,
and finally 10 column volumes of CHC13. Lipid residue, up
to 15 mg suspended in 1 mL of CHC13, was applied to the
column, and then the column was eluted sequentially with 5
bed volumes each of CHC13, 9:1 acetone.MeOH, and MeOH.
Effluents from each different wash were collected separately
and evaporated to dryness by rotary evaporation. The residues
were resuspended in a small volume of elution solvent,
transferred to weighed tubes, evaporated to dryness with N2,
dried in vacuo over P205, and then weighed.
The CHC13 fraction, containing neutral lipid, was further
chromatographed on a 4-mL (1X5 cm) Bio-Sil A column
(200-400 mesh) equilibrated in 6% benzene in hexane (Lo-
Chang & Sweeley, 1963). Neutral lipid in 1 mL of 6%
benzene in hexane was applied to the column, and the column
was eluted sequentially with 5 column volumes each of 6%
benzene in hexane, 20% benzene in hexane, 65% benzene in
hexane, and CHCi3. Effluents were collected and evaporated
to dryness by rotary evaporation. Residues were resuspended
in a small volume of elution solvent, transferred to weighed
tubes, evaporated to dryness with N2, dried in vacuo over P2Os,
and then weighed. Lipids in these fractions were identified
by TLC. Lipids in the acetone/MeOH fraction (glycolipid
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enriched) and the MeOH fraction (phospholipid enriched)
were also identified by TLC, without further purification.
TLC of Lipid Fractions. Whatman silica gel K5 plates
(250-um thickness) used for lipid separation were heated at
100 °C for 12 h and used immediately upon being cooled to
room temperature. Solvent systems used (all solvents were
redistilled before use) were 90:10:1 hexane:diethyl ethenglacial
acetic acid for separation of neutral lipids and 65:25:4
CHCl3:Me0H:H20 or 65:35:8 CHCl3MeOH:2.5% aqueous
ammonia for separation of phospholipids and glycolipids. All
fractions were dissolved in 2:1 CHCl3:MeOH before being
applied to the plates.
All lipids were visualized by 50% sulfuric acid charring or
with I2 vapors followed by spraying with a 1% starch solution.
Glycolipids were specifically visualized with 2% a-naphthol
in ethanol followed by H2S04 charring. Phospholipids were
visualized with 2.5% ammonium molybdate in 2 N H2S04
followed by 0.25% ascorbic acid. Phospholipids were also
visualized with Phospray (Supelco). Choline-containing lipids
were visualized with Chargaffs reagent (Stahl, 1965).
Fatty Acid Analysis. Fatty acids were determined as their
methyl esters after treatment with 14% w/v BF3/MeOH for
3 h at 110 °C. Methyl esters were separated and identified
by gas-liquid chromatography on a column of 10% DEGS-PS
80/100 Supelcoport. The chromatography was conducted
isothermally at 200 °C at a flow rate of 30 mL/min with N2
as a carrier gas. The column was attached to a Perkin-Elmer
900 gas chromatograph equipped with a flame ionization
detector.
Equilibrium Sedimentation Analysis. High- and low-
density delipidated glycoproteins were examined by analytical
equilibrium uitracentrifugation by using the meniscus depletion
method (Yphantis, 1964). Prior to centrifugation, the sample
in PBS was dialyzed against PBS for 24 h.
Results
Results of all the analyses correspond to the mean value of
the seven different samples. After centrifugation of crude
bronchial aspirate material at 12000g, 90-95% of the total
neutral sugar remained in the supernatant. Chromatography
of the supernatant on Sepharose CL-4B (Figure 1) separated
the material into an excluded fraction (peak I) containing a
mucin-type glycoprotein and a heterogeneous included fraction
(peak II) consisting of serum proteins and glycoproteins. The
excluded fraction accounted for 65-75% of the total neutral
sugar. Blood group activity in the crude aspirate material,
measured by hemagglutination inhibition, was recovered in
the excluded fraction. Amino acid analysis of this fraction
(Table I) indicated a composition characteristic of a mucin-
type structure: threonine, serine, proline, glycine, and alanine
comprised 54% of the total amino acid residues. Aromatic
amino acids (phenylalanine and tyrosine) and cysteine were
low. Fucose and galactose comprised 30-40% by weight of
the mucin glycoprotein. The hexosamines were present in
equimolar ratios and accounted for 25-30% by weight of the
mucin glycoprotein. Fraction II had an amino acid compo¬
sition characteristic of serum-type components. The presence
of mannose and extensive cross-reactivity with serum com¬
ponents after double immunodiffusion identified components
in this fraction as circulating serum proteins and glycoproteins
(Figure 2).
A similar type of elution profile was observed when labeled,
spent medium from organ culture was chromatographed
(Figure 3). A high molecular weight, excluded fraction (80%
of the total [3H]glucosamine) and a lower molecular weight
included fraction (30% of the total [l4C]leucine) were observed.
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figure 1: Sepharose CL-4B (5 x 95 cm) chromatography of crude
bronchial aspirate material in 50 mM Tris, pH 8, containing 0.02%
NaN3. A 10 mg/mL solution of mucin in buffer was stirred at room
temperature for 3 h and then centrifuged at 12000g for 10 min. The
supernatant was applied to the column equilibrated in the buffer. 100
x 20 mL fractions were collected and screened for protein (•) and
neutral sugar (O).
figure 2: Ouchterlony immunodiffusion reactions of human tra¬
cheobronchial components (center walls) against antisera (outer wells).
Center wells: A, unfractionated bronchial secretion (K.W.); B, low
molecular weight fraction from Sepharose CL-4B chromatography;
C, unfractionated bronchial secretion (C.L.). Outer wells: 1, rabbit
anti-whole human serum; 2, anti-a,-acid glycoprotein; 3, anti-IgG;
4, anti-IgA; 5, blank; 6A, goat anti-whole human serum; 6B, anti-
human serum albumin.
Table I: Amino Acid Composition of Bronchial Secretions after
Chroifiatography on Sepharose CL-4B
residues/1000 residues




cysteic acid 4 1
aspartic acid 70 115
threonine 170 59
serine 110 59













® Expressed as percent by weight of the total glycoprotein.
NaDodS04-polyacrylamide gel electrophoresis of the ex¬
cluded fractions in 5% polyacrylamide gels indicated the
presence of lower molecular weight contaminants in both the
bronchial aspirate and the organ culture materials. Rechro-
matography of the excluded fraction of Sepharose CL-4B also
indicated the presence of contaminating protein, although
greater than 95% of the total neutral sugar in the bronchial
aspirate material remained in the excluded fraction. CsBr
density gradient centrifugation was used to separate this
contaminating protein from the mucin glycoprotein. A
high-density (1.46) and a low-density (1.34) fraction were
40 80 120
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figure 3: Sepharose CL-4B (2 x 65 cm) chromatography of labeled
spent culture medium in 50 mM Tris, pH B, containing 0.02% NaN3.
140 x 1.5 mL fractions were collected and aliquots of each fraction
counted in ACS II with a liquid scintillation spectrometer. (O)
[3H]Glucosamine; (•) [,4C]leucine.
Table II: Amino Acid Composition of High- and Low-Density
Fractions from Bronchial Aspirates
residues/1000 residues
high low




aspartic acid 46 72
threonine 210 112
serine 127 110















® Expressed as percent by weight of the total glycoprotein.
obtained from both bronchial aspirate material and tracheal
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FRACTION
figure 4: CsBr density gradient centrifugation of void volume
material. (A) Bronchial aspirate material excluded on Sepharose
CL-4B was loaded at a concentration of 1-2 mg/mL and centrifuged
for 85 h at 42000 rpm. Starting density was 1.43 mg/mL. Fractions
(0.7-0.8 mL) were collected and analyzed for protein (•) and neutral
sugar (O). (B) Tracheal organ culture material excluded on Sepharose
CL-4B was centrifuged as above but for 67 h. Fractions (0.7-0.8
mL) were collected and aliquots screened for [3H]glucosamine (O)
and [I4C] leucine (#).
Both high- and low-density fractions from bronchial aspirate
material contained 30-40% neutral sugar and 10-20% protein
by weight. The high-density fraction had an amino acid
composition characteristic of a mucin-type structure (Table
II): threonine, serine, proline, glycine, and alanine totaled
64% of the amino acid residues; aromatic amino acids were
low (phenylalanine and tyrosine totaled 2% of the amino acid
residues). The low-density fraction had an amino acid com¬
position distinct from that of the high-density fraction:
threonine, serine, proline, glycine, and alanine totaled 51% of
the amino acid residues; aromatic amino acids (phenylalanine
and tyrosine) were greater (6% of the total amino acid resi¬
dues) than in the high-density fraction. The high- and low-
density fractions from bronchial aspirate material had similar
carbohydrate compositions, but the ratios of monosaccharides
in the two fractions were different (Table III). The neutral
sugar:hexosamine ratio was 2:1 in the high-density fraction
and 3:1 in the low-density fraction. Sulfate was present in both
the high-density (5.4% by weight) and low-density (3.6% by
weight) fractions. Glucose was also detected in both the high-
and low-density fractions. Delipidation removed most of the
Table III: Carbohydrate Analysis0 of High- and Low-Density
Fractions from Bronchial Aspirates









A-acety lgalac tosamine 11 4
sialic acid (as NeuNAc) 4 3
glucose 1 2
sulfate 5.4 3.6
° These analyses are on nondelipidated samples. Glucose is de¬
creased in delipidated samples (less than 1% by weight of total
glycoprotein in both the high- and low-density fractions).
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figure 5: Bio-Gel P-10 (1 X 30 cm) chromatography in 0.1 N
pyridinium acetate, pH 5.1, of high- (•) and low-density (O) fractions
from bronchial aspirates after treatment with alkaline sodium bo-
rohydride. Aliquots of each fraction were screened for neutral sugar.
glucose, suggesting the presence of glycolipid. The remaining
glucose may be a result of contamination from the dialysis
tubing used during purification. Only trace amounts of
mannose (<0.5% of the total carbohydrate) were detected in
the high-density fraction. A slight amount of mannose was
detected in the low-density fraction (1% of the total carbo¬
hydrate). Neither xylose nor uronic acid was detected in either
the high- or the low-density fractions. The carbohydrate in
both the high- and low-density fractions is linked to protein
via Ser/Thr on the basis of susceptibility to alkaline sodium
borohydride (Figure 5). The oligosaccharides of the high-
and low-density fractions were similar in size distribution and
ranged from 2-14 sugars.
Neither the high- nor the low-density fractions from tracheal
organ culture were susceptible to chondroitinase ABC digestion
as judged by their elution profile on Sepharose CL-4B. These
data indicate the absence of proteoglycan in these fractions.
Equilibrium sedimentation analysis of the high- and low-
density delipidated fractions (Figure 6) yielded molecular
weights of 2.3 X 106 for the high-density fraction and 1.5 X
106 for the low-density fraction. The curvature of the plots
showed a significant degree of polydispersity and/or aggre¬
gation with molecular weights ranging to 4.6 X 106 for the
high-density component and to 5.6 X 106 for the low-density
component.
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figure 6: Equilibrium sedimentation analysis of the high- (O) and
low-density (•) delipidated fractions from bronchial aspirate material
excluded on Sepharose CL-4B.
Table IV: Lipid Composition of Mucin
weight
% of % of total fatty
total acids as palmitate -
class of lipid lipid + stearate + oleate
neutral lipids 56
monoglycerides 5)
diglycerides 4r 61 for glycerides
triglycerides 20 J
cholesterol 15
cholesteryl esters 12 64
glycolipid-enriched fraction 26 63
phospholipid-enriched fraction 18 70
phosphatidylcholine
other phospholipids
The presence of noncovalently associated lipid was dem¬
onstrated by extraction of the high- and low-density fractions
from bronchial aspirates with CHCl3/MeOH. Three times
as much lipid was associated with the low-density fraction than
with the high-density fraction. This result suggested that
variations in lipid binding gave rise to the different buoyant
densities exhibited by the glycoproteins. As a test of this, (1)
bronchial aspirate material excluded from Sepharose CL-4B
was delipidated prior to density gradient centrifugation, and
(2) the low-density fraction from bronchial aspirate material
was delipidated and then rerun in density gradient centrifu¬
gation. The results of these two experiments are indicated in
Figure 7. Both delipidation of bronchial aspirate material
excluded from Sepharose CL-4B before centrifugation and
delipidation of the low-density fraction, followed by recen-
trifugation, yielded only a high-density fraction. Analyses of
material thus treated were substantially unchanged.
Lipid extraction and analysis were performed for seven
different bronchial aspirate void volume fractions (Table IV),
and the results are expressed as the mean value of the samples.
The total weight percent of lipid associated with these fractions
ranged from 5 to 15%. In all cases, neutral lipids (mono-, di-,
and triglyercides, cholesterol, and cholesteryl esters) comprised
the major class (56% of the total lipid). A glycolipid-enriched
fraction (26% of the total lipid) and a phospholipid-enriched
fraction (18% of the total lipid) were also identified. a-Na-
phthol-positive spots on TLC plates were designated glyco-
lipids. Specific glycolipids were not identified, but those
present had Rf values similar to a commercially available
(Sigma) preparation of crude cerebrosides. No gangliosides
were detected, based on comparison of the mobilities of known
gangliosides with the isolated lipids. In addition, no per-












figure 7: CsBr density gradient centrifugation of the low-density
fraction after delipidation [(□) neutral sugar; (■) protein] and
bronchial aspirate void volume material after delipidation [(O) neutral
sugar; (•) protein]. Centrifugation conditions were identical with
those described for Figure 4A.
Phosphatidylcholine was identified by comparison of the Rf
values of standard dipalmitoylphosphatidylcholine with those
lipids present. Several lipids with Rf values less than those
for DPC were visualized but not identified.
The glycolipid fraction was estimated to be contaminated
with 15—20% phospholipid based on spectrodensitometric
scanning of the TLC plates. The phospholipid fraction was
contaminated with 5-8% glycolipids. Palmitate (C16:0),
stearate (C18:0), and oleate (C18.|) were identified as the major
fatty acids in all classes of lipids.
Discussion
Mucin from bronchial aspirate material was chemically
characterized after solubilization in aqueous buffer without
the use of detergents or prior reduction. A similar result was
reported from this laboratory in a study on mucus from an
asthmatic patient (Feldhoff et al., 1979). This mild procedure
allowed the isolation of mucin glycoprotein in a near-native
state from seven different patients. Structurally similar
macromolecules were isolated and characterized from these
different secretions. Sepharose CL-4B chromatography sep¬
arated mucin glycoprotein from lower molecular weight serum
components, but entrapped contaminants were still present as
judged by the presence of lower molecular weight components
on NaDodS04-polyacrylamide gel electrophoresis.
CsBr density gradient centrifugation removed these con¬
taminating components, and in addition, in four of the samples
characterized, high-density and low-density mucin glyco¬
proteins were identified. The high-density mucin glycoprotein
appeared homogeneous by rechromatography on Sepharose
CL-4B, by recentrifugation in CsBr, and by NaDodS04-
polyacrylamide gel electrophoresis. In general, the isolated
glycoprotein fraction met the following criteria: a single, albeit
broad, peak on exclusion (A150M) or ion-exchange (DEAE-
Sephadex A25) chromatography; no detectable amino-terminal
end group; failure to enter a 0.5% agarose/2% acrylamide gel;
no other protein component detectable by polyacrylamide gel
electrophoresis in the presence of sodium dodecyl sulfate (500
Mg loading); absence of uronic acid (proteoglycan) and man-
nose (N-glycosidically linked glycoprotein); and complete
susceptiblity of saccharides to alkaline borohydride catalyzed
elimination. This component had an amino acid composition
characteristic of a mucin-type structure similar to that reported
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for bronchial glycoproteins obtained from a patient with cystic
fibrosis (Rose et al., 1979) but a somewhat higher protein
content than that reported from bronchial glycoproteins ob¬
tained from a patient with asthma (Feldhoff et al., 1979).
Carbohydrate analysis indicated the presence of fucose,
galactose, glucosamine, galactosamine, and /V-acetylneur-
aminic acid. The relative ratios of sugars were different than
those reported in cystic fibrosis bronchial secretions (Rose et
al., 1979; Roussel et al., 1975) and asthmatic bronchial se¬
cretions (Feldhoff et al., 1979). Sulfate was identified,
probably esterified to galactose (Roussel et al., 1975).
Mannose, xylose, and uronic acid, which are constituents of
serum glycoproteins and proteoglycan, respectively, were not
present. Equilibrium sedimentation analysis indicated the
presence of aggregation and/or polydispersity of the glyco¬
protein whose molecular weight ranged from 2.3 X 106 to 4.6
X 106.
The low-density fraction present in some samples contained
a mucin glycoprotein with a slightly altered composition from
that of the high-density component, although the protein/
carbohydrate ratios of the two components were the same
(1:4). In addition, Sepharose CL-4B rechromatography in¬
dicated the presence of lower molecular weight components
which were not further characterized. This low-density gly¬
coprotein appeared homogeneous by NaDodS04-polyacryl-
amide gel electrophoresis.
Previous studies using density gradient centrifugation have
reported the presence of low buoyant density protein/glyco¬
protein components in blood group substances (Creeth &
Denborough, 1970), bronchial glycoproteins from asthmatic
bronchitic patients (Creeth et al., 1977), and glycoproteins
from pig small intestinal mucus (Mantle & Allen, 1981;
Mantle et al., 1981). These studies have not reported the
presence of mucin-like glycoproteins of low buoyant density.
The apparent low density appears to be a result of variations
in lipid binding which can give rise to aggregates with different
buoyant density. There is a slight alteration in carbohydrate
and/or protein composition, but the overall mucin structure
is present. These data suggest that in addition to the clustered,
hydrophilic sugar domain a hydrophobic region is present
which can bind lipid and may thus provide a mechanism for
clearance of such components from the respiratory tract.
It is not known why some of the bronchial aspirate samples
did not contain a low-density glycoprotein fraction. Lack of
this component is probably not a result of a lack of lipid
binding specificity since all seven aspirate samples qualitatively
contained the same lipids. The slight quantitative differences
in the samples (5-8% variations in any given class of lipid)
may be sufficient to prevent resolution of a low-density fraction
by the techniques employed. Quantitative differences of total
associated lipid, however, do not seem to affect whether a
low-density component appears upon centrifugation.
Lipids have been identified in pulmonary lavage of patients
with alveolar proteinosis (Sahu et al., 1976), in secretions
(Chernick & Barbero, 1959) and sputum (Matthews et al.,
1963; Gaiabert et al., 1981) from cystic fibrosis patients, and
from lung lavage of patients with asthma and cystic fibrosis
(Sahu & Lynn, 1977). In these studies, phosphatidylcholine
was identified as the major lipid. Neutral lipids such as mono-,
di-, and triglycerides, cholesterol, and cholesteryl esters were
identified, and some glycolipids were identified (Sahu & Lynn,
1977).
Lipids present in mucus obtained from an asthmatic patient
were found to be different than those described in the above
studies. Lewis (1971) found neutral lipids (mono-, di-, and
triglycerides, free fatty acids, cholesterol, and cholesteryl es¬
ters) to be the major class (64.8% of total lipid weight);
phospholipids were also identified.
The lipids associated with the mucin glycoprotein from
normal bronchial secretions were similar to those described
by Lewis. Neutral lipids comprised the major class of lipid
(56% of the total lipid weight); phospholipids and glycolipids
were present. It should be noted that these lipids were isolated
from fractionated mucus (i.e., Sepharose CL-4B void volume
material) whereas lipids described in the above studies were
isolated from whole mucus. Lhermitte et al. (1977) reported
the presence of lipid associated with mucin glycoproteins ob¬
tained from a patient with chronic bronchitis. They found that
two fractions obtained from affinity chromatography had
associated lipid identified as neutral lipids (steroids, free fatty
acids, and mono-, di-, and triglycerides) and polar lipids
(cardiolipids, cephalins, lecithins, and sphingomyelins).
It is clear from the lipid analysis that the contribution of
lipid to the overall architecture of mucus secretions cannot be
overlooked. The analysis does not indicate any specificity of
a given lipid (or class of lipid) for interacting with mucin
glycoprotein nor does it address the structural requirement of
the glycoprotein for lipid binding. In vitro lipid binding ex¬
periments using intact mucin glycoproteins and mucin gly¬
coprotein fragments may yield answers to these questions.
Experiments with primary explant culture of human tracheal
epithelium suggest that these cells produce macromolecular
components similar to those isolated from bronchial aspirate
materials. The high- and low-density components incorporate
glucosamine into glycoconjugates. In addition, the high-density
component is susceptible to alkaline sodium borohydride
treatment. Fractionation of the alkaline borohydride treated
high-density component on Bio-Gel P-10 gave an elution profile
similar to that obtained by fractionation of the oligosaccharides
obtained from alkaline borohydride treated bronchial aspirate
high-density mucin glycoprotein.
These preliminary data suggest that tracheal epithelial cells
in culture produced macromolecules with physical properties
similar to mucin glycoproteins from bronchial secretions.
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INFLUENCE OF GLYCOSAMINOGLYCANS ON ENDOGENOUS DNA SYNTHESIS
IN ISOLATED NORMAL AND CANCER CELL NUCLEI
DIFFERENTIAL EFFECT OF HEPARIN
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The influence of exogenously-added glycosaminoglycans and glycoproteins on DNA synthesis in isolated
nuclei, from normal and malignant tissues, was investigated. Heparin stimulated DNA synthesis in normal
cell nuclei at concentrations (heparin/DNA (w/w)<0.9) which inhibited DNA synthesis in tumor cell nuclei,
^t higher concentrations (heparin/DNA (w/w)>0.9) heparin inhibited DNA synthesis in both normal and
tumor cell nuclei. The chondroitin-4 and 6-sulfates, heparan sulfate, cartilage proteoglycan, N-desulfated
heparin, and glycophorin caused inhibition of DNA synthesis at all concentrations tested and in all nuclei
examined. Hyaluronic acid, dermatan sulfate, keratan sulfate, a,-acid glycoprotein and fetuin had no
significant influence on DNA synthesis in isolated nuclei.
Introduction
Following the report from this laboratory [1] of
the detection of glycosaminoglycans in the nuclei
of B16 mouse melanoma cells, the presence of
these compounds in the nuclei of a variety of
cultured animal cells and tissues has been reported
[2-7], These findings point to the generality of the
occurrence of glycosaminoglycans in animal cell
nuclei (see review by Stoddart [8]). In addition to
the presence of the strongly anionic glyco¬
saminoglycans, the wide distribution of sialogly-
coproteins in cell nuclei has also been amply docu¬
mented [1-3,6,7,9,10], A related observation of
interest is the detection of a sulfated and phos-
phorylated galactan in the nuclei of the slime mold
Physarum polycephalum [11,12]. Since in our initial
experiments over 90% of the glycosaminoglycans
were sedimentable after exhaustive treatment of
nuclei with DNAase, it was suggested that the
nuclear glycosaminoglycans might be primarily
membrane associated [1], However, subsequent
studies by us [6,7] and by other investigators [2]
indicate that a major portion of the nuclear glyco¬
saminoglycans are localized in the chromatin. The
failure to release glycosaminoglycans by DNAase
digestion may be due to the inaccessibility of the
enzyme to the chromatin and to the formation of
insoluble complexes between the released histones
and anionic glycosaminoglycans.
Several classes of acidic polymers have been
shown to influence nucleic acid synthesis in iso¬
lated nuclei (see review by Coffey et al. [13]).
Indirect evidence for the possible involvement of
acidic polysaccharides in nuclear functions has
been provided by a number of investigators [14-
19]. The ability of polyanionic polysaccharides
such as heparin [20,21], gum tragacanth [22] and
dextran sulfate [23] to inhibit tumor cell growth in
vitro and in vivo has also been observed. We,
0167-4781 /82/0000-0000/S02.75 © 1982 Elsevier Biomedical Press
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therefore, undertook an investigation to determine
the influence of exogenously added glyco-
saminoglycans and glycoproteins on DNA synthe¬
sis in isolated nuclei from normal (rat liver, regen¬
erating rat liver, rat kidney) and from cancer
(hepatomas, melanoma, neuroblastoma), tissues.
Our studies presented here, show that the highly
anionic glycosaminoglycans have differential ef¬
fects on DNA synthesis in normal and cancer
tissues. A preliminary report has been presented
[24],
Materials and Methods
Cells and tissues. Morris hepatoma 7777 [25]
(provided by Dr. John Taylor, Department of
Microbiology, M.S. Hershey Medical Center) was
maintained by bilateral implantation into the thigh
muscle of male Buffalo rats (Simonsen Laborato¬
ries, Gilroy, CA). Normal livers and regenerating
livers (17 h after partial hepatectomy) were ob¬
tained from animals approx. 12 weeks of age. B16
mouse melanoma cells were grown as solid tumors
in C57BL/6J mice [26]. Mouse neuroblastoma
tumors [27] grown in A/J mouse and Morris
hepatoma 3924A [28] grown in ACI rats were
kindly provided by Dr. C.-L. Schengrund and Dr.
K. Rose, respectively.
Isolation of nuclei. Nuclei from perfused normal
and regenerating rat livers and from rat kidneys
were isolated using a modification [5] of the proce¬
dure described by Lynch et al. [29]. Rat liver
nuclei prepared by this method has been sljown to
exhibit semiconservative DNA synthesis [30] com¬
pared to nuclei obtained by other methods [31,32].
Nuclei from solid tumors (hepatoma, melanoma
and neuroblastoma) were similarly isolated except
that in some experiments a different homogeniza-
tion medium (25 mM citric acid/0.5 mM
CaCl 2/0.5 mM MgCl2) was used. Similar results
were obtained in DNA synthesis assays using
tumor nuclei isolated by the two methods. The
absence of contaminating organelles in liver and
hepatoma nuclei was established by assays for
marker enzymes and by electron microscopic ex¬
amination [1,5,7]. All preparations of nuclei were
routinely monitored for purity by light micros¬
copy.
DNA synthesis in isolated nuclei. Assay of DNA
synthesis was done in triplicate in 0.25 M
sucrose/50 mM Tris-HCl (pH 7.5)/25 mM
KC1/7 mM MgCl2/5 mM mercaptoethanol al
37°C using the following final concentrations ol
nucleoside triphosphate, 0.3 mM for dATP, dCTF
and dGTP, 1 mM for ATP and 0.06 mM (5 pCi]
for [3H]dTTP [17]. Nuclei (100-160 jug DNA/ml).
cold nucleoside triphosphates and glycoconjugate
in a final volume of 1 ml were mixed in siliconized
glass test tubes, preincubated for 15 min, and the
reaction started by addition of [3H]dTTP. Aftei
incubating at 37°C for the appropriate time, the
reaction was terminated by addition of cold 10%
trichloroacetic acid/0.1 mM dTTP/10 mM sodiuir
pyrophosphate. The radioactivity in the trichloro¬
acetic acid supernatant was practically all (99%'
dialysable, indicating that the labeled DNA was
completely precipitated under the conditions used
The precipitate was washed three times with 5%
trichloroacetic acid/10 mM sodium pyrophos¬
phate. Control experiments showed that all unin¬
corporated [3H]dTTP was removed after three
washes and that the use of siliconized tubes pre¬
vented the precipitate from sticking to the glass
The pellet was dissolved in 2% SDS (1 ml), mixec
with 10 ml of ACS II scintillant (Amersham) anc
radioactivity determined by scintillation counting
on an Intertechnique SL4000 spectrometei
equipped with a DPM calculating module.
Controls in which the reaction mixtures were
heated (100°C, 15 min) after preincubation anc
before the addition of [3H]dTTP were included ir
every experiment. The radioactivity associated wit!
the trichloroacetic acid precipitate in these con
trols was about 3% for normal and regenerating
liver nuclei and about 0.3% for hepatoma nucle
compared to the radioactivity in trichloroaceti*
acid precipitates of the corresponding unheatec
assays. Further, the amount of radioactivity in th<
trichloroacetic acid precipitate of the heated con
trols was independent of incubation time. Th<
influence of glycoconjugates on DNA synthesis fo
a 3 h time period are reported, unless otherwise
stated or implied.
Assay for protease and nuclease activities. Thi
glycosaminoglycan and glycoprotein samples wen
all tested for contaminating protease and nucleasi
activities under conditions identical to those use*
for the measurement of DNA synthesis. Azocaseii
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(Calbiochem, La Jolla, CA) and [14C]methe-
moglobin (New England Nuclear, Boston, MA)
were used as substrates for proteases. [3H]DNA
(isolated from regenerating livers of rats injected
with [3H]dTTP) and [32P]tRNA from Escherichia
coli (kindly provided by Dr. R. Coleman of this
department) were used as substrates for nucleases.
All samples were found to be free of these enzyme
activities with the exception of a commercial sam¬
ple of hyaluronic acid (Worthington) which had
contaminating protease activity.
Desulfation of sulfated glycosaminoglycans was
done according to the method of Nagasawa et al.
[33]. The N-desulfated heparin was re-TV-acetylated
as described by Cifonelli [34]. The DNA content
of nuclei was determined by the method of Burton
[35] using calf thymus DNA as standard. Hexos-
amine was assayed after hydrolysis of the glyco¬
saminoglycans (6N HC1, 100°C, 12 h) by the
method of Dische [36] or on an amino acid
analyzer. The values were corrected for the decom¬
position of hexosamines during hydrolysis. Sulfate
was determined by the barium chloranilate method
[37], Deoxynucleoside triphosphates were pur¬
chased from Sigma (St. Louis, MO) and adenosine
triphosphate from Calbiochem (La Jolla, CA).
[3H]dTTP (70-80 Ci/mmol) was obtained from
New England Nuclear (Boston, MA). The sources
of the glycoconjugates used are given in the text.
Cellulose acetate electrophoresis of glyco¬
saminoglycans was carried out in 0.1 M pyri-
dine/acetic acid, pH 5.0 at 1 mA/cm for 20 min.
The glycosaminoglycans were detected by staining
with Alcian blue (0.5% acetic acid) and their mo¬
bility relative to that of beef lung heparin (®Hep)
calculated.
Results
The time course of DNA synthesis in the vari¬
ous nuclei is shown in Fig. 1; in all cases the
reaction was linear during the initial hour. The
reaction was also linear at DNA concentrations
tested up to a level of 200 /xg/ml (data not given).
Incorporation of [JH]dTTP into acid insoluble
materials was lowest in normal quiescent liver
nuclei and slightly higher in regenerating liver
nuclei, as expected. In hepatoma nuclei, DNA
synthesis was 5-8-fold higher than in normal liver
Fig. I. Incorporation of [3H]dTTP into DNA (acid-insoluble
material) in isolated nuclei as a function of time. Nuclei from
Morris hepatoma 7777 25 (O O), 32 (• •) or 47
(A A) days after transplantation; nuclei from regenerat¬
ing rat liver 17 h post-hepatectomy (□ □); nuclei from
rat liver (o o ); heated (100°C, 15 min) rat liver nuclei
(A A).
nuclei. The highest rate of incorporation was found
in hepatoma nuclei at early stages of growth (25
days after transplantation); this level of activity
gradually decreased with increasing age of the
tumor. This is apparently due to the increase in
proportion of dormant and necrotic cells in the
tumor. Routinely, hepatomas at 25-32 days of
growth were used in our experiments.
In all cases, the incorporation of [3H]dTTP into
the nuclei was drastically reduced (95%) if un¬
labeled dTTP at 0.3 mM was included in the
incubation mixture. DNA synthesis in the isolated
nuclei was also inhibited 80-95% by 5-10 mM
A-ethylmaleimide (Sigma, St. Louis, MO). This
compound is reported to be a specific inhibitor of
the DNA replicating enzyme, DNA polymerase a
and is considered to have little or no effect on the
DNA repair enzyme, DNA polymerase /? [38], It is
thus likely that the major activity determined in
our assay is that associated with replication. Fur¬
ther experiments are necessary to substantiate this
observation.
Effects of exogenously added hyaluronic acid (100
Hg/100-160 fig DNA) on DNA synthesis
Hyaluronic acid from various tissues and
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sources (human umbilical cord: Boehringer Man¬
nheim, F.R.G.; hog skin: Seikagaku Kogyo, Tokyo,
Japan; bovine vitreous humor: Sigma, St. Louis,
MO., Millipore, Freehold, NJ and isolated by K.F.)
had no significant effect on DNA synthesis in
isolated nuclei. Vitreous humor hyaluronic acid
(from Worthington) caused inhibition, but this
was proved to be due to a protease contaminant.
Inclusion of soybean trypsin inhibitor in the assay
mixture containing the Worthington hyaluronic
acid restored DNA synthesis to within 10% of the
control activity. Further, purification of this hy¬
aluronic acid by chromatography on DEAE-Sep-
harose removed the contaminating component re¬
sponsible for the inhibition.
Effects of exogenously added sulfated glyco
saminoglycans (100 \ig/100-160 jug DNA) on DN/
synthesis
The results of a large number of experiment
are summarized in Table I. Dermatan sulfate ant
keratan sulfate, each from two different sources
did not have significant effects on DNA synthesi
in any of the nuclei tested.
Among the other sulfated glycosaminoglycan
tested, chondroitin-6-sulfate (three different sam
pies) and cartilage proteoglycan inhibited DN/
synthesis in hepatoma by 40-45% but caused lesse
inhibition of DNA synthesis in normal and regen
erating liver nuclei. After additional purificatioi
of the chondroitin-6-sulfate (Seikagaku Kogyo
TABLE I
EFFECT OF SULFATED GLYCOSAMINOGLYCANS ON ENDOGENOUS DNA SYNTHESIS IN ISOLATED NUCLE
FROM RAT LIVER, REGENERATING LIVER AND HEPATOMA
n.d. is not determined.
Several preparations of each of the sulfated glycosaminoglycans from different tissue sources and origins (commercial or gifts) weri
tested. The different preparations showed similar effects, however, quantitative differences were present. The data presented ari
representative. 100 fig sulfated glycosaminoglycan versus nuclei equivalent to 100-160 fig DNA is used in each experiments. RHep
electrophoretic mobility on cellulose acetate relative to bovine lung heparin. Kav is calculated from the elution profile on a Bio-Ge
P-60 column using [3H]porcine submaxillary gland mucin (Mr 830000) and [MC]glucose as markers for V0 and Vt, Respectively
Mean± S.E.M., number of experiments is in parentheses.
Glycosaminoglycan Sulfate RHep Kav [3H]dTTP incorporated into DNA in 3 h;
(Tissue source) ~ T (X10-2) Percent control valuesHexosamine
Normal liver Regenerating Morris
liver hepatoma 7777
Dermatan sulfate a (pig skin) 1.11 0.84 6.45 88.5 ±20 (3) 89.7 84.9 ± 7.0 (2)
Keratan sulfate b
(human costal cartilage) 1.24 0.83 4.84 103.0— 1.0(2) 98.6 ±7.4 (2) 132 ± 10 (2)
Proteoglycan c
(bovine nasal septum) 0.72 n.d. n.d. 91.6 ± 14 (4) 83.3±4.0 (3) 59.6± 2.9 (2)
Chondroitin-4-Sulfate b
(river sturgeon notochord) 1.03 0.86 6.35 67.3 ± 4.1 (2) n.d. 79.0± 2.7 (2)
Chondroitin-6-Sulfate d
(shark cartilage) 1.25 0.92 3.23 76.4 ±13 (7) 69.3 ±4.1 (3) 55.1 ± 7.9 (3)
Heparan Sulfate b
(bovine liver) 1.17 0.86 n.d. 16.6± 3.3 (3) n.d. 30.4
Heparin b (bovine lung) 2.77 1.00 22.2 242 ±22 (5) 183 13.1 ± 7.9 (6)
Chondroitin Sulfate H e
(hagfish notochord) 1.65 0.93 n.d. 270 ±13 (2) n.d. 16.1 ± 4.7 (3)
a Purchased from Sigma.
b Kindly donated by Dr. M.B. Mathews, University of Chicago, Chicago, IL.
c Gift from Dr. E.A. Chandrasekaran, University of Georgia, Athens, GA.
d Obtained from Seikagaku Kogyo.
e Isolated by K.F.
3o5
348
Normal Liver Nuclei Morris Hepatoma 7777 NyQlqi










Fig. 2. Relationship between sulfate content of glyco-
saminoglycans and the degree of inhibition of DNA synthesis
in nuclei isolated from rat normal liver (left panel) and Morris
hepatoma 7777 (right panel). Glycosaminoglycans with differ¬
ent degree of sulfation were purchased from Sigma (1 and 5),
Seikagaku Kogyo (3 and 6) or donated by Dr. M.B. Mathews
(2, 4 and 9) and by Dr. A. Linker (7, 8 and 10), respectively.
Tokyo) and proteoglycan by DEAE-Sepharose
column chromatography and CsCl density gradi¬
ent centrifugation [39], respectively, the same re¬
sults were obtained. Increasing concentrations of
chondroitin-6-sulfate showed increased inhibition
of DNA synthesis in normal liver nuclei. De-
sulfated chondroitin-6-sulfate, in which about 90%
of the sulfate had been removed had no effect on
DNA synthesis in any of the nuclei tested.
Chondroitin-4-sulfates (three different samples)
inhibited DNA synthesis to varying degrees in the
different nuclei. Heparan sulfates (four different
samples) showed marked inhibition of DNA
synthesis in both liver and hepatoma nuclei. The
degree of inhibition of DNA synthesis in nuclei by
the chondroitin sulfates and heparan sulfate is
correlated with the sulfate to hexosamine ratio
(Fig. 2). The electrophoretic mobility (RHep) in
pyridine/acetate buffer (pH 5.0) was also corre¬
lated to the degree of inhibition but the correlation
was not as marked (data not given). However,
additional studies are necessary to further substan¬
tiate these observations since the molecular size of
these sulfated glycosaminoglycans and charge dis¬
tribution may also be factors.
Heparin (two samples) and chondroitin sulfate
H (polysulfated dermatan sulfate) showed con¬
trasting effects on DNA synthesis in the different
nuclei. Whereas, these compounds stimulated
DNA synthesis in nuclei from normal tissues (rat
liver and regenerating rat liver), at equivalent con¬
centrations they consistently inhibited DNA
synthesis in nuclei from the malignant (hepatoma)
tissue (Table I).
The effects of heparin and its derivatives over a
range of concentrations on DNA synthesis in nor¬
mal liver and hepatoma nuclei are illustrated in
Fig. 3. It was evident that in normal liver nuclei,
low levels of heparin (heparin/DNA (w/w) < 0.9)
stimulated DNA synthesis, the maximum stimula¬
tion was exhibited at 40 jag heparin/100 fig DNA.
At higher levels of heparin (heparin/DNA (w/w)
>0.9) a marked inhibition is noted and at 130 fig
heparin/100 jug DNA, the inhibition of DNA
synthesis was essentially total (Fig. 3a). The effect
of heparin on DNA synthesis in regenerating rat
liver and rat kidney nuclei was similar to that
observed in liver nuclei. With increasing heparin
concentration for a fixed amount of nuclei isolated
from regenerating rat liver or rat kidney, the
1.0 1.5
HEPARIN /DNA (w/w)
Fig. 3. Dose effect of heparin and its derivatives on endogenous
DNA synthesis in nuclei isolated from (a) rat liver (b) Morris
hepatoma 7777. Heparin (O O); desulfated heparin
0); A-desulfated re-iV-acetylated heparin
(A A). The effect of very low doses of heparin on DNA
synthesis in hepatoma nuclei is shown in the inset.
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stimulation of DNA synthesis was enhanced re¬
aching a level in regenerating liver nuclei similar to
that observed in normal liver nuclei at a weight
ratio of heparin to DNA of 0.4; in kidney nuclei, a
3-fold enhancement compared to control level was
observed at a heparin DNA ratio (w/w) of 0.4. At
higher ratios, the degree of stimulation gradually
decreases and finally a strong inhibition of DNA
synthesis in both types of nuclei is noted. The
observed effects of heparin on DNA synthesis in
liver nuclei are in general agreement with the
results of Kraemer and Coffey [14] utilizing exoge¬
nous E. coli DNA polymerase; Cook and Aikawa
[17] using the endogenous DNA polymerase in
isolated rat liver nuclei and Shimada and Terayama
[40] using the endogenous DNA polymerase in
isolated rat brain nuclei.
In contrast to the stimulation of DNA synthesis
in normal liver nuclei at low concentrations and
inhibition at higher concentrations, heparin showed
no stimulation of DNA synthesis in hepatoma
nuclei even at very low concentrations (see inset
Fig. 3b). At concentrations of 10 jug heparin/100
jug DNA and higher, heparin consistently in¬
hibited DNA synthesis in hepatoma nuclei. The
inhibition was virtually complete at about 50 /xg
heparin/100 /xg DNA. These data are in sharp
contrast to the 16- and 26-fold stimulation by
heparin of DNA synthesis in rat hepatoma (9618A
and 5123C) nuclei reported by Coffey et al. [13].
However, their studies were done with exogenous
DNA polymerase using [3H]dTMP and a 30 min
incubation and may not be directly comparable to
ours. Desulfated heparin showed no influence on
DNA synthesis in any of the nuclei tested. How¬
ever, /V-desulfated re-yV-acetylated heparin in¬
hibited DNA synthesis in both normal liver and
hepatoma nuclei but to different degrees (Fig. 3).
Effects of exogenously added glycoproteins on DNA
synthesis
In contrast to the striking effects shown by
some of the sulfated glycosaminoglycans, glyco¬
proteins tested showed either little or no effect on
nuclear DNA synthesis. Glycophorin (100
/xg/100-160 /xg DNA) showed 47, 51 and 20%
inhibition in nuclei from normal liver, regenerating
liver and hepatoma, respectively. Fibronectin (47
/xg/100-160 /xg DNA) showed between 20 to 36%
stimulation but the significance of this could nol
be established due to the limited quantities of this
sample available, a,-acid glycoprotein and fetuir
(Sigma) at concentration of 200 jug/100-160 jug
DNA showed no significant effect. A strong in¬
hibition of DNA synthesis in all nuclei by the
fetuin sample from Gibco (Cat. No. 918S, Spire
method) was shown to be due to the presence ol
zinc. After dialysis against ethylenediamine tetra-
acetic acid or chromatography on a column ol
DEAE-Sepharose the inhibitory activity of this
fetuin sample was lost. Atomic absorption spectro
metric analysis showed the presence of 12.8
zinc in 1 mg of this fetuin preparation. Addition o:
2.6 /xg zinc to the reaction mixture caused th<
same degree of inhibition of DNA synthesis a;
that given by 200 /xg of the Gibco fetuin.
Alterations in pH and Mg2+ concentration of reac
tion mixture by heparin
The possibility that the effects of the exoge
nously added heparin on DNA synthesis were dui
to alterations in the pH and/or magnesium con
centration of the reaction mixture was investi
gated. The change in pH of the complete assa;
Fig. 4. Effect of magnesium concentration on DNA synthesis ii
isolated nuclei from normal rat liver. The reaction mixture i
identical with the exception that the MgCl 2 concentration i
varied from 0 to 20 mM in the absence (O O) am
presence (• •) of 150 /xg heparin/155 /xg DNA.
2>ol
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mixtures with and without 200 jug heparin were
identical. In the both cases the pH dropped from
7.5 to 7.40 and 7.35 after 1.5 and 3 h of incuba¬
tion, respectively. The effect of Mg2+ concentra¬
tion on DNA synthesis in normal liver nuclei in
the absence and presence of heparin is illustrated
in Fig. 4. It is clear that the inhibition of DNA
synthesis in liver nuclei (155 jug DNA) by heparin
(150 jag) is not due to limiting Mg2+ concentra¬
tion. In fact, both in the absence and presence of
heparin the optimal Mg2+ concentration for DNA
synthesis is between 5 to 7 mM. The concentration
used in our routine incubation mixture was 7 mM.
Dose effect of heparin on endogenous DNA synthesis
in nuclei isolated from various tumors
Experiments were done to determine whether
the inhibition by heparin of DNA synthesis in
Morris hepatoma 7777 nuclei was a phenomenon
common to nuclei of malignant cells. Heparin
inhibited DNA synthesis in nuclei from B16 mouse
melanoma, mouse neuroblastoma and Morris
hepatoma 3924A at both low and high concentra¬
tions. The degree of inhibition in melanoma and
neuroblastoma was, however, lower than that ob¬
served with hepatoma nuclei at comparable con¬
centrations of heparin. This may be partly due to
the use of these tumor tissues from rather late
stages of growth in comparison to the more ac¬
tively growing hepatoma tissue.
Discussion
Based on our results, the glycoconjugates may
be classified into three groups depending on their
influence on DNA synthesis. The first group, con¬
sisting of a,-acid glycoprotein, fetuin, hyaluronic
acid, dermatan sulfate, keratan sulfate, desulfated
chondroitin-4,6-sulfate and desulfated heparin, has
no effect on DNA synthesis. The second group,
consisting of the chondroitin sulfates, proteo¬
glycan, heparan sulfate, A-desulfated heparin and
glycophorin cause inhibition of DNA synthesis in
both normal and cancer cell nuclei. The most
interesting observation was the differential effect
caused by the third group of glycosaminoglycans
consisting of the highly sulfated heparin and
chondroitin sulfate H.
It is evident from the results that the degree of
anionicity does not by itself determine the nature
of influence of glycoconjugates on DNA synthesis.
Whereas proteoglycan and chondroitin-4-sulfate
with sulfate to hexosamine ratios of 0.72 and 1.03
inhibits DNA synthesis, keratan sulfate and der¬
matan sulfate with higher degree of sulfation
(sulfate to hexosamine ratios of 1.24 and 1.11) do
not have any effect on DNA synthesis under iden¬
tical conditions. However, within classes of glyco¬
saminoglycans (for example, chondroitin sulfate
and heparan sulfate) showing inhibition of DNA
synthesis, the higher the degree of sulfation the
higher the inhibition (Fig. 2). It is thus possible
that dermatan and keratan sulfate samples of
higher sulfate content than those tested in these
studies may influence DNA synthesis.
Our results also show that differences in the
molecular weight (size) among the glyco¬
saminoglycans is not a sufficient factor to account
for differences in their influence on DNA synthe¬
sis. Dermatan sulfate and chondroitin-4-sulfate
have almost similar elution profiles on a Bio-Gel
P-60 column (compare Kav, Table I) but the former
has no effect and the latter inhibits DNA synthe¬
sis.
An important consideration in these studies is
the ability of the various glycosaminoglycans to
enter the nuclei. Preliminary results indicate that
only a small portion of the added heparin enters
the nuclei and only a fraction of this is associated
with the chromatin. There was no significant dif¬
ference in the ability of heparin to enter the nor¬
mal or cancer cell nuclei. It is also found that
saturation levels of heparin inside the nuclei is
reached only after 2 to 3 h. Thus, in order to
determine the maximum influence of exogenously
added polyanions, it is necessary to carry out
incubation for periods of about 3 h rather than the
30 min employed in previous studies [13,40].
The molecular mechanism of the influence of
sulfated polysaccharides, in general, on DNA
synthesis remains unknown. The fact that these
acidic polysaccharides are capable of forming
complexes with histones in vitro (unpublished data)
and the finding that the effect on DNA synthesis
by'heparin was prevented by addition of histones
[17] suggest that the interaction between the acidic
polysaccharides and histones in the nuclei might
be important. Further, the direct interaction of
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glycosaminoglycans with DNA polymerases as
observed in studies with purified bacterial poly¬
merases [19] and animal polymerases (Refs. 41, 42
and unpublished data) may also be relevant.
It is difficult to explain the differential effects
of the highly sulfated polysaccharides on DNA
synthesis in normal and malignant cell nuclei.
Differences in the structural organization of chro¬
matin, endogenous glycosaminoglycan levels and
structures (activities) of the polymerases may all
be contributory factors. Thus, for example, it is
possible that the heparin entering the normal cell
nuclei initially interacts with chromatin increasing
template availability thus resulting in the stimula¬
tion of DNA synthesis. At higher concentrations,
the excess heparin could bind to DNA polymerase
a [42] and inactivate it. In cancer cell nuclei the
added heparin has no effect on template activity,
either due to differences in chromatin organization
or because the template activity is already maxi¬
mal. As a consequence, even at low concentrations
the added heparin interacts with the polymerase
causing inhibition.
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Glycopeptides located at asparagine residues at position 52 in the a-subunit and at position 7 in the
/3-subunit of human follicle-stimulating hormone (FSH) were obtained by pronase digestion of the intact
human FSH molecule. The glycopeptide fractions were isolated by gel filtration and by high-voltage
electrophoresis on paper at pH 6 and/or pH 3.5. Alkaline degradation studies performed on the a- and
/3-subunits of human follicle-stimulating hormone confirmed that carbohydrate moieties linked O-glycosidi-
cally to threonine or to serine are not present in either subunit. Carbohydrate composition of both a-52 and
/3-7 glycopeptides was similar. Sialic acid, mannose, galactose, A7-acety Iglucosamine, ^-acetylgalactosamine
and fucose were present in a ratio of 3:4:3:4:1:1 in both glycopeptides. The results of sequential enzymatic
digestion revealed that the peripheral monosaccharide sequence of both the a-52 and /3-7 glycopeptides
consisted of three chains each containing the following sequence: sialic acid — galactose — /3-/V-acetylglu-
cosamine — mannose. The composition of the undigested 'inner core' of both carbohydrate moieties was
found to be similar and consisted of one residue/mol glycopeptide each of mannose, N-acetylglucosamine,
^-acetylgalactosamine, and fucose. The unique presence of GalNAc attached to an /V-glycosidically linked
GIcNAc was confirmed by hexosamine analysis on an amino acid analyzer, by thin-layer chromatography, by
digestion with enzymes such as exo-a-N-acetylgalactosaminidase and endoglycosidases D and H, and by
ion-exchange chromatography on DEAE-Sephacel. The monosaccharide sequence of the a-52 and the /3-7
glycopeptides of human follicle-stimulating hormone is shown below and is identical to the one at the a-78
position.
NeuAc — Gal — GIcNAc — Man
NeuAc — Gal ^ GIcNAc 5- Man
NeuAc — Gal GIcNAc Man j
Peripheral Region
Man —GalNAc —GIcNAc — Asn
Fucose
Inner core region
* Present address: The Rockefeller University, New York,
NY 10021, U.S.A.
** To whom correspondence should be addressed.
Abbreviations: FSH, follicle-stimulating hormone; LH,
luteinizing hormone; CG, chorionic gonadotropin; TSH,
thyroid-stimulating hormone; NeuAc, /V-acetylneuraminic acid;
GIcNAc, /V-acetylglucosamine; GalNAc, ^-acetylgalactosa¬
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Introduction
Elucidation of the structure of the carbohydrate
moieties of human FSH is important in under¬
standing the metabolism, biological activity and
structure-function relationship of the hormone.
There are four asparagine-linked carbohydrate
moieties in FSH; two are located at residues 52
and 78 in the a-subunit sequence and the other
two at residues 7 and 24 in the /?-subunit sequence
[1,2]. The monosaccharide sequence of the carbo¬
hydrate moiety at residue 78 of the a-subunit has
been reported [3]. The monosaccharide sequence
was unique from other known glycopeptides in
that an ^-acetylgalactosamine residue was at¬
tached to the vV-acetylglucosamine A-glycosidi-
cally linked in the 'inner core' (Fig. 1). Fetherstone
et al. [4] and Kessler et al. [5] have reported an
jV-acetylglucosamine instead of an A-acetylgalac-
tosamine in the inner core of the carbohydrate
moieties of bovine luteinizing hormone and human
chorionic gonadotropin. Since this report, N-
acetylgalactosamine in an A-glycosidically linked
oligosaccharide unit has been reported in ovine
and bovine luteinizing hormones [6]; however, the
galactosamine was found to be present in one of
the peripheral chains rather than in the 'inner
core'. Recently, Parsons and Pierce [7] have re¬
ported a sulfated terminal .^-acetylgalactosamine
in one of the peripheral chains of a carbohydrate
moiety of bovine LH. These observations indicate
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Fig. 1. Proposed common structure for the carbohydrate moie¬
ties of the human FSH-a-52 and human FSH-/8-7 glyco-
peptides.
differences in the carbohydrate structures of closel
related glycoprotein hormones such as bovine Lf
and human CG. In order to resolve the monosac
charide sequence of carbohydrate moieties at posi
tion 52 of human FSH-a and at position 7 o
human FSH-/?, further evidence was obtained b;
additional experiments to confirm the presenc
and location of ^-acetylgalactosamine in thi
carbohydrate moieties of human FSH.
Materials and Methods
Comparison of the N-acetylgalactosamine conten
of human FSH, LH, thyroid-stimulating hormoni
(TSH), bovine LH, bovine TSH, and human CG
Human FSH, FSH-a, FSH-/?, LH, and TSH wen
prepared in our laboratory from crude glycopro
teins supplied to us by the National Pituitan
Agency, MD. Bovine LH was supplied by th<
National Pituitary Agency, and human CG was <
gift from Drs. O.P. Bahl (SUNY, Buffalo, NY
and R.E. Canfield (Columbia University, Nev
York, NY). In addition, highly purified prepara
tions of human FSH, FSH-a, FSH-/?, LH, LH-c
LH-/?, TSH and bovine TSH, supplied by the
National Pituitary Agency, were also used in the
comparison of galactosamine content of th<
hormones. Aliquots of 100 pg protein from each o:
the above hormones were hydrolyzed for 4 h a
105°C with 5.7 M HC1 to release the hexosamines
Equal amounts from the hydrolysates were
analyzed for galactosamine on the amino acic
analyzer with and without the addition of an inter¬
nal standard of similarly hydrolyzed N-acetylga-
lactosamine.
Isolation of glycopeptides of human FSH. Hu
man FSH and its subunits, viz., FSH-a and FSH-/?
were isolated as described earlier [8]. 32 mg o:
purified human FSH were digested with pronase
and gel-filtered as described previously [3] to ob
tain glycopeptide fractions. The glycopeptide-con
taining fractions were purified by high-voltage
paper electrophoresis at pH 6 to isolate the a-5^
and a-78 glycopeptides [3]. The /?-7 glycopeptide
was isolated from the undigested high moleculai
weight material from the column, which was re¬
duced and S-aminoethylated in the presence oi
8 M urea and refractionated on Sephadex G-5C
(superfine). The peptide-containing fraction was
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lyophilized and digested with 100 pg of 1% Pro-
nase in 0.05 M Tris-HCl (pH 8.0)/l mM CaCl2.
Additional aliquots of 100 /ig Pronase were added
at 24 and 48 h intervals and the supernatant was
centrifuged and fractionated on a 1.9X250 cm
column of Sephadex G-50 (superfine) (Fig. 2) in
0.1 M ammonium bicarbonate/5% propanol.
Fractions containing glycopeptides were identified
by the phenol-sulfuric acid test [9], and the J3-7
glycopeptide was purified by high-voltage paper
electrophoresis at pH 6.0 and/or pH 3.5.
The glycopeptides were examined for purity by
high-voltage electrophoresis at pH 3.5, by thin-
layer chromatography on MN-300 cellulose coated
plates (Analtech) using the developing solvent
pyridine/acetic acid/water (50:30:15, v/v) and
visualized with a spray of 1 % ninhydrin in acetone.
Glycopeptide spots were eluted and subjected to
acid hydrolysis and amino acid analysis to de¬
termine their hexosamine content. Amino acid se¬
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Fig. 2. Gel filtration* of the pronase digest of reduced and
.S-aminoethylated peptides on a 1.9X250 cm column of Sep¬
hadex G-50 superfine in 0.1 M ammonium bicarbonate/5%
propanol. Flow rate: 12.9 ml/h; fraction volume: 4.3 ml.
Fractions were pooled as indicated by arrows and lyophilized.
Characterization of the glycopeptides. In addi¬
tion to the determination of the sequence of the
monosaccharides, the isolated carbohydrate moie¬
ties were furhter studied, as follows, in order to
confirm the position of GalNAc and the possible
presence of terminal 'sulfated sugar' in human
FSH carbohydrate moieties.
(1) The glycopeptides showing a single entity in
TLC were analyzed for content of galactosamine
to rule out contamination with other galactosa-
mine-containing glycopeptides. (2) The presence
of galactosamine was substantiated by amino acid
analysis using internal standards as well as by a
TLC separation of hexosamines. (3) The possible
presence of an additional galactosamine residue in
one of the side chains was examined by treatment
of asialoagalactoglycopeptide with exo-a-iV-acetyl-
galactosaminidase following acid hydrolysis of the
glycopeptide to remove any sulfate residues, if
present. (4) The possible source of GalNAc from
a contaminating moiety, where galactosamine may
be singly linked to threonine at position /?-6, was
studied by the digestion of the asialoagalacto-/3-7
with the exo-a-tV-acetylgalactosaminidase. (5) Di¬
gestions with endoglycosidases D and H were per¬
formed to verify the presence of the sequence
-Man-GalNAc-GlcNAc-Asn in the inner core in¬
stead of the sequence of -Man-GlcNAc-GlcNAc-
Asn. Similar digestions using a purified fetuin
glycopeptide were performed to examine the activ¬
ity of these enzymes on a glycopeptide with a
known inner core structure of Man-GlcNAc-
GlcNAc-Asn. (6) Elution behavior of labeled gly¬
copeptides on a DEAE-Sephacel column was
studied to determine the possible presence of a
'sulfate' group. The assumption was based on the
interesting finding of a sulfate group on a terminal
galactosamine residue as described in bovine LH
by Parsons and Pierce [7],
Carbohydrate composition of the a-52 and /3-7
glycopeptides of human FSH. The a-52 and y3-7
glycopeptides were analyzed for neutral sugar,
hexosamine, and sialic acid content. The neutral
sugar and hexosamine contents were determined
by gas-liquid chromatography according to the
procedures of Clamp et al. [10] and Reinhold [11].
In a typical analysis, 2 nmol glycopeptide and 10
nmol inositol, as an internal standard, were dried
and dissolved in 0.5 M methanolic HC1. Methanol-
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ysis was performed for 16 h at 65°C in sealed
tubes under nitrogen for determination of all sugars
except fucose, where methanolysis was performed
for 1.5 h at 65°C. After methanolysis and acetyla-
tion were completed, the samples were dissolved in
25 /rl of Sylon HTP (Supelco) to form O-trimethyl-
silyl ethers of the methyl glycosides. An ap¬
propriate aliquot of this mixture was injected into
a Perkin-Elmer 900 gas chromatograph equipped
with an Infotronics CRS-104 digital readout sys¬
tem. Chromatographic separation was achieved on
a 4 mm (i.d.) X 183 cm glass column packed with
Chromosorb WHP coated with 3% OV-17 polymer
(Supelco). The column was equilibrated at 100°C
and programmed over a temperature gradient of 6
C.deg./min to 250°C, the final temperature being
held until the last peak had eluted. Peak areas
were determined manually or with the integrator.
The hexosamine content was also determined on a
Durrum-500 amino acid analyzer following a 4 h
hydrolysis of the glycopeptide in 5.7 M HC1 con¬
taining 0.2% phenol at 105°C.
In addition, 5 nmol aliquots of the glyco-
peptides which had been hydrolyzed for 4h were
dried, redissolved in water and applied to MN-300
cellulose-coated thin-layer plates. The plates were
developed in ethyl acetate/pyridine/glacial acetic
acid/water (5:5:1:3) to separate hexosamines.
Standard jV-acetylglucosamine and iV-acetylgalac-
tosamine treated similarly, were co-chromato-
graphed. To visualize the hexosamines, the plates
were sprayed with 1% silver nitrate in acetone
solution, air dried and sprayed with 0.5% KOH in
methanol.
The sialic acid content of the glycopeptides was
determined by the thiobarbituric acid method [12],
following hydrolysis of the glycopeptide in 0.1 M
HC1 for 1 h at 85°C. The quantity of each mono¬
saccharide present in the a-52 and y8-7 glyco¬
peptides was calculated as mol monosaccharide/
mol glycopeptide with the asparagine residue set at
1.0.
Enzymatic digestions of a-52 and /3-7 glyco¬
peptides with glycosidases. Neuraminidase (EC
3.2.1.18) (Type IX, Clostridum perfringens) (i-
D-iV-acetylhexosaminidase (EC 3.2.1.52) and yS-D-
galactosidase (EC 3.2.1.23) derived from Aspergil¬
lus niger were gifts from Dr. O.P. Bahl (State
University of New York. NY). y3-Galactosidase
and y3-D-A-acetylhexosaminidase were isolate
from Diplococcus pneumoniae culture filtrates ;
previously described [20]; a-L-fucosidase from be<
kidney (EC 2.3.1.51) was obtained from Boel
ringer-Mannheim. The specific activity of eac
enzyme was determined by reaction with /
nitrophenylglycosidase substrates at 37°C in eac
of the following buffers at pH 4.6: 0.05 M sodiui
citrate; 0.1 M ammonium acetate; 0.1 M pyridir
acetate. One unit of activity was defined as th
amount of enzyme which liberates 1 /cmo! /
nitrophenol/min at 37°C. Exo-a-A-acetylgalai
tosaminidase from Clostridium perfringens was ol
tained from BRL Laboratories (Rockville, MA
endoglycosidases D and H were obtained froi
Miles Laboratories (Elkhart, IN).
In order to determine the sequence of th
monosaccharide units in the carbohydrate moi<
ties, sequential enzymatic digestions using varioi.
combinations of glycosidases were performed o
the glycopeptides as described below.
Aliquots of 20 nmol each of the a-52 and y3-
glycopeptides were digested with a-fucosidat
(0.01 U, 72 h), neuraminidase (1.15 U, 72 h), /
galactosidase (0.01 U, 72 h), yS-A-acetyl-hexost
minidase (0.25 U, 9 days), and a-mannosidas
(1.02U, 6 days). All enzymatic digestions wei
performed at 37°C and pH 4.6 under toluene in
Dubnoff metabolic shaker [3], Control exper
ments consisted of enzyme(s) alone incubated ur
der the identical conditions. After the incubatioi
the samples were fractionated on a 0.5 X 150 cr
column of Sephadex G-50 superfine, equilibrate
with distilled water to separate the enzyme(s
residual glycopeptide, and released sugar(s). Frac
tions were collected at 40 min intervals at a flo\
rate of 2-3 ml/h. Aliquots of the respective frac
tions containing the residual glycopeptide or th
released sugars were lyophilized and trimethylsfl)
lated, and the neutral sugars were identified am
quantitated by gas-liquid chromatography. Amin
acid analysis was performed on acid hydrolysate
for the determination of hexosamines. The amoun
of sugar released was calculated as mol per mc
glycopeptide with reference to the asparagine re
sidue as 1.0.
Digestion with exo-a-N-acetylgalactosamimdast
In order to examine the possibilities of a sulfatei
A'-acetylgalactosamine residue on a periphera
315"
chain as described by Parsons and Pierce in bovine
TSH [7] and of an ^-acetylgalactosamine residue
being linked to a serine or threonine residue, 10
nmol asialogalacto-/?-7-glycopeptide were treated
with 0.5 N H2S04 at 100°C for 9 min [6] to
remove any 'sulfate' groups, if present. The glyco-
peptide, thus treated, was isolated and incubated
with exo-a-A-acetylgalactosaminidase in 0.01 M
phosphate (K^) buffer at pH 6.5 for 24 h at 37°C
to cleave off any terminal galactosamine, if pre¬
sent. The enzyme digest was gel filtered through a
previously calibrated 0.5 X 150 cm column of Sep-
hadex (G-50), equilibrated and eluted in HzO. The
fractions were examined for the content of galac¬
tosamine by thin-layer chromatography and by
analysis of 4 h acid hydrolysates on the amino acid
analyzer, as described.
Digestions with endoglycosidase-D and endogly-
cosidase-H. In order to confirm the absence of the
di-A-acetylchitobiose linkage Man-GlcNAc-
GlcNAc-Asn, commonly found in glycoproteins,
two aliquots of 5 nmol of the asialoagalactoag-
lucosamino (3-1 glycopeptide were incubated with
the above enzymes separately in 0.05 M citrate-
phosphate buffer, pH 6.5 and 5.0, respectively, for
24 h at 37°C. The enzyme digests were applied to
0.5 X 150 cm column of Sephadex G-50 (super¬
fine) equilibrated and eluted with distilled HzO.
Fractions of 1.5 ml, collected at 1 h intervals were,
pooled according to absorbance at 280 and 206
nm and were analyzed for their amino acid and
carbohydrate compositions.
Digestions with glycosidases to prepare the 'inner
core': As described earlier [3], 100 nmol of the
carbohydrate moiety of the /?-7 glycopeptide was
extensively digested with neuraminidase, galac-
tosidase, hexosaminidase and a-mannosidase to
prepare the 'inner core'. The 'inner core' was freed
of the liberated 'peripheral' sugars and enzymes by
gel filtration on a 0.5 X 150 cm column of Sep¬
hadex G-50 (superfine), equilibrated and eluted
with distilled H20. The fraction containing the
'inner core' was identified by its carbohydrate
compositon.
Periodate oxidation. In order to establish the
monosaccharide sequence of the 'inner core,' serial
periodate oxidations were performed on aliquots
of the residual glycopeptides as shown in Table II.
Each oxidation was carried out with 0.05 M sodium
metaperiodate in 0.05 M ammonium acetate buffer
of pH 4.0 in dark for 22 h at 4°C [13]. The residual
glycopeptide was separated from the reactants by
gel-filtration on a 0.7 X 30 cm Bio-Gel P-2 column
equilibrated with 0.05 M pyridine acetate and
analyzer for carbohydrate composition.
Alkaline degradation of human FSH subunits. In
order to determine the possible existence of sugar
moieties linked to serine or threonine, alkaline
degradation of human FSH-n and of human FSH-
/3 subunits was performed by incubation of 100 /xg
of each subunit with 100 pi 1.0 M NaBH4 solution
in 0.1 M NaOH at 45°C [14], Aliquots of 20 pi
were taken at intervals of 4, 8, 12, 24 and 32 h, for
amino acid analysis. Threonine, serine alanine and
galactosamine contents were determined in each
aliquot.
Ion-exchange chromatography on DEAE-Sep-
hacel. The objective of this experiment was to
examine the elution profile for possible content of
sulfate in the glycopeptide. Intact and asialog-
lycopeptides were labeled by reductive methyla-
tion using Hl4CHO [15] and repurified by gel
filtration on Sephadex G-50 (superfine) columns.
[l4C]Dimethyl glycopeptides were mixed with
NeuAc 2 -» 3 [3H]lactitol [21] as the internal stan¬
dard and chromatographed on a DEAE-Sephacel
column. Glucose 6-sulfate (Sigma) was separately
chromatographed under similar conditions and its
elution position was determined by anthrone reac¬
tion.
Results and Discussion
Galactosamine content of human FSH, LH, TSH,
bovine LH and human CG (Table I; Fig. 3)
As shown in Fig. 3, the retention volume of the
internal standard ^-acetylgalactosamine was the
same as the ^-acetylgalactosamine in the unknown
samples, confirming that we were measuring gala-
tosamine, and not an artifact. Further, as shown in
Table I, the known amounts of galactosamine ad¬
ded to the unknown samples were quantitatively
recovered.
Human FSH, LH, their subunits, and human
TSH of pituitary origin purified by different
laboratories have galactosamine present in their
carbohydrate moieties. The carbohydrate moieties
of bovine pituitary LH and TSH also contain
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TABLE I
GALACTOSAMINE CONTENT OF HORMONES
nmol GalNAc Sample + internal GalNAc content
found standard (residues/mol a)
Human FSH 1.2 3.0b 2.7
Human FSH (NPA) (AFP-4822-B) d 1.0 2.6 c 3.5
Human FSH (LER-i978-3)e 1.5 3.6 c 2.6
Human FSH-a 1.4 3.5" 1.6
Human FSH-a (NPA) (LER-1815-2) 1.2 3.4 c 1.6
Human FSH-yS 0.7 2.3 c 0.6
Human FSH-/3 (NPA) (AFP-4911-B) 0.5 2.0C 0.5
Human LH 1.5 3.7 b 2.0
Human LH (NPA) (AFP-4345-B) 1.7 3.2 c 2.2
Human LH-a (NPA) (AFP-2442-C) 0.6 2.5 c 2.3
Human LH-/S (NPA) (AFP-141-B) 0.6 2.5 c 1.1
Bovine LH (NPA) (Batch 1941-1) 1.2 2.8 b 2.1
Bovine LH (NPA) (NlAMDD-bLH-4) 0.6 2.5 c 2.1
Human TSH 1.7 3.5 b 3.1
Human TSH (NPA) (AFP-4370-B) 1.1 2.6 c 3.9
Bovine TSH (NPA) (NIAMDD-bTSH-9) 1.0 2.7 c 4.1
a The following molecular weights were used for the calculation: human FSH, 32600; the subunits, 16000; human LH. human T5
bovine LH and bovine TSH 27000.
b 2 nmol GalNAc were added to the sample.
c 1.7 nmol GalNAc was added as internal standard.
d Hormones received from National Pituitary Agency (NPA), MD.
e hFSH prepared by L.E. Rechert, Jr., The Albany Medical College. Albany, NY.
galactosamine. Human CG, a placental glycopro¬
tein and human LH, which have as much as 80%
homology in their amino acid sequences, differ in
their galactosamine content. However, differences
in the carbohydrate structures of glycoproteins
with identical polypeptide sequences are known.
In fact, even the single carbohydrate unit of highly
purified preparations of ovalbumin has been shown
to be a mixture consisting of nine different struc¬
tures attached to the same position of the poly¬
peptide backbone. Similarly, a-l-acid glycoprotein
from human serum has at least 19 carbohydrate"
structures at the five attachment sites along the
polypeptide chain. Unlike polypeptide chains, the
synthesis of which is under direct control of the
genetic code, the oligo- and polysaccharides are
not primary gene regulated products; therefore,
their synthesis often results in microheterogeneity
[17].
The galactosamine content of the three human
FSH preparations (Table I) indicate two residues
in the a-subunit and one residue in the /i-subunit
[3]. As shown in Table I, the galactosamine co
tent of the human FSH-a and /3 preparations frc
our laboratory as well as of those supplied by t
NPA are similar, attesting to the purity of t
preparations used in the present study [1
Galactosamine was also found to be present
human LH and human TSH, prepared by us
well as by other investigators.
Isolation of glycopeptides
The human FSH-a-52 glycopeptide, which w
isolated and purified after the first pronase dige
of the human FSH [3], consisted of five amii
acid residues, Gln-Lys-Asn(CHO)-Val-Thr, corr
sponding to the sequence of residues 50 to 54
human FSH-a [1], The gel filtration of the secor
pronase digest of the reduced and S-aminoeth
lated fraction is shown in Fig. 2. Human FSH-yS
was isolated by high-voltage paper electrophores
from the fraction (V-X). The isolated give
peptides migrated as a single entity in analytic
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Fig. 3. Determination of galactosamine in 4-h hydrolysates of
pituitary hormones on the amino acid analyzer: (A)
GlcNAc: GalNAc standard (1:1); (B) GlcNAc: GalNAc
standard (5:1); (C) human FSH-a; (D) human FSHa +
GalNAc standard (2.5 nmol); (E) bovine LH; (F) human LH;
(G) human FSH-a-52 glycopeptide; (H) human TSH. Elution
times: GlcNAc (1), 44 min; GalNAc (2), 45 min.
homogeneity of the glycopeptide which was fur¬
ther validated by the integral ratio of the amino
acids in the glycopeptide. The human FSH-/3-7
glycopeptide consisted of three amino acid re¬
sidues with the sequence Thr-Asn(CHO)Ile corre¬
7
sponding to the residues 6-8 in human FSH-/?
subunit [2],
The thin-layer chromatography of /?-7 glyco¬
peptide showed a single spot, which after elution
and analysis contained galactosamine, attesting
that the /?-7 glycopeptide was pure and did not
contain any other contaminating glycopeptide.
Separation of hexosamines, by thin-layer chro¬
matography, after a 4 h hydrolysis of /?-7 glyco¬
peptide, also distinctly revealed the presence of
galactosamine in the /?-7 glycopeptide.
Digestion of human FSH-a-52 moiety with specific
glycosidases
The carbohydrate composition and the se¬
quence of this glycopeptide are presented in
Scheme I. The neuraminidase digestion liberated
three sialic acid residues. Further digestion of the
glycopeptide with /3-galactosidase, y3-jV-acetylhe-
xosaminidase and a-mannosidase released three
residues each of galactose, GlcNAc, and mannose,
indicating the presence of three peripheral chains
with the sequence of monosaccharide units as fol¬
lows: sialic acid -» galactose -> IV-acetylgluco-
samine -»mannose. It should be noted that this
sequence is similar to that of human FSH-a-78
LH-a-52, and TSH-a-52 reported previously [3].
Digestion of human FSH-f-7 glycopeptide with
specific glycosidases
As shown in Scheme I, the digestions of the
carbohydrate moiety attached to the asparagine
residue 7 of human FSH-/3 showed three periph¬
eral chains of the sequence, sialic acid ->• galactose
-* iV-acetylgalactosamine -* mannose, similar to
that of human FSH-a-52.
Digestion of human FSH-fi-7 glycopeptide with exo-
a-N-acetylgalactosaminidase
The enzyme digest was applied to a Sephadex
G-50 (superfine) column in order to separate N-
acetylgalactosamine, if present, from the residual
glycopeptide. Pooled fractions did not contain free
galactosamine indicating the absence of GalNAc
in a terminal position either in a peripheral side-
chain or in a GalNAc-Thr linkage. The acid hy¬
drolysis would have removed any 'sulfate' group, if
present on the galactosamine so that the GalNAc
8
a-52 Glycopeptide, 20 nmol
Composition (mol/mol glycopeptide):
Fucose: 0.5 Galactose: 2.9 GalNAc: 0.9
Mannose: 3.9 GlcNAc: 4.5 Sialic acid: 3.5
a-Fucosidase digestion
Glycopeptide No release of fucose
Neuraminidase digestion
Glycopeptide Sialic acid





(2.8 mol rsd./mol gp)
Glycopeptide GlcNAc
(3.1 mol rsd./mol gp)
a-Mannosidase digestion
Glycopeptide Mannose
(2.9 mol rsd./mol gp)
Composition (mol/mol glycopeptide):
Fucose: 0.4 Galactose: 0.1 GalNAc: 0.8
Mannose: 1.0 GlcNAc: 1.3 Sialic acid: n.d.
/?-7 Glycopeptide, 20 nmol
Composition (mol/mol glycopeptide)
Fucose: 0.7 Galactose: 3.5 GalNAc: 0.8


















(2.5 mol rsd./mol gp)
Composition (mol/mol glycopeptide):
Fucose: 0.7 Galactose: 0.2 GalNAc: 0.9
Mannose: 1.1 GlcNAc: 1.2 Sialic acid: n.d.
Scheme I. Sequential glycosidase digestion of human FSH-or-52
and human FSH-/3-7 glvcopeptides. Mol monosaccharide/mol
glycopeptide was determined by setting Asn = 1.0. rsd., re¬
leased; gp, glycopeptide. n.d., not detectable.
residue would have been susceptible to the enzym
action.
Digestion of human FSH-ji-7 glycopeptides wit
endoglycosidases D and H
The essential sugar residue for the action of th
endoglycosidase D is an unsubstituted a-mannosy
residue linked to the innermost /J-mannosyl re
sidue by 1-3 linkage [18]. The endoglycosidase I
catalyzes the cleavage of the linkage (GlcNAc),
(Man)m-GlcNAc-X-GlcNAc-Asn. After incuba
tion with these enzymes, there was no evidence o
the cleavage of the glycopeptide moiety, indicatin
that the /S-7 glycopeptide did not contain th
linkages specific for these enzymes. In fact, thes
results would be expected with the sequence o
Man-GalNAc-GlcNAc-Asn proposed by us. Oi
the other hand, the fetuin glycopeptide with th
known Man-GlcNAc-GlcNAc-Asn was cleaved.
Alkaline degradation of the subunits of human FSI
The presence of GalNAc in the inner core regioi
of the a-78 glycopeptide of human FSH previous!
studied [3] presented a unique carbohydrate se
quence for an asparagine linked glycopeptide. A1
kaline degradation of human FSH using 0.1 f
NaBH4 did not reveal Ser/Thr-linked carbo
hydrate moieties [3,10]. In order to confirm furthe
the existence of only asparagine-linkec
carbohydrate moieties in the a- and /Tsubunits o
human FSH. alkaline degradation was performei
using stronger conditions than used previously
The results indicated neither an increase in alanim
nor a decrease in galactosamine, serine or threonin
content, thereby confirming the absence of serine
or threonine-linked carbohydrate moieties.
Periodate oxidation
The compositions of the residual 'inner core' o
the a-52 and of the >3-7 carbohydrate moietie
revealed one molecule each of mannose, N
acetylglucosamine, ^-acetylgalactosamine anc
fucose (Table II). From the composition, the se
quence of the inner core appears to be similar t(
that of human FSH-a-78. The periodate oxida
tions of the residual inner core regions of the a-51
and >3-7 glycopeptides indicated the loss of fucosi
and mannose in the first oxidation and the loss o
^-acetylgalactosamine in the second, thus con
3l°i
firming the sequence of the inner core region to
be: »
Man—- GalNAc — GlcNAc — Asn
Fucose
Ion-exchange chromatography on DEAE-Sephacel
(Fig. 4)
The elution pattern of human FSH-/J-7 in¬
dicated microheterogeneity due to variation in the
sialic acid content (Fig. 4a) since after desialyla-
tion the major portion eluted in essentially two
peaks (Fig. 4b). Hence, 90% of the glycopeptide
did not contain 'sulfate' as judged from its elution
prior to neuraminlactitiol. The minor peak (frac¬
tions 79-90, Fig. 4b) eluted in the position of the
control glucose 6-sulfate suggests that 10% of the
glycopeptide may contain a 'sulfate' residue possi¬
bly on a second galactosamine residue in one of
the peripheral side-chains. This is also confirmed
by the treatment of the desialylated ($-1 with acid,
prior to ion-exchange chromatography on DEAE-
Sephacel. Acid treatment would have removed the
sulfate group; and a decrease in the amount of the
minor peak would have been expected, as shown
in Fig. 4c. Analyses of the major peak revealed a
GlcNAc:GalNAc ratio of 4: 1 and of the minor
TABLE II
PER'ODATE OXIDATION OF THE HUMAN FSH-a-52
AND HUMAN FSH-0-7 'INNER CORE' GLYCO-
PEPTIDES
Carbohydrate Composition (mol/mol glycopeptide)4
Prior to 1st 2nd
oxidation b oxidation oxidation
a-52
Fucose 0.4 0.0 0.0
Mannose 1.0 0.5 0.0
GalNAc 0.8 0.8 0.4
GlcNAc 1.3 1.3 1.3
P-l
Fucose 0.7 0.0 0.0
Mannose 1.1 0.1 0.0
GalNAc 0.9 0.9 0.3
GlcNAc 1.2 1.1 1.1
4 Mol monosaccharide/mol glycopeptide determined by set¬
ting Asn value= 1.0.





Fig. 4. Ion-exchange chromatography on DEAE-Sephacel (A)
of untreated [l4C]dimethyl /J-7 glycopeptide (• •); (B)
of neuraminidase treated [14C]dimethyl /3-7 glycopeptide
(• •); and (C) of acid treated asialo [l4C]dimethyl /?-7
glycopeptide. NeuAc — [3H]lactilol (A---A) was used as an
internal standard. The column was eluted with a linear gradient
of 0.01-0.5 M pyridine/actic acid (1 M, 2 M), at the rate of 20
ml per h. Fractions of 2.0 ml were collected and 1.0 ml aliquots
analyzed for radioactivity.
peak of 2:1. According to the monosaccharide
sequence shown in Fig. 1, one GalNAc residue in
the inner core moiety will give a ratio of
GlcNAc:GalNAc of 4:1. If there were one addi¬
tional GalNAc in the peripheral side-chain instead
of a GlcNAc, then the ratio of GlcNAc:GalNAc
would be 1.5:1. If the additional GalNAc in the
peripheral side-chain was a substituent of a galac¬
tose residue, the GlcNAc:GalNAc ratio will be
2:1. If the GalNAc were present only in the
10
(
peripheral chain and were a substituent for a
galactose, then GlcNAc:GalNAc ratio would be
5:1. If it were a substituent of a GlcNAc then the
ratio again would be 2:1. Therefore, it appears
that the major peak contains an ^-acetylgalac¬
tosamine the inner core; whereas, the minor peak
may contain either two residues of A^-acetylgalac-
tosamine or only one in the peripheral chain.
In conclusion, our results indicate that three of
the four carbohydrate moieties of human FSH are
identical and have the monosaccharide sequence
shown in Fig. 1. It is of interest to note that in the
closely related glycoprotein human CG, all the
four asparagine-linked carbohydrate moieties are
identical [5,19]. The carbohydrate moieties of hu¬
man CG, however, contain only two peripheral
chains per moiety [5] as compared to three of
human FSH.
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ABSTRACTS
DETECTION OF GLYCOPHORIN-LIKE GLYCOPROTEINS ON THE SURFACE OF CULTURED
HUMAN CELLS. V. P. Bhavanandan and A. L. Barsoum. Dept. of Biol. Chein. ,
The M.S. Hershey Med. Ctr., The PA State Univ., Hershey, PA 17033.
In previous studies we have isolated and characterized mucin-type gly-
copeptides from mouse and human melanoma cells. These glycopeptides have
clusters of oligosaccharides of the type NeuNAc -* Gal -> (NeuNAc) GalNAc
linked to serine and or threonine (Bhavanandan et_ al^. (1977) Biochemistry
16, 4426) suggesting an apparent similarity to glycophorin. We now report
the interaction of anti-glycophorin antibodies with various cultured cells.
Anti-serum to highly purified glycophorin was prepared in rabbits. Human
melanoma cells (HM7), human breast cells (HBL-100) and two lines of human
breast cancer cells (MCF-7 and MDA-231) showed medium to very strong cell
surface fluorescence pattern after staining with rabbit anti-glycophorin
F(AB)2 and FITC-conjugated goat anti-rabbit F(AB)2- Cells treated with
pre-immune rabbit F(AB)2 and FITC-conjugated goat anti-rabbit F(AB)2 or
with FITC-conjugated goat anti-rabbit F(A3)2 alone did not show detectable
fluorescence.
Immunodiffusion, immunoelectrophoresis and affinity chromatography on
anti-glycophorin IgG-Sepharose 4B of detergent extracts of metabolically
labeled cultured cells gave further evidence for the presence of glyco-
phorin-like components in these cells. (This work was supported in part





PRODUCTION OF MONOCLONAL ANTIBODIES TO GLYCOPHORIN
A.L. Barsoum, V.P. Bhavanandan and E.A. Davidson, Department
of Biological Chemistry, The Milton S. Hershey Medical
Center, The Pennsylvania State University, Hershey, PA 17033
Glycophorin, a transmembrane sialoglycoprotein of the
human erythrocytes, carries on its N-teminal region, the MN
blood group determinants and influenza virus receptors. In
a previous communication (V.P. Bhavanandan and A.L. Barsoum:
Annual meeting, The Society for Complex Carbohydrates>
1980), we showed the presence of Glycophorin-like molecules
on various cultured human cells using polyclonal rabbit
antibodies in an indirect immunofTuorescent test. The pre¬
sent report describes the production of monoclonal-
antibodies to glycophorin by fusion of spleen cells from
BALB/c mice immunized against purified glycophorin and the
non-secreting variant of the P3 myeloma line. The hybrids
were screened for antibody production using a solid-phase
binding radioimmunoassay. Positive wel1s (4/480) were
subcloned by limiting dilution. After screening the sub¬
clones by complement dependent hemolysis in gel, we selected
a clone, Glyco N/P3/1, which reacts with the N-terminal por¬
tion of glycophorin. Further investigations of the nature
of the monoclonal antibody produced by this clone and its
reactivity to human erythrocytes and cultured human cells
are in progress. (This work was supported in part by
U.S.P.H.S. Grant CA15483).
 
INTERACTION OF GLYCOPROTEINS WITH WHEAT GERM AGGLUTININ-SEPHAROSE OF
VARYING CONCENTRATIONS OF LECTIN PER MILLILITER GEL. Kiyoshi Furukawa,
John E. Minor and V.P. Bhavanandan, Dept. of Biol. Chem., The M.S.
Hershey Medical Center, The PA State Univ., Hershey, PA 17033
In previous studies on wheat germ agglutinin (WGA) we had observed
that the interaction of glycoproteins was influenced partly by the den¬
sity of lectin molecules on the gel beads (J. Biol. Chem. 254, 4000,
1979). In the present study we prepared a series of WGA-Sepharose 4B
gels containing 0.08 , 0.53 , 0.95, 1.28 , 3.08 and 7.3Chig WGA per ml gel.
Equal volunes of the gels were packed in colunns and tested for their
ability to bind in vitro labelled glycoproteins and glycopeptides. It
was found that whereas the mucin-type glycoproteins having a high den¬
sity of sialic acid bound virtually completely to all the WGA-Sepharose
gels tested,the serum-type glycoproteins bound very poorly or not at all
to the gels with low concentrations of lectin. To determine the
interaction of membrane sialoglycoproteins with WGA-Sepharose gels,
studies were conducted with plasma membranes isolated from rat liver and
Morris Hepatoma 7777. The membrane glycoproteins were solubilized with
0.5% NP-40 and labelled on sialic acid by treatment with NaI04 and
NaB^H^. The [^H] sialoglycoproteins, after purification by chroma¬
tography on a column of DEAE-Sepharose, were tested for their ability to
interact with the WGA-Sepharose gels. It was found that 38.5%, 51.0%
and 58.4% of the hepatoma membrane sialoglycoproteins bound to
WGA-Sepharose gels having 0.10, 0.53 and 3.08mg WGA per ml gel, respec¬
tively. In contrast only 9.0%, 36.7% and 48.7% of the liver membrane
sialoglycoproteins bound to the same gels.
 
Influences of anionic polysaccharides on DNA synthesis in isolated
nuclei and in vitro; correlation of observed effects with ,
properties of the polysaccharides
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The basis of the differential effect of anionic polysaccharides on
replicative DNA synthesis in liver and hepatoma cell nuclei was investi¬
gated. The differential effect of heparin was lost when more than 40% of
its sulfate was removed. DNA synthesis in liver nuclei was optimally
stimulated by heparin of molecular weight 22,600 and sulfate to hexosamine
ratio 2-42 but inhibited by heparin of molecular weight 4300 and sulfate to
hexosamine ratio 2-35. A heparin fragment, (molecular weight 2800 and
sulfate to hexosamine ratio 1-81) prepared by partial nitrous acid treat¬
ment was a potent inhibitor of DNA systhesis in hepatoma nuclei. There was
no significant difference in the rate of entry of heparin or its subtrac¬
tions into either liver or hepatoma nuclei. In both cases less than 15% of
added polysaccharide entered the nuclei and only about 4.5% was found asso¬
ciated with the chromatin. The influence of the anionic polysaccharides on
DNA synthesis was correlated with their ability to complex.with histones as
determined by relative light scattering in a laser nephelometer. The rela¬
tive light scattered on mixing with histones (HI, H2A + H3, H4) was high
for DNA synthesis stimulators (heparin, dextran sulfate); medium for DNA
synthesis inhibitors (chondroitin 4- and 6-sulfates, (heparan sulfate) and
low for non-effectors (keratan sulfate, hyaluronic acid). Heparin and
chondroitin sulfate H, which at low concentrations stimulate DNA synthesis
in liver nuclei, inhibited in vitro DNA synthesis by calf thymus DNA poly¬
merase a at all concentrations. The inhibition of in vitro DNA synthesis
by anionic polysaccharides was not simply due to electrostatic
interactions.
-4-
Glycosaminoglycans were previously considered to be secretory products
found in the extracellular matrix. It is now clear that in addition to
this localization, these molecules are also present in significant quan¬
tities at the cell surface [1], in the plasma membrane [2], cytosol [3],
nucleus [4,5] and mitochondria [6]. For example, Prinz et al_. [7] showed
that of the glycosaminoglycans synthesized by primary cultures of hepato-
cytes only 13% were secreted whereas 30% became associated with the cell
surface and the balance remained within the cells.
These observations have prompted several investigators to ask whether
these polyanionic macromolecules, in addition to their accepted extracellu¬
lar (structural and organizational) functions, may have regulatory or modu¬
lating roles on intracellular events. Circumstantial evidence has been
obtained indicating the possibility of involvement of acidic poly¬
saccharides in replicative DNA synthesis [8-11], RNA synthesis [9,12,13],
protein synthesis [14], regulation of-development of sea urchin embryos
[15], cell adhesion [16,17] and growth control [18,19].
Previously, we have established beyond doubt the presence of anionic
glycoconjugates in animal cell nuclei and characterized some of these
nuclear components [4,5]. Results of other workers have confirmed and
extended these findings [20-22]. Subsequently we have turned our attention
to an examination of the effects of natural and synthetic (model) anionic
glycoconjugates on DNA synthesis.
In a previous paper we reported the differential response of heparin
and chondroitin sulfate H on endogenous DNA synthesis in isolated normal
and cancer cell nuclei [23]. The present study focuses on the molecular
basis for the action of anionic saccharides on DNA synthesis. The results
show that the molecular size, charge (degree of sulfation) and possibly
special structural features of the polysaccharides are important factors in
determining the type of influence (inhibition or stimulation) exerted.
These studies also provide evidence that the stimulatory and the inhibitory
effects of certain polysaccharides can be correlated with their ability to
interact with histones and DNA polymerase, respectively. It is the ulti¬
mate purpose of our studies to (i) contribute to the understanding of the
biological functions of glycosaminoglyeans, (ii) obtain information on
their possible role in regulation of DNA replication in vivo in animal
cells, (iii) isolate an anionic polysaccharide molecule which would inhibit
DNA synthesis in cancer cell nuclei, but have no or minimal effect on nor¬
mal cell nuclei.
MATERIALS AND METHODS
Male Buffalo rats were obtained from Simonsen Laboratories (Gilroy,
CA). Livers from 12 week-old animals were used for nuclei isolation.
Morris hepatoma 7777 [24] was maintained by bilateral implantation into the
thigh muscle of the rats.
The procedures for the isolation of nuclei and assay of endogenous DNA
synthesis in nuclei were as described previously [23]. When aphidicolin
[25,26] was included in the assay mixture at a concentration of 300ug per ml
DNA synthesis was inhibited by 84%. Addition of N-ethylmaleimide (5-10mM)
also inhibited DNA synthesis by 80-95%.
DNA Synthesis (in Vitro) [27]. Calf thymus DNA polymerase a purchased from
Worthington (Freehold, NJ) was used in these experiments. Assays were done
in triplicate in 50 mM Tris-HCl (pH 7.4) - 8 mM MgCl2 _ l mM dithothreitol
- 30 mM KC1 containing 15% glycerol, 400 yg per ml bovine serum albumin,
-6-
0.1 mM dATP, dCTP and dGTP, 0.06mM (5yCi) [3H] dTTP (New England Nuclear,
Boston, MA) and lOOug of calf thymus DNA which was activated by a com¬
bination of freezing and thawing followed by digestion with DNase I
according to Kornberg and Gefter [28]. DNA polymerase a (0.1 - 0.2 units)
and, where indicated, various concentrations of glycosaminoglycans as their
sodium salts were added and the reaction mixture (total volume 0.5 ml) was
incubated for 3 hours at 37°. The reaction was terminated by the addition
of cold 10% trichloroacetic acid -0.1 mM dTTP - 10 mM sodium pyrophosphate.
The precipitate was collected, washed, dissolved and the radioactivity
determined as described [23].
Histone-Glycosaminog!yean Interaction. Calf thymus histone (Calbiochem, La
Jolla, CA) was fractionated into hi stones HI, H2A + H3, H2B and H4 by chro¬
matography on a column of Bio-Gel P-60 [29]. The histone fractions and
glycosaminoglycan samples were dissolved in 0.1 M Tris-HCl (pH 7.0) - 0.15
M NaCl containing 5% (w/v) polyethylene glycol 6000 and 15-mM NaN^ and the
solutions filtered through 0.2y Millipore filters. Appropriate volumes
(2-40yl) of the glycosaminoglycan solutions (500yg per ml) were placed in
test tubes (10 x 75 mm), diluted with buffer (also filtered through
Millipore filters) to 0.985 ml and 15yl of histone solution (200yg per ml)
added. The solution was mixed by gentle end over end mixing and the rela¬
tive light scattering measured by laser nephelometry using a Hyland Laser
Nephelometer PDQ. The complex formation appeared to be instantaneous,
therefore, measurements were made within one hour of adding the histone.
Incubations up to 24 hours had no further influence on light scattering
provided the solutions were mixed before measurements.
Partial Desulfation of Heparin. In order to prepare heparin with differing
sulfate content, heparin (200 mg) was converted to its pyridine salt and
subjected to partial solvolysis at 80° with dimethyl sulfoxide containing
\
10% water [30]. Aliquots (20 mg) were removed at various times and treated
with acetic anhydride to N-acetylate the free amino groups of the hexosa-
mine residues [31]. The products were analyzed for hexosamine and sulfate
content. The time of treatment in minutes and the percent sulfate removed
are as follows: 0.1, 4.7; 0.2, 18.8; 0.5, 38.5; 5, 55.6; 15, 62.5; 30,
66.1; 45, 67.2; 60, 67.5; 120, 71.1; 180, 79.1 and 240, 83.8.
Preparation of Isotopically Labelled Heparin. Heparin (20 mg) was tri-
tiated according to Hatton et al_. [32] by treatment with 5 mCi of
NaB3H4 (10 Ci/mmol), (Research Products International Corp., Mount
Prospect, 111) in 200pl of 0.2M borate buffer (pH 8.4). After incubation
at room temperature for 3 hours, 300ul of NaBH^ solution (lOmg per ml in
borate buffer) were added and after a further 1.5 hours, the reaction mix¬
ture was extensively dialyzed and lyophilized. The specific activity of
the [3H] heparin preparations varied from 1.0 x 107 to 2.1 x 107 dpm per "
mg. 34C-labelled heparin was also prepared by reductive methylation using
H14CH0 and NaCNBH3 [33].
Partial Nitrous Acid Treatment. Heparin was partially fragmented by expo¬
sure to limiting amounts of nitrous acid followed by dilute sulfuric acid
[34,35]. Heparin (200mg) was dissolved in 4 ml of 0.05 M NaNO,, in 0.2 M
sodium citrate (pH 1.5), incubated for 30 min at 0° and the pH then
adjusted to 8.0 by addition of pyridine. The mixture was chromatographed
on a column of Bio-Gel P-10 (2.0 x 155cm) using 0.1 M pyridine/acetic acid
as eluant. Aliquots of the column fractions were assayed for uronic acid
[36] and the positive fractions were combined and lyophilized. The
-8-
recovered material was dissolved in distilled water, the pH adjusted to 1.9
with dilute sulfuric acid and incubated for 30 min at 50°; the reaction
mixture was then neutralized and chromatographed on Bio-Gel P-10 as above.
Heparin samples were obtained from Sigma (St. Louis, MO) and Fisher
Scientific (Pittsburgh, PA). Semi-purified heparin used in the preparation
of the heparin fractions of different molecular weight was kindly donated
by Scientific Protein Laboratories (Waunakee, WI) and Hepar Industries
(Franklin, Ohio). Heparin fractions of varying molecular size [37] were
provided by Dr. Erik Holmer, Kabi Vitrum, Stockholm (Sweden). Sodium pen¬
tosan sulfate [14] was a gift from Dr. Halse, Benechemie, Munchen (W.
Germany); and carrageenan samples were donated by Dr. D.A. Rees, Unilever
Research, (United Kingdom). Aphidicolin was a gift from Dr. A. H. Todd,
ICI, (United Kingdom). Other glycosaminoglyeans used were as reported pre¬
viously [23]. Dextran sulfates 500, 40 and 8 of molecular weights 500,000,
40,000 and 8,000 respectively were obtained from Sigma (St. Louis, M0) "and
cellulose sulfate from Aldrich (Milwaukee, Wis). All natural and synthetic
polysaccharides were tested for protease and nuclease activities [23]; none
was detected in the samples used. Deoxynucleotide triphosphates were
purchased from Sigma (St. Louis, M0) and adenosine triphosphate from
Calbiochem (La Jolla, CA).
The DNA content of nuclei was determined by the method of Burton [38]
using calf thymus DNA as standard. Hexosamine was assayed after hydrolysis
(6N HC1, 100°C, 12h). The hydrolysates were dried, redissolved in buffer
and aliquots containing 0.5 to 2.0 nmoles of hexosamine analyzed on a
Dionex amino acid analyzer using fluoropa for detection. Sulfate was





Differential effect of sulfated polysaccharides on DNA synthesis.
In Table I, the effects of various highly sulfated polysaccharides on
DNA synthesis in nuclei isolated from rat liver and hepatoma are shown.
The maximum degree of stimulation of DNA synthesis obtainable in liver
nuclei, as well as the polysaccharide to DNA ratio required to stimulate
maximally, varied widely. Polysaccharides with a low degree of sulfation
(chondroitin sulfate H and carrageenans) showed only slight stimulation
(215 to 270%) at rather high polysaccharide to DNA ratios (0.62 and 0.75
respectively). The polysaccharides with high degree of sulfation, and high
(Dextran sulfate 500 and cellulose sulfate) or low (pentosan sulfate) mole¬
cular weights also showed only slight stimulation (231 to 275%). However,
these were active at lower polysaccharide to DNA ratios (0.14 to 0.33) as
compared to the less sulfated polysaccharides. The highest stimulations
were shown by polysaccharides with a high degree of sulfation but of inter¬
mediate molecular weights (heparin, dextran sulfates 40 and 8).
In contrast to the wide variation in their ability to stimulate DNA
synthesis in liver nuclei, the influence of these polysaccharide on DNA
synthesis in hepatoma nuclei was more consistent. All the highly sulfated
polysaccharides (sulfate/ disaccharide 2.77 to 3.90) with the exception of
dextran sulfate 500 gave 50% inhibition of DNA synthesis at polysaccharide
to DNA ratios of 0.07 to 0.09. Larger amounts (polysaccharide to DNA
ratios of 0.18 to 0.40) of the polysaccharides with a low degree of sulfa¬
tion were required to obtain the same degree of inhibition.
The observation that the low molecular weight (about 3000) pentosan
sulfate stimulated DNA synthesis in liver nuclei and inhibited DNA synthe-
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sis in hepatoma nuclei was of particular interest. To understand the role
of size and degree of sulfation within a single class of polysaccharide,
the differential effect of subfractions of heparin on DNA synthesis was
investigated. The influence of the heparin subfractions of varying molecu¬
lar weight (Figure 1) on DNA synthesis in isolated nuclei from liver and
hepatoma is detailed in Table II. At a ratio of heparin to DNA of 0.42,
subfractions I, II (maximum stimulation, 6-fold), III, IV and V (lowest
stimulation, 2.4 fold) stimulated DNA synthesis in liver nuclei. At higher
ratios of heparin to DNA (>0.9), these five subfractions inhibited DNA
synthesis. The lowest molecular weight fraction, VI, inhibited DNA synthe¬
sis in liver nuclei increasingly with increasing concentrations.
All six heparin subfractions consistently inhibited DNA synthesis in
hepatoma nuclei (Table II). In the molecular weight range 6,700 to 31,000
(subfractions V to I), the degree of inhibition was inversely related to
molecular size and independent of the heparin to DNA ratio. The optimum
stimulation of liver nuclear DNA synthesis was shown by heparin of molecu¬
lar weight 22,600, and the optimum inhibition of DNA synthesis in hepatoma
nuclei was by the 6700 molecular weight heparin. The dissimilar molecular
size requirements for optimum stimulation and optimum inhibition is of con¬
siderable interest.
Results identical to those reported above were also obtained with
heparin subfractions of varying molecular weight obtained by fractionation
of heparin from Scientific Protein Laboratories and those donated by
Dr. Erik Holmer [37].
Similar studies with three fractions of dextran sulfates obtained by
chromatography on Bio-Gel P-60 gave analogous results.
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Effect of degree of sulfation (anionic character) of heparin on
DNA synthesis. We reported that the degree of inhibition of DNA synthesis
in liver and hepatoma nuclei by chondroitin sulfates and heparan sulfate
was directly correlated with the sulfate to hexosamine ratio [23]. DNA
synthesis in hepatoma nuclei was likewise inhibited by the partially
desulfated heparin fractions. At all the heparin to DNA ratios tested, the
degree of inhibition was directly correlated with the sulfate content
(Figure 2).
Heparin with sulfate to hexosamine ratio of more than 1.7 exhibited a
differential effect on DNA synthesis in liver nuclei which was dependent on
the ratio of heparin to DNA. At ratios below 0.9, DNA synthesis was stimu¬
lated while above this ratio DNA synthesis was inhibited (cf. results
obtained with native heparin [23]). At a fixed heparin to DNA ratio, the
degree of stimulation decreased linearly with the degree of sulfation
(sulfate/hexosamine 2.7 to 1.7) (Figure 2). Heparin fractions having
sulfate to hexosamine ratios less than 1.7, showed only inhibition of DNA
synthesis in liver nuclei.
Effects of heparin fragments obtained by partial nitrous acid treatment on
DNA synthesis. To study the combined effect of size and charge, the
influence of heparin fragments prepared by partial nitrous acid treatment
on DNA synthesis was determined. The estimated molecular size, the sulfate
to hexosamine ratio and the influence of these randomly cleaved fractions
on DNA synthesis in hepatoma nuclei are summarized in Table III.
The most effective inhibitors of DNA synthesis were fractions B and C
having estimated molecular weights of 2,800 and 1,600, respectively.
Fraction B also has a low sulfate to hexosamine ratio. Thus, we have iden-
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tified a heparin fragment having about fourteen saccharides and 1.8 sulfate
residues per hexosamine which is a potent inhibitor of DNA synthesis in
isolated hepatoma nuclei. In agreement with the result obtained with
heparin subtraction VI (Table II), this fragment had no stimulatory acti¬
vity on DNA synthesis in liver nuclei at any concentration; at low con¬
centrations it had no effect and at high concentrations it inhibited DNA
synthesis.
Entry of heparin into nuclei and association with chromatin. The time
course of the entry of heparin into liver and hepatoma nuclei and the rela¬
tionship of the entry to the concentration of DNA in the incubation mixture
are illustrated in Figure 3. It is clear that there is no significant dif¬
ference in the rate of entry of heparin into liver or hepatoma nuclei and
that saturation levels of heparin in both cases are reached after 2 to 3
hours. Thus, in all experiments assessing the influence of anionic poly¬
saccharides on DNA synthesis in intact nuclei, incubation was for a period
of 3 hours.
The nmoles of [3H] heparin and three [3H] heparin fractions of varying
molecular weight which were associated with liver or hepatoma nuclei are
given in Table IV. The results indicate that there is no significant dif¬
ference in the total amount of heparin associated with the liver and hepa¬
toma nuclei; in both cases about 1 nmole of heparin per 100 yg DNA was
found. There was also no correlation between the molecular size of heparin
and its ability to enter (or associate with) the nuclei, suggesting a
passive entry mechanism.
The distribution of the [3H] heparin within the nucleus was also
studied. Nuclei, after incubation with [3H] heparin as described, were
successively extracted twice with 75 mM NaCl - 24 mM EDTA (pH 8.0), twice
with 50 mM Tris-HCl (pH 8.0), and finally with water adjusted to pH 8.0 to
solubilize the chromatin [42]. Each extraction was done by mixing for 2
min followed by centrifugation at 1,000 x g for 10 min. This procedure was
employed rather than the high ionic salt extraction [43] which is liable to
dissociate heparin-chromatin complexes. Of the total [3H] heparin asso¬
ciated with the nuclei 62.5%, 30.4% and 7.1% were recovered in the buffer
extracts, water extract (chromatin) and residue, respectively. In com¬
parison the distribution of DNA in these fractions was 17%, 78% and 5%.
Thus, about 30% and 78% of the recovered [3H] heparin and DNA respectively,
were present in the chromatin fraction. It can be calculated that
0.3 ± 0.09 nmoles (4.0 ± 1.3 yg) of [3H] heparin was associated with lOOyg
of DNA in chromatin.
Interaction of qlycosaminoglycans with histones. The observed stimulation
of DNA synthesis in nuclei isolated from normal tissues may be attributable
to the interaction of anionic polysaccharides with histones, thereby
removing template restrictions [44,45]. Experimental support for this was
provided by the observation that addition of histones to the incubation
mixture nullifies the stimulatory effect of heparin on DNA synthesis [46].
Additional correlation was sought between the effect of various glycosami-
noglyeans on DNA synthesis and their ability to interact with histones.
Complex formation of the polysaccharides with histones was determined by
laser nephelometry, a technique which has been used for the measurement of
antigen-antibody complexes [47], glycoprotein-lectin interactions [48] and
circulating immune complexes [49] and serum glycosaminoglycans [50].
Based on the results shown in Figure 4 we examined the interaction of
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various glycosaminoglycans at 20ug per ml with unfractionated histones or
histories HI, H2A + H3, H2B, and H4 at 3pg per ml (Figure 5). Heparin and
dextran sulfate 40, which have differential effects on DNA synthesis,
showed the highest light scattering on interaction with unfractionated
histones as well as histones HI, H2A + H3 and H4. Chondroitin 4- and
6-sulfates, heparan sulfate and N-desulfated heparin, all of which inhibit
DNA synthesis, showed moderate light scattering with these histones.
Hyaluronic acid, keratan sulfate, and desulfated heparin, which have no
effect on DNA synthesis, showed the lowest light scattering with the same
histones. The complex formation between the glycosaminoglycans and
histones H2B was poor and could not be correlated to the effects on DNA
synthesis.
Similar results were obtained when the heparin subtractions varying in
molecular size (Figure 1) were tested for complex formation with histones.
The complex forming ability of subtractions I to V with histones
(unfractionated, HI and H2A +H3) roughly paralleled the degree of stimula¬
tion of DNA synthesis (see Table II). For example, fractions II and V
which were the most and least stimulatory for DNA synthesis showed the
highest and lowest light scattering, respectively, when mixed with unfrac¬
tionated histones and histones HI or H2A + H3.
Effect of glycosaminoglycans on DNA Synthesis in Vitro. These experiments
were carried out to assess the effect of glycosaminoglycans on DNA poly¬
merase a. DNA synthesis, assayed by incorporation of [^H]dTTP, was linear
with time (up to the 3 hours tested) and with increasing concentrations of
DNA polymerase (tested up to 0.2 units per lOOug DNA per 0.5ml (Figure 6a
and c). At an enzyme concentration of 0.1 units per 0.5ml, the reaction
reached saturation at lOOug DNA per 0.5ml (Figure 6b).
The effects of various glycosaminoglycans on polymerase activity
during a 3 hour incubation are summarized in Table V. The most potent
inhibitors were heparin and heparin subtractions II to V (data not
presented), followed by chondroitin sulfate H. It is of interest that
heparin inhibited in vitro DNA synthesis at all levels tested, even if
added 15 min after the onset of the reaction. In contrast, in liver nuclei
these polysaccharides stimulate DNA synthesis (Tables I and II). Heparan
sulfate, chondroitin-4 and 6-sulfates, and N-desulfated heparin also inhi¬
bit DNA synthesis and in this group the degree of inhibition parallels the
degree of sulfation and was directly dependent on the polysaccharide to DNA
ratio. Hyaluronic acid, dermatan sulfate, keratan sulfate and desulfated
heparin had no significant effect on in vitro DNA synthesis which is in
agreement with their influence on DNA synthesis in isolated nuclei [23].
DISCUSSION
The process of DNA replication and the mechanism of its regulation is
very complex [51]. Conflicting views have been presented regarding the
cytoplasmic and/or nuclear localization of DNA polymerase a, the replica-
tive enzyme in manmalian cells [52]. Recently, immunochemical methods were
used to demonstrate that the bulk of this enzyme is present in the peri¬
nuclear region of the cytoplasm [53], veer Reddy and Pardee [54] have
shown that although DNA polymerase a is virtually all cytoplasmic in
phase cells, in S-phase, this enzyme is assembled into a replication
apparatus in the nucleus. Thus, the level of DNA replication observed in
isolated nuclei is probably an indication of the proportion of S-phase
cells in the original population.
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We used the method of Lynch et al_. [55] for the isolation of nuclei,
which yielded nuclear preparations suitable for replicative DNA synthesis
studies [56], Further, the conditions used by us to assay DNA synthesis
were similar to those previously demonstrated to carry out replicative DNA
synthesis rather than repair [46,57,58]. The inhibition of DNA synthesis
by aphidicolin and N-ethylmaleimide, believed to be specific for DNA poly¬
merase o, is further evidence that replicative DNA synthesis was being
measured. Using the identical procedure for nuclei isolation and assay,
the level of [^H]dTTP incorporation into DNA was lowest in rat liver, high
in regenerating liver and highest in hepatoma nuclei, data which support
the replicative rather than repair process. The system employed is also
well suited to study the effects of nucleocytoplasmic interactions on DNA
replicaton with endogenous templates.
The present study confirms that the stimulatory effects shown by
several highly sulfated polysaccharides in liver nuclei can be attributed
to the abolishing of template restriction. Although the polyanionic
character of these molecules plays a crucial role in this, the degree of
stimulation was not directly correlated to the degree of sulfation (Tables
I and II, Figure 2). These results, as do previous data, confirm that the
observed effects are not simply due to electrostatic interactions. In
addition to the overall charge of the polysaccharide, factors such as
charge distribution, conformational change with alteration of charge and
perhaps the degree of ionization may all play a role in the interaction
with template and/or DNA polymerases. In addition to an optimum charge,
the importance of an optimum polysaccharide size for stimulating DNA
synthesis was also clearly demonstrated. For example, a heparin subfrac-
tion with molecular weight 9500 and sulfate to hexosamine ratio 2.31 stimu¬
lated DNA synthesis in liver nuclei four-fold, whereas the fraction with
molecular weight 4300 and a sulfate to hexosamine ratio 2.35 did not
(Table II).
The inhibitory influence of the various polyanions tested appears to
be due to the direct interaction with the polymerase. Once again, the
effects observed are not simply due to electrostatic interactions although
these do play a role. Thus, in in vitro DNA synthesis, keratan sulfate
with a sulfate to hexosamine ratio of 1.43 was a very poor inhibitor but
heparan sulfate with a sulfate to hexosamine ratio of 1.31 inhibited DNA
synthesis by 50%. Polysaccharides with higher sulfate content were
generally better inhibitors in intact nuclei than those with a lower degree
of sulfation (Figure 2). The effect of polysaccharide molecular size on
inhibition of DNA synthesis in intact nuclei was striking. Intermediate
size polysaccharides were more potent inhibitors than either the very Targe
or very small molecular weight species. Thus, pentosan sulfate (M W 3,000
and S0^/disaccharide 3.64) and heparin subtraction V (M W 6,700 and
S0^/disaccharide 2.19) were both very effective inhibitors. A similar
molecular weight dependence of the anticoagulant activity of heparin has
been demonstrated by several investigators [35,37,59]. We failed to detect
any significant difference in the ability of the heparin fractions of
varying molecular size to enter the nuclei (Table IV). Therefore, the
observed differences in the inhibition of nuclear DNA synthesis by these
subtractions are unlikely to be due to different rates of entry. The
secondary structure, shape and conformations of the saccharides are pro¬
bably involved in their interaction with the DNA polymerase.
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The influence of glycosaminoglycans on DNA synthesis can be correlated
to their ability to complex with histones; most strikingly with HI, but
also to lesser extents with H2A + H3, H4 and mixture (Figure 5). Histone
HI gave very high light scattering (>180) with DNA synthesis stimulators
(heparin, dextran sulfate 40 and heparin fractions I to IV), intermediate
light scattering (100 to 136) with DNA synthesis inhibitors (chondroitin 4-
and 6-sulfates, heparan sulfate, N-desulfated N-reacetylated heparin and
heparin subfraction VI) and very low light scattering (<30) with non-
effectors of DNA synthesis (keratan sulfate, hyaluronic acid and desulfated
heparin). The interaction of the polyanionic glycosaminoglycans and the
cationic histones is complex and will be influenced by factors such as salt
concentration and pH, among others. We have therefore measured the light
scattering under conditions (pH and ionic concentrations) as close as
possible to those used in the DNA synthesis assay. The relative light
scattering is probably a reflection of both the size and number of
complexes which are formed but at the present it is not possible to
distinguish between the contributing effects of these two factors. The
ability of heparin, dextran sulfate 40 and heparin subfractions I to IV to
interact strongly with histones HI and H2A + H3 may be crucial in removing
template restriction and thereby stimulating DNA synthesis. These
saccharides caused only inhibition when in vitro DNA synthesis was assayed,
further proving that the stimulation in whole nuclei is due to their
ability to remove histones from DNA in chromatin.
Since five out of six of the heparin subfractions still show differen¬
tial effects on DNA synthesis, it is unlikely that different species in the
unfractionated heparin is responsible for the differential effect. The
rates of entry of heparin into liver and hepatoma nuclei were similar,
therefore the differential effects on DNA synthesis are not simply
ascribable to different rates of entry. It is likely that the observed
differences are due to high and low binding affinities of heparin to
hi stones and DNA polymerase a, respectively. In the DNA synthesis assays
although large amounts of polysaccharide were used, (polysaccharide to DNA
(w/w) ratios of 0.1 to 1.0) only a minor portion is associated with the
chromatin. Further, it is possible that only a fraction of this may be
responsible for the observed effects on DNA synthesis. This suggests that
the small levels of glycosaminoglycans detected in the cell nucleus [5,21]
or a small portion of the cytoplasmic glycosaminoglycans entering the
nucleus could be sufficient to affect nuclear DNA replication. Thus, a
physiological role for glycosaminoglycans or sialoglycoproteins in in vivo
DNA replication needs to be further investigated.
In the studies reported here, heparin and semi-synthetic sulfated
polysaccharides were used as models to understand the influence of
polyanionic saccharides on DNA synthesis. The glycosaminoglycans most
likely to be physiologically relevant are the heparan and chondroitin
sulfates. The presence of these glycosaminoglycans in the nucleus,
cytoplasm and cell surface has been reported; although no data on their
size and degree of sulfation are available. Our previous [23] and present
results have shown that subtle changes in the degree of sulfation and/or
size of these glycosaminoglycans can drastically change their influence on
DNA synthesis and thus play a role in the control of DNA synthesis during
differentiation and development. In view of the reported alterations in
the sulfation level of heparan sulfate in malignant cells [60-63], the
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importance of this in the loss of growth control of transformed cells
should be considered. It should also be pointed out that even though
heparin has not been found in cells other than mast cells, heparin-1ike
molecules have been detected in sea urchin embryos [64] and cultured
endothelial cells [65].
In conclusion, the results reported are consistent with our previous
finding that heparin and other highly anionic polysaccharides play a dual
role in DNA synthesis in whole nuclei. Both the extent of sulfation and
molecular size of the polysaccharides had an effect on the type and degree
of influence on DNA synthesis. These studies support our contention that
the lack of heparin stimulation of DNA synthesis in cancer cell nuclei is
due to the already maximal template activity. The isolation of a heparin
subfraction which at low concentrations is capable of inhibiting DNA
synthesis in hepatoma nuclei but not normal liver nuclei is of phar¬
macological interest. It may be possible to exploit these polysaccharide
fractions in suppressing the division of cancer cells without affecting
normal cells.
ACKNOWLEDGEMENTS
We wish to thank Dr. E.A. Davidson for his support, interest and many
valuable suggestions during the course of this work. We are grateful to
the following for their generous gifts of samples: Mr. John Bard,
Scientific Protein Laboratories (Waunakee, WI); Dr. Margaret Haines, Hepar
Industries (Franklin, OH); Dr. Halse, Benechemie (Muchen, W. Germany);
Dr. Erik Holmer, KABI Vitrim (Stockholm, Sweden); Dr. David Rees, Unilever
Research (United Kingdom) and Dr. A.H. Todd, ICI (United Kingdom). We also
thank Mrs. Filomena Cramer for secretarial assistance. This investigation
was supported by research grant CA 15483 from the National Institutes of




1. Kraemer, P.M. (1971) Biochemistry 10, 1437-1445
2. Kjellen, L., Oldberg, A., and Hook, M. (1980) J. Biol. Chem. 255,
10407-10413
3. Glimelius, B., Norling, B., Westermark, B., and Wasteson, A. (1978)
Biochem. J. 172, 443-456
4. Bhavanandan, V.P., and Davidson, E.A. (1975) Proc. Natl. Acad. Sci.
U.S.A 72, 2032-2036
5. Furukawa, K., and Terayama, H. (1977) Biochim. Biophys. Acta 499,
278-289
6. Dietrich, C.P., Sampaio, L.O., and Toledo, O.M.S. (1976) Biochem.
Biophys. Res. Commun. 71, 1-10
7. Prinz, R., Kelin, U., Sudhakaran, P.R., Sinn, W., Ullrich, K., and Von
Figura, K. (1980) Biochm. Biophys. Acta 630, 402-413
8. Lazarus, L.H., and Kitron, N. (1974) Arch. Biochem. Biophys. 164,
414-419
9. Schaffrath, D., Stuhlsatz, H.W., and Greiling, H. (1976)
Hoppe-Seyler's Z. Physiol. Chem. 357, 499-508
10. Janakidevi, K. (1978) Exp. Cell Res. 112, 345-351
11. Winterbourne, D.J., and Salisbury, J.G. (1981) Biochim. Biophys. Res.
Commun. 101, 30-37
12. Kinoshita, S. (1971) Exp. Cell Res. 64, 403-411
13. Warnick, C.T., and Lazarus, H.M. (1975) Nucleic Acids Res. 2, 735-744
14. Gressner, A.M., and Greiling, H. (1977) Hoppe-Seyler's Z. Physiol.
Chem. 358, 69-78
15. Kinoshita, S., and Yoshii, K. (1979) Exp. Cell Res. 124, 361-369
34^
-23-
16. Mikuni-Takagaki, Y., and Toole, B.P. (1980) J. Cell Biol. 85, 481-488
17. Laterra, J., Ansbacher, R., and Culp, L.A. (1980) Proc. Natl. Acad.
Sci. U.S.A. 77, 6662-6666
18. Wever, J., Schachtschabel, D.O., Sluke, G., and Wever, G. (1980)
Mech. Ageing Dev. 14, 89-99
19. Kawakami, H., and Terayama, H. (1981) Biochim. Biophys. Acta 646,
161-168
20. Stein, G.S., Roberts, R.M., Davis, J.L., Head, W.J., Stein, J.L.,
Thrall, C.L., Veen, J.V., and Welch, D.W. (1975) Nature 258, 639-641
21. Margolis, R.K., Crockett, C.P., Kiang, W.-L., and Margolis, R.U. (1976)
Biochim. Biophys. Acta 451, 465-469
22. Fromme, H.G., Buddecke, E., Von Figura, K., and Kresse, H. (1976) Exp.
Cell Res. 102, 445-449
23. Furukawa, K., and Bhavanandan, V.P. (1982) Biochim. Biophys. Acta
697, 344-352
24. Tse, T.P.M., Morris, H.P., and Taylor, J.M. (1978) Biochemistry 17,
3121-3128
25. Huberman, J.A. (1981) Cell 23, 647-648
26. Spadari, S., Sala, F., and Pedrali-Noy, G. (1982) Trends in Biochem.
Sci. 6, 29-32
27. Yamaguchi, M. Matsukage, A., and Takahashi, T. (1980) J. Biol. Chem.
255, 7002-7009
28. Kornberg, T., and Gefter, M.L. (1971) Proc. Natl. Acad. Sci. U.S.A.
68, 761-764
29. Von Holt, C., and Brandt, W.F. (1977) in Methods in Cell Biology, 16,
pp. 205-255, Academic Press, New York




31. Cifonelli, J.A. (1974) Carbohydrate Res. 37, 145-154
32. Hatton, M.W.C., Berry, L.R., Machovich, R., arid Regoeczi, E. (1980)
Anal. Biochem. 106, 417-426
33. Jentoft, N., and Dearborn, D. (1979) J. Biol. Chem. 254, 4359-4365
34. Shively, J.E., and Conrad, H.E. (1976) Biochemistry 15, 3932-3942
35. Oosta, G.M., Gardner, W.T., Beeler, D.L., and Rosenberg, R.D. (1981)
Proc. Natl. Acad. Sci. U.S.A. 78, 829-833
36. Davidson, E.A. (1966) Methods Enzymol. 8, 53-55
37. Holmer, E., Kurachi, K., and Soderstrom, G. (1981) Biochem. J. 193,
395-400
38. Burton, K. (1956) Biochem. J. 62, 315-323
39. Spencer, B. (1960) Biochem. J. 75, 435-440
40. Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., and Smith, F.
(1956) Anal. Chem. 28, 350-356
41. Blobel, G., and Potter, V.R. (1966) Science 154, 1662-1665
42. Ueda, K., Reeder, R.H., Honjo, T., Nishizuka, Y., and Hayaishi, 0.
(1968) Biochem. Biophys. Res. Commun. 31, 379-385
43. Steele, W.J., and Busch, H. (1966) Biochim. Biophys. Acta 119, 501-509
44. Coffey, D.S., Barrack, E.R., and Heston, W.D.W. (1974) Adv. Enzyme
Regul. 12, 219-266
45. Smith, M.R., and Cook, R.T. (1977) Exp. Cell Res. 110, 15-23
46. Cook, R.T., and Aikawa, M. (1973) Exp. Cell Res. 78, 257-270
47. Deaton, C.D., Maxwell, K.W., Smith, R.S., and Creveling, R.L. (1976)
Clin. Chem. 22, 1465-1471
48. Kottgen, E., Bauer, C., and Gerok, W. (1979) Anal. Biochem. 96, 391-394
49. Hoffken, K., Bestek, U., Sperber, U., and Schmidt, C.G. (1979) J.
351
-25-
Immunol. Methods 29, 237-244
50. Warren, C., and Manley, G. (1981) Clin. Chim. Acta 116, 369-380
51. Weissbach, A. (1979) Arch. Biochem. Biophys. 198, 386-396
52. Scorvassi, A.I., Plevani, P., and Bertazzoni, U. (1980) Trends in
Biochem. Sci. 5, 335-337
53. Brown, M., Bollum, F.J., and Chang, L.M.S. (1981) Proc. Natl. Acad.
Sci U.S.A. 78, 3049-3052
54. veer Reddy, G., and Pardee, A.B. (1980) Proc. Natl. Acad. Sci. U.S.A
77, 3312-3316
55. Lynch, W.E., Brown, R.F., Umeda, T., Langreth, S.G. and Lieberman, I.
(1970) J. Biol. Chem. 245, 3911-3916
56. Smuckler, E.A., Koplitz, M. and Smuckler, D.E. (1976) in Subnuclear
Components (Birnie G.D., ed.), pp. 1-58, Butterworths, London
57. Hallick, L.M., and Namba, M. (1974) Biochemistry 13, 3152-3158
58. Krokan, H., Bjorklid, E., and Prydz, H. (1975) Biochemistry 14,
- 4227-4232
59. Laurent, T.C., Tengblad, A., Thunberg, L., Hook, M., and Lindahl, U.
(1978) Biochem J. 175, 691-701
60. Keller, K.L., Keller, J.M., and Moy, J.N. (1980) Biochemistry 19,
2529-2536
61. Nakamura, N., and Kojima, J. (1981) Cancer Res. 41, 278-283
62. Winterbourne, D.J., and Mora, P.T. (1981) J. Biol. Chem. 256,
4310-4320
63. Bhavanandan, V.P. (1981) Biochemistry 20, 5595-5602
64. Kinoshita, S. (1974) Exp. Cell Res. 85^, 31-40
65. Castellot, Jr., J.J., Addonizio, M.L., Rosenberg, R., and Karnovsky,
M.J. (1981) J. Cell Biol. 90, 372-379
-26-
FIGURE LEGENDS
Figure 1: Fractionation of heparin by gel filtration.
Heparin (200mg) was applied to a column (2.5 x 93 cm) of Sephadex
G-100 and the column eluted at a rate of 10 ml per h with 50mM
Tris-HCl, pH 8.0 containing 0.1 M NaCl. Four milliliter frac¬
tions were collected and aliquots analyzed for uronic acid. The
material was pooled in six fractions (I to VI) as indicated, and
recovered by dialysis using 3500 dalton cut off membrane
followed by lyophilization. Each fraction was then individually
rechromatographed on the same column and the material eluting in
the area indicated by horizontal arrows recovered as above.
Only the rechromatographic profiles of fractions II, III, IV and
V are illustrated for clarity. The elution positions of [3H]
porcine submaxillary mucin (VQ) and C] glucose (Vt) are
indicated.
Figure 2: Effect of sulfate content of heparin on endogenous DNA synthesis
in liver and hepatoma nuclei. Endogenous DNA synthesis in
nuclei was assayed [23] in the presence of varying con¬
centrations of partially desulfated heparin fractions. The
results illustrated are for the effect of 54yg heparin per 100ng
liver nuclear DNA (o o) and of 45yg heparin per 100yg hepa¬
toma nuclear DNA (• • ). Different concentrations showed
similar effects, however, quantitative differences were present.
Figure 3: Kinetics of entry of [3H] heparin into nuclei isolated from rat
liver (o) and Morris hepatoma 7777 (»).
[3H] Heparin (specific activity 10^ DPM per mg) was incubated
with isolated nuclei under conditions identical to those used
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for the DNA synthesis assay except that [^H]dTTP was replaced by
unlabel led dTTP. After incubation for the selected time, the
nuclei were sedimented by centrifugation (1000 x g), washed 3
times with 0.15 M NaCl buffered with phosphate (pH 7.2) and
twice with 0.5% Triton X-100 in the same buffer. The latter
wash was expected to remove the outer nuclear membrane [41].
The radioactivity in the washes and in the pellet (after
solubilization in 2% sodium dodecyl sulfate) was determined by
scintillation counting.
Figure 4: Complex formation between hi stone and glycosaminoglycans as
measured by relative light scattering. Details of the measure¬
ment of relative light scattering are described in "Materials
and Methods". Panel (a) shows the effect of increasing amounts
of glycosaminoglycans on the light scattering by a fixed amount
(3ug per ml) of histones, Panel (b) shows the effect of
increasing amounts of histones on the light scattering by fixed
amount (5ug per ml) of various glycosaminoglycans: heparin (•),
chondroitin-6-sulfate (o), N-desulfated N-reacetylated heparin
(x), keratan sulfate (■), desulfated heparin (a), dermatan
sulfate (▼), heparan sulfate (A) and hyaluronic acid (□).
Figure 5: Complex formation between glycosaminoglyeans and histones HI,
H2A+H3, H2B and H4 as determined by relative light scattering.
Details of the experiment are described in "Materials and
Methods". The results obtained with dextran sulfate 40 were
similar to that of heparin.
-28-
Figure 6: Kinetics of in vitro DNA synthesis using calf thymus DNA
polymerase a.
[3H]dTTP incorporation into activated calf thymus DNA was deter¬
mined as described in "Materials and Methods". >
5-55"
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Table I: Differential Effect of Sulfated Polysaccharides on Endogenous DNA
Synthesis in Isolated Nuclei From Rat Liver and Hepatoma
Liver Nuclei Hepatoma Nuclei
>
Sulfate Maximum Stimulation
Sulfated Polysaccharide Kava Disaccharide % Control Activity 50% Inhibition
(Polysaccharide)13 (Polysaccharide^
DNA DNA
Heparin 0.22 2.77 400(0.31)c (0.09)c
Dextran Sulfate 500 0.00 3.66 231(0.20) (0.24)
Dextran Sulfate 40 n.d 3.90 520(0.52) (0.07)
Dextran Sulfate 8 0.71 3.70 525(0.80) (0.08)
Cellulose Sulfate 0.03 3.08 275(0.14) (0.07)
Pentosan Sulfate 1.00 3.64 271(0.33) (0.08)
Chondroitin Sulfate H n.d 1.65 270(0.62) (0.18)
Carrageenan (Type IV) 0.00 2.04 229(0.75) (0.20)
Carrageenan (Type V) n.d 1.30 215(0.63) (0.40)
a
Kav estimated by gel filtration on Bio-Gel P-60.
b
u9 polysaccharide per 100 u9 DNA in 1 ml incubation mixture.
c
At least five different polysaccharide to DNA ratios were tested in each case and the
experiments were repeated. The ratios showing the maximum stimulation of DNA synthesis
in liver nuclei and 50% inhibition of DNA synthesis in hepatoma nuclei are reported in
parentheses.
















































a similarresultswereobtainedithsubfractionsfheparfroScien ficPr t iLaand heparinfractionsprovidedbyDr.E.Holmer b Kavandmolecularweightestimatedbygfiltr tionocalibr teolufSephad xG-100. c Heparin/DNA(w/w)=0.42 b Heparin/DNA(w/w)=0.40t.
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Table III: Effect of Heparin Fragments Obtained by Partial Nitrous Acid Treatment
on Endogenous DNA Synthesis in Nuclei Isolated from Morris Hepatoma 7777
Sulfate [^HjdTTP Incorporated into DNA in 3h:
Subtractions3 G1 CNH2 Kavb Percent Control Valuesc
Heparin 2.51 0 8.4
Fraction A 2.16 0.01 84.6
B 1.81 0.38 6.6
C 2.24 0.65 7.9
D 2.12 0.71 12.2
E 1.69 Q.75 23.9
F 1.71 0.82 33.3
G 0.42 0.91 105
a
Subfractions prepared as described in the text.
k
Kav's were estimated by gel filtration on a column of BioGel P10 which was
calibrated with glycopeptides of known molecular weights.
c
Heparin/DNA (w/w) = 0.45
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Table IV: Entry of [3H1 Heparin and Its Fractions Into Nuclei Isolated
From Rat Liver arid Morris Hepatoma 7777
nmol. [^h] Heparin or its
fractions associated with 100 ug
DNA after incubation for 3h
Molecular Specific Activity
Weight (X106DPM/mg) Liver Nuclei Hepatoma Nuclei
Heparin 14000 9.1 1.12 0.79 ± 0.18(2)a
Fr. I 21000 11.9 1.16 ± 0.14(2) 0.85 ± 0.40(3)
Fr. II 7300 17.6 1.02 ± 0.04(2) 1.31 ± 0.21(2)
Fr. Ill 4000 14.2 0.83 1.16 -
a
Number of experiments is denoted in parentheses.
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Table V: Effect of Glycosaminoglycans on In Vitro DNA Synthesis Using Calf
Thymus DNA Polymerase cta
[3H]dTTP incorporated into DNA






Desulfated Heparin 0.42 95.8
Heparan Sulfate 1.31 47.9
Chondroitin Sulfate H 1.65 44.0
Chondroitin-6-Sulfate 1.25 75.1
Chondroitin-4-Sulfate 1.24 78.5
Dermatan Sulfate 1.11 83.6
Keratan Sulfate 1.43 93.0
Hyaluronic Acid - 99.3
a
Conditions of assay are described in Materials and Methods. The effects of
different concentrations of glycosaminoglycans were tested. The data presented
are that obtained with 5ug of glycosaminoglycans per lOOug DNA in 0.5ml reaction
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Epiglycanin, the major glycoprotein of TA3-Ha mammary carcinoma ascites cell
was radiolabeled with tritium in the terminal galactose and ]T-acetyl galac-
tosamine residues. A1kaline-borohydride treatment, reported to release five 0-
glycosyl-linked chain types from epiglycanin [J. Biol. Chem. 254- (1979) 12153],
resulted in the cleavage of 98-99% of the radioactivity from the protein. Of
this, 63% of the radioactivity from epiglycanin and 70% from asialoepiglycanin
co-migrated with an authentic sample of 2-acetamido-2-deoxy-3-£-(0-D-
galactopyranosyl)-D-galactitol on a column of Bio-Gel P-6. Incubation of
[3H-galactose]epiglycanin with endo-N-acetyl-a-D-galactosaminidase (D.
Pneumoniae), and fractionation of the mixture on a column of Bio-Gel P-4 gave
only one oligosaccharide peak containing 62 and 70%, respectively, of the
radioactivity of epiglycanin and asialoepiglycanin. This oligosaccharide co-
migrated with authentic 2-acetamido-2-deoxy-3-O-(0-D-galactopyranosyl)-D-
galactose [I] on Bio-Gel P-2 and P-4 columns and on paper chromatograms.
Results of experiments in which unlabelled epiglycanin was treated with
enzyme and the products analyzed, by three different methods, suggested that
78-35% of [I] had been cleaved. Another enzyme, Jl-acetyl-a-D-galactosaminyl
oligosaccharidase from £. Perfringens, exhibited similar specificity and cleaved
65% of the radioactivity from [^H-galactosejasialoepiglycanin which was eluted




Epiglycanin, glycoprotein of about 500,000 molecular weight, is the major
1 2
cell-surface component of the mouse TA3-Ha mammary carcinoma ascites cell ' .
Immunochemical and chemical evidence has shi^wn that about 60% of the car-
bohydrate in epiglycanin is present as 0-D-Gal (l-*-3)-D-GalNAc bound by an
3
O^glycosyl linkage to serine and threonine . The anomeric nature of the gly-
copeptide linkage has not been reported, even though, based on an analogy to
other glycoproteins containing similar structures4-6, an a-anomeric linkage
was considered likely. In order to obtain an uneqivocal proof for the con¬
figuration of this linkage we examined the effect of endo-ji-acetyl-
a-D-galactosaminidase on epiglycanin. In addition, we were interested in par¬
tial enzymatic deglycosylaton of epiglycanin in order to investigate the speci¬
ficity of the anti-epiglycanin antibody'7. Our results show that the
disaccharide e-D-Gal (1^-3)-D-GalNAc is linked to serine or threonine via an
a-anomeric linkage, and that the disaccharide can be virtually quantitatively
removed from intact epiglycanin by the enzyme.
EXPERIMENTAL
Epiglycanin was purified from TA3-Ha ascites cells as described
1 3
previously ' . Endo-N-acetyl-a-D-galactosaminidase and neuraminidase were
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purified from culture filtrates of Diplococcus pneumoniae * . These prepara-
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tions were free from contaminating glycosidases and proteases '. Vibrio cho-
1erae neuraminidase was purchased from Calbiochem, La Jolla, CA. Jack bean
exo-e-D-galactosidase*0 and Escherichia freundii endo-e-D-galactosidase11 were
gifts from Prof. Y-T. Li, Tulane University, New Orleans, LA. ^-acetyl-a-D-
galactosaminyl-oligosaccharidase (Clostridium Perfringens) was purchased from
Bethesda Research Laboratories, Rockville, MD. Galactose oxidase and horse
radish peroxidase were bought from Uorthington Biochem. Corp., Freehold,'N.J.
NaB (340mCi/mmol) was purchased from New England Nuclear, Boston, MA.
3
Asialoepiglycanin was prepared by treatment of epiglycanin with Vibrio cho-
lerae neuraminidase (1 unit) in 2Q0u1 0.1M sodium acetate buffer, pH 5.6 con¬
taining ImM Ca3+ at 37° for 24h.
[3H]-Galactose-1 abelled epiglycanin and asialoepiglycanin were prepared by
treatment with galactose oxidase followed by NaB3H4 according to the method of
Morel! and Ashwell1^ After heat inactivation of the enzymes the labelled
samples were recovered by exhaustive dialysis against water followed by
lyophilization.
Digestion with enzymes: Treatment with endo-N-acetyl-a-D-galactosaminidase
from £. Pneumoniae was performed in 50nM Tris/maleate buffer, pH 7.0, with 2mU
of enzyme at 37°C for 24h in a volume of 50ul. In some experiments the treat¬
ment was continued for 72h, with addition of enzyme (2mU) every 24h. Treatment
with E. Freundii endo-3-D-galactosidase was in 0.05P4 sodium acetate buffer,
pH 5.8, at 37°C for 24h^. Incubation with £. Perfringens N-acetyl-a-
D-galactosaminyl oligosaccharase was in 50mM potassium phosphate buffer, pH 6.5,
with 10 mU of enzyme at 37°C for 72h^. All digestions were terminated by
heating at 100°C for 2-5 min.
Gel filtration: Columns of Bio-Gel P-2 (minus 400 mesh), P-4, P-6 (200-400
mesh) and P-100 (100-200 mesh) were equilibrated and eluted with 0.1M
pyridine/acetic acid, pH 5.0.
RESULTS AND DISCUSSION
Characterization of [JH]-galactose-labe11ed epigl.ycanin. The specific activi¬
ties of [^Hj-epiglycanin and [^H]-asialoepiglycanin prepared by treatment with
galactose oxidase followed by sodium borotritide were 13 x 10^ and 20 x 10^ DPM
per ug, respectively. On acid hydrolysis of the labelled asialoepiglycanin
(lji HC1, 100°, 5h) and examination of the products by paper chromatography using
1-butanol/pyridine/water (6:4:3 v/v) as solvent it was found that 91% of the
tritium was associated with galactose and 9% with galactosamine. Previous
4
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results have shown that about 19% of the N-acetylgalactosamine residues in
epiglycanin are present as single non-reducing units®. The lower than
expected level of labelling of GalNAc may be due to the unavailability of these
residues for the galactose oxidase due to steric reasons1^ and to the obser¬
vation that non-reducing terminals of GalNAc is a poorer substrate than Gal for
the enzyme (Bhavanandan, unpublished results). Bonnet monkey cervical mucin15
labelled similarly yielded on hydrolysis [3H]-galactose (64%) and
[3H]-galactosamine (36%).
On alkaline borohydride treatment1® of the [3H]-labelled epiglycanin and
asialoepiglycanin, followed by chromatography on a calibrated column of Bio-Gel
P-6, it was found that 98 and 99%, respectively, of the labelled material was
released by 0-elimination. Sixty-three and seventy percent, respectively, of
the eliminated oligosaccharides co-migrated with authentic 2-acetamido-2-deoxy-
3-0-(3-D-galactopyranosyl)-D-galactitol isolated from fetuin®'1^.
Action of endo N-acetyl-q-D-galactosaminidase. The result of a typical experi¬
ment in which an epiglycanin sample was treated with the endo-N-acetyl-a-D-
galactosaminidase and the digest examined by gel filtration is illustrated in
Figure 1. After 24h incubation, between 43 to 50% of the label was released as
a disaccharide which co-migrated with authentic 2-acetamido-2-deoxy-3-0-
(6-D-galactopyranosyl )-D-galactose on Bio-Gel P-4 (Figure 1) and P-2 columns
(not illustrated). Incubation for longer periods (up to 72h) or isolation of
the material excluded from the Bio-Gel P-2 or P-4 column (see Figure 1) and re-
treatment with the enzyme resulted in release of additional quantities of the
disaccharide. A maximum of 62% and 70% of the label in epiglycanin and
asialoepiglycanin, respectively, could be released as the disaccharide.
The product released from [3H]-asialoepiglycanin was recovered by combining
fractions 78-86 (Figure 1) and lyophilizing to remove pyridine/acetic acid. On
paper chromatography the recovered material comigrated with 0-B-[3H]-Gal(l->3)
5
D-GalNAc isolated from asialoglycophorin A and with g-D-Gal (1-K3)-D GalNAc
isolated from fetuin (Figure 2). Another portion of the material was dissolved
in 50jil of 0.0514 citrate/phosphate buffer, pH 4.0, and incubated with 2 units of
jack bean e-galactosidase at 37° for 29h. Carrier galactose (lmg) was added to
the digest and the mixture chromatographed on a Bio-Gel P-2 column. Thirty-
seven percent of the radioactivity was coeluted with galactose (Figure 3), con¬
firming that the disaccharide consists of terminal [^H]-Galactose linked in a
B-configuration*®. The partial cleavage of the disaccharide is due to the
fact that this enzyme is known to act very poorly on galactose linked el 3 to
the aglycone1®. In fact, under the same incubation conditions as above this
enzyme failed to release [^H]-galactose from [3H]-asialoepiglycanin or from the
reduced disaccharide, e-D-[^H]Gal (l-K3)GalNAcOl, isolated from asialoepiglycanin
by alkaline borohydride treatment. Thus, it appears that the nature of the
aglycone influences the activity of jack bean e-galactosidase on galactose in
B 1-K3 linkages.
To determine on a mass basis the percent of disaccharide, 2-acetamido-2-
deoxy-3-0-(e-D-galactopyranosyl)-D-galactose, released from epiglycanin we
carried out the following experiments. Epiglycanin was incubated with endo
_N-acetyl-a-D-galactosaminidase alone or in the presence of 2- pneumoniae neura¬
minidase, at 37° for 48h. The released disaccharide was quantitatively deter¬
mined by the modified Morgan-El son assay*9 using GalNAc as standard. In
calculating the amount of the disaccharide released, the report that GalNAc
substituted at position 3 gives 60% more color than unsubstituted GalNAc^°
was taken into consideration. It was found that 15yg of epiglycanin yielded
17.9 and 21.4 nmol of the disaccharide when treated with the endoenzyme alone or
with the endoenzyme and neuraminidase, respectively. This corresponds to the
release of 60% and 73%, respectively, of total GalNAc as the disaccharide.
In other experiments, 66ug aliquots of epiglycanin were incubated with
6
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buffer alone or with the endo-enzyme (6mU) and neuraminidase (42mU). The
digests were fractionated on pre-calibrated Bio-Gel P-2 columns to yield undi¬
gested material and enzyme (void volume peak) and the released disaccharide
(included peak). An enzyme control was also similarly fractionated. Each of
the fractions was hydrolyzed (6N HC1, 110°, 24h in vacuo) and the products ana¬
lyzed on a Dionex amino acid analyzer equipped with a fluorescence detector.
The results are summarized in Table 1. It is clear that about 63% of the totaV
GalNAc was released from epiglycanin which had been treated with both the
endoenzyme and neuraminidase.
In further experiments, 200ug of the glycoprotein was treated with the
endoenzyme and neuraminidase and the digest fractionated on a column of BioGel
P-100. The undigested material, as well as the released oligosaccharides, were
recovered, subjected to methanolysis, and the glycosides analyzed as per-
trimethylsilylated methyl glycosides by gas liquid chromatography^!. jj,e
composition of the high-molecular-weight (epiglycanin) peak suggested that 70%
of the Gal and 62% of the GalNAc, but no GlcNAc, had been cleaved. These
results suggest that as much as 78-85% of the disaccharide had been released
from the epiglycanin.
Our results clearly establish that the major carbohydrate component of
epiglycanin is e-D-Gal (l->-3)-D-Gal NAc (which is partially substituted by NeuNAc),
and that this disaccharide is linked to the protein via an a-anomeric linkage.
Further, we have shown that up to about 80% of the disaccharide may be released
from asialoepiglycanin by endo-N-acetyl-a-galactosaminidase.
Action of N-acetyl-g-D galactosaminyl oligosaccharidase. A minor portion of
the carbohydrate in epiglycanin is present as a hexasaccharide and as a tetra-
saccharide^. Since the Clostridium perfringens N-acetyl-q-D-galactosaminyl
oligosaccharidase has been reported to cleave oligosaccharides larger than
disaccharides which are bound by £-glycosyl linkages to protein!^, we tested
7
the action of this enzyme on [3H]-asialoepiglycanin. The results obtained on
gel filtration of the incubation mixture on a column of Bio-Gel P-4 were iden¬
tical to those obtained with JD. Pneumoniae endo-N-acetyl-a-B-galactosaminidase.
About 65% of the cleaved material comigrated with e-D-gal(l-*3)GalNAc, and no
labelled components corresponding to higher oligosaccharides were detected; the
tetrasaccharide B-D-[3H]Gal (l-»4)e-D-GlcNAc(l->-3)B-Gal (l-»-3)-B-Q-Gal NAc was
expected. Retreatment of the material eluted at the void volume of the Bio-Gel
P-4 column with the same enzyme also failed to release any tetrasaccharide.
Action of E. Freundii endo-B-P-qalactosidase. When the excluded asialo-material
from the Bio-Gel P-4 column (Figure 1) was treated with E. Freundii
endo-B-galactosidase, and the digest chromatographed on a Bio-Gel P-4 column,
the results illustrated in Figure 4 were obtained. About 14% of the radioac¬
tivity eluted in the same region as maltotriose. Insufficient material pre¬
vented further examination of the released saccharide. Tentatively, it appears
that this endo-B-galactosidase may have released the trisaccharide,
B-Q-Gal(l->4)-B-D-GlcNAc(l->3)-B-D-Gal , from the above tetrasaccharide.
The specificity of endo-ji-acetyl-a-D-galactosaminidase, as well as N-acetyl-
a-D-galactosaminyl oligosaccharidase, for cleaving the disaccharide in epiglyca-
nin suggests a unique role for this carbohydrate chain. Although the
disaccharide structure itself has been identified in a variety of mammalian
tissues and cells3, it represents not only the predominant carbohydrate
structure in epiglycanin, but, as part of a glycopeptide structure, it serves
uniquely as a receptor for either the anti-epiglycanin antibody^ and the lec¬
tin from Vicia graminea beans22. Whether or not this chain is involved in
the suggested antigen-masking function23 of epiglycanin has not yet been
determined.
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Table 1: Hexosamine and amino acid composition of epiglycan before and after
treatment with D. Pneumoniae endo-a-N-acetyl galactosaminidase and
neuraminidase and fractionation on BioGel P-4 column












nmol. per 33yg Epiqlycanin
Asparatic Acid 0.28 1.12 0 0.24* 0*
Threonine 13.10 9.92 0.12 11.14 0.02
Serine 8.79 9.38 0 8,54 0.04
Glutamic Acid 0.44 1.44 0 0.58 0.12
Glycine 2.33 2.56 0 2.48 0
A1 ani ne 3.38 2.40 0 2.79 0
Voline 0.43 0.40 0 0.31 0
Isoleucine 0.18 0.23 0 0.12 0
Leucine 1.06 0.86 0 0.89 0.01
Phenyl Alanine 0.05 0.16 0 0.02 0
G1ucosamine 0.81 1.07 0.15 1.11 0.18
Galactosamine 10.01 9.88 0.12 3.53 6.03
*The values in these columns are corrected for contributins from the enzymes.
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Figure Legends
Fig. 1: Elution profiles on Bio-Gel P-4 of [3H]-epiglycanin (».—• ) and
C3H] -asialoglycophorin (0 0) after treatment with endo-a-N-acetyl galac-
tosaminidase. The treated samples were mixed with [^C]-glucose (a a) and
chromatographed on a Bio-Gel P-4 column (0.9 x 108cm). The column was eluted
with 0.1M pyridine/acetic acid, 1ml fractions collected and analyzed for
radioactivity by liquid scintillation counting. The void volume (Vq) and elu¬
tion position of authentic 0-D-Gal (l->- 3)GalNAc are indicated.
Fig. 2: Paper chromatography of the endo-a-N-acetylgalactosaminidase released
products from [3H] asialoepiglycanin ( ) and [3H] asialoglycophorin
( ). The [3H]-labelled products recovered from the Bio-Gel P-4 fractions
78-86 (Figure 1) were chromatographed using butyl acetate/acetic acid/water
(3:2:1, v/v) as solvent. The paper strips containing the labelled samples were
cut into 1 cm wide pieces, extracted with 1ml water and the extracts analyzed
for radioactivity. The migration positions of standard sugars were detected by
the silver nitrate staining procedure.
Fig. 3: Elution profiles on a column of Bio-Gel P-2 (0.9 x 70cm) of
0-D-[3H]-Gal(l-* 3)Gal NAc (0 0) and [3H]-asialoepiglycanin (• •) after
treatment with jack bean g-galactosidase as described in the text. The column
was eluted with 0.1M pyridine/acetic acid, 1ml fractions were collected and ali-
quots analyzed for radioactivity and galactose (by the phenol-sulfuric acid
reaction). The elution pattern of [^C]-glucose (□ □) and the peak elution
positions of blue dextran (VQ) and NeuNAc are indicated.
Fig, 4: Elution profile on Bio-Gel P-2 of endo-a-N-acetyl galactosaminidase
resistant [3H]-asialoepiglycanin after treatment with E_. Freundii endo-0-
galactosidase. The enzyme digest was mixed with C] glucose (a a) and
12
chromatographed on a Bio-Gel P-2 column (0.9 x 68 cm). The column was eluted
with Q.1M pyridine acetic acid, 1ml fractions were collected and analyzed for
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Abstract
An anti-epiglycanin antibody was induced by repeated
inoculation of either rabbits or mice with viable TA3-Ha
mammary carcinoma ascites cells. Picogram quantities of
epiglycanin were detected in a radioimmunoassay by inhibition
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of the formation of the complex of the antibody and I-epiglycanin.
The probable involvement of carbohydrate in the antigenic
determinant for the antibody was shown by the loss of inhibitory
activity following periodate oxidation. The requirement of
the disaccharide , 0-6-Dygalactopyranosyl - (l-i-3) -N-acetyl-a -
D-galactopyranose, attached to ^-serine or j^-threonine, was
demonstrated by the action of endo-N-acetyl-a-D-galactosaminidase
(D. pneumoniae), which cleaved this type of chain (75-801 in
epiglycanin) only, with 991 loss of activity. The resulting
partially deglycosylated epiglycanin was inactive, as was
the isolated disaccharide chain, suggesting the requirement
for specific peptide linkages. This result is consistent
with the inactivity or the weak activity exhibited by
glycoproteins with similar disaccharide chains but with
different amino acid sequences. Epiglycanin was at least
500-fold more active than any other substance tested. Both
chromatographic and immunologic data suggest that the rabbit
antibody was of the IgG and IgM classes.
INTRODUCTION
Long rod-like molecules of epiglycanin dominate the
surfaces of the TA3-Ha and TA3-MM/1 ascites cells and appear
to mask histocompatibility antigens. This phenomenon may
explain, at least in part, the allotransplantability of
these cells. The characteristics of the TA3 tumor and of
epiglycanin have been reviewed (Codington & Frim, 1982).
Previous attempts to detect anti-epiglycanin antibody in the
serum of either rabbits or mice injected with the glycoprotein
emulsified in Freund's complete adjuvant were unsuccessful.
We report herein the presence of anti-epiglycanin antibody
in high titre in the sera of both mice and rabbits inoculated
with a suspension of viable TA3-Ha ascites cells emulsified
in Freund's complete adjuvant followed by repeated intravenous
injections of the tumor cells. We describe the characteristics
of these antibodies and the development of a radioimmunoassay
for the detection of epiglycanin based on these antibodies.
MATERIALS AND METHODS
Cells
TA3-Ha and TA3-St ascites cells of the strain A mouse
were obtained as described by Codington et al^. , (1979). The
description of these cells was reported by Hauschka et ad.,
(1971) and Cooper et_ aA^. , (1979) . Tumor cells were maintained
by passage in A/HeJ mice (Jackson Laboratories, Bar Harbor,
ME 04609), and were harvested on day 7 following the intraperitoneal
inoculation of 10S TA3-Ha or 10^ TA3-St cells. Cells were
washed several times with phosphate buffered saline (PBS)
(Dulbecco § Vogt, 1954) and their concentration was determined.
Antigens
Epiglycanin of 500,000 molecular weight (Fraction II)
was isolated from the ascites fluid of A/HeJ mice bearing
TA3-Ha ascites cells (Codington et al., 1979). Fragments of
epiglycanin (avg. molecular weight 200,000, Fraction A) were
obtained by incubation of viable TA3-Ha ascites cells with
TPCK-trypsin and were purified by gel filtration (Codington
et al. , 1979). Fraction C was obtained by further purification
of Fraction A (Slayter § Codington, 1973). Reduced oligosaccharides
of one, two, three and four carbohydrate residues were
obtained by alkaline borohydride reduction of Fraction A,
followed by gel filtrate ion chromatography (van den Eijnden et_
al., 1979). Glycopeptide BH (borohydride) was obtained by
the same procedure, and its effluent volume suggested a
molecular weight of about 4,000.
3-0-6 -D-galactopyranosyl-(1*3)-0-(2 -acetamido-2-deoxy-
a-D-galactopyranosyl) - (l-»-3) -N-g- toluenesulfonyl-L-serine was
supplied by Professor T. Osawa of Tokyo University, and 0-6-
D-galactopyranosyl- (1*3)-2-acetamido-2-deoxy-a-D-galactopyranosyl)-
(1*3)-L-threonine by Professor H. Paulsen of the University
of Hamburg. Glycophorin A (Tomita et_ al_. , 1978) was a gift
from Dr. H. Furthmayr, Department of Pathology, Yale University.
The freezing-point-lowering glycoprotein from Antarctic fish
(Osuga 5 Feeney, 1980) was a gift from Dr. R. E. Feeney,
University of California, Davis, and fetuin (Spiro 5 Bhoyroo,
1974) was a gift from Drs. Robert and Mary Jane Spiro,
Department of Biological Chemistry, Harvard Medical School.
The bovine lubricating glycoprotein (Garg et aK , 1980) was
obtained as a gift from Drs. David Swann and Hari Garg of
the Massachusetts General Hospital. 2-Acetamido-2-deoxy-4-
0-(6-D-galactopyranosyl)-D-glucose (N-acetyllactosamine) and
methyl 2-acetamido-2-deoxy-6-D-galactopyranoside were purchased
from Pfanstiehl Laboratories, Waukegan, IL.
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Enzymes
Neuraminidase (3.2.1.18) from Vibrio cholerae (1 U/ml)
was obtained from Calbiochem-Behring, San Diego, CA. Endo-
N-acetyl-a-D-galactosaminidase was prepared from D. pneumoniae,
as described (Bhavanandan et_ ad., 1976; Umemoto et_ al. ,
1977). No protease was detected when the enzyme was tested
with either azocasein or methemoglobin as substrate. 6-D-
Galactosidase (3.2.1.23, Canavalia ensiformis, 23 U/ml) was
a gift from Dr. Y.-T. Li, Tulane Medical Center, New Orleans,
LA. a-D-Mannosidase (3.2.1.24, C. ensiformis, 10 U/mg) was
obtained from Boehringer Mannheim, Indianapolis, IN, and N-
acetyl-a-D-galactosaminidase (3.2.1.49, C. lampas, 0.4 U/mg)
was purchased from Miles Laboratory, Kankakee, IL. N-
Acetyl-a-D-galactosaminidase (3.2.1.49) from C. perfringens
was purchased from Bethesda Research Laboratories, Rockville,
MD. B-D-Hexosaminidase (3.2.1.52) was obtained from Seikagaku
Kogyo Co., Ltd., Tokyo, Japan. N-Acetyl-a-D-galactosaminidase
(3.2.1.49) from pig liver was donated by Dr. B. Weissmann,
University of Chicago. L.-1-Tosylamido-2-phenylethyl-chloromethylketone
trypsin (3.4.4.4, TPCK-trypsin) and galactose oxidase (1.1.3.9,






(Bolton Hunter Reagent) (Bolton 5 Hunter, 1973), (2000 Ci/mmol)
was purchased from New England Nuclear Corp., Boston, MA,
and used within one week.
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I -Epiglycanm
A stream of dry air was passed into a vial containing
1.0 mCi of the Bolton-Hunter Reagent (2000 Ci/mmol), as
received from the supplier, to remove the benzene solvent.
To the residue was added a solution of 15 yg of epiglycanin
(500,000 molecular weight) in 30 yl of 0.1 M borate buffer
12 5
(pH 8.5). After 19 hours at 0-4°, I-epiglycanin was
separated from unreacted reagent and reaction by-products by
elution with PBS from a column (0.6 x 21 cm) of Bio-Gel P-4
(200-400 mesh). The solution of radiolabelled epiglycanin was
stored at -20°.
Induction of anti-epiglycanin antibody
A. Iii mice
An emulsion (0.1 ml) composed of equal volumes of PBS
containing 1 x 10^ TA3-Ha ascites cells per ml and Freund's
complete adjuvant was injected into an axilla of each of
four male C57BL mice 7 weeks of age. Injections of 10^ cells
in 0.1 ml of PBS were given in the tail vein of each mouse
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each week for 8 weeks. As a control, one mouse was given an
initial injection of Freund's complete adjuvant with PBS,
and was given additional injections of 0.1 ml of PBS, without
the tumor cells, according to the same schedule. Mice were
bled from the retroorbital venous plexus every two weeks,
beginning at week 1 and continuing until week 9. The serum
samples were stored at -20° until tested in the radioimmunoassay
for antibody activity.
B. In rabbits
Each of two New Zealand white rabbits was inoculated
in the four foot pads with a total of 4 ml of an emulsion
prepared from 2.0 ml of Freund's adjuvant and 2.0 ml of PBS
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containing 1.2 x 10 TA3-Ha ascites cells. Thereafter, eacn
rabbit was injected intravenously, usually at two or three
week intervals, with 2 x 10^ TA3-Ha cells in 2.0 ml of PBS.
The rabbits were bled before each injection. Nineteen
months following the initial injection of TA3-Ha ascites
cells, 120 yg of epiglycanin in Freund's complete adjuvant
was injected intramuscularly. Serum was obtained after 6
weeks and after an additional 4 weeks; during these intervals
4 and 3 intravenous injections, respectively, sDf 2 x 10^
TA3-Ha ascites cells, were given. All radioimmunoassays
reported herein utilized serum obtained from these latter
two bleedings.
Radioimmunoassays
Radioimmunoassays were employed in the determination of
anti-epiglycanin antibody activity and in the determination
of the concentration of epiglycanin or epiglycanin-like
material in solution. For determining the antibody titre, a
mixture of 100 yl of rabbit or mouse antiserum at appropriate
2-fold dilutions and 50 yl of I-epiglycanin (3 ng, 1600-2200
cpm) was incubated for 16-20 hours at 4° in 1.2 ml plastic
centrifuge tubes. Precipitation was completed by the addition
of a second antigen-antibody system consisting, for the
rabbit antibody, of 0.20 ml of normal rabbit serum (1:50)
and 0.15 ml of goat anti-rabbit IgG antiserum, and for the
mouse antibody, 0.20 ml of normal mouse serum (1:50) and
0.075 ml of rabbit anti-mouse antiserum (Cappel Laboratories
Inc., Cochranville, PA). After 16-20 hours at 4°, 0.30 ml
of PBS was added. After centrifugation, the radioactivity
of each supernatant and precipitate was determined by
crystal scintillation spectrometry.
Inhibitory activity was determined by adding the inhibitor
in 50 y 1 of PBS to 100 yl of rabbit or mouse anti-epiglycanin
antiserum at about 1:1000 or 1:200 dilutions, -respectively,
in a 1.2 ml tube and incubating the mixture at 37° for 60
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min and at 22° for 60 min. Thereafter, " I-epiglycanin (50 yl
3 ng, 1600-2200 cpm) was added to each tube, and the mixture
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incubated at 4° for 16-20 hours. The second antigen-antibody
mixture, as described above, was then added, and incubation
continued for 16-20 hours at 4°. The radioactivity in both
the supernatants and precipitates was determined after
centrifugation. The proportion of radioactivity in the
precipitates was plotted versus the concentration of antigenic
substances added. Activity was determined by comparison
with a standard curve prepared with epiglycanin as the
inhibitor.
Characterization of antibody induced in the rabbit
(A) Fractionations
Antiserum of maximum titre (1.0 ml) was applied to a
column (1.0 x 15 cm) of DEAE-cellulose (DE-52, Whatman
Chemical Separation, Inc., Clifton, NJ) and fractions were
eluted, successively, with 0.01 M sodium phosphate (pH 7.5),
0.02 M sodium phosphate (pH 6.2), and 1.0 M sodium chloride,
according to a modification of the procedure of Fahey (1967).
Fractions (1.5 ml) were tested for protein content (Lowry et_
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al. , 1951) and for the ability to bind I-labelled epiglycanin
in the radioimmunoassay.
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For the comparison of the elution characteristics of the
antibody in gel filtration with those of known antibody
classes (Fireman et_ al. , 1963), fractions from the DE-52
column constituting peaks of antibody activity, after dialysis
against 0.1 M pyridine acetate and lyophilization, were
dissolved in 0.2 M NaCl and applied to the same column (1.0
x 111 cm) of Sephadex G-200 (Pharmacia, Piscataway, NJ
08854). Fractions (1.5 ml) were eluted with 0.2 M NaCl and
tested for protein content and capacity to bind labelled
epiglycanin, as described above for fractions from the ion-
exchange column.
B. Immunoprecipitation of antibody
Four tubes, each containing anti-epiglycanin antiserum
(100 ul) at a dilution of 1:150, were each incubated with
100 ul of goat anti-rabbit IgA, IgG, IgM antiserums (all
heavy chain specific; Cappel Laboratories) or buffer at 37°
for 60 min and 4° for 20 hours. After centrifugation, 185
ul of supernatant was removed from each tube, and the residues
were discarded. The radioimmunoassay was performed to
determine the concentration of antibody remaining in the
supernatants.
Modification of epiglycanin
For the complete removal of sialic acid, epiglycanin
(100 yg) was incubated with 20 yl (0.02 U) of neuraminidase
in 500 y 1 of PBS at 22° for 16 hours. The cleavage of 0-D-
galactopyranosyl-(1*3)-2-acetamido-2-deoxy-^-galactose from
epiglycanin was performed, as reported elsewhere (Bhavanandan
5 Codington, 1982) ; 200 yg of the glycoprotein (molecular
weight 500,000) in 90 yl of 50 mM tris-maleate buffer (pH
6.8) was treated at 0, 24 and 48 hours with 10 yl of the
same buffer containing 0.002 U of endo-N-acetyl-a-D-galactosaminidase
The solution was incubated at 37°, and the reaction terminated
at 72 hours by freezing. For the reaction with asialoepiglycanin,
0.014 U of neuraminidase (D. pneumoniae) was added to a
similar reaction mixture containing endo-N-acety1-a-D-
galactosaminidase at 0 hours.
Periodate oxidation was performed with 30 yg of sodium
metaperiodate in a solution of 17 yg of epiglycanin (500,000
molecular weight) in 200 yl of PBS at 22°. Aliquots were
removed at appropriate intervals. The reaction was terminated
at 20 hours by the addition of 50 yl of ethylene glycol.
[^H-Galactose]-epiglycanin
Epiglycanin was radiolabelled in the galactose residues
by a modification of the method of Morell and Ashwell (1972).
The glycoprotein (100-200 yg) in 0.1 M phosphate buffer (pH
7.0) was incubated with galactose oxidase (5 U, Worthington
Biochemical Corp., 150 U/mg) at 37° for 30 min. Sodium
borotritide (0.5 mCi, New England Nuclear Corp., 246 Ci/ir.ol)
was added, and the mixture incubated at 23° for 2 hours.
After the addition of sodium borohydride (0.7 mg) and reaction
for 60 min, the mixture was acidified, and borate was removed
by repeated evaporation with dry methanol.
RESULTS
Induction of antibody
A. Iii the mouse
Epiglycanin-binding activity in the sera of CS7BL mice
is illustrated in Figure 1A. The level of binding activity
had risen markedly 3 weeks after the initial injection of
tumor (TA3-Ha) cells and had reached a plateau at about week
4. With continued biweekly injections of the viable cells,
this level was maintained for at least 4 additional weeks.
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The binding of I-epiglycanin by the antiserum at several
dilutions, as determined in the radioimmunoassay, is illustrat
in Figure 2. In this experiment, approximately 2 ng of the
labelled glycoprotein (specific activity, 8 x 10^ cpm/yg)
was added to each tube; there was a progressive loss of
binding activity on dilution of the antiserum.
B. Iii the rabbit
The appearance of epiglycanin-binding activity in the
rabbit is illustrated in Figure IB. The initial injection
of tumor cells, emulsified with Freund's complete adjuvant,
was made in the foot pads of two rabbits, as compared with
the axillae in the mouse, but periodic intravenous injections
with viable cells were performed in each species. Since one
of the rabbits died before the completion of the injection
schedule, the results are presented only for the surviving
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rabbit. The partial results suggest, however, that the
epiglycanin-binding capacity in the sera of the two rabbits
was approximately the same. Epiglycanin-binding activity
was first detected in the serum 4 weeks following the initial
injection (Figure IB). Similar and essentially complete
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precipitation of I-epiglycanin was observed at dilutions
of 1:100 and 1:400 for all of the antisera tested (Figure
IB). Therefore, comparisons among antisera were at a higher
dilution (1:1600). The highest binding activity was obtained
7 weeks following the initial injection. Thereafter the
binding activity at this dilution decreased; no further
effort was made to obtain antisera following this period.
More than a year later, however, it was found that the serum
of the rabbit still possessed the anti-epiglycanin antibody,
and a renewed effort was made to prepare antisera of high
antibody content. Following an intensive program of injecting
viable cells, two separate bleedings made at a four week
interval yielded antisera with high binding activity (Figure
12 5
IB). The almost identical binding of I-epiglycanin by
various dilutions of the latter two antisera is shown in
Figure 3. These two samples of antiserum were^used in all
subsequent experiments described in this report.
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Inhibitory activity
The activity of epiglycanin, isolated from the ascites
125fluid (Fraction II), in inhibiting the binding of I-epiglycanin
to mouse or rabbit anti-epiglycanin antibody is shown in
Figure 4. The two experiments were performed with different
preparations of labelled glycoprotein; therefore, a direct
comparison of the two binding curves is not possible.
The inhibitory activities of a number of glycoproteins
and asialoglycoproteins were compared with those of two
epiglycanin and asialoepiglycanin fractions (Table I). The
results indicate a marked degree of specificity of the
antibody for structures present in epiglycanin, since no
other substance tested approaches epiglycanin in inhibitory
activity. Of the most active glycoproteins tested were
those isolated from the cell surfaces of rat mammary carcinoma
ascites cells by Carraway et al_. (1978) . After removal of
sialic acid residues, several glycoproteins, such as fetuin,
glycophorin and the bovine lubricating glycoprotein, exhibited weak
activity.
Antigenic determinant
A summary of the inhibitory activities in the radioimmunoassay
remaining after treatment of epiglycanin with various glycosyl
hydrolases and with periodate is presented in Table II.
Periodate oxidation destroyed all inhibitory activity, which
suggested that carbohydrate linkages were involved in the
antigenic determinant. One glycosylhydrolase, endo-N-
acetyl-a-D-galactosaminidase, was found to eliminate 99% of
the inhibitory activity. It has been reported that this
enzyme is capable of cleaving the disaccharide, 2-acetamido-
2-deoxy-3-0-8-D-galactopyranosyl-a-D-galactopyranose, linked
to serine or threonine in a glycopeptide structure (Figure
5,11) (Umemoto et_ cQ., 1978). Of the seven other glycosylhydrolases
used, only one, neuraminidase from Vibrio cholerae, displayed
a significant effect upon activity, which was increased from
2- to 5-fold. This result is consistent with the finding
(van den Eijnden et_ al., 1979) that treatment of epiglycanin
with neuraminidase results in the exposure of approximately
20% more disaccharide chains.
Following the incubation of asialoepiglycanin with
endo-N-acetyl-a-D-galactosaminidase, the reaction mixture,
which possessed about 1% of the activity of the original
asialoepiglycanin sample, was eluted from a column of Bio-Gel
P-100, and each fraction was tested for inhibitory activity
in the radioimmunoassay (Fig. 6). Only one peak of activity
was observed. The active material was eluted in an effluent
volumne only slightly greater than that required to elute an
unreacted sample of asialoepiglycanin (position a), a result
consistent with a 20-25% loss in molecular weight, due to
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deglycosylation. No activity was detected at the effluent
volume required to elute an authentic sample of the disaccharide
(location Id, Fig. 6). The carbohydrate analysis of the
active material eluted from the column showed proportions of
both galactose and N-acetylgalactosamine lower than those of
the original epiglycanin sample. On the assumption that no
loss in the proportion of N-acetylglucosamine occurred, the
enzyme-treated product exhibited a loss of 71% galactose and
62% N-acetylgalactosamine. No loss in mannose was observed.
Based upon published values for the proportion of O-glycosyl
linked chains in epiglycanin (van den Eijnden et al., 1979) ,
these values suggest that 75-85% of the disaccharide chains
were cleaved by the enzyme.
The inhibitory activities of O-linked oligosaccharides
found in epiglycanin, or closely related to those present in
epiglycanin, are given in Table III. Weak activity (approximately
0.005% of that of epiglycanin) was found in the reduced
disaccharide and the reduced sialylated disaccharide. No
activity was detected for the disaccharide itself, but this
substance was not tested at high concentration. Neither the
disaccharide bound by an a-linkage to serine (with a g_-toluenesulfonyl
residue linked to the amino group of the serine), nor the
disaccharide bound to threonine, exhibited any detectable
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activity. No activity was detected for the reduced tetrasaccharide
containing one N-acetyl-D-glucosamine residue and two D-
galactose residues, which had also been isolated from epiglycanin
following alkaline borohydride reduction (van den Eijnden et
al. , 1979). One of the most active inhibitors listed is the
glycopeptide BH (borohydride). This material, which resulted
from the same reduction with sodium borohydride, was isolated
in small yield by gel filtration, and the effluent volume
suggests an apparent molecular weight of about 4,000. The
analysis by gas-liquid chromatography indicated the presence
of both carbohydrate and amino acid residues and was consistent




Fractionation of anti-epiglycanin antiserum from the
rabbit on a column of DEAE cellulose yielded four major
protein peaks. The first peak (I) was eluted with 0.01 M
phosphate buffer. Antibody activity was present in the
fractions constituting this peak. Elution wit.h 0.02 M
phosphate buffer (pH 6.2) gave rise to two protein peaks,
(II) and (III). Peak (II) exhibited weak antibody activity; peak
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(Ill) possessed no detectable activity. Elution with 1.0 M
NaCl produced a large protein peak (IV), which possessed
antibody activity. Based upon earlier reports (Fahey,
1967) , it was expected that IgG class antibodies would be
found in peak (I), and that IgM class antibodies would be
present in peak (IV).
The relative apparent molecular weight of antibodies
present in peak (I) was compared with those in peak (IV) by
elution from the same Sephadex G-200 column. Antibody
activity in peak (I) was eluted in the 40-60-ml fraction of
effluent (Figure 7A), and that in peak (IV) was eluted in
the 31-33 ml fraction (Figure 7B). These elution volumes
are consistent with the behavior on a Sephadex G-200 gel
filtration column of IgG and IgM molecules, respectively
(Fireman e£ al_. , 1963) .
B. Immunoprecipitation of antibody
Incubation of rabbit anti-epiglycanin antiserum with
either goat anti-rabbit-IgG (y-chain) anti-rabbit IgM (y-chain)
antiserums resulted in the loss of 54-57% of the antigen-
binding activity (Table IV). Incubation with goat anti-IgA
(a-chain) antiserum' resulted in only a 16-18% .loss of activity.
Based upon the results of this experiment, as well as those
of the fractionation experiments, it appears that anti-epiglycanin
antibody activity is distributed approximately equally
between the IgG and IgM classes of rabbit antibodies.
DISCUSSION
The surfaces of mammalian cells are generally composed
of many different types of macromolecules with potential
antigenic activity. It was thus fortuitous that injection
of mice or rabbits with TA3-Ha mouse mammary carcinoma
ascites cells emulsified in Freund's complete adjuvant
initiated a strong immune response to at least one of the
glycoproteins, epiglycanin, of the tumor cell surface. This
success may be due to the dominant position occupied by
epiglycanin at the surface of the TA3-Ha cell. Epiglycanin
is not only the most abundant glycoprotein at the surface of
the TA3-Ha cell, but probably possesses the greatest molecular
weight and molecular length (Codington et al_. , 1979) , factors
which may enhance its immunogenic activity in intact cells.
The evidence (Tables II and III) suggests that both the
carbohydrate and protein moieties of epiglycanin are required
for binding the antibody. The involvement of carbohydrate
in the antigenic determinant is strongly supported by the
observations (Table II) that both periodate oxidation and
incubation with endo-N-acetyl-a-D-galactosaminidase (D. pneumoniae)
destroy the binding activity of epiglycanin. This enzyme
was shown to be free of proteases (Umemoto et al., 1978).
-22-
In a study of its action on epiglycanin (Bhavanandan §
Codington, 1982) evidence was obtained that only one type of
carbohydrate chain, the disaccharide, 2-acetamido-2-deoxy-3-
O-g-D-galactopyranose (Fig. 5,1) was cleaved by the enzyme.
Approximately 801 of the total number of chains of this type
(van den Eijnden et_ al_. , 1979) were cleaved in the incubations.
A similar specificity had been demonstrated for synthetic
substrates (Umemoto e_t eQ. , 1978) . The observation that
none of the other glycosyl hydrolases used in these experiments
reduced the binding activity (Table II) was consistent with
the involvement of the disaccharide (Fig. 5,11) since none
of these enzymes had been found to be capable of cleaving
the galactose-N-acetylgalactosamine linkage in the disaccharide
(van den Eijnden et al. , 1979). The enhancement of binding
of epiglycanin to the anti-epiglycanin antibody after neuramini
treatment may be due to the exposure by this treatemnt of
about 20% more disaccharide chains in the molecule (van den
Eijnden et_ aJ. , 1979).
Since the structures of both 0-glycosyl (van den Eijnden
et al. , 1979) and N-glycosyl (Frim et al., in preparation)
chains in epiglycanin have been established, it was possible
to anticipate the probable effect of each of the enzymes
(Table II) on the carbohydrate structure. Thus, the 3-D
galactosidase used was incapable of cleaving the 0-D-
galactopyranosyl moiety in the disaccharide (Fig. 5) but was
able to remove the 3-D-galactopyranosyl group from a lactosamine-
type structure present in tetrasaccharide or desialyated
hexasaccharide chains (van den Eijnden et al., 1979), or
from a similar structure in an N-glycosyl-linked chain (Li,
1979), if this were present. The failure of the a-D-
mannosidase, the 0-D-galactosidase and the 0-D-hexosaminidase
to reduce inhibitory activity strongly supports the conclusion
that N-glycosyl-linked chains are not involved in the
antigenic determinant.
Since the carbohydrate structure (Fig. 5,1) probably
involved in the binding of the antibody is commonplace in
mammalian glycoproteins (van den Eijnden, 1979) , at least
two additional factors may play a role in the antigen-
antibody interaction, namely, an unusual amino acid sequence
at the site of the carbohydrate chain attachment and a
relatively easy accessibility of the binding site to the
antibody. Two types of evidence suggest strongly that a
peptide moiety is a requirement for binding activity. From
Table III it can be noted that little or no inhibitory
activity was found for the isolated disaccharide (Fig. 5,1)
the reduced disaccharide, or the disaccharide attached to a
single amino acid (serine or threonine). Furthermore, the
so-called antifreeze glycoprotein (Osuga § Feeney, 1978)
was found to be without activity, even though this material
consists of repeated disaccharide units, each attached to
the threonine residue of a repeating tripeptide unit. None
of the glycoproteins listed in Table I exhibited an inhibitory
activity comparable to that of epiglycanin. The most active
of these, the asialo-bovine lubricating glycoprotein (Garg
et al. , 1980) was reported to possess a high concentration
of disaccharide (Fig. 5,11) chains. Other active glycoproteins,
such as asialoglycophorin (Tomita et. al_. , 1978) , asialofetuin
(Spiro § Bhoyroo, 1974), and the glycoproteins from rat
mammary carcinoma ascites cells (Carraway e^t al. , 1980) ,
were each reported to contain the same disaccharide as found
in epiglycanin. Since the amino acid sequence of epiglycanin
is not yet known, it is not known whether or not regions of
amino acid sequence homologies exist in epiglycanin and
other molecules which bind the antibody.
It is of interest that a lectin from Vicia graminea
beans appears to bind, with a high degree of specificity, a
similar or related structure in epiglycanin (Cooper et_ al. ,
1974; Codington et al., 1975). This lectin has also been
reported to bind to the disaccharide (Fig. 5,11) present in
a glycoprotein of the human erythrocyte surface (Uhlenbruck
8 Dahr, 1971). Furthermore, the binding was reported to be
dependent upon a specific amino acid sequence at the amino
terminal of the polypeptide chain (Duk § Lisowska, 1981; Duk
et al., 1982). Further experimentation will be required to
determine whether or not the antibody and the lectin bind to
the same receptor site in epiglycanin.
The same disaccharide as illustrated in Fig. 5,11, at
the human erythrocyte surface, following removal of the
sialic acid with neuraminidase, is known as the Thomsen-
Friedenreich antigen (Vaith § Uhlenbruck, 1978). Little
information appears to be available regarding the possible
involvement of amino acids in the antigenic determinant for
the Thomsen-Friedenreich antigen. In a recent paper (Bray
et al., 1981), however, it was reported that a synthetic
hapten, 8-methoxycarbonyloctyl 2-acetamido-2-deoxy-3-0-g-D-
galactopyranosyl-a-D-galactopyranoside, a derivative of the
.disaccharide (Fig. 5,1) when coupled to bovine serum albumin,
induced antibody in the rabbit which was capable of agglutinating
neuraminidase-treated human erythrocytes. The possible
relationship between the antibody induced by the synthetic
hapten and that induced by epiglycanin may be of significance
in view of the reports (Springer e_t al. , 19 77^; 1979) that
the Thomsen-Friedenreich antigen occurs at the cell surfaces
in human mammary carcinoma tissue, but not in normal tissue.
This finding, however, has been contradicted by others
(Newman et al., 1979; Klein et al., 1979).
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The presence at the tumor cell surface of high concentrations
of endogenous O-glycoproteins of high molecular weight is
associated with allotransplantability (Codington et_ al^. ,
1973; Sanford et_ al_. , 1973 ; Codington, 1980 ; Codington &
Frim, 1982) and metastatic properties (Cooper et_ a]U , 1977)
in mouse mammary carcinomas, metastatic properties (Carraway
et al. , 1978) and xenotransplantability (Buck et_ al^. , 1979;
Sherblom et al., 1980) in rat mammary carcinomas, and metastatic
properties in the B 16 mouse melanoma (Bhavanandan & Davidson,
1976), in the HM7 human melanoma (Bhavanandan et_ al_. , 1981;
Umemoto et_ al^. , 1981) , and in MDA-MB-231 human metastatic
mammary carcinoma cells in culture (Walker-Nasir et_ al_. ,
1982). In the mouse mammary carcinoma and melanoma, and the
human MDA-MB-231 cells, the O-glycoproteins were characterized
by the probable presence of the same disaccharide chain
(attached to serine or threonine) that is present in epiglycanin.
The results suggest that a relationship exists between the
presence of cell-surface O-glycoproteins and the capacity of
tumor cells to escape the immune defense of the host. The
125
radioimmunoassay with anti-epiglycanin antibody and I-epiglycanin
described herein offers a means for investigating O-glycoproteins
at the surfaces of tumor cells, particularly those with
epiglycanin-related O-glycosyl-linked carbohydrate chains.
-27 -
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Table I. Amounts of glycoproteins and neuraminidase-treated
125
glycoproteins required to inhibit the reaction of I-epiglycanin




Epiglycanin (Fr. II, ascites fluid) ++++ 2
+ Neuraminidase ++++ 0.5
Epiglycanin (Fr. A, cleaved by protease ++++ 1.5
+ Neuraminidase ++++ 0.3
ASGP-BI (Rat mammary carcinoma) ++ 1,700
+ Neuraminidase ++ 1,700
ASGP-C1 (Rat mammary carcinoma) ++ 2,100
+ Neuraminidase ++ 2,000
Carcinoembryonic antigen (CEA) + 40,000
Bovine lubricating glycoprotein (LPG-I) + 5,000
+ Neuraminidase ++ >500
Glycophorin - >5,000
+ Neuraminidase + >5,000—
v.
Fetuin - >5,000
+ Neuraminidase + >5,000—
-Acid glycoprotein - >5,000
+ Neuraminidase - >5,000
-29-
Antifreeze glycoprotein - >5,000
Porcine submaxillary mucin + >30,000—
Bovine submaxillary mucin + >30,000—
—After incubating samples (50 yl) with anti-epiglycanin antiserum
(100 yl, 1 :1600), then incubating with 1251-epiglycanin (50 yl, 2 ng),
they were incubated with normal rabbit serum (200 yl, 1:50) and
goat anti-rabbit antiserum (150 yl). After incubation, the
mixtures were centrifuged, and the radioactivities of the
supernatants and residues determined. Values were calculated
from a standard curve produced with epiglycanin.




Table II. Effect of various treatments on the inhibitor^




Epiglycanin (Fr. II, untreated) 100%
Periodate oxidation 0%
Neuraminidase (V. cholerae) 150-500%
TPCK-trypsin 100-200%
N-Acetyl-a-D-galactosaminidase (C. lampas) 100%
N-Acetyl-a-D-galactosaminidase (C. perfringens) 100%
N-Acetyl-a-D-galactosaminidase (pig liver) 100%
Endo-N-Acetyl-a-D-galactosaminidase (D. pneumonia) 1%
1. Neuraminidase (V. cholerae)— 100%
2. g-D-Galactosidase (C. ensiformis)— 100%
3. g-D-Hexosaminidase (C. ensiformis)— 100%
4. a-D-Mannosidase (C. lampas)— 100%
—Independent incubations were made with each enzyme. Also, epiglycanin
was treated in the sequence 1-4 with each enzyme, and aliquots were
tested after each incubation.
Table III. Capacity of various oligosaccharides or modified
oligosaccharides present, or related to those present, in epiglycanin
125






@ -D-Galg_- (1+3) -D-GalNAc >500
6 -D-Galg_- (1+3) -a-D-GalNAc - (1+3) -Ser-Tosyl >9,000
0 -D-Galj3- (1+3) -a-D-GalNAc- (1+3) -Thr >400 ,000
0-D-Gal£-(l+4)-D-GlcNAc >5 ,000
Me a-D-GalNAc >5 ,000
[ 0 - D-Gal£- (1+3) - at -D-GalNAc - (1+3) -Thr-Ala-Ala] >5,000
0-D-Gal£- (1+3)-D-GalNAc-ol 43 ,000
a-D-NeuNAc-(2+3)-0-D-Gal£-(1+3)-D-GalNAc*ol 33 ,000
0 - D-Galg_- (1+4) - 0 - D-G1cNAc£- (1+3) - 0-D-Gal£-(1+3) -D-GalNAc • ol— >18 ,000
Glycopeptide "BH" 16 ,000
Asialoglycopeptide "BH" 8 ,000
—Structure not rigorously established.
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Figure 1A: Induction of anti-epiglycanin antibody in two
C57BL mice. An initial injection of 105 TA3-Ha cells with
Freund's complete adjuvant (V, Day 0) was followed by
injections (T) of 10^ cells in the tail vein at approximately
7-day intervals. Blood was obtained at two-week intervals,
and the sera tested for activity in the radioimmunoassay, as
illustrated by the broken and solid bars. All sera were
tested for antigen-binding activity at a dilution of 1:60.
Figure IB: Induction of anti-epiglycanin antibody in one
rabbit. An initial injection (V, day 0) of 1.2 x 107 TA3-Ha
ascites cells emulsified in Freund's complete adjuvant was
followed by intravenous injections (T) of 2 x 10^ cells. A
single intravenous injection of 120 yg of epiglycanin in PBS
CO) was also given. Blood was obtained prior to injections,
and the sera were compared for the presence of antigen-binding
activity; all sera were tested at a dilution of 1:1600.
Results are illustrated by the broken bars.
12S
Figure 2. Binding of I-epiglycanin (2 ng, SO yl) to
mouse anti-epiglycanin antibody in 2-fold dilutions of the
antiserum (100 yl). Normal mouse serum (100 yl, 1:50) and
rabbit anti-mouse antiserum (75 yl) were added to coprecipitate
the epiglycanin-anti-epiglycanin antibody complexes.
125
Figure 3. Binding of 3 ng of I-epiglycanin by two samples
of rabbit anti-epiglycanin antiserum obtained at days 482
and 512 (see Figure IB) is shown by the two curves. Normal
rabbit serum and goat antirabbit antiserum were added to
coprecipitate the epiglycanin-anti-epiglycanin antibody
complexes.
Figure 4. Inhibition curves obtained by adding various
amounts of epiglycanin in 50 yl volumes to 100 yl of rabbit
anti-epiglycanin antiserum (1:1000; 0 0) or 100 yl of
mouse anti-epiglycanin antiserum (1:60; A A). In each
125
experiment, approximately 2 ng of I-epiglycanin was used.
The rabbit and mouse antiserums were tested with different
12 5
batches of I-epiglycanin, which differed in specific activity.
Figure 5. Structure of the disaccharide chain: I, 2-acetamido-
2-deoxy-3-0-8-D-galactopyranosyl-a-D-pyranose; II, attached
to serine or threonine residues in the polypeptide chain.
This glycopeptide structure appears to be part of the antigenic
determinant against which anti-epiglycanin antibody is
directed.
-44-
Figure 6. Fractionation of endo-N-acetyl-a-D-galactosaminidase-
treated asialo-epiglycanin on a column (1.0 x 110 cm) of
Bio-Gel P-100. Fractions (2.0 ml) were tested for inhibition
125of the binding of I-epiglycanin by anti-epiglycanin
antiserum in the radioimmunoassay. The effluent volume of
the untreated asialo epiglycanin is represented by a.
b, Represents the effluent volume of the disaccharide (Fig. 5,1)
as determined by a separate fractionation on the same column.
Figure 7. Gel filtration on a Sephadex G-200 column (1.0 x
111 cm) with 0.2 M sodium chloride as eluent. Upper figure
(A): The first protein peak obtained by DEAE-cellulose
chromatography of rabbit anti-epiglycanin antiserum (eluted
with 0.01 M phosphate, pH 7.5). Lower figure (B) : Fractionation
on the same Sephadex G-200 column of material (peak IV)
e'luted from the DEAE-cellulose column with 1.0 M sodium
chloride. Solid lines indicate protein concentration (mg/ml
125
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